Citrus Sinensis ID: 008607
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 560 | 2.2.26 [Sep-21-2011] | |||||||
| Q8W4J2 | 567 | Mitogen-activated protein | yes | no | 0.991 | 0.978 | 0.819 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | yes | no | 0.962 | 0.994 | 0.790 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | yes | no | 0.885 | 0.995 | 0.823 | 0.0 | |
| Q5ZCI1 | 611 | Mitogen-activated protein | no | no | 0.894 | 0.819 | 0.739 | 0.0 | |
| Q9SJG9 | 606 | Mitogen-activated protein | no | no | 0.898 | 0.830 | 0.714 | 0.0 | |
| Q5SN53 | 569 | Mitogen-activated protein | no | no | 0.901 | 0.887 | 0.661 | 0.0 | |
| Q9LV37 | 510 | Mitogen-activated protein | no | no | 0.801 | 0.880 | 0.784 | 0.0 | |
| Q67C40 | 569 | Mitogen-activated protein | no | no | 0.867 | 0.854 | 0.683 | 0.0 | |
| Q9C9U4 | 576 | Mitogen-activated protein | no | no | 0.733 | 0.713 | 0.785 | 0.0 | |
| Q6L5F7 | 582 | Mitogen-activated protein | no | no | 0.737 | 0.709 | 0.786 | 0.0 |
| >sp|Q8W4J2|MPK16_ARATH Mitogen-activated protein kinase 16 OS=Arabidopsis thaliana GN=MPK16 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 955 bits (2468), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/572 (81%), Positives = 506/572 (88%), Gaps = 17/572 (2%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPD RKKSS +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTD+LGTPS EAI RVRNEKARRYLSSMRKKKPIPFS KFP+ +PLALRLLE+ML+FE
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALAD YFKGLAKVEREPSAQPVTK+EFEFERRRITKEDVRELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPER-QHASLPRPCVLY 419
P+MLKE+L+GSEPT FMYPSAV+HFKKQFAYLEEHY GT+ PPER QHASLPR CVLY
Sbjct: 361 PKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVLY 420
Query: 420 SDKT----VQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQGA--ARPG 473
SD Q+SA VTD LSKCSI++ DR + +PM+R+PI VPQ +QGA ARPG
Sbjct: 421 SDNNHPVAQQSSAEVTDGLSKCSIRDERPRGADRNAQMPMSRIPINVPQTIQGAAVARPG 480
Query: 474 KVVSSVLRYNNCGAAAAAEALD--QRRVVRNPAVSTQYAASSYPRRSSACKNERVNDE-- 529
KVV SVLRYNNCGAA EAL+ QRR+VRNPA AAS YP+R+ CK+ R +++
Sbjct: 481 KVVGSVLRYNNCGAATGVEALEQQQRRMVRNPA-----AASQYPKRTQPCKSNRGDEDCA 535
Query: 530 -SVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 560
+ EG + L+P QYI +KV+AAQ + S WY
Sbjct: 536 TAAEGPSRLKPNTQYIPQKVSAAQDTAMSRWY 567
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 906 bits (2341), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/550 (79%), Positives = 484/550 (88%), Gaps = 11/550 (2%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
+DFFTEYGEG+RYKIEEVIGKGSYGVVCSA DT TG+KVAIKKINDIFEHVSDATRILRE
Sbjct: 1 MDFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILRE 60
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 120
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF+DTPTAIFWTDY+AT
Sbjct: 121 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI+TDLLGTPSP
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSP 240
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
E I+R+RNEKARRYL+SMR+KKPIPF+QKFPNA+PLA+RLLERMLAF+PKDRP+AEEALA
Sbjct: 241 ETISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEALA 300
Query: 313 DPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSE 372
DPYFK +A V+REPSAQP+TK+EFEFERRRITKED+RELIYREILEYHP+ML+EFLEG+E
Sbjct: 301 DPYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGTE 360
Query: 373 PTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTD 432
TGFMYPSAVDHFKKQFAYLEEHY KG+T APPERQH SLPRPCV+YSD Q++A+VT+
Sbjct: 361 STGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPCVVYSDNRPQSTASVTE 420
Query: 433 DLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQGAARPGKVVSSVLRYNNCGAAAAAE 492
DLS+C I++ D S + +R +PQG AARPGK V SVLRY NC +AA +
Sbjct: 421 DLSRCLIRDNNLKSQDSAS-VGASR----IPQG--AAARPGKAVGSVLRYGNCSTSAAEQ 473
Query: 493 ALDQRRVVRNPAVSTQYA---ASSYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVA 549
+QRRVVRNPA++ + SSYPRR+ CK+E + E ++ S PKP Y+A K+
Sbjct: 474 QYEQRRVVRNPAIAPNSSVPLGSSYPRRNQTCKSETGDVERIDSSQTGPPKP-YVANKLP 532
Query: 550 AAQGGSGSNW 559
A G +W
Sbjct: 533 ATVDGRSGHW 542
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 862 bits (2227), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/505 (82%), Positives = 451/505 (89%), Gaps = 9/505 (1%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
+DFFTEYGEG+RYKIEEVIGKGSYGVVCSA DT TGEKVAIKKINDIFEHVSDATRILRE
Sbjct: 1 MDFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILRE 60
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 120
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF+DTPTAIFWTDYVAT
Sbjct: 121 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI+TDLLGTPS
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPST 240
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
EAI+R+RNEKARRYLSSMR+KKPIPF+QKFPNA+PLALRLLERML+FEPKDRP AEEALA
Sbjct: 241 EAISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEALA 300
Query: 313 DPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSE 372
DPYF+ +A V+REPSAQPVTK+EFEFERRRITKED+RELIYR+ILEYHP ML+E+LEG+E
Sbjct: 301 DPYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGTE 360
Query: 373 PTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTD 432
GFMYPSAVDHFKKQFAYLEEHY KG+T APPERQH SLPRP VLYSD QN+A + +
Sbjct: 361 SAGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPSVLYSDDRPQNTANIAE 420
Query: 433 DLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQGAARPGKVVSSVLRYNNCGAAAAAE 492
DLSKC + + + ++ + R VPQG GAARPGKVV S LRY NC + + AE
Sbjct: 421 DLSKCVLGDNTQKMHQGSASVCANR----VPQG--GAARPGKVVGSALRYGNC-STSTAE 473
Query: 493 ALDQRRVVRNPAVSTQYAA--SSYP 515
+ RR RNPA++T + SYP
Sbjct: 474 QYEHRRTDRNPALATNTVSPRGSYP 498
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5ZCI1|MPK10_ORYSJ Mitogen-activated protein kinase 10 OS=Oryza sativa subsp. japonica GN=MPK10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 744 bits (1921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/510 (73%), Positives = 425/510 (83%), Gaps = 9/510 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ DQRKKSS + DFFTEYG+ SRYKI+EVIGKGSYGVVCSA D TGEKVAIKKI+DIF
Sbjct: 1 MQQDQRKKSSTEADFFTEYGDASRYKIQEVIGKGSYGVVCSAIDVHTGEKVAIKKIHDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILREIKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILAN++CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANSNCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS + I+RVRN+KARRYLSSMRKK+PI FSQKFP+A+PLAL LL+++LAF+
Sbjct: 241 DLMTDLLGTPSMDTISRVRNDKARRYLSSMRKKEPILFSQKFPSADPLALDLLQKLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALA PYFKGLAKVEREPS QP+TKMEFEFERRR+TKED+RELI+REILEYH
Sbjct: 301 PKDRPTAEEALAHPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
PQ+LK+++ G+E T F+YPSAVD F+KQFA+LEE+ G G V P +R+H SLPR +++S
Sbjct: 361 PQLLKDYINGTERTTFLYPSAVDQFRKQFAHLEENGGNG-PVIPMDRKHTSLPRSTIVHS 419
Query: 421 DKT-VQNSAAVTDDLSKCSIKEVEKP-PMDRTSGIPMARLPIQVPQGMQGAARPGKVVSS 478
+ + K S + P DR SG A Q PQ + ARPG+VV
Sbjct: 420 TPIPAKEQPRIGPSRDKPSDEPYSNPREFDRFSG--NAPRTSQAPQRVP-TARPGRVVGP 476
Query: 479 VLRYNNCGAAAAAEALDQRRVVRNPAVSTQ 508
VL Y N A ++ D RR+ N Q
Sbjct: 477 VLPYEN---GATKDSYDARRLAMNSGYPPQ 503
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9SJG9|MPK20_ARATH Mitogen-activated protein kinase 20 OS=Arabidopsis thaliana GN=MPK20 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/514 (71%), Positives = 423/514 (82%), Gaps = 11/514 (2%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ D RKK++ +++FF++YG+ +R+K++EVIGKGSYGVVCSA DT TGEKVAIKKI+DIF
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILREIKLLRLLRHPDIVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAE+L GKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS + I+RVRNEKARRYL+SMRKK PIPF+QKFPNA+PL+L+LLER+LAF+
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREPS QP+TKMEFEFERR++TKED+RELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
PQ+LK+ + G++ F+YPSAVD F++QFA+LEE+ GK VAP ER+HASLPR V++
Sbjct: 361 PQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIH- 419
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQGAARPGKVVSSVL 480
S AV + + T IP IQ Q AA+P + V
Sbjct: 420 ------STAVARGGQPKLMNNTNTLNPETTQNIPFNHATIQAQQRNLSAAKPSTFMGPVA 473
Query: 481 RYNNCGAAAAAEALDQRRVVR--NPAVSTQYAAS 512
++N + +A D R +R N S Q AA+
Sbjct: 474 PFDN--GRISRDAYDPRSFIRSTNLPFSQQSAAT 505
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5SN53|MPK8_ORYSJ Mitogen-activated protein kinase 8 OS=Oryza sativa subsp. japonica GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 736 bits (1900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/541 (66%), Positives = 431/541 (79%), Gaps = 36/541 (6%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
+DFF+EYG+ +RYKI+EVIGKGSYGVVCSA D TG+KVAIKKI++IFEH+SDA RILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
IKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELM++DLHQVIKANDDLT EH+QFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFL 120
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQ+LR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDTPT +FWTDYVAT
Sbjct: 121 YQMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
RWYRAPELCGSFF+KY+PAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD+MTDLLGTPS
Sbjct: 181 RWYRAPELCGSFFTKYSPAIDIWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+ + R+RNEKARRYLSSMRKK+P+PFS++FP A+P AL+LL+R+LAF+PKDRPTAEEALA
Sbjct: 241 DTVTRIRNEKARRYLSSMRKKQPVPFSERFPKADPAALKLLQRLLAFDPKDRPTAEEALA 300
Query: 313 DPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSE 372
DPYFKGLAK EREPS QP+TKMEFEFERR++TKEDV+ELI+REILEYHPQ+LK+++ G+E
Sbjct: 301 DPYFKGLAKAEREPSCQPITKMEFEFERRKVTKEDVKELIFREILEYHPQLLKDYMNGTE 360
Query: 373 PTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTD 432
T F+YPSA+D+F++QFA LEE+ GK P +R+H SLPR T +SA +
Sbjct: 361 KTNFLYPSALDNFRRQFANLEENGGKNGDAVPSDRKHVSLPR-------TTTVHSAPI-- 411
Query: 433 DLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQGAARPGKVVSSVLRYNNCGAAAAAE 492
PP D + + QVPQ + G R G+ V+ + N A
Sbjct: 412 ------------PPKDHQN------ITSQVPQRIPG--RTGRGACPVIPFENLSAMG--- 448
Query: 493 ALDQRRVVRNPAV---STQYAASSYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVA 549
+QRRVVRNP + +T +A +Y R+S + + E + E + QP ++ KV
Sbjct: 449 PYNQRRVVRNPVLPPATTNLSAYAYHRKSDSSERE-LQQELEKDRMRYQPSEHFMDAKVV 507
Query: 550 A 550
+
Sbjct: 508 S 508
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LV37|MPK9_ARATH Mitogen-activated protein kinase 9 OS=Arabidopsis thaliana GN=MPK9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 725 bits (1872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/450 (78%), Positives = 395/450 (87%), Gaps = 1/450 (0%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
D KK + + +FFTEYGE SRY+I+EVIGKGSYGVV SA DT +GEKVAIKKIND+FEHV
Sbjct: 2 DPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHV 61
Query: 64 SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
SDATRILREIKLLRLLRHPDIVEIKH++LPPSRREF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 62 SDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 121
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
TPEHYQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARV+FND P+A
Sbjct: 122 TPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSA 181
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDIM
Sbjct: 182 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIM 241
Query: 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 303
TDLLGTP PEAIAR+RNEKARRYL +MR+K P+PF+ KFP+ +PLALRLL R+LAF+PKD
Sbjct: 242 TDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKD 301
Query: 304 RPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 363
RP+AEEALADPYF GLA V+REPS QP+ K+EFEFERR+ITKEDVRELIYREILEYHPQM
Sbjct: 302 RPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQM 361
Query: 364 LKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKT 423
L+E+L G E T FMYPS VD FK+QFA+LEE+YGKG +P +RQHASLPR V K
Sbjct: 362 LQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERVPAPKKE 421
Query: 424 VQNSAAVTDDLSKCS-IKEVEKPPMDRTSG 452
+ ++ S S + +E PP + G
Sbjct: 422 NGSHNHDIENRSIASLVTTLESPPTSQHEG 451
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q67C40|MPK7_ORYSJ Mitogen-activated protein kinase 7 OS=Oryza sativa subsp. japonica GN=MPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 715 bits (1846), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/521 (68%), Positives = 423/521 (81%), Gaps = 35/521 (6%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
+DFF+EYG+ SRYKI+E++GKGSYGVVCSA D TG+KVAIKKI++IFEH+SDA RILRE
Sbjct: 1 MDFFSEYGDSSRYKIQEIVGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
IKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELM++DLHQVIKANDDLT EH+QFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFL 120
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQ+LR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDTPT +FWTDYVAT
Sbjct: 121 YQMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
RWYRAPELCGSFFSKY+PAID WSIGCIFAE+LTGKPLFPGKNVVHQLD+MTDLLGTPS
Sbjct: 181 RWYRAPELCGSFFSKYSPAIDTWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+AI+R+RN+KARRYLSSMR+K+P+PFS+KFPN +PLAL+LL+R+LAF+PKDRPTAEEALA
Sbjct: 241 DAISRIRNDKARRYLSSMRRKQPVPFSEKFPNVDPLALKLLQRLLAFDPKDRPTAEEALA 300
Query: 313 DPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSE 372
DPYFKGLAKVEREPS QP++KMEFEFERR++TK+D++ELI+REILEYHPQ+LK+++ GSE
Sbjct: 301 DPYFKGLAKVEREPSCQPISKMEFEFERRKVTKDDIKELIFREILEYHPQLLKDYMNGSE 360
Query: 373 PTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTD 432
T F+YPSAVD+F++QFA LEE+ GK + +R+H SLPR ++S N
Sbjct: 361 NTSFLYPSAVDNFRRQFAILEENGGKSGAL---DRKHVSLPRATTVHSTSIPPNEG---- 413
Query: 433 DLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQGAARPGKVVSSVLRYNNCGAAAAAE 492
+D TS + R+P ARPG+ V VL + N GAA
Sbjct: 414 --------------LDATSQV-TQRIP---------TARPGRTVGPVLPFENPGAADPHS 449
Query: 493 ALDQRRVVRNPAVSTQYA-ASSYPRRSSACKNERVNDESVE 532
A RRVVRNP V A S Y + ++R + E +E
Sbjct: 450 A---RRVVRNPMVPPAAANKSGYSYNLKSDYSDRQHQEELE 487
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9C9U4|MPK15_ARATH Mitogen-activated protein kinase 15 OS=Arabidopsis thaliana GN=MPK15 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 710 bits (1833), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/411 (78%), Positives = 371/411 (90%)
Query: 7 KKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA 66
KK + +FFTEYGE +RY+I+EV+GKGSYGVV SA DT TGE+VAIKKIND+F+H+SDA
Sbjct: 72 KKGIPNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDA 131
Query: 67 TRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 126
TRILREIKLLRLL HPD+VEIKHI+LPPSRREF+D+YVVFELMESDLHQVIKANDDLTPE
Sbjct: 132 TRILREIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPE 191
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186
H+QFFLYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARV+FND PTAIFW
Sbjct: 192 HHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFW 251
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
TDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQLDIMTD
Sbjct: 252 TDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDF 311
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
LGTP PEAI+++RN+KARRYL +MRKK+P+PFS+KFP A+P ALRLLER++AF+PKDRP+
Sbjct: 312 LGTPPPEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPS 371
Query: 307 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKE 366
AEEALADPYF GL+ REPS QP++K+EFEFER+++TK+D+RELIYREILEYHPQML+E
Sbjct: 372 AEEALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEE 431
Query: 367 FLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCV 417
+L G FMYPS VD F++QFA+LEE+ G G +RQHASLPR V
Sbjct: 432 YLRGGNQLSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQHASLPRERV 482
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5F7|MPK17_ORYSJ Mitogen-activated protein kinase 17 OS=Oryza sativa subsp. japonica GN=MPK17 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 709 bits (1829), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/413 (78%), Positives = 373/413 (90%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
+P + S + DFFTEYGE +RYK+ EVIGKGSYGVV +A DT+TGE+VAIKKIND+F+
Sbjct: 82 EPRRMDPSKKEPDFFTEYGEANRYKVSEVIGKGSYGVVAAAVDTQTGERVAIKKINDVFD 141
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND 121
HVSDATRILREIKLLRLLRHPDIVEIKHI+LPPSRREF+DIYV+FELMESDLHQVIKAND
Sbjct: 142 HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVIFELMESDLHQVIKAND 201
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
DLTPEH+QFFLYQLLRG+KYIH A+VFHRDLKPKNILANADCKLK+CDFGLARV+FNDTP
Sbjct: 202 DLTPEHHQFFLYQLLRGMKYIHAASVFHRDLKPKNILANADCKLKVCDFGLARVSFNDTP 261
Query: 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
+AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAELLTGKPLFPGKNVVHQLD
Sbjct: 262 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAELLTGKPLFPGKNVVHQLD 321
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 301
+MTDLLGTPS E++A++RNEKARRYLS+MRKK +PF++KFP +P+AL LLER+LAF+P
Sbjct: 322 LMTDLLGTPSAESLAKIRNEKARRYLSNMRKKPRVPFTKKFPGVDPMALHLLERLLAFDP 381
Query: 302 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
KDRP+AEEAL DPYF GLA EREP AQP++K+EFEFE+R++ K+DVRELIYREILEYHP
Sbjct: 382 KDRPSAEEALTDPYFNGLANSEREPIAQPISKLEFEFEKRKLAKDDVRELIYREILEYHP 441
Query: 362 QMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPR 414
ML+E+L G + FMYPS VD FK+QFA+LEE KG +P RQ+ASLPR
Sbjct: 442 HMLQEYLRGGDQMSFMYPSGVDRFKRQFAHLEEGVSKGEKSSPQLRQNASLPR 494
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 560 | ||||||
| 224107249 | 562 | predicted protein [Populus trichocarpa] | 0.998 | 0.994 | 0.912 | 0.0 | |
| 224102587 | 562 | predicted protein [Populus trichocarpa] | 0.998 | 0.994 | 0.909 | 0.0 | |
| 359477479 | 563 | PREDICTED: mitogen-activated protein kin | 1.0 | 0.994 | 0.904 | 0.0 | |
| 255551501 | 564 | big map kinase/bmk, putative [Ricinus co | 1.0 | 0.992 | 0.904 | 0.0 | |
| 356549019 | 563 | PREDICTED: mitogen-activated protein kin | 0.998 | 0.992 | 0.893 | 0.0 | |
| 449454432 | 565 | PREDICTED: mitogen-activated protein kin | 0.998 | 0.989 | 0.890 | 0.0 | |
| 449523117 | 565 | PREDICTED: LOW QUALITY PROTEIN: mitogen- | 0.998 | 0.989 | 0.888 | 0.0 | |
| 356555610 | 561 | PREDICTED: mitogen-activated protein kin | 0.994 | 0.992 | 0.888 | 0.0 | |
| 297748113 | 554 | mitogen-activated protein kinase 16 [Gos | 0.985 | 0.996 | 0.882 | 0.0 | |
| 357447643 | 564 | Mitogen activated protein kinase 16-2 [M | 0.998 | 0.991 | 0.897 | 0.0 |
| >gi|224107249|ref|XP_002314421.1| predicted protein [Populus trichocarpa] gi|222863461|gb|EEF00592.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1069 bits (2765), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/563 (91%), Positives = 536/563 (95%), Gaps = 4/563 (0%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQRKKSS D+DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDT GEKVAIKKINDIF
Sbjct: 1 MQPDQRKKSSVDIDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTHIGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA+PLALRLLERMLAFE
Sbjct: 241 DLMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNADPLALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREP+AQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPTAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKEFL+GSEPTGFMYPSAVDHFKKQFAYLEEHYG G VAPPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEFLDGSEPTGFMYPSAVDHFKKQFAYLEEHYGNGAPVAPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQ-GAARPGKVVSSV 479
D T+Q SA VT+DLSKCSIKE+EKP +DR+ G+PM RLP+QVPQ +Q GAAR GKV SSV
Sbjct: 421 DNTIQKSAEVTNDLSKCSIKEIEKPHVDRSDGMPMTRLPLQVPQSIQAGAARSGKVASSV 480
Query: 480 LRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGL 537
LRYNNCG AAAAE LDQ+R+VRNPA+STQYA + SYPRR+ ACKNER DE VEG NGL
Sbjct: 481 LRYNNCG-AAAAENLDQQRMVRNPAISTQYATANCSYPRRNPACKNERGEDEGVEGPNGL 539
Query: 538 QPKPQYIARKVAAAQGGSGSNWY 560
QPKPQY+ARKVAAAQGG G++WY
Sbjct: 540 QPKPQYMARKVAAAQGGPGNHWY 562
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224102587|ref|XP_002312737.1| predicted protein [Populus trichocarpa] gi|222852557|gb|EEE90104.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1066 bits (2758), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/563 (90%), Positives = 536/563 (95%), Gaps = 4/563 (0%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQRKKSS DVDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT GEKVAIKKINDIF
Sbjct: 1 MQPDQRKKSSVDVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHIGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF+ELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFSELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTP+PEAIARVRNEKARRYLSSMRKKKP+PFSQKFPNA+PLALRLLERMLAFE
Sbjct: 241 DLMTDLLGTPTPEAIARVRNEKARRYLSSMRKKKPVPFSQKFPNADPLALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREP+AQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPTAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKE L+GSEPTGFMYPSAVDHFKKQFAYLEEHYG G V PPERQHASLPR CVLYS
Sbjct: 361 PKMLKEHLDGSEPTGFMYPSAVDHFKKQFAYLEEHYGNGAPVTPPERQHASLPRACVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQ-GAARPGKVVSSV 479
D T+QNSA VT+DLSKCSIKE+EKP +DR+ GIPM RLP+QVPQ +Q GAARPGKVVSSV
Sbjct: 421 DNTIQNSAEVTNDLSKCSIKEIEKPHVDRSGGIPMTRLPLQVPQSIQAGAARPGKVVSSV 480
Query: 480 LRYNNCGAAAAAEALDQRRVVRNPAVSTQY--AASSYPRRSSACKNERVNDESVEGSNGL 537
LRYNNCG A +AE LDQRR+VRNPA+STQY A SS+PRR+ ACKNER DE VEGSNGL
Sbjct: 481 LRYNNCG-APSAENLDQRRMVRNPAISTQYTTANSSHPRRNPACKNERGEDEGVEGSNGL 539
Query: 538 QPKPQYIARKVAAAQGGSGSNWY 560
QPKPQY+ARKVAAAQGG G++WY
Sbjct: 540 QPKPQYMARKVAAAQGGPGNHWY 562
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477479|ref|XP_002279719.2| PREDICTED: mitogen-activated protein kinase 16-like [Vitis vinifera] gi|297736969|emb|CBI26170.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1063 bits (2750), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/563 (90%), Positives = 535/563 (95%), Gaps = 3/563 (0%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQR+K+S +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT GEKVAIKKINDIF
Sbjct: 1 MQPDQRRKASVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHCGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSSREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS EAIARVRNEKARRYLSSMRKKKPIP SQKFPNA+PLALRLLERMLAFE
Sbjct: 241 DLMTDLLGTPSAEAIARVRNEKARRYLSSMRKKKPIPLSQKFPNADPLALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRP+AEEALADPYFKGLAKVEREPSAQPVTK+EFEFERRRITKEDVR+LIYREILEYH
Sbjct: 301 PKDRPSAEEALADPYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRDLIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKE+LEG+EPT FMYPSAVD FKKQFAYLEEHYG G TVAPPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEYLEGTEPTSFMYPSAVDQFKKQFAYLEEHYGNGATVAPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQ-GAARPGKVVSSV 479
D ++ NSA V DDLSKC IKEVEKP MDR+ GIPMARLP+QVPQ Q GAARPGKVV SV
Sbjct: 421 DNSLHNSAEVADDLSKCCIKEVEKPHMDRSCGIPMARLPLQVPQSTQGGAARPGKVVGSV 480
Query: 480 LRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGL 537
LRYNNCGAAAAAE L+QRR+VRNP V++QY AS SYPRR+S+CKNER ++E VEGSNGL
Sbjct: 481 LRYNNCGAAAAAEVLEQRRMVRNPPVASQYNASSCSYPRRNSSCKNERGDNEGVEGSNGL 540
Query: 538 QPKPQYIARKVAAAQGGSGSNWY 560
QPKPQY+ARKVAAAQGGSGS+WY
Sbjct: 541 QPKPQYMARKVAAAQGGSGSHWY 563
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255551501|ref|XP_002516796.1| big map kinase/bmk, putative [Ricinus communis] gi|223543884|gb|EEF45410.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1063 bits (2748), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 510/564 (90%), Positives = 533/564 (94%), Gaps = 4/564 (0%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQRKKSS DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDT GEKVAIKKINDIF
Sbjct: 1 MQPDQRKKSSVDVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTHIGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRG+KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGMKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA+PLAL LLERMLAFE
Sbjct: 241 DLMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNADPLALHLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PK+RPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKNRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKE+LEGSEPT FMYPSAVDHFKKQFAYLEEHYG G TVAPPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEYLEGSEPTSFMYPSAVDHFKKQFAYLEEHYGNGATVAPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQG-AARPGKVVSSV 479
D TVQ+SA V +DLSKCSIKE+EKP +DR+ GIPM RLP+QVPQ +Q AARPGKVV SV
Sbjct: 421 DNTVQSSAEVANDLSKCSIKEMEKPQVDRSGGIPMTRLPLQVPQSIQASAARPGKVVGSV 480
Query: 480 LRYNNCGAAAAA-EALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNG 536
LRYNNCGA A EAL+QRR+VRNPA+STQY A+ SYPRR+ CKNER DE VEGS G
Sbjct: 481 LRYNNCGATATTVEALEQRRMVRNPAISTQYTAANCSYPRRNPVCKNERGEDEGVEGSGG 540
Query: 537 LQPKPQYIARKVAAAQGGSGSNWY 560
LQPKPQY+ARKVAAAQGG G++WY
Sbjct: 541 LQPKPQYMARKVAAAQGGPGNHWY 564
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549019|ref|XP_003542896.1| PREDICTED: mitogen-activated protein kinase 16-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1045 bits (2702), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/564 (89%), Positives = 529/564 (93%), Gaps = 5/564 (0%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M PDQRKKSS +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MLPDQRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRG+KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGMKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS EAIARVRNEKARRYLSSMRKKKP+P SQKFPNA+PLALRLLE+MLAFE
Sbjct: 241 DLMTDLLGTPSLEAIARVRNEKARRYLSSMRKKKPVPLSQKFPNADPLALRLLEKMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKG TV PPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGGTVTPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQG-AARPGKVVSSV 479
D ++QN++ V DDLSKC IKEVEK P+D +S IPM+RLP+Q PQ +QG AARPGKVV SV
Sbjct: 421 DHSMQNTSEVADDLSKCCIKEVEKQPIDSSSAIPMSRLPLQAPQNIQGVAARPGKVVGSV 480
Query: 480 LRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDE-SVEGSNG 536
+RYNNCG A AEA +QRRVVRNP+VS QYAAS SYPRR+S K+ER +E +EGSNG
Sbjct: 481 MRYNNCGVAGTAEA-EQRRVVRNPSVSAQYAASSCSYPRRNSGYKSERGTEEGGIEGSNG 539
Query: 537 LQPKPQYIARKVAAAQGGSGSNWY 560
LQPKPQY+ARKVAAAQ G G WY
Sbjct: 540 LQPKPQYMARKVAAAQAGPGGQWY 563
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454432|ref|XP_004144959.1| PREDICTED: mitogen-activated protein kinase 16-like [Cucumis sativus] gi|449471012|ref|XP_004153181.1| PREDICTED: mitogen-activated protein kinase 16-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1036 bits (2678), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/566 (89%), Positives = 533/566 (94%), Gaps = 7/566 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQR+KSS DVDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TG+KVAIKKINDIF
Sbjct: 1 MQPDQRRKSSIDVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGDKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTD LGTP+ EAIARVRNEKARRYLSSMRKKKP+PFSQKFP+A+PLALRLLERMLAFE
Sbjct: 241 DLMTDFLGTPNAEAIARVRNEKARRYLSSMRKKKPVPFSQKFPHADPLALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKEFL+GSEPTGFMYPSAVDHFKKQFA+LEEHYG G VAPPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEFLDGSEPTGFMYPSAVDHFKKQFAFLEEHYGNGAPVAPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQG-AARPGKVVSSV 479
D VQN A V +DLSKCSIKEVE+PP+DRT IP+AR+PIQVPQ +QG ARPGKVV SV
Sbjct: 421 DNMVQNPAQVANDLSKCSIKEVERPPVDRTCNIPLARVPIQVPQSIQGNGARPGKVVGSV 480
Query: 480 LRYNNCGAAAAA---EALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGS 534
LRY NCGAAAAA E L+QRR+ RNP++ QYA + SY RR+S+CKNER ++E++EG
Sbjct: 481 LRY-NCGAAAAAVAPEVLEQRRMTRNPSIPPQYAGNNCSYTRRNSSCKNERADEEAIEGP 539
Query: 535 NGLQPKPQYIARKVAAAQGGSGSNWY 560
NGLQPKPQYIARKVAAAQGG G+NWY
Sbjct: 540 NGLQPKPQYIARKVAAAQGGPGNNWY 565
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523117|ref|XP_004168571.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase 16-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1034 bits (2673), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/566 (88%), Positives = 532/566 (93%), Gaps = 7/566 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQR+KSS DVDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TG+KVAIKKINDIF
Sbjct: 1 MQPDQRRKSSIDVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGDKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP NILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPXNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTD LGTP+ EAIARVRNEKARRYLSSMRKKKP+PFSQKFP+A+PLALRLLERMLAFE
Sbjct: 241 DLMTDFLGTPNAEAIARVRNEKARRYLSSMRKKKPVPFSQKFPHADPLALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKEFL+GSEPTGFMYPSAVDHFKKQFA+LEEHYG G VAPPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEFLDGSEPTGFMYPSAVDHFKKQFAFLEEHYGNGAPVAPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQG-AARPGKVVSSV 479
D VQN A V +DLSKCSIKEVE+PP+DRT IP+AR+PIQVPQ +QG ARPGKVV SV
Sbjct: 421 DNMVQNPAQVANDLSKCSIKEVERPPVDRTCNIPLARVPIQVPQSIQGNGARPGKVVGSV 480
Query: 480 LRYNNCGAAAAA---EALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGS 534
LRY NCGAAAAA E L+QRR+ RNP++ QYA + SY RR+S+CKNER ++E++EG
Sbjct: 481 LRY-NCGAAAAAVAPEVLEQRRMTRNPSIPPQYAGNNCSYTRRNSSCKNERADEEAIEGP 539
Query: 535 NGLQPKPQYIARKVAAAQGGSGSNWY 560
NGLQPKPQYIARKVAAAQGG G+NWY
Sbjct: 540 NGLQPKPQYIARKVAAAQGGPGNNWY 565
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555610|ref|XP_003546123.1| PREDICTED: mitogen-activated protein kinase 16-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1031 bits (2666), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/564 (88%), Positives = 526/564 (93%), Gaps = 7/564 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M PDQRKKSS +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MLPDQRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS EAIARVRNEKARRYLSSMRKKKP+PFSQKFP+A+P ALRLLERMLAFE
Sbjct: 241 DLMTDLLGTPSLEAIARVRNEKARRYLSSMRKKKPVPFSQKFPHADPRALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRETLEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKEFLEG+EPTGFMYPSAVDHFKKQFAYLEEHYGKG TVAPPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEFLEGAEPTGFMYPSAVDHFKKQFAYLEEHYGKGGTVAPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQG-AARPGKVVSSV 479
D ++QN++ V DDLSKC IKEVEK P++R+S IPM+RLP+Q PQ +QG AARP KVV SV
Sbjct: 421 DHSMQNTSEVADDLSKCCIKEVEKQPIERSSAIPMSRLPLQAPQNIQGVAARPRKVVGSV 480
Query: 480 LRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNER-VNDESVEGSNG 536
+RYNNCG A AEA +QRRVVRNP+VS QYAAS SYPRR+ KNER D+ +EGSNG
Sbjct: 481 MRYNNCGVAVTAEA-EQRRVVRNPSVSAQYAASSCSYPRRNPGYKNERGAEDDGIEGSNG 539
Query: 537 LQPKPQYIARKVAAAQGGSGSNWY 560
LQPK Y+ARKVAAAQ G G WY
Sbjct: 540 LQPK--YMARKVAAAQAGPGGQWY 561
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297748113|gb|ADI52623.1| mitogen-activated protein kinase 16 [Gossypium hirsutum] gi|297748125|gb|ADI52629.1| mitogen-activated protein kinase 16 [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 1028 bits (2659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/562 (88%), Positives = 521/562 (92%), Gaps = 10/562 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQR+KS+ADVDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MQPDQRRKSAADVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHIL PPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILFPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS EAIARVRNEKARRYLSSMRKKKPIP S KFPNA+PLA+ LLERMLAFE
Sbjct: 241 DLMTDLLGTPSAEAIARVRNEKARRYLSSMRKKKPIPLSHKFPNADPLAVLLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRP+AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKDRPSAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKE+LEGSEPTGFMYPSAVDHFKKQFA+LEEHYG GTT AP ERQHASLPRPCVLYS
Sbjct: 361 PKMLKEYLEGSEPTGFMYPSAVDHFKKQFAFLEEHYGNGTTAAPLERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQGAARPGKVVSSVL 480
D +VQNS VTD+LSKCSIKE EKP +R+ IPM+RLP QVPQ +QGAARPGKVV SVL
Sbjct: 421 DNSVQNSTDVTDNLSKCSIKETEKPQPERSFPIPMSRLPPQVPQSIQGAARPGKVVGSVL 480
Query: 481 RYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGLQ 538
RYNNCGA AA EAL+QRR+ RNP+V TQY A+ SYPRR+ CK++ N+ LQ
Sbjct: 481 RYNNCGAVAAGEALEQRRMARNPSVPTQYTATNCSYPRRNPVCKDDEENE--------LQ 532
Query: 539 PKPQYIARKVAAAQGGSGSNWY 560
PKPQY+ARKVAAAQGGS S WY
Sbjct: 533 PKPQYMARKVAAAQGGSRSQWY 554
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357447643|ref|XP_003594097.1| Mitogen activated protein kinase 16-2 [Medicago truncatula] gi|355483145|gb|AES64348.1| Mitogen activated protein kinase 16-2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1023 bits (2646), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/565 (89%), Positives = 527/565 (93%), Gaps = 6/565 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M DQRKKSS DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MSHDQRKKSSVDVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
DIMTD LGTPSP+AIARVRNEKARRYLSSMRKKKP+PFS KFPNA+PLALRLLERMLAFE
Sbjct: 241 DIMTDFLGTPSPDAIARVRNEKARRYLSSMRKKKPVPFSHKFPNADPLALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 AKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHA-SLPRPCVLY 419
P+MLKEFLEG+EPTGFMYPSAVD FKKQFAYLEEHYGKG TVAPPERQHA SLPR CVLY
Sbjct: 361 PKMLKEFLEGAEPTGFMYPSAVDLFKKQFAYLEEHYGKGGTVAPPERQHASSLPRACVLY 420
Query: 420 SDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGI-PMARLPIQVPQGMQG-AARPGKVVS 477
SD T+QN+A V DDLSKC IKEVE+PP+DR+S I PM R+P+Q PQ MQG AARPGKVV
Sbjct: 421 SDNTMQNTAEVADDLSKCCIKEVERPPVDRSSDIHPMTRIPLQAPQNMQGLAARPGKVVG 480
Query: 478 SVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSN 535
S +RYNNCG A AE +QRRVVRNP VS+QYAAS SYPRR+ K+ERV D+ +EGSN
Sbjct: 481 SAMRYNNCGVAVTAET-EQRRVVRNPPVSSQYAASSCSYPRRNPNYKSERVEDDVIEGSN 539
Query: 536 GLQPKPQYIARKVAAAQGGSGSNWY 560
GLQPKPQYIARKVAAAQGG+G WY
Sbjct: 540 GLQPKPQYIARKVAAAQGGAGGQWY 564
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 560 | ||||||
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.989 | 0.977 | 0.783 | 8.8e-237 | |
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.851 | 0.787 | 0.714 | 9.3e-189 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.801 | 0.880 | 0.755 | 2.4e-186 | |
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.964 | 0.903 | 0.635 | 2e-182 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.857 | 0.780 | 0.668 | 4e-177 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.748 | 0.727 | 0.747 | 6.5e-177 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.798 | 0.758 | 0.709 | 8.3e-177 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.823 | 0.948 | 0.633 | 1.7e-162 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.592 | 0.627 | 0.507 | 5.9e-89 | |
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.580 | 0.864 | 0.481 | 1.8e-85 |
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2283 (808.7 bits), Expect = 8.8e-237, P = 8.8e-237
Identities = 449/573 (78%), Positives = 487/573 (84%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPD RKKSS +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDAT HPDIVEIKHILLPPSRREF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTD+LGTPS EAI RVRNEKARRYLSSMRKKKPIPFS KFP+ +PLALRLLE+ML+FE
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALAD YFKGLAKVEREPSAQPVTK+EFEFERRRITKEDVRELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ-HASLPRPCVLY 419
P+MLKE+L+GSEPT FMYPSAV+HFKKQFAYLEEHY GT+ PPERQ HASLPR CVLY
Sbjct: 361 PKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVLY 420
Query: 420 SDKT----VQNSAAVTDDLSKCSIKEVEKPP-MDRTSGIPMARLPIQVPQGMQGAA--RP 472
SD Q+SA VTD LSKCSI++ E+P DR + +PM+R+PI VPQ +QGAA RP
Sbjct: 421 SDNNHPVAQQSSAEVTDGLSKCSIRD-ERPRGADRNAQMPMSRIPINVPQTIQGAAVARP 479
Query: 473 GKVVSSVLRYNNCGXXXXXXXLDQ--RRVVRNPAVSTQXXXXXXXXXXXXCKNERVNDE- 529
GKVV SVLRYNNCG L+Q RR+VRNPA ++Q CK+ R +++
Sbjct: 480 GKVVGSVLRYNNCGAATGVEALEQQQRRMVRNPAAASQYPKRTQP-----CKSNRGDEDC 534
Query: 530 --SVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 560
+ EG + L+P QYI +KV+AAQ + S WY
Sbjct: 535 ATAAEGPSRLKPNTQYIPQKVSAAQDTAMSRWY 567
|
|
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1814 (643.6 bits), Expect = 9.3e-189, Sum P(2) = 9.3e-189
Identities = 346/484 (71%), Positives = 398/484 (82%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ D RKK++ +++FF++YG+ +R+K++EVIGKGSYGVVCSA DT TGEKVAIKKI+DIF
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHVSDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA HPDIVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAE+L GKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS + I+RVRNEKARRYL+SMRKK PIPF+QKFPNA+PL+L+LLER+LAF+
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREPS QP+TKMEFEFERR++TKED+RELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
PQ+LK+ + G++ F+YPSAVD F++QFA+LEE+ GK VAP ER+HASLPR V++S
Sbjct: 361 PQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIHS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQGAARPGKVVSSVL 480
+A K P + T IP IQ Q AA+P + V
Sbjct: 421 ------TAVARGGQPKLMNNTNTLNP-ETTQNIPFNHATIQAQQRNLSAAKPSTFMGPVA 473
Query: 481 RYNN 484
++N
Sbjct: 474 PFDN 477
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1807 (641.2 bits), Expect = 2.4e-186, P = 2.4e-186
Identities = 340/450 (75%), Positives = 382/450 (84%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
D KK + + +FFTEYGE SRY+I+EVIGKGSYGVV SA DT +GEKVAIKKIND+FEHV
Sbjct: 2 DPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHV 61
Query: 64 SDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
SDAT HPDIVEIKH++LPPSRREF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 62 SDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 121
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
TPEHYQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARV+FND P+A
Sbjct: 122 TPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSA 181
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDIM
Sbjct: 182 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIM 241
Query: 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 303
TDLLGTP PEAIAR+RNEKARRYL +MR+K P+PF+ KFP+ +PLALRLL R+LAF+PKD
Sbjct: 242 TDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKD 301
Query: 304 RPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 363
RP+AEEALADPYF GLA V+REPS QP+ K+EFEFERR+ITKEDVRELIYREILEYHPQM
Sbjct: 302 RPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQM 361
Query: 364 LKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKT 423
L+E+L G E T FMYPS VD FK+QFA+LEE+YGKG +P +RQHASLPR V K
Sbjct: 362 LQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERVPAPKKE 421
Query: 424 VQNSAAVTDDLSKCS-IKEVEKPPMDRTSG 452
+ ++ S S + +E PP + G
Sbjct: 422 NGSHNHDIENRSIASLVTTLESPPTSQHEG 451
|
|
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1770 (628.1 bits), Expect = 2.0e-182, P = 2.0e-182
Identities = 354/557 (63%), Positives = 417/557 (74%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ Q KK+ +++FFTEYG+ +RY+I EVIGKGSYGVVC+A DT+TGEKVAIKKIND+F
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHVSDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDA HPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EH+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARV+FNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT +FWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D++TDLLGTP E IA VRNEKAR+YL+ MRKK +PFSQKFPNA+PLALRLL+R+LAF+
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTA EALADPYFK LAKVEREPS QP++KMEFEFERRR+TK+D+RELIYREILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
PQ+LK+++ SE + F+YPSA+ H +KQFAYLEE+ GK V PP+R+HASLPR V S
Sbjct: 361 PQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSAVHSS 419
Query: 421 --DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARL--PIQVPQGMQGAARPGKVV 476
+ Q S +D + SI+ + TS L P +VP G +PG+VV
Sbjct: 420 AVNSNAQPSLNASDS-RRVSIEPSRNGVVPSTSAYSTKPLGPPPRVPSG-----KPGRVV 473
Query: 477 SSVLRYNNCGXXXXXXXLDQRRVVRNPAVSTQXXXXXXXXXXXXCKNERVNDESVEGSNG 536
S + Y N D R ST N +N E G+
Sbjct: 474 ESSVTYEN-DRNLKESSYDARTSYYR---STVLPPQTVSPNCYFLPNT-MNQEKRSGTEA 528
Query: 537 L-QPKPQYIARKVAAAQ 552
QPKPQ++ + +A+
Sbjct: 529 ASQPKPQFVPTQCNSAK 545
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1720 (610.5 bits), Expect = 4.0e-177, P = 4.0e-177
Identities = 328/491 (66%), Positives = 396/491 (80%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ +Q KK + +++FFTEYG+ +RY+I EVIGKGSYGVVC+A DT TGEKVAIKKIND+F
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHVSDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA HPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EH+QFFLYQ+LR LK++HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAFNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT +FWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
+++TDLLGTP E I+ VRN+KAR+YL+ MRKK P+ FSQKF A+PLALRLL+R+LAF+
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPT EALADPYFKGL+K+EREPS+Q ++KMEFEFERRR+TK+D+RELIYREILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
PQ+LK+++ GSE + F+YPSA+ H ++QF YLEE+ + V P ER+HASLPR V +S
Sbjct: 361 PQLLKDYMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPRSTV-HS 419
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDR---TSGIPM-ARLP---IQVPQGMQGAARPG 473
TV +S + +L + V P ++G P + P I P + + RPG
Sbjct: 420 --TVVHSTS-QPNLGATDSRRVSFEPSKNGASSAGHPSTSAYPTKSIGPPPRVPPSGRPG 476
Query: 474 KVVSSVLRYNN 484
+VV S + Y N
Sbjct: 477 RVVESSVSYEN 487
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1718 (609.8 bits), Expect = 6.5e-177, P = 6.5e-177
Identities = 314/420 (74%), Positives = 365/420 (86%)
Query: 7 KKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA 66
KK + +FFTEYGE +RY+I+EV+GKGSYGVV SA DT TGE+VAIKKIND+F+H+SDA
Sbjct: 72 KKGIPNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDA 131
Query: 67 TXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 126
T HPD+VEIKHI+LPPSRREF+D+YVVFELMESDLHQVIKANDDLTPE
Sbjct: 132 TRILREIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPE 191
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186
H+QFFLYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARV+FND PTAIFW
Sbjct: 192 HHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFW 251
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
TDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQLDIMTD
Sbjct: 252 TDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDF 311
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
LGTP PEAI+++RN+KARRYL +MRKK+P+PFS+KFP A+P ALRLLER++AF+PKDRP+
Sbjct: 312 LGTPPPEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPS 371
Query: 307 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKE 366
AEEALADPYF GL+ REPS QP++K+EFEFER+++TK+D+RELIYREILEYHPQML+E
Sbjct: 372 AEEALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEE 431
Query: 367 FLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS-DKTVQ 425
+L G FMYPS VD F++QFA+LEE+ G G +RQHASLPR V S ++TV+
Sbjct: 432 YLRGGNQLSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQHASLPRERVPASKNETVE 491
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1717 (609.5 bits), Expect = 8.3e-177, P = 8.3e-177
Identities = 323/455 (70%), Positives = 372/455 (81%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
D KK + +FFTEYGE +RY+I+EV+GKGSYGVV SA D+ TGE+VAIKKIND+FEHV
Sbjct: 85 DPHKKG--ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVFEHV 142
Query: 64 SDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
SDAT HPD+VEIKHI+LPPSRREF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 143 SDATRILREIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 202
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
TPEHYQFFLYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARV+FND PTA
Sbjct: 203 TPEHYQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTA 262
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQLD+M
Sbjct: 263 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDLM 322
Query: 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 303
TD LGTP PE+I+R+RNEKARRYLSSMRKK+P+PFS KFP A+PLALRLLER+LAF+PKD
Sbjct: 323 TDFLGTPPPESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAFDPKD 382
Query: 304 RPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 363
R +AE+ALADPYF GL+ EREP+ QP++K+EF+FER+++ K+DVRELIYREILEYHPQM
Sbjct: 383 RASAEDALADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDVRELIYREILEYHPQM 442
Query: 364 LKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGK-----GTTVAPPERQHASLPRPCV- 417
L+E+L G + FMYPS VD FK+QFA+LEE+ GK G R HASLPR V
Sbjct: 443 LEEYLRGGDQLSFMYPSGVDRFKRQFAHLEENQGKPGAAGGGRSTALHRHHASLPRERVP 502
Query: 418 LYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSG 452
+ +T + S+ V + +E D G
Sbjct: 503 APNGETAEESSDVERRAAAAVASTLESEEADNGGG 537
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1582 (562.0 bits), Expect = 1.7e-162, P = 1.7e-162
Identities = 299/472 (63%), Positives = 376/472 (79%)
Query: 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATXXXXXX 73
+FFTEYGE S+Y+I+EV+GKGSYGVV SA TG KVAIKK+ ++FEHVSDA
Sbjct: 5 EFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRILREI 64
Query: 74 XXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
HPDIVEIKHI+LPP R+EFKDIYVVFELMESDLH V+K NDDLTP+H+QFFLY
Sbjct: 65 KLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQFFLY 124
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
QLLRGLK++H+A+VFHRDLKPKNILANADCK+KICD GLARV+F D+P+A+FWTDYVATR
Sbjct: 125 QLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYVATR 184
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
WYRAPELCGSF+S YTPAID+WS+GCIFAE+LTGKPLFPGKNVVHQL+++TDLLGTPSP
Sbjct: 185 WYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTPSPI 244
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
++R+RNEKAR+YL +MR+K P+PF+ KFPN +P+AL+LL+R++AF+PKDRP+AEEALAD
Sbjct: 245 TLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEEALAD 304
Query: 314 PYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEP 373
PYF+GLA V+ EPS QP++K+EFEFERR++T++DVREL+YREILEYHPQML+E+L+G E
Sbjct: 305 PYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVRELMYREILEYHPQMLQEYLQGEEN 364
Query: 374 TG--FMYPSAVDHFKKQFAYLEEHYG-KGTTVAPP-ERQHASLPRPCVLYSDKTVQNSAA 429
F+YPS VD FK++FA LEEH + +PP +R++ SLPR V S+ + S +
Sbjct: 365 INSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPPHQRKYTSLPRERVCSSED--EGSDS 422
Query: 430 VTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQGAARPGKVVSSVLR 481
V S S+ V PP + ++ Q + AA P K + ++R
Sbjct: 423 VHAQSSSASV--VFTPPQTPNTATGLSS---QKASQVDKAATPVKRSACLMR 469
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 888 (317.7 bits), Expect = 5.9e-89, P = 5.9e-89
Identities = 173/341 (50%), Positives = 234/341 (68%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATXXXXXXXXXXXXXHPD 83
RY I + IG G+YGVVCSA D TGEKVAIKKI+ F+++ D H +
Sbjct: 148 RYSIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLLRHFKHEN 207
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
++ IK IL P S+ +F+D+Y+V ELM++DLHQ+I + L+ +H Q+F+YQ+LRGLK+IH
Sbjct: 208 LISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIH 267
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L N DC LKICD GLARV D F T+YVATRWYRAPE+ S
Sbjct: 268 SANVLHRDLKPSNLLINEDCLLKICDLGLARV--EDATHQGFMTEYVATRWYRAPEVILS 325
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
+ +KYT AIDIWS+GCIFAELL KPLF GK+ +HQ+ ++ + +G+PS E I + NE+A
Sbjct: 326 W-NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQA 384
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323
R+++ +M + + F+ FP ANP A+ LLERML F+P R T EEALA PYF+ L
Sbjct: 385 RQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYFQSL---- 440
Query: 324 REPSAQPVT--KMEFEFERRRITKEDVRELIYREILEYHPQ 362
+PS +P+ K FE + ++ ++ELIY E+L YHP+
Sbjct: 441 HDPSDEPICLHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481
|
|
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 855 (306.0 bits), Expect = 1.8e-85, P = 1.8e-85
Identities = 160/332 (48%), Positives = 232/332 (69%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATXXXXXXXXXXXXXHPDIVEIKHI 90
IG+G+YG+VC+A ++ TGE+VAIKKI + F+++ DA H +++ +K I
Sbjct: 49 IGRGAYGIVCAATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDI 108
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
+ PP R F D+Y+V+ELM++DLHQ+I++N LT +H +FFLYQLLRGLKY+H+ANV HR
Sbjct: 109 IKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHR 168
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 210
DLKP N+L NA+C LK+ DFGLAR ++T F T+YV TRWYRAPEL + S+YT
Sbjct: 169 DLKPSNLLLNANCDLKLGDFGLARTK-SETD---FMTEYVVTRWYRAPELLLNC-SEYTA 223
Query: 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 270
AIDIWS+GCI E +T +PLFPGK+ VHQL ++T+L+G+P ++ +R++ ARRY+ +
Sbjct: 224 AIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQL 283
Query: 271 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 330
+ F+ +FPN + A+ LLE+ML F+P R T +EAL PY L + EP
Sbjct: 284 PQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVC-- 341
Query: 331 VTKMEFEFERRRITKEDVRELIYREILEYHPQ 362
V F+FE+ +T+E+++ELIYRE ++++PQ
Sbjct: 342 VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LV37 | MPK9_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7844 | 0.8017 | 0.8803 | no | no |
| Q53N72 | MPK15_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8237 | 0.8857 | 0.9959 | yes | no |
| Q8W4J2 | MPK16_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8199 | 0.9910 | 0.9788 | yes | no |
| Q5ZCI1 | MPK10_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7392 | 0.8946 | 0.8199 | no | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7668 | 0.7410 | 0.8201 | N/A | no |
| Q9SJG9 | MPK20_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7140 | 0.8982 | 0.8300 | no | no |
| Q75KK8 | MPK14_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7909 | 0.9625 | 0.9944 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | 0.994 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_X4145 | hypothetical protein (562 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 560 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-164 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-150 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-145 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-127 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-124 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-123 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-110 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-110 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-105 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-100 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-98 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-96 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-93 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-93 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-92 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-92 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-90 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-89 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-88 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-85 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-81 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-80 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-76 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-74 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-71 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-71 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-71 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-71 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-70 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-69 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-68 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-68 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-67 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-67 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-66 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-64 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-63 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-62 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-62 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-61 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-61 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-60 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-60 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-59 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-54 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-54 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-51 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-51 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-51 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-48 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-46 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-45 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-44 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-43 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-42 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-41 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-40 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-40 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-37 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-37 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-18 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-13 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-11 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 751 bits (1942), Expect = 0.0
Identities = 318/338 (94%), Positives = 334/338 (98%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RYKI+EVIGKGSYGVVCSA DT TGEKVAIKKIND+FEHVSDATRILREIKLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLR LKYIH
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
FFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPSPE I+RVRNEKA
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323
RRYLSSMRKK+P+PFSQKFPNA+PLALRLLER+LAF+PKDRPTAEEALADPYFKGLAKVE
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300
Query: 324 REPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
REPSAQP+TK+EFEFERRR+TKEDVRELIYREILEYHP
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 549 bits (1418), Expect = 0.0
Identities = 193/332 (58%), Positives = 247/332 (74%), Gaps = 2/332 (0%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY++ + IG G+YGVVCSA D RTG KVAIKKI+++F+ + DA RILREIKLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
I+ + IL PPS +F D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LRGLKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP NIL N++C LKICDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
S+YT AIDIWS+GCIFAELLT KPLFPG++ + QL+++ ++LGTPS E + + +EKA
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323
R YL S+ KK P S+ FP A+P A+ LLE+ML F+PK R TA+EALA PY L E
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299
Query: 324 REPSAQPVTKMEFEFERRRITKEDVRELIYRE 355
EP A+P +F F+ +T+E+++ELIY E
Sbjct: 300 DEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 470 bits (1212), Expect = e-164
Identities = 191/339 (56%), Positives = 248/339 (73%), Gaps = 6/339 (1%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
++Y + IG+G+YG+VCSA ++ T EKVAIKKI + F++ DA R LREIKLLR L H
Sbjct: 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+++ IK I+ PP R F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQLLRGLKYI
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ANV HRDLKP N+L NA+C LKICDFGLAR + F T+YV TRWYRAPEL
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---SEKGDFMTEYVVTRWYRAPELLL 181
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ S+YT AID+WS+GCIFAELL KPLFPGK+ VHQL ++T+LLG+PS E + +RNEK
Sbjct: 182 N-CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322
ARRY+ S+ F++ FP+ANPLA+ LLE+ML F+P R T EEALA PY L
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300
Query: 323 EREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
EP Q T F+FE +T+ED++ELIY E+L YHP
Sbjct: 301 SDEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 433 bits (1115), Expect = e-150
Identities = 174/341 (51%), Positives = 237/341 (69%), Gaps = 14/341 (4%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G RY+ IG+G+YG+VCSA TG KVAIKKI+ FEH + R LREIK+LR +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKH 62
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LRGLKY
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKY 121
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
IH+ANV HRDLKP N+L N +C LKICDFGLAR+A + F T+YVATRWYRAPE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+ YT AIDIWS+GCI AE+L+ +PLFPGK+ +HQL+++ +LGTPS E + + +
Sbjct: 182 LNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
+AR Y+ S+ K +P+++ FPNA+P AL LL++ML F P R T EEALA PY
Sbjct: 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY------ 294
Query: 322 VER--EPSAQPVTKMEFEFE---RRRITKEDVRELIYREIL 357
+E+ +PS +PV + F F+ + KE ++ELI+ EI+
Sbjct: 295 LEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 420 bits (1083), Expect = e-145
Identities = 175/335 (52%), Positives = 243/335 (72%), Gaps = 5/335 (1%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
GSRYK E IG G+YGVVCSA DTR+G+KVAIKKI F+ + A R LRE+K+LR +H
Sbjct: 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH 63
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ I+ IL PP +FKD+YVV +LMESDLH +I ++ LT EH ++FLYQLLRGLKY
Sbjct: 64 DNIIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKY 122
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRAPEL 200
IH+ANV HRDLKP N+L N DC+L+I DFG+AR ++ + T F T+YVATRWYRAPEL
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
S +YT AID+WS+GCIFAE+L + LFPGKN VHQL ++ +LG+PS E + R+ +
Sbjct: 183 LLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320
++ R+Y+ ++ +K+P+P+S+ FP A+P AL LL +ML F+P++R T E+AL P+
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301
Query: 321 KVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE 355
+ EP+ P +F+FE +++E ++E I +E
Sbjct: 302 DPDDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 375 bits (966), Expect = e-127
Identities = 155/339 (45%), Positives = 218/339 (64%), Gaps = 12/339 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ +G G+YG VCSA+DT+TG KVAIKK++ F+ A R RE++LL+ + H +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 84 IVEIKHILLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ + + P S E F+D+Y+V LM +DL+ ++K L+ +H QF +YQ+LRGLKYI
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQILRGLKYI 134
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI N DC+LKI DFGLAR ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
++ Y +DIWS+GCI AELLTGK LFPG + + QL + +L+GTP E + ++ +E
Sbjct: 189 NWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322
AR Y+ S+ + F + F ANPLA+ LLE+ML +P R TA EALA PY
Sbjct: 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307
Query: 323 EREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
E EP A P + FE R +T ++ +EL+Y+EI+ + P
Sbjct: 308 EDEPVAPP---YDQSFESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 368 bits (947), Expect = e-124
Identities = 150/339 (44%), Positives = 212/339 (62%), Gaps = 13/339 (3%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-H 81
+Y+I + +GKG+YG+V A D RT E VA+KKI D F + +DA R REI L+ L H
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 82 PDIVEIKHILLPPSRREF-KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P+IV++ +++ + E KDIY+VFE ME+DLH VI+AN L H ++ +YQLL+ LK
Sbjct: 67 PNIVKLLNVI----KAENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALK 121
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVA--FNDTPTAIFWTDYVATRWYRAP 198
YIH+ NV HRDLKP NIL N+DC++K+ DFGLAR + P TDYVATRWYRAP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
E L GS ++YT +D+WS+GCI E+L GKPLFPG + ++QL+ + +++G PS E I
Sbjct: 182 EILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+++ A L S+ + P + P A+ AL LL+++L F P R TAEEAL PY
Sbjct: 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
Query: 318 GLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREI 356
EP + + + +++ + R +Y EI
Sbjct: 300 QFHNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 365 bits (939), Expect = e-123
Identities = 168/340 (49%), Positives = 225/340 (66%), Gaps = 15/340 (4%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRT--GEKVAIKKINDIFEHVSDATRILREIKLLRLLR- 80
RY++ + +G+G+YG+VCSA + T E VAIKKI ++F A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 81 HPDIVEI--KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
H +I + I+ P + F ++Y+ ELME+DLHQ+I++ LT H+Q F+YQ+L G
Sbjct: 61 HKNITCLYDMDIVFPGN---FNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCG 117
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP--TAIFWTDYVATRWYR 196
LKYIH+ANV HRDLKP N+L NADC+LKICDFGLAR F++ P A F T+YVATRWYR
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATRWYR 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
APE+ SF YT AID+WS+GCI AELL KP+F GK+ V QL+ + +LGTP E ++
Sbjct: 177 APEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
R+ + KA+ Y+ S+ PF FPNANPLAL LLE++LAF+P R + EEAL PY
Sbjct: 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295
Query: 317 KGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREI 356
+ EP Q FE E + E++R++I E+
Sbjct: 296 AIWHDPDDEPVCQKPFDFSFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 329 bits (845), Expect = e-110
Identities = 137/294 (46%), Positives = 181/294 (61%), Gaps = 13/294 (4%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y+ IG+G+YGVV A D TGE VAIKKI FE LREIKLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
+++ + D+Y+VFE M++DL+++IK L + +LYQLL+GL + H
Sbjct: 61 IKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCG 202
+ + HRDLKP+N+L N + LK+ DFGLAR +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y+ +DIWS+GCIFAELL+ +PLFPGK+ + QL + LGTP PE + +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-L 229
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
AR Y S KK +P + FPNA+P AL LL +ML ++P R TAE+ALA PYF
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 331 bits (849), Expect = e-110
Identities = 155/335 (46%), Positives = 219/335 (65%), Gaps = 18/335 (5%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+RY + +G G++G+VCSA D TG+ VAIKKI F A R RE+KLL+ LRH
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+I+ + I + P +DIY V EL+ +DLH+++ + L + Q+FLYQ+LRGLKY+
Sbjct: 70 NIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYV 124
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A V HRDLKP NIL N +C LKICDFGLAR+ T YV+TR+YRAPE+
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM------TGYVSTRYYRAPEIML 178
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
++ KY +DIWS GCIFAE+L GKPLFPGK+ V+Q I+TDLLGTP + I + +E
Sbjct: 179 TW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322
R++ S+ K++P+PFS+KF NA+P A+ LLE+ML F+P+ R +A EALA PY
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY--- 294
Query: 323 EREPSAQPVTKMEFE--FERRRITKEDVRELIYRE 355
+P+ +PV + +F+ F + + + ++Y E
Sbjct: 295 -HDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 317 bits (816), Expect = e-105
Identities = 127/297 (42%), Positives = 175/297 (58%), Gaps = 20/297 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI---NDIFEHVSDATRILREIKLLRLLRH 81
Y+ E +G+G+YGVV A D +TGE VA+KKI N+ E + LREI LL+ L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTA--LREISLLKELKH 57
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
P+IV++ ++ + +Y+VFE + DL + + L+P + +YQLLRGL
Sbjct: 58 PNIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
Y H+ + HRDLKP+NIL N D LK+ DFGLAR T +T V T WYRAPE
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT---YTHEVVTLWYRAPEI 169
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
L GS Y+ A+DIWS+GCIFAE++TGKPLFPG + + QL + +LGTP+ E+ V
Sbjct: 170 LLGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV- 226
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
K Y + K P + P +P + LL +ML + P R +A+EAL PYF
Sbjct: 227 -TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 308 bits (791), Expect = e-100
Identities = 146/354 (41%), Positives = 211/354 (59%), Gaps = 32/354 (9%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG G++GVV S D R G++VA+KK+ ++F+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
L PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LRGLKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYT 209
D+KP N+L N++C LKICDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 210 PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 269
A+DIWS+GCIFAELL + LF ++ + QLD++TDLLGTPS EA+ E AR ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILR 242
Query: 270 MRKKKPIPFSQKFPNANPL---ALRLLERMLAFEPKDRPTAEEALADPYFKG-------- 318
KP + ++ A+ LL RML F+P R +A +ALA PY
Sbjct: 243 -GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTC 301
Query: 319 ------------LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
+ + EPSA P E+E+ + V+E +++ ILE
Sbjct: 302 MCKCCYTTSGGRVYTSDFEPSANPPFD--DEYEKNLTSVRQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 301 bits (773), Expect = 3e-98
Identities = 146/339 (43%), Positives = 215/339 (63%), Gaps = 12/339 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ +G G+YG VC+A+DT+TG +VA+KK++ F+ + A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 84 IVEIKHILLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+LRGLKYI
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A++ HRDLKP N+ N DC+LKI DFGLAR T T YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWYRAPEIML 190
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
++ Y +DIWS+GCI AELLTG+ LFPG + + QL ++ L+GTP E + ++ +E
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322
AR Y+ S+ + + F+ F ANPLA+ LLE+ML + R TA +ALA YF
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309
Query: 323 EREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
+ EP A P + FE R + ++ + L Y E++ + P
Sbjct: 310 DDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 295 bits (756), Expect = 7e-96
Identities = 149/339 (43%), Positives = 214/339 (63%), Gaps = 12/339 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ +G G+YG VCSAYDTR +KVA+KK++ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 84 IVEIKHILLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ + + P S F ++Y+V LM +DL+ ++K L+ EH QF +YQLLRGLKYI
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N DC+L+I DFGLAR A ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM------TGYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
++ Y +DIWS+GCI AELL GK LFPG + + QL + +++GTPSPE + ++ +E
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322
AR+Y+ S+ + F ANPLA+ LLE+ML + R +A EALA PYF
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307
Query: 323 EREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
E EP A+P + E + T E+ +EL Y E+ + P
Sbjct: 308 EDEPEAEPYDE---SPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 289 bits (741), Expect = 2e-93
Identities = 143/340 (42%), Positives = 209/340 (61%), Gaps = 12/340 (3%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
RY+ + +G G+YG VCSA D RTG KVAIKK+ F+ A R RE++LL+ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 83 DIVEIKHILLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+++ + + P S F D Y+V M +DL +++K ++ L+ + QF +YQ+L+GLKY
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKY 133
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
IH A + HRDLKP N+ N DC+LKI DFGLAR ++ T YV TRWYRAPE+
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM------TGYVVTRWYRAPEVI 187
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
++ YT +DIWS+GCI AE+LTGKPLF G + + QL + + GTPS E + ++++E
Sbjct: 188 LNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
A+ Y+ + + + F PNANPLA+ +LE+ML + + R TA EALA PYF+
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306
Query: 322 VEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
E E A P + F+ + E+ + L + EIL + P
Sbjct: 307 PEDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 288 bits (739), Expect = 3e-93
Identities = 138/339 (40%), Positives = 204/339 (60%), Gaps = 13/339 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY + +G G+YG VCSA D RTGEKVAIKK++ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 84 IVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ + + S EF+D Y+V M++DL +++ L+ + Q+ +YQ+L GLKYI
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N DC+LKI DFGLAR A + T YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTRWYRAPEVIL 187
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
++ Y +DIWS+GCI AE+LTGK LF GK+ + QL + + G P PE + ++ ++
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322
A+ Y+ S+ K FS FP A+P A+ LLE+ML + R TA EAL PYF
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
Query: 323 EREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
+ E QP + E +++ ++ ++ IY+E+ + P
Sbjct: 307 DEETEQQP---YDDSLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 283 bits (727), Expect = 2e-92
Identities = 108/293 (36%), Positives = 152/293 (51%), Gaps = 40/293 (13%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y+I E +G+GS+G V A D +TG+ VAIK I D RILREIK+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 85 VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V + + +Y+V E E DL ++K L+ + +F+L Q+L L+Y+H
Sbjct: 60 VRLYDVFEDE-----DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + D +K+ DFGLAR T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL----TTFVGTPEYMAPEVLLG 170
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
Y A+DIWS+G I ELLTGKP FPG + QL + +G P
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKP------------- 212
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
PF + +P A L+ ++L +P+ R TAEEAL P+F
Sbjct: 213 -----------KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 282 bits (725), Expect = 7e-92
Identities = 122/302 (40%), Positives = 176/302 (58%), Gaps = 29/302 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
YK+ + +G G++G V A + TGE VAIKK+ F + LRE+K L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKY 141
IV++K + RE ++Y VFE ME +L+Q++K + + +YQ+L+GL +
Sbjct: 60 IVKLKEVF-----RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL- 200
IH FHRDLKP+N+L + +KI DFGLAR + P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 201 --CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS----PEA 254
S Y+ +DIW++GCI AEL T +PLFPG + + QL + +LGTP+ PE
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+ A + + P Q PNA+P A+ L++ ML ++PK RPTA +AL P
Sbjct: 227 Y-----KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 315 YF 316
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 277 bits (712), Expect = 9e-90
Identities = 124/300 (41%), Positives = 165/300 (55%), Gaps = 20/300 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRI--LREIKLLRLLR 80
RY+ + +G+G+Y VV A D TG VAIKKI + D LREIKLL+ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGL 139
HP+I+ + + S I +VFE ME+DL +VIK LTP + ++ LRGL
Sbjct: 61 HPNIIGLLDVFGHKSN-----INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+Y+H+ + HRDLKP N+L +D LK+ DFGLAR +F + T V TRWYRAPE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKM--THQVVTRWYRAPE 172
Query: 200 LCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
L F Y +D+WS+GCIFAELL P PG + + QL + + LGTP+ E
Sbjct: 173 L---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
V + + P P Q FP A+ AL LL+R+L P R TA +AL PYF
Sbjct: 230 V---TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 278 bits (714), Expect = 2e-89
Identities = 135/348 (38%), Positives = 203/348 (58%), Gaps = 24/348 (6%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
RY+ + IG G+ G+VC+AYDT TG+ VAIKK++ F++V+ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 83 DIVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ + ++ P S EF+D+Y+V ELM+++L QVI DL E + LYQ+L G+K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ +DC LKI DFGLAR A T+ T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVVTRYYRAPEVI 189
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
Y +DIWS+GCI E++ G LFPG + + Q + + + LGTPS E ++R+
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QP 246
Query: 262 KARRYLSSMRKKKPIPFSQKFP-------NANPLALR------LLERMLAFEPKDRPTAE 308
R Y+ + K F + FP + + L+ LL +ML +P+ R + +
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 309 EALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREI 356
+AL PY E A P + + R T E+ +ELIY+E+
Sbjct: 307 DALQHPYINVWYD-PSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 272 bits (699), Expect = 7e-88
Identities = 116/302 (38%), Positives = 172/302 (56%), Gaps = 25/302 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHP 82
Y+ IG+G+YG V A + +TGE VA+KKI E+ + I +REIKLL+ LRHP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKY 141
+IV +K I+ + IY+VFE M+ DL ++ T + ++ QLL GL+Y
Sbjct: 59 NIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
+H+ + HRD+K NIL N D LK+ DFGLAR + +A + T+ V T WYR PE L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELL 173
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
G+ ++Y P +D+WS+GCI AEL GKP+F G + QL+ + +L G+P+ E V
Sbjct: 174 LGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 261 EKARRYLSSMRKKKPIP------FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+ +++ KKP F + AL LL+++L +PK R +A++AL
Sbjct: 232 LP---WFENLKPKKPYKRRLREFFKHLIDPS---ALDLLDKLLTLDPKKRISADQALQHE 285
Query: 315 YF 316
YF
Sbjct: 286 YF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 264 bits (678), Expect = 7e-85
Identities = 124/299 (41%), Positives = 175/299 (58%), Gaps = 20/299 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RYKI IG+G++G+V A D TGE VA+KK+ + LREIK L+ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 142
+V++ + S +V E M SDL +V++ + L + ++ LL+G+ Y+
Sbjct: 61 VVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC- 201
H + HRDLKP N+L +AD LKI DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPELLY 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN- 260
G+ KY P +D+W++GCIFAELL G PLFPG+N + QL I+ LGTP+ E + +
Sbjct: 174 GA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 261 ---EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
K + KPIP + FP+A+P AL LL+ +L ++P R +A EAL PYF
Sbjct: 232 PDYNKIT-----FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 1e-81
Identities = 132/337 (39%), Positives = 184/337 (54%), Gaps = 27/337 (8%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI---LREIKL 75
+ GSRY +G GS G+V SA D+ ++VA+KKI ++D + LREIK+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 76 LRLLRHPDIVEIKHILLPPSRR---------EFKDIYVVFELMESDLHQVIKANDDLTPE 126
+R L H +IV++ +L P E +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIF 185
H + F+YQLLRGLKYIH+ANV HRDLKP N+ N D LKI DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245
++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTGKPLF G + + Q+ ++ +
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 246 LLGTPSPE---AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 302
+ E + V R R+ P P NP AL LE++L F P
Sbjct: 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRR----PLRDLLPGVNPEALDFLEQILTFNPM 289
Query: 303 DRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFE 339
DR TAEEAL PY + EP + +E E +
Sbjct: 290 DRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 253 bits (647), Expect = 3e-80
Identities = 114/296 (38%), Positives = 171/296 (57%), Gaps = 12/296 (4%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y++ V+G+G+YGVV + TGE VAIKK + + LRE+K+LR LRH +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 142
IV +K RR+ + +Y+VFE +E L ++++A+ L P+ + +++QLL+ + Y
Sbjct: 62 IVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 201
H+ N+ HRD+KP+NIL + LK+CDFG AR A TDYVATRWYRAPE L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLV 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
G + Y +D+W+IGCI AELL G+PLFPG + + QL ++ LG P +
Sbjct: 175 GD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 262 KARRYLSSMRKKKPIPFSQKFPNA-NPLALRLLERMLAFEPKDRPTAEEALADPYF 316
++ +P +++P + AL L+ L +PK+R T +E L PYF
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 251 bits (644), Expect = 4e-80
Identities = 95/293 (32%), Positives = 144/293 (49%), Gaps = 34/293 (11%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y++ +G GS+G V A TG+ VA+K + E REI++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 85 VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V + + +Y+V E E DL + L+ + + Q+LRGL+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + + +KI DFGLA+ + + T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
+ Y P +D+WS+G I ELLTGKP F G+N++ QL + I R+
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL------------QLIRRI----- 214
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
+ + + A L+++ L +P RPTAEE L P+F
Sbjct: 215 ------LGPPLEFDEPKWSSG-SEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 244 bits (624), Expect = 1e-76
Identities = 121/303 (39%), Positives = 168/303 (55%), Gaps = 31/303 (10%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHP 82
+IEE G+YGVV A D +TGE VA+KK+ E + I LREI +L L+HP
Sbjct: 11 NRIEE----GTYGVVYRARDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLKLQHP 64
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 141
+IV +K +++ IY+V E +E DL +++ + + QLL G+ +
Sbjct: 65 NIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
+H + HRDLK N+L N LKICDFGLAR + +T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKP--YTQLVVTLWYRAPELL 178
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
G+ +Y+ AID+WS+GCIFAELLT KPLFPGK+ + QL+ + LLGTP+ +
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 261 EKARRYLSSMRKKKPI--PFSQ---KFPNA--NPLALRLLERMLAFEPKDRPTAEEALAD 313
L +KK P++Q KFP + LL R+L ++P R +AE+AL
Sbjct: 237 ------LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290
Query: 314 PYF 316
PYF
Sbjct: 291 PYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 2e-74
Identities = 115/297 (38%), Positives = 177/297 (59%), Gaps = 20/297 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPD 83
YKI IG+G++ V A +TG+ AIK + F+ + LREI+ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 84 IVEIKHILL-PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKY 141
I+ + +L + R + +VFELM+ +L+++IK PE + ++YQLL+ L +
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-- 199
+H +FHRD+KP+NIL D LK+ DFG R ++ P +T+Y++TRWYRAPE
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYRAPECL 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
L + Y P +DIW++GC+F E+L+ PLFPG N + Q+ + D+LGTP E + + R
Sbjct: 171 LTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
K+R + KK + PNA+ L LL+++LA++P +R TA++AL PYF
Sbjct: 228 --KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 2e-71
Identities = 114/302 (37%), Positives = 154/302 (50%), Gaps = 25/302 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR---H 81
Y+ IG+G+YG V A D TG VA+KK+ LREI LL+ L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLLRGL 139
P+IV + + P + +VFE ++ DL + L PE + + QLLRG+
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
++H+ + HRDLKP+NIL +D ++KI DFGLAR+ + T V T WYRAPE
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL----TSVVVTLWYRAPE 176
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS----PEA 254
L S Y +D+WS+GCIFAEL +PLF G + QLD + D++G PS P
Sbjct: 177 VLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
++ R SS P F P L LL++ML F P R +A EAL P
Sbjct: 234 VSLPR--------SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285
Query: 315 YF 316
YF
Sbjct: 286 YF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 2e-71
Identities = 122/297 (41%), Positives = 170/297 (57%), Gaps = 22/297 (7%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD---ATRILREIKLLRLLRHP 82
K+E+ IG+G+YGVV A D TGE VA+KKI E + +T I REI LL+ L HP
Sbjct: 3 KVEK-IGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAI-REISLLKELNHP 58
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLK 140
+IV + ++ ++ +Y+VFE ++ DL + + L P + +LYQLL+G+
Sbjct: 59 NIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
Y H+ V HRDLKP+N+L + + LK+ DFGLAR AF P + T V T WYRAPE
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEI 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
L GS Y+ +DIWSIGCIFAE++ +PLFPG + + QL + LGTP + V
Sbjct: 171 LLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV- 227
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
Y + K S+ PN + L LL +ML ++P R +A+ AL PYF
Sbjct: 228 -TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 2e-71
Identities = 130/348 (37%), Positives = 198/348 (56%), Gaps = 23/348 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ + IG G+ G+VC+A+DT G VA+KK++ F++ + A R RE+ LL+ + H +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 84 IVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ + ++ P S EF+D+Y+V ELM+++L QVI +L E + LYQ+L G+K++
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHL 139
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ +DC LKI DFGLAR A T T YV TR+YRAPE+
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----CTNFMMTPYVVTRYYRAPEVIL 195
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y +DIWS+GCI EL+ G +F G + + Q + + + LGTPS E + R++
Sbjct: 196 GM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ-PT 252
Query: 263 ARRYLSSMRKKKPIPFSQKFPN------------ANPLALRLLERMLAFEPKDRPTAEEA 310
R Y+ + + I F + FP+ A LL +ML +P R + +EA
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 311 LADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILE 358
L PY + E A P + + E R E+ +ELIY+E+++
Sbjct: 313 LRHPYIT-VWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 4e-71
Identities = 110/313 (35%), Positives = 167/313 (53%), Gaps = 28/313 (8%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
Y+I +G+G++G V A +TG VA+KKI + + D I LREIK+L+ L+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLK 65
Query: 81 HPDIVEIKHILL---PPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLL 136
HP++V + + + S+R+ +Y+V M+ DL +++ LT + ++ QLL
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF--------WTD 188
G+ Y+H ++ HRD+K NIL + LKI DFGLAR P +T+
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
V TRWYR PEL G +YT A+DIW IGC+FAE+ T +P+ GK+ + QL ++ L
Sbjct: 186 LVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243
Query: 248 GTPSPEAIARVRN----EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 303
GTP+ E R+ E + + R ++F P L LL ++L+ +P
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRT-----LEERFGKLGPEGLDLLSKLLSLDPYK 298
Query: 304 RPTAEEALADPYF 316
R TA +AL PYF
Sbjct: 299 RLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 1e-70
Identities = 122/293 (41%), Positives = 170/293 (58%), Gaps = 19/293 (6%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHPDIVEIK 88
IG+G+YG+V A DT +GE VA+KK+ ++ D I LREI LL LRHP+IVE+K
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANV 147
+++ + I++V E E DL ++ + + + QLLRGL+Y+H +
Sbjct: 73 EVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFS 206
HRDLK N+L LKI DFGLAR + + T V T WYRAPE L G +
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLART-YGLPAKPM--TPKVVTLWYRAPELLLGC--T 184
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE--KAR 264
YT AID+W++GCI AELL KPL PGK+ + QLD++ LLGTP+ E+I ++
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDLPLVG 243
Query: 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
++ ++ K+ KFP + LRLL +L ++PK R TAEEAL YFK
Sbjct: 244 KF--TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 6e-69
Identities = 114/296 (38%), Positives = 170/296 (57%), Gaps = 17/296 (5%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+K E +G+G+Y V + TGE VA+K+I+ E + +T I REI L++ L+H +I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKHENI 60
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKY 141
V + ++ ++ + +VFE M+ DL + + + L P + F YQLL+G+ +
Sbjct: 61 VRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
H V HRDLKP+N+L N +LK+ DFGLAR AF P F + V T WYRAP+ L
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPDVL 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
GS Y+ +IDIWS+GCI AE++TG+PLFPG N QL + ++GTP+ +
Sbjct: 173 LGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
Y + + P Q FP+A+PL + LL R+L P+ R +A +AL P+F
Sbjct: 231 --LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 4e-68
Identities = 131/347 (37%), Positives = 203/347 (58%), Gaps = 23/347 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ + IG G+ G+VC+AYD VAIKK++ F++ + A R RE+ L++ + H +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 84 IVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ + ++ P S EF+D+Y+V ELM+++L QVI+ +L E + LYQ+L G+K++
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHL 135
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ +DC LKI DFGLAR A T+ T YV TR+YRAPE+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVVTRYYRAPEVIL 191
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y +DIWS+GCI E++ K LFPG++ + Q + + + LGTP PE + +++
Sbjct: 192 GM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 248
Query: 263 ARRYLSSMRKKKPIPFSQKFPNA--------NPL----ALRLLERMLAFEPKDRPTAEEA 310
R Y+ + K + F + FP++ N L A LL +ML +P R + +EA
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308
Query: 311 LADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREIL 357
L PY + E A P + + + R T E+ +ELIY+E++
Sbjct: 309 LQHPYIN-VWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 223 bits (569), Expect = 9e-68
Identities = 135/371 (36%), Positives = 211/371 (56%), Gaps = 29/371 (7%)
Query: 8 KSSADVDFFT-EYGEGS-----RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
+S D +F++ E G+ + RY+ + IG G+ G+VC+AYD VAIKK++ F+
Sbjct: 3 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKAN 120
+ + A R RE+ L++ + H +I+ + ++ P S EF+D+Y+V ELM+++L QVI+
Sbjct: 63 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM- 121
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
+L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR A
Sbjct: 122 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---- 176
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + + Q
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA--------NPL---- 288
+ + + LGTP PE + +++ R Y+ + K F + FP+ N L
Sbjct: 235 NKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ 293
Query: 289 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 348
A LL +ML + R + +EAL PY + E A P + + + R T E+
Sbjct: 294 ARDLLSKMLVIDASKRISVDEALQHPYIN-VWYDPSEAEAPPPKIPDKQLDEREHTIEEW 352
Query: 349 RELIYREILEY 359
+ELIY+E+++
Sbjct: 353 KELIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 4e-67
Identities = 119/320 (37%), Positives = 168/320 (52%), Gaps = 35/320 (10%)
Query: 23 SRYK-IEEVIGKGSYGVVCSAYDTRTGEKVAIKK--INDIFEHVSDATR----------I 69
RY +G+G+YG V AYDT TG+ VAIKK I +I V+ +
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 70 LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 129
LRE+K++ ++H +I+ + + + +F I +V ++M SDL +V+ LT +
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQVK 122
Query: 130 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----VAFNDTPTAI 184
L Q+L GL +H HRDL P NI N+ KI DFGLAR +
Sbjct: 123 CILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 185 F------WTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
T V T WYRAPEL G+ KY A+D+WS+GCIFAELLTGKPLFPG+N +
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240
Query: 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 297
QL + +LLGTP+ + + + + +KP FPNA+ A+ LL+ +L
Sbjct: 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFT---PRKPKDLKTIFPNASDDAIDLLQSLL 297
Query: 298 AFEPKDRPTAEEALADPYFK 317
P +R +A+EAL YFK
Sbjct: 298 KLNPLERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 5e-67
Identities = 116/324 (35%), Positives = 171/324 (52%), Gaps = 39/324 (12%)
Query: 24 RYKIEEVIGKGSYGVVCSAY--DTRTGEKVAIKKI---NDIFEHVSDATRILREIKLLRL 78
+Y+IE IG+G+YG V A + + G++ AIKK + + +S + REI LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIK-----ANDDLTPEHYQFFLY 133
L+H ++V + + L + + +Y++F+ E DL Q+IK + P + L+
Sbjct: 59 LKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVAFNDTPTAIFWTD- 188
Q+L G+ Y+H+ V HRDLKP NIL + +KI D GLAR+ FN + D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDP 174
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---------VH 238
V T WYRAPEL G+ YT AIDIW+IGCIFAELLT +P+F G+
Sbjct: 175 VVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 239 QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS------QKFPNANPLALRL 292
QL+ + ++LGTP+ + ++ L K K P + +K + L
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292
Query: 293 LERMLAFEPKDRPTAEEALADPYF 316
L ++L ++P R TAEEAL PYF
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 218 bits (556), Expect = 1e-66
Identities = 117/299 (39%), Positives = 170/299 (56%), Gaps = 20/299 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI----LREIKLLRLL 79
+Y+ IG+GSYGVV + TG+ VAIKK F D I LREI++L+ L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQL 57
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRG 138
+HP++V + + RR+ K +++VFE + + ++ N PEH + ++Q L+
Sbjct: 58 KHPNLVNLIEVF----RRKRK-LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+ + H N HRD+KP+NIL ++K+CDFG AR+ T +TDYVATRWYRAP
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAP 169
Query: 199 EL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
EL G ++Y P +D+W+IGC+FAELLTG+PL+PGK+ V QL ++ LG P
Sbjct: 170 ELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
+ + LS + P KFPN + AL L+ L +P +R + EE L PYF
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 4e-64
Identities = 116/295 (39%), Positives = 172/295 (58%), Gaps = 17/295 (5%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
KIE+ IG+G+YGVV + +TG+ VA+KKI E + +REI LL+ L+HP+IV
Sbjct: 4 KIEK-IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 86 EIKHILLPPSRREFKDIYVVFELMESDLHQ---VIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ +L+ SR +Y++FE + DL + + + E + +LYQ+L+G+ +
Sbjct: 63 CLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 201
H+ V HRDLKP+N+L + +K+ DFGLAR AF P ++ T V T WYRAPE L
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAPEVLL 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
GS +Y+ +DIWSIG IFAE+ T KPLF G + + QL + +LGTP+ + V
Sbjct: 175 GS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV--T 230
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
Y ++ K K N + L LLE+ML ++P R +A++AL PYF
Sbjct: 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 8e-63
Identities = 115/291 (39%), Positives = 165/291 (56%), Gaps = 15/291 (5%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+IV++
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTAN 146
++ +Y+VFE + DL + + A+ + + +L+QLL+GL + H+
Sbjct: 66 DVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFF 205
V HRDLKP+N+L N + +K+ DFGLAR AF P + T V T WYRAPE L G +
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEILLGCKY 177
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265
Y+ A+DIWS+GCIFAE++T + LFPG + + QL + LGTP V +
Sbjct: 178 --YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP--D 233
Query: 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
Y S K FS+ P + LL +ML ++P R +A+ ALA P+F
Sbjct: 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 1e-62
Identities = 114/304 (37%), Positives = 168/304 (55%), Gaps = 19/304 (6%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ YK + +G+GSY V TG+ VA+K+I E + T I RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKD 59
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLR 137
L+H +IV + I+ K + +VFE +++DL Q + L+ + + FL+QLLR
Sbjct: 60 LKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL Y H V HRDLKP+N+L + +LK+ DFGLAR + T +++ V T WYR
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT---YSNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMTDLLGTPSPEAI 255
P+ L GS ++Y+ ++D+W +GCIF E+ TG+PLFPG +V QL + +LGTP+ E
Sbjct: 172 PDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 256 ARV-RNEKARRYLSSMRKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEALA 312
V N + + Y S P P P + P L + L +EPK R +A EA+
Sbjct: 230 PGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287
Query: 313 DPYF 316
PYF
Sbjct: 288 HPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 5e-62
Identities = 122/306 (39%), Positives = 171/306 (55%), Gaps = 35/306 (11%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFEHV-SDATRILREIKLLRLLR 80
+Y+ E IG+G+YG V A + T E VA+K++ +D E V S A LREI LL+ L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELK 57
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGL 139
H +IV + +L + + +VFE + DL + + N D+ PE + F++QLL+GL
Sbjct: 58 HKNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+ H+ NV HRDLKP+N+L N + +LK+ DFGLAR AF P + + V T WYR P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPD 169
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
L G+ Y+ +ID+WS GCIFAEL G+PLFPG +V QL + LLGTP
Sbjct: 170 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP------- 220
Query: 258 VRNEKARRYLSSMRKKKPIP-------FSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
E++ +S + KP P P N LL+ +L P R +AEEA
Sbjct: 221 --TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278
Query: 311 LADPYF 316
L PYF
Sbjct: 279 LQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 4e-61
Identities = 116/308 (37%), Positives = 178/308 (57%), Gaps = 38/308 (12%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI-LREIKLLRLLRHP 82
+Y+ ++G+GSYG+V TG+ VAIKK + E +I +REI++L+ LRH
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLE-SEDDKMVKKIAMREIRMLKQLRHE 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY---------QFFLY 133
++V L+ RR+ K +Y+VFE ++ H V+ DDL E Y + +L+
Sbjct: 61 NLVN----LIEVFRRK-KRLYLVFEFVD---HTVL---DDL--EKYPNGLDESRVRKYLF 107
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
Q+LRG+++ H+ N+ HRD+KP+NIL + +K+CDFG AR P ++ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 194 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
WYRAPEL G +KY A+DIW++GC+ E+LTG+PLFPG + + QL + LG P
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222
Query: 253 EAIARVRNEKAR-RYLSSMR---KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308
R + + + MR K+ P ++FP + L L L ++ L +P DRP++
Sbjct: 223 ----RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278
Query: 309 EALADPYF 316
+ L +F
Sbjct: 279 QLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 6e-61
Identities = 114/302 (37%), Positives = 166/302 (54%), Gaps = 20/302 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHP 82
+ I IG+G+YG V A D TGE VA+KK+ ++ + I +REIK+LR L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHR 66
Query: 83 DIVEIKHILLPPS-----RREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLL 136
+IV +K I+ +++ Y+VFE M+ DL ++++ + +H + F+ QLL
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
GL Y H N HRD+K NIL N ++K+ DFGLAR+ ++ +T+ V T WYR
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--YTNKVITLWYR 184
Query: 197 APELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
PEL G +Y PAID+WS GCI EL T KP+F + QL++++ L G+P P
Sbjct: 185 PPELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 256 ARVRNEKARRYLSSMRKKKPI--PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
V Y ++M+ KK ++F AL LL+ ML +P R TAEEAL
Sbjct: 243 PDVIKLP---YFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 314 PY 315
P+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 2e-60
Identities = 114/300 (38%), Positives = 165/300 (55%), Gaps = 16/300 (5%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PD 83
Y+ E IG+G+YG V A D TG+ VA+KK + LREI LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRG 138
IV + + + +Y+VFE ++SDL + + +N L + + F+YQLL+G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 139 LKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
+ + H V HRDLKP+N+L + LKI D GL R AF+ P + T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFS-IPVKSY-THEIVTLWYRA 179
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PE L GS + Y+ +DIWS+GCIFAE+ +PLFPG + + QL + LLGTP+ +
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
V R + KP S+ P+ +P L LL++ML ++P R +A+ AL PYF
Sbjct: 238 GVSK---LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 2e-60
Identities = 119/303 (39%), Positives = 169/303 (55%), Gaps = 16/303 (5%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y+ E IG+G+YGVV A D T E +A+KKI E + +REI LL+ ++H +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY--QFFLYQLLRGLKY 141
IV ++ ++ R +Y+VFE ++ DL + + ++ D + +LYQ+LRG+ Y
Sbjct: 63 IVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 142 IHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
H+ V HRDLKP+N+L + LK+ DFGLAR AF P F T V T WYRAPE
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPEI 174
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
L GS Y+ +DIWS+GCIFAE++ KPLFPG + + +L + +LGTP+ E V
Sbjct: 175 LLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
+ Y S+ K P + P P + LL +ML +P R TA AL YFK L
Sbjct: 233 S--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290
Query: 320 AKV 322
Sbjct: 291 GDA 293
|
Length = 294 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 7e-59
Identities = 111/314 (35%), Positives = 157/314 (50%), Gaps = 31/314 (9%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRL 78
E S+Y+ IG+G++G V A +T + VA+KK+ + E+ + I LREIK+L+L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQL 67
Query: 79 LRHPDIV---EIKHILLPPSRREFKDIYVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQ 134
L+H ++V EI P R Y+VFE E DL ++ N T + +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV---AFNDTPTAIFWTDYVA 191
LL GL YIH + HRD+K NIL D LK+ DFGLAR + N P +T+ V
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR--YTNRVV 185
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T WYR PE L G Y P ID+W GCI AE+ T P+ G HQL +++ L G+
Sbjct: 186 TLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP--------NANPLALRLLERMLAFEPK 302
+PE V + KK +P QK +P AL L++++L +P
Sbjct: 244 TPEVWPGVDK-------LELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA 296
Query: 303 DRPTAEEALADPYF 316
R A+ AL +F
Sbjct: 297 KRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 7e-55
Identities = 115/305 (37%), Positives = 169/305 (55%), Gaps = 16/305 (5%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ Y E +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 137
L+H +IV + I+ K + +VFE ++ DL Q + ++ H + FLYQ+LR
Sbjct: 61 LKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL Y H V HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT---YSNEVVTLWYRP 172
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
P+ L GS S+Y+ ID+W +GCIF E+ +G+PLFPG V +L ++ LLGTP+ E
Sbjct: 173 PDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230
Query: 257 RV-RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ N++ + Y + K KP P P + + LL + L +E K R +AEEA+ Y
Sbjct: 231 GISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288
Query: 316 FKGLA 320
F+ L
Sbjct: 289 FRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 4e-54
Identities = 80/294 (27%), Positives = 126/294 (42%), Gaps = 35/294 (11%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ E++G+GS+G V A D TGE +A+K + + + + REI++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV E + + E + L ++K L + + Q+L GL Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL ++D +K+ DFG A+ D T T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+Y A DIWS+GC E+ TGKP + + P
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-LYKIGSSGEPP---------- 223
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
IP + + A L + L +PK RPTA+E L P+
Sbjct: 224 ------------EIP-----EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 4e-54
Identities = 113/306 (36%), Positives = 165/306 (53%), Gaps = 16/306 (5%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ Y + +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 137
L+H +IV + I+ K + +VFE ++ DL Q + + H + FL+QLLR
Sbjct: 61 LKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR 115
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL Y H V HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT---YSNEVVTLWYRP 172
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
P+ L GS + Y+ ID+W +GCIF E+ TG+PLFPG V QL + +LGTP+ E
Sbjct: 173 PDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230
Query: 257 RV-RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ NE+ + Y + K + P + LL ++L FE + R +AEEA+ PY
Sbjct: 231 GILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288
Query: 316 FKGLAK 321
F L +
Sbjct: 289 FHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 179 bits (454), Expect = 6e-52
Identities = 110/301 (36%), Positives = 165/301 (54%), Gaps = 16/301 (5%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ Y + +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKN 59
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 137
L+H +IV + I+ + + +VFE ++SDL Q + +L H + F++QLLR
Sbjct: 60 LKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL Y H + HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT---YSNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
P+ L GS ++Y+ ID+W +GCI E+ TG+P+FPG V +L ++ LLGTP+ E
Sbjct: 172 PDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229
Query: 257 RV-RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ NE+ R YL + + P P + + LL +L +E K R +AE AL Y
Sbjct: 230 GITSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
Query: 316 F 316
F
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 1e-51
Identities = 71/197 (36%), Positives = 109/197 (55%), Gaps = 13/197 (6%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G+G +G V A D +TG+KVAIK I S +LREI++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 91 LLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVF 148
+ +Y+V E E L ++K N+ L+ + L Q+L GL+Y+H+ +
Sbjct: 60 FEDENH-----LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 149 HRDLKPKNIL-ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP+NIL + + K+K+ DFGL+++ +D V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL---KTIVGTPAYMAPEVL-LGKGY 170
Query: 208 YTPAIDIWSIGCIFAEL 224
Y+ DIWS+G I EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 101/296 (34%), Positives = 166/296 (56%), Gaps = 11/296 (3%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+++++ V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 141
+IVE+K RR K +Y+VFE +E ++ ++++ + + PE + ++YQL++ + +
Sbjct: 61 NIVELKEAF----RRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
H ++ HRD+KP+N+L + + LK+CDFG AR + +T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELL 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+ Y A+D+WS+GCI EL G+PLFPG++ + QL + +LG E + +
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 262 KARRYLSSMRKKKPIPFSQKFPNA-NPLALRLLERMLAFEPKDRPTAEEALADPYF 316
L P +++ + + L L++ +L P DR E+ L P F
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 3e-51
Identities = 82/303 (27%), Positives = 131/303 (43%), Gaps = 35/303 (11%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-TRILREIKLLRLLRHPD 83
Y+I +G+GS+G V A D + VA+K + E S R LREI++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 84 -IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHYQFFLYQLLRGL 139
IV++ V+ + L ++K L+ F L Q+L L
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 140 KYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDT---PTAIFWTDYVATRWY 195
+Y+H+ + HRD+KP+NIL + D +K+ DFGLA++ + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
APE+ G + + + DIWS+G ELLTG P F G+ +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-----------QT 223
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+ + S + P + A LL+++LA +PK+R ++ L+
Sbjct: 224 LKIILELPTPSLASPLSPSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 315 YFK 317
Sbjct: 277 LLA 279
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 86/304 (28%), Positives = 141/304 (46%), Gaps = 57/304 (18%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRH 81
+Y+I + IGKGS+G V G+ +K+I+ ++S+ R L E+K+L+ L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID--LSNMSEKEREDALNEVKILKKLNH 58
Query: 82 PDIVE-IKHILLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHYQ--FFLYQ 134
P+I++ + E + +V E + DL Q IK PE Q + Q
Sbjct: 59 PNIIKYYESFE------EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-QILDWFVQ 111
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
L LKY+H+ + HRD+KP+NI ++ +K+ DFG+++V + A V T +
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGTPY 168
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
Y +PELC + Y DIWS+GC+ EL T K F G+N+ E
Sbjct: 169 YLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENL---------------LEL 211
Query: 255 IARVRNEKARRYLSSMRKKKPIP--FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
++ + PIP +S + N L+ +L +P++RP+ + L
Sbjct: 212 ALKILKG----------QYPPIPSQYSSELRN-------LVSSLLQKDPEERPSIAQILQ 254
Query: 313 DPYF 316
P+
Sbjct: 255 SPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-46
Identities = 114/315 (36%), Positives = 163/315 (51%), Gaps = 41/315 (13%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G + Y E +G+GSY V G+ VA+K I+ E T I RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKG 59
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQ-VIKANDDLTPEHYQFFLYQLLR 137
L+H +IV + I+ F VFE M +DL Q +I+ L P + + F++QLLR
Sbjct: 60 LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL YIH ++ HRDLKP+N+L + +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMTDLLGTPSPEAI 255
P+ L G+ + Y+ A+DIW GCIF E+L G+P FPG +V QL+ + +LG P+ +
Sbjct: 172 PDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR--------------LLERMLAFEP 301
V S + KP + F P LR L +ML P
Sbjct: 230 PGV---------SKLPNYKP----EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276
Query: 302 KDRPTAEEALADPYF 316
KDR +A++AL PYF
Sbjct: 277 KDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 5e-46
Identities = 110/337 (32%), Positives = 175/337 (51%), Gaps = 29/337 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
YK+ +IG GS+GVV A T EKVAIKK+ + D RE+ +++ L H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINI 121
Query: 85 VEIKHILLPPS-RREFKDIY--VVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLR 137
+ +K ++ K+I+ VV E + +H+ +K N L + + YQL R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 138 GLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L YIH+ + HRDLKP+N+L + + LK+CDFG A+ + Y+ +R+YR
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS----VSYICSRFYR 237
Query: 197 APEL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APEL G+ + YT ID+WS+GCI AE++ G P+F G++ V QL + +LGTP+ + +
Sbjct: 238 APELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANP-LALRLLERMLAFEPKDRPTAEEALADP 314
+ A + KP + FP P A+ + + L +EP R EALADP
Sbjct: 296 KEMNPNYADIKFPDV---KPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352
Query: 315 YFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVREL 351
+F L R+P + ++ + +++E+
Sbjct: 353 FFDDL----RDPCIKLPKYIDKLPDLFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 45/294 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++I E IGKG +G V A RTG++VAIK I E +I+ EI++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNI 59
Query: 85 VE-IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPE-HYQFFLYQLLRGLKY 141
V+ L ++++V E L ++K+ + E + +LL+GL+Y
Sbjct: 60 VKYYGSYLKK------DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+ + HRD+K NIL +D ++K+ DFGL+ +DT V T ++ APE+
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI 169
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
Y DIWS+G EL GKP + +L M +A+ ++
Sbjct: 170 --NGKPYDYKADIWSLGITAIELAEGKPPY------SELPPM---------KALFKIATN 212
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ K F + F L++ L P+ RPTAE+ L P+
Sbjct: 213 GPPGLRNPE--KWSDEF-KDF----------LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-44
Identities = 103/305 (33%), Positives = 160/305 (52%), Gaps = 28/305 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEK-VAIKKINDIFEHVSDATRILREIKLLRLLR-- 80
+Y+ IG+G+YG V A D + G + VA+K++ +RE+ +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 81 -HPDIVEIKHI-LLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLL 136
HP++V + + + + RE K + +VFE ++ DL + + + E + ++QLL
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVATRWY 195
RGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ +F T++ V T WY
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-----VVTLWY 175
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE-- 253
RAPE+ S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P E
Sbjct: 176 RAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
Query: 254 --AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+A R + P + + + L LL + L F P R +A AL
Sbjct: 234 PRDVALPRQAFHSKSAQ--------PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285
Query: 312 ADPYF 316
+ PYF
Sbjct: 286 SHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 4e-43
Identities = 92/298 (30%), Positives = 139/298 (46%), Gaps = 49/298 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFEHVSDATRILREIKLLRLLRH 81
Y++ ++IG+G++GVV + TG+ VAIK+I I E I++EI LL+ L+H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKH 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGL 139
P+IV K+I S +Y++ E E+ L Q+IK PE ++YQ+L+GL
Sbjct: 59 PNIV--KYI---GSIETSDSLYIILEYAENGSLRQIIKKFGPF-PESLVAVYVYQVLQGL 112
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAP 198
Y+H V HRD+K NIL D +K+ DFG+A ++ V T ++ AP
Sbjct: 113 AYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD----ASVVGTPYWMAP 168
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
E+ S + A DIWS+GC ELLTG P + DL + I +
Sbjct: 169 EVIE--MSGASTASDIWSLGCTVIELLTGNPPY------------YDLNPMAALFRIVQ- 213
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
P+P +P L + +P RPTA++ L P+
Sbjct: 214 ------------DDHPPLP-----EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 3e-42
Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 56/305 (18%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHP 82
Y++ E IGKGS+G V G+ + K+I+ + ++++ + ++ E+ +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 83 DIVE-IKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHY--QFFLYQL 135
+IV I+ ++ +Y+V E E DL Q+I K E + + QL
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QL 114
Query: 136 LRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
L L H + V HRDLKP NI +A+ +K+ DFGLA++ +D+ A YV
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA---KTYV 171
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T +Y +PE Y DIWS+GC+ EL P F +N QL
Sbjct: 172 GTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QL---------- 216
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
+ ++++ K RR IP + N +++ ML +P RP+ EE
Sbjct: 217 --QLASKIKEGKFRR----------IP-YRYSSELN----EVIKSMLNVDPDKRPSTEEL 259
Query: 311 LADPY 315
L P
Sbjct: 260 LQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 1e-41
Identities = 101/299 (33%), Positives = 145/299 (48%), Gaps = 17/299 (5%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--- 80
+Y+ IG G+YG V A D +G VA+K + +RE+ LL+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRG 138
HP+IV + + + +VFE ++ DL + L E + + Q LRG
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L ++H + HRDLKP+NIL + ++K+ DFGLAR+ + T V T WYRAP
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALTPVVVTLWYRAP 176
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
E+ S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P +
Sbjct: 177 EVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-- 232
Query: 259 RNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
R+ R S R +P+ Q P +LL ML F P R +A AL P+F
Sbjct: 233 RDVTLPRGAFSPRGPRPV---QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 2e-41
Identities = 108/310 (34%), Positives = 169/310 (54%), Gaps = 25/310 (8%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ Y+ E +G+GSY V G+ VA+K I E + T I RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKG 59
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLR 137
L+H +IV + I+ + + +VFE + +DL Q + K L PE+ + FL+QLLR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL YIH + HRDLKP+N+L + +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMTDLLGTPSPE-- 253
P+ L GS ++Y+ +D+W +GCIF E++ G FPG K++ QL+ + +LGTP+ +
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 254 ----AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
++ + E+ Y ++ S +A LA +LL+ PK+R +A+
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSY-VNHAEDLASKLLQ----CFPKNRLSAQA 284
Query: 310 ALADPYFKGL 319
AL+ YF L
Sbjct: 285 ALSHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 89/310 (28%), Positives = 136/310 (43%), Gaps = 73/310 (23%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHP 82
YK E IG+G+ G V A D TG++VAIKK+ + + I+ EI +++ +HP
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-----LRKQNKELIINEILIMKDCKHP 75
Query: 83 DIVE-IKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGL 139
+IV+ L+ +++VV E M+ L +I N + + ++L+GL
Sbjct: 76 NIVDYYDSYLVG------DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVAFNDTPTAIFWTDYV 190
+Y+H+ NV HRD+K NIL + D +K+ DFG A R + TP +W
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTP---YWM--- 183
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
APE+ Y P +DIWS+G + E+ G+P P L P
Sbjct: 184 ------APEVIKR--KDYGPKVDIWSLGIMCIEMAEGEP--P-------------YLREP 220
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN---PLALRLLERMLAFEPKDRPTA 307
A+ + K IP N P L + L +P+ RP+A
Sbjct: 221 PLRALFLIT-------------TKGIP---PLKNPEKWSPEFKDFLNKCLVKDPEKRPSA 264
Query: 308 EEALADPYFK 317
EE L P+ K
Sbjct: 265 EELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 7e-40
Identities = 114/327 (34%), Positives = 168/327 (51%), Gaps = 59/327 (18%)
Query: 31 IGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G+G+YG V A D + A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 89 HILLPPSRREFKDIYVVFELMESDL------HQVIKAND---DLTPEHYQFFLYQLLRGL 139
+ L + R+ ++++F+ E DL H+ KAN L + LYQ+L G+
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 140 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFNDTPTAIFWTD-YVATRW 194
Y+H V HRDLKP NIL + ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 195 YRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-------NVVH--QLDIMT 244
YRAPEL G+ YT AIDIW+IGCIFAELLT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 245 DLLGTPS----------PEAIARVRNEKARRY-----LSSMRKKKPIPFSQKFPNANPLA 289
+++G P+ PE +++ + Y + M K K P S+ F
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF------- 291
Query: 290 LRLLERMLAFEPKDRPTAEEALADPYF 316
LL+++L +P R T+E+A+ DPYF
Sbjct: 292 -HLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 117/327 (35%), Positives = 169/327 (51%), Gaps = 59/327 (18%)
Query: 31 IGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G+G+YG V A D + ++ A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 89 HILLPPSRREFKDIYVVFELMESDL------HQVIKAND---DLTPEHYQFFLYQLLRGL 139
+ L S R+ ++++F+ E DL H+ KAN L + LYQ+L G+
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 140 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFNDTPTAIFWTD-YVATRW 194
Y+H V HRDLKP NIL + ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 195 YRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-------NVVH--QLDIMT 244
YRAPEL G+ YT AIDIW+IGCIFAELLT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238
Query: 245 DLLGTPS----------PEAIARVRNEKARRYLSS-----MRKKKPIPFSQKFPNANPLA 289
++G P+ PE ++ + Y +S M K K P S+ F
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVF------- 291
Query: 290 LRLLERMLAFEPKDRPTAEEALADPYF 316
LL+++L +P R T+E+AL DPYF
Sbjct: 292 -LLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 1e-38
Identities = 80/301 (26%), Positives = 130/301 (43%), Gaps = 67/301 (22%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLL 79
+ + +G+G++G V + +VA+K + E S+ LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK---EDASEQQIEEFLREARIMRKL 58
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 137
HP++V++ + +Y+V E ME DL ++ N L+ F Q+ R
Sbjct: 59 DHPNVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT----- 192
G++Y+ + N HRDL +N L + +KI DFGL+R ++D DY
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYRKRGGKL 165
Query: 193 --RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLG 248
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 166 PIRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE----------- 210
Query: 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308
E + ++N R +P PN P L+ + A +P+DRPT
Sbjct: 211 ----EVLEYLKNGY--------RLPQP-------PNCPPELYDLMLQCWAEDPEDRPTFS 251
Query: 309 E 309
E
Sbjct: 252 E 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 81/291 (27%), Positives = 125/291 (42%), Gaps = 39/291 (13%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH 89
V+G+GS GVV TG+ A+KKI+ + ++LRE+K LR P +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 90 ILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANV 147
I +V E M+ L ++K + + Q+L+GL Y+HT ++
Sbjct: 67 AFYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
HRD+KP N+L N+ ++KI DFG+++V + T +V T Y +PE
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNT-FVGTVTYMSPERIQG--ES 176
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 267
Y+ A DIWS+G E GK F ++M + P P
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL------------- 223
Query: 268 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
FS +F + + L +PK RP+A E L P+ K
Sbjct: 224 ------PAEEFSPEFRD-------FISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 87/288 (30%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG G++G V +A + TGE +A+K+I I E+K+L LL+HP++V+ +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 91 LLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 149
+ RE +Y+ E L ++++ L + + QLL GL Y+H+ + H
Sbjct: 68 EV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 150 RDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPEL-CGSFFSK 207
RD+KP NI + + +K+ DFG A ++ N T T Y APE+ G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 267
+ A DIWS+GC+ E+ TGK + +LD NE +
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPW------SELD------------------NEFQIMFH 218
Query: 268 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
K PIP S + +P L+R L +PK RPTA E L P+
Sbjct: 219 VGAGHKPPIPDSLQ---LSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 54/295 (18%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+GKGS+G V TG+ A+K + I + + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 89 HILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
F+ +Y+V E +L + + E +F+ +++ L+Y+H+
Sbjct: 60 --------YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS 111
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL +AD +K+ DFGLA+ ++ + T Y APE+
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG- 167
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264
Y A+D WS+G + E+LTGKP F ++ R
Sbjct: 168 -KGYGKAVDWWSLGVLLYEMLTGKPPFYAED----------------------------R 198
Query: 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYF 316
+ + K P+ F + P A L+ +L +P R AEE A P+F
Sbjct: 199 KEIYEKILKDPLRFPEFLS---PEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 5e-37
Identities = 78/302 (25%), Positives = 127/302 (42%), Gaps = 68/302 (22%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLL 79
+ + +G+G++G V +VA+K + + S+ LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE---DASEQQIEEFLREARIMRKL 58
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLL 136
HP+IV++ + + +V E M DL ++ N L+ F Q+
Sbjct: 59 DHPNIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT---- 192
RG++Y+ + N HRDL +N L + +KI DFGL+R ++D DY
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYKVKGGK 165
Query: 193 ---RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 166 LPIRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA---------- 211
Query: 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA 307
E + ++ R KP PN P +L+ + A +P+DRPT
Sbjct: 212 -----EVLEYLKKGY--------RLPKP-------PNCPPELYKLMLQCWAEDPEDRPTF 251
Query: 308 EE 309
E
Sbjct: 252 SE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 86/327 (26%), Positives = 140/327 (42%), Gaps = 84/327 (25%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK---------- 74
+K ++IG+GS+ V A + T ++ AIK ++ +++E K
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ--------LIKEKKVKYVKIEKEV 54
Query: 75 LLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQF 130
L RL HP I+++ + F+D +Y V E + +L Q I+ L + +F
Sbjct: 55 LTRLNGHPGIIKLYY--------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF 106
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--------AFNDTPT 182
+ ++L L+Y+H+ + HRDLKP+NIL + D +KI DFG A+V + T
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 183 AIFWTD---------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
I +V T Y +PEL + D+W++GCI ++LTGKP F G
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRG 224
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 293
N ++ + F FP P A L+
Sbjct: 225 SN---------------EYLTFQKILKLE-------------YSFPPNFP---PDAKDLI 253
Query: 294 ERMLAFEPKDRPTA----EEALADPYF 316
E++L +P+DR +E A P+F
Sbjct: 254 EKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 52/302 (17%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKIND---IFEHVSDATRILREIKLLRLLRHPDIVEI 87
I KG+YG V A TG+ AIK I I ++ D ++L E +L + P +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD--QVLTERDILSQAQSPYVVKL 58
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
+ S + K++Y+V E + DL +++ L + + ++ +++ L+Y+H+
Sbjct: 59 YY-----SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-----VATRWYRAPELC 201
+ HRDLKP NIL +++ LK+ DFGL++V + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI-ARVRN 260
++ +D WS+GCI E L G P F G+ PE I + N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGET----------------PEEIFQNILN 215
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA---EEALADPYFK 317
K I + + + A+ L+ ++L +P+ R A EE P+FK
Sbjct: 216 GK-------------IEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
Query: 318 GL 319
G+
Sbjct: 262 GI 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 33/233 (14%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
++ + +G+G++G V T KVA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
P+IV + + + + +Y+V E M DL ++ + + LT + Q+ +G+
Sbjct: 61 PNIVRLLGVCT-----QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
+Y+ + N HRDL +N L + +KI DFGL+R + D Y
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-------DYYRKRGGGKLPI 168
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W APE K+T D+WS G + E+ T G+ +PG + V+ L+
Sbjct: 169 KWM-APESL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218
|
Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 84/300 (28%), Positives = 138/300 (46%), Gaps = 51/300 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLLR 77
R++ E++G GS+G V + G+ A+K+++ E V ++ +EI LL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK---QLEQEIALLS 57
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLL 136
L+HP+IV+ + RE ++Y+ EL+ L +++K + + Q+L
Sbjct: 58 KLQHPNIVQYLG-----TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL 112
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWY 195
GL+Y+H N HRD+K NIL + + +K+ DFG+A+ V F + + ++
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-----FAKSFKGSPYW 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ Y A DIWS+GC E+ TGKP + QL+ + A+
Sbjct: 168 MAPEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPW------SQLEGV---------AAV 211
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
++ K PIP A L+ L+R +P RPTA E L P+
Sbjct: 212 FKIGRSKEL---------PPIPDHLS-DEAKDFILKCLQR----DPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 90/315 (28%), Positives = 134/315 (42%), Gaps = 78/315 (24%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATR-----ILREIKLLRLLR 80
E+IGKG+YG V A + TGE +A+K++ I + + EI+ L+ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLH------------QVIKANDDLTPEHY 128
H +IV+ Y+ FE E L ++ +
Sbjct: 67 HLNIVQ----------------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110
Query: 129 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR----VAFNDTPT-- 182
+FF Q+L GL Y+H+ + HRDLK N+L +AD KI DFG+++ + ND
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 183 --AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
++FW APE+ S+ Y+ +DIWS+GC+ E+ G+ P +
Sbjct: 171 QGSVFWM---------APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR--PWSDE---- 215
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
EAIA A L + R PIP N +P+AL L
Sbjct: 216 ------------EAIA------AMFKLGNKRSAPPIP-PDVSMNLSPVALDFLNACFTIN 256
Query: 301 PKDRPTAEEALADPY 315
P +RPTA E L P+
Sbjct: 257 PDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD-ATRILREIKLLRLLRH 81
+ + E IGKGS+G V A D RT + VAIK I+ E D I +EI+ L R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 137
P I + L S+ ++++ E DL + K L + F L ++L
Sbjct: 59 PYITKYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLL 109
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL+Y+H HRD+K NIL + + +K+ DFG V+ T T +V T ++ A
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDVKLADFG---VSGQLTSTMSKRNTFVGTPFWMA 166
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
PE+ S Y DIWS+G EL G+P
Sbjct: 167 PEVIKQ--SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 71/289 (24%), Positives = 121/289 (41%), Gaps = 55/289 (19%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATR-ILREIKLLRLLRH 81
+++ VIGKG++G VC T + A+K +N E + R +L E ++L+ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE--KGSVRNVLNERRILQELNH 59
Query: 82 PDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 137
P +V + F+D +Y+V +L+ DL + + E +F++ +++
Sbjct: 60 PFLVNL--------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVL 111
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L+Y+H+ + HRD+KP NIL + + I DF +A DT T T T Y A
Sbjct: 112 ALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT----TSTSGTPGYMA 167
Query: 198 PELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PE+ + Y+ A+D WS+G E L GK + G T + I
Sbjct: 168 PEV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH------------SRTIR-DQIR 211
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR-LLERMLAFEPKDR 304
+ +P + ++L +P+ R
Sbjct: 212 AKQETA----------------DVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 7e-29
Identities = 77/305 (25%), Positives = 125/305 (40%), Gaps = 73/305 (23%)
Query: 29 EVIGKGSYGVVCSA-YDTRTGEK--VAIKKINDIFEHVSDATR--ILREIKLLRLLRHPD 83
+ +G+G++G V + G+ VA+K + E S+ R L+E ++++ L HP+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEERKDFLKEARVMKKLGHPN 57
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN---------DDLTPEHYQFFLY 133
+V + + E + +Y+V E ME DL ++ + L+ + F
Sbjct: 58 VVRLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT- 192
Q+ +G++Y+ + HRDL +N L D +KI DFGL+R ++D Y
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD-------DYYRKKT 165
Query: 193 ------RWYRAPELCGSFFS-KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245
RW APE S +T D+WS G + E+ T
Sbjct: 166 GGKLPIRWM-APE---SLKDGIFTSKSDVWSFGVLLWEIFT------------------- 202
Query: 246 LLGTPSPEAIARVRNEKARRYLSS-MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 304
L TP P + NE+ YL R KP + L+ +P+DR
Sbjct: 203 LGATPYPG----LSNEEVLEYLRKGYRLPKPEYCPDEL-------YELMLSCWQLDPEDR 251
Query: 305 PTAEE 309
PT E
Sbjct: 252 PTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 46/290 (15%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR---ILREIKLLRLLRHPDIVEI 87
IG+GS G+VC A D TG +VA+KK++ + R + E+ ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD-----LRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
L +++VV E +E I + + E +L+ L ++H V
Sbjct: 82 YSSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
HRD+K +IL +D ++K+ DFG + P V T ++ APE+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEVISR--LP 191
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 267
Y +DIWS+G + E++ G+P + P +A+ R+R+
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLQAMKRIRDNLP---- 232
Query: 268 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
P + +P L+RML +P R TA E L P+
Sbjct: 233 ---------PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 85/299 (28%), Positives = 137/299 (45%), Gaps = 54/299 (18%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ I E +G+GSYG V A TG+ VAIK + + E + + I++EI +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQE---IIKEISILKQCDSPYI 60
Query: 85 VEIKHILLPPSRREFKDIYVVFELME-------SDLHQVIKANDDLTPEHYQFFLYQLLR 137
V+ S + D+++V ME SD+ ++ N LT E LYQ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIV---MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLK 110
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL+Y+H+ HRD+K NIL N + + K+ DFG V+ T T + T ++ A
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG---VSGQLTDTMAKRNTVIGTPFWMA 167
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PE+ Y DIWS+G E+ GKP P + +H + + + P P
Sbjct: 168 PEVIQE--IGYNNKADIWSLGITAIEMAEGKP--PYSD-IHPMRAIFMIPNKPPPTL--- 219
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
P +S +F + +++ L +P++RP+A + L P+
Sbjct: 220 ---------------SDPEKWSPEFND-------FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 74/208 (35%), Positives = 112/208 (53%), Gaps = 20/208 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHP 82
+KIE+ IGKG + VV A G VA+KK+ IFE + R L+EI LL+ L HP
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIK---ANDDLTPEH--YQFFLYQLL 136
++ IK++ S E ++ +V EL ++ DL ++IK L PE +++F QL
Sbjct: 63 NV--IKYL---ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLC 116
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L+++H+ + HRD+KP N+ A +K+ D GL R F+ TA V T +Y
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAH--SLVGTPYYM 173
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEL 224
+PE + Y DIWS+GC+ E+
Sbjct: 174 SPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 81/303 (26%), Positives = 127/303 (41%), Gaps = 45/303 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y++ EVIG G+ VV +A EKVAIK+I D+ + + + +E++ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA--NDDLTPEHY-QFFLYQLLRG 138
++V+ S ++++V + L ++K+ E L ++L+G
Sbjct: 60 NVVKYY-----TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRA 197
L+Y+H+ HRD+K NIL D +KI DFG+ A +A T +V T + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKP----LFPGKNVVHQLDIMTDLLGTPSPE 253
PE+ Y DIWS G EL TG P K ++ L P
Sbjct: 175 PEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQNDPPS 226
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
L + K +S+ F ++ L +P RPTAEE L
Sbjct: 227 -------------LETGADYK--KYSKSFRK-------MISLCLQKDPSKRPTAEELLKH 264
Query: 314 PYF 316
+F
Sbjct: 265 KFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 81/302 (26%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRH 81
Y V+GKG++G T V K++N + E L EI +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA--LNEIVILSLLQH 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDD-LTPEHY-QFFLYQL 135
P+I+ + F D + ME L+ I L E ++L+Q+
Sbjct: 59 PNIIAYYN--------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ + YIH A + HRD+K NI +K+ DFG++++ ++ A V T +Y
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA---ETVVGTPYY 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG---TPSP 252
+PELC KY DIW++GC+ ELLT K F N L+++ ++ TP
Sbjct: 168 MSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTPVV 222
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
Y S + L+ +L +P+ RPTA+E L
Sbjct: 223 S-----------VYSSELIS-------------------LVHSLLQQDPEKRPTADEVLD 252
Query: 313 DP 314
P
Sbjct: 253 QP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 89/303 (29%), Positives = 134/303 (44%), Gaps = 61/303 (20%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRH 81
+K+ + +GKGSYG V + A+K+++ +S R + EI++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI---KANDDLTPEH--YQFFLYQL 135
P+I+ K L ++ + +V E DL + I K L PE ++ F+ QL
Sbjct: 59 PNIISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-TPTAIFWTDYVATRW 194
LRGL+ +H + HRDLK NIL A+ +KI D G+++V + T I T
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI------GTPH 166
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
Y APE+ Y+ DIWS+GC+ E+ T P F ++ M DL
Sbjct: 167 YMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDL-------- 209
Query: 255 IARVRNEKARRYLSSMRKK-KPIP--FSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
R K PIP +SQ N + ML +PK RP ++ L
Sbjct: 210 -----------RYKVQRGKYPPIPPIYSQDLQN-------FIRSMLQVKPKLRPNCDKIL 251
Query: 312 ADP 314
A P
Sbjct: 252 ASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 62/225 (27%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA---TRILREIKLLRLLRHPDIVEI 87
+G G +G V A+K + H+ + I E ++L HP IV++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK--RHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 88 KHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
R FKD ++ LME +L +++ +F++ ++ +Y+H
Sbjct: 59 --------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ +RDLKP+N+L +++ +K+ DFG A+ + T WT + T Y APE+
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPEII-- 164
Query: 204 FFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
+K Y ++D WS+G + ELLTG+P F G++ ++I D+L
Sbjct: 165 -LNKGYDFSVDYWSLGILLYELLTGRPPF-GEDDEDPMEIYNDIL 207
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 76/298 (25%), Positives = 133/298 (44%), Gaps = 44/298 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-----ILREIKLLRLL 79
++ +++G+G++G V YD TG ++A+K++ F+ S T+ + EI+LL+ L
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLKNL 61
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+H IV+ L R+ + + + E M + +KA LT + + Q+L G
Sbjct: 62 QHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
E+ Y D+WS+GC E+LT KP P EA+A +
Sbjct: 177 EVISG--EGYGRKADVWSVGCTVVEMLTEKP--PWAEF----------------EAMAAI 216
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
+ + P Q + +P A L R K RP+AEE L +
Sbjct: 217 FK---------IATQPTNP--QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 9e-26
Identities = 75/286 (26%), Positives = 131/286 (45%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A + +G +VA+K ++ + E+ ++R +H ++VE+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
L ++++V+ E ++ I + L E +L+ L Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL D ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 270
+DIWS+G + E++ G+P + + V +A+ R+R+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPV---------------QAMKRLRDS--------- 232
Query: 271 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
P P + +P+ LERML EP++R TA+E L P+
Sbjct: 233 ----PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 82/293 (27%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G G+ GVV TG+ +A+K I +I E + +ILRE+ +L P IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ--KQILRELDILHKCNSPYIVGFY 65
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTA- 145
DI + E M+ L +++K PE +L+GL Y+H
Sbjct: 66 GAFY----NN-GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
+ HRD+KP NIL N+ ++K+CDFG++ N +V T Y APE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-----KTFVGTSSYMAPERIQG-- 173
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265
+ Y+ DIWS+G EL TG+ FP E + + NE R
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR--FPYPP--ENDPPDGIF------ELLQYIVNEPPPR 223
Query: 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
S FS F + + L +P++RP+ +E L P+ K
Sbjct: 224 LPSGK-------FSPDFQD-------FVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 53/299 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRH 81
+Y+ V+G+G++G+V + V IK+I E ++ R E ++L+LL H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP--VEQMTKDERLAAQNECQVLKLLSH 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI-KANDDLTPEH--YQFFLYQLLR 137
P+I+E L E K + +V E L + I K + L E FF+ Q+L
Sbjct: 59 PNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV-QILL 112
Query: 138 GLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L ++HT + HRDLK +NIL + +KI DFG++++ + + V T Y
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV----VGTPCYI 168
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPEAI 255
+PELC Y DIW++GC+ EL + K F N+ L IM+ GT +P
Sbjct: 169 SPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS---GTFAP--- 220
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+ RY +R +L+ ML +P RP + +A P
Sbjct: 221 ------ISDRYSPDLR-------------------QLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 88/304 (28%), Positives = 133/304 (43%), Gaps = 62/304 (20%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKK--INDIFEHVSDATRIL-----REIKLLRLLRHP 82
+IG GS+G V + +GE +A+K+ + + D R + REI LL+ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 141
+IV+ L + +I++ E + + N E + F+ Q+L+GL Y
Sbjct: 67 NIVQY---LGSSLDADHLNIFL--EYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPEL 200
+H + HRD+K NIL + +KI DFG++ ++ N T T R P L
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST--------KTNGAR-PSL 172
Query: 201 CGSFF---------SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
GS F + YT DIWS+GC+ E+LTGK FP T L
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD---------CTQL----- 218
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+AI ++ E A P S N + A+ LE+ + RPTA E L
Sbjct: 219 -QAIFKI-GENAS----------PEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELL 262
Query: 312 ADPY 315
P+
Sbjct: 263 KHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 75/293 (25%), Positives = 127/293 (43%), Gaps = 43/293 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++I IGKGS+GVV A+K+I+ + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKY 141
I++ S + + +V E E+ DLH+++K L + F Q+L GL +
Sbjct: 62 --IRYY---ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+ + HRD+K N+ +A +KI D G+A++ + F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
Y D+W++G + E TGK H D N+
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGK---------HPFD----------------ANNQ 206
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
A L +R P P SQ + + +L+++ L + + RP + L +P
Sbjct: 207 GA-LILKIIRGVFP-PVSQMY---SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 40/287 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A + TG++VA+KK++ + E+ ++R H ++V++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
L +++VV E +E I + + E +LR L Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL +D ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 270
+DIWS+G + E++ G+P + P +A+ R+R+ R S
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY---------------FNEPPLQAMRRIRDNLPPRVKDSH 242
Query: 271 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ + + L+ ML EP R TA+E L P+ K
Sbjct: 243 K-------------VSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 54/309 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-R 80
+++ EVIG+G+YG V A +TG+ VAIK ++ I + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSN 61
Query: 81 HPDIVEIKHILLPPSRREFKD-IYVVFELME----SDLHQ-VIKANDDLTPEHYQFFLYQ 134
HP+I + + D +++V EL +DL + + K L E + L +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----VAFNDTPTAIFWTDY 189
LRGL Y+H V HRD+K +NIL + ++K+ DFG++ + +T +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--------F 173
Query: 190 VATRWYRAPE--LCG-SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
+ T ++ APE C + Y D+WS+G EL GKP +H + + +
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD---MHPMRALFKI 230
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
P P K P +S+KF + + L + RP
Sbjct: 231 PRNPPP------------------TLKSPENWSKKFND-------FISECLIKNYEQRPF 265
Query: 307 AEEALADPY 315
EE L P+
Sbjct: 266 MEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 93/300 (31%), Positives = 129/300 (43%), Gaps = 61/300 (20%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH 89
V+GKG+YG+V +A D T ++AIK+I + + EI L L+H +IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQY-- 70
Query: 90 ILLPPSRREFKDIYVVFELME-------SDLHQV----IKANDDLTPEHYQFFLYQLLRG 138
L S F I+ ME S L + +K N+ F+ Q+L G
Sbjct: 71 -LGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQTI----IFYTKQILEG 120
Query: 139 LKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYR 196
LKY+H + HRD+K N+L N +KI DFG + R+A + T F T Y
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF----TGTLQYM 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
APE+ Y DIWS+GC E+ TGKP F + LG P
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------IE-------LGEP------ 217
Query: 257 RVRNEKARRYLSSMRKKKP-IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+A + M K P IP S A LR E +P R +A + L DP+
Sbjct: 218 -----QAAMFKVGMFKIHPEIPESLS-AEAKNFILRCFEP----DPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 15/221 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+I + IG+GS+G + A E IK+I+ V + +E+ LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLY--QLLRGLK 140
IV S +E +++V E + DL + I + Q + Q+ GLK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 141 YIHTANVFHRDLKPKNILANADCKL-KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+IH + HRD+K +NI + + + K+ DFG+AR ND+ V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSME--LAYTCVGTPYYLSPE 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
+C + Y DIWS+GC+ EL T K F G N +HQL
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 85/299 (28%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y++ + IG G+YG V A D TGE VAIK I E D I +EI +L+ RHP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
+IV L RR+ +++V E D++QV L+ + + L+G
Sbjct: 61 NIVAYFGSYL---RRD--KLWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKG 113
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L Y+H HRD+K NIL D +K+ DFG V+ T T ++ T ++ AP
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAP 170
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
E Y DIW++G EL + P+F L M L
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMF-------DLHPMRALFLISKSNFPP 223
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+K + +S F + +++ L +PK RPTA + L P+
Sbjct: 224 PKLKDKEK-------------WSPVFHD-------FIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 79/305 (25%), Positives = 130/305 (42%), Gaps = 58/305 (19%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI----NDIFEHVSDATRILREIKLLRLLRHPDI 84
+ +G G++ A D +TG +A+K++ N E + +EI+L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 85 VEIKHILLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
+ + + E + E M L + + + + QLLRGL
Sbjct: 66 IR-----MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRGL 116
Query: 140 KYIHTANVFHRDLKPKNILANADCK-LKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRA 197
Y+H + HRD+K N+L ++ + L+I DFG A R+A T F + T + A
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL---LGTPS-P 252
PE L G +Y + D+WS+GC+ E+ T KP + + + L ++ + PS P
Sbjct: 177 PEVLRG---EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
E ++ P + LR LE +P+DRP + E L
Sbjct: 234 EHLS--------------------------PGLRDVTLRCLEL----QPEDRPPSRELLK 263
Query: 313 DPYFK 317
P F+
Sbjct: 264 HPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 90/309 (29%), Positives = 134/309 (43%), Gaps = 50/309 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLL 79
S Y+ E+IG+G+YG V TG VA+K IN + VSD I RE+ LL L
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSD---IQREVALLSQL 56
Query: 80 RH---PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQL 135
R P+I + L R ++++ E E + ++KA + ++ + ++
Sbjct: 57 RQSQPPNITKYYGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREV 110
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L LKYIH V HRD+K NIL +K+CDFG VA + + +V T ++
Sbjct: 111 LVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTPYW 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ Y DIWS+G E+ TG P + V M L+ P +
Sbjct: 168 MAPEVITE-GKYYDTKADIWSLGITIYEMATGNPPYSD---VDAFRAM-MLIPKSKPPRL 222
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ Y +R+ F +A L E EPK+R +AEE L +
Sbjct: 223 ------EDNGYSKLLRE-----F---------VAACLDE-----EPKERLSAEELLKSKW 257
Query: 316 FKGLAKVER 324
K +K
Sbjct: 258 IKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 73/212 (34%), Positives = 108/212 (50%), Gaps = 16/212 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y + V+G+GS+G + +K A+K+I + + S +E LL ++HP+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEH--YQFFLYQLLRGL 139
IV K S +Y+V E + DL Q IK L PE Q+F+ Q+ G+
Sbjct: 60 IVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV-QMCLGV 113
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
++IH V HRD+K KNI + K+K+ DFG AR+ + P A + YV T +Y PE
Sbjct: 114 QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPPE 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ + Y DIWS+GCI EL T K F
Sbjct: 171 IWENM--PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A +G+ VA+KK++ + E+ ++R +H ++VE+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
L +++VV E +E I + + E +L+ L +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL D ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 270
+DIWS+G + E++ G+P + NE + + +
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY---------------------------FNEPPLKAMKMI 228
Query: 271 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
R P P + +P L+R+L +P R TA E L P+
Sbjct: 229 RDNLP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 102/333 (30%), Positives = 150/333 (45%), Gaps = 74/333 (22%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLLRHPDIVE 86
IG GS+G V A D RT E VAIKK++ E D I++E++ L+ LRHP+ +E
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD---IIKEVRFLQQLRHPNTIE 79
Query: 87 IKHILLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
K L RE + + +ME SD+ +V K L + L+GL
Sbjct: 80 YKGCYL----RE----HTAWLVMEYCLGSASDILEVHK--KPLQEVEIAAICHGALQGLA 129
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+H+ HRD+K NIL +K+ DFG A + +P F V T ++ APE+
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPANSF----VGTPYWMAPEV 182
Query: 201 CGSF-FSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
+ +Y +D+WS+G EL K PLF ++ M+ L IA
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALY------HIA-- 227
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
+N+ LS +S F N ++ L P+DRP++EE L +
Sbjct: 228 QNDSPT--LS------SNDWSDYFRN-------FVDSCLQKIPQDRPSSEELLKHRF--- 269
Query: 319 LAKVEREPSAQPVTKMEFEFERRRITKEDVREL 351
V RE +P T + +R TK+ VREL
Sbjct: 270 ---VLRE---RPPTVIIDLIQR---TKDAVREL 293
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y + IG+GS+G G++ IK+IN + +E+ +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF--FLYQLLRGLK 140
IV+ + S E ++Y+V + E DL++ I A + Q + Q+ LK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
++H + HRD+K +NI D +K+ DFG+ARV + A + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA---RTCIGTPYYLSPEI 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
C + Y DIW++GC+ E+ T K F N+
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 8e-22
Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 35/219 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK--KINDIF-----EHVSDATRILREIKLLR 77
++ + +G GS+G V +G+ A+K I EHV L E ++L+
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV------LNEKRILQ 56
Query: 78 LLRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLY 133
+RHP +V + F+D +Y+V E + +L ++ + +F+
Sbjct: 57 SIRHPFLVNLYG--------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA 108
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
Q++ L+Y+H+ ++ +RDLKP+N+L ++D +KI DFG A+ T +T T
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-----YT-LCGTP 162
Query: 194 WYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLF 231
Y APE+ SK Y A+D W++G + E+L G P F
Sbjct: 163 EYLAPEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 55/221 (24%), Positives = 106/221 (47%), Gaps = 27/221 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIF-----EHVSDATRILREIKL 75
+ + +G G++G V D + A+K + ++ +HV + R+L+E+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-- 58
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 134
HP I+ L + + + +Y++ E + +L ++ + + F+ +
Sbjct: 59 ----SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
++ L+Y+H+ + +RDLKP+NIL + + +K+ DFG A+ + T WT T
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPE 163
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y APE+ S + A+D W++G + E+L G P F N
Sbjct: 164 YLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-21
Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 49/300 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLR 80
RY +++ +GKGS+G V D + + +K + +I + ++ + +E +LL L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLH---QVIKANDDLTPEHYQF-FLYQL 135
HP IV+ L E ++ E E DL + +K E+ + QL
Sbjct: 61 HPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L G+ Y+H + HRDLK KNI + LKI DFG++R+ A T + T +Y
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFTGTPYY 171
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
+PE Y DIWS+GCI E+ F G+N L ++ ++ P+P
Sbjct: 172 MSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPSL- 225
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
Y + N+ +++ ML +P RP+A E L +P+
Sbjct: 226 -------PETYSRQL-------------NS------IMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-21
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 20/210 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
+ ++IE+ IG+G + V A + VA+KK+ IFE + R ++EI LL+ L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLN 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEH--YQFFLYQ 134
HP++ IK++ S E ++ +V EL ++ DL Q+I K L PE +++F+ Q
Sbjct: 61 HPNV--IKYL---DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-Q 114
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
L ++++H+ V HRD+KP N+ A +K+ D GL R + T A V T +
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPY 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224
Y +PE + Y DIWS+GC+ E+
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 85/298 (28%), Positives = 134/298 (44%), Gaps = 50/298 (16%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHP 82
Y V+GKGSYG V G++ IKK+N + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DL-HQVIKANDDLTPEH--YQFFLYQLLRG 138
+IV + E +Y+V E DL H++ + L PE+ ++F+ Q+
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMA 114
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+Y+H ++ HRDLK +N+ +K+ D G+ARV N A + + T +Y +P
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPYYMSP 171
Query: 199 ELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
EL F +K Y D+W++GC E+ T K F K++
Sbjct: 172 EL---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------------------- 207
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
N R + K P+P + +P L+ ML+ P+ RP+ + L PY
Sbjct: 208 --NSLVYRIIEG--KLPPMP-----KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
IE+VIG G +G VC G+K VAIK + SD R+ L E ++
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFD 63
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 138
HP+I+ ++ ++ ++ + + ++ E ME+ L + ++ ND T L + G
Sbjct: 64 HPNIIRLEGVV---TKS--RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+KY+ N HRDL +NIL N++ K+ DFGL+R + T + RW AP
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAP 177
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLT 226
E + K+T A D+WS G + E+++
Sbjct: 178 EAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-21
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 33/221 (14%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATR--ILREIKL 75
+ S KIE+VIG G +G VCS G++ VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 134
+ HP+I+ ++ ++ + K + +V E ME+ L ++ +D QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSKPVMIVTEYMENGSLDAFLRKHDG------QFTVIQ 107
Query: 135 L---LRG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
L LRG +KY+ HRDL +NIL N++ K+ DFGL+RV D P A + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 188 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW APE + K+T A D+WS G + E+++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 75/294 (25%), Positives = 132/294 (44%), Gaps = 37/294 (12%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLLRH 81
+++ +++G+G++G V YD TG ++A+K++ D E + + EI+LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
IV+ L P ++ I+V + + + +KA LT + + Q+L+G+ Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
Y D+WS+ C E+LT KP P E A
Sbjct: 182 SG--EGYGRKADVWSVACTVVEMLTEKP--------------------PWAEYEA----- 214
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
++++ K P P+ A R + + E K RPTAE L P+
Sbjct: 215 -----MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 71/216 (32%), Positives = 104/216 (48%), Gaps = 40/216 (18%)
Query: 31 IGKGSYGVVCSA-YD---TRTGEKVAIKKINDIFE--HVSDATRILREIKLLRLLRHPDI 84
+G+G +G V YD TGE+VA+K +N E H SD REI++LR L H +I
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHENI 68
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLY--QLLRG 138
V+ K + P R + ++ E + S D Q + + + L+ Q+ +G
Sbjct: 69 VKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQIN----LKRLLLFSSQICKG 121
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR----- 193
+ Y+ + HRDL +NIL ++ +KI DFGLA+V D DY +
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED-------KDYYYVKEPGES 174
Query: 194 ---WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
WY APE C SK++ A D+WS G EL T
Sbjct: 175 PIFWY-APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 7e-20
Identities = 70/255 (27%), Positives = 125/255 (49%), Gaps = 18/255 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAI+++N + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP---SPEAIARVR 259
Y P +DIWS+G + E++ G+P + +N + L ++ GTP +PE ++ +
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIF 246
Query: 260 NEKARRYLSSMRKKK 274
+ R L +K+
Sbjct: 247 RDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 69/248 (27%), Positives = 113/248 (45%), Gaps = 29/248 (11%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEK-VAIKKIN--------DIFEHVSDATRILREIKL 75
Y + E +G G++G V G+ +A+K+IN D E I+ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 76 LR-LLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEH--Y 128
++ LRHP+IV L R +Y+V +L+E + +K E +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 129 QFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
F+ Q++ L+Y+H + HRDL P NI+ D K+ I DFGLA+ P + T
Sbjct: 117 NIFV-QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPES-KLT 171
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
V T Y PE+ + Y D+W+ GCI ++ T +P F N++ + + +
Sbjct: 172 SVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229
Query: 248 GTPSPEAI 255
P PE +
Sbjct: 230 YEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 8e-20
Identities = 90/296 (30%), Positives = 140/296 (47%), Gaps = 33/296 (11%)
Query: 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREI 73
FF E E + E IG GS+G V A D RT E VAIKK++ + ++ + I++E+
Sbjct: 18 FFKEDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 76
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM---ESDLHQVIKANDDLTPEHYQF 130
K L+ ++HP+ +E K L RE ++V E SDL +V K L
Sbjct: 77 KFLQRIKHPNSIEYKGCYL----RE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAA 129
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+ L+GL Y+H+ N+ HRD+K NIL ++K+ DFG A +A +P +V
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPA----NSFV 182
Query: 191 ATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
T ++ APE+ + +Y +D+WS+G EL KP N + L +
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQN 239
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305
SP + ++ R ++ S QK P P + LL+ M F ++RP
Sbjct: 240 ESPTLQSNEWSDYFRNFVDSCL--------QKIPQDRPTSEELLKHM--FVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPD 83
++I +G+G YG V A TGE VA+K++ + R +L E +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
+V++ + F+D ++ ME D ++ L+ +H +F++ ++ +
Sbjct: 63 LVKLLY--------AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+H HRDLKP+N L +A +K+ DFGL++ + + DY+ APE
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------APE 168
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
+ Y +D WS+GC+ E L G P F G
Sbjct: 169 VLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 68/219 (31%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
+ ++IE+ IG+G + V A G VA+KK+ IF+ + R ++EI LL+ L
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLN 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEH--YQFFLYQ 134
HP++++ + E ++ +V EL ++ DL ++I K L PE +++F+ Q
Sbjct: 61 HPNVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-Q 114
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
L L+++H+ V HRD+KP N+ A +K+ D GL R + T A V T +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPY 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
Y +PE + Y DIWS+GC+ E+ + F G
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 80/329 (24%), Positives = 129/329 (39%), Gaps = 70/329 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+++ +VIG+G++G V D TG+ A+K + + +R + +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI------ 54
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+ + + F+D +Y+V E M DL ++ D E +F++ +L+
Sbjct: 55 -LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------------RVAFNDTPT 182
L +H HRD+KP NIL +AD +K+ DFGL
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 183 AIFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ D+ V T Y APE L G + Y D WS+G I E+L G P F
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 291
+ E ++ N K L P P A+
Sbjct: 231 YSDTLQ---------------ETYNKIINWK--ESLR-------FPPDPPVS---PEAID 263
Query: 292 LLERMLAFEPKDR-PTAEEALADPYFKGL 319
L+ R+L +P+DR + EE + P+FKG+
Sbjct: 264 LICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 81/302 (26%), Positives = 137/302 (45%), Gaps = 49/302 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAIK+IN + I+ EI +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
V HRD+K N+L D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP---SPEAIARVR 259
Y P +DIWS+G + E++ G+P + +N + L ++ GTP +PE ++
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLS--- 242
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
P+ L R L + + R +A+E L P+ K L
Sbjct: 243 ---------------------------PIFRDFLNRCLEMDVEKRGSAKELLQHPFLK-L 274
Query: 320 AK 321
AK
Sbjct: 275 AK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 9/211 (4%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLL 79
+ +++ +++G+G++G V YD TG ++A+K++ + E + + EI+LL+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
H IV+ L P R + E M + +K+ LT + + Q+L G
Sbjct: 62 LHERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEG 118
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+ Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
E+ Y DIWS+GC E+LT KP
Sbjct: 179 EVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 71/248 (28%), Positives = 121/248 (48%), Gaps = 18/248 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAIK++N + I+ EI ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP---SPEAIARVR 259
Y P +DIWS+G + E++ G+P + +N + L ++ GTP +PE ++ V
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPERLSAVF 245
Query: 260 NEKARRYL 267
+ R L
Sbjct: 246 RDFLNRCL 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 80/283 (28%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 89
IG GS+G V A ++ T E VA+KK++ + ++ + I++E+K L+ L+HP+ +E K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 90 ILLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
L K+ + + +ME SDL +V K L + L+GL Y+H
Sbjct: 89 CYL-------KE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH 138
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ N+ HRD+K NIL ++K+ DFG A + +P +V T ++ APE+ +
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPA----NSFVGTPYWMAPEVILA 191
Query: 204 F-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+Y +D+WS+G EL KP N + L + SP + +
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNDSPTLQSNEWTDS 248
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305
R ++ QK P P + LL F +DRP
Sbjct: 249 FRGFVDYCL--------QKIPQERPASAELLRH--DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 76/306 (24%), Positives = 135/306 (44%), Gaps = 43/306 (14%)
Query: 26 KIEEV--IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
KI E+ +G+G+ G V TG A+K I + +ILRE+++ + + P
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSPY 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQ-LLRG 138
IV+ L S I + E E +++ +K E + + +L+G
Sbjct: 61 IVKYYGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L Y+H+ + HRD+KP NIL ++K+CDFG++ N + T +Y AP
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-----LAGTFTGTSFYMAP 172
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP--GKNVVHQLDIMTDLLGTPSPEAI 255
E + G Y+ D+WS+G E+ + FP G+ + +++++ ++ P+PE
Sbjct: 173 ERIQG---KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
N I +S++F + +++ L +P RPT + L P+
Sbjct: 230 DEPGNG--------------IKWSEEFKD-------FIKQCLEKDPTRRPTPWDMLEHPW 268
Query: 316 FKGLAK 321
K K
Sbjct: 269 IKAQMK 274
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 72/250 (28%), Positives = 111/250 (44%), Gaps = 23/250 (9%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV---SDATRILREIKLLRLLRHPDIVEI 87
IGKGS+G V T A+K I H+ S+ T L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
K P + +Y+V + +L ++ +F+ +LL L+ +H N
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN 113
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
V +RDLKP+NIL + + +CDFGL ++ D + T Y APEL
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH-- 168
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGTPSPEAIARVRNEKARR 265
YT A+D W++G + E+LTG P F +NV I+ + L P + A+
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG------FDRDAKD 222
Query: 266 YLSSMRKKKP 275
L + + P
Sbjct: 223 LLIGLLSRDP 232
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 43/299 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAIK++N + I+ EI ++R +HP+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKHPN 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L+++H
Sbjct: 78 IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y P +DIWS+G + E++ G+P + +N + L
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---------------------- 224
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
YL + + +K + + L R L + + R +A+E L P+ K +AK
Sbjct: 225 ---YLIATNGTPELQNPEKL---SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK-IAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 33/217 (15%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
KIEEVIG G +G VC G++ VAIK + + ++ R L E ++
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFD 63
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQL---L 136
HP+I+ ++ ++ + + + ++ E ME+ L ++ ND QF + QL L
Sbjct: 64 HPNIIHLEGVV-----TKSRPVMIITEFMENGALDSFLRQNDG------QFTVIQLVGML 112
Query: 137 RG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--- 189
RG +KY+ N HRDL +NIL N++ K+ DFGL+R +DT + +
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW APE + K+T A D+WS G + E+++
Sbjct: 173 IPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 7e-19
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI----NDIFEHVSDATRILREIKLLRLLRHPDI 84
EV+GKG+YG V T G+ +A+K++ +++ + ++ E+ LL+ L+H +I
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V+ L + I + E + + ++ L + + Q+L G+ Y+H
Sbjct: 65 VQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLAR----VAFNDTPTAIFWTDYVATRWYRAPE 199
V HRD+K N++ + +K+ DFG AR V + T + + + + T ++ APE
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMAPE 178
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
+ S Y DIWSIGC E+ TGKP
Sbjct: 179 VINE--SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 38/232 (16%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+E +G G +G V T KVA+K + L+E ++++ LRH +V
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGT-TKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYI 142
++ + S E IY+V E M L +K+ + L Q+ G+ Y+
Sbjct: 65 QLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWY 195
+ N HRDL +NIL + KI DFGLAR+ +D TA I WT
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT-------- 171
Query: 196 RAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE G F K D+WS G + E++T G+ +PG V+ Q++
Sbjct: 172 -APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G +GVV R VAIK I E + E K++ L HP++V++ +
Sbjct: 12 LGSGQFGVVHLGK-WRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 91 LLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFL---YQLLRGLKYIHTAN 146
+ + I++V E M + L ++ ++ L + ++Y+ +
Sbjct: 68 CT-----KQRPIFIVTEYMANGCLLNYLRERKGK--LGTEWLLDMCSDVCEAMEYLESNG 120
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
HRDL +N L D +K+ DFGLAR +D T+ T + +W PE+ +S
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-PVKW-APPEVFD--YS 176
Query: 207 KYTPAIDIWSIGCIFAELLT-GKPLFPGK 234
+++ D+WS G + E+ + GK +
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-18
Identities = 81/285 (28%), Positives = 132/285 (46%), Gaps = 39/285 (13%)
Query: 12 DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILR 71
D+D T+ R+KI ++G+G++G V A+D + E A+K + ++ ++ DA +I
Sbjct: 123 DIDVSTQ-----RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDA-KI-- 174
Query: 72 EIKLLRLLRHPDIVEIKHILLPPSRREFKD----IYVVFELMESDLHQVIKANDDLTPEH 127
EI+ + +R D + L +R F++ + +V L I + + H
Sbjct: 175 EIQFMEKVRQADPAD--RFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRH 232
Query: 128 YQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD----------------CKLKICDF 170
++Q L Y HT ++ H DLKP+NIL C+++ICD
Sbjct: 233 LAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
G + TAI V+TR YR+PE+ Y+ D+WS+GCI EL TGK L
Sbjct: 293 G-GCCDERHSRTAI-----VSTRHYRSPEVVLGLGWMYS--TDMWSMGCIIYELYTGKLL 344
Query: 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 275
+ + + L +M LG E R E+AR +S + +P
Sbjct: 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRP 389
|
Length = 467 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 74/292 (25%), Positives = 127/292 (43%), Gaps = 41/292 (14%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLLRHPDIV 85
+++G+G++G V YD TG ++A K++ + E + + + EI+LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ L R K + + E M + +KA LT + + Q+L G+ Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ HRD+K NIL ++ +K+ DFG ++ + T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG- 183
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGTPSPEAIARVRNEKA 263
Y D+WS+GC E+LT KP + + + I T P I+ E A
Sbjct: 184 -EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHIS----EHA 238
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
R +L + E + RP+AEE L P+
Sbjct: 239 RDFL---------------------------GCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 82/283 (28%), Positives = 131/283 (46%), Gaps = 38/283 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 89
IG GS+G V A D R E VAIKK++ + ++ + I++E++ L+ LRHP+ ++ +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 90 ILLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
L RE + + +ME SDL +V K L + L+GL Y+H
Sbjct: 83 CYL----RE----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ N+ HRD+K NIL + +K+ DFG A + P +V T ++ APE+ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APA----NXFVGTPYWMAPEVILA 185
Query: 204 F-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+Y +D+WS+G EL KP N + L + SP + +E
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNESPALQSGHWSEY 242
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305
R ++ S QK P P + LL+ F ++RP
Sbjct: 243 FRNFVDSCL--------QKIPQDRPTSEVLLKHR--FVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK---KINDIFEHVSDATRILREIKLLRLLRH 81
++I E IGKG+YG V + + G K A+K I+DI E + IL+ L H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKA-----LSDH 74
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQ-VIKANDDLTPEHYQFFLYQLL 136
P++V+ + + +++V EL +DL + +K + + + L++ L
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
GL+++H HRD+K NIL + +K+ DFG V+ T T + V T ++
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 191
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAELLTGKP 229
APE+ S Y D+WS+G EL G P
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 71/213 (33%), Positives = 110/213 (51%), Gaps = 35/213 (16%)
Query: 31 IGKGSYGVV--CSAYD---TRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHPDI 84
+GKG++G V C YD TGE VA+KK+ + EH+ D REI++L+ L+H +I
Sbjct: 12 LGKGNFGSVELCR-YDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQHDNI 67
Query: 85 VEIKHILLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLY--QLLRGLKY 141
V+ K + RR + +V E L L ++ + + +H + LY Q+ +G++Y
Sbjct: 68 VKYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICKGMEY 123
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR-------- 193
+ + HRDL +NIL ++ ++KI DFGL +V D +Y R
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-------KEYYKVREPGESPIF 176
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
WY APE SK++ A D+WS G + EL T
Sbjct: 177 WY-APESLTE--SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-18
Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 18/240 (7%)
Query: 29 EVIGKGSYG---VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+V+G+GS+G +V G+ A+K + V D R E +L + HP IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
++ + + +Y++ + + DL + T E +F+L +L L ++H+
Sbjct: 62 KLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + + +K+ DFGL++ + + A + T Y APE+
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR- 172
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEAIARVRN 260
+T + D WS G + E+LTG F GK+ + I+ LG P SPEA + +R
Sbjct: 173 -RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRA 231
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 28 EEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++VIG G +G V G K VAIK + + L E ++ H +I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNI 68
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLYQLLRGLKYI 142
+ ++ ++ +FK ++ E ME+ L + ++ +D + + L + G+KY+
Sbjct: 69 IRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVATRWYRAPEL 200
N HRDL +NIL N++ + K+ DFGL+RV D P + T + RW APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TAPEA 181
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT 226
+ K+T A D+WS G + E+++
Sbjct: 182 IA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 47 TGEKVAIKKINDIFEHVSDA---TRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103
TG +VAIK + + + R RE L L HP+IV LL ++
Sbjct: 2 TGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVA----LLDSGEAPPGLLF 55
Query: 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI-LANA 161
VFE + L +V+ A+ L + Q+L L H + HRDLKP+NI ++
Sbjct: 56 AVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
Query: 162 DCK--LKICDFGLAR----VAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDI 214
+ K+ DFG+ V D T T+ + T Y APE L G TP D+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSDL 172
Query: 215 WSIGCIFAELLTGKPLFPGKNV 236
++ G IF E LTG+ + G +V
Sbjct: 173 YAWGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G +GVV R KVAIK IN E + E K++ L HP +V++ +
Sbjct: 12 LGSGQFGVV-HLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 91 LLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
+ K +Y+V E ME+ L+ + + L+ + + G++Y+ +
Sbjct: 68 CT-----QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRDL +N L ++ +K+ DFG+ R +D T+ + +W PE+ FSKY
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN--FSKY 178
Query: 209 TPAIDIWSIGCIFAELLT-GKPLFPGKN 235
+ D+WS G + E+ T GK F K+
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 61/300 (20%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRH-----PD 83
I KG++G V A TG+ AIK K +D+ A + +K R + P
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM-----IAKNQVTNVKAERAIMMIQGESPY 58
Query: 84 IVEIKHILLPPSRREFKD-IYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+ ++ + + KD +Y+V E L D +IK L + + ++ +++ G++
Sbjct: 59 VAKLYYSF------QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVED 112
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
+H + HRD+KP+N+L + LK+ DFGL+R + +V T Y APE +
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDYLAPETI 165
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
G D WS+GC+ E L G P F + +P+A+ N
Sbjct: 166 LG---VGDDKMSDWWSLGCVIFEFLFGYPPFHAE----------------TPDAV--FDN 204
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA---EEALADPYFK 317
+RR K+ +P A+ L+ R+L +P R A +E + P+FK
Sbjct: 205 ILSRRINWPEEVKE---------FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 82/296 (27%), Positives = 126/296 (42%), Gaps = 49/296 (16%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G+ G V TG +A KK+ I S +ILRE++++ R P IV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 91 LLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VF 148
L + +I + E M+ L ++ K + E ++ GL Y++ + +
Sbjct: 72 FLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFN---DTPTAIFWTDYVATRWYRAPELCGSFF 205
HRD+KP NIL N+ ++K+CDFG++ N DT +V T Y +PE
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--------FVGTSTYMSPERIQG-- 176
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-----VHQLDIMTDLLGTPSPEAIARVRN 260
KYT D+WS+G EL GK F N+ + I+ DLL ++
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-DLL--------QQIVQ 227
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
E R SS FP ++ L +P +RPT ++ A P F
Sbjct: 228 EPPPRLPSS-----------DFP---EDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK---KINDIFEHVSDATRILREIKLLRLLRH 81
++I E IGKG+YG V + + G A+K I+D+ E + IL+ L H
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS-----LPNH 78
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHYQFFLYQLL 136
P++V+ + + +++V EL + ++ L + LY L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
GL+++H + HRD+K NIL + +K+ DFG V+ T T + V T ++
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 195
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAELLTGKP 229
APE+ + Y D+WS+G EL G P
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 23/237 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRH 81
+ +E +G G +G V + +VAIK + +D D + E++ L+ LRH
Sbjct: 6 EEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRH 61
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRG 138
++ + + S E +Y++ ELME L +++ + L Q+ G
Sbjct: 62 KHLISLFAVC---SVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVATRWYR 196
+ Y+ N HRDL +NIL D K+ DFGLAR+ D ++ + + +W
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED----VYLSSDKKIPYKW-T 171
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252
APE ++ D+WS G + E+ T G+ +PG N D +T P P
Sbjct: 172 APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 81/300 (27%), Positives = 126/300 (42%), Gaps = 74/300 (24%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+ + +G G +G V Y KVAIK + + L E L++ L+HP +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL-------R 137
+ ++ + IY++ E ME+ L +K TPE + + +L+
Sbjct: 65 RLYAVVTQ------EPIYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMAAQIAE 113
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYV 190
G+ +I N HRDL+ NIL + KI DFGLAR+ ++ TA I WT
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT--- 170
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 249
APE + +T D+WS G + E++T G+ +PG MT+
Sbjct: 171 ------APEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG---------MTN---- 209
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL-RLLERMLAFEPKDRPTAE 308
PE I + E+ R P+ P L L+ +P++RPT E
Sbjct: 210 --PEVIQNL--ERGYRMPR--------------PDNCPEELYELMRLCWKEKPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 74/299 (24%), Positives = 121/299 (40%), Gaps = 49/299 (16%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKH 89
+GKG +G VC+ TG+ A KK++ + L E K+L + IV + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 90 ILLPPSRREFKDIYVVFELMES-DLH-QVIKANDDLTPE-HYQFFLYQLLRGLKYIHTAN 146
D+ +V LM DL + + PE F+ Q++ GL+++H
Sbjct: 61 AFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLKP+N+L + ++I D GLA T Y APE+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI----KGRAGTPGYMAPEVLQG--E 169
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266
Y ++D +++GC E++ G+ F R R EK +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF-------------------------RQRKEKVEKE 204
Query: 267 -LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFKGL 319
L + + + KF +P A L E +L +P+ R +A+E P FK L
Sbjct: 205 ELKRRTLEMAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-17
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 15/211 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLR 80
S +++ E +G GS+G V A TGE AIK K +I + + + +E +L L
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK-MKQVQHVAQEKSILMELS 76
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
HP IV + +R F +VV + + L + + +D+ +F+ +L+ +
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA----KFYHAELVLAFE 132
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+H+ ++ +RDLKP+N+L + +K+ DFG A+ + T T T Y APE+
Sbjct: 133 YLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT------LCGTPEYLAPEV 186
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
S + A+D W++G + E + G P F
Sbjct: 187 IQS--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 80/288 (27%), Positives = 123/288 (42%), Gaps = 51/288 (17%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V D RT + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF-----LYQLLRGLKYIH 143
L ++ ++++ E + A D L + F L ++L+GL Y+H
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGG-----SALDLLRAGPFDEFQIATMLKEILKGLDYLH 118
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ HRD+K N+L + +K+ DFG VA T T I +V T ++ APE+
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
S Y DIWS+G EL G+P P + +H + ++ + P
Sbjct: 176 --SAYDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPPTLTGE------ 224
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
FS+ F ++ L +P RPTA+E L
Sbjct: 225 --------------FSKPFK-------EFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V D RT + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
L ++ ++++ E + + L L ++L+GL Y+H+
Sbjct: 69 GSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 123
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRD+K N+L + ++K+ DFG VA T T I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 209 TPAIDIWSIGCIFAELLTGKP 229
DIWS+G EL G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S + + IG G +G+V Y KVAIK I + D + E +++ L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEED---FIEEAQVMMKLSHP 59
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
+V++ + E I +VFE ME L ++A + E + G+
Sbjct: 60 KLVQLYGVCT-----ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA 114
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+ ++NV HRDL +N L + +K+ DFG+ R +D T+ T + +W +PE+
Sbjct: 115 YLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVKW-SSPEV 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT 226
FSKY+ D+WS G + E+ +
Sbjct: 173 FS--FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V D RT E VAIK I D+ E + I +EI +L P I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
L ++ ++++ E + + L + L ++L+GL Y+H+
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRD+K N+L + +K+ DFG VA T T I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 209 TPAIDIWSIGCIFAELLTGKP 229
DIWS+G EL G+P
Sbjct: 179 DFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 86/351 (24%), Positives = 147/351 (41%), Gaps = 69/351 (19%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLL-RHPDIVEI 87
V+GKGS+G V A T E A+K + D+ D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 88 KHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
R +F +ME DL I+ + +F+ +++ GL+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAF-NDTPTAIFWTDYVATRWYRAPELCG 202
+ +RDLK N+L +++ +KI DFG+ + T+ F T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF----CGTPDYIAPEILS 169
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ Y PA+D W++G + E+L G+ F G + + + + E
Sbjct: 170 --YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----------------EDELFQSILED 211
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR----PTAEEALAD-PYFK 317
RY + K+ A +L+ L P+ R PT E+ + P+F+
Sbjct: 212 EVRYPRWLSKE---------------AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
Query: 318 GL--AKVER---EPSAQPVTKMEF-------EFERRRITKEDVRELIYREI 356
+ K+ER +P +P K F EF + + E I R I
Sbjct: 257 EIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNI 307
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 82/316 (25%), Positives = 126/316 (39%), Gaps = 47/316 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y + + + GS G V A + V +K + L E LL+ + HP +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK--------IGQKGTTLIEAMLLQNVNHPSV 119
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY-QLLRGLKYIH 143
+ +K L+ + V SDL+ + P + Q+L GL+Y+H
Sbjct: 120 IRMKDTLV---SGAITCM--VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ HRD+K +NI N ++ I D G A+ P + V T APE+
Sbjct: 175 AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVET---NAPEVLAR 230
Query: 204 FFSKYTPAIDIWSIGCIFAELLT-GKPLF---------PGKNV-VHQLDIMTDLLGTPSP 252
KY DIWS G + E+L +F K+ H L I++ L P
Sbjct: 231 --DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL--KVHP 286
Query: 253 EAIARVRNEKARR----YLSSMRKKKPIPFSQKFPNANPLALR-----LLERMLAFEPKD 303
E R + R Y S R+ P+++ +P + L L+ +ML F+
Sbjct: 287 EEFPRDPGSRLVRGFIEYASLERQ----PYTR-YPCFQRVNLPIDGEFLVHKMLTFDAAM 341
Query: 304 RPTAEEALADPYFKGL 319
RP+AEE L P F L
Sbjct: 342 RPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 83/299 (27%), Positives = 126/299 (42%), Gaps = 54/299 (18%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLL----RHPD 83
V+G+G +G V A +TGE AIK K DI D L K + RHP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR--DEVESLMCEKRIFETANSERHPF 63
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V + + V E DL I + P F+ ++ GL+Y+
Sbjct: 64 LVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHTDVFSEPRA-VFYAACVVLGLQYL 117
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPEL 200
H + +RDLK N+L + + +KI DFGL + + F D T+ F T + APE+
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TSTF----CGTPEFLAPEV 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
+ YT A+D W +G + E+L G+ FPG + E + N
Sbjct: 173 LTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDD---------------EEEVFDSIVN 215
Query: 261 EKAR--RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
++ R R+LS ++ I ++ NP ER L KD AE+ P+F+
Sbjct: 216 DEVRYPRFLS----REAISIMRRLLRRNP------ERRLGSGEKD---AEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 78/297 (26%), Positives = 123/297 (41%), Gaps = 67/297 (22%)
Query: 29 EVIGKGSYGVVCSA-YDTRTGEK--VAIK--KINDIFEHVSDATRILREIKLLRLLRHPD 83
IG+G +G V Y + EK VA+K K S + L+E ++R HP
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPH 68
Query: 84 IVE-IKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLK 140
IV+ I I P +++V EL +L ++ N L + YQL L
Sbjct: 69 IVKLIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR------W 194
Y+ + HRD+ +N+L ++ +K+ DFGL+R +++ Y A++ W
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-------YKASKGKLPIKW 174
Query: 195 YRAPELCGSFFSKYTPAIDIWSIG-CIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSP 252
APE F ++T A D+W G C++ L+ G KP G +
Sbjct: 175 M-APESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ----------------GVKNN 215
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
+ I R+ E R P+P PN P L+ + A++P RP E
Sbjct: 216 DVIGRI--ENGERL--------PMP-----PNCPPTLYSLMTKCWAYDPSKRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 33/225 (14%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G YG V + VA+K + E + L+E +++ ++HP++V+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQ---- 66
Query: 91 LLPPSRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANV 147
LL RE Y++ E M +L ++ + ++ + Q+ ++Y+ N
Sbjct: 67 LLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWYRAPEL 200
HRDL +N L + +K+ DFGL+R+ DT TA I WT APE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------APE- 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 176 -SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 76/293 (25%), Positives = 120/293 (40%), Gaps = 47/293 (16%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A TG A K I E + + EI +L +HP+IV +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII--QIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 91 LLPPSRR----EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
++ EF D + +M + LT ++ Q+L L ++H+
Sbjct: 71 YFYENKLWILIEFCDGGALDSIML-------ELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL--CGSF 204
V HRDLK NIL D +K+ DFG V+ + T ++ T ++ APE+ C +F
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 205 FSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
Y DIWS+G EL +P P ++ + ++ +L + P
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRVLLKILKSEPPTLDQ------- 230
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
P +S F + L+ L +P DRPTA E L P+
Sbjct: 231 -----------PSKWSSSFND-------FLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 74/327 (22%), Positives = 123/327 (37%), Gaps = 59/327 (18%)
Query: 30 VIGKGSYG--VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+IGK +V A T VA+KKIN D + +EI R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY---------QFFLYQLLRG 138
+ S ++YVV LM + +DL H+ F L +L
Sbjct: 65 VTSFIVDS-----ELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLNA 113
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDF---------GLARVAFNDTPTAI----F 185
L YIH+ HR +K +IL + D K+ + G + +D P +
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245
W +PE+ Y DI+S+G EL G P K++ ++
Sbjct: 174 WL---------SPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEK 222
Query: 246 LLGTPS--------PEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERM 296
+ GT P + ++ + R P+++ F + + L+R
Sbjct: 223 VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR- 281
Query: 297 LAFEPKDRPTAEEALADPYFKGLAKVE 323
+P+ RP+A + L +FK +
Sbjct: 282 ---DPESRPSASQLLNHSFFKQCKRRN 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVE 86
+E++G G+ G V AY T +A+K I DI + +I+ E+++L P I+
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYIIG 63
Query: 87 IKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKYIHTA 145
+R I + E M+ V + PEH +++GL Y+ +
Sbjct: 64 FYGAFFVENR-----ISICTEFMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYLWSL 114
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
+ HRD+KP N+L N ++K+CDFG++ N YV T Y APE
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-----YVGTNAYMAPERISG-- 167
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFP 232
+Y D+WS+G F EL G+ FP
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR--FP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 84/312 (26%), Positives = 134/312 (42%), Gaps = 52/312 (16%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPDIVEI 87
+G G+ GVV +G +A K I+ E + A R I+RE+K+L P IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFL-YQLLRGLKYIHTA 145
+I + E M+ L QV+K + PE+ + +LRGL Y+
Sbjct: 65 YGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRI-PENILGKISIAVLRGLTYLREK 118
Query: 146 -NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGS 203
+ HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L G
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQG- 172
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
+ YT DIWS+G E+ G+ P + +L+ M G P E A+ +
Sbjct: 173 --THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAM---FGRPVSEGEAKESHRPV 226
Query: 264 RRYLSSMRK------------KKPIP------FSQKFPNANPLALRLLERMLAFEPKDRP 305
+ + +P P FS +F + +++ L PK+R
Sbjct: 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQD-------FVDKCLKKNPKERA 279
Query: 306 TAEEALADPYFK 317
+E P+ K
Sbjct: 280 DLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 43/225 (19%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
IGKG +G V G+KVA+K + D + A L E ++ LRHP++V++
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLVQLL 66
Query: 89 HILLPPSRREFKDIYVVFELME---------SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
++L + +Y+V E M S VI L F + G+
Sbjct: 67 GVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG------FALDVCEGM 115
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF---WTDYVATRWYR 196
+Y+ N HRDL +N+L + D K+ DFGLA+ A + WT
Sbjct: 116 EYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------- 166
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GK---PLFPGKNVV 237
APE K++ D+WS G + E+ + G+ P P K+VV
Sbjct: 167 APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 83/303 (27%), Positives = 130/303 (42%), Gaps = 55/303 (18%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIND--IFEHVSDATRILREIKLLRLLRHPDIVEI 87
V+GKG +G VC+ TG+ A KK+ I + +A L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSL 65
Query: 88 KHILLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
+ E KD + +V LM DL H N E F+ ++ GL+ +H
Sbjct: 66 AYAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ +RDLKP+NIL + ++I D GLA + +T V T Y APE+
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG-----RVGTVGYMAPEVVK 174
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ +YT + D W +GC+ E++ GK F R R EK
Sbjct: 175 N--ERYTFSPDWWGLGCLIYEMIEGKSPF-------------------------RQRKEK 207
Query: 263 ARRYLSSMR-KKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYF 316
+R R K+ +S+KF + A + ++L +P R AEE A P+F
Sbjct: 208 VKREEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264
Query: 317 KGL 319
+
Sbjct: 265 RTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIK-LLRLLRHPDIVE 86
+VIGKGS+G V A G+ A+K + I + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ + S + + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCGS 203
N+ +RDLKP+NIL ++ + + DFGL + +A +DT T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-----FCGTPEYLAPEVIRK 170
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
Y +D W +G + E+L G P F ++V D
Sbjct: 171 --QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLR---LLRHPDIVE 86
IGKG++G V T A+K ++ + + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+K S D+Y+V + M +L ++ + + +F++ +L+ L+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
++ +RDLKP+NIL +A + +CDFGL++ D T + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 206 SKYTPAIDIWSIGCIFAELLTG 227
YT +D WS+G + E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+V+GKGS+G V A T E AIK + D+ D + E ++L L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------- 53
Query: 88 KHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
KH L F+ +F +ME DL I+ + +F+ ++ L ++H
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
V +RDLK NIL +A+ K+ DFG+ + + T T + T Y APE+
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQE 170
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+Y P++D W++G + E++ G+P F N
Sbjct: 171 L--EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 27/231 (11%)
Query: 29 EVIGKGSYGVVCSA-YDTRTGEKV--AIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
VIGKG +G V G+K+ A+K +N I + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 86 EIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT 144
+ I LP E + V+ + DL I++ + T + F Q+ +G++Y+ +
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
HRDL +N + + +K+ DFGLAR I+ +Y + + +L +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVKW 168
Query: 205 FS-------KYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247
+ K+T D+WS G + EL+T G P +P V DI LL
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VDSFDITVYLL 216
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 35/242 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFEHVSDATRILREIKLLRLLRH-- 81
+ IG G+ G V +TG +A+K++ E RIL ++ ++ L H
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK---RILMDLDVV-LKSHDC 73
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL-YQLLRGLK 140
P IV+ + S D+++ ELM + L +++K PE + +++ L
Sbjct: 74 PYIVKCYGYFITDS-----DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALH 128
Query: 141 YIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-TR----- 193
Y+ V HRD+KP NIL +A +K+CDFG++ D A TR
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLVDSKAKTRSAGCA 178
Query: 194 WYRAPELCG--SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
Y APE KY D+WS+G EL TG+ FP KN + +++T +L
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEEP 236
Query: 252 PE 253
P
Sbjct: 237 PS 238
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLR-HPDIVE 86
V+GKGS+G V A +G A+K + D+ D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ P R ++ V E + DL I+ + +F+ ++ L ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLK N+L + + K+ DFG+ + FN T+ F T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF----CGTPDYIAPEILQEM 171
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y P++D W++G + E+L G F +N
Sbjct: 172 L--YGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 13/209 (6%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
H R +Y V E + DL I+ H F+ ++ GL ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 148 FHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+RDLK N++ +A+ +KI DFG+ + F T F T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF----CGTPDYIAPEIIA--YQ 176
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y ++D W+ G + E+L G+P F G++
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPDIVE 86
E IGKG++G V + +VA+K + + + L+E ++L+ HP+IV+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVK 56
Query: 87 IKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ + + + + IY+V EL+ S L + K + LT + G++Y+ +
Sbjct: 57 LIGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
N HRDL +N L + LKI DFG++R T + +W APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEALN-- 168
Query: 205 FSKYTPAIDIWSIGCIFAELLTG 227
+ +YT D+WS G + E +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-15
Identities = 62/250 (24%), Positives = 118/250 (47%), Gaps = 19/250 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+++GKG++G V + +G+ A+K + ++ + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
K+ R F YV + L + ++D T +F+ +++ L Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT----RFYGAEIVSALDYLHSGKI 116
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + D +KI DFGL + D T + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKN--VVHQLDIMTDLLGTPSPEAIARVRNEKARR 265
Y A+D W +G + E++ G+ F ++ + +L +M D+ R + A+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-------KFPRTLSADAKS 224
Query: 266 YLSSMRKKKP 275
LS + K P
Sbjct: 225 LLSGLLIKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 73/334 (21%), Positives = 132/334 (39%), Gaps = 78/334 (23%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
+K +++GKG G V TG+ A+K ++ + R+L E ++L L H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFEL-MESDLHQVIKANDD--LTPEHYQFFLYQLLRG 138
P + + S + + +V + +L ++++ L+ E +F+ ++L
Sbjct: 61 PFLPTLYA-----SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT----------- 187
L+Y+H + +RDLKP+NIL + + + DF L++ + + P +
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS-DVEPPPVSKALRKGSRRSSVN 174
Query: 188 ----------------DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGK 228
+V T Y APE+ G + A+D W++G + E+L G
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEMLYGT 229
Query: 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 288
F G N R+E L KK + F P ++
Sbjct: 230 TPFKGSN-----------------------RDETFSNIL-----KKEVTFPGSPPVSS-S 260
Query: 289 ALRLLERMLAFEPKDR----PTAEEALADPYFKG 318
A L+ ++L +P R A E P+F+G
Sbjct: 261 ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 69/241 (28%), Positives = 114/241 (47%), Gaps = 22/241 (9%)
Query: 30 VIGKGSYGVVCSAYDTR---TGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPDI 84
V+GKG YG V TG+ A+K K I + D E +L ++HP I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 85 VEIKHILLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V++ + + +Y++ E L +L ++ + F+L ++ L+++H
Sbjct: 63 VDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVATRWYRAPELCG 202
+ +RDLKP+NIL +A +K+ DFGL + + T T F T Y APE+
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF----CGTIEYMAPEILM 173
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEAIARV 258
S + A+D WS+G + ++LTG P F +N +D I+ L P +PEA +
Sbjct: 174 R--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLL 231
Query: 259 R 259
+
Sbjct: 232 K 232
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 76/293 (25%), Positives = 123/293 (41%), Gaps = 38/293 (12%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+++ + IG G+YG V A + TGE AIK I E D + +EI +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V L RR+ +++ E L + L+ + + L+GL Y+H
Sbjct: 69 VAYFGSYL---RRD--KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL + +K+ DFG V+ T T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y DIW++G EL +P + + L +MT P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP----------- 229
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ K + +S F + +A L PK RPTAE+ L P+
Sbjct: 230 --------KLKDKMKWSNSFHHFVKMA-------LTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
K+E+ +G G +G V A Y+ T KVA+K + V L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
V++ ++ + IY++ E M D + + + P+ F Q+ G+
Sbjct: 64 VKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-QIAEGMA 116
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATR 193
+I N HRDL+ NIL +A KI DFGLARV ++ TA I WT
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT------ 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
APE F +T D+WS G + E++T G+ +PG
Sbjct: 171 ---APEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 29/225 (12%)
Query: 31 IGKGSYG-VVCSAYDTRTGE--KVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVE 86
+G G++G VV Y ++G+ +VA+K + EH + LRE ++ L HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ + + +V EL L + +K ++ + +Q+ G+ Y+ +
Sbjct: 61 LIGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDT----PTAIFWTDYVATRWYRAPEL 200
+ HRDL +N+L + KI DFG++R + TA W +WY APE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW----PLKWY-APE- 168
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT--GKPL--FPGKNVVHQLD 241
C ++ K++ D+WS G E + KP G V+ L+
Sbjct: 169 CINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 60/250 (24%), Positives = 118/250 (47%), Gaps = 19/250 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG+ A+K + ++ + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
K+ R F Y +L + + + +F+ +++ L Y+H+ +V
Sbjct: 61 KYSFQTHDRLCFVMEYA----NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + D +KI DFGL + +D T + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGK--NVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265
Y A+D W +G + E++ G+ F + + +L +M ++ R + +A+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------RFPRTLSPEAKS 224
Query: 266 YLSSMRKKKP 275
L+ + KK P
Sbjct: 225 LLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 36/233 (15%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+ + +G G +G V Y KVA+K + V L E L++ L+H +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKY 141
+ ++ ++ E IY++ E M + L +K+++ L P+ F Q+ G+ Y
Sbjct: 65 RLYAVV---TKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-QIAEGMAY 118
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRW 194
I N HRDL+ N+L + KI DFGLARV ++ TA I WT
Sbjct: 119 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT------- 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246
APE F +T D+WS G + E++T GK +PG + D+M+ L
Sbjct: 172 --APEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 31 IGKGSYGVV--CSAYDTR---TGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPD 83
+G+G +G V C YD TGE+VA+K K H++D + +EI++LR L H +
Sbjct: 12 LGEGHFGKVELCR-YDPEGDNTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHEN 67
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 141
IV+ K I K ++ E + S L + + N + + + + Q+ +G+ Y
Sbjct: 68 IVKYKGICTEDGGNGIK---LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+ + HRDL +N+L ++ ++KI DFGL + D D + ++ APE
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLT 226
SK+ A D+WS G ELLT
Sbjct: 185 --IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRL-LRHPDIVEI 87
V+GKGS+G V A T E AIK + D+ D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT-- 59
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
H+ +E ++ V E + DL I+++ +F+ +++ GL+++H
Sbjct: 60 -HLFCTFQTKEH--LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L + D +KI DFG+ + N A + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKG--Q 171
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
KY ++D WS G + E+L G+ F G++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 34/225 (15%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G +G V T VA+K + D L E ++++ LRHP ++++ +
Sbjct: 14 LGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 91 LLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANV 147
+ E IY+V ELM+ L + ++ L Q+ G+ Y+ N
Sbjct: 70 C---TLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWYRAPEL 200
HRDL +N+L + K+ DFGLARV D A I WT APE
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT---------APE- 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
+ +++++ D+WS G + E++T G+ +PG V+ Q+D
Sbjct: 175 -AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 79/310 (25%), Positives = 123/310 (39%), Gaps = 56/310 (18%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPDIVEIK 88
IG G+ G V TG A+K I + + D R I REI++LR + HP++V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
+ +I V+ E M+ + D+ Q+L G+ Y+H ++
Sbjct: 139 DMF-----DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR---QILSGIAYLHRRHIV 190
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-----LCGS 203
HRD+KP N+L N+ +KI DFG++R+ T V T Y +PE L
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRI-LAQTMDPC--NSSVGTIAYMSPERINTDLNHG 247
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD---IMTDLLGTPSPEAIARVRN 260
+ Y A DIWS+G E G+ F V Q D +M + + PEA
Sbjct: 248 AYDGY--AGDIWSLGVSILEFYLGRFPFG---VGRQGDWASLMCAICMSQPPEA------ 296
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320
P S++F + + L EP R +A + L P+
Sbjct: 297 --------------PATASREFRH-------FISCCLQREPAKRWSAMQLLQHPFILRAQ 335
Query: 321 KVEREPSAQP 330
+ +
Sbjct: 336 PGQGQGGPNL 345
|
Length = 353 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 53/303 (17%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKL-LRLLRHPDI 84
IEE +G+G+YGVV TG +A+K+I R+L ++ + +R + P
Sbjct: 5 VIEE-LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYT 62
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIK---ANDDLTPEHYQFFL----YQLLR 137
V L RE D+++ E+M++ L + K PE L +++
Sbjct: 63 VTFYGALF----RE-GDVWICMEVMDTSLDKFYKKVYDKGLTIPED---ILGKIAVSIVK 114
Query: 138 GLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L+Y+H+ +V HRD+KP N+L N + ++K+CDFG++ + + T + Y
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VAKTIDAGCKPYM 170
Query: 197 APELCGSFFSK--YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
APE ++ Y D+WS+G EL TG+ FP + + ++ PSP
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPSP-- 226
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
++ EK FS +F + + + L K+RP E L P
Sbjct: 227 --QLPAEK---------------FSPEFQD-------FVNKCLKKNYKERPNYPELLQHP 262
Query: 315 YFK 317
+F+
Sbjct: 263 FFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 17/238 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRL 78
+ + +V+G G++G V GEK VAIK + + ++ IL E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN-KEILDEAYVMAS 65
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLL 136
+ HP +V + I L + ++ +LM L V D++ ++ + Q+
Sbjct: 66 VDHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
+G+ Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM- 178
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253
A E YT D+WS G EL+T G + G V D++ P P
Sbjct: 179 ALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A K++ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 89 HILLPPSRREFKD-IYVVFELMES---DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ E KD + +V +M H N E F+ ++L GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
N +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGRVGTVGYMAPEVLNN- 175
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234
+YT + D W +GC+ E++ G+ F G+
Sbjct: 176 -QRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
H R +Y V E + DL I+ H F+ ++ GL ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N++ +++ +KI DFG+ + D T + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA--YQP 177
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y ++D W+ G + E+L G+ F G++
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 73/307 (23%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+GKG+YG V TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLT---PEH-YQFFLYQLLRGLKYIHTA- 145
+Y+ E M++ + A T PE + Y +++GLK++
Sbjct: 68 FFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE----LC 201
N+ HRD+KP N+L N + ++K+CDFG++ + ++ T+ + + Y APE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN-IGCQSYMAPERIKSGG 177
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK---NVVHQLDIMTDLLGTPSPEAIARV 258
+ YT D+WS+G E+ G+ +P + N+ QL + D G P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPP------- 228
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
P +S +A + L ++ P RPT + L P+
Sbjct: 229 --------------TLPSGYS---DDAQDFVAKCLNKI----PNRRPTYAQLLEHPWLVK 267
Query: 319 LAKVERE 325
+ +
Sbjct: 268 YKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 26 KIEEVIGKGSYGVV-CSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++ + +G G +G V ++ T KVA+K + L E ++++ LRH +
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNT--KVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKL 63
Query: 85 VEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLRGLKY 141
V++ ++ S IY+V E M + L +K + + Q+ G+ Y
Sbjct: 64 VQLYAVV---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRW 194
I N HRDL+ NIL KI DFGLAR+ ++ TA I WT
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT------- 170
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235
APE + + ++T D+WS G + EL+T G+ +PG N
Sbjct: 171 --APE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
E+IG+G +G V TG+KVA+K I D+ A L E ++ L H ++V +
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRL 64
Query: 88 KHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDL---TPEHYQFFLYQLLRGLKYIH 143
++L +Y+V ELM + +L ++ + QF L + G++Y+
Sbjct: 65 LGVIL------HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL-DVAEGMEYLE 117
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARV---AFNDTPTAIFWTDYVATRWYRAPEL 200
+ + HRDL +NIL + D K+ DFGLARV +++ + WT APE
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT---------APEA 168
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFP 232
K++ D+WS G + E+ + G+ +P
Sbjct: 169 LKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 64/250 (25%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFE-----HVSDATRILREIKLLRLLRH 81
+VIG+G++G V TG A+KK+ +++ E HV IL E +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------N 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 137
P +V++ + F+D ++ +ME D+ ++ D T E +F++ + +
Sbjct: 61 PWVVKLYY--------SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL 112
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGL------------ARVAFNDTPTAIF 185
+ IH HRD+KP N+L +A +K+ DFGL R+ + P+
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 186 WTDY-----------------------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIF 221
V T Y APE+ F Y D WS+G I
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV---FLQTGYNKECDWWSLGVIM 229
Query: 222 AELLTGKPLF 231
E+L G P F
Sbjct: 230 YEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 48/230 (20%)
Query: 29 EVIGKGSYGVV-----CSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHP 82
+G+G++G V E VA+K + + +DA + RE +LL +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHE 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND--------------DLTPEH 127
+IV+ + E +VFE ME DL++ ++++ +LT
Sbjct: 69 NIVKFYGVCT-----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
Q+ G+ Y+ + + HRDL +N L D +KI DFG++R ++ T
Sbjct: 124 LLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVYTT 175
Query: 188 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 228
DY + RW PE + K+T D+WS G + E+ T GK
Sbjct: 176 DYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLL-RHPDIVE 86
+++GKGS+G V A T + AIK + D+ D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT- 59
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
H+ +E +++ V E + DL I++ F+ +++ GL+++H+
Sbjct: 60 --HLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLK NIL + D +KI DFG+ + D T F T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEIL--L 169
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
KY ++D WS G + E+L G+ F G +
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 8e-14
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 31 IGKGSYGVVCSA-YDTRTGEK-VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G G++G V Y + EK VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
I E + +V EL E L++ ++ N +T ++ ++Q+ G+KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFND-----TPTAIFWTDYVATRWYRAPELCG 202
HRDL +N+L KI DFGL++ D T W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 203 SFFSKYTPAIDIWSIGCIFAE 223
+++ K++ D+WS G + E
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 78/321 (24%), Positives = 125/321 (38%), Gaps = 50/321 (15%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
E + + I E G+ G + D +T E V IK E +LR +
Sbjct: 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIK--------AGQRGGTATEAHILRAIN 141
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
HP I+++K ++ ++DL+ + A ++ +LR ++
Sbjct: 142 HPSIIQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQ 196
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF-WTDYVATRWYRAPE 199
Y+H + HRD+K +NI N + + DFG A + + W +AT APE
Sbjct: 197 YLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT---NAPE 253
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNV------VHQLDIMTDLLGTPSP 252
L Y PA+DIWS G + E+ T LF + Q+ ++ GT
Sbjct: 254 LLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE----------RMLAFEPK 302
E + Y+ +K S + P + PL L E +MLAF+
Sbjct: 312 EFPIDAQANLDEIYIGLAKK------SSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAH 365
Query: 303 DRPTAE--------EALADPY 315
RP+AE + + DPY
Sbjct: 366 HRPSAEALLDFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 63/253 (24%), Positives = 119/253 (47%), Gaps = 25/253 (9%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + ++ + + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
K+ R F V E +L + T E +F+ +++ L+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
V +RD+K +N++ + D +KI DFGL + +D T + T Y APE+ +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH----QLDIMTDLLGTPSPEAIARVRNEK 262
Y A+D W +G + E++ G+ P N H +L +M ++ R + +
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEI-------RFPRTLSPE 221
Query: 263 ARRYLSSMRKKKP 275
A+ L+ + KK P
Sbjct: 222 AKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 26/254 (10%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + ++ + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA- 145
K+ R F V E +L + + + +F+ +++ L Y+H+
Sbjct: 61 KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
NV +RDLK +N++ + D +KI DFGL + D T + T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-- 170
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH----QLDIMTDLLGTPSPEAIARVRNE 261
+ Y A+D W +G + E++ G+ P N H +L +M ++ R +
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEI-------RFPRTLSP 221
Query: 262 KARRYLSSMRKKKP 275
+A+ LS + KK P
Sbjct: 222 EAKSLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 79/311 (25%), Positives = 121/311 (38%), Gaps = 68/311 (21%)
Query: 24 RY-KIEEVIGKGSYG-VVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILR-----EI 73
RY K V+G+G +G V YD TGE VA+K + + + EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK------RECGQQNTSGWKKEI 57
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFF 131
+L+ L H +IV+ K S + K + ++ E + S + K +L F
Sbjct: 58 NILKTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLF 112
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------RVAFN-DT 180
Q+ G+ Y+H+ + HRDL +N+L + D +KI DFGLA RV + D+
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVVH 238
P +FW A E K++ A D+WS G ELLT P K
Sbjct: 173 P--VFWY---------AVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE 219
Query: 239 QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR-LLERML 297
+ + R + + + +P P P + L++
Sbjct: 220 MIGPKQGQM--------------TVVRLIELLERGMRLP----CPKNCPQEVYILMKNCW 261
Query: 298 AFEPKDRPTAE 308
E K RPT
Sbjct: 262 ETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 72/313 (23%), Positives = 121/313 (38%), Gaps = 84/313 (26%)
Query: 31 IGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+G+GS+G+V A GE +VAIK +N+ + + L E +++ +V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNCHHVV 72
Query: 86 EIKHILL---PPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDLTPEHYQFFLY- 133
+ ++ P VV ELM + DL +++ N L P Q F+
Sbjct: 73 RLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 134 --QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-- 189
++ G+ Y+ HRDL +N + D +KI DFG+ R I+ TDY
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYETDYYR 176
Query: 190 ------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDI 242
+ RW APE +T D+WS G + E+ T + + G +
Sbjct: 177 KGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS------- 226
Query: 243 MTDLLGTPSPEAIARVRNEKARRYLSS---MRKKKPIPFSQKFPNANPLALRLLERMLAF 299
NE+ +++ + + P + L L L+ +
Sbjct: 227 -----------------NEEVLKFVIDGGHLDLPENCP--------DKL-LELMRMCWQY 260
Query: 300 EPKDRPTAEEALA 312
PK RPT E ++
Sbjct: 261 NPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 18/234 (7%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRH---PDIV 85
+IG+G +G V TG+ A+K ++ + T L E +L L+ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ + P + F + +LM DLH + + + + +F+ +++ GL+++H
Sbjct: 61 CMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQK- 169
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAIA 256
+ Y + D +S+GC+ +LL G F H++D MT + P++ +
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 75/290 (25%), Positives = 120/290 (41%), Gaps = 38/290 (13%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y++ + +G G+YG V A + TGE A+K I E D + I +EI +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V L SR + +++ E L + L+ + + L+GL Y+H
Sbjct: 69 VAYFGSYL--SREK---LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL + +K+ DFG VA T T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y DIW++G EL +P + + L +M+ P
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP----------- 229
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+ K +S F N ++ L PK RPTAE L
Sbjct: 230 --------KLKDKTKWSSTFHNFVKIS-------LTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 30 VIGKGSYGVV--CSAY---DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPD 83
+G G++G V +AY + KVA+K + H S+ ++ E+K++ L H +
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMSHLGNHEN 100
Query: 84 IVEIKHILLPPSRREFKDIYVVFEL-MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLK 140
IV LL I V+ E DL ++ + LT E F YQ+ +G+
Sbjct: 101 IVN----LLGACTIG-GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
++ + N HRDL +N+L +KICDFGLAR ND+ + + +W APE
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM-APE- 213
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
F YT D+WS G + E+ + G +PG
Sbjct: 214 -SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
H R +Y V E + DL I+ F+ ++ GL ++H +
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N++ +++ +KI DFG+ + D T + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA--YQP 177
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y ++D W+ G + E+L G+P F G++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-13
Identities = 87/332 (26%), Positives = 132/332 (39%), Gaps = 78/332 (23%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHP 82
RY I +IGKG G V AYD +VA+KKI D+ E+ R LRE K+ L HP
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR----- 137
IV + I + Y+ ++S L V + + + L
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 138 --GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----------VAFNDT---- 180
++Y+H+ V HRDLKP NIL ++ I D+G A + ++
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 181 -----PTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP-- 232
P I V T Y APE L G S+ T DI+++G I ++LT FP
Sbjct: 183 SSMTIPGKI-----VGTPDYMAPERLLGVPASEST---DIYALGVILYQMLTLS--FPYR 232
Query: 233 ---GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 289
G+ + ++ I SP +A R IP P
Sbjct: 233 RKKGRKISYRDVI-------LSPIEVAPYRE---------------IP---------PFL 261
Query: 290 LRLLERMLAFEPKDRPTAEEALAD---PYFKG 318
++ + LA +P +R ++ + L P+ +G
Sbjct: 262 SQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293
|
Length = 932 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 20/233 (8%)
Query: 8 KSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT 67
+S D+D +++ EV+G G+YG V +TG+ AIK + D+ E +
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTE--DEEE 57
Query: 68 RILREIKLLRLLRHPDIVEIKHILL----PPSRREFKDIYVVFELME----SDLHQVIKA 119
I EI +L+ H + + PP + +++V E +DL + K
Sbjct: 58 EIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD--QLWLVMEFCGAGSVTDLVKNTKG 115
Query: 120 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
N L + + ++LRGL ++H V HRD+K +N+L + ++K+ DFG V+
Sbjct: 116 NA-LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQL 171
Query: 180 TPTAIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTGKP 229
T ++ T ++ APE+ + + Y DIWS+G E+ G P
Sbjct: 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+++ +G+G +G V T KVAIK + L+E ++++ LRH +V
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLRGLKYI 142
+ ++ + IY+V E M + L +K D + Q Q+ G+ YI
Sbjct: 65 PLYAVV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
N HRDL+ NIL + KI DFGLAR+ ++ TA + +W APE
Sbjct: 119 ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKW-TAPE--A 174
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
+ + ++T D+WS G + EL+T G+ +PG + V+ Q++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 70/311 (22%), Positives = 133/311 (42%), Gaps = 55/311 (17%)
Query: 25 YKIEEVIGKGSYGVV-----CSAYDT------RTGEKVAIKKINDIFEHVSDATRILREI 73
+++ +V+G G+YG V + +DT + +K A+ + EH +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
+ + P +V + + ++ YV M + L+Q D+ + + +F+
Sbjct: 62 R-----QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSG 112
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
+++ L+++H + +RD+K +NIL +++ + + DFGL++ ++ + + T
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y APE+ + A+D WS+G + ELLTG SP
Sbjct: 171 EYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGA----------------------SPF 207
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAE 308
+ RN ++ ++ P P P A LL ++L +PK R A
Sbjct: 208 TLEGERNTQSEVSRRILKCDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGAS 262
Query: 309 EALADPYFKGL 319
E P+FKGL
Sbjct: 263 EIKEHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 76/300 (25%), Positives = 128/300 (42%), Gaps = 49/300 (16%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 89 HILLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ E KD + +V LM DL H F+ ++ GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVVKN- 175
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264
+YT + D W++GC+ E++ G+ +P + +++ E+
Sbjct: 176 -ERYTFSPDWWALGCLLYEMIAGQ--------------------SPFQQRKKKIKREEVE 214
Query: 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFKGL 319
R + K+ +S+KF +P A L + +L +PK+R A E P FK +
Sbjct: 215 RLV----KEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 45/293 (15%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A + TG A K I E + + EI++L HP IV+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVK---- 73
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVF 148
LL + K ++++ E I D LT Q Q+L L+Y+H+ +
Sbjct: 74 LLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKII 132
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRDLK N+L D +K+ DFG V+ + T ++ T ++ APE+ K
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 209 TP---AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265
TP DIWS+G E+ +P H+L+ M R
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPH------HELNPM---------------------R 222
Query: 266 YLSSMRKKKPIPFSQKFPNANPLALR-LLERMLAFEPKDRPTAEEALADPYFK 317
L + K +P SQ P+ + R L+ L P+ RP+A + L P+
Sbjct: 223 VLLKIAKSEPPTLSQ--PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 86/358 (24%), Positives = 148/358 (41%), Gaps = 57/358 (15%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
D T + +Y I V+G G+ G V A GE A+K ++ +D R E
Sbjct: 22 KDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAE 81
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLT---P 125
+ L IV+ R +++ ++ +++ DL Q IK+
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 126 EHYQFFLY-QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184
EH L+ Q+L + ++H+ ++ HRD+K NIL ++ +K+ DFG +++ +
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244
T + T +Y APE+ Y+ D++S+G + ELLT K F G+N+ ++M
Sbjct: 202 GRT-FCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMH 255
Query: 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 304
L A RY P+P P+ +P ++ +L+ +PK R
Sbjct: 256 KTL---------------AGRY-------DPLP-----PSISPEMQEIVTALLSSDPKRR 288
Query: 305 PTAEEALADPYFKGLAKVERE----------------PSAQPVTKMEFEFERRRITKE 346
P++ + L P K E TK + ERRRI ++
Sbjct: 289 PSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQQTKQLLQVERRRIVRQ 346
|
Length = 496 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 67/306 (21%), Positives = 135/306 (44%), Gaps = 44/306 (14%)
Query: 25 YKIEEVIGKGSYGVV-----CSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL 79
+++ +V+G G+YG V S +D+ + + K I + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 80 RH-PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
R P +V + + ++ Y+ + + L Q + + Q + +++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLA 117
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+++H + +RD+K +NIL +++ + + DFGL++ D + + T Y AP
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAP 175
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
++ + A+D WS+G + ELLTG F + +
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF-------------------TVDGEKNS 216
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR----PT-AEEALAD 313
+ E +RR L K +P P+ Q+ + LA +++R+L +PK R P+ A+E
Sbjct: 217 QAEISRRIL----KSEP-PYPQEM---SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 269 PFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 66/309 (21%), Positives = 129/309 (41%), Gaps = 52/309 (16%)
Query: 25 YKIEEVIGKGSYGVVCSA-----------YDTRTGEKVAIKKINDIFEHVSDATRILREI 73
+++ V+G G+YG V Y + +K I + EH TR R++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH----TRTERQV 57
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
L + R P +V + + ++ YV + + L+Q + T + ++
Sbjct: 58 -LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIA 112
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
+++ L ++H + +RD+K +NIL +++ + + DFGL++ + + + T
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y APE+ + A+D WS+G + ELLTG SP
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA----------------------SPF 208
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEA 310
+ +N ++ ++ K P P + A ++++L +PK R A+E
Sbjct: 209 TVDGEQNSQSEISRRILKSKPPFP-----KTMSAEARDFIQKLLEKDPKKRLGANGADEI 263
Query: 311 LADPYFKGL 319
P+F+G+
Sbjct: 264 KNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 14/232 (6%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIND--IFEHVSDATRILREIKLLRLLRHPDIVE 86
+VIGKGS+G V A G A+K + I + + LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ + + +Y V + + +L ++ +F+ ++ + Y+H+
Sbjct: 61 LHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
N+ +RDLKP+NIL ++ + + DFGL + T + + T Y APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK-- 170
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTPSPEAIA 256
Y +D W +G + E+L G P F ++V D I+ L P + +A
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVA 222
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 67/236 (28%), Positives = 108/236 (45%), Gaps = 23/236 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRH---PDIV 85
+IG+G +G V TG+ A+K ++ + T L E +L L+ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ + P + F + +LM DLH + + + +F+ +++ GL+++H
Sbjct: 61 CMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQKG 170
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV--HQLDIMT-----DLLGTPSPE 253
+ Y + D +S+GC+ +LL G F H++D MT +L + SPE
Sbjct: 171 VA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 21/219 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV---SDATRILREIK-LLRLLRHPDIV 85
VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ + + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 60 GLHYSFQTADK-----LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCG 202
N+ +RDLKP+NIL ++ + + DFGL + + + T + + T Y APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FCGTPEYLAPEVLR 169
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
Y +D W +G + E+L G P F ++ D
Sbjct: 170 K--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 49/239 (20%)
Query: 11 ADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL 70
+ V F E GEG+ GK G + + + VAIK + + E
Sbjct: 5 SAVRFLEELGEGA-------FGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFR 56
Query: 71 REIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQ----------VIKA 119
+E +L+ L+HP+IV + + + + ++FE + DLH+ V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111
Query: 120 NDDLTPEH---YQFFL---YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
+ D T + FL Q+ G++Y+ + + HRDL +N L +KI DFGL+
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 174 RVAFNDTPTAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224
R I+ DY + RW PE + K+T DIWS G + E+
Sbjct: 172 R--------DIYSADYYRVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 93 PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 152
P S + D V L+ D + + D L+ F YQ+ RG++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAI 212
+N+L +KICDFGLAR +D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 213 DIWSIGCIFAELLT-GKPLFPG 233
D+WS G + E+ + G +PG
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 29 EVIGKGSYGVVCSA--------YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+VIGKGS+G V A Y + +K AI K + +S+ +L+ +K
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK------ 54
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
HP +V + + +Y V + + +L ++ +F+ ++ L
Sbjct: 55 HPFLVGLHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 109
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T + + T Y APE
Sbjct: 110 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYLAPE 166
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
+ Y +D W +G + E+L G P F +N D
Sbjct: 167 VLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++E +G+G +G V T +VAIK + L+E ++++ LRH +V
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLRGLKYI 142
++ ++ + IY+V E M + L +K Q Q+ G+ Y+
Sbjct: 65 QLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWY 195
N HRDL+ NIL + K+ DFGLAR+ ++ TA I WT
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-------- 170
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
APE + + ++T D+WS G + EL T G+ +PG
Sbjct: 171 -APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
+ ++ ++G+G +G V + TG+ A+K + + E + +L + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 141
I ++++ ++ ++Y+V E DL ++ +D E QF+L +L+ +
Sbjct: 63 IPQLQYAF-----QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFG-LARVAFNDTPTAIFWTDYVATRWYRAPEL 200
+H HRD+KP+N+L + +K+ DFG AR+ N + V T Y APE+
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM---VNSKLPVGTPDYIAPEV 174
Query: 201 C----GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
G Y D WS+G I E++ G+ F
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+V+GKGS+G V A GE A+K + D+ D + E ++L L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF--L 58
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
H+ +E ++ V E + DL I+ F+ +++ GL+++H+
Sbjct: 59 THLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
+ +RDLK N++ + D +KI DFG+ + F D + F T Y APE+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEILQGL- 171
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
KYT ++D WS G + E+L G+ F G +
Sbjct: 172 -KYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 61/256 (23%), Positives = 119/256 (46%), Gaps = 23/256 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+++ E++G G+YG V +TG+ AIK ++ + + I +EI +L+ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRN 64
Query: 85 VEIKHILL----PPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLL 136
+ + PP + +++V E +DL + K N L E + ++L
Sbjct: 65 IATYYGAFIKKNPPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREIL 121
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
RGL ++H V HRD+K +N+L + ++K+ DFG V+ T ++ T ++
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTPYWM 178
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
APE+ + + Y D+WS+G E+ G P +H + + + P+P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD---MHPMRALFLIPRNPAPR 235
Query: 254 AIARVRNEKARRYLSS 269
++ ++K + ++ S
Sbjct: 236 LKSKKWSKKFQSFIES 251
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 65/285 (22%), Positives = 118/285 (41%), Gaps = 50/285 (17%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IG+G++G V S VA+K + A + L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLI 59
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR-------GLKY 141
+ + + IY+V EL++ L E + + +L++ G++Y
Sbjct: 60 GVC-----TQKQPIYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+ + + HRDL +N L LKI DFG++R + + + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+ +Y+ D+WS G + E + L P + N+
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS-------------------LGAVPYAN----LSNQ 203
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
+ R + + +P + P+A RL+ER ++P RP+
Sbjct: 204 QTREAI---EQGVRLPCPELCPDA---VYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 31 IGKGSYG-VVCSAYDTRTGEKVAIKKINDIFEHVS-----DATRILREIKLLRLLRHPDI 84
+G GS+G V+ + Y VAIK+ FE + E K+L + HP
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKR----FEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 85 VEIKHILLPPSRREFKD---IYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
V + FKD +Y+V E ++ + ++ N + F+ Q++ +
Sbjct: 94 VNL--------YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE 145
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+ + N+ +RDLKP+N+L + D +K+ DFG A+V T T T Y APE+
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT------LCGTPEYIAPEI 199
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ + A D W++G E+L G P F
Sbjct: 200 LLNV--GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 3e-12
Identities = 83/340 (24%), Positives = 135/340 (39%), Gaps = 60/340 (17%)
Query: 23 SRYKIEEVIGKGSYG--VVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL---------- 70
+ +++ + + G++G +C A T E A + +N + R++
Sbjct: 148 AHFRVIDDLPAGAFGKIFIC-ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 71 -----REIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND---D 122
EI L L H +I++I+ IL + + Y++ + + DL+ +
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWK 261
Query: 123 LTPEHYQF--FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND- 179
P Q + QLL ++YIH + HRD+K +NI N D K+ + DFG A +
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP----GKN 235
W VAT +PE+ Y DIWS G I ++L+ P G
Sbjct: 322 EAFDYGWVGTVAT---NSPEILAG--DGYCEITDIWSCGLILLDMLS-HDFCPIGDGGGK 375
Query: 236 VVHQLDIMTDLLGT-----PSP-----EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA 285
QL + D L P P + I + A + + + +P ++P
Sbjct: 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP-- 433
Query: 286 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 325
L +ML F+ RP A E LA P F A+ E E
Sbjct: 434 -------LVKMLTFDWHLRPGAAELLALPLFS--AEEEEE 464
|
Length = 501 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 40/212 (18%)
Query: 102 IYVVFELMESDLHQVIKANDDL-----TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156
++ F+ S + DDL T E + +Q+ RG++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 215
IL + + +KICDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 216 SIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKK 274
S G + E+ + G +PG ++ E +R R +
Sbjct: 261 SFGVLLWEIFSLGASPYPG----------------------VQINEEFCQRLKDGTRMRA 298
Query: 275 PIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
P NA P R++ +PK+RPT
Sbjct: 299 P-------ENATPEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPDIVEIK 88
+G G+ GVV +G +A K I+ + A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN- 146
+I + E M+ L QV+K + E +LRGL Y+ +
Sbjct: 70 GAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFF 205
+ HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFP 232
S + DIWS+G EL G+ P
Sbjct: 180 SVQS---DIWSMGLSLVELAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 53/245 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCSA----YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLR 77
R + + +G+G++G V A D VA+K + D D + ++ E+++++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMK 70
Query: 78 LL-RHPDIVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKAN--------------- 120
++ +H +I+ LL +E +YVV E +L ++A
Sbjct: 71 MIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 121 -DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
+ LT + F YQ+ RG++++ + HRDL +N+L D +KI DFGLAR
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----- 180
Query: 180 TPTAIFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GK 228
I DY + +W APE + F + YT D+WS G + E+ T G
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233
Query: 229 PLFPG 233
P +PG
Sbjct: 234 P-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 74/308 (24%), Positives = 119/308 (38%), Gaps = 37/308 (12%)
Query: 24 RYKIEEVIGKGSYG--VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+Y I + GS G VC+ + +KV +K V+ REI +L+ + H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKA-------VTGGKTPGREIDILKTISH 145
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
I+ + H + R + +V + DL + + L E +LL L Y
Sbjct: 146 RAIINLIH-----AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAY 200
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLA--RVAFNDTPTAIFWTDYVATRWYRAPE 199
+H + HRD+K +NI + + DFG A A DTP W+ + T +PE
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET---NSPE 257
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---VHQLDIMTDLLGTPSPEAIA 256
L Y DIWS G + E+ GK V QL + + E
Sbjct: 258 L--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF-- 313
Query: 257 RVRNEKAR------RYLSSMRKKKPIPFSQKFPNANPL--ALRLLERMLAFEPKDRPTAE 308
+N +Y ++ + P L+ +ML F+ + RP+A+
Sbjct: 314 -PQNGSTNLCKHFKQY--AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ 370
Query: 309 EALADPYF 316
+ L+ P F
Sbjct: 371 DILSLPLF 378
|
Length = 392 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 72/285 (25%), Positives = 128/285 (44%), Gaps = 46/285 (16%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
E++GKG++G V + VA+K D+ + + + L E ++L+ HP+IV++
Sbjct: 1 ELLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKL 57
Query: 88 KHILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ ++R+ IY+V EL+ L + K D+L + F G+ Y+ +
Sbjct: 58 IGVC---TQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
N HRDL +N L + LKI DFG++R +D + + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN--Y 168
Query: 206 SKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264
+Y+ D+WS G + E + G +PG MT N++AR
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPG---------MT---------------NQQAR 204
Query: 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
+ K + QK P+ ++++R ++P++RP E
Sbjct: 205 E---QVEKGYRMSCPQKCPDD---VYKVMQRCWDYKPENRPKFSE 243
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 33/225 (14%)
Query: 30 VIGKGSYGVVCSAY---DTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIV 85
++GKG +G V A + + +KVA+K + DIF SD LRE ++ HP+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVI 64
Query: 86 EIKHILLPPSRREFKDI-YVVFELME-SDLHQVIKAND------DLTPEHYQFFLYQLLR 137
++ + L + I V+ M+ DLH + + L + F+ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-------- 189
G++Y+ + N HRDL +N + N + + + DFGL++ I+ DY
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--------KIYSGDYYRQGCASK 176
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
+ +W L + YT D+W+ G E++T G+ + G
Sbjct: 177 LPVKWLALESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPDIVE 86
IG+G++G V +G +A+K+I + + R+L ++ ++R P IV+
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 87 IKHILLPPSRREFK--DIYVVFELMESDL-------HQVIKANDDLTPEHYQFFL----Y 133
L F+ D ++ ELM+ L ++V+K+ PE L
Sbjct: 68 FYGAL-------FREGDCWICMELMDISLDKFYKYVYEVLKSV---IPEE---ILGKIAV 114
Query: 134 QLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
++ L Y+ + HRD+KP NIL + + +K+CDFG++ + +I T
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAKTRDAGC 170
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQL 240
R Y APE + S Y D+WS+G E+ TGK +P +V QL
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 20/128 (15%)
Query: 118 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
+ LT E + +Q+ RG++++ + HRDL +NIL + + +KICDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 178 NDTPTAIFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT-GK 228
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KD-------PDYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 229 PLFPGKNV 236
+PG +
Sbjct: 274 SPYPGVQI 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 33/213 (15%)
Query: 29 EVIGKGSYGVVCSA-YDTRTGE--KVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPDI 84
+ +G GS+GVV + T G+ VA+K + + +SD L+E ++ L H ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS--DKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 85 VEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQF-FLYQLLRGLKY 141
+ + ++L + +V EL S L ++ K + Q+ G++Y
Sbjct: 59 IRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYR---- 196
+ + HRDL +NIL +D K+KI DFGL R + N+ D+ +
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--------DHYVMEEHLKVPF 164
Query: 197 ---APELCGSFFSKYTPAIDIWSIGCIFAELLT 226
APE ++ A D+W G E+ T
Sbjct: 165 AWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV--SDATRILREIKLLRLLRHP 82
Y + +VIG+G++G V ++ +KV K+ FE + SD+ E ++ P
Sbjct: 45 YDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ L + ++ K +Y+V E M + +N D+ + +F+ +++ L I
Sbjct: 104 WVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAI 158
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTDYVATRWYRAP 198
H+ + HRD+KP N+L + LK+ DFG + TA+ DY+ +P
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYI------SP 212
Query: 199 ELCGSFFSK--YTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
E+ S Y D WS+G E+L G F ++V
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 44/130 (33%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 110 ESDLHQVIKANDDLT--PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167
+ D+ I D+L E F YQ+ +G+ ++ + N HRDL +NIL KI
Sbjct: 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKI 255
Query: 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT- 226
CDFGLAR ND+ + + +W APE F YT D+WS G + E+ +
Sbjct: 256 CDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFESDVWSYGILLWEIFSL 312
Query: 227 GKPLFPGKNV 236
G +PG V
Sbjct: 313 GSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 21/222 (9%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A + TG A K I+ E + + EI +L HP+IV+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVK---- 66
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
LL E +++++ E + + LT + Q L L Y+H +
Sbjct: 67 LLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRDLK NIL D +K+ DFG V+ +T T ++ T ++ APE+ SK
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 209 TP---AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
P D+WS+G E+ +P H+L+ M LL
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPH------HELNPMRVLL 218
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKV----AIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+V+G G++G V GE V AIK +N+ ++ + E ++ + HP +
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMASMDHPHL 71
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
V + + L P+ I +V +LM L V + D++ + + Q+ +G+ Y+
Sbjct: 72 VRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ HRDL +N+L + +KI DFGLAR+ D + +W L
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---ALEC 182
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT--GKP 229
+ K+T D+WS G EL+T GKP
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 31/226 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+ + IGKG +G V D R G KVA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDVMLG-DYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 86 EIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYI 142
++ +++ E +Y+V E M + L +++ L + F + ++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA---IFWTDYVATRWYRAPE 199
N HRDL +N+L + D K+ DFGL + A + T + WT APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APE 169
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GK---PLFPGKNVVHQLD 241
K++ D+WS G + E+ + G+ P P K+VV +++
Sbjct: 170 ALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 31 IGKGSYGVVCSAYDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH 89
+G G +GVV Y G+ VAIK I E + E K++ L H +V++
Sbjct: 12 LGTGQFGVV--KYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 90 ILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
+ + + IY+V E M + L+ + + P + G+ Y+ +
Sbjct: 67 VC-----TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
HRDL +N L + +K+ DFGL+R +D T+ + + RW PE+ +SK
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW-SPPEVL--LYSK 177
Query: 208 YTPAIDIWSIGCIFAELLT-GK 228
++ D+W+ G + E+ + GK
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 27 IEEVIGKGSYGVVCSAYDTRTGEK-----VAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+ + +G+G +G V A R + VA+K + + S+ +L E LL+ + H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNH 62
Query: 82 PDIVEI-----------------KHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-- 122
P ++++ K+ L RE + + + + + + N D
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 123 -LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
LT F +Q+ RG++Y+ + HRDL +N+L K+KI DFGL+R + +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 182 TAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 233
+ +W A E S F YT D+WS G + E++T G P +PG
Sbjct: 183 YVKRSKGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 38/115 (33%), Positives = 61/115 (53%), Gaps = 6/115 (5%)
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
LT E + +Q+ +G++++ + HRDL +NIL + + +KICDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT-GKPLFPG 233
P + D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 62/254 (24%), Positives = 112/254 (44%), Gaps = 32/254 (12%)
Query: 3 PDQRKKSSADVDFFTEYGE-----------GSRYKIEEVIGKGSYGVVCSAYDTRTGEKV 51
P RK + D +F Y + Y++ +VIG+G++G V T +
Sbjct: 13 PALRKNKNID-NFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVY 71
Query: 52 AIKKINDIFEHV--SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109
A+K ++ FE + SD+ E ++ P +V++ + ++ + +Y+V E M
Sbjct: 72 AMKLLSK-FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDRYLYMVMEYM 125
Query: 110 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
+ +N D+ + +F+ +++ L IH+ HRD+KP N+L + LK+ D
Sbjct: 126 PGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 185
Query: 170 FG----LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAE 223
FG + + TA+ DY+ +PE+ S Y D WS+G E
Sbjct: 186 FGTCMKMNKEGMVRCDTAVGTPDYI------SPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
Query: 224 LLTGKPLFPGKNVV 237
+L G F ++V
Sbjct: 240 MLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 21/223 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-TRILREIKLLRLLRHPD 83
++I +VIG+G++G V + + E++ KI + +E + A T RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 84 IVEIKHILLPPSRREFKD---IYVVFEL-MESDLHQVIKANDDLTPEHY-QFFLYQLLRG 138
I + F+D +Y+V + + DL ++ +D PE +F++ +++
Sbjct: 60 CQWITTL-----HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND----TPTAIFWTDYVATRW 194
+ IH + HRD+KP N+L + + +++ DFG D + A+ DY++
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
+A E KY P D WS+G E+L G+ F +++V
Sbjct: 175 LQAME---DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 67/309 (21%), Positives = 119/309 (38%), Gaps = 75/309 (24%)
Query: 30 VIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRIL---REIKLLRLLRHP 82
+G+G +G V A + GE + + K + D RE+ + R L H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKA---LQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------LTPEHYQFFL 132
++V + + RE + Y++ E + DL Q ++A L+ +
Sbjct: 69 NVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--- 189
Q+ G+ ++ A HRDL +N L ++ ++K+ L++ +N +Y
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS--------EYYKL 175
Query: 190 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244
+ RW APE ++ D+WS G + E+ T G+ F G ++
Sbjct: 176 RNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG---------LS 223
Query: 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL-RLLERMLAFEPKD 303
D E + R++ K P P L +L+ R A PKD
Sbjct: 224 D------EEVLNRLQAGKLE---------------LPVPEGCPSRLYKLMTRCWAVNPKD 262
Query: 304 RPTAEEALA 312
RP+ E ++
Sbjct: 263 RPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 15/220 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-TRILREIKLLRLLRHPD 83
++I +VIG+G++G V + + +KV KI + +E + A T RE + + +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 84 IVEIKHILLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 141
+ H ++ ++Y+V + + DL ++ +D PE +F+L +++ +
Sbjct: 62 WITTLHYAF----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND----TPTAIFWTDYVATRWYRA 197
+H + HRD+KP NIL + + +++ DFG D + A+ DY++ +A
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
E KY P D WS+G E+L G+ F +++V
Sbjct: 178 ME---DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 62/307 (20%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDI-------FEHVSDATRILREIKLLRLLRHPD 83
+GKG +G V + TG+ A KK+N +E RIL ++ H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTP---EHYQ-FFLYQLLRG 138
+ + L + + D+ +V +M DL I D+ P E F+ Q++ G
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + D ++I D GLA V D + Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
EL +Y ++D +++G E++ + F R
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPF-------------------------RA 199
Query: 259 RNEKA-RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALA 312
R EK + L + + KF +P + E +LA +P+ R +
Sbjct: 200 RGEKVENKELKQRILNDSVTYPDKF---SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256
Query: 313 DPYFKGL 319
P F+ L
Sbjct: 257 HPLFRDL 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 33/229 (14%)
Query: 26 KIEEVIGKGSYGVVCSA---YDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
K+ +++G+G +G V D + KVA+K + DI + S+ L E ++ H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDH 60
Query: 82 PDIVEIKHILLPPSRRE-FKDIYVVFELME-SDLHQ-VIKANDDLTPEHYQF-----FLY 133
P+++++ + S + V+ M+ DLH ++ + PE F+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY---- 189
+ G++Y+ N HRDL +N + D + + DFGL++ I+ DY
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYRQG 172
Query: 190 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
+ +W L YT D+W+ G E+ T G+ +PG
Sbjct: 173 RIAKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 89 HILLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ E KD + +V +M DL H N + F+ +L GL+ +
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN- 175
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLF 231
KYT + D W +GC+ E++ G+ F
Sbjct: 176 -EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 77/319 (24%), Positives = 127/319 (39%), Gaps = 66/319 (20%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ Y++ + IG G +G V RT E K I+ + ++++ E+ ++R L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDL---TPEHYQF-FLYQLLR 137
+IV L + ++ +Y++ E ++ DL + I+ + EH QLL
Sbjct: 73 NIVRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 138 GLKYIHT-------ANVFHRDLKPKNILANADCK-----------------LKICDFGLA 173
L Y H V HRDLKP+NI + + KI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ + V T +Y +PEL Y D+W++GCI EL +GK F
Sbjct: 190 K----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 293
N QL +S +++ +P K N L+
Sbjct: 246 ANNFSQL--------------------------ISELKRGPDLPIKGKSKELN----ILI 275
Query: 294 ERMLAFEPKDRPTAEEALA 312
+ +L K+RP+A + L
Sbjct: 276 KNLLNLSAKERPSALQCLG 294
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 40/123 (32%), Positives = 58/123 (47%), Gaps = 22/123 (17%)
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
F YQ+ G++++ + N HRDL +N+L +KICDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
+W APE F + YT D+WS G + E+ T L GTP
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFT-------------------LGGTP 341
Query: 251 SPE 253
PE
Sbjct: 342 YPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPD 83
KI E +G G+ GVV +G +A K I+ + A R I+RE+++L P
Sbjct: 9 KISE-LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPY 64
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV +I + E M+ L QV+K + + +++GL Y+
Sbjct: 65 IVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 143 HTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
+ + HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERL 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFP 232
G+ +S + DIWS+G E+ G+ P+ P
Sbjct: 175 QGTHYSVQS---DIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 43/199 (21%)
Query: 51 VAIKKINDIFEHVSDATRI--LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108
VA+K + SD R L+E+K+L L P+I LL + + ++ E
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIAR----LLGVCTVD-PPLCMIMEY 100
Query: 109 ME-SDLHQVIKANDDLTPEH--------YQFFLY---QLLRGLKYIHTANVFHRDLKPKN 156
ME DL+Q ++ + T + LY Q+ G++Y+ + N HRDL +N
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160
Query: 157 ILANADCKLKICDFGLARVAF-ND-------TPTAIFWTDYVATRWYRAPELCGSFF-SK 207
L + +KI DFG++R + +D P I RW A E S K
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPI--------RWM-AWE---SVLLGK 208
Query: 208 YTPAIDIWSIGCIFAELLT 226
+T D+W+ G E+LT
Sbjct: 209 FTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 68/298 (22%), Positives = 126/298 (42%), Gaps = 43/298 (14%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLL-RHPDIVEI 87
VIG+GSY V +T A+K I ++ D + E + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
SR ++ V E + DL ++ L EH +F+ ++ L ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A+ +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266
Y ++D W++G + E++ G+ F DI+ + +P+ + Y
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF---------DIVGM---SDNPD-------QNTEDY 212
Query: 267 LSSMRKKKPIPFSQKFPNANPL-ALRLLERMLAFEPKDR--PTAEEALAD----PYFK 317
L + +K I + P + + A +L+ L +PK+R + D P+F+
Sbjct: 213 LFQVILEKQI----RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEI-- 87
+GKG +G VC+ TG+ A KK++ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 88 -----KHILLPPSRREFKDI-YVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
H+ L S D+ Y ++ + E ++ +VI + Q+ G+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI------------HYSAQITCGI 108
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
++H+ ++ +RD+KP+N+L + ++ D GLA + T T Y APE
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI----TQRAGTNGYMAPE 164
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ Y+ +D +++GC E++ G+ F
Sbjct: 165 ILKE--EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
F Q+ +G+ ++ + N HRD+ +N+L KICDFGLAR ND+ + +
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
+W APE F YT D+WS G + E+ + GK +PG
Sbjct: 277 PVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 70 LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTP 125
L+EIK++ L+ P+I+ + + + + ++ E ME+ DL+Q + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 126 EHYQFFLY--------QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
Y Q+ G+KY+ + N HRDL +N L + +KI DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ I + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIND---IFEHVSDATRILREIKLLRLLRHPDIVE 86
+I G+YG V T ++ A+KKIN I + + R+I L +P +V
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFAENPFVVS 65
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ S + + +V E +E D ++K L + + + + + L+Y+H
Sbjct: 66 -----MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF-WTDYVATRWYRAPELCGS- 203
+ HRDLKP N+L + +K+ DFGL+++ T ++ TR + ++CG+
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 204 --------FFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
Y +D W++G I E L G F G
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 112 DLHQVIKA--NDDLTPEHYQ--FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167
DL++ IK + L + Y+ YQ++ L +H+ + HRDLK NI +K+
Sbjct: 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL 210
Query: 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 227
DFG ++ ++D+ + + + T +Y APEL +Y+ D+WS+G I ELLT
Sbjct: 211 GDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTL 267
Query: 228 KPLFPGKNVVHQLDIMTDLL-GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 286
F G + Q +IM +L G P P P S
Sbjct: 268 HRPFKGPS---QREIMQQVLYGKYDP---------------------FPCPVSSGMK--- 300
Query: 287 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 325
LL+ +L+ P RPT ++ L + K +A + ++
Sbjct: 301 ----ALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 58/236 (24%), Positives = 104/236 (44%), Gaps = 48/236 (20%)
Query: 24 RYKIEEVIGKGSYGVV--CSA----------YDTRTGEK--VAIKKINDIFEHVSDATR- 68
+ +++E +G+G +G V C A G+ VA+K + +D T+
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR------ADVTKT 59
Query: 69 ----ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI------ 117
L+EIK++ L++P+I+ + + + + ++ E ME+ DL+Q +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD-----PLCMITEYMENGDLNQFLSQREIE 114
Query: 118 ----KANDDLTPEHYQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170
AN+ + LY Q+ G+KY+ + N HRDL +N L +KI DF
Sbjct: 115 STFTHANN-IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF 173
Query: 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
G++R ++ I + RW + K+T A D+W+ G E+ T
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 31 IGKGSYGVV--------CSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
+G+G++G V C D VA+K + D SD R RE +LL L+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKIL---VAVKTLKD----ASDNARKDFHREAELLTNLQ 65
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN-------------DDLTPE 126
H IV+ + + E + +VFE M+ DL++ ++A+ +LT
Sbjct: 66 HEHIVKFYGVCV-----EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186
Q+ G+ Y+ + + HRDL +N L + +KI DFG++R ++ +
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW PE + K+T D+WS+G + E+ T
Sbjct: 181 HTMLPIRWM-PPE--SIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 64/293 (21%), Positives = 111/293 (37%), Gaps = 46/293 (15%)
Query: 29 EVIGKGSYGVVCSAYDTRTGE--KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVE 86
+ +G+G +G V + KVA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 87 IKHILLPPSRRE-FKDIYVVFELME-SDLHQVI---KANDD---LTPEHYQFFLYQLLRG 138
+ + L E + V+ M+ DLH + + D L + F+ + G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
++Y+ + + HRDL +N + N + + + DFGL++ +N + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG------------------------ 217
Query: 258 VRNEKARRYL-SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
V N + YL R K+P P+ L+ PKDRP+ E
Sbjct: 218 VENSEIYDYLRQGNRLKQP-------PDCLDGLYSLMSSCWLLNPKDRPSFET 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 63/246 (25%), Positives = 99/246 (40%), Gaps = 59/246 (23%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+VIG+G++G V TG A+K ILR+ +L + I +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMK--------------ILRKADMLEKEQVAHIRAER 52
Query: 89 HILLPP----------SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 137
IL+ S ++ +++Y++ E + D+ ++ D L+ E QF++ + +
Sbjct: 53 DILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL 112
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-------RVAF------------- 177
+ IH HRD+KP N+L +A +K+ DFGL R F
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 178 ----NDTPTAIFWT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225
N A W V T Y APE+ + Y D WS+G I E+L
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEML 230
Query: 226 TGKPLF 231
G P F
Sbjct: 231 IGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 63/243 (25%), Positives = 100/243 (41%), Gaps = 53/243 (21%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFE-----HVSDATRILREIKLLRLLRH 81
+VIG+G++G V TG A+K + D+ E H+ IL E L +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVK- 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
+ S ++ ++Y++ E + D+ ++ D LT E QF++ + + +
Sbjct: 66 ----------MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAID 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLA-------RVAF---------------- 177
IH HRD+KP N+L ++ +K+ DFGL R F
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 178 -NDTPTAIFWT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
N A W V T Y APE+ + Y D WS+G I E+L G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233
Query: 229 PLF 231
P F
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEK----VAIKKIND-----IFEHVSDATRILREIKLLRLL 79
+++G G +G V G+ VAIK I D F+ ++D + + L
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD------HMLAMGSL 66
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 137
H IV + I S + +V +L S L V + D L P+ + Q+ +
Sbjct: 67 DHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
G+ Y+ + HR+L +NIL +D ++I DFG+A + + D + +W
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM-- 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT 226
L F +YT D+WS G E+++
Sbjct: 179 -ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 22/247 (8%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL--RLLRHPDIVEI 87
VIG+GSY V + + A+K + H + ++ K + + +P +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
SR +++V E + DL ++ L EH +F+ ++ L ++H
Sbjct: 62 HSCFQTTSR-----LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +AD +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266
+Y ++D W++G + E++ G+ F DI+TD + + + +V EK R
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPF---------DIITDNPDMNTEDYLFQVILEKPIRI 222
Query: 267 LSSMRKK 273
+ K
Sbjct: 223 PRFLSVK 229
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 51/227 (22%)
Query: 31 IGKGSYGVV----CSAYDTRTGEK-VAIKKINDIFEHVSDATR--ILREIKLLRLLRHPD 83
+G+G++G V C + VA+K + + S++ R RE +LL +L+H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTVLQHQH 68
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND---------------DLTPEH 127
IV + E + + +VFE M DL++ ++++ LT
Sbjct: 69 IVRFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123
Query: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
Q+ G+ Y+ + + HRDL +N L +KI DFG++R I+ T
Sbjct: 124 MLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYST 175
Query: 188 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
DY + RW PE + K+T DIWS G + E+ T
Sbjct: 176 DYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLL-RLLRHPDIVEI 87
VIG+GSY V +T A+K + ++ D + E + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 62 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +++ +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 37/102 (36%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR N +
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
+W APE F YT D+WS G + E+ T G +PG
Sbjct: 201 KWM-APE--ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 27/224 (12%)
Query: 22 GSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV--SDATRILREIK 74
R K E+ VIG+G++G V + + A+K ++ FE + SD+ E
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERD 95
Query: 75 LLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLY 133
++ IV++ + K +Y+V E M DL ++ +N D+ + +F+
Sbjct: 96 IMAHANSEWIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTA 149
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTDY 189
+++ L IH+ HRD+KP N+L + LK+ DFG + TA+ DY
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 190 VATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ +PE+ S Y D WS+G E+L G F
Sbjct: 210 I------SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 37/104 (35%), Positives = 54/104 (51%), Gaps = 8/104 (7%)
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQ+ RG++Y+ + HRDL +N+L + +KI DFGLAR N +
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 193 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 233
+W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 204 KWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPG 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 50/214 (23%)
Query: 50 KVAIKKI-NDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVFE 107
KVA+K + +D E D + ++ E+++++++ +H +I+ LL ++ +YV+ E
Sbjct: 52 KVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIIN----LLGACTQD-GPLYVIVE 104
Query: 108 LM-ESDLHQVIKA----------NDDLTPEHYQFF------LYQLLRGLKYIHTANVFHR 150
+ +L + ++A N PE F YQ+ RG++Y+ + HR
Sbjct: 105 YASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--------VATRWYRAPELCG 202
DL +N+L D +KI DFGLAR I DY + +W APE
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKKTTNGRLPVKWM-APE--- 212
Query: 203 SFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 233
+ F + YT D+WS G + E+ T G P +PG
Sbjct: 213 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 31 IGKGSYGVVCSA-YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G G++G V Y R + VAIK + + E S ++RE +++ L +P IV +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 89 HILLPPSRREFKDIYVVFELMESD-LHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTAN 146
+ E + + +V E+ L++ + D++T + ++Q+ G+KY+ N
Sbjct: 62 GVC------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW---YRAPELCGS 203
HRDL +N+L KI DFGL++ D ++ A +W + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS---YYKARSAGKWPLKWYAPECIN- 171
Query: 204 FFSKYTPAIDIWSIGCIFAELLT--GKP 229
F K++ D+WS G E + KP
Sbjct: 172 -FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 39/112 (34%), Positives = 56/112 (50%), Gaps = 24/112 (21%)
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--- 189
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR + DY
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--------GVHDIDYYKK 192
Query: 190 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 233
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 193 TSNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 43/238 (18%)
Query: 21 EGSRYKIEEV--IGKGSYGVVCSA-----YDTRTGEKVAIKKINDIFEHVSDATR--ILR 71
E R IE V IG+G++G V A VA+K + E S + R
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQR 57
Query: 72 EIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND--------- 121
E L+ HP+IV++ + K + ++FE M DL++ ++
Sbjct: 58 EAALMAEFDHPNIVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112
Query: 122 -------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
L+ Q+ G+ Y+ HRDL +N L + +KI
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 172
Query: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
DFGL+R ++ D + RW PE F+++YT D+W+ G + E+ +
Sbjct: 173 DFGLSRNIYSADYYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 31 IGKGSYGVVCSA--YD-TRTGEK--VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+G+G++G V A Y+ + T +K VA+K + D ++ RE +LL L+H IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIV 70
Query: 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKA----------------NDDLTPEHY 128
+ + + + +VFE M+ DL++ ++A +L
Sbjct: 71 KFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 129 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188
Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R ++ +
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW PE + K+T D+WS G I E+ T
Sbjct: 186 MLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 40/229 (17%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKV--AIKKINDIFEHVSDATRILREIKLL-RLLRHP 82
K ++VIG+G++G V A + G ++ AIK++ + + D E+++L +L HP
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHP 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFE---------------LMESDLHQVI--KANDDLTP 125
+I+ ++L R + +Y+ E ++E+D I L+
Sbjct: 69 NII---NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 126 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR---VAFNDTPT 182
+ F + RG+ Y+ HRDL +NIL + KI DFGL+R V T
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-- 181
Query: 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 182 ----MGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 62/244 (25%), Positives = 105/244 (43%), Gaps = 55/244 (22%)
Query: 23 SRYKIEEVIGKGSYGVV--CSA------------YDTRTGEK--VAIKKINDIFEHVSDA 66
+E +G+G +G V C ++ R G VA+K + DA
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR------PDA 58
Query: 67 TR-----ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA- 119
+ L+E+K+L L+ P+I+ + + + + + ++ E ME+ DL+Q + +
Sbjct: 59 NKNARNDFLKEVKILSRLKDPNIIRLLGVCV-----DEDPLCMITEYMENGDLNQFLSSH 113
Query: 120 ---------NDDLTPEH------YQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANA 161
ND + P H Y L+ Q+ G+KY+ + N HRDL +N L
Sbjct: 114 HLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE 173
Query: 162 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
+ +KI DFG++R + I + RW A E K+T A D+W+ G
Sbjct: 174 NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGVTL 230
Query: 222 AELL 225
E+L
Sbjct: 231 WEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 56/229 (24%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++I +VIG+G++G V V +K ++ A +IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEVAV---------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 85 VEIKHILLPPSRR-------EFKD---IYVVFEL-MESDLHQVI-KANDDLTPEHYQFFL 132
E + +L+ RR F+D +Y+V + + DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTD 188
+++ + +H HRD+KP N+L + + +++ DFG L + A+ D
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
Y++ +A E +Y P D WS+G E+L G+ F +++V
Sbjct: 169 YISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK-KINDIFEHVSDAT--RILREIKLLRLL 79
+ +K +V+G G++G V GEKV I I ++ E S IL E ++ +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLR 137
+P + + I L + + ++ +LM L V + D++ ++ + Q+ +
Sbjct: 67 DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
G+ Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ YT D+WS G EL+T
Sbjct: 181 ESI---LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 49/235 (20%)
Query: 31 IGKGSYGVVC--SAYD---TRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+G G++G V +A D +G +VA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL------- 136
V++ + L + Y++ ELME DL ++ L +LL
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 137 RGLKYIHTANVFHRDLKPKNILA-----NADCKLKICDFGLARVAFNDTPTAIFWTDY-- 189
+G Y+ + HRDL +N L +AD +KI DFGLAR I+ +DY
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------DIYKSDYYR 168
Query: 190 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235
+ RW APE L G F T D+WS G + E+LT G+ +P N
Sbjct: 169 KEGEGLLPVRWM-APESLLDGKF----TTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 56/219 (25%), Positives = 85/219 (38%), Gaps = 40/219 (18%)
Query: 31 IGKGSYGVVC--SAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI---- 84
IG G +G V A+ + +V +K++ + L+E++ R L HP++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 85 ---VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-----DLTPEHYQFFLYQL 135
+E LL V E DL +++N + Q ++
Sbjct: 62 GQCIESIPYLL------------VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD---YVAT 192
GL ++H A+ H DL +N AD +KI D+GL A P + T V
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGL---ALEQYPEDYYITKDCHAVPL 166
Query: 193 RWYRAPELCGSFFS-----KYTPAIDIWSIGCIFAELLT 226
RW APEL T +IWS+G EL T
Sbjct: 167 RWL-APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSA--YDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLR 77
S + E +G+ +G V + T GE+ VAIK + D E E +
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRS 63
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI----------KANDD---- 122
L+HP+IV LL +E + + ++F SDLH+ + +DD
Sbjct: 64 RLQHPNIV----CLLGVVTKE-QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 123 --LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
L P + + Q+ G++++ + +V H+DL +N+L +KI D GL R +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ + RW +PE + K++ DIWS G + E+ +
Sbjct: 179 YYKLMGNSLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 46/232 (19%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKV--AIKKINDIFEHVSDATRILREIKLL-RLLRHP 82
K E+VIG+G++G V A + G K+ AIK + + F +D E+++L +L HP
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHP 63
Query: 83 DIVEIKHILLPPSRREFKDIYVVFE----------LMESDLHQVIKANDDLTPEH---YQ 129
+I+ ++L R + +Y+ E L +S +V++ + EH
Sbjct: 64 NII---NLLGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTAST 115
Query: 130 FFLYQLLR-------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR---VAFND 179
QLL+ G++Y+ HRDL +N+L + KI DFGL+R V
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGKP 229
T + RW L +S YT D+WS G + E+ L G P
Sbjct: 176 T------MGRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTG----EKVAIKKINDIFEHVSDATRILREIKLLRL 78
S + E +G+ ++G + + G + VAIK + DI + +E L+
Sbjct: 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAE 63
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFE-LMESDLHQVI-----------KANDDLTP- 125
L HP+IV LL +E + + ++FE L + DLH+ + +++D T
Sbjct: 64 LHHPNIV----CLLGVVTQE-QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 126 ---EHYQFF--LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
+H F Q+ G++Y+ + H+DL +NIL +KI D GL+R ++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ + RW PE + K++ DIWS G + E+ +
Sbjct: 179 YYRVQPKSLLPIRWM-PPE--AIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 58/255 (22%), Positives = 96/255 (37%), Gaps = 65/255 (25%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFE-----HVSDATRILREIKLLRLLRH 81
+ +G G++G VC A T A+K + D+ HV IL E +++
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVK- 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 140
L S ++ ++Y V + + + ++ PE +F++ +L ++
Sbjct: 66 ----------LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIE 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGL----------------ARVAFNDTPTAI 184
+H HRD+KP NIL + D +K+ DFGL + + + +
Sbjct: 116 SVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 185 FWTD----------------------------YVATRWYRAPELCGSFFSKYTPAIDIWS 216
W D V T Y APE+ YT D WS
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWS 233
Query: 217 IGCIFAELLTGKPLF 231
+G I E+L G+P F
Sbjct: 234 VGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 29/221 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSA----YDTRTGEKVAIKKINDIFEHVSDA--TRILREIKLL 76
R + +++ +G++G + E+V +K + D H S+ T +L+E LL
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLL 62
Query: 77 RLLRHPDIVEIKH----------ILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTP 125
L H +I+ I H +L P + K L E++ Q + +
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH- 121
Query: 126 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185
Q+ G+ Y+H V H+D+ +N + + + ++KI D L+R F +
Sbjct: 122 -----MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ +W L +S A D+WS G + EL+T
Sbjct: 177 DNENRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIK-KINDIFEHVSDAT--RILREIKLLRLLRHPDIVE 86
V+G G++G V GE V I I + E+ S IL E ++ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 87 IKHILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ I L + + +V +LM L V + D + + + Q+ +G+ Y+
Sbjct: 74 LLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVATRWYRAPELCG 202
+ HRDL +N+L + +KI DFGLAR+ D + D V +W +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKWMALESI-- 183
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT--GKPL--FPGKNV 236
++T D+WS G EL+T KP P + +
Sbjct: 184 -LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 82/348 (23%), Positives = 128/348 (36%), Gaps = 100/348 (28%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIF-----EHVSDATRILREIKLLRLLRH 81
+ +G G++G VC A T A+K + D+ HV IL E ++R
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVR- 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 140
L S ++ ++Y V + + + + PE +F++ +L ++
Sbjct: 66 ----------LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVE 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF--------------- 185
+H HRD+KP NIL + D +K+ DFGL F T + +
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC-TGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 186 --WTD----------------------------YVATRWYRAPELCGSFFSKYTPAIDIW 215
W D V T Y APE+ + YT D W
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWW 232
Query: 216 SIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 275
S+G I E+L G+P F L TP + K + +S+
Sbjct: 233 SVGVILYEMLVGQPPF--------------LAQTPLETQM------KVINWQTSLH---- 268
Query: 276 IPFSQKF-PNANPLALRLLERMLAFEPKDR---PTAEEALADPYFKGL 319
IP K P A+ L ++L P+DR A+E A P+FK +
Sbjct: 269 IPPQAKLSPEASDLIIKLCR-----GPEDRLGKNGADEIKAHPFFKTI 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 12/119 (10%)
Query: 112 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 170
DL ++K L+ + + QL+ L +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 171 GLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
GL ++ TP+ Y T Y +PE + G Y + D W++G + ELLTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 47/230 (20%)
Query: 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKL 75
E G+GS + E I KG VV +TR VAIK +N E S RI L E +
Sbjct: 13 ELGQGSFGMVYEGIAKG---VVKDEPETR----VAIKTVN---EAASMRERIEFLNEASV 62
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDLTPEH 127
++ +V + ++ + + V+ ELM DL +++ N P
Sbjct: 63 MKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPS 117
Query: 128 YQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184
+ + ++ G+ Y++ HRDL +N + D +KI DFG+ R I
Sbjct: 118 LKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DI 169
Query: 185 FWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ TDY + RW L F+ Y+ D+WS G + E+ T
Sbjct: 170 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 25/160 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-------NDIFEHVSDATRILREIKLLR 77
+ +VIGKG++G V TG+ A+K + D HV +L E
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD--- 59
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLY 133
P +V + + F+D ++ +ME DL ++ D + + +F++
Sbjct: 60 ---SPWVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA 108
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
+ + ++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 53/198 (26%), Positives = 80/198 (40%), Gaps = 20/198 (10%)
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
QLL + YIH + HRD+K +N+L N + + DFG A A T + T
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY-GIAGTV 326
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIG-CIFAELLTGKPLFPGKN-------------VVHQ 239
APE+ YTP++DIWS G IF + LF ++ Q
Sbjct: 327 DTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQ 384
Query: 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 299
+ D A +R+ ++ R + R P ++ + L+ R L F
Sbjct: 385 AQVHVDEF---PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTF 441
Query: 300 EPKDRPTAEEALADPYFK 317
+ RP+A E L P F+
Sbjct: 442 DGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 39/156 (25%), Positives = 55/156 (35%), Gaps = 59/156 (37%)
Query: 125 PEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
E +F++ +L ++ +H HRD+KP NIL + D +K+ DFGL T
Sbjct: 99 EEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC--------TG 150
Query: 184 IFWT------------------------------------------------DYVATRWY 195
WT V T Y
Sbjct: 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNY 210
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
APE+ + YT D WS+G I E+L G+P F
Sbjct: 211 IAPEVLLR--TGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKV--AIKKINDIFEHVSDATRILREIKLL-RLLRHPDIV 85
+VIG+G++G V A + G ++ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 86 EIKHILLPPSRREFKDIYVVFELMESDL-----HQVIKANDDLTPEH---YQFFLYQLLR 137
++L R + + + + + L +V++ + + QLL
Sbjct: 60 ---NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 138 -------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR---VAFNDTPTAIFWT 187
G+ Y+ HRDL +NIL + KI DFGL+R V T
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT------M 170
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 171 GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 47/234 (20%)
Query: 21 EGSRYKIEEV--IGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LR 71
E SR KI + +G+GS+G+V A D GE +VA+K +N E S RI L
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLN 58
Query: 72 EIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDL 123
E +++ +V + ++ + + VV ELM DL +++ N
Sbjct: 59 EASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 124 TPEHYQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
P Q + ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR------ 167
Query: 181 PTAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
I+ TDY + RW L F+ + D+WS G + E+ +
Sbjct: 168 --DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 32/118 (27%), Positives = 51/118 (43%), Gaps = 8/118 (6%)
Query: 115 QVIKANDDLTPE--HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
+ + + +TP+ Q ++ GL ++H N H DL +N L AD +KI D+GL
Sbjct: 87 RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146
Query: 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-----TPAIDIWSIGCIFAELL 225
+ + + +V RW APEL T ++WS+G EL
Sbjct: 147 SHNKYKEDYYVTPDQLWVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 17/155 (10%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIK------KINDIFEHVSDATRILREIKLLRLLRHPDI 84
I +G++G V + A+K IN H A R L L + P I
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAER-----DALALSKSPFI 66
Query: 85 VEIKHILLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V + + S + ++Y+V E L+ D+ ++ E ++ ++ L Y+H
Sbjct: 67 VHLYY-----SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178
+ HRDLKP N+L + + +K+ DFGL++V N
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG-LARVAFNDTPTAIFWTDYVAT 192
+++ L +H + RDL P NIL + +++ F + V + A+
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-------E 145
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
Y APE+ G S+ T A D WS+G I ELLTGK L
Sbjct: 146 NMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 52/213 (24%), Positives = 81/213 (38%), Gaps = 31/213 (14%)
Query: 31 IGKGSYG-VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI----- 84
IG G +G V+ S T TG + K + L++ R+L+HP+I
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 85 --VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLY----QLLR 137
VE LL VFE E DL + L ++
Sbjct: 63 QCVEAIPYLL------------VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
G+ ++H N H DL +N +D +K+ D+G+ + + V RW A
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-A 169
Query: 198 PELCGSFF-----SKYTPAIDIWSIGCIFAELL 225
PEL G F ++ T ++W++G EL
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 75/330 (22%), Positives = 122/330 (36%), Gaps = 48/330 (14%)
Query: 30 VIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
VIG+G V A TGE V +++IN T + E+ + +L HP+IV
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ---------FFLYQLLRG 138
+ + + +++VV M + DL H+ + L +L+
Sbjct: 65 RATFIADN-----ELWVVTSFM------AYGSAKDLICTHFMDGMSELAIAYILQGVLKA 113
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY----VATRW 194
L YIH HR +K +IL + D K+ + N D+ V
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP 173
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT----- 249
+ +PE+ Y DI+S+G EL G P K++ ++ L GT
Sbjct: 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKLNGTVPCLL 231
Query: 250 -----PSPEAIARVRNEKARRYL------SSMRKKKPIPFSQKFPNA-NPLALRLLERML 297
P+ E + A L S+ R S + +P +E+ L
Sbjct: 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL 291
Query: 298 AFEPKDRPTAEEALADPYFKGLAKVEREPS 327
P RP+A L +FK +++R S
Sbjct: 292 QRNPDARPSASTLLNHSFFK---QIKRRAS 318
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 21/214 (9%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATR--ILREIKL 75
+ KIE ++G G +G +C ++ VAI + SD R L E
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA---GCSDKQRRGFLAEALT 59
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLY 133
L H +IV ++ ++ + + +V E M + L ++ ++ L L
Sbjct: 60 LGQFDHSNIVRLEGVITRGN-----TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-DYVAT 192
L G+KY+ H+ L +L N+D KI F + D AI+ T +
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSGKSP 171
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ APE + ++ A D+WS G + E+++
Sbjct: 172 VLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 80/330 (24%), Positives = 137/330 (41%), Gaps = 66/330 (20%)
Query: 31 IGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILR-EIKLLRLLRHPDIVEI 87
IG+G + V A T TG V ++ I D+ + + L+ E+ L RHP+I+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 88 KHILLPPSRREFKDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHT 144
+ S ++V+ M + ++K + ++ L+ LRGL Y+H
Sbjct: 65 WTVFTTGSW-----LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ 119
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGL------------ARVAFNDTPTAIFWTDYVAT 192
HR++K +IL + D + + GL A+V + D P F T +
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY-DFPQ--FSTSVLP- 173
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS- 251
W +PEL Y DI+S+G EL TG+ P ++++ ++ L G P
Sbjct: 174 -WL-SPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRTQMLLQKLKGPPYS 229
Query: 252 -------PEAIARVRNEKA---------------RRYLSSMRKKKPIP--FSQKFPNANP 287
P +R++N ++ + ++S R + P FS F N
Sbjct: 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQN--- 286
Query: 288 LALRLLERMLAFEPKDRPTAEEALADPYFK 317
L+E L +P+ RP+A L+ +FK
Sbjct: 287 ----LVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 60/234 (25%), Positives = 94/234 (40%), Gaps = 50/234 (21%)
Query: 30 VIGKGSYGVVCSA-YDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+G G++G V Y R G+ +VA+K + + D + L E ++ H +I
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNI 71
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR------ 137
V + + R +++ ELM DL ++ N + LL
Sbjct: 72 VRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 138 -GLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVAFNDTPTAIFWTDY-- 189
G KY+ + HRD+ +N L CK KI DFG+AR I+ Y
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLT--CKGPGRVAKIADFGMAR--------DIYRASYYR 176
Query: 190 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGK 234
+ +W PE L G F SK D+WS G + E+ + G +PG+
Sbjct: 177 KGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGR 225
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
+ Q+L GL+ +H + HRD+KP+N+L D ++KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 62/237 (26%), Positives = 89/237 (37%), Gaps = 76/237 (32%)
Query: 129 QFFLYQLLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLA---RVAFNDTPTAI 184
Q + Q+L L +H+ + HRD+KP+NI+ + KI D G A RV N P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP--- 314
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPA----------------------IDIWSIGCIFA 222
+++ Y APE S TP+ DI+S G IF
Sbjct: 315 --KEFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 223 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY-LSSMRKKKPIPFSQK 281
++ FP L + S I R K Y L + RK
Sbjct: 371 QM-----AFPN-------------LRSDS-NLIQFNRQLKRNDYDLVAWRKLVE------ 405
Query: 282 FPNANP--------------LALRLLERMLAFEPKDRPTAEEALADPYF--KGLAKV 322
P A+P LL+ M+ F+ + R +A+ ALA PYF +GL +
Sbjct: 406 -PRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLLGL 461
|
Length = 566 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S K E VI +G G + G + +K+IND+ + EI + L+HP
Sbjct: 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV------NSIPSSEIADMGKLQHP 743
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+IV++ + R K Y++ E +E +L +V++ +L+ E + + + L++
Sbjct: 744 NIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRF 795
Query: 142 IH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+H + V +L P+ I+ + + + L + DT I + Y AP
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI-------SSAYVAP 847
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
E + T DI+ G I ELLTGK
Sbjct: 848 ETRET--KDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 560 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.46 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.19 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.06 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.03 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.67 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.55 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.35 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.34 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.24 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.11 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.98 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.97 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.91 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.85 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.81 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.77 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.7 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.55 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.53 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.5 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.4 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.4 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.37 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.24 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.16 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.15 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.09 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.0 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.91 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.83 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.79 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.72 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.64 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.44 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.31 | |
| PLN02236 | 344 | choline kinase | 96.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.01 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.33 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.63 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.56 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.36 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.01 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.9 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.35 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.71 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.68 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 91.8 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-78 Score=601.20 Aligned_cols=342 Identities=60% Similarity=0.995 Sum_probs=324.7
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
+.|.++.+|..++.||+|+||+||.|.++.||+.||||+|.+.|.+..++++.+||+++|+.++|+||+.+++++..+..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 44777888888999999999999999999999999999999999999999999999999999999999999999998888
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 97 ~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
+.++++|+|+|+|+.||+++|+.+..+++++++++++|||+||+|+|+++|+||||||.|+|+|.+|.+||||||||+..
T Consensus 96 ~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 96 DKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred cccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 88999999999999999999999988999999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... ....+++.|+.|+||+|||++... ..|+.++||||+||||+|||+|+++|+|++..+|+.+|.+++|+|+.+.+.
T Consensus 176 ~~~-~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 176 DKF-FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccc-CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 665 566778999999999999999764 789999999999999999999999999999999999999999999999999
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchh
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 336 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 336 (560)
.+.+++++.|+++++...+.+|...|+++++.++|||++||.+||.+|+|++|+|+||||..++.++.||++++....
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~-- 331 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS-- 331 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999988886554
Q ss_pred hHHhhcCCHHHHHHHHHHHHHhhChhHH
Q 008607 337 EFERRRITKEDVRELIYREILEYHPQML 364 (560)
Q Consensus 337 ~~e~~~~~~e~~~e~i~~ei~~~~p~~~ 364 (560)
++.. .+.+++++++|+|+++|+|...
T Consensus 332 -~~~~-~~~~~~r~~i~~e~~~~~~~~~ 357 (359)
T KOG0660|consen 332 -FEHE-LTEEELRELIYKEILDFHPDVS 357 (359)
T ss_pred -cccc-ccHHHHHHHHHHHHHhhCcccc
Confidence 4444 8999999999999999999754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-61 Score=469.20 Aligned_cols=286 Identities=37% Similarity=0.707 Sum_probs=245.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|+.+.++|+|+||+||+|+++.||+.||||++.....+..-.+-.+|||++|++|+|+|+|.++++| +....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 469999999999999999999999999999999986555555556678999999999999999999999 344569
Q ss_pred EEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
++|||||+.++.+.+... ..++++.++.+++|++.|+.|||+++||||||||+||||+.+|.+||||||+|+....
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--- 153 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--- 153 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC---
Confidence 999999998877777664 4699999999999999999999999999999999999999999999999999998753
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
....+++|+.|+||+|||++.+. ..|++.+|||++||+++||++|.++|+|.++.+|+..|.+.+|.-.+.-..-....
T Consensus 154 pgd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CcchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 23356899999999999999774 68999999999999999999999999999999999999999998776544322211
Q ss_pred HHHHHHHhhc---cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 262 KARRYLSSMR---KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 262 ~~~~~l~~~~---~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.++..+. ...+.++...+++++..+.||+++||..||.+|++.+|+|.|+||.++.
T Consensus 233 ---~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 233 ---PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred ---CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 1222221 1233455678899999999999999999999999999999999997543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-59 Score=482.13 Aligned_cols=338 Identities=94% Similarity=1.478 Sum_probs=308.6
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.++||+|+||.||+|++..+|..||||++...........++.+|+.+|+.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999976555555667789999999999999999999998766555566799
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 008607 104 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (560)
+|||||+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998654443333
Q ss_pred ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHH
Q 008607 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (560)
Q Consensus 184 ~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 263 (560)
..+...+||++|+|||++.+....++.++|||||||++|+|++|++||.+.+...++..+.+.+|.|..+.+..+.....
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 34466789999999999865435788999999999999999999999999999999999999999999999999998888
Q ss_pred HHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhhHHhhcC
Q 008607 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRI 343 (560)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~ 343 (560)
..++..+....+.++...++..++.+.+||.+||+.||.+|||++|+|+||||+++......+..++...+++.++++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL 320 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence 88999888888888888888999999999999999999999999999999999999998888999999999999999999
Q ss_pred CHHHHHHHHHHHHHhhCh
Q 008607 344 TKEDVRELIYREILEYHP 361 (560)
Q Consensus 344 ~~e~~~e~i~~ei~~~~p 361 (560)
+++++++.+++++++|||
T Consensus 321 ~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 321 TKEDVRELIYREILEYHP 338 (338)
T ss_pred CHHHHHHHHHHHHHhcCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-60 Score=454.44 Aligned_cols=288 Identities=42% Similarity=0.708 Sum_probs=250.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
.+|..+++||+|.||+||+|+|..||+.||||+|+.......-....+|||++|+.++|+||+.++++|.+. ..+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----Cce
Confidence 579999999999999999999999999999999986544444456778999999999999999999999554 368
Q ss_pred EEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
.||+|||+.||..+|+... .++..+++.|+.++++||+|||+++|+||||||.|+||+.+|.+||+|||+|+.......
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9999999999999998765 699999999999999999999999999999999999999999999999999998754332
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
. .+..+.|+||+|||++.|. ..|+..+||||.|||++||+.|.+.|+|.++.+|+..|...+|+|.++.|..+..-
T Consensus 157 ~---~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 I---QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c---cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 2445899999999999774 68999999999999999999999999999999999999999999999988776542
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
.+|.+ +......+....|+.++..+.||+.+||.+||.+|+|+.|+|+|+||+....+
T Consensus 233 --pdY~~-~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 233 --PDYVK-IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred --ccHHH-HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 22222 11223334455899999999999999999999999999999999999975433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-60 Score=487.48 Aligned_cols=289 Identities=39% Similarity=0.699 Sum_probs=253.6
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~ 99 (560)
+-+||.++++||.|+||.||+|..+.+|+.||||++++.+....+... +||++.|++|. |||||+|++++.+..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~---- 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDND---- 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccC----
Confidence 346899999999999999999999999999999999987776555544 58999999999 999999999995433
Q ss_pred ccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+|||||+.+|+++++.++ .|++..++.|++||++||+|+|++|++||||||+||||..+..|||+||||||...+
T Consensus 83 ~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 83 RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 3799999999999999998765 599999999999999999999999999999999999999999999999999997655
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
..+ ++.|+.|+||+|||+|... ..|+.++|||++|||++|+.+-+++|+|.+..||+.+|++++|+|..+.+...
T Consensus 163 kpP----YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 163 KPP----YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred CCC----cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 443 5889999999999998653 68999999999999999999999999999999999999999999998877543
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
- ..+...--.+....+.++...++.+++++.+||.+||.+||.+||||+|+|+||||+.-.
T Consensus 238 ~-~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 238 Y-NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred H-HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 1 111111113445667778888999999999999999999999999999999999998543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-60 Score=486.35 Aligned_cols=287 Identities=37% Similarity=0.609 Sum_probs=250.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.+.|+.+++||+|.||.||+|++..||+.||+|++..............|||.||+.|.||||++|.++.+.. ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 3679999999999999999999999999999999987666667777788999999999999999999998765 2357
Q ss_pred EEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|||||||+.||..++...+ .|++.+++.|+.||+.||.|||++||+|||||.+|||||.+|.+||+|||||+++....
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99999999999999998754 79999999999999999999999999999999999999999999999999999875444
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.. .++..+.|+||+|||+|.|. ..|+.++|+||+||||.||++|++.|.|.+.++|+.+|.+++|.|..+.|....-
T Consensus 273 ~~--~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 273 SA--PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred Cc--ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 33 36889999999999999874 7899999999999999999999999999999999999999999999988773222
Q ss_pred HHHHHHHHhhccC--CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 261 EKARRYLSSMRKK--KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 261 ~~~~~~l~~~~~~--~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
. +...+... ....+.+.|..+++.+++|+..||..||.+|.||.++|+|+||..
T Consensus 350 P----~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 350 P----HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred C----cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 1 11111111 122344567788999999999999999999999999999999953
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-59 Score=461.36 Aligned_cols=294 Identities=38% Similarity=0.607 Sum_probs=253.5
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
...-+.|+.+.+|++|+||+||+|+|+.|++.||+|+++..-......-.-+|||++|.+++|||||.+..+.+....
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~-- 149 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM-- 149 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc--
Confidence 344578999999999999999999999999999999998655555555567899999999999999999999876543
Q ss_pred CccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
+.+|||||||+.||..++.... +|...+++.++.|+|+||+|||.++|+||||||+|+|++..|.+|||||||||.+.
T Consensus 150 -d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 150 -DKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred -ceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 5699999999999999998865 89999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
+.. ..++..+.|.||+|||+|.+. ..|+.++|+||+|||++||++++++|+|+...+|+++|.+++|+|+...|..
T Consensus 229 sp~---k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 229 SPL---KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred CCc---ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 542 235788999999999999874 7899999999999999999999999999999999999999999999988876
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCC--CHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNA--NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~--s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.....+.+.+. +.......+...|+.. +....+|+..+|.+||.+|.||+|+|+|.||....
T Consensus 305 ~~~lp~~k~~~-f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 305 YSELPAVKKMT-FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred ccccchhhccc-cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 65544333221 1222223344455544 58999999999999999999999999999999743
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-57 Score=456.58 Aligned_cols=262 Identities=35% Similarity=0.603 Sum_probs=220.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh-----hHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-----SDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-----~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.+.|.+.+.||+|+||.|.+|+++.||+.||||+|++..... .....+.+|+++|++|+|||||+++++|..+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-- 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-- 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--
Confidence 456999999999999999999999999999999998543222 1234467999999999999999999999544
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC---CcEEEecccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGL 172 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~---~~lKL~DFGl 172 (560)
...|||||||+ |+|.+.+..++.+.++..+.+++||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 249 ---ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 ---DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ---CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 35799999998 5999999999999999999999999999999999999999999999999877 8899999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCC-CCCccchhhHHHHHHHHhhCCCCCCCCChhh-HHHHHHHhcCCC
Q 008607 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLGTP 250 (560)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~-y~~~~DIWSlG~il~eLltG~~pF~~~~~~~-~~~~i~~~~g~p 250 (560)
|+.... ..++.+.|||+.|.|||++.+.... |..++|||||||+||.+|+|.+||.+....- ..++|.+
T Consensus 326 AK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~----- 396 (475)
T KOG0615|consen 326 AKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK----- 396 (475)
T ss_pred hhcccc----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc-----
Confidence 998653 3466889999999999999653233 3448999999999999999999998765333 2222221
Q ss_pred CHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 251 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
......+..|..++.++++||.+||..||++|||++|+|+||||+..
T Consensus 397 ----------------------G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 397 ----------------------GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred ----------------------CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 12222334566789999999999999999999999999999999853
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-56 Score=445.25 Aligned_cols=286 Identities=39% Similarity=0.679 Sum_probs=247.2
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.|+-.+++|+|+||+||.|....+++.||||++-.. ..--.+|+.+|+.+.|||||++...|......+.-++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d------~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD------KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC------CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 588899999999999999999999999999998521 11223799999999999999999988765433334667
Q ss_pred EEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC-CcEEEecccccccccC
Q 008607 104 VVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFN 178 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-~~lKL~DFGla~~~~~ 178 (560)
+|||||+.+|.++++. +..++.-.++-+++||++||+|||+.||+||||||+|||+|.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999999999984 5679999999999999999999999999999999999999987 9999999999999877
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
+.++ .+|..|+.|+|||++.+. ..|+.++||||.||+++||+.|++.|+|++..+|+.+|.+++|+|+.+.+..+
T Consensus 179 ~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 7765 568999999999999874 78999999999999999999999999999999999999999999999999877
Q ss_pred hhHHHHHHHHhhccCCCCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccC
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQ-KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~-~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~ 323 (560)
...... ..+......++.. .+...++++.+|+.++|+++|.+|.++-|+|+||||..+....
T Consensus 254 n~~y~~---~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 254 NPNYTE---FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred Cccccc---ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 654221 1122233344444 5567899999999999999999999999999999999887653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-54 Score=453.99 Aligned_cols=263 Identities=33% Similarity=0.571 Sum_probs=231.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecC-cccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~-~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..+|+..+.||+|+|+.||.+++..+|+.||+|+|.+ ...+......+.+||+|.+.|+|||||++++.| ++.+
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~ 91 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSN 91 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCC
Confidence 3789999999999999999999999999999999975 334555677899999999999999999999999 5556
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
++|||+|+|. ++|..+++++..++|.++++|++||+.||.|||+.+|+|||||..|||++++..|||+|||||.....+
T Consensus 92 nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 8999999999 799999999999999999999999999999999999999999999999999999999999999987644
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
... ..+.||||.|.|||++.. ..++..+||||+|||||.||.|+|||..++..+.+..|...-
T Consensus 172 ~Er---k~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~------------ 234 (592)
T KOG0575|consen 172 GER---KKTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE------------ 234 (592)
T ss_pred ccc---cceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC------------
Confidence 322 367899999999999986 689999999999999999999999999999888887775410
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCC
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 325 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~ 325 (560)
| .....++..|+|||.+||+.||.+|||++++|.|+||+.-..+...
T Consensus 235 ------Y-------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~l 281 (592)
T KOG0575|consen 235 ------Y-------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARL 281 (592)
T ss_pred ------c-------------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCC
Confidence 0 1113678999999999999999999999999999999544333333
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=433.92 Aligned_cols=292 Identities=38% Similarity=0.675 Sum_probs=248.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC-ccccceeecCCCc-CCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD-IVEIKHILLPPSR-REFK 100 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn-Iv~l~~i~~~~~~-~~~~ 100 (560)
..|+.+++||+|+||+||+|+++.+|+.||+|+++.....+.-.....||+.+|+.|+|+| |+.+++++.+... +...
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4578888999999999999999999999999999865544334455689999999999999 9999999976542 2334
Q ss_pred cEEEEEecCCccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 101 DIYVVFELMESDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~~~~----~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
.+|+||||++.||..++.... .++...++.|++||++||+|||++||+||||||+||||+.+|.+||+|||+|+..
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 689999999999999998755 5888999999999999999999999999999999999999999999999999964
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.-.. ...+..++|.||+|||++.+. ..|+..+||||+|||++||++++++|+|.+..+|+..|.+++|+|+.+.|.
T Consensus 171 ~ip~---~~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 171 SIPM---RTYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred cCCc---ccccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 3222 125778999999999999874 579999999999999999999999999999999999999999999988876
Q ss_pred HhhhHHHHHHHHhhccCC-CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 257 RVRNEKARRYLSSMRKKK-PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.+..-...+. .+.... +.++....+..++.+.+|+.+||+.||.+|.|++.+|.||||..+.
T Consensus 247 ~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 247 GVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred Cccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 6543211111 223333 5666677778889999999999999999999999999999999764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-53 Score=423.16 Aligned_cols=260 Identities=28% Similarity=0.494 Sum_probs=223.2
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+..+.++.||+|+.|+||+|+|+.|++.+|+|+|.. ..+....+++.+|+++|+..+||+||.+|++|+.... .+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eE
Confidence 367788999999999999999999999999999953 3455677889999999999999999999999976531 59
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+||||+ |+|..+++..++++|..+..++.+|++||.|||. .+||||||||+|||||..|.|||||||.+....+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999 5999999998999999999999999999999995 99999999999999999999999999999877554
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCC--ChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK--NVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~--~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
...+++||..|||||.+.+ ..|+.++||||||+.+.||.+|+.||... ...+.+.++..++..|++
T Consensus 233 ----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP------ 300 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP------ 300 (364)
T ss_pred ----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC------
Confidence 2367899999999999988 68999999999999999999999999874 233334433333332222
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.+... .+|+++++||..||++||.+|+|+.|+|+|||+++..
T Consensus 301 ------------------~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 301 ------------------RLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ------------------CCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 11111 4799999999999999999999999999999998654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=416.28 Aligned_cols=343 Identities=38% Similarity=0.689 Sum_probs=294.6
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS- 95 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~- 95 (560)
+.|.+..||.-++.+|.|+- .|..|.|..++..||+|++...+.+.....+..||+.++..+.|+||++++.+|.+..
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 34567889999999999999 8999999999999999999888888888899999999999999999999999997643
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
-.++.++|+|||+|..+|.+++. ..+.-+.+.++++|+++|++|||++||+||||||+||+++.+|.+||+|||+|+.
T Consensus 90 l~~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 24567899999999999999998 3588899999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...+ ...++|+.|+.|+|||++.+ ..|...+||||+|||++||++|+.+|+|++..+|..+|.+.+|+|.+.++
T Consensus 168 e~~~----~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 168 EDTD----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred cCcc----cccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 4332 35689999999999999988 45999999999999999999999999999999999999999999999999
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCC------------CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccC
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNA------------NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~------------s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~ 323 (560)
.++.. .++.|+.++.+.....+...||+. +..++||+.+||..||++|.+++++|+||||+-|. ..
T Consensus 242 ~qL~~-~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~-~~ 319 (369)
T KOG0665|consen 242 KQLQP-TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWY-DP 319 (369)
T ss_pred HHhhH-HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeec-cc
Confidence 88754 467777766666556666555542 45699999999999999999999999999999443 33
Q ss_pred CCCCCCCCCcchhhHHhhcCCHHHHHHHHHHHHHhhChhHHHhhhcC
Q 008607 324 REPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEG 370 (560)
Q Consensus 324 ~~~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~~~~~~~~~ 370 (560)
.++..++....+..++.+..+.++++++|++|+.+|.+....+.+++
T Consensus 320 ~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~~~~~I~~~ 366 (369)
T KOG0665|consen 320 DEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEFNKNNIMNG 366 (369)
T ss_pred ccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhcccccchhhcC
Confidence 44444444455566777888899999999999999988544444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=420.43 Aligned_cols=261 Identities=29% Similarity=0.507 Sum_probs=228.0
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
.-..+.|+++++||+|+||+||+++.+.|++.||+|++++.. ....+...+.+|..||..++||.||+++..|.+.
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~--- 97 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE--- 97 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC---
Confidence 345678999999999999999999999999999999998532 2334677889999999999999999999999554
Q ss_pred CCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 98 EFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 98 ~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+|+|+||+.| +|...|++.+.|+|+.+++|+.+|+.||.|||+.||+||||||+|||+|.+|+++|+||||++..
T Consensus 98 --~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 98 --EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred --CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 469999999985 99999999999999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
...... ..+.|||+.|||||++.+ ..|+.++|.|||||++|+||+|.+||.+.+....++.|...
T Consensus 176 ~~~~~~---t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~---------- 240 (357)
T KOG0598|consen 176 LKDGDA---TRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG---------- 240 (357)
T ss_pred ccCCCc---cccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC----------
Confidence 433222 245899999999999987 69999999999999999999999999999987776666431
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCC-CCHHHHHHHHHhcccCCCCCC----CHHHHhcCccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPN-ANPLALRLLERMLAFEPKDRP----TAEEALADPYFKGLA 320 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~s~~~~dLI~~mL~~DP~~Rp----ta~elL~hp~f~~~~ 320 (560)
+ ....+. ++.++++||+++|..||.+|. ++++|-+||||.++.
T Consensus 241 -----------------k----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 241 -----------------K----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred -----------------c----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 0 112234 789999999999999999995 699999999999754
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-52 Score=439.79 Aligned_cols=284 Identities=36% Similarity=0.650 Sum_probs=239.5
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-C-----CCccccceeecCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-H-----PDIVEIKHILLPP 94 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-H-----pnIv~l~~i~~~~ 94 (560)
++.+|+|+++||+|+||.|.+|.|..|++.||||+|++ +.....+...|+.+|..|+ | -|+|++++.|...
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 35689999999999999999999999999999999985 4556677788999999997 4 3799999999654
Q ss_pred CcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC--CcEEEecc
Q 008607 95 SRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDF 170 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~--~~lKL~DF 170 (560)
+++|||+|+++.+|.++|+.+. .|+...++.|+.|||.||.+||+.||||+||||+||||..- +.|||+||
T Consensus 261 -----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 261 -----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred -----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence 4699999999999999999876 58999999999999999999999999999999999999864 56999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCC
Q 008607 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p 250 (560)
|.++...... ..|+-++.|+|||++.| ..|+.++||||||||++||++|.++|+|.+..+|+..|.+++|.|
T Consensus 336 GSSc~~~q~v------ytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 336 GSSCFESQRV------YTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred ccccccCCcc------eeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 9998653222 37899999999999998 699999999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhHHHHHHHHh----------------------------hccCCCC-----CCCCCCC-CCCHHHHHHHHHh
Q 008607 251 SPEAIARVRNEKARRYLSS----------------------------MRKKKPI-----PFSQKFP-NANPLALRLLERM 296 (560)
Q Consensus 251 ~~~~~~~~~~~~~~~~l~~----------------------------~~~~~~~-----~~~~~~~-~~s~~~~dLI~~m 296 (560)
+...+....+. ..|++. ....... .+....+ .....+.|||++|
T Consensus 408 p~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~ 485 (586)
T KOG0667|consen 408 PPKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC 485 (586)
T ss_pred CHHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence 99888765432 222222 1111111 1122222 2235689999999
Q ss_pred cccCCCCCCCHHHHhcCccccccccc
Q 008607 297 LAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 297 L~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
|.+||.+|+|+.|+|+||||.+....
T Consensus 486 L~~dP~~R~tp~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 486 LEWDPAERITPAQALNHPFLTGTSLE 511 (586)
T ss_pred hccCchhcCCHHHHhcCccccccccc
Confidence 99999999999999999999976543
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-51 Score=423.26 Aligned_cols=337 Identities=56% Similarity=0.998 Sum_probs=290.9
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
|.++++|++.+.||+|+||+||+|++..+++.||||++............+.+|+.+|+.++|+||+++++++.......
T Consensus 1 ~~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred CccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 45678999999999999999999999999999999998765444455667889999999999999999999886655455
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
...+|+|+||++++|.+++...+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 81 FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred cCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 56799999999999999999888899999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. .....+.++..|+|||.+... ..++.++|||||||++|+|++|++||.+.+....+..+...+|.+..+.+...
T Consensus 161 ~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 161 KG---DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred Cc---ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 21 223456789999999988642 35888999999999999999999999999999999999999999988887777
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhhH
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEF 338 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 338 (560)
.......++..+.......+...++.+++.+.+||++||+.||.+|||++|+|+||||..+......+..+. .++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~--~~~~~~ 314 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQT--PFSFDF 314 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCC--ccchhh
Confidence 777777777766555444555566788999999999999999999999999999999998877766655543 457778
Q ss_pred HhhcCCHHHHHHHHHHHHHhhCh
Q 008607 339 ERRRITKEDVRELIYREILEYHP 361 (560)
Q Consensus 339 e~~~~~~e~~~e~i~~ei~~~~p 361 (560)
+....++++++|+|+.|.+.|||
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 315 EEDALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hhhhcCHHHHHHHHHHHHhhcCC
Confidence 88889999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-52 Score=428.67 Aligned_cols=261 Identities=30% Similarity=0.534 Sum_probs=228.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (560)
.+.|.+.+.||+|+|++|++|+++.+++.||||++.+... ......-+.+|-.+|.+| .||.|++|+..|.+.
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~----- 146 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE----- 146 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc-----
Confidence 4679999999999999999999999999999999975432 333445678899999999 799999999999544
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+|+||++ |+|.++|++-+.|++...++|+.||+.||+|||++|||||||||+|||+|.|+++||+|||.|+....
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 46999999998 79999999999999999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC----------cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcC
Q 008607 179 DTPT----------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 179 ~~~~----------~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g 248 (560)
.... .....++|||-.|.+||+|.. ...++.+|||+||||||.|+.|.+||.+.|....+++|.++-
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~- 303 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD- 303 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc-
Confidence 2111 111256899999999999987 678899999999999999999999999999998888887631
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
. ...++.++.+.|||+++|..||.+|+|++||.+||||.++.
T Consensus 304 ---------------------------y---~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 304 ---------------------------Y---EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred ---------------------------c---cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 1 12246679999999999999999999999999999999764
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=419.13 Aligned_cols=330 Identities=45% Similarity=0.833 Sum_probs=271.4
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (560)
+.+.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++|+||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 566789999999999999999999999999999999997644444455678899999999999999999998864322 3
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
....+|+++++++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 91 NFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3456899999999999888754 469999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.. ...++||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..
T Consensus 170 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 170 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred CC------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 22 2456899999999998652 4688999999999999999999999999999999999999999999988888
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhh
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (560)
+.......++..+.......+...+...++.+.+||.+||..||.+|||+.|+|+||||..+......+...+. ...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~---~~~ 319 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPY---DES 319 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCcc---ccc
Confidence 87777777777666555555555667788999999999999999999999999999999987655444333222 222
Q ss_pred HHhhcCCHHHHHHHHHHHHHhh
Q 008607 338 FERRRITKEDVRELIYREILEY 359 (560)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~ 359 (560)
.+....+.+++++..+.+...+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~ 341 (343)
T cd07878 320 PENKERTIEEWKELTYEEVSSF 341 (343)
T ss_pred hhhhhccHHHHHHHHHHHHHhc
Confidence 2334555566666666555433
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-52 Score=405.36 Aligned_cols=292 Identities=38% Similarity=0.630 Sum_probs=241.0
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCc----EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
..|++...||+|.||.||+|..++++. .+|||+++.......-.....||+.++|.|+|||++.+..+|+..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d--- 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD--- 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC---
Confidence 459999999999999999997766544 6899999754333344456779999999999999999999997643
Q ss_pred CccEEEEEecCCccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC----CcEEEec
Q 008607 99 FKDIYVVFELMESDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICD 169 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~-----~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~----~~lKL~D 169 (560)
..+++++||.+.||.++|+-+. .++...++.|++||+.|+.|||++.|+||||||.||||..+ |+|||+|
T Consensus 101 -~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 -KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred -ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 4799999999999999997532 48999999999999999999999999999999999999988 8999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCC---------hhhHH
Q 008607 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN---------VVHQL 240 (560)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~---------~~~~~ 240 (560)
||+|+...+--..-......+.|.||+|||+|.|- ..|++++|||++|||++|||+..++|.|.. ..+|+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999875443332234567899999999999774 789999999999999999999999998742 45799
Q ss_pred HHHHHhcCCCCHHHHHHhhhHH-HHHHHHhhccCCCCC-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008607 241 DIMTDLLGTPSPEAIARVRNEK-ARRYLSSMRKKKPIP-----FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (560)
Q Consensus 241 ~~i~~~~g~p~~~~~~~~~~~~-~~~~l~~~~~~~~~~-----~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp 314 (560)
+.|.+++|+|..+.|..+.+-. ....++.++...... +.+....-++.+.+||.+||..||.+|+|++++|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 9999999999999988776532 224555554332211 1223344467799999999999999999999999999
Q ss_pred ccccc
Q 008607 315 YFKGL 319 (560)
Q Consensus 315 ~f~~~ 319 (560)
||..-
T Consensus 339 yF~~d 343 (438)
T KOG0666|consen 339 YFTED 343 (438)
T ss_pred ccccC
Confidence 99853
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=413.19 Aligned_cols=335 Identities=51% Similarity=0.895 Sum_probs=281.0
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
|..+++|++.+.||+|+||.||+|.+..+|+.||||++... .......++.+|+.+|+.++|+||+++++++.......
T Consensus 1 ~~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred CccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 45678999999999999999999999999999999998632 23334567889999999999999999999886655555
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
...+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 80 FNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred cceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 567899999999999988854 4799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
...........+||+.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...++..+.+.++.|..+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 33222233456889999999987542 46788999999999999999999999999999999999999999999888877
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhhH
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEF 338 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 338 (560)
.....+.++.........++....+..++.+.+||.+||+.||++|||+.|+|+||||+.+.....++..+....++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFEL 317 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhcc
Confidence 77777777776665555555566677899999999999999999999999999999999988766666554444445443
Q ss_pred HhhcCCHHHHHHHHHHHHH
Q 008607 339 ERRRITKEDVRELIYREIL 357 (560)
Q Consensus 339 e~~~~~~e~~~e~i~~ei~ 357 (560)
. ..+.++..+++|+.+|+
T Consensus 318 ~-~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 318 F-DDLPKEKLKELIFEEIM 335 (336)
T ss_pred c-cccCHHHHHHHHHHHhc
Confidence 3 45568889999988875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=417.36 Aligned_cols=330 Identities=42% Similarity=0.707 Sum_probs=260.3
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.|++.+.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++|+||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 37889999999999999999999999999999976555555667889999999999999999999998765544445789
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 008607 104 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (560)
+||||+.++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999986533221
Q ss_pred ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHH
Q 008607 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (560)
Q Consensus 184 ~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 263 (560)
......++|++|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+++..|.+.+|.|..+.+..... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GA 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HH
Confidence 123456789999999998652 4578999999999999999999999999999999999999999999877655432 23
Q ss_pred HHHHHhhccCCCC--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCC----------------C
Q 008607 264 RRYLSSMRKKKPI--PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER----------------E 325 (560)
Q Consensus 264 ~~~l~~~~~~~~~--~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~----------------~ 325 (560)
..++.......+. .........++.+.+||.+||++||.+|||++|+|+||||.+...... .
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYT 316 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCC
Confidence 3333222221111 011233456889999999999999999999999999999987321100 0
Q ss_pred CCCCC--CCcchhhHHhhcCCHHHHHHHHHHHHH
Q 008607 326 PSAQP--VTKMEFEFERRRITKEDVRELIYREIL 357 (560)
Q Consensus 326 ~~~~~--~~~~~~~~e~~~~~~e~~~e~i~~ei~ 357 (560)
....+ ...++++++....+..++++.++.++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (372)
T cd07853 317 SDFEPSANPPFDDEYEKNLTSVRQVKEELHQFIL 350 (372)
T ss_pred cccCCCCCCCCCcccccccCCHHHHHHHHHHHHH
Confidence 00111 112344455555667777777766654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-49 Score=414.00 Aligned_cols=328 Identities=37% Similarity=0.673 Sum_probs=260.3
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-RE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~~ 98 (560)
...++|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+.+++++..... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 34589999999999999999999999999999999998655555666788899999999999999999998865432 33
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
...+|+||||++++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 456899999999999988864 488999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. .....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|.++....+
T Consensus 179 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 179 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred CC----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 21 2245689999999999977 57899999999999999999999999999999999999999999988776655
Q ss_pred hhHHHHHHHHhhccCCCCCCCCC------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCC
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQK------------FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 326 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~------------~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~ 326 (560)
... ...++..........+... ....+..+++||.+||+.||.+|||++|+|+||||..+......+
T Consensus 253 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 331 (364)
T cd07875 253 QPT-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331 (364)
T ss_pred hHH-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence 433 2333333222111111111 112356799999999999999999999999999998766554443
Q ss_pred CCCCCCcchhhHHhhcCCHHHHHHHHHHHHH
Q 008607 327 SAQPVTKMEFEFERRRITKEDVRELIYREIL 357 (560)
Q Consensus 327 ~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~ 357 (560)
...+.. -+.....+..+.+++++.++.+++
T Consensus 332 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 361 (364)
T cd07875 332 APPPKI-PDKQLDEREHTIEEWKELIYKEVM 361 (364)
T ss_pred CCCCCC-CCccchhhhccHHHHHHHHHHHHH
Confidence 322211 122233456677778888777764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=407.01 Aligned_cols=258 Identities=32% Similarity=0.493 Sum_probs=221.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
-..|.+.+.||+|+||+||+|+++.++..||||.|.+........+-+..|+++|+.++|||||.+++++... +.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----DF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----Ce
Confidence 3569999999999999999999999999999999987554666677788999999999999999999998554 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC------CcEEEecccccc
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD------CKLKICDFGLAR 174 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~------~~lKL~DFGla~ 174 (560)
+|+|||||. |||.++|++.+.++|..++.|+.||+.||++||+++||||||||+||||+.. -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999 6999999999999999999999999999999999999999999999999875 459999999999
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
....+. ...+.||++.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+...
T Consensus 164 ~L~~~~----~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~------ 231 (429)
T KOG0595|consen 164 FLQPGS----MAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE------ 231 (429)
T ss_pred hCCchh----HHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc------
Confidence 876443 3467899999999999976 6899999999999999999999999998887666543332110
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
. ++ ......++...+|+..+|+.++..|.+.++-+.|+++..
T Consensus 232 ------------------~--~~--~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 232 ------------------I--VP--VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ------------------c--cC--chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 0 00 001133555678999999999999999999999999874
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=412.33 Aligned_cols=295 Identities=40% Similarity=0.722 Sum_probs=243.1
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-RE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~~ 98 (560)
...++|++.+.||+|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34689999999999999999999999999999999997655555566788899999999999999999999865432 33
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
...+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 456899999999999888754 489999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+++..+.+.++.|..+.....
T Consensus 176 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 176 NF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred Cc----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 21 2245688999999999976 57899999999999999999999999999999999999999999988776654
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCC------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccC
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFP------------NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~------------~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~ 323 (560)
.. ....++..........+...++ ..++.+.+||.+||+.||++|||++|+|+||||..+....
T Consensus 250 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 325 (359)
T cd07876 250 QP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325 (359)
T ss_pred HH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence 32 2233333322222222222221 2367899999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=395.65 Aligned_cols=259 Identities=30% Similarity=0.449 Sum_probs=219.5
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
...-..|+|+++||+|+||.||++.+..+|+.||+|+|+-...+....+.+..|+.+|++|+|||||++++.-+. ++
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~ 91 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---ED 91 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---cc
Confidence 444567999999999999999999999999999999998655566677789999999999999999999884332 22
Q ss_pred CccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--eeeccCCCCCeeeCCCCcEEEec
Q 008607 99 FKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHT--AN--VFHRDLKPKNILANADCKLKICD 169 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs--~g--IiHrDLKP~NILl~~~~~lKL~D 169 (560)
..-++||||||+ |||.+.|+. ...++|..+|+++.||++||..||+ .+ |+||||||.||+++.+|.+||+|
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence 234899999998 799999964 3469999999999999999999999 45 99999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCC
Q 008607 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (560)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~ 249 (560)
|||++...+.. .+..+++|||+||+||++.+ .+|+.++||||+||++|||+..++||.|.+......+|...-
T Consensus 172 fGL~r~l~s~~---tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd-- 244 (375)
T KOG0591|consen 172 FGLGRFLSSKT---TFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD-- 244 (375)
T ss_pred chhHhHhcchh---HHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC--
Confidence 99999875443 34578999999999999988 799999999999999999999999999998877777776421
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
++..+ ..+|..+..||..|+..||..||+. +|++..+.
T Consensus 245 ----------------------------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~ 283 (375)
T KOG0591|consen 245 ----------------------------YPPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ 283 (375)
T ss_pred ----------------------------CCCCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence 11112 2457788999999999999999996 56665543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=420.34 Aligned_cols=258 Identities=32% Similarity=0.578 Sum_probs=229.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|.+.+.||+|+||.||+|+.+.|.+.||||.+.+......+...+.+|++|++.|+|||||.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 579999999999999999999999999999999998777788888999999999999999999999988 455689
Q ss_pred EEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 103 YVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
|+|+||+.|+|+.++..++.++|+.++.|+++++.||.|||+++|+|||+||.|||++..|.+|+||||+|+.....
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--- 153 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--- 153 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999986442
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 262 (560)
....+..-|||.|||||+..+ ..|+..+|+||||||+|||..|++||......+....|..
T Consensus 154 t~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~----------------- 214 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK----------------- 214 (808)
T ss_pred ceeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc-----------------
Confidence 234567789999999999987 7999999999999999999999999987665554444322
Q ss_pred HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
.+..+. ..++..+++||+.+|.+||.+|+|..++|.|||+++--.
T Consensus 215 -----------d~v~~p---~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 215 -----------DPVKPP---STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred -----------CCCCCc---ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence 122221 378899999999999999999999999999999986433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=416.76 Aligned_cols=257 Identities=33% Similarity=0.535 Sum_probs=220.2
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC---hhHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH---VSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR 96 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~---~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~ 96 (560)
...+|++.+.||+|+||.|+.|.+..+|..||+|++.+.... ......+.||+.+++.++ ||||+++++++.+..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~- 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT- 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence 346899999999999999999999999999999977653111 133456779999999999 999999999996654
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC-CcEEEecccccc
Q 008607 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLAR 174 (560)
Q Consensus 97 ~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-~~lKL~DFGla~ 174 (560)
++|||||||.| +|+++|...+++.|..++.+|+||+.||+|||+.||+||||||+|||++.+ +++||+|||++.
T Consensus 94 ----~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 ----KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred ----eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 49999999995 999999998899999999999999999999999999999999999999999 999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCC-CC-CccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~-y~-~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
... .......+.|||+.|+|||++.+. . |+ .++||||+||+||.|++|+.||...+....+..|..
T Consensus 170 ~~~---~~~~~l~t~cGsp~Y~aPEvl~~~--~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------- 237 (370)
T KOG0583|consen 170 ISP---GEDGLLKTFCGSPAYAAPEVLSGK--GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------- 237 (370)
T ss_pred ccC---CCCCcccCCCCCcccCCHHHhCCC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-------
Confidence 763 222345788999999999999873 4 65 789999999999999999999998776665554332
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCC-CHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA-NPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
....+ ...+ ++.+.+||++||..||.+|+|+.+++.||||+.
T Consensus 238 ---------------------~~~~~---p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 ---------------------GEFKI---PSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---------------------CCccC---CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 11111 1233 999999999999999999999999999999985
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=401.53 Aligned_cols=286 Identities=35% Similarity=0.649 Sum_probs=236.4
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
|+.-++|++.++||.|+||.||+|++..++..||+|++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 75 (288)
T cd07871 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE---- 75 (288)
T ss_pred CCccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC----
Confidence 466778999999999999999999999999999999986432 222345677999999999999999999988543
Q ss_pred CccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|+||||++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 76 -~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 76 -RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred -CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 4689999999999999987654 58999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 155 VPTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred CCCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 2221 12446789999999998652 4688999999999999999999999999999999999999999998887765
Q ss_pred hhhHH-HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 258 VRNEK-ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 258 ~~~~~-~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
+.... ...++ +......+.....+..++.+++||.+||++||.+|||++|+|+||||
T Consensus 231 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 231 ITSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccchhhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 44321 11111 11111222233345778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=423.61 Aligned_cols=262 Identities=31% Similarity=0.512 Sum_probs=229.1
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
...-|++.+.||.|+.|.|-+|.|..||+.+|||+|.+... ..+....|.+||-||+.|.|||++.++++| ++.
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~ 84 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENK 84 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccC
Confidence 34569999999999999999999999999999999987532 334457799999999999999999999999 455
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.++|+|.||++ |.|++++...+++++.++.+||+||+.||.|||..+|+||||||+|+|+|.++.+||+|||.|.....
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 68999999998 69999999999999999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCcccccccccCcccccccccccccCCC-CCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
+. .+.+.||++.|+|||++.| ..| +.++||||+|||||.||+|+.||.+.|....+.++...
T Consensus 165 gk----lLeTSCGSPHYA~PEIV~G--~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G----------- 227 (786)
T KOG0588|consen 165 GK----LLETSCGSPHYAAPEIVSG--RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG----------- 227 (786)
T ss_pred Cc----cccccCCCcccCCchhhcC--CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-----------
Confidence 43 4577999999999999987 455 57899999999999999999999988866655554431
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCC
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~ 324 (560)
..+...++++++++||.+||.+||.+|+|.+||++|||+.+......
T Consensus 228 --------------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 228 --------------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred --------------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 12233678999999999999999999999999999999998765443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-50 Score=387.44 Aligned_cols=254 Identities=25% Similarity=0.471 Sum_probs=224.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++++.||.|+||.|.+++++.+|..+|+|++++. .-.....+...+|..+|+.+.||+++.+.+.+. +..+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-----d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-----DNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-----cCCe
Confidence 5799999999999999999999999999999999742 234455677889999999999999999999884 4457
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+||||||++| .|+.++++.++|++.++++++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+.....+
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT 198 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT 198 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcE
Confidence 9999999984 999999999999999999999999999999999999999999999999999999999999998764432
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.+.||||.|+|||++.+ .+|+.++|.|||||++|||+.|.+||.+.+....+++|...-
T Consensus 199 ------~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~------------- 257 (355)
T KOG0616|consen 199 ------WTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK------------- 257 (355)
T ss_pred ------EEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc-------------
Confidence 56899999999999987 789999999999999999999999999999888777776420
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC-----CCHHHHhcCccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFKGLA 320 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~R-----pta~elL~hp~f~~~~ 320 (560)
....+-+++.++|||+++|+.|-.+| ...++|..||||+++.
T Consensus 258 ------------------v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 258 ------------------VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred ------------------ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 01123568999999999999999999 4688999999999753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=364.86 Aligned_cols=278 Identities=41% Similarity=0.696 Sum_probs=239.9
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.|.-.++||+|.||+||+|++..|++.||+|.++....+..-....+|||-+|+.|+|.|||+++++... .+.+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----CceeE
Confidence 4667789999999999999999999999999998655555556778999999999999999999998733 34689
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 104 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
+|||||..+|..++.. ++.+..+.++.++.|+++||.|+|+.+++||||||+|+||+.+|.+||+|||+|+... .+.
T Consensus 78 lvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg--ipv 155 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG--IPV 155 (292)
T ss_pred EeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC--Cce
Confidence 9999999999999986 6689999999999999999999999999999999999999999999999999998642 222
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
..++..+.|.||++|.++.+- .-|+.++|+||.|||++|+.. |+++|+|.+..+|+..|..++|+|+.+.|..+.
T Consensus 156 -rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t-- 231 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT-- 231 (292)
T ss_pred -EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc--
Confidence 123556889999999999773 679999999999999999986 889999999999999999999999988775442
Q ss_pred HHHHHHHhhccCCCC-------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 262 KARRYLSSMRKKKPI-------PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~-------~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.+....+. .|++..|+++...+||++++|.-+|.+|++++++|+||||...
T Consensus 232 -------~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 232 -------KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred -------cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 22222222 2345567778889999999999999999999999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=387.75 Aligned_cols=259 Identities=31% Similarity=0.498 Sum_probs=224.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|.|++|+++.+..||..+|+|.|+...-...+.+.+.+|+.|-+.|+||||+++++.+. ....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-----~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-----ccce
Confidence 45799999999999999999999999999999999743334446788999999999999999999998773 3346
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC---CcEEEeccccccccc
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAF 177 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~---~~lKL~DFGla~~~~ 177 (560)
.|||||+|+| +|..-|.++.-++|..+.++++|||+||.|+|.+||+|||+||+|+|+-.. .-+||||||+|....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 8999999996 898888777779999999999999999999999999999999999998654 359999999998765
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
....|...+|||.|+|||++.. ..|+..+|||+.|||||-||.|.+||.+.+....++.|....
T Consensus 165 ----~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~---------- 228 (355)
T KOG0033|consen 165 ----DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA---------- 228 (355)
T ss_pred ----CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc----------
Confidence 2345678999999999999987 689999999999999999999999999988777776665311
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
..--...|+.+++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus 229 -----------------yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 229 -----------------YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred -----------------cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 11112367899999999999999999999999999999999975
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-51 Score=389.87 Aligned_cols=288 Identities=43% Similarity=0.760 Sum_probs=248.1
Q ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008607 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
-.+-||.|+||+||.+.|.+.|+.||+|++.+.+.+....+++.+|+++|..++|.|++..+++...+...-+..+|+|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 34679999999999999999999999999998888888889999999999999999999999998877666677899999
Q ss_pred ecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccc
Q 008607 107 ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (560)
Q Consensus 107 E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (560)
|+|..||+.+|..-..++.++++-|++||++||+|||+.+|+||||||.|+|+|.||.+||||||||+....+.. ..+
T Consensus 137 ELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~--~hM 214 (449)
T KOG0664|consen 137 ELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR--LNM 214 (449)
T ss_pred HHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh--hhh
Confidence 999999999999999999999999999999999999999999999999999999999999999999998654433 335
Q ss_pred cccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Q 008607 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (560)
Q Consensus 187 ~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 266 (560)
+..+.|-+|+|||++.|. ..|+.++||||+|||+.|||-.+.+|...+...|+++|++++|+|+.|.+.--.. .++..
T Consensus 215 TqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE-GAk~H 292 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE-GAKNH 292 (449)
T ss_pred HHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh-hhHHH
Confidence 677899999999999764 6899999999999999999999999999999999999999999999988754432 23332
Q ss_pred HHhhccCCCCCCCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 267 LSSMRKKKPIPFSQKF-----PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 267 l~~~~~~~~~~~~~~~-----~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
+-.-..+. ..+...+ .....++++++.+||.+||.+|++.++++.|+|+.+.
T Consensus 293 ~LR~~~k~-Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 293 VLRAGLRA-PDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhccCCCC-CCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 22111111 1122211 1334678999999999999999999999999998754
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=405.56 Aligned_cols=293 Identities=39% Similarity=0.710 Sum_probs=241.7
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~~~ 99 (560)
..++|++.+.||+|+||.||+|.+..+++.||||++...........++.+|+.+++.++||||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999999999999999998655555566788899999999999999999999865432 334
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
..+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 56899999999999888864 4899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.|.++....+.
T Consensus 173 ~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 173 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred c----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 1 2245689999999999976 578999999999999999999999999999999999999999999888776654
Q ss_pred hHHHHHHHHhhccCCCCCCC------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFS------------QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~------------~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
.. ...++..........+. ......+..+.+||.+||+.||.+|||++|+|+||||..+...
T Consensus 247 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 247 PT-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred HH-HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 32 33333332221111111 1112345678999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=403.96 Aligned_cols=330 Identities=52% Similarity=0.947 Sum_probs=281.8
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..+.+|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+|+.++|+||+++++++.... ...
T Consensus 2 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 80 (334)
T cd07855 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADF 80 (334)
T ss_pred chhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCC
Confidence 4568899999999999999999999999999999999765444455677889999999999999999999875443 344
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
..+|+||||+.++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 81 KDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred ceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 57899999999999999988888999999999999999999999999999999999999999999999999999765332
Q ss_pred CCC-cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~-~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
... .......+++.+|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+...++..+...+|.|..+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 221 1122346789999999998652 45889999999999999999999999999999999999999999999998888
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhhH
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEF 338 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 338 (560)
.......++.........++...++..+..+.+||++||+.||.+|||++++|.||||.++.....++.+. ...++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~ 317 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCP--PPFDFDF 317 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCC--CCCCCCh
Confidence 88777778877777777777777788899999999999999999999999999999999888777665543 3456677
Q ss_pred HhhcCCHHHHHHHHH
Q 008607 339 ERRRITKEDVRELIY 353 (560)
Q Consensus 339 e~~~~~~e~~~e~i~ 353 (560)
+....+.|.+.+.|.
T Consensus 318 ~~~~~~~~~~~~~~~ 332 (334)
T cd07855 318 EAIELSREQLKEAIV 332 (334)
T ss_pred hhhhcChhhHHHHhh
Confidence 777777777666553
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-48 Score=401.74 Aligned_cols=332 Identities=46% Similarity=0.858 Sum_probs=285.5
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (560)
+..+++|++.+.||+|+||.||+|++..++..||||++............+.+|+.+++.+.|+||+.+++++..... .
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 456789999999999999999999999999999999987544444455678899999999999999999998755432 3
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
....+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 91 DFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 3456899999999999998875 469999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.. ...+.++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+.+.++.+.++.+.+
T Consensus 170 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 170 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred cc------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 22 2446789999999998542 3678899999999999999999999999999889999999999999988888
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhh
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (560)
+..+....++..+.......+...+...++.+.+||.+||..||.+|||+.|||+||||..+...+.++.. .....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~---~~~~~~ 319 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVA---PPYDQS 319 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccccc---cccCcc
Confidence 88888888887777666666666667789999999999999999999999999999999988776655442 223466
Q ss_pred HHhhcCCHHHHHHHHHHHHHhhCh
Q 008607 338 FERRRITKEDVRELIYREILEYHP 361 (560)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p 361 (560)
++...+..++++++++.++.+|.|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 320 FESRDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred hhhhhcCHHHHHHHhHHHHHhccC
Confidence 788899999999999999998876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=396.98 Aligned_cols=291 Identities=34% Similarity=0.593 Sum_probs=228.0
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
||..++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 75 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTK---- 75 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecC----
Confidence 6788999999999999999999999999999999999874322 22334577899999999999999999998543
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|+||||+.++|.+++..+ +.++++.++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 76 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 76 -ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred -CeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 468999999999999888764 469999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCC-ChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-NVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~-~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... ......++|+.|+|||++.+. ..++.++|||||||++|+|++|..||.+. +..+++..+...++.|....+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 211 122456789999999998652 46788999999999999999999999875 4456777777778877765443
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
......... -..+....+..+...+ ...++.+.+||.+||+.||.+|||++|+|+||||+.+.
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 231 GVHSLPHFK-PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred chhhccccc-cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 322100000 0000000011111111 12467899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=405.48 Aligned_cols=266 Identities=27% Similarity=0.449 Sum_probs=224.0
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
-.+.|+++++||+|+||.||+|+.+.||+.+|+|++++.. ........++.|-.+|....++.||+|+..|.+.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~----- 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK----- 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC-----
Confidence 3467999999999999999999999999999999998632 2334557788999999999999999999999544
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.++||||||++ ||+..+|.+.+.|+++++++++.+++.|+.-||+.|+|||||||+|+|||..|++||+||||+.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 47999999998 59999999999999999999999999999999999999999999999999999999999999964311
Q ss_pred C-------------------CCCc-c------------------------cccccccCcccccccccccccCCCCCccch
Q 008607 179 D-------------------TPTA-I------------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (560)
Q Consensus 179 ~-------------------~~~~-~------------------------~~~~~~gT~~Y~APEll~~~~~~y~~~~DI 214 (560)
. .+.. . .....+|||.|+|||++.+ .+|+..+|.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDw 371 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDW 371 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccH
Confidence 0 0000 0 0124699999999999988 689999999
Q ss_pred hhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHH
Q 008607 215 WSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 294 (560)
Q Consensus 215 WSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~ 294 (560)
||||||+||||.|.+||.+.+..+.+.+|...-- .+ .+. .-..+++++.|||.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~--------------------~l------~fP-~~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE--------------------TL------KFP-EEVDLSDEAKDLIT 424 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh--------------------hc------cCC-CcCcccHHHHHHHH
Confidence 9999999999999999999999888877764210 00 011 11245689999999
Q ss_pred HhcccCCCCCC---CHHHHhcCcccccccc
Q 008607 295 RMLAFEPKDRP---TAEEALADPYFKGLAK 321 (560)
Q Consensus 295 ~mL~~DP~~Rp---ta~elL~hp~f~~~~~ 321 (560)
+||. ||.+|. .++||-+||||+++..
T Consensus 425 rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 425 RLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 9999 999997 4999999999998753
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=391.99 Aligned_cols=284 Identities=35% Similarity=0.609 Sum_probs=230.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECC-CCcEEEEEEecCcccChhHHHHHHHHHHHHHhc---CCCCccccceeecCCCcCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~-tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l---~HpnIv~l~~i~~~~~~~~ 98 (560)
++|++++.||+|+||.||+|.+.. +|..||+|++............+.+|+.+++.+ .||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999865 578899999875443333445566788887766 5999999999986443334
Q ss_pred CccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
...+++||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 4578999999999999999764 35899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..|.+..+.|.++.+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 3321 2245679999999999976 578899999999999999999999999999999999999988888765543
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
...... . ..+......++....+.+++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 235 ~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALP-R---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhccc-c---hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 221100 0 0111222333344456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=399.29 Aligned_cols=329 Identities=58% Similarity=0.984 Sum_probs=284.5
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++|+||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999986554455567889999999999999999999998765434556789
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 008607 104 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (560)
+||||++++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998765433211
Q ss_pred ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHH
Q 008607 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (560)
Q Consensus 184 ~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 263 (560)
.......++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 223456789999999999762 3788999999999999999999999999999999999999999999888877777777
Q ss_pred HHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhhHHhhcC
Q 008607 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRI 343 (560)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~ 343 (560)
..++..........+...++.+++.+.+||++||++||.+|||++++|.||||+++.....+........+. .++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 318 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFD-FFDDDEL 318 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCccccc-ccchhhc
Confidence 888887777777777778888999999999999999999999999999999999988776665554443321 3567788
Q ss_pred CHHHHHHHHHH
Q 008607 344 TKEDVRELIYR 354 (560)
Q Consensus 344 ~~e~~~e~i~~ 354 (560)
++++.+++|+.
T Consensus 319 ~~~~~~~~~~~ 329 (330)
T cd07834 319 TEEELKELIYE 329 (330)
T ss_pred CHHHHhHHhhc
Confidence 99999998875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=411.54 Aligned_cols=286 Identities=36% Similarity=0.619 Sum_probs=229.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc---CC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR---RE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~---~~ 98 (560)
..+|++.++||+|+||.||+|.+..+++.||||++... .....+|+.+|+.++|+||+++++++..... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 46899999999999999999999999999999988532 1234579999999999999999998755432 12
Q ss_pred CccEEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC-cEEEeccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLA 173 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~-~lKL~DFGla 173 (560)
...+++||||++++|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 235789999999998877753 45799999999999999999999999999999999999999765 7999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
+....... ...++||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+++..+...+|+|..+
T Consensus 219 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred hhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 86543322 2356889999999998652 468999999999999999999999999999999999999999999887
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFP-NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
.+.......... .+....+..+...++ ..++++++||.+||++||.+|||+.|+|+||||..+..
T Consensus 294 ~~~~~~~~~~~~---~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 294 QLKEMNPNYADI---KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhchhhhcc---cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 665432211000 000111111222222 46789999999999999999999999999999988754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=387.48 Aligned_cols=285 Identities=34% Similarity=0.637 Sum_probs=225.0
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++|+||+++++++.. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEE
Confidence 47999999999999999999999999999999997543444455678899999999999999999998843 3468
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+||||+++++.+.+.. ...++++.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99999999876665544 45799999999999999999999999999999999999999999999999999986533221
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+..+.+.+......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 A--NYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred c--cccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 1 1234679999999999976 56889999999999999999999999999888888778777776655443322111
Q ss_pred HHHHHHHhhccCCCCC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 262 KARRYLSSMRKKKPIP-FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~-~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
........-....+.. .......++..+.+||++||++||++|||++|+|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000000000000000 011123468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=390.26 Aligned_cols=291 Identities=36% Similarity=0.660 Sum_probs=240.5
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
|+..++|++.+.||+|+||.||+|++..+++.||+|++..... ......+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 76 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTD---- 76 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeC----
Confidence 5777899999999999999999999999999999999874322 22334567899999999999999999988543
Q ss_pred CccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
...|+||||++++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 77 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 77 -KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred -CeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 4689999999999999887654 58999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 156 VPTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred CCcc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 2221 12345789999999988652 4688899999999999999999999999999999999999999998887765
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
+......... ......+.++....+.+++.+.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 232 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 232 ISSNDEFKNY-NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hcchhhhhhh-hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 5433211111 1122223333445567899999999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=385.64 Aligned_cols=283 Identities=35% Similarity=0.592 Sum_probs=229.3
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc---CCCCccccceeecCCCcCCCc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l---~HpnIv~l~~i~~~~~~~~~~ 100 (560)
+|++++.||+|+||+||+|+++.+|+.||+|.+............+.+|+.+++.+ .||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 59999999999999999999999999999999875433333334566788777665 699999999988654444445
Q ss_pred cEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+++||||+.++|.+++.... .++++.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 789999999999999887643 489999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. ......+|..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+...
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QM----ALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cc----cCCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 22 1244678999999999976 57899999999999999999999999999888888888888887765443221
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.... -..+....+.......+.++..+.+||.+||+.||.+|||+.|+|.||||
T Consensus 235 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLP----RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccc----ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1000 00111122233344556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=393.85 Aligned_cols=327 Identities=39% Similarity=0.703 Sum_probs=258.5
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (560)
|...++|++.+.||+|+||.||+|.+..+|+.||||++.+..........+.+|+.+++.++|+||+++++++..... .
T Consensus 12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 345789999999999999999999999999999999987655555566778899999999999999999998865432 3
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
+....|+||||+.++|.+.+... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 44568999999999999988754 9999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+...++..+...+|.|..+....
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 170 TSFM----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred CCCC----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 3221 234578899999999976 5789999999999999999999999999999999999999999998877665
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCC-------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCC
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQK-------------FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~-------------~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~ 324 (560)
+.... ..++..........+... ....+..+.+||.+||+.||.+|||+.|+|.||||+.+.....
T Consensus 244 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~ 322 (353)
T cd07850 244 LQPTV-RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE 322 (353)
T ss_pred hhhhh-hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence 44322 222222221111111111 1234667899999999999999999999999999998776433
Q ss_pred CCCCCCCCcchhhHHhhcCCHHHHHHHHHHH
Q 008607 325 EPSAQPVTKMEFEFERRRITKEDVRELIYRE 355 (560)
Q Consensus 325 ~~~~~~~~~~~~~~e~~~~~~e~~~e~i~~e 355 (560)
.....+ ...+...+.+..+.+++++.++.+
T Consensus 323 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 323 VEAPPP-APYDHSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred CCCCCC-CccccccccccccHHHHHHHHHhh
Confidence 322222 122333445566677777777654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=375.50 Aligned_cols=303 Identities=33% Similarity=0.522 Sum_probs=251.7
Q ss_pred cccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 008607 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (560)
Q Consensus 15 ~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~ 94 (560)
+++...+++.|+-+.+||+|.||.||+|+++++|+.||+|++....++.......++|+++|..|+|+|++.+++++.+.
T Consensus 9 ~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 9 YEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred cCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 34556778999999999999999999999999999999998765555556667788999999999999999999887543
Q ss_pred ---CcCCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecc
Q 008607 95 ---SRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (560)
Q Consensus 95 ---~~~~~~~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DF 170 (560)
.......+|+||++|+.||..++... .+|+..+++.++.+++.||.|+|.+.|+|||+|+.|+||+.+|.+||+||
T Consensus 89 ~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 33344569999999999999999765 57999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCC
Q 008607 171 GLARVAFND-TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (560)
Q Consensus 171 Gla~~~~~~-~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~ 249 (560)
|+|+..... ......++..+.|.||++||++.+. ..|++++|||..|||++||++|.+.|.|++...++..|..++|.
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 999764322 2222335778999999999999874 68999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhHHHHHHHHhh--ccCCCCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 250 PSPEAIARVRNEKARRYLSSM--RKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~--~~~~~~~~~~~~~--~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
-..+.|..+.+-....-++.- .+........... .-++.+.|||++||..||.+|++++++|.|.||..
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 999988877765544444211 1111111111111 12678999999999999999999999999999974
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=411.96 Aligned_cols=285 Identities=26% Similarity=0.437 Sum_probs=227.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCC------CccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP------DIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hp------nIv~l~~i~~~~~ 95 (560)
.++|+++++||+|+||+||+|.+..+++.||||+++.. ......+..|+.+++.++|. +++.+++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 47899999999999999999999999999999999642 12234456788888877654 477777777432
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCC-----------
Q 008607 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADC----------- 163 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~----------- 163 (560)
..++|||||+++++|.+++...+.+++..++.|+.||+.||.|||+ .||+||||||+|||++.++
T Consensus 204 ---~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 204 ---TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred ---CceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 2468999999999999999888889999999999999999999998 5999999999999998765
Q ss_pred -----cEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhh
Q 008607 164 -----KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH 238 (560)
Q Consensus 164 -----~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~ 238 (560)
.+||+|||++..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998754221 1245789999999999977 579999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCC---------CC--CCCCHHHHHHHHHhcccCCCCCCCH
Q 008607 239 QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ---------KF--PNANPLALRLLERMLAFEPKDRPTA 307 (560)
Q Consensus 239 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~---------~~--~~~s~~~~dLI~~mL~~DP~~Rpta 307 (560)
++..|.+.+|.++.+..........+.++.......+..... .+ ...++.+.|||.+||++||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 999999999988776655443333444443322211110000 00 0125678899999999999999999
Q ss_pred HHHhcCcccccccc
Q 008607 308 EEALADPYFKGLAK 321 (560)
Q Consensus 308 ~elL~hp~f~~~~~ 321 (560)
+|+|+||||.....
T Consensus 433 ~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhcCccccccCC
Confidence 99999999987654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=401.30 Aligned_cols=282 Identities=25% Similarity=0.359 Sum_probs=222.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
.+|++++.||+|+||.||+|++..+++.||||+.. ...+.+|+++|+.|+||||+++++++... ...
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~ 158 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYN-----KFT 158 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-----Cee
Confidence 57999999999999999999999999999999753 23467899999999999999999988543 358
Q ss_pred EEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 103 YVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
++|||++.++|..++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.......
T Consensus 159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999975322211
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCC-------ChhhHHHHHHHhcCCCCHHHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-------NVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~-------~~~~~~~~i~~~~g~p~~~~~ 255 (560)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+. +...++..+...+|.++.+..
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred -cccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 12245689999999999976 57899999999999999999999776543 234567777777777654432
Q ss_pred HHhhhHHHHHHHHhhccCCC----CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKP----IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~----~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
..........++........ .+.......++..+.+||.+||++||.+|||++|+|+||||+.+..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 11111111111111111111 1111112245678999999999999999999999999999987643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=401.97 Aligned_cols=254 Identities=31% Similarity=0.536 Sum_probs=222.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
..|...++||+|+.|.||.|+...+++.||||.+....+ ...+-+++|+.+|+..+|+|||.+++.|+.. ..+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deL 345 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DEL 345 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhccc-----cee
Confidence 568889999999999999999999999999999976433 3455688999999999999999999998665 459
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+|||||+| +|.+++... .++|.++..+++++|.||+|||.+||+|||||.+|||++.+|.+||+|||++........
T Consensus 346 WVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999995 888887665 599999999999999999999999999999999999999999999999999987654443
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
...+.+||++|||||+... ..|++++||||||+++.||+-|.+||-..+....+.+|.. .|+|.
T Consensus 425 ---KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~---------- 488 (550)
T KOG0578|consen 425 ---KRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPK---------- 488 (550)
T ss_pred ---ccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCC----------
Confidence 3477899999999999976 6899999999999999999999999998887776666654 23332
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
-.....+|+.++|||.+||+.|+.+|++|.|||+||||+
T Consensus 489 -----------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 489 -----------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred -----------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 223457899999999999999999999999999999995
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=388.26 Aligned_cols=333 Identities=42% Similarity=0.773 Sum_probs=278.5
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR- 96 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~- 96 (560)
.|...++|++++.||+|+||.||+|.+..+|..||||++............+.+|+.+|+.++|+||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3567889999999999999999999999999999999986544444445678899999999999999999998865432
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 97 ~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
.....+++||||++++|.+++.. ..++++.++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 90 DRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred cccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 22345799999998899888864 47999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... .....++++|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..+...
T Consensus 169 ~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 169 DSE------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccC------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 321 1345678999999998652 357889999999999999999999999998888888888888888888777
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchh
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 336 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 336 (560)
.+.......++..+.......+....+.+++.+.+||.+||..||.+|||+.+++.||||+.......++... .+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~---~~~~ 318 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAP---PYDD 318 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCC---Cccc
Confidence 7777777777776665555555555678899999999999999999999999999999999887665544333 3455
Q ss_pred hHHhhcCCHHHHHHHHHHHHHhhCh
Q 008607 337 EFERRRITKEDVRELIYREILEYHP 361 (560)
Q Consensus 337 ~~e~~~~~~e~~~e~i~~ei~~~~p 361 (560)
+++....+-|+++.+.+-||+.++|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 319 SFDEVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred cHHhhccchHHHHHHHHHHHHhcCC
Confidence 5777788899999999999998876
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=387.92 Aligned_cols=332 Identities=43% Similarity=0.831 Sum_probs=275.7
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (560)
+...++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|+||+++++++..... .
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 556789999999999999999999999999999999997644444445678899999999999999999998754322 2
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
....+|+++++++++|.+++... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhcccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 33468999999988998887654 69999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.. .....++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+.......
T Consensus 172 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 172 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cc------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 21 2346789999999988552 4678899999999999999999999999988888888999899988888877
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhh
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (560)
+.....+.++..+.......+...+...++.+.+||.+||+.||.+||++.++|+||||+++.....++... .++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~---~~~~~ 321 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD---PYDQS 321 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC---CccCc
Confidence 776666777776665555555555567789999999999999999999999999999999988776666443 24444
Q ss_pred HHhhcCCHHHHHHHHHHHHHhhCh
Q 008607 338 FERRRITKEDVRELIYREILEYHP 361 (560)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p 361 (560)
++.+.+..+++....|.++..|-|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 322 FESRDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred chhcccCHHHHHHHHHHHHHhcCC
Confidence 555566667788888988876654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=386.31 Aligned_cols=264 Identities=29% Similarity=0.443 Sum_probs=213.5
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
...+|...+.||+|+||.||++.+.++|...|||.+... +......+.+|+.+|+.|+|||||++++...... . .
T Consensus 15 ~~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~ 89 (313)
T KOG0198|consen 15 EISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-D 89 (313)
T ss_pred ccchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-e
Confidence 356799999999999999999999999999999998753 2222677899999999999999999999643221 1 3
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC-CCcEEEeccccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAF 177 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-~~~lKL~DFGla~~~~ 177 (560)
.++|.|||+. |+|.++++..+ .|+++.++.+.+||++||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 6899999998 59999999877 7999999999999999999999999999999999999999 7999999999998765
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCC-ChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-NVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~-~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.............||+.|||||++... .....++|||||||++.||+||++||... .... .+..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~---~~~~----------- 234 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE---ALLL----------- 234 (313)
T ss_pred cccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHH---HHHH-----------
Confidence 311121223467899999999999741 22335999999999999999999999763 2111 1111
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..... .. ......+++++++||.+||.+||++||||+++|.|||....
T Consensus 235 ------------ig~~~-~~--P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 235 ------------IGRED-SL--PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ------------HhccC-CC--CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 11111 11 13345689999999999999999999999999999999754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=389.99 Aligned_cols=272 Identities=28% Similarity=0.436 Sum_probs=221.7
Q ss_pred cccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc------------cChhHHHHHHHHHHHHHhcCCC
Q 008607 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF------------EHVSDATRILREIKLLRLLRHP 82 (560)
Q Consensus 15 ~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~------------~~~~~~~~i~rEi~iL~~l~Hp 82 (560)
-+...-.-++|++.+.||+|.||+|.+|++..+++.||||++.+.- ......+++.+||.+|++|.||
T Consensus 89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~ 168 (576)
T KOG0585|consen 89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP 168 (576)
T ss_pred CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence 3445566789999999999999999999999999999999996421 1122246789999999999999
Q ss_pred CccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 83 nIv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~-lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
|||+|+++.-++ ....+|||+|||.. .+. +.-.... +++++++.|++.++.||.|||.+|||||||||+|+||+
T Consensus 169 nVV~LiEvLDDP---~s~~~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 169 NVVKLIEVLDDP---ESDKLYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS 244 (576)
T ss_pred CeeEEEEeecCc---ccCceEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc
Confidence 999999998443 34689999999994 443 3333344 99999999999999999999999999999999999999
Q ss_pred CCCcEEEecccccccccCC--CCCcccccccccCccccccccccccc--CCCCCccchhhHHHHHHHHhhCCCCCCCCCh
Q 008607 161 ADCKLKICDFGLARVAFND--TPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~--~~~~~~~~~~~gT~~Y~APEll~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~ 236 (560)
++|++||+|||.+.....+ ......+...+|||.|+|||+|.+.. ...+.+.||||+||+||.|+.|+.||.+...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999999999998754221 22223345579999999999996521 2245689999999999999999999999988
Q ss_pred hhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 237 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.+.+++|.. .+..+ ...+++...++|||.+||.+||++|+++.+|..|||.
T Consensus 325 ~~l~~KIvn----------------------------~pL~f-P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 325 LELFDKIVN----------------------------DPLEF-PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHHHHHHhc----------------------------CcccC-CCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 888777653 12222 2234678999999999999999999999999999998
Q ss_pred ccc
Q 008607 317 KGL 319 (560)
Q Consensus 317 ~~~ 319 (560)
..-
T Consensus 376 t~~ 378 (576)
T KOG0585|consen 376 TRD 378 (576)
T ss_pred ccC
Confidence 754
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=386.28 Aligned_cols=331 Identities=41% Similarity=0.775 Sum_probs=266.8
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (560)
|....+|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++|+||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 445678999999999999999999999999999999987544333445668899999999999999999998864322 2
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
....+|+|+||+..+|..++ ...++++.++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 91 EFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CCceEEEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 33467999999998887765 3369999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.. .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....|.+.+.....
T Consensus 169 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 169 AE------MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CC------CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 21 2345788999999998652 3578899999999999999999999999998888899999999888887776
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhh
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (560)
........+...+.......+...++..++.+.+||++||+.||.+||+++++|.||||..+.....++...+ +...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~~~~ 318 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDDS 318 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---ccch
Confidence 6655555555544443444455556778899999999999999999999999999999999876554443322 2333
Q ss_pred HHhhcCCHHHHHHHHHHHHHhhCh
Q 008607 338 FERRRITKEDVRELIYREILEYHP 361 (560)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p 361 (560)
-+......+++...||.|+..+.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~ 342 (342)
T cd07879 319 LENEKLSVDEWKKHIYKEVKSFSP 342 (342)
T ss_pred hhhhhCCHHHHHHHhhhhhhccCC
Confidence 344456667788888887655443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=382.88 Aligned_cols=275 Identities=28% Similarity=0.430 Sum_probs=225.0
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
-.+.+.|++.++||.|..++||+|+...+++.||||+++....+ .+...+.+|+..|+.++||||++++..|....
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~--- 97 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS--- 97 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc---
Confidence 34578899999999999999999999999999999999854333 34788999999999999999999999997654
Q ss_pred CccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
.+|+||.||. |++.++++.. ..|+|..+..|++++|+||.|||.+|-||||||+.||||+.+|.|||+|||.+..
T Consensus 98 --~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 98 --ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred --eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeee
Confidence 5999999998 6999999873 3599999999999999999999999999999999999999999999999999877
Q ss_pred ccCCCCCcccc-cccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 176 AFNDTPTAIFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 176 ~~~~~~~~~~~-~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
........... ...+||++|||||++...-.+|+.|+||||||++..||.+|..||..--.... ++.++-+.|+--.
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tLqn~pp~~~ 253 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTLQNDPPTLL 253 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHhcCCCCCcc
Confidence 65544333222 67899999999999654447899999999999999999999999976544332 2334444443111
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
+.....+. ....+..++.+|..||+.||.+||||+++|+|+||+...
T Consensus 254 t~~~~~d~-------------------~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 254 TSGLDKDE-------------------DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred cccCChHH-------------------hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 11111111 123355789999999999999999999999999998654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=382.88 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=213.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-----QRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-----CCe
Confidence 46999999999999999999999999999999986421 122344568899999999999999999987743 346
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 899999998 5899999988889999999999999999999999999999999999999999999999999997653221
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 23579999999999976 57889999999999999999999999887755444333210
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~ 319 (560)
. .. .....++.+.+||++||+.||.+|++ ++++++||||+.+
T Consensus 214 ------------~--~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 214 ------------K--LE---FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred ------------C--cC---CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 0 01 11245788999999999999999995 9999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=383.13 Aligned_cols=326 Identities=50% Similarity=0.845 Sum_probs=269.4
Q ss_pred ceEEEEEEeecCCeEEEEEEECCC--CcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRT--GEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~t--g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~ 100 (560)
+|++.+.||+|+||.||++.+..+ +..||||++............+.+|+.+++.++ |+||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999988 999999998765444444567889999999995 999999988754321 2335
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 101 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
.+|+++++++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999997643222
Q ss_pred CC-cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 181 PT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 181 ~~-~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. .......+||..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...+|.|..+.+..+.
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 1112346799999999987542 468899999999999999999999999999999999999999999988887777
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhhHH
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFE 339 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 339 (560)
......++..+.......+....+..+..+.+||.+||+.||.+|||+.++|.||||+.+......+.|.......|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~- 317 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES- 317 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc-
Confidence 7766666666655555566666777899999999999999999999999999999999998776777676655555442
Q ss_pred hhcCCHHHHHHHHHH
Q 008607 340 RRRITKEDVRELIYR 354 (560)
Q Consensus 340 ~~~~~~e~~~e~i~~ 354 (560)
.-+.++++..|..
T Consensus 318 --~~~~~~~~~~~~~ 330 (332)
T cd07857 318 --EDSMEELRDMIIE 330 (332)
T ss_pred --cccHHHHHHHHhh
Confidence 2345666666544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=386.93 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=214.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
-+.|++.+.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----N 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----C
Confidence 367999999999999999999999999999999986421 2223456788999999999999999999988543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+||||+. ++|.+++...+.++++.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 6899999998 599999998888999999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 172 ~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-------------- 229 (329)
T PTZ00263 172 T------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-------------- 229 (329)
T ss_pred c------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Confidence 1 24579999999999976 5788999999999999999999999987765443333221
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKG 318 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~ 318 (560)
.. .. ....++..+.+||++||+.||.+|++ +++++.||||++
T Consensus 230 ------------~~--~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 230 ------------GR--LK---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred ------------CC--cC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 00 01 11246788999999999999999997 799999999985
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=381.54 Aligned_cols=281 Identities=34% Similarity=0.610 Sum_probs=216.9
Q ss_pred EEEEeecCCeEEEEEEEC--CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008607 28 EEVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV 105 (560)
.++||+|+||+||+|+++ .+++.||+|.+... .....+.+|+.+|+.++||||+++++++.... ...+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC----CCcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEE
Confidence 357999999999999976 47789999998642 12345678999999999999999999885432 2468999
Q ss_pred EecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee----CCCCcEEEecccc
Q 008607 106 FELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGL 172 (560)
Q Consensus 106 ~E~~~gdL~~~i~~~---------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl----~~~~~lKL~DFGl 172 (560)
|||++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999999888642 248999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCCh---------hhHHHHH
Q 008607 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---------VHQLDIM 243 (560)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~~~~i 243 (560)
++...............+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+. .+++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 98654332222223457899999999998652 4588999999999999999999999976542 4677888
Q ss_pred HHhcCCCCHHHHHHhhhHH-HHHHHHhhccCCC--C----CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 244 TDLLGTPSPEAIARVRNEK-ARRYLSSMRKKKP--I----PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 244 ~~~~g~p~~~~~~~~~~~~-~~~~l~~~~~~~~--~----~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
...+|.|....+....... ....+..+..... . .+.......+..+.+||++||++||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8999988877665543211 1111111111100 0 0011122346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=385.02 Aligned_cols=331 Identities=44% Similarity=0.764 Sum_probs=271.6
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~ 98 (560)
.+.++|++.+.||+|+||.||+|.+..+|+.+|||++...+........+.+|+.+++.+ +|+||+++++++....
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~--- 80 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN--- 80 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC---
Confidence 345789999999999999999999999999999999876554555566778999999999 9999999999875422
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
...+|+||||+.++|.+++..+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 81 DKDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred CceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 2458999999999999999776 789999999999999999999999999999999999999999999999999986543
Q ss_pred CCCC--cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 179 DTPT--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 179 ~~~~--~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.... ......++||.+|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+..+....+.+..+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred ccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3211 1223456799999999987542 467889999999999999999999999999999999999999999888887
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchh
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 336 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 336 (560)
.+........+...............+.++..+.+||.+||+.||.+|||+.++|+||||+++.....+++........+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPL 318 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCc
Confidence 77766666666665555555566667778999999999999999999999999999999999876666654432222222
Q ss_pred hHHhhcCCHHHHHHHHHHHH
Q 008607 337 EFERRRITKEDVRELIYREI 356 (560)
Q Consensus 337 ~~e~~~~~~e~~~e~i~~ei 356 (560)
. ..+.+...++|..+|+||
T Consensus 319 ~-~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07852 319 D-DNVKLSVAEYRNKLYEEI 337 (337)
T ss_pred c-ccceeeHHHHHhhhhhcC
Confidence 2 335566677777777653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=385.64 Aligned_cols=250 Identities=25% Similarity=0.451 Sum_probs=209.7
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E 107 (560)
+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+.+++++... ..+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-----DRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-----CEEEEEEe
Confidence 46999999999999999999999999987432 2233456778999999999999999999988443 46899999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccc
Q 008607 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (560)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (560)
|+. ++|.+++..++.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---~~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---ATM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---Ccc
Confidence 998 5899999888889999999999999999999999999999999999999999999999999987532211 122
Q ss_pred cccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Q 008607 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (560)
Q Consensus 187 ~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 266 (560)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 45689999999999976 5789999999999999999999999988765444333221
Q ss_pred HHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
. .. .....+++.+.+||++||+.||++|| ++.++++||||.++
T Consensus 210 -----~--~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 210 -----E--EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -----C--CC---CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0 00 11235788999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=386.61 Aligned_cols=263 Identities=31% Similarity=0.520 Sum_probs=226.6
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR 96 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~ 96 (560)
..+...|++.+.||+|.||+||+|+++.||+.+|+|+|.+... ...+...+.+|+.+|+.|. |||||.++++|.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-- 108 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-- 108 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--
Confidence 3456789999999999999999999999999999999975433 2234567899999999999 99999999999544
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC----CcEEEeccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFG 171 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~----~~lKL~DFG 171 (560)
..+|+|||+|. |+|++.|.+. .+++..+..++.||+.|++|||+.||+||||||+|+|+... +.+|++|||
T Consensus 109 ---~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 109 ---DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred ---CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 47999999999 5999999887 49999999999999999999999999999999999998654 479999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
++..... .......|||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......|..
T Consensus 185 la~~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~------ 252 (382)
T KOG0032|consen 185 LAKFIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR------ 252 (382)
T ss_pred CceEccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc------
Confidence 9987654 223477899999999999986 6899999999999999999999999999886655544332
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.........|+.++..+.+||++||.+||.+|+|+.++|+|||+++..
T Consensus 253 ---------------------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 253 ---------------------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred ---------------------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 112233466788999999999999999999999999999999998753
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=376.72 Aligned_cols=291 Identities=35% Similarity=0.636 Sum_probs=233.9
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
|+.-++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~---- 76 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE---- 76 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecC----
Confidence 4566789999999999999999999999999999999864322 22334577899999999999999999998543
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 77 -~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 77 -KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred -CeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 468999999999999988764 468999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.|....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 156 IPTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 2211 12345678999999998652 4578899999999999999999999999999899999999999887766544
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
+........ ...............+.+++.+.+||.+||+.||.+|||++|+|+||||+.+.
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 232 ILSNEEFKS-YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hhccccccc-cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 322110000 00000011111122356788999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=398.05 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=221.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~ 100 (560)
..|.++++||+|+||+|++|..+.+++.+|||++++. .....+......|.+|+.... ||.++.++..|.+.+
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~----- 442 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE----- 442 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC-----
Confidence 5799999999999999999999999999999999853 345567788899999998886 999999999997664
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
++|+||||+.| | ...+...+.|++..+++|+..|+.||+|||++||||||||.+|||+|.+|.+||+|||+++-.-.
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~- 520 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG- 520 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC-
Confidence 69999999986 6 44445556899999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.....++.|||+.|+|||++.+ ..|+.++|.|||||+|||||.|..||+|.+..+.++.|..-
T Consensus 521 --~g~~TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------------- 583 (694)
T KOG0694|consen 521 --QGDRTSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------------- 583 (694)
T ss_pred --CCCccccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Confidence 2223477999999999999988 78999999999999999999999999999988877766430
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~~ 320 (560)
. ......++.+++++|++||.+||++|.. +++|.+||||+.+.
T Consensus 584 --------------~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 584 --------------E----VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred --------------C----CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 0 1112367899999999999999999975 68899999999764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=377.89 Aligned_cols=255 Identities=30% Similarity=0.538 Sum_probs=223.7
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecC-cccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~-~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
..-.||++.+.||+|.||.|-+|++...|+.||||.|++ ...+..+..+|.|||+||..|+||||+.++.+| ++
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----EN 124 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----EN 124 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cC
Confidence 455789999999999999999999999999999999974 456677888999999999999999999999999 44
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
...+.|||||.. |+|+++|...+.|+|.++++||+||+.|+.|||.++++|||||.+|||+|.||++||+||||+..+.
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 456999999998 6999999999999999999999999999999999999999999999999999999999999997764
Q ss_pred CCCCCcccccccccCcccccccccccccCCC-CCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
. ..++.++||++.|.+||++.+ ..| ++.+|.|||||+||.|+.|..||.|.+....+..|....-
T Consensus 205 ~----~kfLqTFCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY-------- 270 (668)
T KOG0611|consen 205 D----KKFLQTFCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY-------- 270 (668)
T ss_pred c----ccHHHHhcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc--------
Confidence 3 336688999999999999988 455 5889999999999999999999999987666555543110
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
. -|.-+..+.-||+.||-.||++|.|+++|-.|=|.+
T Consensus 271 ----------------r--------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 271 ----------------R--------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ----------------c--------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 0 123355688899999999999999999999997765
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=386.74 Aligned_cols=262 Identities=26% Similarity=0.436 Sum_probs=214.2
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+|+.++|+||+++++.+... ..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-----NY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----Ce
Confidence 46999999999999999999999999999999997421 1223445678899999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|||||||. |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 899999997 5999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred CCc-----------------------------------ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHh
Q 008607 181 PTA-----------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225 (560)
Q Consensus 181 ~~~-----------------------------------~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLl 225 (560)
... ......+||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 000 01123579999999999976 57899999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 008607 226 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305 (560)
Q Consensus 226 tG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp 305 (560)
+|.+||.+.+....+..+... .....+. ....+++.+.+||++||. ||.+|+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~--------------------------~~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINW--------------------------KETLQFP-DEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcC--------------------------CCccCCC-CCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 999999887765544333211 0001111 112468899999999997 999999
Q ss_pred C---HHHHhcCcccccc
Q 008607 306 T---AEEALADPYFKGL 319 (560)
Q Consensus 306 t---a~elL~hp~f~~~ 319 (560)
+ ++|+|+||||++.
T Consensus 286 ~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 286 GNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 8 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=381.72 Aligned_cols=261 Identities=25% Similarity=0.468 Sum_probs=217.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-----DEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-----CCE
Confidence 469999999999999999999999999999999974322 22345668899999999999999999998843 346
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+||||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 899999998 59999998888899999999999999999999999999999999999999999999999999976433
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+......
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------- 216 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------- 216 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-----------
Confidence 1245689999999999977 57899999999999999999999999987766554443321000
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
+ ..+ ........+++.+.+||.+||..+|.+||+++++++||||.+.
T Consensus 217 ---------~--~~~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 217 ---------L--QRP-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred ---------c--cCC-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 0 000 0111113568899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=385.24 Aligned_cols=262 Identities=25% Similarity=0.382 Sum_probs=212.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++..++|+||+++++.+.. ...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCe
Confidence 469999999999999999999999999999999974321 22334567889999999999999999998843 346
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|||||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 899999998 5999999988899999999999999999999999999999999999999999999999999987542211
Q ss_pred CC--------------------------------cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCC
Q 008607 181 PT--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (560)
Q Consensus 181 ~~--------------------------------~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~ 228 (560)
.. .......+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 001134689999999999976 57899999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCC---CCC
Q 008607 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK---DRP 305 (560)
Q Consensus 229 ~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~---~Rp 305 (560)
.||.+.+..+.+..+.... ....+.. ...+++.+++||.+||. +|. .||
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~--------------------------~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 234 PPFCSETPQETYKKVMNWK--------------------------ETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCCHHHHHHHHHcCc--------------------------CcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 9999877665554443210 0111111 12468899999999876 454 458
Q ss_pred CHHHHhcCcccccc
Q 008607 306 TAEEALADPYFKGL 319 (560)
Q Consensus 306 ta~elL~hp~f~~~ 319 (560)
+++||++||||++.
T Consensus 286 ~~~ei~~hp~f~~~ 299 (363)
T cd05628 286 GVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHhCCCCCCCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=363.96 Aligned_cols=263 Identities=29% Similarity=0.492 Sum_probs=220.7
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-----Chh-HHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-----HVS-DATRILREIKLLRLLR-HPDIVEIKHILLPPSR 96 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-----~~~-~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~ 96 (560)
.|.-.++||+|..++|-.+.++.||..+|+|+|..... +.. -.+...+|+.||+++. ||+|+.+.++|.+++
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s- 96 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA- 96 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc-
Confidence 47777899999999999999999999999999964221 111 1244568999999985 999999999996655
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
.+++|||+|. |.|++++...-.++|...+.|++||+.|+.|||.++|+||||||+|||++++.++||+|||+|+.
T Consensus 97 ----F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 ----FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred ----hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 4899999998 89999999888899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccccccccc----ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~----~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
...+. .+...||||.|.|||.+.- ...+|+..+|+|++|||+|.||.|.+||-.....-.+..|..
T Consensus 173 l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime------ 242 (411)
T KOG0599|consen 173 LEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME------ 242 (411)
T ss_pred cCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh------
Confidence 65444 4578999999999998742 124688999999999999999999999976554444444432
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
.+...-+..|.+++..++|||.+||+.||.+|+|++|+|+||||..+...
T Consensus 243 ---------------------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 243 ---------------------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred ---------------------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 22222345677889999999999999999999999999999999876543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=387.37 Aligned_cols=263 Identities=23% Similarity=0.361 Sum_probs=211.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.|++++.||+|+||+||+|++..+++.||||++... .........+.+|+.+|+.++|+||+++++.+... ..
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~ 75 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-----DN 75 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-----CE
Confidence 3699999999999999999999999999999999742 22334456788999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C--------------------------------------------CcccccccccCcccccccccccccCCCCCccchhh
Q 008607 181 P--------------------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (560)
Q Consensus 181 ~--------------------------------------------~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWS 216 (560)
. ........+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceee
Confidence 0 0000124589999999999976 57899999999
Q ss_pred HHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHh
Q 008607 217 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296 (560)
Q Consensus 217 lG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~m 296 (560)
|||++|||++|+.||.+.+..+....+..... . .. ......+++.+.+||.+|
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------------------~--~~-~~~~~~~s~~~~dli~~l 286 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWEN------------------------T--LH-IPPQVKLSPEAVDLITKL 286 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc------------------------c--cC-CCCCCCCCHHHHHHHHHH
Confidence 99999999999999988765443333221100 0 00 111235789999999996
Q ss_pred ccc--CCCCCCCHHHHhcCcccccc
Q 008607 297 LAF--EPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 297 L~~--DP~~Rpta~elL~hp~f~~~ 319 (560)
|.. ++..|++++|+++||||+++
T Consensus 287 l~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 287 CCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred ccCcccccCCCCHHHHhcCcccCCC
Confidence 654 55559999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=387.87 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=212.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|+++++||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++|+||+++++.+... ..
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CE
Confidence 36999999999999999999999999999999987421 1223456788999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C--------------------------------------------CcccccccccCcccccccccccccCCCCCccchhh
Q 008607 181 P--------------------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (560)
Q Consensus 181 ~--------------------------------------------~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWS 216 (560)
. ........+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 0000123579999999999976 57899999999
Q ss_pred HHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHh
Q 008607 217 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296 (560)
Q Consensus 217 lG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~m 296 (560)
|||++|||++|++||.+.+.......+... ...... .....+++.+.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------------~~~~~~---p~~~~~s~~~~~li~~l 286 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINW------------------------QTSLHI---PPQAKLSPEASDLIIKL 286 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHcc------------------------CCCcCC---CCcccCCHHHHHHHHHH
Confidence 999999999999999887654433332211 000000 11245789999999998
Q ss_pred cccCCCCCCC---HHHHhcCcccccc
Q 008607 297 LAFEPKDRPT---AEEALADPYFKGL 319 (560)
Q Consensus 297 L~~DP~~Rpt---a~elL~hp~f~~~ 319 (560)
+ .||.+|++ ++|+++||||++.
T Consensus 287 ~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred c-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 7 49999997 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=371.63 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=210.2
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+|+.++|+||+.+++.+... ..++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-----DALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeEE
Confidence 8899999999999999999999999999999864322 222334578999999999999999999988433 4689
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 104 lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|||||. |+|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999998 5888777543 368999999999999999999999999999999999999999999999999997643222
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 157 ----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-------------- 216 (285)
T cd05631 157 ----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-------------- 216 (285)
T ss_pred ----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH--------------
Confidence 1244679999999999976 57899999999999999999999999876643322222111
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~~ 320 (560)
+. .. .......+++.+.+||++||+.||.+||+ ++++++||||.++.
T Consensus 217 ---------~~-~~---~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 217 ---------VK-ED---QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ---------hh-cc---cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 00 00 01123457889999999999999999997 99999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=387.58 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=211.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+++|+.++||||+++++.+... ..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-----QY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----Ce
Confidence 46999999999999999999999999999999986421 1223456788999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+||||||++ |+|.+++...+.+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 899999997 5999999888889999999999999999999999999999999999999999999999999996321100
Q ss_pred CC------------c--------------------------------ccccccccCcccccccccccccCCCCCccchhh
Q 008607 181 PT------------A--------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (560)
Q Consensus 181 ~~------------~--------------------------------~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWS 216 (560)
.. . ......+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 00013579999999999976 57899999999
Q ss_pred HHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHh
Q 008607 217 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296 (560)
Q Consensus 217 lG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~m 296 (560)
|||++|||++|.+||.+.+..+.+..+.... . ...+ .....++..+.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------------~--~~~~-p~~~~~s~~~~dli~~l 286 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWR------------------------E--TLYF-PDDIHLSVEAEDLIRRL 286 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccC------------------------C--ccCC-CCCCCCCHHHHHHHHHH
Confidence 9999999999999998877655544433210 0 0111 11224688999999999
Q ss_pred cccCCCCC---CCHHHHhcCcccccc
Q 008607 297 LAFEPKDR---PTAEEALADPYFKGL 319 (560)
Q Consensus 297 L~~DP~~R---pta~elL~hp~f~~~ 319 (560)
|. +|.+| +++.|+|.||||++.
T Consensus 287 L~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 98 77765 599999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=372.46 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=222.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.|++++.||.|.-|+||+|+...++..+|+|++.+... ......++..|-+||..+.||.++.||..|.+ ...
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-----~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-----DKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-----cce
Confidence 578999999999999999999999999999999986432 34556788899999999999999999999944 356
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+|+|||||. |||+.+.++. ..|+++.+++|+.+++.||+|||..|||+|||||+||||.++|+|.|+||.|+.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999998 5999998764 4699999999999999999999999999999999999999999999999999853210
Q ss_pred ---------------------------------C--------------------CCCcccccccccCccccccccccccc
Q 008607 179 ---------------------------------D--------------------TPTAIFWTDYVATRWYRAPELCGSFF 205 (560)
Q Consensus 179 ---------------------------------~--------------------~~~~~~~~~~~gT~~Y~APEll~~~~ 205 (560)
. .+.......+|||-.|.|||++.|
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-- 309 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-- 309 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec--
Confidence 0 001112235799999999999988
Q ss_pred CCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCC
Q 008607 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA 285 (560)
Q Consensus 206 ~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 285 (560)
...+.++|.|+|||++||||.|.-||.|.+..+.+..|.. ++..|.. .+.+
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----------------------------~~l~Fp~-~~~v 360 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----------------------------QPLKFPE-EPEV 360 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----------------------------CCCcCCC-CCcc
Confidence 6788999999999999999999999999997776655432 1122222 2366
Q ss_pred CHHHHHHHHHhcccCCCCCCC----HHHHhcCccccccccc
Q 008607 286 NPLALRLLERMLAFEPKDRPT----AEEALADPYFKGLAKV 322 (560)
Q Consensus 286 s~~~~dLI~~mL~~DP~~Rpt----a~elL~hp~f~~~~~~ 322 (560)
+..++|||+++|.+||.+|.. |.||-+||||+++...
T Consensus 361 s~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 361 SSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred hhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 789999999999999999998 9999999999987654
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=369.81 Aligned_cols=282 Identities=38% Similarity=0.621 Sum_probs=225.8
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||+|+||.||+|++..+|+.||+|.+............+.+|+.+++.++|+||+++++++... ..+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceE
Confidence 59999999999999999999999999999999875333333345677899999999999999999988433 4689
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 104 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
+|+||++++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999998875 45799999999999999999999999999999999999999999999999999975432211
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCC-CCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
......++..|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+...++..+.+.++.+....+..+...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12345788999999998652 4578899999999999999998866 6777777888888888888776554432211
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.....+... .....+.+..+.+++.+.+||++||+.||.+|||++++|.||||
T Consensus 232 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMY--PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCC--CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000000000 00111233456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=387.98 Aligned_cols=259 Identities=30% Similarity=0.448 Sum_probs=229.4
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|.++++||+|+||.+++++++..++.|++|+|...............|+.++++++|||||.++++|...+ .
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~ 77 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----Q 77 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----c
Confidence 356899999999999999999999999999999999866555556667889999999999999999999995433 3
Q ss_pred cEEEEEecCCc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 101 DIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
.++|||+||+| +|.+.|+... .|+++.++.|+.||+.||.|||+++|+|||||+.|||++.++.|||+|||+|+...
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 48999999995 9999997644 59999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... ....+++||+.|+.||+|.+ .+|+.++|||||||++|||++-+++|.+.+....+.+|......|.
T Consensus 158 ~~~---~~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl------ 226 (426)
T KOG0589|consen 158 PED---SLASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL------ 226 (426)
T ss_pred Cch---hhhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC------
Confidence 554 23467999999999999998 7999999999999999999999999999999888888776544333
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
...++.+++.||+.||..+|..||++.++|.+|.+..
T Consensus 227 ------------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 227 ------------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ------------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 2456888999999999999999999999999988763
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=382.00 Aligned_cols=262 Identities=29% Similarity=0.468 Sum_probs=216.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-----EEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-----CCe
Confidence 479999999999999999999999999999999874321 22345668899999999999999999988843 346
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999997654322
Q ss_pred C--------------------------CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCC
Q 008607 181 P--------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (560)
Q Consensus 181 ~--------------------------~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~ 234 (560)
. ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 0 0011234679999999999977 57899999999999999999999999887
Q ss_pred ChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcC
Q 008607 235 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-AEEALAD 313 (560)
Q Consensus 235 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-a~elL~h 313 (560)
+....+..+..... .... .....+++.+.+||.+||. ||.+|++ ++++|+|
T Consensus 234 ~~~~~~~~i~~~~~------------------------~~~~---p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKE------------------------SLRF---PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCC------------------------cccC---CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 75544443332100 0001 1112368999999999998 9999999 9999999
Q ss_pred cccccc
Q 008607 314 PYFKGL 319 (560)
Q Consensus 314 p~f~~~ 319 (560)
|||+++
T Consensus 286 p~~~~~ 291 (350)
T cd05573 286 PFFKGI 291 (350)
T ss_pred CCcCCC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=381.92 Aligned_cols=254 Identities=23% Similarity=0.360 Sum_probs=213.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCC-cEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg-~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
-+.|++.+.||+|+||.||+|.+..++ ..||+|++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~----- 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE----- 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-----
Confidence 467999999999999999999876655 689999986421 2233456788999999999999999999998543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+||||+. |+|.+++..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 46899999997 59999999888999999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 184 ~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~------------ 243 (340)
T PTZ00426 184 R------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG------------ 243 (340)
T ss_pred C------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC------------
Confidence 1 134689999999999976 57889999999999999999999999887655443333210
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
. . ...+.+++.+.+||++||+.||.+|+ +++++++||||+++
T Consensus 244 --------------~--~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 244 --------------I--I---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred --------------C--C---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0 0 11235678899999999999999995 89999999999865
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=386.69 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=212.2
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++|+||+++++.+... ..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-----DN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CE
Confidence 46999999999999999999999999999999986421 1222345678999999999999999999988543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+|||||+ |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999998 5999999988889999999999999999999999999999999999999999999999999975321000
Q ss_pred C----------------------------------------CcccccccccCcccccccccccccCCCCCccchhhHHHH
Q 008607 181 P----------------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (560)
Q Consensus 181 ~----------------------------------------~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~i 220 (560)
. ........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999976 578999999999999
Q ss_pred HHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 008607 221 FAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300 (560)
Q Consensus 221 l~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~D 300 (560)
+|+|++|+.||.+.+..+....+.... .... ......+++.+.+||.+|+ .|
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~------------------------~~~~---~~~~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWE------------------------TTLH---IPSQAKLSREASDLILRLC-CG 285 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccC------------------------cccc---CCCCCCCCHHHHHHHHHHh-cC
Confidence 999999999998877554433322100 0000 1112457899999999987 59
Q ss_pred CCCCC---CHHHHhcCcccccc
Q 008607 301 PKDRP---TAEEALADPYFKGL 319 (560)
Q Consensus 301 P~~Rp---ta~elL~hp~f~~~ 319 (560)
|.+|+ |++|+++||||+++
T Consensus 286 p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 286 AEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred HhhcCCCCCHHHHhCCCCcCCC
Confidence 99999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=373.00 Aligned_cols=321 Identities=48% Similarity=0.866 Sum_probs=263.9
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
+.+.++|++++.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++.+++....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 82 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL--- 82 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC---
Confidence 56788999999999999999999999999999999998754444445567889999999999999999999885422
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+|+||++++|.+++.. ..+++..+..++.||+.||+|||+.||+||||+|+|||++.++.+||+|||++.....
T Consensus 83 -~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 83 -EDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred -CcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 35899999999999888764 4689999999999999999999999999999999999999999999999999875322
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
. .....++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+.......+.+.+|.+..+.....
T Consensus 161 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 Q------MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C------cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 1 1345788899999987542 46889999999999999999999999999988888889999999998888776
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhhH
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEF 338 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 338 (560)
.......++..+....+.+.....+.+++.+.+||++||+.||++|||++++|.||||..+.....++.. ..+++..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~--~~~~~~~~ 311 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVA--EEKFDWSF 311 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCc--hhhcCCch
Confidence 6666666666666666666666677889999999999999999999999999999999877655444332 22444444
Q ss_pred HhhcCCHHHHHHHHH
Q 008607 339 ERRRITKEDVRELIY 353 (560)
Q Consensus 339 e~~~~~~e~~~e~i~ 353 (560)
....+..+.++-..|
T Consensus 312 ~~~~~~~~~~~~~~~ 326 (328)
T cd07856 312 NDADLPVDTWKVMMY 326 (328)
T ss_pred hcccCCHHHHHHHhc
Confidence 555555555554443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=375.84 Aligned_cols=248 Identities=31% Similarity=0.502 Sum_probs=207.5
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008607 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (560)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~ 109 (560)
||+|+||.||+|++..+++.||+|++.... ........+.+|+.+|+.++||||+++++++... ..+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-----EKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-----CeEEEEEcCC
Confidence 799999999999999999999999986422 2334456788999999999999999999988433 4689999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccc
Q 008607 110 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188 (560)
Q Consensus 110 ~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 188 (560)
. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 8 59999998888899999999999999999999999999999999999999999999999999975422221 1245
Q ss_pred cccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHH
Q 008607 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 268 (560)
Q Consensus 189 ~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~ 268 (560)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 689999999999976 5789999999999999999999999987765443322211
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccccc
Q 008607 269 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP---TAEEALADPYFKGL 319 (560)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp---ta~elL~hp~f~~~ 319 (560)
.+. .....+++.+.+||.+||..||.+|| ++.|+|.||||...
T Consensus 208 -----~~~---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 -----EPL---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred -----CCC---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 011 11245788999999999999999997 58999999999854
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=364.70 Aligned_cols=282 Identities=38% Similarity=0.644 Sum_probs=227.1
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.|++.+.||+|++|.||+|.+..++..||||++............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEE
Confidence 48999999999999999999999999999999875433334456778999999999999999999998543 4689
Q ss_pred EEEecCCccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 104 VVFELMESDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~~---~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999998888653 468999999999999999999999999999999999999999999999999987542211
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---ccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 112345678999999988652 4578899999999999999999999999888887777777777776555443221
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
. ..+..................+++++.+||++||+.||.+|||+.+++.||||
T Consensus 232 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 L--PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred h--HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 1 11111111111111222345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=370.94 Aligned_cols=294 Identities=40% Similarity=0.625 Sum_probs=235.1
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..+.|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|+||+++++++.... ..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CC
Confidence 456799999999999999999999999999999998743333333345678999999999999999999885432 24
Q ss_pred cEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+||||++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 58999999999999888763 56999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. ......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.+....+....
T Consensus 162 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AK---PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cC---CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 21 12344568899999998652 457889999999999999999999999999999999999999888766554332
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
.......+. +.......+...+...++.+.+||.+||++||++|||++|+|+||||++....
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 238 DLPLVGKFT-LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred ccccccccc-ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 211000000 00111111223345568999999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=376.68 Aligned_cols=250 Identities=24% Similarity=0.452 Sum_probs=208.5
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E 107 (560)
++||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++.+... ..+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-----DRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CEEEEEEe
Confidence 46999999999999999999999999997532 2233456788999999999999999999988443 46899999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccc
Q 008607 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (560)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (560)
|++ ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cc
Confidence 998 58999998888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred cccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Q 008607 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (560)
Q Consensus 187 ~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 266 (560)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 44689999999999976 5789999999999999999999999987665443332211
Q ss_pred HHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
... .....+++.+.+||++||+.||.+|+ ++.|+++||||.+.
T Consensus 210 -------~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 210 -------EDI---KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -------CCc---cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 11235688999999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=374.77 Aligned_cols=250 Identities=25% Similarity=0.453 Sum_probs=208.8
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E 107 (560)
+.||+|+||.||++.+..+|..||+|++..... .......+.+|+.+|+.++||||+++++.+... ..+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEe
Confidence 469999999999999999999999999875321 223445677899999999999999999988543 46899999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccc
Q 008607 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (560)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (560)
|++ ++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cc
Confidence 998 58999998888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred cccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Q 008607 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (560)
Q Consensus 187 ~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 266 (560)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------- 209 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Confidence 44679999999999976 5789999999999999999999999987765544333221
Q ss_pred HHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
.. . .....+++.+.+||++||+.||.+|+ ++.++++||||.+.
T Consensus 210 -----~~--~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 210 -----EE--I---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred -----CC--C---CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 00 0 11235688999999999999999998 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=376.36 Aligned_cols=262 Identities=23% Similarity=0.400 Sum_probs=214.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+++.++|+||+.+++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence 469999999999999999999999999999999975322 22344567889999999999999999998843 346
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|+||||++ ++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 899999997 5999999876 67999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCcccccccccccc----cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
... .....+||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--------- 224 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--------- 224 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---------
Confidence 221 12345799999999998631 145788999999999999999999999877655444333221
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.....+ ...+.+++.+.+||++||. ||.+|||++++++||||..+
T Consensus 225 -----------------~~~~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 225 -----------------QRFLKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred -----------------CCccCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 001111 1224578999999999998 99999999999999999854
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=371.16 Aligned_cols=259 Identities=28% Similarity=0.488 Sum_probs=225.2
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
+..-|.+.+.||+|-|.+|.+|+|.-||++||||+|.+.-.+.-....+..|+..|+.++|||||++|+++-+. .
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-----T 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-----T 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-----c
Confidence 45679999999999999999999999999999999987655555567789999999999999999999998443 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCee-eCCCCcEEEeccccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLARVAF 177 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NIL-l~~~~~lKL~DFGla~~~~ 177 (560)
.+|||+|+-+ |||+++|.++. .++|+.+++||.||+.|+.|||..+++||||||+||. +..-|-|||.|||++....
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 6999999998 59999998865 6999999999999999999999999999999999986 5566999999999986654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCC-CccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~-~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.+. .+++.||+..|-|||+|.+ ..|+ +++||||||||||-|++|++||...|..+.+-+|.+---
T Consensus 171 PG~----kL~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-------- 236 (864)
T KOG4717|consen 171 PGK----KLTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-------- 236 (864)
T ss_pred Ccc----hhhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--------
Confidence 433 3578899999999999987 4565 789999999999999999999999998888877765211
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
.....++.+++|||..||..||++|.+.+||..|+|++....
T Consensus 237 -----------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 237 -----------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred -----------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 122356889999999999999999999999999999997654
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=369.50 Aligned_cols=281 Identities=35% Similarity=0.599 Sum_probs=214.5
Q ss_pred EEEEeecCCeEEEEEEECC--CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008607 28 EEVIGKGSYGVVCSAYDTR--TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~--tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV 105 (560)
..+||+|+||.||+|.+.. ++..||+|.+... .....+.+|+.+|+.++||||+++++++.... ...+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEE
Confidence 3679999999999999654 6689999998642 22345678999999999999999999886432 2468999
Q ss_pred EecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee----CCCCcEEEecccc
Q 008607 106 FELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGL 172 (560)
Q Consensus 106 ~E~~~gdL~~~i~~~---------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl----~~~~~lKL~DFGl 172 (560)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999998888532 248899999999999999999999999999999999999 5667899999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCCh---------hhHHHHH
Q 008607 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---------VHQLDIM 243 (560)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~~~~i 243 (560)
++...............++|+.|+|||++.+. ..++.++|||||||++|||++|++||.+... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98654333222223456889999999998652 4578999999999999999999999976432 3567778
Q ss_pred HHhcCCCCHHHHHHhhhHH-HHHHHHhhccCC-----C-CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 244 TDLLGTPSPEAIARVRNEK-ARRYLSSMRKKK-----P-IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 244 ~~~~g~p~~~~~~~~~~~~-~~~~l~~~~~~~-----~-~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
...+|.+..+.+..+.... ............ . ..........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 8888888777665543211 000000000000 0 00111122346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=357.60 Aligned_cols=279 Identities=32% Similarity=0.492 Sum_probs=226.2
Q ss_pred cCCCcccccccCCCCceEEE-EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccc
Q 008607 9 SSADVDFFTEYGEGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVE 86 (560)
Q Consensus 9 ~~~~~~~~~~~~~~~~Y~i~-~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~ 86 (560)
+..+++| .++.+.+.|+|. ++||-|-.|.|..+.++.||+++|+|++.+ .....||+++--.. .|||||.
T Consensus 48 ~~~~m~~-k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~ 119 (400)
T KOG0604|consen 48 EESDMDF-KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVS 119 (400)
T ss_pred hhhhcch-hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEE
Confidence 3556666 889999999886 679999999999999999999999999853 34556888886555 5999999
Q ss_pred cceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC--
Q 008607 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-- 161 (560)
Q Consensus 87 l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~--lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-- 161 (560)
++++|. ++......+.||||.|+| +|+..|..++. |+|.++..|+.||..|+.|||+.+|.||||||+|+|...
T Consensus 120 IidVye-Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~ 198 (400)
T KOG0604|consen 120 IIDVYE-NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS 198 (400)
T ss_pred eehhhh-hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC
Confidence 999984 344556788999999995 99999998775 999999999999999999999999999999999999875
Q ss_pred -CCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHH
Q 008607 162 -DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240 (560)
Q Consensus 162 -~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~ 240 (560)
|..+||+|||+|+.... ...+.+-|.|++|.|||+++. .+|+...|+||+|||+|.||+|.+||..+.....
T Consensus 199 ~na~lKLtDfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai- 271 (400)
T KOG0604|consen 199 PNAPLKLTDFGFAKETQE----PGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI- 271 (400)
T ss_pred CCcceEecccccccccCC----CccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCccC-
Confidence 56799999999986432 233466789999999999987 6899999999999999999999999987653211
Q ss_pred HHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 241 ~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
++..-.++ +....-.....|..+|..++|||++||..+|.+|.|++|++.|||+.+..
T Consensus 272 ----------spgMk~rI------------~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 272 ----------SPGMKRRI------------RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred ----------ChhHHhHh------------hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 11110111 11111122345667889999999999999999999999999999998766
Q ss_pred ccCCC
Q 008607 321 KVERE 325 (560)
Q Consensus 321 ~~~~~ 325 (560)
.....
T Consensus 330 ~vp~t 334 (400)
T KOG0604|consen 330 AVPQT 334 (400)
T ss_pred cCCCC
Confidence 54443
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=379.13 Aligned_cols=263 Identities=24% Similarity=0.370 Sum_probs=214.1
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+.+++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~----- 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD----- 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence 3468999999999999999999999999999999986421 2223345577899999999999999999988443
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+|||||+ |+|.+++... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 46999999998 5899888654 689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCcccccccccccc--cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~--~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... ......+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+....+..|...
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~---------- 262 (370)
T cd05596 195 NGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH---------- 262 (370)
T ss_pred CCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC----------
Confidence 211 112456899999999998642 124788999999999999999999999987765544443221
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKG 318 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--Rpta~elL~hp~f~~ 318 (560)
.....+ .....++..+.+||++||+.+|.+ |+|++|+++||||++
T Consensus 263 ----------------~~~~~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 263 ----------------KNSLTF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred ----------------CCcCCC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 111111 122357899999999999999988 999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=373.21 Aligned_cols=260 Identities=23% Similarity=0.396 Sum_probs=208.2
Q ss_pred ceEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEecCcc--cChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcC
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRR 97 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~ 97 (560)
.|++++.||+|+||.||+|++. .+++.||+|++.+.. ........+.+|+.+|+.++ |+||+.+++++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--- 77 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--- 77 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC---
Confidence 4899999999999999999864 578999999986421 22234456788999999995 89999999888433
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+|+||||+. ++|.+++.....++++.++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 78 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 78 --AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred --CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 46899999998 599999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+..
T Consensus 156 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----------- 221 (332)
T cd05614 156 LSEEKE--RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----------- 221 (332)
T ss_pred cccCCC--ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH-----------
Confidence 332221 12346899999999998752 3578899999999999999999999975432211111110
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKG 318 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~ 318 (560)
.+.... ......+++.+.+||.+||+.||++|| +++++++||||++
T Consensus 222 ------------~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 222 ------------RILKCD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred ------------HHhcCC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 000111 111235788999999999999999999 8999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=371.52 Aligned_cols=255 Identities=24% Similarity=0.410 Sum_probs=211.4
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCC-CccccceeecCCCcCCCcc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHP-DIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~Hp-nIv~l~~i~~~~~~~~~~~ 101 (560)
.|++++.||+|+||.||+|.+..+++.||||++.... ........+..|+.+++.+.|+ +|+.+++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CE
Confidence 4899999999999999999999999999999987432 1233456778899999999765 577888877433 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 899999998 5999999888889999999999999999999999999999999999999999999999999987532211
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 1 1234679999999999976 57889999999999999999999999887765544433221
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta-----~elL~hp~f~~~ 319 (560)
. . .....++..+.+||.+||..||.+|++. +++++||||+..
T Consensus 217 ------------~--~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 217 ------------N--V---SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred ------------C--C---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 0 1123568899999999999999999976 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=369.82 Aligned_cols=279 Identities=25% Similarity=0.390 Sum_probs=217.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||.||++++..+|..||+|.+.... ......++.+|+++|+.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CE
Confidence 468999999999999999999999999999999987432 233456789999999999999999999998543 46
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+++||||+++ +|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 8999999985 9999998888899999999999999999999986 6999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH----
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI---- 255 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~---- 255 (560)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.... ++.+.....
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccccccccCCc
Confidence 1 234679999999999976 5789999999999999999999999987665433222 221110000
Q ss_pred -------------------HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 256 -------------------ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 256 -------------------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
...........+..+........ ....+++.+.+||.+||++||++|||++|+|+||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcCC--CCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00000001111111111111111 113467899999999999999999999999999999
Q ss_pred ccc
Q 008607 317 KGL 319 (560)
Q Consensus 317 ~~~ 319 (560)
+..
T Consensus 305 ~~~ 307 (331)
T cd06649 305 KRS 307 (331)
T ss_pred hhc
Confidence 853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=372.49 Aligned_cols=250 Identities=24% Similarity=0.434 Sum_probs=208.2
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
+.||+|+||.||+|.++.+++.||||++.... ........+.+|+.++..+ +||||+++++++... ..+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-----~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-----DRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-----CEEEEEE
Confidence 46999999999999999999999999987432 2223455677899999876 699999999988443 4689999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||++ ++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------------------- 211 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------------------- 211 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-------------------
Confidence 244679999999999976 57889999999999999999999999987765544433210
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCcccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA------EEALADPYFKGL 319 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta------~elL~hp~f~~~ 319 (560)
. . .....+++.+.+||++||+.||.+|+++ +++++||||..+
T Consensus 212 --------~-~---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 212 --------E-V---VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred --------C-C---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 0 0 1123468899999999999999999998 999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=369.83 Aligned_cols=281 Identities=32% Similarity=0.570 Sum_probs=225.7
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCC--C----ccccceeecCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP--D----IVEIKHILLPP 94 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hp--n----Iv~l~~i~~~~ 94 (560)
..+||+++..+|+|.||.|..+.|..++..||||+|+.. .......+-|+++|.+|.+. + +|.+.++|
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--- 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--- 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh---
Confidence 378999999999999999999999999999999999742 12334455699999999532 2 45554544
Q ss_pred CcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC-----------
Q 008607 95 SRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----------- 161 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~----------- 161 (560)
+-.++++||+|.++-++++++++|+ .++.++++.+.+||+.+++|||+++|+|.||||+|||+.+
T Consensus 161 --dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 161 --DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred --hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 3446799999999999999999876 5899999999999999999999999999999999999643
Q ss_pred ---------CCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCC
Q 008607 162 ---------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (560)
Q Consensus 162 ---------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~ 232 (560)
+..|||+|||.|+...... +..+.|+.|+|||++.+ -+++..+||||+||||+||.+|..+|.
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceecc
Confidence 2348999999997643322 56789999999999998 589999999999999999999999999
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccC---------------CCCCCCCCCCCCC---HHHHHHHH
Q 008607 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKK---------------KPIPFSQKFPNAN---PLALRLLE 294 (560)
Q Consensus 233 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~---------------~~~~~~~~~~~~s---~~~~dLI~ 294 (560)
+.+..+.+..|..++|..+...+.+.+ ..+|+...+-. .+.++.......+ ..+.|||+
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 999999999999999977776666654 33343332100 0111111111112 34889999
Q ss_pred HhcccCCCCCCCHHHHhcCccccccc
Q 008607 295 RMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 295 ~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
+||.+||.+|+|+.|+|.||||+.+.
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhcCC
Confidence 99999999999999999999998753
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=371.06 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=207.7
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHH---HhcCCCCccccceeecCCCcCCCc
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLL---RLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL---~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.++ +.++||||+++++++... .
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----D 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----C
Confidence 789999999999999999999999999999997432 1223345677777765 456799999999988443 4
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+||||+++ +|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 68999999985 88877754 47999999999999999999999999999999999999999999999999998653221
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 155 ~---~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------- 216 (324)
T cd05589 155 G---DRTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------------- 216 (324)
T ss_pred C---CcccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 1 11245689999999999976 57889999999999999999999999887765544433210
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
.. .....+++.+.+||.+||+.||.+|| +++++++||||+++
T Consensus 217 --------------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 217 --------------EV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred --------------CC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 00 11235688999999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=373.62 Aligned_cols=250 Identities=26% Similarity=0.461 Sum_probs=207.8
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E 107 (560)
+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+++++.++||||+.+++.+... ..+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-----~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-----CEEEEEEe
Confidence 46999999999999999999999999997532 2233456678899999999999999999988443 46899999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
|++ ++|..++.....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 998 5899998888889999999999999999999997 7999999999999999999999999999875322211 1
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------- 210 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--------------------
Confidence 244679999999999976 5789999999999999999999999987765443332211
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
... .....+++.+.+||++||+.||.+|+ ++.++|+||||.+.
T Consensus 211 --------~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 211 --------EEI---RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred --------CCC---CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 000 11135688999999999999999997 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=377.78 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=213.2
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|..++|+||+++++.+.. ...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-----~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-----KRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence 36999999999999999999999999999999986422 122345677889999999999999999998843 346
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+|||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred CC--------------------------------cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCC
Q 008607 181 PT--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (560)
Q Consensus 181 ~~--------------------------------~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~ 228 (560)
.. .......+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 000124579999999999976 67899999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---
Q 008607 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP--- 305 (560)
Q Consensus 229 ~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp--- 305 (560)
+||.+.+....+..+... .....+.. ...+++.+++||.+|+. ||.+|+
T Consensus 234 ~Pf~~~~~~~~~~~i~~~--------------------------~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 234 PPFCSETPQETYRKVMNW--------------------------KETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCCHHHHHHHHHcC--------------------------CCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 999887765544433211 00111111 12368899999999875 999998
Q ss_pred CHHHHhcCcccccc
Q 008607 306 TAEEALADPYFKGL 319 (560)
Q Consensus 306 ta~elL~hp~f~~~ 319 (560)
+++|+++||||+++
T Consensus 286 ~~~ei~~hp~f~~~ 299 (360)
T cd05627 286 GVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHhcCCCCCCC
Confidence 58999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=359.05 Aligned_cols=282 Identities=39% Similarity=0.645 Sum_probs=228.0
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.|++++.||.|++|.||+|++..+|..||||++............+.+|+++++.++||||+++++++.. ....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-----CCcEE
Confidence 3899999999999999999999999999999987543333344578899999999999999999998743 34689
Q ss_pred EEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 104 VVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
+||||+.++|..++.. ...+++..++.++.||+.||+|||+.||+||||+|+||+++.++.+||+|||++........
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 9999999899998865 34689999999999999999999999999999999999999999999999999875432211
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+......
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 12344678899999988652 34678899999999999999999999999888888888888888876544332221
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
..+...+.......+....+.+++.+.+||.+||+.||.+|||++++|.||||
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 --PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred --HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11111222222222333345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=359.11 Aligned_cols=285 Identities=42% Similarity=0.731 Sum_probs=233.3
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|+||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 5999999999999999999999999999999987544334445678899999999999999999999854 34689
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 104 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
+|+||++++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999997799999865 45699999999999999999999999999999999999999999999999999986543321
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 262 (560)
.......++.+|+|||.+.+. ..++.++|||||||++|+|++|.++|.+.+....+..+...++.|....+.......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 112445789999999998652 456889999999999999999999999999888888888888888776554432211
Q ss_pred HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
....+ .........+...+++.+..+.+||++||..||.+|||++++|+||||.
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKI-TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhcc-cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00000 0111222233445567789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=370.29 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=208.6
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
++||+|+||.||+|.+..+++.||||++.... ........+..|..++..+ +||||+.+++++... ..+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEE
Confidence 46999999999999999999999999987432 2233445677899999866 799999999998543 4689999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||++ ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875432221 2
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~------------------- 211 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD------------------- 211 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 245679999999999976 57899999999999999999999999988766555443220
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-------CHHHHhcCcccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-------TAEEALADPYFKGL 319 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-------ta~elL~hp~f~~~ 319 (560)
.. .....++..+.+||.+||+.||++|+ +++++++||||..+
T Consensus 212 --------~~----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 212 --------DV----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred --------CC----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 00 01124678999999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=377.14 Aligned_cols=262 Identities=25% Similarity=0.386 Sum_probs=211.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+. .........+.+|+.+++.++||||+++++++... .
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-----~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-----K 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----C
Confidence 46899999999999999999999999999999998642 12223445678999999999999999999988543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+|||||+ |+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 6999999998 5999988654 6899999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccCccccccccccccc--CCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
. .......+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+.+....+..|....
T Consensus 196 ~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~---------- 263 (370)
T cd05621 196 G--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK---------- 263 (370)
T ss_pred C--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 1 11224568999999999986521 237889999999999999999999999877655544433211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKG 318 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--Rpta~elL~hp~f~~ 318 (560)
....+. ....++..+++||.+||..++.+ |+|++|+++||||+.
T Consensus 264 ----------------~~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 264 ----------------NSLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred ----------------cccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 011111 11356889999999999865543 899999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=368.97 Aligned_cols=264 Identities=23% Similarity=0.416 Sum_probs=212.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||++++..+++.||||++.+. .........+.+|+.++..++|+||+.+++++... ..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-----NN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-----Ce
Confidence 4799999999999999999999999999999998642 12223445678899999999999999999988433 46
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999997 599999976 457999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... .....+||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~---------- 223 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC----------
Confidence 211 11235799999999998531 135788999999999999999999999887765554433211
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGL 319 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--Rpta~elL~hp~f~~~ 319 (560)
.....+....+.++..+++||++||..++++ |++++++|+||||.++
T Consensus 224 ----------------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 224 ----------------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ----------------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 1111223334557899999999999765544 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=369.51 Aligned_cols=251 Identities=28% Similarity=0.484 Sum_probs=207.4
Q ss_pred EEEEeecCCeEEEEEEEC---CCCcEEEEEEecCcc--cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 28 EEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++.||+|+||.||+|++. .+++.||||++.... ........+.+|+.+|+.++||||+++++++... ..+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-----GKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-----CeE
Confidence 368999999999999864 578899999987421 1223345677899999999999999999988543 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+||||+.+ +|.+++...+.++++.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999985 9999998888899999999999999999999999999999999999999999999999999875322221
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~---------------- 214 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK---------------- 214 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Confidence 1234679999999999976 5688999999999999999999999988765444333221
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
.. ....+.+++.+.+||++||+.||.+|| +++++++||||...
T Consensus 215 ----------~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 215 ----------GK-----LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------CC-----CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 112245688999999999999999999 89999999999853
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=368.60 Aligned_cols=300 Identities=42% Similarity=0.681 Sum_probs=231.7
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC-
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR- 97 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~- 97 (560)
|..+.+|++.+.||.|+||.||+|++..+|+.||+|++... .......+.+|+.+|+.++||||+++++++......
T Consensus 1 ~~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CCcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC--CCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 45678999999999999999999999999999999998643 223456688999999999999999999877543211
Q ss_pred --------CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC-CCcEEEe
Q 008607 98 --------EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKIC 168 (560)
Q Consensus 98 --------~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-~~~lKL~ 168 (560)
+...+|+||||++++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 1246899999999999888864 46999999999999999999999999999999999999985 5678999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcC
Q 008607 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g 248 (560)
|||+++...............+++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+....+..+.+...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999997653222211222334688999999987542 4678899999999999999999999999888777777666555
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccC
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~ 323 (560)
.+..+......+... ..+.........++....+..+..+.+||.+||+.||.+|||++|+|.||||+.+..+.
T Consensus 237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~ 310 (342)
T cd07854 237 VVREEDRNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF 310 (342)
T ss_pred CCChHHhhhhhhhhh-hhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence 544433332221111 11111111222223334567889999999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=367.70 Aligned_cols=255 Identities=23% Similarity=0.396 Sum_probs=211.8
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCcc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.|++.+.||+|+||.||+|++..+++.||||++.+... .......+..|..++..+. |++|+.+++++... ..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CE
Confidence 48999999999999999999999999999999875321 2233456778888888774 78899998888433 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+||||++ |+|.+.+...+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 899999998 5999999888889999999999999999999999999999999999999999999999999987532211
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1245679999999999976 57899999999999999999999999987765554443321
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~ 319 (560)
. . .....++..+.+||.+||+.||.+|++ ..++++||||+.+
T Consensus 217 ------------~--~---~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 217 ------------N--V---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred ------------C--C---CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 0 0 111356889999999999999999997 4899999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=369.68 Aligned_cols=250 Identities=27% Similarity=0.472 Sum_probs=205.5
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~-iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
++||+|+||+||+|++..+|+.||||++.... ........+.+|.. +++.++||||+++++.+... ..+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-----~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-----DKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-----CEEEEEE
Confidence 46999999999999999999999999986422 12233445666655 46789999999999988443 4689999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||+.+ +|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 99984 8999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------------------- 210 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------------------- 210 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999976 5789999999999999999999999988775544333321
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCcccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGL 319 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta----~elL~hp~f~~~ 319 (560)
. + ....+..++.+.+||++||+.||.+||++ .++++||||...
T Consensus 211 -------~-~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 211 -------K-P---LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred -------C-C---CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 0 0 11234668999999999999999999987 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=359.80 Aligned_cols=288 Identities=37% Similarity=0.633 Sum_probs=229.2
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++ |+||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4699999999999999999999999999999998754333334456788999999995 699999999886554333345
Q ss_pred EEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC-CCcEEEeccccccc
Q 008607 102 IYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARV 175 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~~-----~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-~~~lKL~DFGla~~ 175 (560)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999999988653 35899999999999999999999999999999999999999 89999999999875
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... ......++++|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+....+..+...++.|....+
T Consensus 161 ~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVK---SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCcc---ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 422111 11334678899999988542 45789999999999999999999999999888888888888887776554
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
.......... ......+.......+.+++.+.+||.+||..||.+||+++|+|.||||+
T Consensus 237 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWH---EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchh---hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 3322211100 0111112222333457889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=360.50 Aligned_cols=286 Identities=42% Similarity=0.678 Sum_probs=232.5
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC---hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH---VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~---~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
+|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 589999999999999999999999999999999753322 2234556789999999999999999999854 34
Q ss_pred cEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+||||+.++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 689999999889999998776 7999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. ......+++.|+|||.+.+. ..++.++|||||||++|+|++|.++|.+.+..+.+..+...++.|....+....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR---KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc---cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 12334678899999988542 467889999999999999999999999988888888888877777665543322
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
... .+. ........+....+...+..+.+||.+||.+||++|||+.|+|.|+||++...
T Consensus 232 ~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 232 SLP--DYV-EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred ccc--ccc-cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 111 111 11112223334455677889999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=367.47 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=205.4
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
++||+|+||.||+|.++.+|+.||+|++..... .......+..|..++..+ +||||+.+++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence 479999999999999999999999999975321 123445667788888754 89999999998843 34699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||+. ++|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NR 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---Cc
Confidence 9998 5999999888889999999999999999999999999999999999999999999999999987432211 12
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------------------- 210 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------------------- 210 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245689999999999976 5789999999999999999999999988765443332211
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-HHHhcCcccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-EEALADPYFKGL 319 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta-~elL~hp~f~~~ 319 (560)
.. ......++..+.+||++||+.||.+|+++ +++++||||+..
T Consensus 211 -------~~----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 211 -------DT----PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred -------CC----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 00 01112468899999999999999999997 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=355.38 Aligned_cols=258 Identities=36% Similarity=0.606 Sum_probs=212.9
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
|++++.||+|+||+||++.+..+++.||+|++..............+|+.+++.++|+||+++++++.. ...+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999998643333333445679999999999999999999855 346899
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 008607 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (560)
Q Consensus 105 V~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (560)
|||++.+ +|.+++.....+++..++.++.||+.||++||+.||+|+||||+|||++.++.++|+|||++.... ...
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~---~~~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS---ENN 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST---STT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc
Confidence 9999997 999999977789999999999999999999999999999999999999999999999999987541 111
Q ss_pred ccccccccCcccccccccc-cccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHH
Q 008607 184 IFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (560)
Q Consensus 184 ~~~~~~~gT~~Y~APEll~-~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 262 (560)
.......++..|+|||++. + ..++.++|||||||++|+|++|..||...+..+....+.+.......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------- 220 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP---------- 220 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH----------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhccccccc----------
Confidence 2335678999999999987 4 57889999999999999999999999987555555444432211110
Q ss_pred HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.... ........+.+||++||+.||++||++.++++||||
T Consensus 221 -----~~~~---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 221 -----SSSQ---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----HHTT---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----cccc---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0000 001113789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=357.31 Aligned_cols=282 Identities=38% Similarity=0.698 Sum_probs=219.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|+||+++++++... ..+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-----RKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEE
Confidence 479999999999999999999999999999999864322223345678999999999999999999988443 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+||||+++ .|..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999997 4555555566799999999999999999999999999999999999999999999999999986533221
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
......++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++............
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST- 230 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc-
Confidence 12345688999999998652 4578899999999999999999999999887777766666555433221111000
Q ss_pred HHHHHHHhhccCCC---CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 262 KARRYLSSMRKKKP---IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 262 ~~~~~l~~~~~~~~---~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
..+...+....+ .+....++.++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 231 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 231 --NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred --ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001111100000 11122345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=360.12 Aligned_cols=296 Identities=34% Similarity=0.547 Sum_probs=228.5
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc--
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-- 96 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-- 96 (560)
...-++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 344567999999999999999999999999999999986433333334456789999999999999999998865432
Q ss_pred -CCCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 97 -REFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 97 -~~~~~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.....+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 88 NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred cCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 1234679999999999998887654 68999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCC-cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 175 VAFNDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 175 ~~~~~~~~-~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
........ .......+++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+..+.|....+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 65332211 1112345678999999988552 347889999999999999999999999999888888888888876665
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQ--KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.+...........+. +.......... .....+..+.+||.+||..||.+|||++|+|+||||
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 443332111111100 00000000000 011236778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=378.22 Aligned_cols=281 Identities=23% Similarity=0.294 Sum_probs=217.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC--CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..+|++++.||+|+||.||+|... .++..||+|.+... ....+|+++|+.++||||+++++++.. .
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~-----~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRW-----K 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEee-----C
Confidence 357999999999999999999754 45688999987531 234589999999999999999998843 3
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
..+|+|||++.++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 46899999999999999987788999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCC---hhhHHHHHHHhcCCCCHHHHH
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN---VVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~---~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.. ...++..+.+.++....+...
T Consensus 239 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 239 PDT-PQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred ccc-ccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 221 11234679999999999976 578999999999999999999999998754 345566666666544333221
Q ss_pred HhhhHHHHHHHHhhcc--CCCCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 257 RVRNEKARRYLSSMRK--KKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~--~~~~~~~~~~--~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
... ......+..... ..+......+ ...+..+.+||.+||.+||.+|||+.|+|.||||..
T Consensus 316 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 316 NGS-TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred ccc-hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 111 111111111111 1111111111 245678999999999999999999999999999975
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=358.43 Aligned_cols=287 Identities=37% Similarity=0.659 Sum_probs=226.2
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
||.-++|++.+.||+|++|.||+|.++.+++.||||.+...... .....+.+|+++++.++|+||+++++++...
T Consensus 1 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 75 (291)
T cd07844 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTK---- 75 (291)
T ss_pred CCCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecC----
Confidence 56778999999999999999999999999999999998643222 2234467899999999999999999998433
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
...|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 76 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 76 -KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred -CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 468999999999999988764 468999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.... ......++..|+|||++.+. ..++.++||||+||++|+|++|+.||.+.. ..+++..+.+.++.+..+.+.
T Consensus 155 ~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 155 VPSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CCCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 2111 11234578899999988642 457889999999999999999999998766 667778888888888776554
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNAN--PLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s--~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.......... ..............++..+ ..+.+||.+||..||.+|||+.|+|+||||
T Consensus 231 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 231 GVSSNPEFKP-YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhcccccc-ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 4321100000 0000011111222333444 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=365.92 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=205.0
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
++||+|+||.||+|.+..+++.||||+++... ........+..|..++..+ +||||+++++++... ..+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-----EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence 46999999999999999999999999987432 1223445566777777654 799999999988433 4689999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||++ ++|..++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GK 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Cc
Confidence 9997 5999999888889999999999999999999999999999999999999999999999999997543222 12
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------------------- 210 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999976 5789999999999999999999999998776544333221
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-HHHhcCcccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-EEALADPYFKGL 319 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta-~elL~hp~f~~~ 319 (560)
.. ......++..+.+||.+||+.||.+||++ .+++.||||...
T Consensus 211 -------~~----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 211 -------DR----PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred -------CC----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 00 01113467889999999999999999986 588899999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=361.12 Aligned_cols=296 Identities=36% Similarity=0.615 Sum_probs=231.7
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc--
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-- 96 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-- 96 (560)
...-++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+++|+.++|+||+++++++.....
T Consensus 4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 344578999999999999999999999999999999986433333333456789999999999999999998765432
Q ss_pred -CCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 97 -REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 97 -~~~~~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.....+|+|+||++++|...+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 84 KRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 233468999999999988888653 479999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC--------cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHh
Q 008607 175 VAFNDTPT--------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246 (560)
Q Consensus 175 ~~~~~~~~--------~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~ 246 (560)
........ ....+...+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 65332211 1122445788999999987542 45788999999999999999999999999999888888888
Q ss_pred cCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 247 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.+.+.+..+.....-..... .......+......+..+++.+.+||.+||..||.+|||+.|+|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hCCCChhhchhhhhcccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 88776554332211000000 0001111122223345567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=369.26 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=208.7
Q ss_pred EEEEeecCCeEEEEEEE---CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008607 28 EEVIGKGSYGVVCSAYD---TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d---~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
++.||+|+||.||++++ ..+|+.||+|++............+.+|+++|+.++||||+++++++... ..+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-----GKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CEEEE
Confidence 36799999999999976 46889999999975433333455678899999999999999999988543 46899
Q ss_pred EEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 008607 105 VFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (560)
Q Consensus 105 V~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (560)
||||++ ++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999998 59999998888899999999999999999999999999999999999999999999999999876433211
Q ss_pred ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHH
Q 008607 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (560)
Q Consensus 184 ~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 263 (560)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 154 -~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~----------------- 213 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA----------------- 213 (318)
T ss_pred -ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 1234679999999999976 57889999999999999999999999887755444333210
Q ss_pred HHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccccc
Q 008607 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (560)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~ 319 (560)
. ......+++.+.+||++||+.||.+||+ +++++.||||..+
T Consensus 214 ---------~-----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 214 ---------K-----LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred ---------C-----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 0 0112356889999999999999999999 7889999999853
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=366.62 Aligned_cols=264 Identities=23% Similarity=0.406 Sum_probs=212.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.++||+|+||.||++++..+++.||+|++.+.. ........+.+|+.++..++|++|+.+++.+... ..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-----NN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----CE
Confidence 46999999999999999999999999999999986421 1222334577899999999999999999988443 46
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|+||||+. |+|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 899999997 699999977 457999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... .....+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (332)
T cd05623 156 GTV--QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (332)
T ss_pred Ccc--eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----------
Confidence 211 12345799999999998531 14578899999999999999999999988776555444322
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGL 319 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--Rpta~elL~hp~f~~~ 319 (560)
......+......+++.+.+||++||..++.+ |++++|+++||||.++
T Consensus 223 ---------------~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 223 ---------------HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ---------------CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 11112233334567899999999999765554 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=372.15 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=212.0
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..++|++.+.||+|+||.||+|++..+++.||+|++... .........+.+|+.+++.++||||+++++++...
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~----- 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD----- 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----
Confidence 347999999999999999999999999999999998642 12223345677899999999999999999988443
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+|||||+ |+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 46999999997 5899888654 589999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccccccccccc--CCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... ......+||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.+.+....+..|...
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---------- 262 (371)
T cd05622 195 EGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH---------- 262 (371)
T ss_pred CCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------
Confidence 211 1123568999999999986421 23788999999999999999999999987765544443321
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKG 318 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--Rpta~elL~hp~f~~ 318 (560)
.....+ .....++..+.+||.+||..++.+ |++++|+++|+||++
T Consensus 263 ----------------~~~~~~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 263 ----------------KNSLTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred ----------------CCcccC-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 111111 123467899999999999844433 789999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=342.30 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=222.9
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
..-+.|++.+.||+|-||.||+|+.+.++..||+|++.+. ........++.||++|-..|+||||+++++.|.+.
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~---- 94 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS---- 94 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc----
Confidence 4456799999999999999999999999999999998643 22333446788999999999999999999999554
Q ss_pred CccEEEEEecCC-ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~--~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..+|+++||.. |+|+..+. ....+++...+.+++|++.||.|||..+||||||||+|+|++.++.+||+|||-+..
T Consensus 95 -~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 95 -KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred -ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 45999999998 79999998 566799999999999999999999999999999999999999999999999999865
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
.. .....+.|||..|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+.+..|.++-
T Consensus 174 ~p-----~~kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-------- 238 (281)
T KOG0580|consen 174 AP-----SNKRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-------- 238 (281)
T ss_pred cC-----CCCceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc--------
Confidence 42 123467899999999999987 689999999999999999999999999888777776665421
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
-+ ....++..+.|||.+||.++|.+|.+..|++.|||+...
T Consensus 239 ----------------~~-------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 239 ----------------LK-------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ----------------cc-------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 00 114678999999999999999999999999999998643
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=373.19 Aligned_cols=256 Identities=30% Similarity=0.464 Sum_probs=220.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
...|+.++.||+|+||.||+|+|..|++.||||++... ........+..|+.+|..++++||.++++.|+... .
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~ 85 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----K 85 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----c
Confidence 45688889999999999999999999999999999753 23345677889999999999999999999997665 4
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
++++||||. |++.+.++....+.+.++..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+.......
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 899999998 5899999888878999999999999999999999999999999999999999999999999997765443
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.. ..+++||+.|||||++.. ..|+.++||||||++.+||++|.+||.......
T Consensus 166 ~r---r~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------------------- 218 (467)
T KOG0201|consen 166 KR---RKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------------------- 218 (467)
T ss_pred hc---cccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------------
Confidence 32 367899999999999986 689999999999999999999999997655421
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
++-.+.+..|..+.. .+++.+++||..||++||+.||+|.++|+|+|++.
T Consensus 219 -----vlflIpk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 219 -----VLFLIPKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -----EEEeccCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 112222333333332 67899999999999999999999999999999986
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=383.74 Aligned_cols=268 Identities=25% Similarity=0.385 Sum_probs=219.9
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC--
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR-- 97 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~-- 97 (560)
...++|++.+.||+|+||+||+|.+..+|+.||||++............+.+|+.+|..++|+||+++++.+......
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345899999999999999999999999999999999976544555667788999999999999999998877543211
Q ss_pred -CCccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccc
Q 008607 98 -EFKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (560)
Q Consensus 98 -~~~~i~lV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFG 171 (560)
....+++||||+. |+|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 1124789999998 599998865 3468999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
+++........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 189 ls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~------ 259 (496)
T PTZ00283 189 FSKMYAATVSD-DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA------ 259 (496)
T ss_pred cCeeccccccc-cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc------
Confidence 99865332211 11245689999999999976 5789999999999999999999999988765444332211
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.. .....+.+++.+.+||.+||..||.+||++.++|+|||++.+.
T Consensus 260 ---------------------~~---~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 260 ---------------------GR---YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred ---------------------CC---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 00 1112346789999999999999999999999999999987643
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=364.83 Aligned_cols=250 Identities=24% Similarity=0.447 Sum_probs=207.4
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
+.||+|+||+||+|.+..++..||||++.... ........+.+|+.+++.+ +||||+++++++... ..+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-----~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-----DRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence 46999999999999999999999999987432 2233456677899999888 699999999988443 4689999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||+. ++|...+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9998 58999998888899999999999999999999999999999999999999999999999999865322111 1
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------------- 210 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999976 5789999999999999999999999987765443332211
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCcccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYFKGL 319 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta-----~elL~hp~f~~~ 319 (560)
... .....++..+.+||++||+.||.+||++ .++++||||+..
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 211 -------DEV----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred -------CCC----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 0113468899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=381.07 Aligned_cols=282 Identities=25% Similarity=0.326 Sum_probs=211.7
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.+..|.+.+.||+|+||.||+|.+..++..||||... ...+.+|+++|+.|+|+||+++++++... .
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~ 233 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVG-----G 233 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----C
Confidence 4567999999999999999999999999999999643 22356899999999999999999987543 3
Q ss_pred cEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
..++|||++.++|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 234 ~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 234 LTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 58999999999999988764 46999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCC-CCCCC------hhhHHHHHHHhcCCCCH
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKN------VVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~------~~~~~~~i~~~~g~p~~ 252 (560)
... ......+||+.|+|||++.+ ..++.++|||||||+||||++|..+ |.... ...++..+....+....
T Consensus 314 ~~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 314 WST-PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccc-ccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 211 11234579999999999977 5789999999999999999998754 43321 12334444333332211
Q ss_pred HHHHHhhhHHHHHHHHhh----ccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 253 EAIARVRNEKARRYLSSM----RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~----~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
+............+.... ......+....+...++.+.+||.+||++||.+|||++|||+||||+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 110000000011111111 111111112233456788999999999999999999999999999973
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=365.64 Aligned_cols=259 Identities=23% Similarity=0.402 Sum_probs=204.7
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
++||+|+||.||+|.+..+++.||||+++.... .......+.+|+.+++.+ +||||+++++++... ..+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEE
Confidence 479999999999999999999999999975322 233445678899999988 699999999988543 4689999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
|||+ ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---~~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---DT 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC---Cc
Confidence 9998 4899999888889999999999999999999999999999999999999999999999999987432211 12
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~~~--------~~ 212 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQNTE--------DY 212 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------cccccch--------HH
Confidence 245689999999999976 578899999999999999999999996422111 0000000 00
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCcccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT------AEEALADPYFKGL 319 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt------a~elL~hp~f~~~ 319 (560)
....+... ... ....++..+.+||++||+.||.+|++ ++++++||||..+
T Consensus 213 ~~~~~~~~-~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 213 LFQVILEK-QIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHHHcC-CCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 00111111 111 12356889999999999999999987 7999999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=356.94 Aligned_cols=288 Identities=39% Similarity=0.675 Sum_probs=229.2
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||+|++|.||+|.+..+|+.||||++............+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-----CeE
Confidence 479999999999999999999999999999999865433333445678899999999999999999998533 468
Q ss_pred EEEEecCCccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC-CCcEEEecccccccccCC
Q 008607 103 YVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~~~~~--lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-~~~lKL~DFGla~~~~~~ 179 (560)
|+||||++++|.+.+..... +++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999999999998876543 588899999999999999999999999999999999985 567999999999754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. .......++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|....+....
T Consensus 157 ~---~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 V---RTFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred c---cccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 1 112345778999999988552 457889999999999999999999999988888888888888877665543221
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
.. ..+................+..++.+.+||.+||+.||++||+++++|+||||.++..
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 233 SL--PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred cc--hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 11 1111111111122222334677899999999999999999999999999999987653
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=353.26 Aligned_cols=281 Identities=41% Similarity=0.693 Sum_probs=230.3
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
|++.+.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.++|+||+++++++... ...|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEE
Confidence 6789999999999999999999999999999875433333445678899999999999999999998543 46899
Q ss_pred EEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 105 VFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 105 V~E~~~gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
||||++++|.+++.... .+++..++.++.||+.||+|||+.+++||||+|+||+++.++.++|+|||++........
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999999999998765 699999999999999999999999999999999999999999999999999875422111
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 262 (560)
......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+.+..++|....+......
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL- 230 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc-
Confidence 12334678899999987552 35788999999999999999999999999888888888888888877665433211
Q ss_pred HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
..+...+............+.++..+.+||.+||+.||.+|||++|++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 231 -PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred -hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 12222222222333344456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=369.26 Aligned_cols=279 Identities=25% Similarity=0.338 Sum_probs=208.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
...|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+|+.++|+||+++++++... ..
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeC-----Ce
Confidence 35699999999999999999999999999999975421 234699999999999999999988543 35
Q ss_pred EEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
.|+|||++.++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred eEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 899999999999998876 4469999999999999999999999999999999999999999999999999997532221
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCC-CCCCCCCh---------hhHHHHHHHhcCCC
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNV---------VHQLDIMTDLLGTP 250 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~---------~~~~~~i~~~~g~p 250 (560)
......||+.|+|||++.+ ..++.++|||||||++|||+++. ++|.+... ..++..+...++..
T Consensus 212 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 212 ----AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred ----ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 1234679999999999976 57899999999999999999865 44443221 12233333334433
Q ss_pred CHHHHHHhhhHHHHHHHHhhcc-CCCCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 251 SPEAIARVRNEKARRYLSSMRK-KKPIPFS--QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 251 ~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~--~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..+............++..... +.+.... ....+++..+.+||.+||++||.+|||++|+|+||||+.+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 2221111111111222221110 1111000 0112567788999999999999999999999999999853
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=356.15 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=209.7
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
.|++.++||+|+||.||++.+..+++.||||++.... ........+.+|+.+|+.++|+||+.+++.+... ..+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeE
Confidence 4899999999999999999999999999999986422 2222334577899999999999999999988433 468
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
|+||||+. ++|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||+++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998 5888887653 36999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. ....+|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~------------- 216 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR------------- 216 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-------------
Confidence 21 134578999999999976 57889999999999999999999999876643332222111
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
+. . .. ......+++.+.+||.+||..||.+|| +++++++||||...
T Consensus 217 -------~~---~-~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 217 -------VK---E-DQ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred -------hh---h-cc---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 00 0 00 112235688899999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=354.34 Aligned_cols=282 Identities=37% Similarity=0.694 Sum_probs=221.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+++|+.++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-----KKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-----CCeE
Confidence 46999999999999999999999999999999986543333345667899999999999999999998843 3468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+||||+++ .|..++.....+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999996 566666556679999999999999999999999999999999999999999999999999987653322
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
.......++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.............
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred --cccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 123456789999999998652 45778999999999999999999999988877777776666555432211111000
Q ss_pred HHHHHHHhhcc---CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 262 KARRYLSSMRK---KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 262 ~~~~~l~~~~~---~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
. .+..+.. .........+++++..+.+||.+||..||.+||++.++|+||||
T Consensus 232 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 P---LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred h---HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 0000000 01111223356788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=354.63 Aligned_cols=281 Identities=37% Similarity=0.689 Sum_probs=227.8
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||.|++|.||+|.+..+|+.||||++..... ......+.+|+.+++.++|+||+++++.+... ...|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEE
Confidence 48999999999999999999999999999999875322 22345677899999999999999999988543 4689
Q ss_pred EEEecCCccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 104 VVFELMESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~~~---~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+||||++++|.+++.... .++++.+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 999999999999887643 58999999999999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. .....+++..|++||.+.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.|....+..+..
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12345678999999988552 4578899999999999999999999999998888888888888888766654431
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
. ..+................+..++.+.++|.+||+.||.+||+++|+++||||
T Consensus 231 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 L--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred C--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1 11111111111111122334568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=362.49 Aligned_cols=255 Identities=23% Similarity=0.397 Sum_probs=210.1
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCcc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.|++.+.||+|+||.||+|.++.+|+.||||++..... .......+..|+.+++.+. |++|+.+++++... ..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-----DR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-----CE
Confidence 47889999999999999999999999999999874321 2234456778999998886 56777888877433 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 899999998 5999999888889999999999999999999999999999999999999999999999999987532221
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1234679999999999976 57899999999999999999999999887755444433220
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~ 319 (560)
. ......++..+.+||.+||+.||.+|++ .+++++||||..+
T Consensus 217 ------------~-----~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 217 ------------N-----VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ------------C-----CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 0 0112356788999999999999999997 5799999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=356.36 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=202.7
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008607 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (560)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~ 109 (560)
||+|+||+||++.+..+|+.||+|++.... ........+..|+.+|+.++|+||+.+.+++... ..+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-----TDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-----CeEEEEEeCC
Confidence 799999999999999999999999986432 1222345677899999999999999999888433 4689999999
Q ss_pred C-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcc
Q 008607 110 E-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (560)
Q Consensus 110 ~-gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~ 184 (560)
+ ++|...+.. +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 8 588877643 346999999999999999999999999999999999999999999999999999765332221
Q ss_pred cccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHH
Q 008607 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264 (560)
Q Consensus 185 ~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 264 (560)
.....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 154 -~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~------------------- 211 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------------- 211 (280)
T ss_pred -ccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------------------
Confidence 234679999999999976 5788999999999999999999999976543211111100
Q ss_pred HHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccccc
Q 008607 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (560)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~~ 320 (560)
... ..+ ......+++.+.+||.+||+.||.+|| +++++++||||+++.
T Consensus 212 ----~~~-~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 212 ----RIL-NDS---VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred ----hhc-ccC---CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 000 001 112245788999999999999999999 899999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=357.32 Aligned_cols=286 Identities=40% Similarity=0.661 Sum_probs=230.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.|++.+.||.|+||.||+|.+..+++.+|+|.++...........+.+|+.+++.++||||+.+++++.... ...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 5799999999999999999999999999999999754333333446778999999999999999999885432 2579
Q ss_pred EEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+|+||+.++|.+++.... .+++..++.++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++........
T Consensus 82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9999999999999987654 599999999999999999999999999999999999999999999999999986543211
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
......+++.|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|....+.....-
T Consensus 162 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 162 ---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred ---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 12345678999999998652 34688999999999999999999999999988888888888888877765543211
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCC--CHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNA--NPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~--s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
..... ..........+...++.. ++.+.+||++||+.||++|||+.|+|.||||
T Consensus 238 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00000 001111112223344543 8899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=365.45 Aligned_cols=250 Identities=28% Similarity=0.492 Sum_probs=204.7
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~-iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
+.||+|+||+||+|.+..+|+.||||++.... ........+.+|.. +++.++||||+++++.+... ..+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-----EKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-----CEEEEEE
Confidence 46999999999999999999999999986432 12233455666665 46789999999999988443 4689999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||+.+ +|...+.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 99984 8999998888899999999999999999999999999999999999999999999999999875322221 1
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-------------------- 210 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-------------------- 210 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245689999999999976 5788999999999999999999999988765444332221
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCcccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGL 319 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta----~elL~hp~f~~~ 319 (560)
. . ....+..+..+.+||++||+.||.+||++ .+++.||||...
T Consensus 211 -------~-~---~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 211 -------K-P---LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred -------C-C---ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0 0 11224678899999999999999999976 699999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=364.15 Aligned_cols=258 Identities=23% Similarity=0.429 Sum_probs=203.9
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
+.||+|+||.||+|++..+++.||+|++.+.. ........+.+|+.++..+ +||||+++++++... ..+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEE
Confidence 47999999999999999999999999997542 2333455678899998776 799999999988543 4689999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||++ ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9998 58999888888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------~~~~~---------~~~ 211 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQN---------TED 211 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcC----------Ccccc---------cHH
Confidence 244689999999999976 578899999999999999999999995321100 00000 000
Q ss_pred H-HHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCcccccc
Q 008607 266 Y-LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT------AEEALADPYFKGL 319 (560)
Q Consensus 266 ~-l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt------a~elL~hp~f~~~ 319 (560)
+ ...+... .. ......+..+.+||++||+.||.+|++ ++++++||||+..
T Consensus 212 ~~~~~i~~~-~~---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 212 YLFQVILEK-QI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHhcC-CC---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 0 0111111 11 122456889999999999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=362.46 Aligned_cols=251 Identities=25% Similarity=0.427 Sum_probs=205.8
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHh-cCCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRL-LRHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~-l~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
+.||+|+||.||+|++..+++.||||++..... .......+..|..++.. ++||||+++++++... ..+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence 469999999999999999999999999875321 12334556778888876 4899999999998543 4689999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||++ |+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9998 59999998887899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------------------- 210 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 234679999999999976 5789999999999999999999999988765443332211
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCccccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE-EALADPYFKGLA 320 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~-elL~hp~f~~~~ 320 (560)
..+ .....++..+.+||.+||+.||.+|+++. ++++||||+.+.
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 211 -------DNP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred -------CCC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 000 01124678899999999999999999996 899999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=351.91 Aligned_cols=280 Identities=39% Similarity=0.733 Sum_probs=222.5
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
|++.+.||+|+||.||+|.+..+++.||+|+++...... ......+|+.+++.+. |+||+++++++.... ...++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEE
Confidence 788999999999999999999999999999987543332 2234457999998886 999999999986531 24689
Q ss_pred EEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 104 VVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
+||||++++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++. +.+||+|||+++.......
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999999888764 46899999999999999999999999999999999999999 9999999999976533222
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 262 (560)
.....++..|+|||.+... ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+............
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1345689999999976432 456889999999999999999999999999988888898888888765532221110
Q ss_pred HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
...+ .+.......+....+.++..+.+||.+||.+||.+|||++++|+||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 000000111112234568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=368.51 Aligned_cols=258 Identities=26% Similarity=0.331 Sum_probs=203.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
-+.|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+++|+.++|+||+++++++.. ...
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH-----NGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-----CCe
Confidence 356889999999999999999999999999999986422 22345678899999999999999999998843 346
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+|||||.+ +|.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 8999999985 66432 346788899999999999999999999999999999999999999999999998653221
Q ss_pred CCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
. .....+||..|+|||++... ...++.++|||||||++|||++|+.||......+....+..
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~------------ 287 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------------ 287 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH------------
Confidence 1 12446899999999987431 12345689999999999999999999974332221111111
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..... .......++..+.+||.+||+.||++|||+.|+|+||||.+.
T Consensus 288 ------------~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 288 ------------ICMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ------------HhccC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 00000 111234678899999999999999999999999999999864
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=363.06 Aligned_cols=263 Identities=22% Similarity=0.378 Sum_probs=212.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||++++..+++.||+|++.+.. ........+.+|+.+++.+.|+||+.+++.+.. ...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-----~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-----ENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence 47999999999999999999999999999999986421 222334457789999999999999999998843 346
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|+||||+. |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 899999997 599999987 457999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCccccccccccccc---CCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~---~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... .....+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (331)
T cd05624 156 GTV--QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (331)
T ss_pred Cce--eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc-----------
Confidence 211 113357999999999986421 3577899999999999999999999988775544433321
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKG 318 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--Rpta~elL~hp~f~~ 318 (560)
.....++......++..+.+||.+||..++.+ |++++++++||||++
T Consensus 223 ---------------~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 223 ---------------HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred ---------------CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 11112233344567899999999999976654 579999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=362.77 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=203.3
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~-iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
++||+|+||.||+|++..+|+.||+|++.+.. ........+.+|.. +++.++||||+++++.+... ..+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-----EKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CEEEEEE
Confidence 47999999999999999999999999986432 12223345556654 67889999999999888433 4689999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
|||++ +|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 99985 8998888888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 245679999999999976 5789999999999999999999999988765443332211
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCcccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGL 319 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta----~elL~hp~f~~~ 319 (560)
.+. ...+..+..+.+||.+||+.||.+|+++ .++++|+||..+
T Consensus 211 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 211 --------KPL---QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred --------CCC---CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 011 1224567889999999999999999875 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=345.86 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=211.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC---hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH---VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~---~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
+.|++.+.||+|++|.||.|.+..++..||+|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD----- 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----
Confidence 4699999999999999999999999999999998643221 12345688999999999999999999998443
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+|+||+.+ +|.+++...+.+++..++.+++||+.||.|||+.||+||||||+||+++.++.++|+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 379999999984 8999998888899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
............++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT------------- 221 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-------------
Confidence 2221111134568899999999977 4688999999999999999999999976554332221111
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
... .......++..+.+||++||..||.+|||+.++|+||||
T Consensus 222 -------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 222 -------------QPT---NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------cCC---CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 000 011223578889999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=362.78 Aligned_cols=249 Identities=27% Similarity=0.461 Sum_probs=203.9
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~-iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
+.||+|+||+||+|++..+++.||+|++..... .......+.+|.. +++.++|+||+++++++... ..+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEE
Confidence 469999999999999999999999999864221 1222334555544 56889999999999988443 4689999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||+.+ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 99985 8999998888899999999999999999999999999999999999999999999999999975322211 1
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-------------------- 210 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245689999999999976 5789999999999999999999999988776554433321
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH----HHhcCccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE----EALADPYFKG 318 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~----elL~hp~f~~ 318 (560)
.+ ....+.+++.+.+||++||+.||.+|+++. ++++|+||..
T Consensus 211 --------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 211 --------KP---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred --------CC---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 01 112356789999999999999999999865 8999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=364.39 Aligned_cols=253 Identities=32% Similarity=0.434 Sum_probs=207.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcE-EEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEK-VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~-vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.....+.+.||+|+||+||++. ..|.. ||||++............+.+|+.+|..++|||||.+++++..+..
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---- 113 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---- 113 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEE--eCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----
Confidence 4455667779999999999995 45666 9999998644444446789999999999999999999999965431
Q ss_pred cEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCCCCeeeCCCC-cEEEeccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADC-KLKICDFGLARV 175 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~g-IiHrDLKP~NILl~~~~-~lKL~DFGla~~ 175 (560)
.++||||||+ |+|.+++.. ...++...+..|+.||++||.|||+.+ ||||||||+|||++.++ ++||||||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 5899999998 699999987 568999999999999999999999999 99999999999999998 999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
..... ...+...||+.|||||++.+....|+.++||||||+++|||+||+.||.+.........+.....+|
T Consensus 194 ~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp----- 265 (362)
T KOG0192|consen 194 KVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP----- 265 (362)
T ss_pred ecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-----
Confidence 64321 1224478999999999998412579999999999999999999999999888643333222111111
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.+ ...+++.+..||++||..||.+||+..+++.
T Consensus 266 -------------------~~-----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 -------------------PI-----PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -------------------CC-----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11 1227888999999999999999999999874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.28 Aligned_cols=283 Identities=22% Similarity=0.367 Sum_probs=215.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++|+.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CE
Confidence 468999999999999999999999999999999887532 233456788999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 899999997 59999999888899999999999999999999975 7999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHH-hcCCCCHHHHH--
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD-LLGTPSPEAIA-- 256 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~-~~g~p~~~~~~-- 256 (560)
. ....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.. ..+.+......
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1 134579999999999976 5788999999999999999999999987654332221110 11111100000
Q ss_pred ---------Hhhh-----HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 257 ---------RVRN-----EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 257 ---------~~~~-----~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.... ..............+..+. ....+.++.+||.+||++||.+|||++|+|.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP--SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCC--CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 0000111111111111111 12357889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=365.27 Aligned_cols=249 Identities=25% Similarity=0.414 Sum_probs=201.9
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhc---CCCCccccceeecCCCcCCCccEEEEE
Q 008607 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l---~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
||+|+||+||+|++..+|+.||||++.+.. ..........+|..++..+ .||||+.+++++... ..+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEE
Confidence 799999999999999999999999986421 1222344556777777665 699999999988443 4689999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||+. ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9998 58999998888899999999999999999999999999999999999999999999999999875322221 1
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------- 212 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG------------------- 212 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 2456899999999998652 45789999999999999999999999887654433332210
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC----CHHHHhcCccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP----TAEEALADPYFKG 318 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp----ta~elL~hp~f~~ 318 (560)
.. .+. ...+++.+.+||++||..||.+|| +++++++||||..
T Consensus 213 -------~~--~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 213 -------KV--RFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred -------CC--CCC--CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 00 010 124688899999999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.61 Aligned_cols=286 Identities=38% Similarity=0.688 Sum_probs=223.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+++++.++|+||+++++++.. ...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 47999999999999999999999999999999987544444455778899999999999999999999854 2468
Q ss_pred EEEEecCCccHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMESDLHQV-IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~gdL~~~-i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+||||+++++... +.....+++..++.++.||+.||.|||++||+||||+|+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99999999765554 44455799999999999999999999999999999999999999999999999999977544332
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
.....++++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++...+.........
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 122456789999999998762 37889999999999999999999999998888877777777776554332221110
Q ss_pred HHHHHHHhhccCCCCCCCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFP-NANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~-~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
....-...........+...++ .++..+.+||++||..||++|||++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000000000000000111222 348889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=353.77 Aligned_cols=288 Identities=38% Similarity=0.650 Sum_probs=219.7
Q ss_pred ceEEEEEEeecCCeEEEEEEECC--CCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTR--TGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~--tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
+|++.+.||+|+||.||+|.+.. ++..||||.+.... ........+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 58999999999999999999988 89999999987532 1122345678899999999999999999998653 224
Q ss_pred cEEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC----CCcEEEeccc
Q 008607 101 DIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----DCKLKICDFG 171 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~~~-----~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~----~~~lKL~DFG 171 (560)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 68999999999888877532 26899999999999999999999999999999999999999 8999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChh---------hHHHH
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV---------HQLDI 242 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~---------~~~~~ 242 (560)
++................+++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.. ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998653322211122345789999999987552 45788999999999999999999999876543 34556
Q ss_pred HHHhcCCCCHHHHHHhhhHH-HHHHHHhhccCCCCC------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008607 243 MTDLLGTPSPEAIARVRNEK-ARRYLSSMRKKKPIP------FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (560)
Q Consensus 243 i~~~~g~p~~~~~~~~~~~~-~~~~l~~~~~~~~~~------~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~ 315 (560)
+...++.+....+....... .....+... ....+ +...+...+..+.+||.+||+.||++|||+.|+++|||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFK-TKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhcc-CCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 66667766554443222110 011100110 00000 00111256788999999999999999999999999999
Q ss_pred c
Q 008607 316 F 316 (560)
Q Consensus 316 f 316 (560)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=347.98 Aligned_cols=286 Identities=37% Similarity=0.628 Sum_probs=220.0
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
|+..+.|++++.||+|+||.||+|.+..+|..||||.+..... ......+.+|+.+|+.++|+||+++++++...
T Consensus 1 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 75 (291)
T cd07870 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTK---- 75 (291)
T ss_pred CCccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC----
Confidence 3566889999999999999999999999999999999864321 22234567899999999999999999988432
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
...|+||||+.++|.+.+... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++...
T Consensus 76 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 76 -ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred -CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 468999999999888877653 468899999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.... ......++..|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+ ..+++..+...+|.|......
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 155 IPSQ---TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CCCC---CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 2111 12345678999999998642 457889999999999999999999998654 345566666677777665443
Q ss_pred HhhhHHHHHHHHhh-ccCCCCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 257 RVRNEKARRYLSSM-RKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 257 ~~~~~~~~~~l~~~-~~~~~~~~~~~~~--~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.+... ..+.... ....+......+. ..++.+.+||.+||..||.+|||++|+|.||||
T Consensus 231 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 231 GVSKL--PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhhc--ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 33211 0000000 0001111111111 136789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=348.02 Aligned_cols=282 Identities=48% Similarity=0.794 Sum_probs=234.2
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
|++.+.||.|++|.||+|.+..+|+.+++|++............+.+|+.+|+.++|+||+++++++... ..+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 6788999999999999999999999999999875444434556788999999999999999999988543 46899
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 008607 105 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (560)
Q Consensus 105 V~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (560)
|+||++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 9999999999888764 579999999999999999999999999999999999999999999999999997654332
Q ss_pred ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHH
Q 008607 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (560)
Q Consensus 184 ~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 263 (560)
.......++.+|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+..+++..+...++.+..+.+...... .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-A 230 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh-h
Confidence 122345688999999998762 36889999999999999999999999999999999888888888877665544331 1
Q ss_pred HHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
....-.+............+.++..+.+||.+||..||.+||++.++|.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11111222233333344556788999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=358.13 Aligned_cols=295 Identities=39% Similarity=0.611 Sum_probs=233.5
Q ss_pred cCCCCceEE-EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChh------------HHHHHHHHHHHHHhcCCCCcc
Q 008607 19 YGEGSRYKI-EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS------------DATRILREIKLLRLLRHPDIV 85 (560)
Q Consensus 19 ~~~~~~Y~i-~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~------------~~~~i~rEi~iL~~l~HpnIv 85 (560)
+.+.++|.. .+.||.|+||+||+|.+..+++.||||++........ ....+.+|+++|+.++|+||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 456788875 5779999999999999999999999999864322110 012467899999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcE
Q 008607 86 EIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (560)
Q Consensus 86 ~l~~i~~~~~~~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~l 165 (560)
++++++... ..+|+||||+.++|.+++.....++++.+..++.||+.||+|||+.||+|+||||+|||++.++.+
T Consensus 84 ~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 84 GLVDVYVEG-----DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeEEEecC-----CcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 999998543 468999999999999999888889999999999999999999999999999999999999999999
Q ss_pred EEecccccccccCCC-----------CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCC
Q 008607 166 KICDFGLARVAFNDT-----------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (560)
Q Consensus 166 KL~DFGla~~~~~~~-----------~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~ 234 (560)
||+|||+++...... ..........++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999997654111 011122334678899999998652 35788999999999999999999999999
Q ss_pred ChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008607 235 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (560)
Q Consensus 235 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp 314 (560)
+..+++..+...++.|....+....... .+ .......+..+...++..+..+.+||.+||+.||++|||++|+|.||
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLP--LY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcc--cc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 9999998888888888765433221100 00 00111112223334456788999999999999999999999999999
Q ss_pred cccccccc
Q 008607 315 YFKGLAKV 322 (560)
Q Consensus 315 ~f~~~~~~ 322 (560)
||+.....
T Consensus 315 ~~~~~~~~ 322 (335)
T PTZ00024 315 YFKSDPLP 322 (335)
T ss_pred ccCCCCCC
Confidence 99876443
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=346.65 Aligned_cols=281 Identities=43% Similarity=0.737 Sum_probs=233.4
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
|++.+.||+|.||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++... ..+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 6788999999999999999999999999999976443344456778899999999999999999988543 46899
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 008607 105 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (560)
Q Consensus 105 V~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (560)
|+||++++|.+++... ..+++..++.++.||+.||+|||++||+||||+|+||+++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5799999999999999999999999999999999999999999999999999976533221
Q ss_pred ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHH
Q 008607 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (560)
Q Consensus 184 ~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 263 (560)
......++..|+|||.+.+. ..++.++|||||||++++|++|++||.+.+....+..+...++.+....+..+....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12345668889999998652 378899999999999999999999999999999999999999988877665443321
Q ss_pred HHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.+-..+...........++..+..+.+||++||..||++||++++++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 -DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred -cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111112222223334556678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=357.98 Aligned_cols=257 Identities=22% Similarity=0.393 Sum_probs=204.3
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..+ +|+||+.+++++... ..+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-----SRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-----CEEEEEE
Confidence 479999999999999999999999999975322 223455678999999888 599999999988443 4689999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||+. ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DT 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC---Cc
Confidence 9998 5999999888889999999999999999999999999999999999999999999999999987532211 11
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~---------~~-----------~~ 210 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN---------TE-----------DY 210 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc---------cH-----------HH
Confidence 245689999999999976 578999999999999999999999996432111000 00 00
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCcccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT------AEEALADPYFKGL 319 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt------a~elL~hp~f~~~ 319 (560)
....+. ..+.. ....++..+.+||++||..||.+|++ +++++.||||+.+
T Consensus 211 ~~~~~~-~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 211 LFQVIL-EKPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHHH-hCCCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 000111 11111 12356888999999999999999998 5799999999865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=338.19 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=210.0
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.|++.+.||+|++|.||++.+..+++.||+|++............+.+|+++++.++|+|++++++.+... ...+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE----DGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC----CCEEE
Confidence 49999999999999999999999999999999975444444556788999999999999999998876322 23589
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 104 lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+||||++ ++|.+++... ..+++..++.++.||+.||.+||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999998 5899988763 358999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. ......+++.|+|||++.+ ..++.++|||||||++++|++|+.||.+.+.......+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------------- 216 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------------
Confidence 1 2244578999999999876 5788899999999999999999999987664333222111
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
. . ........++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 217 --------~---~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 --------G---K----LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred --------c---C----CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0 011123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=389.64 Aligned_cols=264 Identities=27% Similarity=0.409 Sum_probs=213.5
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
-..-++|++++.||+|+||+||+|.+..++..||+|++............+.+|+.+|+.|+|||||+++++|....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~--- 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA--- 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---
Confidence 33446899999999999999999999999999999998755445556678899999999999999999999886432
Q ss_pred CccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CeeeccCCCCCeeeCC-----
Q 008607 99 FKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-------NVFHRDLKPKNILANA----- 161 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~-------gIiHrDLKP~NILl~~----- 161 (560)
...+||||||+. ++|.++|.. .+.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 246899999998 599998865 35799999999999999999999985 4999999999999964
Q ss_pred ------------CCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCC
Q 008607 162 ------------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229 (560)
Q Consensus 162 ------------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~ 229 (560)
.+.+||+|||++....... .....+||+.|+|||++.+....++.++||||||||||+|++|+.
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 3458999999997653222 123467999999999986433468899999999999999999999
Q ss_pred CCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 008607 230 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309 (560)
Q Consensus 230 pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~e 309 (560)
||...+...++..+. ...... .....+..+.+||.+||.+||.+||++.|
T Consensus 242 PF~~~~~~~qli~~l--------------------------k~~p~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 242 PFHKANNFSQLISEL--------------------------KRGPDL----PIKGKSKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred CCCcCCcHHHHHHHH--------------------------hcCCCC----CcCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence 997655433321111 111111 12346788999999999999999999999
Q ss_pred HhcCcccccc
Q 008607 310 ALADPYFKGL 319 (560)
Q Consensus 310 lL~hp~f~~~ 319 (560)
+|.|+||+.+
T Consensus 292 lL~h~~ik~i 301 (1021)
T PTZ00266 292 CLGYQIIKNV 301 (1021)
T ss_pred HhccHHHhhc
Confidence 9999999744
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=348.96 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=207.2
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
.|++.++||+|+||.||++.+..+++.||+|++..... .......+.+|+.+|+.++|++|+.+++.+... ..+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEE
Confidence 37889999999999999999999999999999864322 222335577899999999999999999888433 468
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999998 58988886533 5999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. ....+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~--------------- 214 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------------- 214 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---------------
Confidence 21 133579999999999976 578999999999999999999999997643211111110
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~ 319 (560)
..+.... . .....+++.+.+||++||+.||.+||| ++|+++||||+++
T Consensus 215 -----~~~~~~~----~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 215 -----RLVKEVQ----E---EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -----hhhhhhh----h---hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 0111000 0 112356788999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=350.30 Aligned_cols=289 Identities=38% Similarity=0.654 Sum_probs=228.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-----c
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-----R 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~-----~ 96 (560)
.++|++.+.||+|+||.||+|.++.+|+.||||+++...........+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 46799999999999999999999999999999998754333334456778999999999999999999886543 1
Q ss_pred CCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 97 REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 97 ~~~~~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
.+...+|+|+||++++|...+... ..++++.++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 123378999999999988888764 3699999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
....... ......++..|+|||.+.+. ..++.++|||||||++++|++|++||...+....+..+.+..+.+....+
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 166 YNSEESR--PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccCCccc--ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 5433221 11234567889999988542 35788999999999999999999999999988888888888887776544
Q ss_pred HHhhhHHHHHHHHhhcc--CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 256 ARVRNEKARRYLSSMRK--KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~--~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
..+.... +...... .........+..++..+.+||.+||..||.+|||++++|.||||
T Consensus 243 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLP---YFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccc---cccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 3221110 0000000 00011122344568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=373.39 Aligned_cols=257 Identities=24% Similarity=0.325 Sum_probs=211.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCC-CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRT-GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~t-g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
..|.+.+.||+|++|.||+|.+..+ +..||+|++.. ........+.+|+.+|+.++||||+++++.+... ..
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CE
Confidence 3499999999999999999998887 78899998743 2334455678899999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 102 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
+||||||++ |+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999998 589887753 346899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 220 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~---------- 286 (478)
T PTZ00267 220 SDSVS-LDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG---------- 286 (478)
T ss_pred CCccc-cccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Confidence 33221 112345679999999999976 57899999999999999999999999877654443332210
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.. ......+++.+.+||.+||..||++||+++++|.|+|++.+
T Consensus 287 -----------------~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 287 -----------------KY---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred -----------------CC---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 00 01123567889999999999999999999999999998753
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.15 Aligned_cols=282 Identities=40% Similarity=0.653 Sum_probs=224.9
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc---CCCCccccceeecCCCcCCCcc
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l---~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.+ .|+||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999999999999999975433333345567888888766 4999999999987654333445
Q ss_pred EEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
++++|||+.++|.+++.... .+++..++.++.||+.||+|||+.+|+|+||+|+|||++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 89999999999999887643 5899999999999999999999999999999999999999999999999999775333
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 133467889999999976 568889999999999999999999999999888888887776655443221111
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
... ...........+....+..++.+.+||.+||+.||.+||+++|+|.||||
T Consensus 235 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLP----RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccc----hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000 00111122222334445667889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.90 Aligned_cols=283 Identities=24% Similarity=0.379 Sum_probs=214.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++... ..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEE
Confidence 36999999999999999999999999999999987432 233456688999999999999999999998543 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
|+||||+++ +|.+++...+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999984 999999888889999999999999999999997 599999999999999999999999999987543221
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH-----
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI----- 255 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~----- 255 (560)
....+++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+............
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 134678999999999876 56889999999999999999999999876643322222111000000000
Q ss_pred ----HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 256 ----ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 256 ----~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
..............+....+.. .....++..+.+||.+||..||++|||++|+++||||.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPPK--LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCcc--CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 0000000011111111111110 11123678899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=345.79 Aligned_cols=283 Identities=40% Similarity=0.696 Sum_probs=227.9
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
|++.+.||.|+||.||+|.+..+|+.+|+|++............+.+|+.+++.++|+|++++++++.... ...+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 78999999999999999999999999999999864433444567889999999999999999999985431 256899
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 008607 105 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (560)
Q Consensus 105 V~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (560)
|+||++++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+|||++.++.+||+|||++........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9999999999998765 5799999999999999999999999999999999999999999999999999986543321
Q ss_pred ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHH
Q 008607 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (560)
Q Consensus 184 ~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 263 (560)
...+...++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+....+..+.+..+.+....+.....-
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-- 232 (287)
T ss_pred ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc--
Confidence 112345678899999987542 45789999999999999999999999999988888888888887766554332211
Q ss_pred HHHHHhhccCC--CCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 264 RRYLSSMRKKK--PIPFSQKFPN-ANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 264 ~~~l~~~~~~~--~~~~~~~~~~-~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.+........ +..+...+.. .++.+.++|++||..||.+||+++++++||||
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 -PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred -hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0001110000 0011122333 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=332.18 Aligned_cols=290 Identities=30% Similarity=0.586 Sum_probs=234.6
Q ss_pred ccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCC
Q 008607 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPP 94 (560)
Q Consensus 16 ~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~ 94 (560)
..+||..+.|++++++|+|.|+.||.|++..+.++++||+++. -....|.||++||+.|+ ||||+.++++..++
T Consensus 31 ~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 31 VIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred eeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 3468999999999999999999999999999999999999863 45677899999999998 99999999998765
Q ss_pred CcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC-CcEEEecccc
Q 008607 95 SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGL 172 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-~~lKL~DFGl 172 (560)
.. ....+||||+.. |...+.. .|+.-.++.+++|||.||.|||+.||+|||+||.|++||.. ..++|+||||
T Consensus 106 ~S---ktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 106 ES---KTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred cc---cCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecch
Confidence 43 346899999996 6655553 48888999999999999999999999999999999999975 4699999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCC-CCCCChhhHHHHHHHhcCCCC
Q 008607 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~~~~i~~~~g~p~ 251 (560)
|..+..+..- .-.+.++.|--||+|... ..|+.+-|+|||||+|+.|+..+.| |.|.+..+|+-+|.+++|+-.
T Consensus 180 AEFYHp~~eY----nVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 180 AEFYHPGKEY----NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred HhhcCCCcee----eeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 9987655432 446889999999999874 6799999999999999999998855 678999999999999999864
Q ss_pred HHHH-HHhhhHHHHHHHHhhccCCCCCCCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 252 PEAI-ARVRNEKARRYLSSMRKKKPIPFSQKF-----PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 252 ~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~-----~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
.... .+..-+-...|-+-+......+|.... .-++++++|||.++|..|-.+|+||.|++.||||..+..
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 4322 222211112222222222233333222 235799999999999999999999999999999986543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=346.40 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=199.6
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEecCcccC-hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008607 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (560)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~ 109 (560)
||+|+||.||++.++.+|+.||+|++...... ......+..|+++|+.++||||+++++++.. ...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-----KTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-----CCeEEEEEecC
Confidence 79999999999999999999999998642221 2223445679999999999999999998843 34689999999
Q ss_pred C-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccc
Q 008607 110 E-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (560)
Q Consensus 110 ~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (560)
. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TI 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----ee
Confidence 8 58988886543 58899999999999999999999999999999999999999999999999987653322 12
Q ss_pred cccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Q 008607 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (560)
Q Consensus 187 ~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 266 (560)
....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+. ...
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~-------------------~~~ 210 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK-------------------RRT 210 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH-------------------HHh
Confidence 34578999999999976 468999999999999999999999997643211100000 000
Q ss_pred HHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCcccccc
Q 008607 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGL 319 (560)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta----~elL~hp~f~~~ 319 (560)
+ ... .......+++.+.+||.+||+.||.+||++ ++++.||||+.+
T Consensus 211 ~---~~~----~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 211 L---EDE----VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred h---ccc----cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 0 000 011123578899999999999999999999 778899999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.31 Aligned_cols=259 Identities=25% Similarity=0.408 Sum_probs=210.1
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
.|++.+.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+|+.++|+||+.+.+.+... ..+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-----DAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-----CEE
Confidence 4888999999999999999999999999999986432 2222334577899999999999999998888443 468
Q ss_pred EEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
|+||||+.+ +|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999985 888877543 36999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+....
T Consensus 156 ~----~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~------------ 217 (285)
T cd05632 156 E----SIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV------------ 217 (285)
T ss_pred C----cccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh------------
Confidence 1 1234579999999999976 578899999999999999999999998766543333222110
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~~ 320 (560)
. .. . ......+++.+.+||.+||+.||++||+ +.+++.|+||+...
T Consensus 218 --------~---~~-~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 218 --------L---ET-E---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred --------h---cc-c---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 0 00 0 0112456788999999999999999999 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=359.75 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=214.5
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh-hHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-SDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.--..|.-++.||.|+||-||.|+|..+.+.||||++....... ..-..|+.|+.+|+.|+|||++.+.++|+-..
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--- 99 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--- 99 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc---
Confidence 33457888899999999999999999999999999997543332 33467999999999999999999999997543
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..|||||||-|+-.+++.-. .++.+.++..|+.+.|.||+|||+.+.||||||..|||+++.|.|||+|||.|....
T Consensus 100 --TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 100 --TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred --hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 46999999988555555432 369999999999999999999999999999999999999999999999999997753
Q ss_pred CCCCCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
. ..+++|||+|||||++... .+.|+-++||||||++..||...++|+...|....+.-|..
T Consensus 178 P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ----------- 239 (948)
T KOG0577|consen 178 P-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----------- 239 (948)
T ss_pred c-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-----------
Confidence 2 2458999999999998532 25699999999999999999999999887776665554432
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
+.+..+. -+.++..+++||..||++-|.+|||.+++|.|+|...
T Consensus 240 ----------------NesPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 240 ----------------NESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred ----------------cCCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 1111111 3567889999999999999999999999999999863
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.60 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=207.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc---ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~---~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA---E 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC---C
Confidence 468999999999999999999999999999999864322 2233456889999999999999999999875422 2
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+++|+||+.+ +|.+++...+.+++..++.++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 468999999984 8999998887899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........+..+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~---~~~-------- 225 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA---TQP-------- 225 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh---cCC--------
Confidence 2211111233568889999999876 568899999999999999999999997654332221111 000
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
. ........++.+.+|| +||..||++||+++|+++||||+
T Consensus 226 -------------~-----~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 226 -------------T-----NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -------------C-----CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0 0011124577888899 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=355.67 Aligned_cols=287 Identities=23% Similarity=0.307 Sum_probs=207.6
Q ss_pred EEEEEeec--CCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008607 27 IEEVIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 27 i~~~IG~G--~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
++++||+| +||+||++.++.+|+.||||++............+.+|+.+++.++||||+++++++... ..+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 57889999 678999999999999999999975443444456678899999999999999999998544 36899
Q ss_pred EEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 105 VFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 105 V~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
||||++ ++|.+++..+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||..........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999998 5899998653 4599999999999999999999999999999999999999999999999987644321111
Q ss_pred C----cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCH-HHHH
Q 008607 182 T----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP-EAIA 256 (560)
Q Consensus 182 ~----~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~-~~~~ 256 (560)
. .......+++..|+|||++.+....|+.++|||||||++|+|++|+.||........+... ..+.... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH--hcCCcccccccc
Confidence 0 0011224577889999998653246889999999999999999999999875543322221 1111100 0000
Q ss_pred HhhhHHHHHHH------Hhhcc----------CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 257 RVRNEKARRYL------SSMRK----------KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 257 ~~~~~~~~~~l------~~~~~----------~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
....+...... ..+.. ............+++.+.+||++||+.||++|||++|+|+||||+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00000000000 00000 000001112234578899999999999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=354.83 Aligned_cols=254 Identities=26% Similarity=0.467 Sum_probs=199.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEE-----CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~ 95 (560)
.++|++.++||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|+.+ +||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 36899999999999999999975 345678999998743 2233456788999999999 8999999999875322
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~------------------------------------------------------ 120 (560)
..+|+||||++ |+|.+++...
T Consensus 85 ----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 85 ----GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ----CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 35899999998 5999988753
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccC
Q 008607 121 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192 (560)
Q Consensus 121 --------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT 192 (560)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........ .......++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~ 239 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLP 239 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCC
Confidence 23778899999999999999999999999999999999999999999999999865332211 111234466
Q ss_pred cccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhc
Q 008607 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMR 271 (560)
Q Consensus 193 ~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~ 271 (560)
..|+|||++.+ ..++.++|||||||++|||++ |..||.+......+.... .
T Consensus 240 ~~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~--------------------------~ 291 (338)
T cd05102 240 LKWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL--------------------------K 291 (338)
T ss_pred ccccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH--------------------------h
Confidence 78999999876 578999999999999999997 999998765332221110 0
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 272 KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 272 ~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... ......+++.+.+||.+||+.||.+|||+.|+++
T Consensus 292 ~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 292 DGTR---MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred cCCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000 0112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=334.32 Aligned_cols=253 Identities=27% Similarity=0.439 Sum_probs=211.1
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++.+... ...|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence 38899999999999999999999999999999875444455667888999999999999999999988543 4689
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 104 lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999997 5999999774 468999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. ......++.+|+|||++.+ ..++.++|||||||++++|++|+.||...+.......+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--------------- 215 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1234578899999999976 5688999999999999999999999987764333222211
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.. .......++..+.++|++||+.+|++||++.++++|||+
T Consensus 216 ------------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 ------------GV---FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------------CC---CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00 011112567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=343.13 Aligned_cols=254 Identities=25% Similarity=0.461 Sum_probs=213.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||++.+..+++.||+|++.... ........+.+|+++|+.+.||||+++++++... ..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----Ce
Confidence 46999999999999999999999999999999986421 2233456788999999999999999999988443 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+|+||+|.|||++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 899999995 699999998889999999999999999999999999999999999999999999999999999765433
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
....++++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 212 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------------- 212 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 134578999999999866 4678899999999999999999999987664332222211
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~~ 320 (560)
.. .. .....+..+.+||++||..||.+|+ +++|+++||||+.+.
T Consensus 213 -----------~~--~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 213 -----------GK--VR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -----------CC--cc---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 00 01 1134578899999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=361.03 Aligned_cols=268 Identities=28% Similarity=0.433 Sum_probs=209.3
Q ss_pred ccccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeec
Q 008607 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILL 92 (560)
Q Consensus 14 ~~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~ 92 (560)
++++. .+..|+++++||+|+.+.||++.... ...||+|++.....+......+.+|+.+|.+|+ |.+||+|+++-+
T Consensus 354 ~~i~V--kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 354 EIIKV--KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred eeEEE--CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 44444 46789999999999999999997543 356777777655566777888999999999997 999999999876
Q ss_pred CCCcCCCccEEEEEecCCccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccc
Q 008607 93 PPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~gdL~~~i~~~~~-lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFG 171 (560)
.. ..+|||||+-+.||..++++... ++.-.++++.+|+|.|++++|..||||.||||.|+|+- .|.+||+|||
T Consensus 431 ~d-----~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFG 504 (677)
T KOG0596|consen 431 TD-----GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFG 504 (677)
T ss_pred cC-----ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeec
Confidence 53 46999999999999999988654 34358999999999999999999999999999999885 6799999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccC---------CCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHH
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS---------KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~---------~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (560)
.|.....++. .+.....+||+.||+||.+..... +.+.++||||||||||+|+.|++||..- ..++.+
T Consensus 505 IA~aI~~DTT-sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aK 581 (677)
T KOG0596|consen 505 IANAIQPDTT-SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAK 581 (677)
T ss_pred hhcccCcccc-ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHH
Confidence 9988766554 345567899999999998753211 2567899999999999999999999421 111111
Q ss_pred HHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 243 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
+..+ -.| ...++|....++ .+++++++.||..||++|||+.|+|+|||+..
T Consensus 582 l~aI-~~P----------------------~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 582 LHAI-TDP----------------------NHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHhh-cCC----------------------CccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 1111 011 122233222221 23999999999999999999999999999974
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=343.45 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=222.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.|.++++||+|.||.|-+++.+.+|+.||||++++.. .........+.|-++|+..+||.+..+...|.+.+ .
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d-----r 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD-----R 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc-----e
Confidence 56888999999999999999999999999999998643 34455677788999999999999999988886654 5
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+||||.. |+|+-.+.+...|+++..+++...|+.||.|||+++|+.||||.+|+|+|.+|++||+||||++-..
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--- 319 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--- 319 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc---
Confidence 999999998 5899999888889999999999999999999999999999999999999999999999999997532
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.......++||||.|.|||++.. ..|+.++|.|.+||++|||++|+.||...+....+.+|..-
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------------- 383 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------------- 383 (516)
T ss_pred cccceeccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--------------
Confidence 22233467999999999999987 68999999999999999999999999998877776665420
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~~ 320 (560)
.+ .....++++++.||..+|.+||.+|. .+.||.+|+||.++.
T Consensus 384 --------d~---------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 384 --------DL---------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred --------hc---------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 00 11236799999999999999999996 488999999998753
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=342.01 Aligned_cols=260 Identities=26% Similarity=0.413 Sum_probs=209.0
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++.+...
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~----- 78 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR----- 78 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----
Confidence 3446899999999999999999999999999999998643 223445678899999999999999999988443
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 46899999998 49999998888999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccccccccc-ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... ......|+..|+|||++.. ....++.++|||||||++|+|++|..||........+..+..
T Consensus 159 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~------------ 223 (267)
T cd06645 159 TIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK------------ 223 (267)
T ss_pred ccc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc------------
Confidence 211 1234578999999998742 124578899999999999999999999865443222211110
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~ 315 (560)
....+ +.......++..+.+||.+||..||++|||++++|+|||
T Consensus 224 -------------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 -------------SNFQP-PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -------------cCCCC-CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00001 111112246778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=349.98 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=217.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+-|.++++||+|+||.||+|+|+.+|..+|||++.. .++.+.|..||.|++++..|++|++++.|+-. .++
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDL 103 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDL 103 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccC-----Cce
Confidence 347889999999999999999999999999999863 47889999999999999999999999988544 469
Q ss_pred EEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 103 YVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
|||||||+ |++.++++.+ ..|+++++..+++..|.||+|||...-||||||..|||+|.+|..||+|||.|..+....
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999999 7999999764 579999999999999999999999999999999999999999999999999997654333
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. ...+.+||+.|||||++.. -.|++++||||||++..||..|++||.+-... ..|..+
T Consensus 184 A---KRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMI-------------- 241 (502)
T KOG0574|consen 184 A---KRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMI-------------- 241 (502)
T ss_pred H---hhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEec--------------
Confidence 2 2367899999999999987 58999999999999999999999999653322 222211
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
...|.+.......++.++.|||++||.+.|++|-||-++++|||+++
T Consensus 242 -----------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 242 -----------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred -----------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 12233333444567889999999999999999999999999999985
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.32 Aligned_cols=275 Identities=25% Similarity=0.400 Sum_probs=219.6
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEEEEEe
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVVFE 107 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~i~lV~E 107 (560)
+.||+|+|+.|-.+....||..||||+|.+.- .-...++.||++++.+.+ |+||++++++| ++...+|||||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYLVfE 156 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYLVFE 156 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEEEEe
Confidence 68999999999999999999999999998753 234678999999999997 99999999998 44456999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC---cEEEecccccccccCCCC--
Q 008607 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFNDTP-- 181 (560)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~---~lKL~DFGla~~~~~~~~-- 181 (560)
-|. |.|...|.++..|+|.++..++..|+.||+|||.+||.||||||+|||..... -||||||.|+....-..+
T Consensus 157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 998 58999999999999999999999999999999999999999999999987654 489999999865322111
Q ss_pred --CcccccccccCcccccccccc---cccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 182 --TAIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 182 --~~~~~~~~~gT~~Y~APEll~---~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
....+.+.||+-.|||||+.. +....|+.+.|+||||||+|.||+|.+||.|....+. |.-..+...
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrGe~Cr 308 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRGEVCR 308 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCCCccH
Confidence 112235678999999999753 3346799999999999999999999999998653221 111111111
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
.. -..++.++.....-.....|..+|.+++|||.++|..|+..|.++.++|+|||++.....
T Consensus 309 ~C----Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 309 VC----QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HH----HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 11 123444554444444455677889999999999999999999999999999999976543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=344.65 Aligned_cols=262 Identities=26% Similarity=0.441 Sum_probs=213.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC-hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+++|+.++|+||+++++.+.. ...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-----ETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-----CCE
Confidence 4799999999999999999999999999999998753222 2345678899999999999999999998743 346
Q ss_pred EEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 8999999985 999998764 4699999999999999999999999999999999999999999999999999875432
Q ss_pred CCCC--------------------------cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCC
Q 008607 179 DTPT--------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (560)
Q Consensus 179 ~~~~--------------------------~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~ 232 (560)
.... .......+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 2110 001123578999999999976 568899999999999999999999998
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HH
Q 008607 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT----AE 308 (560)
Q Consensus 233 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt----a~ 308 (560)
+.+....+..+.. .. ..+. ....++..+.+||++||..||++||| ++
T Consensus 234 ~~~~~~~~~~~~~--------------------------~~--~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 234 GSNRDETFSNILK--------------------------KE--VTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCchHHHHHHHhc--------------------------CC--ccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 8775444332211 00 0111 11236889999999999999999999 99
Q ss_pred HHhcCccccccc
Q 008607 309 EALADPYFKGLA 320 (560)
Q Consensus 309 elL~hp~f~~~~ 320 (560)
|+|.||||++..
T Consensus 285 ~ll~~~~~~~~~ 296 (316)
T cd05574 285 EIKQHPFFRGVN 296 (316)
T ss_pred HHHcCchhhcCC
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=341.28 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=211.5
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
...+.|++++.||.|+||.||+|.+..++..|++|.+... .......+.+|+.+++.++|+||+++++.+...
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 81 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD----- 81 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----
Confidence 4457899999999999999999999999999999998642 334566788999999999999999999988543
Q ss_pred ccEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 100 KDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|+||||+++ +|..++.+ ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 368999999985 77777654 4568999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
.... ......++..|+|||++.+. ...++.++|||||||++|+|++|.+||...+....+..+..
T Consensus 162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--------- 229 (292)
T cd06644 162 KTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--------- 229 (292)
T ss_pred cccc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---------
Confidence 2211 12345688999999998421 14578899999999999999999999976554332221111
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.. .+.......++..+.+||.+||..||++||+++++|+||||..+.
T Consensus 230 ------------------~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 230 ------------------SE-PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ------------------CC-CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 011112345678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=339.44 Aligned_cols=280 Identities=42% Similarity=0.728 Sum_probs=226.1
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
|++.+.||+|++|.||+|.+..+++.|+||++...... .......+|+..++.++ |+||+++++++.. ....|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEE
Confidence 78899999999999999999999999999998754332 23334567999999999 9999999998854 34689
Q ss_pred EEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 104 VVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
+||||+.++|.+.+.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 999999989999998765 789999999999999999999999999999999999999999999999999976533221
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
.....++..|+|||.+.+. ..++.++|+|||||++++|++|++||.+.+..+.+..+...++.|....+......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 2446789999999988542 45788999999999999999999999999999999999999998876544322110
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
. ...-..+....+......++..+..+.+||++||+.||.+|||++|++.||||
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 A-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred h-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 00000011111122223344557889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=342.19 Aligned_cols=261 Identities=27% Similarity=0.461 Sum_probs=213.2
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
+.-+...+|++.+.||+|+||.||+|++..++..||+|.+.... ......+.+|+.+++.+.|+||+++++.+...
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-- 89 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVG-- 89 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC--
Confidence 33445579999999999999999999999999999999987432 23456788999999999999999999988543
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 97 ~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
...|+||||+.+ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 90 ---~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 90 ---DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred ---CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchh
Confidence 368999999984 89998865 4689999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 166 ~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~---------- 230 (296)
T cd06654 166 ITPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---------- 230 (296)
T ss_pred cccccc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc----------
Confidence 432221 1234578899999999876 5678999999999999999999999987654332221110
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
. ..+.......+++.+.+||.+||..||.+|||+.++++||||..
T Consensus 231 ----------------~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 231 ----------------N--GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred ----------------C--CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 0 00111122456788999999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=340.82 Aligned_cols=261 Identities=24% Similarity=0.427 Sum_probs=210.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+|+.++|+||+++++.+... ..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-----GAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-----CeE
Confidence 36899999999999999999999999999999986432 333456788999999999999999999987543 468
Q ss_pred EEEEecCCc-cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 103 YVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~---~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
|+||||+++ +|..++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999985 888888763 369999999999999999999997 599999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccccccccccc----CCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~----~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
... .....++..|+|||++.+.. ..++.++|||||||++|+|++|+.||...........+...
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~------- 222 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI------- 222 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH-------
Confidence 221 13356888999999985421 23578999999999999999999999765433322222111
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
.... .....+.++..+.+||.+||..||.+||++++++.||||.....
T Consensus 223 -----------------~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 223 -----------------VDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred -----------------hhcC---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 1111 11223457899999999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=333.90 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=211.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||.|+||+||+|.+..++..+++|++....... ....+.+|+.+|+.++|+||+++++.+.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEE
Confidence 46999999999999999999999999999999986433222 56778999999999999999999998743 3468
Q ss_pred EEEEecCCc-cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 103 YVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~---~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
|+|||++.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++++++.+||+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999985 899998764 4589999999999999999999999999999999999999999999999999977644
Q ss_pred CCCCc-ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~-~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
..... ......+++..|+|||.+... ..++.++|+|||||++++|++|+.||...+....+..+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~-------- 222 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---N-------- 222 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---C--------
Confidence 32221 112345789999999998662 3678899999999999999999999976654332222111 0
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
..........+..+++.+.+||.+||..||.+|||++++++||||
T Consensus 223 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 223 --------------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 000111111234678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.41 Aligned_cols=260 Identities=26% Similarity=0.453 Sum_probs=208.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc---ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~---~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..|++.++||+|+||.||++.+..+|..||||++..... .......+.+|+.+++.++|+||+++++.+.... .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 579999999999999999999999999999999863221 1233567889999999999999999999874322 2
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 35889999998 48999998877899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
............++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~-------- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQP-------- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCC--------
Confidence 2111111234568899999999876 568899999999999999999999997654332221111 100
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
. ........+..+.++|.+||. +|++||+++|+++|||+.
T Consensus 226 ----------------~--~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 226 ----------------T--NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----------------C--CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0 011123557789999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=337.74 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=207.5
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..+.|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++.+... .
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~ 79 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----E 79 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----C
Confidence 346799999999999999999999999999999998642 223445678999999999999999999988543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+||||++ ++|.+++...+.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 6899999998 489999988888999999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccCccccccccccc-ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. ......++..|+|||.+.. ....++.++|||||||++|+|++|+.||...+.......+..
T Consensus 160 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~------------- 223 (267)
T cd06646 160 IA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK------------- 223 (267)
T ss_pred cc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec-------------
Confidence 11 1134578899999998742 124577899999999999999999999965443221111100
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~ 315 (560)
....+ +.......++..+.+||++||..||.+|||++++|+|+|
T Consensus 224 ------------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 ------------SNFQP-PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ------------CCCCC-CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00000 111112346789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.15 Aligned_cols=262 Identities=25% Similarity=0.421 Sum_probs=209.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+... ......+.+|+.+++.+ +|||++++++++.........
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 57799999999999999999999999999999998642 12345677899999998 799999999998755433345
Q ss_pred cEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 101 DIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
.+|+||||+++ +|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 68999999985 88888753 45689999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCccccccccccccc---CCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~---~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
....... .....++..|+|||.+.... ..++.++|||||||++|+|++|++||...+....+..+..
T Consensus 178 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------- 247 (291)
T cd06639 178 LTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR------- 247 (291)
T ss_pred ccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc-------
Confidence 5322211 13356889999999975421 1367899999999999999999999977654333222111
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
... +.......++..+.+||.+||+.||.+||++.|+|+||||+
T Consensus 248 --------------------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 --------------------NPP-PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------------------CCC-CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000 00111234567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=335.36 Aligned_cols=256 Identities=27% Similarity=0.491 Sum_probs=208.3
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh-------hHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-------SDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-------~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
+|.+.+.||.|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 5888999999999999999999999999999886432221 1225678999999999999999999987443
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 97 ~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
...++||||+++ +|.+++...+.+++..++.++.||+.||.|||++||+||||+|+|||++.++.+||+|||+++.
T Consensus 79 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 79 ---DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred ---CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 468999999985 8999998888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCc---ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 176 AFNDTPTA---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 176 ~~~~~~~~---~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
........ .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-------
Confidence 64221111 11123468889999999876 5678899999999999999999999987554332221111
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
. .........+..+.+||++||+.||.+||++.|+++||||
T Consensus 227 --------------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 --------------------N---ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred --------------------c---CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0 0111223567889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=338.25 Aligned_cols=260 Identities=23% Similarity=0.416 Sum_probs=207.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC-C
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE-F 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~-~ 99 (560)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +|+||+++++.+....... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 467999999999999999999999999999999986432 2345678899999998 6999999999986543221 2
Q ss_pred ccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 100 KDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.+|+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999998 4899988763 36899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
..... ......|+..|+|||++.+. ...++.++|||||||++|+|++|+.||...........+.
T Consensus 162 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~--------- 229 (272)
T cd06637 162 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------- 229 (272)
T ss_pred ccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---------
Confidence 32211 12446789999999998531 1357889999999999999999999996544322111110
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.... .......++..+.+||.+||..||.+|||+.+++.||||
T Consensus 230 ------------------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 230 ------------------RNPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ------------------cCCC--CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0000 001123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=354.56 Aligned_cols=261 Identities=28% Similarity=0.466 Sum_probs=224.4
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.-.-|.+.+.||+|.|++|.+|++..|+..||||.|++...+......+.+|+++|+.|.|||||+++.++.+. .
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-----~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-----A 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----c
Confidence 34569999999999999999999999999999999998877777778899999999999999999999998554 3
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+||||+. |++++++.+++++.+..++.+|.|++.|++|||+.+|+|||||.+|||++.+..+||+|||++......
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 6999999997 699999999999999999999999999999999999999999999999999999999999999876533
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. ...++||++.|.|||++.+. ..-++.+|+||+|++||.|+.|.+||.|.+....-..
T Consensus 209 ~----~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r----------------- 266 (596)
T KOG0586|consen 209 L----MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR----------------- 266 (596)
T ss_pred c----cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccch-----------------
Confidence 3 34678999999999999884 3446899999999999999999999998774332111
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
.++.+..+++ -++.++.+||++||..+|.+|++.+++..|.|.......
T Consensus 267 ---------vl~gk~rIp~-----~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 267 ---------VLRGKYRIPF-----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ---------heeeeecccc-----eeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 1112222222 246778999999999999999999999999998765443
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=331.06 Aligned_cols=253 Identities=28% Similarity=0.501 Sum_probs=213.2
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++++.||.|+||.||.+.+..+++.+++|++............+.+|+.+|+.++|+||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEE
Confidence 69999999999999999999999999999999875544455567788999999999999999999998543 4689
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 104 lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999998 5999999775 468999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.. +
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~------------ 216 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--G------------ 216 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--C------------
Confidence 1 2244678999999999876 4678899999999999999999999987665444333321 0
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
. +......++..+.+||.+||..||.+||+++++|+|+|+
T Consensus 217 -------------~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 217 -------------N---YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -------------C---CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0 111124568889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.44 Aligned_cols=262 Identities=29% Similarity=0.502 Sum_probs=214.6
Q ss_pred ccC-CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 18 EYG-EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 18 ~~~-~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
+++ ...+|++.+.||.|+||.||+|++..+|+.|+||.+... .......+.+|+.+++.++|+||+.+++.+...
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 88 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLVG-- 88 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEecC--
Confidence 344 356899999999999999999999999999999998642 223456788999999999999999999988543
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 97 ~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..+|+|+||+.+ +|..++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 89 ---~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 89 ---DELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred ---ceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 468999999985 888877654 699999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 165 ~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~--------- 230 (296)
T cd06655 165 ITPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--------- 230 (296)
T ss_pred cccccc---cCCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------
Confidence 433221 1134578899999999876 56888999999999999999999999887654433222110
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
..+.......+++.+.+||++||..||.+|||+.+++.||||+...
T Consensus 231 -------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 231 -------------------GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred -------------------CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 0011122345788999999999999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=335.00 Aligned_cols=261 Identities=25% Similarity=0.449 Sum_probs=209.8
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC----hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH----VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~----~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
.|+..+.||+|+||.||++.+..+++.||+|++...... ......+.+|+++|+.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED----- 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----
Confidence 488899999999999999999999999999998643211 12346788999999999999999999998433
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC-cEEEeccccccccc
Q 008607 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAF 177 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~-~lKL~DFGla~~~~ 177 (560)
..+++||||+.+ +|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 468999999985 8999998888899999999999999999999999999999999999998876 59999999987654
Q ss_pred CCCCCc-ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~-~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 224 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--------- 224 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---------
Confidence 332111 11123468889999999876 578899999999999999999999997655433332222110
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
... .........++.+.+||.+||..||.+|||+.++|+||||+
T Consensus 225 --------------~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 225 --------------SAT---TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred --------------ccC---CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000 01112235678899999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.69 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=207.9
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc----ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE----HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~----~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
+|++.+.||.|+||.||+|.+ .+|+.+|+|.+..... .......+.+|+.+|+.++|+||+++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD----- 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----
Confidence 588999999999999999986 5789999999864221 122335688999999999999999999988433
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+|+||+.+ +|.+++.+.+.++++.++.++.||+.||+|||+.+|+|+||+|+||+++.++.+||+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 468999999985 9999998888899999999999999999999999999999999999999999999999999875421
Q ss_pred CC---CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 179 DT---PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 179 ~~---~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
.. ..........++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR-------- 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc--------
Confidence 11 11112234578999999999976 568899999999999999999999997655433222111100
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.........++..+.+||++||..||.+||++.|+|+||||
T Consensus 225 --------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 225 --------------------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred --------------------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=371.13 Aligned_cols=286 Identities=24% Similarity=0.295 Sum_probs=205.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCC-cEEEEEEe--------------cC-cccChhHHHHHHHHHHHHHhcCCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKI--------------ND-IFEHVSDATRILREIKLLRLLRHPDIV 85 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg-~~vAiK~i--------------~~-~~~~~~~~~~i~rEi~iL~~l~HpnIv 85 (560)
.++|++++.||+|+||.||+|..+... ...++|.+ .+ ..........+.+|+.+|+.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 368999999999999999998765432 22222211 11 111222345678999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCCccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 86 EIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 86 ~l~~i~~~~~~~~~~~i~lV~E~~~gdL~~~i~~~~-----~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
++++++... ...|+|++++.++|..++.... ......++.|+.||+.||+|||++||+||||||+|||++
T Consensus 227 ~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999998543 3589999999999988875432 244677889999999999999999999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCC-CCC--CChh
Q 008607 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPG--KNVV 237 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~--~~~~ 237 (560)
.++.+||+|||+++....... ......+||..|+|||++.+ ..|+.++|||||||++|||++|..+ |.+ .+..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999976533221 11234689999999999977 5789999999999999999999854 432 2344
Q ss_pred hHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhcc-CCCCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008607 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRK-KKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (560)
Q Consensus 238 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~--~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp 314 (560)
.++..+...++.+..+... . ..+...++....- ..+..+...+ ...+..+.+||.+||++||.+|||+.|+|+||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~-~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPD-P-PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHhcccChhhcCC-c-HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 5555555555543322111 0 1112223322110 0000111111 13567789999999999999999999999999
Q ss_pred cccc
Q 008607 315 YFKG 318 (560)
Q Consensus 315 ~f~~ 318 (560)
||..
T Consensus 456 ~f~~ 459 (501)
T PHA03210 456 LFSA 459 (501)
T ss_pred hhhc
Confidence 9975
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=331.81 Aligned_cols=257 Identities=29% Similarity=0.462 Sum_probs=208.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||.|+||.||+|.+..+++.+++|++... .......+.+|+.+++.++||||+++++.+... ..+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~ 75 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DKL 75 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CEE
Confidence 5799999999999999999999999999999998743 223567788999999999999999999987433 468
Q ss_pred EEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 103 YVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
|++|||+++ +|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++.......
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999995 888888776 689999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. .....+++..|+|||.+.+. ...++.++|||||||++|+|++|++||.+.+.......+...
T Consensus 156 ~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~------------- 219 (262)
T cd06613 156 A---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS------------- 219 (262)
T ss_pred h---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Confidence 1 12345788899999998651 126788999999999999999999999876644433222110
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~ 315 (560)
...+ .........+..+.+||++||..||.+|||+.+++.|+|
T Consensus 220 ------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 220 ------------NFPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ------------cCCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0000 000111234677999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=330.81 Aligned_cols=255 Identities=33% Similarity=0.530 Sum_probs=211.8
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||.|+||.||+|.+..++..||+|.+...........++.+|+.+++.++|+||+++++.+.... ...+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS---NQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC---CCEEE
Confidence 489999999999999999999999999999998754444556677889999999999999999999875432 24689
Q ss_pred EEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 104 VVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIH-----TANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 104 lV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLH-----s~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
++|||++ ++|.+++.. ...+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999998 589988875 357999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
........ ......++..|+|||.+.+ ..++.++|+|||||++++|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 224 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-------- 224 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc--------
Confidence 87543321 1244678999999999876 5688899999999999999999999987663332222111
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.. ........+..+.+||.+||..||.+|||++++|+|||+
T Consensus 225 -------------------~~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 225 -------------------GK---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -------------------CC---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 10 111223567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=331.30 Aligned_cols=253 Identities=26% Similarity=0.465 Sum_probs=209.8
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||+|+||.||++.+..+|+.||+|.+............+.+|+.+++.++|+||+++++.+.. ....|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-----NGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-----CCeEE
Confidence 5999999999999999999999999999999987533334455678899999999999999999998843 34689
Q ss_pred EEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 104 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+||||+. ++|.+.+.... .+++..+..|+.||+.||.|||++||+|+||+|+|||++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999998 48999887643 58999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.. .....|+..|+|||++.+ ..++.++|+|||||++++|++|+.||...+..+.+..+.. +
T Consensus 156 ~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~------------ 216 (256)
T cd08218 156 EL---ARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--G------------ 216 (256)
T ss_pred hh---hhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--C------------
Confidence 11 123468889999999876 5678899999999999999999999976655443332211 0
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
. ........+..+.+||.+||+.||.+||++.++|+||||
T Consensus 217 ------------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 217 ------------S----YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ------------C----CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0 011123567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.43 Aligned_cols=267 Identities=24% Similarity=0.413 Sum_probs=210.4
Q ss_pred ccccC-CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 008607 16 FTEYG-EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (560)
Q Consensus 16 ~~~~~-~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~ 93 (560)
|..+. ..++|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44444 458999999999999999999999999999999987642 12235677899999999 69999999998865
Q ss_pred CCcCCCccEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEe
Q 008607 94 PSRREFKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~ 168 (560)
........+|+||||+++ +|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 443445679999999984 88887753 3468999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHH
Q 008607 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245 (560)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~ 245 (560)
|||+++....... ......|++.|+|||++... ...++.++|||||||++|+|++|+.||...+....+..+.
T Consensus 167 dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~- 242 (286)
T cd06638 167 DFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP- 242 (286)
T ss_pred cCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc-
Confidence 9999876532211 12345789999999998531 1357889999999999999999999997655333221110
Q ss_pred hcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 246 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 246 ~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
...... ......++..+.+||.+||+.||++|||+.|+|+|+||
T Consensus 243 --------------------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 243 --------------------------RNPPPT-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------------------------ccCCCc-ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000000 00112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=329.38 Aligned_cols=252 Identities=29% Similarity=0.477 Sum_probs=209.1
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||+|+||.||+|.+..++..+|||.+............+.+|+.+|+.++|+||+++++.+.. ...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence 5999999999999999999999999999999997544444556788899999999999999999998743 24689
Q ss_pred EEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC-CcEEEecccccccccCC
Q 008607 104 VVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFND 179 (560)
Q Consensus 104 lV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-~~lKL~DFGla~~~~~~ 179 (560)
+||||+++ +|.+++... ..+++..++.++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999985 899999764 358999999999999999999999999999999999999865 46899999999865433
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 156 ~~~----~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-------------- 215 (256)
T cd08220 156 SKA----YTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------------- 215 (256)
T ss_pred ccc----cccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------------
Confidence 221 33568899999999976 5678899999999999999999999987665433322211
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.. .......+++.+.+||.+||..||.+|||+.|+|+||||
T Consensus 216 -------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 216 -------------GT---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -------------cC---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00 011123468889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=362.56 Aligned_cols=264 Identities=28% Similarity=0.492 Sum_probs=222.2
Q ss_pred ccccCCCCce-EEEEEEeecCCeEEEEEEECCCCcEEEEEEec--CcccChhHHHHHHHHHHHHHhcCCCCccccceeec
Q 008607 16 FTEYGEGSRY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (560)
Q Consensus 16 ~~~~~~~~~Y-~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~--~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~ 92 (560)
|-+-....|| ++.++||+|+|-+||+|.|..+|..||+-.++ +........+++..|+.+|+.|+|+||+++++.|.
T Consensus 32 ~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 32 FVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV 111 (632)
T ss_pred ccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence 4444445666 78899999999999999999999999986554 45566677799999999999999999999999997
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeCCC-CcEEEe
Q 008607 93 PPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANAD-CKLKIC 168 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~~~-~~lKL~ 168 (560)
+... ..+-+|+|+|. |+|..++++.++++...++.|++|||+||.|||++. |||||||.+||+|+.+ |.|||+
T Consensus 112 d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 112 DTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred cCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence 7543 56899999998 799999999999999999999999999999999986 9999999999999986 899999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcC
Q 008607 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g 248 (560)
|+|||....... ....+|||.|||||+... .|+..+||||||+++.||+|+..||.......|+.+-.. .
T Consensus 189 DLGLAtl~r~s~-----aksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~--S 258 (632)
T KOG0584|consen 189 DLGLATLLRKSH-----AKSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT--S 258 (632)
T ss_pred chhHHHHhhccc-----cceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH--c
Confidence 999998864332 244799999999999974 799999999999999999999999987776665543221 1
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..+|..+.. --+|++++||++||.. ..+|+|+.|+|.||||..-
T Consensus 259 -----------------------GiKP~sl~k---V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 259 -----------------------GIKPAALSK---VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred -----------------------CCCHHHhhc---cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 111211211 1268899999999999 9999999999999999864
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=335.82 Aligned_cols=258 Identities=25% Similarity=0.444 Sum_probs=203.0
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHH-HHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKL-LRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~i-L~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.|++.+.||+|+||.||+|.+..+|+.||||++...... .....+..|+.+ ++.+.|+||+++++.+... ..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----Cc
Confidence 4699999999999999999999999999999998754332 233456667665 6777899999999988533 46
Q ss_pred EEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 102 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
+|+||||++++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 899999999998887754 23689999999999999999999997 9999999999999999999999999998764
Q ss_pred cCCCCCcccccccccCcccccccccccc--cCCCCCccchhhHHHHHHHHhhCCCCCCCCC-hhhHHHHHHHhcCCCCHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~--~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~~~~i~~~~g~p~~~ 253 (560)
..... .+...++..|+|||.+.+. ...++.++|+|||||++|+|++|+.||.... ....+..+.
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 221 (283)
T cd06617 155 VDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------- 221 (283)
T ss_pred ccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH---------
Confidence 32211 1234688899999988541 1346889999999999999999999996422 111111110
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.... ..+ ....++..+.+||.+||..||.+||+++++++||||...
T Consensus 222 --------------~~~~----~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 222 --------------EEPS----PQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred --------------hcCC----CCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0000 000 012467889999999999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.05 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=211.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.|++++.||+|+||.||++.+..+++.|++|.+..... .......+.+|+++++.++||||+++++.+.. ...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-----KRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-----CCE
Confidence 369999999999999999999999999999999874321 22334577899999999999999999998843 346
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+||||++| +|.+++...+.+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 8999999985 999999888889999999999999999999999999999999999999999999999999987421111
Q ss_pred CC------------cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcC
Q 008607 181 PT------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 181 ~~------------~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g 248 (560)
.. ........++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~-- 231 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-- 231 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--
Confidence 00 001122467889999999876 57889999999999999999999999876644333222110
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccccc
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGL 319 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt---a~elL~hp~f~~~ 319 (560)
...+......++..+.+||++||+.||++||+ +.++|+||||...
T Consensus 232 --------------------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 232 --------------------------DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred --------------------------ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 00111112356888999999999999999998 7999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=338.76 Aligned_cols=259 Identities=26% Similarity=0.416 Sum_probs=210.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++++.||.|+||.||++.+..++..||+|.+.. ........+.+|+++++.++|+||+++++.+... ..+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NKL 77 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----CeE
Confidence 569999999999999999999999999999999863 2344556788999999999999999999998543 468
Q ss_pred EEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 103 YVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
|+||||+++ +|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 78 WILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred EEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999985 898888764 469999999999999999999999999999999999999999999999999987543222
Q ss_pred CCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
. ......++..|+|||++... ...++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus 158 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 222 (280)
T cd06611 158 Q---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK------------ 222 (280)
T ss_pred c---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc------------
Confidence 1 12345789999999997421 13467899999999999999999999987654333222211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.. .+.......++..+.+||.+||..||.+||+++++|+||||...
T Consensus 223 ---------------~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 223 ---------------SE-PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ---------------CC-CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 00 00111123567889999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=333.64 Aligned_cols=254 Identities=27% Similarity=0.467 Sum_probs=210.3
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++.+. +...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-----DEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-----CCCeE
Confidence 59999999999999999999999999999999975322 2245678889999999999999999998874 33469
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+|+||+.+ +|.+.+.....+++..++.|+.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 999999985 899999887789999999999999999999999999999999999999999999999999987654332
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.... ..+.
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~----------------- 211 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIR----------------- 211 (258)
T ss_pred ---cccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHH-----------------
Confidence 1234568889999999976 4688999999999999999999999987664211 0000
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH--HHHhcCccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA--EEALADPYF 316 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta--~elL~hp~f 316 (560)
..... ........++..+.+||++||..||.+||++ .|+++||||
T Consensus 212 ------~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 212 ------AKQET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ------HHhcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 00110 0111223567899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=329.43 Aligned_cols=261 Identities=30% Similarity=0.467 Sum_probs=211.6
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
||++.+.||+|+||.||++.+..++..|++|.+............+.+|+.+++.++|+||+++++.+... ..++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEE
Confidence 69999999999999999999999999999999875444444677899999999999999999999987433 4689
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 104 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
+|+||+. ++|.+++.....++++.++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 589999988777999999999999999999999999999999999999999999999999999875443322
Q ss_pred ccc-ccccccCccccccccccccc-CCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 183 AIF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 183 ~~~-~~~~~gT~~Y~APEll~~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~--------------- 220 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--------------- 220 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh---------------
Confidence 211 22456888999999987631 2378899999999999999999999976532211111000
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
. ...+.......+++.+.+||++||+.||.+|||+++++.|||+
T Consensus 221 ---------~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 221 ---------A---GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ---------c---CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0001111223458889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.00 Aligned_cols=261 Identities=28% Similarity=0.466 Sum_probs=209.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc-CCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR-REF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~-~~~ 99 (560)
.++|++.+.||.|++|.||+|.+..+++.+++|++... ......+.+|+.+++.+ .|+||+++++.+..... ...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 47899999999999999999999999999999998642 22346788999999999 69999999999865442 234
Q ss_pred ccEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 100 KDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
..+|+||||+++ +|.+++.. +..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 568999999995 88888764 3579999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
....... ......++..|+|||++... ...++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 162 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 232 (275)
T cd06608 162 QLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR------ 232 (275)
T ss_pred ecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc------
Confidence 6432221 12346789999999987431 13477899999999999999999999976543332222111
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
... +.......++..+.+||++||..||++|||++++++|||+
T Consensus 233 ---------------------~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 ---------------------NPP-PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------------------cCC-CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000 0011112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=336.97 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=211.2
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++|+||+++++.+... ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeE
Confidence 47999999999999999999999999999999986432 233456688999999999999999999988543 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+|+||+.+ +|.+++..+ .+++..++.++.||+.||.|||+.+|+||||+|+||+++.++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999985 899998766 799999999999999999999999999999999999999999999999999987643321
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------------- 212 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK---------------- 212 (274)
T ss_pred ---ccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----------------
Confidence 1234578889999999977 4689999999999999999999999976553322221111
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..+.... ...++..+.+||.+||..||++|||++++++||||...
T Consensus 213 -----------~~~~~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 213 -----------NNPPSLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred -----------cCCCCCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0010011 11267889999999999999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.54 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=207.5
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
|++.+.||.|+||.||++.+..++..+++|.+... .......+.+|+++++.++|+||+++++.+... ...|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEE
Confidence 78899999999999999999999999999998642 334566788999999999999999999988543 46899
Q ss_pred EEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 105 VFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 105 V~E~~~g-dL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
|+||+++ +|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 9999985 77777654 45799999999999999999999999999999999999999999999999999875432211
Q ss_pred cccccccccCccccccccccc---ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 183 AIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~---~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
......++..|+|||++.. ....++.++|||||||++|+|++|++||...+....+..+...
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------------- 223 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------------- 223 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-------------
Confidence 1234578999999999742 1145778999999999999999999999876644333222110
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
... .......++..+.+||.+||+.||.+||+++++++||||..
T Consensus 224 --------------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 224 --------------EPP-TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred --------------CCC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 000 01112346788999999999999999999999999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.76 Aligned_cols=260 Identities=29% Similarity=0.484 Sum_probs=212.4
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
+...+|++++.||.|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++|+||+++++.+...
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----- 88 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVG----- 88 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 3448899999999999999999999999999999998642 223456688999999999999999999988543
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+||||+++ +|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 468999999985 89888865 4689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.. .+.+
T Consensus 168 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~-------- 233 (297)
T cd06656 168 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-------- 233 (297)
T ss_pred Ccc---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC--------
Confidence 221 1234578899999999876 5788999999999999999999999977654332211110 0111
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.......++..+.+||.+||..||.+||+++++|+||||....
T Consensus 234 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 234 -------------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred -------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 1112235678899999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=381.41 Aligned_cols=265 Identities=24% Similarity=0.391 Sum_probs=225.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
...|+|+++||+|+||.|.+++++.|++.||+|++++.. .+..+...|..|-.+|..-..+=|+.++-.|. +..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ-----D~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ-----DER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc-----Ccc
Confidence 467999999999999999999999999999999998622 23445567888999999888899999999884 445
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
++|+|||||. |||..++.+.++++++.+++|+..|+.||.-||+.|+|||||||+|||||..|+|||+|||.+-....+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 7999999998 599999998889999999999999999999999999999999999999999999999999988765433
Q ss_pred CCCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
. .......+|||.|.+||+|... .+.|++.+|.||+||++||||.|..||...+.++.+.+|+..
T Consensus 229 G--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h---------- 296 (1317)
T KOG0612|consen 229 G--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH---------- 296 (1317)
T ss_pred C--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----------
Confidence 2 2344678999999999998432 256999999999999999999999999988888777776542
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGLAK 321 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt---a~elL~hp~f~~~~~ 321 (560)
+....|+. -..+|..+++||+++|. +|..|.. ++++-.||||.++..
T Consensus 297 ----------------k~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 297 ----------------KESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ----------------hhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 22233332 23589999999999987 6889988 999999999998754
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.86 Aligned_cols=258 Identities=25% Similarity=0.432 Sum_probs=204.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.++||+|+||.||+|++..++..||+|.+.... .......+.+|+++|+.+.||||+++++.+... ...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEE
Confidence 36899999999999999999999999999999986432 233446788999999999999999999988543 458
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
++||||+++ +|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999999996 55433 357899999999999999999999999999999999999999999999999997643221
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
....++|..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... +..
T Consensus 150 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---------~~~--------- 205 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS---------LMP--------- 205 (279)
T ss_pred ----ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc---------cch---------
Confidence 234679999999999976 57889999999999999999999999653211100 000
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
...........+.. ......++.+.+||.+||+.||.+||+++|++.||||...
T Consensus 206 --~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 206 --LQLLQCIVDEDPPV--LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred --HHHHHHHhccCCCC--CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00001101111110 1123467889999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=334.90 Aligned_cols=261 Identities=24% Similarity=0.427 Sum_probs=207.8
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc-CC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR-RE 98 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~-~~ 98 (560)
..+.|++.+.||.|+||.||+|.+..+++.+|+|.+... ......+..|+.+++.+ +|+||+++++.+..... ..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 456899999999999999999999999999999998642 23445678899999988 69999999998864321 23
Q ss_pred CccEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 99 FKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
...+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 4578999999985 899988753 3588999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
...... .....+|+..|+|||.+... ...++.++|||||||++|+|++|..||........+..+.
T Consensus 171 ~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~-------- 239 (282)
T cd06636 171 LDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP-------- 239 (282)
T ss_pred hhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh--------
Confidence 422111 12346789999999987521 1457889999999999999999999997654322211110
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
... ........++..+.+||++||..||.+|||+.|+|.||||
T Consensus 240 -------------------~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 -------------------RNP--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -------------------hCC--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000 0111123568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=329.03 Aligned_cols=252 Identities=30% Similarity=0.521 Sum_probs=208.2
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||.|+||.||+|.+..++..|++|.+... .....+.+|+.+++.++|+||+++++.+... ..+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcE
Confidence 5799999999999999999999999999999998642 2266788999999999999999999988543 468
Q ss_pred EEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 103 YVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
|+++||+++ +|.+++.. ...+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++.......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999995 89999875 4468999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---------------- 212 (256)
T cd06612 154 A---KRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---------------- 212 (256)
T ss_pred c---ccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc----------------
Confidence 1 1233457889999999876 578899999999999999999999997654332211110
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.. ..........++..+.+||.+||+.||++|||+.|+|+||||
T Consensus 213 -----------~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 213 -----------NK-PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -----------cC-CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00 001111223467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=353.29 Aligned_cols=266 Identities=31% Similarity=0.500 Sum_probs=213.1
Q ss_pred cccccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeec
Q 008607 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (560)
Q Consensus 13 ~~~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~ 92 (560)
++|=-+|.+.++= =+||+|.||+||.|+|..|..++|||.|... .....+-+..||.+-+.|+|.|||++++.+
T Consensus 568 iefeYeyde~~er---vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~- 641 (1226)
T KOG4279|consen 568 IEFEYEYDESNER---VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSV- 641 (1226)
T ss_pred eEEEeeecCCCce---EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhcc-
Confidence 4453344444432 3599999999999999999999999999742 344567788999999999999999999987
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC-CCcEEE
Q 008607 93 PPSRREFKDIYVVFELME-SDLHQVIKA-NDDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKI 167 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~-gdL~~~i~~-~~~l--se~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-~~~lKL 167 (560)
.+.+.+-|.||-++ |+|..+++. .+++ +|..+-++..||++||+|||++.|+|||||.+|||||. .|.+||
T Consensus 642 ----senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKI 717 (1226)
T KOG4279|consen 642 ----SENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKI 717 (1226)
T ss_pred ----CCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEe
Confidence 33346889999998 589998875 5777 89999999999999999999999999999999999985 689999
Q ss_pred ecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc
Q 008607 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~ 247 (560)
+|||-++......+-. .++.||..|||||++.....+|+.++|||||||++.||.||++||........
T Consensus 718 SDFGTsKRLAginP~T---ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-------- 786 (1226)
T KOG4279|consen 718 SDFGTSKRLAGINPCT---ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-------- 786 (1226)
T ss_pred cccccchhhccCCccc---cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------
Confidence 9999998765444332 45789999999999965457899999999999999999999999964332211
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.-|--.|-+..| .....++.+++.||.+|+.+||.+||+|.++|++||++.-
T Consensus 787 ----------------AMFkVGmyKvHP----~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 787 ----------------AMFKVGMYKVHP----PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ----------------hhhhhcceecCC----CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 111111111111 1223567889999999999999999999999999999864
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=330.43 Aligned_cols=262 Identities=27% Similarity=0.480 Sum_probs=208.0
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC--------hhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH--------VSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~--------~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++|+||+++++.+...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 589999999999999999999999999999988532111 11134577899999999999999999987433
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
..+++||||+. ++|.+++...+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.+||+|||+++
T Consensus 81 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 ----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ----CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 46899999997 5999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
...... .........++..|+|||.+......++.++|+|||||++|+|++|..||...+....+..+..
T Consensus 157 ~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 226 (272)
T cd06629 157 KSDDIY-DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN--------- 226 (272)
T ss_pred cccccc-cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---------
Confidence 643221 1111234568899999999865323478899999999999999999999965443322111100
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
. ...........+.++..+.+||.+||..||.+|||++++|+||||
T Consensus 227 ---------------~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 227 ---------------K-RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ---------------c-ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0 001111112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.04 Aligned_cols=258 Identities=28% Similarity=0.526 Sum_probs=209.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.|.....||.|+||.||++.+..++..||||++... .......+.+|+.+++.++|+||+++++.+... ...
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~ 94 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----DEL 94 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeE
Confidence 5566678899999999999999999999999998642 233456688999999999999999999987543 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+||||+++ +|.+++. .+.++++.++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 95 ~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 95 WVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 999999985 7877764 45699999999999999999999999999999999999999999999999999875432221
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+....+..+...+
T Consensus 174 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-------------- 234 (292)
T cd06658 174 ---KRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-------------- 234 (292)
T ss_pred ---cCceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------------
Confidence 1234678999999999876 578899999999999999999999998766544333221110
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
+ .........+..+.+||.+||..||.+|||++|+|+||||.....
T Consensus 235 -------------~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 235 -------------P-PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred -------------C-CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 0 001112346788999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=335.04 Aligned_cols=246 Identities=19% Similarity=0.243 Sum_probs=200.6
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhH-HHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD-ATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~-~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E 107 (560)
..||+|++|.||+|.. +|+.||||++......... ...+.+|+.+|+.++||||+++++++.... .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5699999999999976 7899999999754332222 466789999999999999999999885411 22346899999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
|+. |+|.+++.....+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 999 5899999988889999999999999999999998 499999999999999999999999999997653221
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
...+++..|+|||++.+....++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~------------------ 238 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN------------------ 238 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC------------------
Confidence 2356889999999997644578999999999999999999999998876554443332110
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... ....+++.+.+||.+||+.||.+|||++|+++
T Consensus 239 --------~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 239 --------NSLK---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------CCCC---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0011 11256889999999999999999999999985
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=326.23 Aligned_cols=254 Identities=28% Similarity=0.489 Sum_probs=208.5
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc---ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~---~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
+|++.+.||+|+||.||+|.+..+++.|++|.+..... .......+.+|+.+++.++|+||+++++.+... .
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----D 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----C
Confidence 58889999999999999999998999999999864221 123456788999999999999999999987433 4
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+|+||+++ +|.+++.....+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 68999999985 89999988878999999999999999999999999999999999999999999999999998765333
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. ......++..|++||.+... ..++.++|+|||||++|+|++|+.||...........+...
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------- 217 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS------------- 217 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-------------
Confidence 2 12345788999999998652 23788999999999999999999999765532222111100
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.........+++.+.+||.+||..||.+||++.++|.|||+
T Consensus 218 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 218 ----------------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00112234568899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.70 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=209.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||+++++.+... ..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEE
Confidence 358889999999999999999999999999999875432 24556788999999999999999999988544 468
Q ss_pred EEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
|+|+||++ ++|.+++... ..+++..++.++.||+.||.|||+ .||+|+||||+||+++.++.+||+|||++......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999 5999999876 689999999999999999999999 99999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCCh--hhHHHHHHHhcCCCCHHHHHH
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~--~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.. ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+. ....+.+
T Consensus 155 ~~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------- 213 (265)
T cd06605 155 LA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL-------------- 213 (265)
T ss_pred Hh-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH--------------
Confidence 11 12578889999999977 5788999999999999999999999975431 0011111
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFP-NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~-~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..+....... ... .++..+.+||.+||..||++|||+.+++.||||+.+
T Consensus 214 ----------~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 214 ----------QYIVNEPPPR---LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ----------HHHhcCCCCC---CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 1111111111 111 168889999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=351.92 Aligned_cols=254 Identities=29% Similarity=0.570 Sum_probs=214.5
Q ss_pred eEE--EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 25 YKI--EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 25 Y~i--~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
|+| .++||+|-||+||-|.|+++|+.||||+|.+..-.......+.+|+.||+.+.||.||.+.-.|.++. .+
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-----rv 638 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-----RV 638 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-----eE
Confidence 444 38999999999999999999999999999864444445577889999999999999999998886554 59
Q ss_pred EEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC---cEEEeccccccccc
Q 008607 103 YVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAF 177 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~---~lKL~DFGla~~~~ 177 (560)
++|||-+.||+.+.|.. .++|++..-++++.|||.||+|||-.+|+|+||||+|||+.... .+||||||+|++..
T Consensus 639 FVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 639 FVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred EEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 99999999999998865 45799999999999999999999999999999999999998763 59999999999864
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCCh-hhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~-~~~~~~i~~~~g~p~~~~~~ 256 (560)
.. .+..+.+||+.|.|||+|.. ..|..+-|+||+|||+|.-|.|..||....+ .+|++.-.
T Consensus 719 Ek----sFRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa------------ 780 (888)
T KOG4236|consen 719 EK----SFRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA------------ 780 (888)
T ss_pred hh----hhhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchhHHhhccc------------
Confidence 43 35678899999999999987 7899999999999999999999999975432 22222110
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
| -.. ..-|.++++.++|||..+|+..-.+|-+++..|.|||+++.
T Consensus 781 ---------F-----MyP----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 781 ---------F-----MYP----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ---------c-----ccC----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 0 011 22356789999999999999999999999999999999864
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=326.27 Aligned_cols=259 Identities=31% Similarity=0.474 Sum_probs=213.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.|++.+.||+|++|.||+|.+..+++.|+||++...... .....+.+|+.++..++|+||+++++.+... ..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeE
Confidence 3689999999999999999999999999999998753322 4467788999999999999999999998544 468
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
|+||||++ ++|.+++.....+++..++.++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999 6999999888889999999999999999999999 999999999999999999999999999998654332
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.....+.+..
T Consensus 155 ~~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--------------- 214 (264)
T cd06623 155 DQ---CNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--------------- 214 (264)
T ss_pred Cc---ccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH---------------
Confidence 22 134568899999999876 5788899999999999999999999977642111111111
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPN-ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~-~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
+..... ...... ++..+.+||++||..+|++||++.|+|+||||+..
T Consensus 215 ---------~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 215 ---------ICDGPP---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ---------HhcCCC---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 111111 111223 67889999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=318.26 Aligned_cols=268 Identities=25% Similarity=0.390 Sum_probs=211.1
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
+.+-+++||+|.+.||+|+|+-||++.+..+++.||+|+|... ...+....++|++..++++|||++++++..+....
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 3466789999999999999999999999999999999999753 34667889999999999999999999987765544
Q ss_pred CCCccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeCCCCcEEEec
Q 008607 97 REFKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICD 169 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~~~~~lKL~D 169 (560)
+.....||+++|+. |+|.+.|.. ...++|.++..|+.+|++||++||+.. .+||||||.|||+.+.+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 45567999999998 789998865 236999999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCC------cccccccccCccccccccccc-ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHH
Q 008607 170 FGLARVAFNDTPT------AIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (560)
Q Consensus 170 FGla~~~~~~~~~------~~~~~~~~gT~~Y~APEll~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (560)
||.++...-.... ...|.....|..|+|||++.- .....+.++|||||||+||.|+.|..||.-
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~--------- 243 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER--------- 243 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------
Confidence 9999754211111 112344567889999999842 224567899999999999999999999942
Q ss_pred HHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 243 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
+....|.-.. . .......+... +.++..+.+||+.||+.||.+||++.++|.+
T Consensus 244 ~~~~GgSlaL----A-------------v~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 244 IYQQGGSLAL----A-------------VQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HhhcCCeEEE----e-------------eeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1111110000 0 00011112222 2378899999999999999999999999864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=335.23 Aligned_cols=261 Identities=26% Similarity=0.443 Sum_probs=204.6
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~i 102 (560)
.|+..+.||+|+||.||++.+..++..||||++...... .....+.+|+.++..+. |+||+++++++... ...
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~ 78 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDC 78 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcE
Confidence 567788999999999999999999999999998743222 44567889999999996 99999999987543 358
Q ss_pred EEEEecCCccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 103 YVVFELMESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~-----~~~~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
++||||+..+|.++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9999999876555432 235799999999999999999999975 9999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccccccccccc-CCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... ....++..|+|||++.+.. ..++.++|||||||++|+|++|+.||...+ .....+.....
T Consensus 159 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~------- 225 (288)
T cd06616 159 VDSIAK----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVK------- 225 (288)
T ss_pred ccCCcc----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcC-------
Confidence 332211 3346889999999986521 268899999999999999999999997544 11111111110
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
...+.........++..+.+||.+||+.||.+|||++++++||||+..
T Consensus 226 ----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 226 ----------------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ----------------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 011111111224578899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=335.24 Aligned_cols=259 Identities=21% Similarity=0.325 Sum_probs=199.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECC----------------CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTR----------------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~----------------tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv 85 (560)
.++|++.++||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999997532 34479999987432 233456788999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 008607 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-------------------DLTPEHYQFFLYQLLRGLKYIHTA 145 (560)
Q Consensus 86 ~l~~i~~~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~-------------------~lse~~~~~i~~Qll~aL~yLHs~ 145 (560)
++++++... ..+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999988543 35899999998 59999886532 367788999999999999999999
Q ss_pred CeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHh
Q 008607 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225 (560)
Q Consensus 146 gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLl 225 (560)
||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999765332211 11123456788999999876 57899999999999999998
Q ss_pred h--CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 008607 226 T--GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 303 (560)
Q Consensus 226 t--G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~ 303 (560)
+ +..||.+.+....+..+... +.... ...+....+.++..+.+||.+||+.||.+
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~--------------------~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEF--------------------FRDQG---RQVYLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHH--------------------hhhcc---ccccccCCCCCCHHHHHHHHHHccCCchh
Confidence 7 56788766544433322211 11000 00011123456788999999999999999
Q ss_pred CCCHHHHhc
Q 008607 304 RPTAEEALA 312 (560)
Q Consensus 304 Rpta~elL~ 312 (560)
|||+++|.+
T Consensus 292 RPs~~~i~~ 300 (304)
T cd05096 292 RPSFSDIHA 300 (304)
T ss_pred CcCHHHHHH
Confidence 999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=329.19 Aligned_cols=251 Identities=20% Similarity=0.308 Sum_probs=201.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.++|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG---- 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC----
Confidence 467999999999999999999765 456789999987532 223445788999999999999999999988543
Q ss_pred CccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+|+||||+++ +|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||.+...
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 79 -NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred -CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 468999999985 888888764 47999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+.+..
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------- 225 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF-------- 225 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--------
Confidence 211110 0112335678999999876 578999999999999999775 999998776554443332211
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.. .....++..+.+|+.+||+.||.+||++++|++
T Consensus 226 -------------------~~---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 226 -------------------RL---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -------------------CC---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 11 112456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=324.97 Aligned_cols=253 Identities=29% Similarity=0.503 Sum_probs=207.7
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||+|+||.||++.+..+|..||+|.+............+.+|+.+++.++|+||+++++.+... ..+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-----GRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-----CeEE
Confidence 58999999999999999999999999999999865322334456778999999999999999999988443 4689
Q ss_pred EEEecCCc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc-EEEecccccccccCC
Q 008607 104 VVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFND 179 (560)
Q Consensus 104 lV~E~~~g-dL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~-lKL~DFGla~~~~~~ 179 (560)
+|+||+.+ +|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+||+++.++. +||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999974 9999887643 4799999999999999999999999999999999999998864 699999999765432
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. ......|++.|+|||.+.+ ..++.++|+|||||++++|++|..||.+.+....+..+..
T Consensus 156 ~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 ME---LAYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred cc---cccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 21 1133568899999999876 4688999999999999999999999977654333221110
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
. .+....+.++..+.++|.+||..+|++|||+.|+++||||
T Consensus 217 -------------~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 -------------G---YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -------------c---cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 0112234567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=325.29 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=209.0
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc---cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~---~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++|+||+++++.+.... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 57999999999999999999999999999999875321 12234567889999999999999999999875432 2
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+++|+||+.+ +|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 458899999984 8999998877899999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
............++..|+|||++.+ ..++.++|+|||||++|+|++|+.||........+ .+....+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~------- 226 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI---FKIATQPT------- 226 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH---HHHHcCCC-------
Confidence 2111111234578999999999876 56788999999999999999999999765433322 22111110
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.......+++.+.++|++||. +|..||++.++|.|||.
T Consensus 227 -------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 -------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 011224578899999999999 57999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.38 Aligned_cols=258 Identities=29% Similarity=0.528 Sum_probs=211.0
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
..|...+.||+|++|.||++.+..++..+++|++... .......+.+|+.+++.+.|+||+++++.+... ...
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeE
Confidence 3566678999999999999999999999999998632 233455688999999999999999999987543 458
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+|+||+.+ +|.+++.. ..++++.++.++.||+.||+|||++||+||||+|+||+++.++.++|+|||++........
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 999999975 89998877 5799999999999999999999999999999999999999999999999998875433222
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
. .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--------------- 230 (285)
T cd06648 171 R---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--------------- 230 (285)
T ss_pred c---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---------------
Confidence 1 133568999999999876 56889999999999999999999999876654433322211
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
..+.......++..+.+||++||..||++|||+.++|+||||+....
T Consensus 231 -------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 231 -------------LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred -------------CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 00111112346788999999999999999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=365.23 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=205.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCcccccee-ecCCCcCC-
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHI-LLPPSRRE- 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i-~~~~~~~~- 98 (560)
..+++|.+.|.+|+|+.||+|.+...|..||+|++... +......+.+||.+|++|+ |+|||.+++. ........
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 36789999999999999999999998899999998643 6667788999999999998 9999999994 33222222
Q ss_pred CccEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
.-.++|+||||. |.|.+++.. ...|+|.++.+||+|+++||++||... |||||||-+||||+.+|.+||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 246889999999 699999975 346999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCccc------ccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHh
Q 008607 174 RVAFNDTPTAIF------WTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246 (560)
Q Consensus 174 ~~~~~~~~~~~~------~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~ 246 (560)
+-.......... --....|+.|||||.|.-. ....+.|+|||+|||+||.||....||.+.....+++
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln----- 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN----- 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe-----
Confidence 754332211100 0123579999999987321 1467899999999999999999999998653221110
Q ss_pred cCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 247 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.+..+ ..++.++..+.+||+.||+.||.+||++-|++.+
T Consensus 269 -------------------------g~Y~~---P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 269 -------------------------GNYSF---PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred -------------------------ccccC---CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 01111 2246788999999999999999999999999864
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=336.44 Aligned_cols=257 Identities=29% Similarity=0.533 Sum_probs=209.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
.-|+....||+|+||.||+|.+..++..||||++... .......+.+|+.+++.+.||||+++++.+... ..+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~ 93 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EEL 93 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeE
Confidence 4455666899999999999999999999999998642 223456688999999999999999999988543 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+|+||+++ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 94 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 999999985 78877654 5699999999999999999999999999999999999999999999999999875432221
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
.....+++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------------- 231 (297)
T cd06659 173 ---KRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---------------- 231 (297)
T ss_pred ---cccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----------------
Confidence 1234678999999999976 5788999999999999999999999987665444332211
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
. ..........++..+.+||++||+.||.+||+++++++||||.+..
T Consensus 232 -----------~-~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 232 -----------S-PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred -----------c-CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 0 1111222345678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=331.03 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=203.0
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008607 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (560)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~ 109 (560)
||+|+||+||+|.+..+|+.||+|.+..... .......+.+|+++|+.++||||+.+++++.. ...+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence 6899999999999999999999999864322 22234456789999999999999999998843 24689999999
Q ss_pred C-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccc
Q 008607 110 E-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (560)
Q Consensus 110 ~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (560)
+ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++....... ..
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KI 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----cc
Confidence 8 59999987765 69999999999999999999999999999999999999999999999999987643321 12
Q ss_pred cccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Q 008607 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (560)
Q Consensus 187 ~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 266 (560)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------------- 209 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-------------------- 209 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--------------------
Confidence 34567889999999876 45889999999999999999999999776532211111110
Q ss_pred HHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccccc
Q 008607 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (560)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~~ 320 (560)
....+ ....+..++.+.+||++||+.||.+|| ++.++++||||..+.
T Consensus 210 ----~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 210 ----TLEMA---VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred ----ccccc---ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 00011 112245688999999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.35 Aligned_cols=248 Identities=29% Similarity=0.450 Sum_probs=204.6
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||.|+||.||++.+..++..||+|.++... .......+.+|+.+++.++|+||+++++.+... ..+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-----GHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEE
Confidence 5899999999999999999999999999999986432 234556788999999999999999999988433 4689
Q ss_pred EEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 104 VVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 104 lV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+||||++ ++|.+++.. ...++++.++.|+.||+.||.|||++||+|+||||+|||++.++.++|+|||+++......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999998 589988865 3358999999999999999999999999999999999999999999999999987653221
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+....+..+..
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--------------- 214 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------------- 214 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc---------------
Confidence 1 1234678999999999876 5688999999999999999999999987664433322211
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ......++..+.+||.+||+.||.+|||+.++|+
T Consensus 215 ------------~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 215 ------------GSY---KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ------------CCC---CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 000 1112346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=326.76 Aligned_cols=249 Identities=23% Similarity=0.404 Sum_probs=204.9
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008607 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (560)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~ 109 (560)
||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++|+||+++++.+... ..+|+|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence 6999999999999999999999999874322 223456788999999999999999999987433 4689999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccc
Q 008607 110 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188 (560)
Q Consensus 110 ~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 188 (560)
+ ++|.+++.....+++..+..++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence 8 5999999888789999999999999999999999999999999999999999999999999998764432 1134
Q ss_pred cccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCC--hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Q 008607 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN--VVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (560)
Q Consensus 189 ~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~--~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 266 (560)
..++..|++||.+.+ ..++.++|+|||||++|+|++|..||.... ....+..+..
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 208 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--------------------- 208 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc---------------------
Confidence 578899999999876 568899999999999999999999997765 2222111110
Q ss_pred HHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccccc
Q 008607 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (560)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~ 319 (560)
..... ......++.+.+||.+||..||.+||+ ++|+++||||+++
T Consensus 209 -----~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 209 -----GNGKL---EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred -----cCCCC---CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 00011 111234788999999999999999999 9999999999865
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.72 Aligned_cols=262 Identities=25% Similarity=0.408 Sum_probs=214.0
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
+-...|+|+..||.|+||.||+|.++.++-..|.|+|.. ........++-||.||..+.||+||+|++.|+...
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~en---- 102 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN---- 102 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC----
Confidence 334568889999999999999999999999999998853 34456778889999999999999999999986653
Q ss_pred ccEEEEEecCCcc-HHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 100 KDIYVVFELMESD-LHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 100 ~~i~lV~E~~~gd-L~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
.+||+.|||+|. +..++.. ...|++++++.+++|+|.||.|||+++|||||||..|||++-+|.++|+|||.+....
T Consensus 103 -kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 103 -KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK 181 (1187)
T ss_pred -ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch
Confidence 599999999975 4444444 4469999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCcccccccccCccccccccccc---ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~---~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
. +.....+++|||+|||||+... ...+|++++||||||++|.||..+.+|-..-+....+-+|.+
T Consensus 182 ~---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK--------- 249 (1187)
T KOG0579|consen 182 S---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--------- 249 (1187)
T ss_pred h---HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---------
Confidence 2 2223467899999999998521 125799999999999999999999999876665544433332
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..|..+ -....++..+.|||++||.+||..||++.++|+||||.+.
T Consensus 250 ------------------SePPTL-lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 250 ------------------SEPPTL-LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred ------------------cCCCcc-cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 111111 1234678889999999999999999999999999999864
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=342.87 Aligned_cols=261 Identities=28% Similarity=0.448 Sum_probs=216.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChh-HHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS-DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~-~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
-+.|+.-++||+|+||.||-++-+.||+.||+|++.+...+.. ...-.++|-.||.+++.+.||.+-..|.+. .
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk-----d 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK-----D 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC-----C
Confidence 4678889999999999999999999999999999875333222 234467999999999999999998888554 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
.+++|+.+|. |||.-.|.+.+ .|+++.+.+++.+|+.||.+||..+|+.|||||+|||+|++|+++|+|.|||....
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 6999999998 59999888766 79999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.+.+. ...+||..|||||++.+ ..|+.+.|.|||||+||||+.|+.||.....-..-
T Consensus 339 ~g~~~----~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----------------- 395 (591)
T KOG0986|consen 339 EGKPI----RGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----------------- 395 (591)
T ss_pred CCCcc----ccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-----------------
Confidence 55443 55699999999999987 57999999999999999999999999654321111
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~~ 320 (560)
++ ++.+....+..++ ...|+++++|.+.+|++||.+|. +++++-+||||+.+.
T Consensus 396 ---eE----vdrr~~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 396 ---EE----VDRRTLEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred ---HH----HHHHHhcchhhcc---cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 11 1111112222222 46789999999999999999996 588999999999864
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.06 Aligned_cols=256 Identities=31% Similarity=0.542 Sum_probs=211.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~ 100 (560)
++|++.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.++ |+||+++++++... .
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----E 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----c
Confidence 47999999999999999999999999999999987522 23344567889999999999 99999999987433 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+++|||++. ++|.+++.+.+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 6899999995 699999998888999999999999999999999999999999999999999999999999999865432
Q ss_pred CCC-----------------cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHH
Q 008607 180 TPT-----------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (560)
Q Consensus 180 ~~~-----------------~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (560)
... ........++..|+|||.+.+ ..++.++|||||||++++|++|+.||...+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 211 011234567899999999876 4678899999999999999999999987664332222
Q ss_pred HHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccc
Q 008607 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYF 316 (560)
Q Consensus 243 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta----~elL~hp~f 316 (560)
+.. .. ......+++.+.+||++||+.||.+||++ +++|+||||
T Consensus 234 ~~~--------------------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILK--------------------------LE-----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHh--------------------------cC-----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 211 00 11123557889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=330.68 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=203.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCC-----cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg-----~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC---
Confidence 46999999999999999999876655 689999986432 233456788999999999999999999988433
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
...|++|||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 81 --~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 --QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 35899999998 5999999764 4578899999999999999999999999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhH
Q 008607 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (560)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEECCCcceeeccccccc-cccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999754322211 11234567889999999876 578999999999999999998 9999987765443
Q ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 240 ~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
...+.. ... ......+++.+.+|+.+||+.||.+||++.|++++
T Consensus 236 ~~~i~~---------------------------~~~---~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRS---------------------------RQL---LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCc---CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 332221 111 11124678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=320.01 Aligned_cols=253 Identities=29% Similarity=0.520 Sum_probs=212.1
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||+|+||.||++.+..++..|++|++............+.+|+++++.++|+|++++.+.+... ..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 58999999999999999999999999999999976544445667788999999999999999999988544 4689
Q ss_pred EEEecCCc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 104 VVFELMES-DLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 104 lV~E~~~g-dL~~~i~~~----~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+|+|++++ +|.+.+... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999985 899988763 6799999999999999999999999999999999999999999999999999976544
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
... ......+++.|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+.......+..
T Consensus 156 ~~~---~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 217 (258)
T cd08215 156 TVD---LAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK------------- 217 (258)
T ss_pred Ccc---eecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-------------
Confidence 321 1234578899999999876 5688899999999999999999999977653322221111
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.. .......++..+.++|++||..||.+|||+.++|+||||
T Consensus 218 --------------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 218 --------------GQ---YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred --------------CC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 11 111122567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=328.22 Aligned_cols=266 Identities=24% Similarity=0.404 Sum_probs=207.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||.|++|.||+|.+..+++.+|+|.+... .......++.+|+++++.++|+||+++++++.... ...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD-PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC-CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeE
Confidence 4699999999999999999999999999999998743 22245567899999999999999999999885432 2468
Q ss_pred EEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 103 YVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
|+||||+++ +|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999985 88877643 3468999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCCh--hhHHHHHHHhcCCCCHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~--~~~~~~i~~~~g~p~~~~~ 255 (560)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ....+...
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------- 218 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS----------- 218 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH-----------
Confidence 2221 23467889999999876 5788999999999999999999999976532 11111111
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
++..............-..+++.+.+||.+||..||.+|||+.|++.||||+...
T Consensus 219 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 219 ----------YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred ----------HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 1111000000000000113467899999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=345.11 Aligned_cols=280 Identities=32% Similarity=0.540 Sum_probs=227.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCC------CCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH------PDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~H------pnIv~l~~i~~~~~ 95 (560)
.++|.+....|+|-||+|..|.|...|..||||+|.+ +..-...=++|++||++|.. -+++.++..|...
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk- 506 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK- 506 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc-
Confidence 5899999999999999999999999999999999974 33334455689999999963 3678888877443
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC-CcEEEeccc
Q 008607 96 RREFKDIYVVFELMESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFG 171 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~gdL~~~i~~~~---~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-~~lKL~DFG 171 (560)
+++|||||-+.-+|.+++++-+ .|....++.|++||+.||+.|-..||+|.||||+|||||+. ..+||||||
T Consensus 507 ----nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 ----NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ----ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 5799999999999999998754 58999999999999999999999999999999999999986 568999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
.|....... .+.|..++.|+|||++.| ..|+..+|+||+||+||||.||+.+|+|.+..+.+..++++-|..+
T Consensus 583 SA~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 583 SASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 997654332 377899999999999998 6899999999999999999999999999999999999999999887
Q ss_pred HHHHHHhhhHHHHHHHHh--------------------hccCCC-CCCC------CCCC----CCCHHHHHHHHHhcccC
Q 008607 252 PEAIARVRNEKARRYLSS--------------------MRKKKP-IPFS------QKFP----NANPLALRLLERMLAFE 300 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~--------------------~~~~~~-~~~~------~~~~----~~s~~~~dLI~~mL~~D 300 (560)
...+.+..-. ...|+. |...+| ..+. +.++ ..-..+.+||.+||..|
T Consensus 656 ~KmlRKgqF~--dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 656 NKMLRKGQFK--DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred HHHhhhcchh--hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 7766543210 000110 000011 0000 0111 12245899999999999
Q ss_pred CCCCCCHHHHhcCccccc
Q 008607 301 PKDRPTAEEALADPYFKG 318 (560)
Q Consensus 301 P~~Rpta~elL~hp~f~~ 318 (560)
|.+|.|..++|.||||.+
T Consensus 734 P~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 734 PEKRITVNQALKHPFITE 751 (752)
T ss_pred hhhcCCHHHHhcCCcccC
Confidence 999999999999999974
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.28 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=197.1
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEecCcccChh-HHHHHHHHHHHHHh---cCCCCccccceeecCCCcCCCccEEEE
Q 008607 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS-DATRILREIKLLRL---LRHPDIVEIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~-~~~~i~rEi~iL~~---l~HpnIv~l~~i~~~~~~~~~~~i~lV 105 (560)
+||+|+||.||++.+..+++.+|+|.+........ ......+|..+++. ..|+||+.+++.+... +.+|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence 48999999999999999999999999865332212 22334455554444 4699999998888543 358999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcc
Q 008607 106 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (560)
Q Consensus 106 ~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~ 184 (560)
|||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99998 5899999888889999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHH
Q 008607 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264 (560)
Q Consensus 185 ~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 264 (560)
.....||..|+|||.+... ..++.++||||+||++|+|++|..||.+........ +..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~------------------- 209 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDR------------------- 209 (279)
T ss_pred -ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHH-------------------
Confidence 1235789999999998531 457889999999999999999999997643221110 000
Q ss_pred HHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccccc
Q 008607 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (560)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~~ 320 (560)
...... ....+.+++.+.+||++||..||.+|+ |++|+++||||+++.
T Consensus 210 -----~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 210 -----MTLTVN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred -----HhhcCC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 000000 112345788999999999999999999 699999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=320.40 Aligned_cols=259 Identities=24% Similarity=0.431 Sum_probs=211.0
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.+++..||.|+.|+||+++.+.+|...|||.+.+. .+.....+|++.+.++..-. +|+||+.+++|.... +++
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV~ 167 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DVF 167 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hHH
Confidence 35678899999999999999999999999999864 45567789999999987665 899999999997654 589
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 104 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 104 lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|.||.|..-+..+++. .+.++|..+-++...++.||.||.. +||+|||+||+|||+|+.|.+||||||.+-.......
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 9999999766666654 3469999999999999999999975 5899999999999999999999999999976544332
Q ss_pred CcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 182 TAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.+...|-+.|||||.+.-. ...|+..+||||||+.++||.||+.||.+.+.. ++.+++++.
T Consensus 248 ----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln------------ 309 (391)
T KOG0983|consen 248 ----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLN------------ 309 (391)
T ss_pred ----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHh------------
Confidence 2456788999999998532 467999999999999999999999999986642 222222211
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
..| +.-..-.++|+.+.+|+..||++|+.+||...++|+|||+....
T Consensus 310 ------------~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 310 ------------EEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred ------------cCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 111 11111234799999999999999999999999999999998654
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.08 Aligned_cols=258 Identities=29% Similarity=0.497 Sum_probs=210.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
..+|++.+.||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+... ..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----Cc
Confidence 47899999999999999999999999999999998632 233456788999999999999999999988543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
.|+|+||++ ++|.+++.+. .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 899999998 4899988654 58999999999999999999999999999999999999999999999999887543222
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. ......+++.|+|||.+.. ..++.++|+|||||++|+|++|+.||...+...++..+.. .+
T Consensus 170 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~------------ 231 (293)
T cd06647 170 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG------------ 231 (293)
T ss_pred c---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CC------------
Confidence 1 2234578899999999866 5688999999999999999999999987664433221110 00
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.+.......++..+.+||++||..||.+||++.+++.|+||+...
T Consensus 232 ---------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 232 ---------------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ---------------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 001112234577899999999999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=323.16 Aligned_cols=248 Identities=22% Similarity=0.449 Sum_probs=202.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
..|++.+.||+|+||.||+|.+..+++.||+|++.. .......+.+|+++|+.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecC---CchHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCc
Confidence 469999999999999999999999999999999864 223456788999999999999999999988443 458
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
++||||++ ++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999997 58999987643 5899999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 158 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~------------ 221 (263)
T cd05052 158 TYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG------------ 221 (263)
T ss_pred eeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC------------
Confidence 2211 112234567999999876 578899999999999999998 99999887654433322110
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... .....++..+.+||.+||+.||++|||+.++++
T Consensus 222 ---------------~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 222 ---------------YRM---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ---------------CCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000 112456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.90 Aligned_cols=258 Identities=27% Similarity=0.419 Sum_probs=210.1
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
....+|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~---- 87 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE---- 87 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC----
Confidence 344679999999999999999999999999999999864322 233446788999999999999999999998543
Q ss_pred CccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
...|+||||+.|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++....
T Consensus 88 -~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 88 -HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred -CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 35899999999998888764 4469999999999999999999999999999999999999999999999999986542
Q ss_pred CCCCCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.. ....++..|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 167 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~----------- 228 (307)
T cd06607 167 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----------- 228 (307)
T ss_pred CC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-----------
Confidence 21 235688899999987421 14578899999999999999999999987664433222111
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
..+. ......++..+.+||.+||..||++||++.+++.||||..
T Consensus 229 ----------------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 229 ----------------NDSP--TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ----------------CCCC--CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0000 0011235778999999999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.99 Aligned_cols=288 Identities=30% Similarity=0.500 Sum_probs=224.2
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-----C---CCccccceeec
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-----H---PDIVEIKHILL 92 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-----H---pnIv~l~~i~~ 92 (560)
.+.||.+.++||.|-|++||+|.|..+.+.||+|+++.. ....+..+.||++|++++ | ..||+|++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 358999999999999999999999999999999998732 223455779999999995 2 35999999886
Q ss_pred CCCcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeCCC-------
Q 008607 93 PPSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD------- 162 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~~~------- 162 (560)
... .+..+++||||+++.+|..+|+... .++...++.|++|||.||.|||.. ||||.||||+|||+..+
T Consensus 153 hsG-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 153 HSG-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred ecC-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhh
Confidence 543 5667999999999999999998754 699999999999999999999965 99999999999995110
Q ss_pred --------------------------------------------------------------------------------
Q 008607 163 -------------------------------------------------------------------------------- 162 (560)
Q Consensus 163 -------------------------------------------------------------------------------- 162 (560)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 008607 163 -------------------------------------------------------------------------------C 163 (560)
Q Consensus 163 -------------------------------------------------------------------------------~ 163 (560)
.
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred cEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCC------CChh
Q 008607 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG------KNVV 237 (560)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~------~~~~ 237 (560)
++||+|||.|+-.. ..++..+.|+.|+|||++.+ ..|++.+||||++|++|||+||..+|.- ....
T Consensus 392 ~vKIaDlGNACW~~------khFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE 463 (590)
T KOG1290|consen 392 RVKIADLGNACWVH------KHFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE 463 (590)
T ss_pred eEEEeeccchhhhh------hhhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence 13444444443211 12355678999999999988 7999999999999999999999999963 2356
Q ss_pred hHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhc------cCCCCCCCCC------CC-CCCHHHHHHHHHhcccCCCCC
Q 008607 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMR------KKKPIPFSQK------FP-NANPLALRLLERMLAFEPKDR 304 (560)
Q Consensus 238 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~------~~~~~~~~~~------~~-~~s~~~~dLI~~mL~~DP~~R 304 (560)
+.+..|.+++|..+...+..-.. -++|++.-. +-++.++... |+ .....+.|||.-||+++|++|
T Consensus 464 DHiA~i~ELLG~iPr~ia~~Gk~--SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR 541 (590)
T KOG1290|consen 464 DHIALIMELLGKIPRKIALGGKY--SRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR 541 (590)
T ss_pred HHHHHHHHHHhhccHHHHhcCcc--hHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence 78899999999888877654433 245555322 2222222211 11 123458899999999999999
Q ss_pred CCHHHHhcCccccccccc
Q 008607 305 PTAEEALADPYFKGLAKV 322 (560)
Q Consensus 305 pta~elL~hp~f~~~~~~ 322 (560)
|||.++|+|||++.....
T Consensus 542 ~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 542 PTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred ccHHHHhcCccccCCCCC
Confidence 999999999999977654
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=317.78 Aligned_cols=253 Identities=32% Similarity=0.542 Sum_probs=212.3
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||+|++|.||++.+..+++.|++|.+............+.+|+++++.++|+|++++++++... ..+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEE
Confidence 58999999999999999999999999999999976544445667889999999999999999999987443 4689
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 104 lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
+||||+++ +|.+++...+.++++.++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999985 89999988888999999999999999999999999999999999999999999999999999876443321
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 262 (560)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+....+..+.
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 212 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------------------ 212 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------------------
Confidence 234568889999999876 457889999999999999999999997655322221110
Q ss_pred HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.. ........++..+.+||.+||..||++|||+++++.||||
T Consensus 213 ---------~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 213 ---------QD---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------cc---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 00 0111224567899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.67 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=210.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++++.||+|+||.||++.+..+|..||+|++.... .......+.+|+++++.++||||+++++.+... ..+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence 57999999999999999999999999999999886432 233456788999999999999999999998543 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
|+||||+++ +|.+++...+.+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999985 899998887889999999999999999999997 589999999999999999999999999986542221
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. ...+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....... . .
T Consensus 159 ~-----~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--------~--------~ 215 (284)
T cd06620 159 A-----DTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--------D--------P 215 (284)
T ss_pred c-----CccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--------h--------h
Confidence 1 23578999999999876 4788899999999999999999999986553211000 0 0
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
......+..+....+..+. ...++..+.+||.+||+.||.+|||++|+++|+||...
T Consensus 216 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 216 MGILDLLQQIVQEPPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hHHHHHHHHHhhccCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0001111111111111111 11357789999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=322.60 Aligned_cols=251 Identities=29% Similarity=0.451 Sum_probs=199.4
Q ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008607 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E 107 (560)
...||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++|+||+++++++... ..+++|+|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----GFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----CEEEEEEe
Confidence 45799999999999999999999999988642 234556788999999999999999999988543 46899999
Q ss_pred cCC-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC-CCcEEEecccccccccCCCCC
Q 008607 108 LME-SDLHQVIKAN-DDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 108 ~~~-gdL~~~i~~~-~~l--se~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-~~~lKL~DFGla~~~~~~~~~ 182 (560)
|+. ++|.+++... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 998 5999998764 445 88999999999999999999999999999999999986 67899999999876533221
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 262 (560)
......++..|+|||.+......++.++|||||||++|+|++|+.||............
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~------------------- 223 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK------------------- 223 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-------------------
Confidence 12334688999999998653234788999999999999999999999653321110000
Q ss_pred HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
...... .......+++.+.+||++||+.+|.+|||+.|++.||||
T Consensus 224 -----~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 224 -----VGMFKI----HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----hhhhcc----CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 000000 011123567889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=323.66 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=199.5
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHH-HhcCCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL-~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
+.||.|+||.||+|.+..+|+.||||.+.+... .......+..|..++ ..+.|+||+++++++.. ...+|+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence 579999999999999999999999999864321 112223445555554 45589999999998843 24689999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++.....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9998 49999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 207 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-------------------- 207 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------------------
Confidence 123468889999999876 4588999999999999999999999987665433322211
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP---TAEEALADPYFKGL 319 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp---ta~elL~hp~f~~~ 319 (560)
............+++.+.+||.+||+.||.+|| +++|+|.||||+.+
T Consensus 208 -------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 208 -------RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred -------cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 000001112235788999999999999999999 45899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.15 Aligned_cols=257 Identities=31% Similarity=0.504 Sum_probs=208.6
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCCCc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR---HPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~---HpnIv~l~~i~~~~~~~~~~ 100 (560)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ |+|++++++.+... .
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-----~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-----P 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-----C
Confidence 5889999999999999999999999999999986432 2234567889999999997 99999999987533 4
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
..|+||||+.+ +|.+++... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 68999999985 898888654 7999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. ......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--------------- 215 (277)
T cd06917 155 SS---KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--------------- 215 (277)
T ss_pred cc---ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---------------
Confidence 32 12445789999999988542 457889999999999999999999998765433221110
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
...+..+. ...++..+.+||.+||..||++||++.+++.|+||+...
T Consensus 216 ------------~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 216 ------------KSKPPRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ------------cCCCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 01111111 112678899999999999999999999999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=322.93 Aligned_cols=256 Identities=21% Similarity=0.361 Sum_probs=202.3
Q ss_pred eEEEEEEeecCCeEEEEEEECC---CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCc
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFK 100 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~---tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~~~~ 100 (560)
|++.+.||+|+||.||+|.+.. ++..||||++............+.+|+.+|+.++|+||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998765 44789999987544444556778999999999999999999998765443 2334
Q ss_pred cEEEEEecCC-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 101 DIYVVFELME-SDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
..++||||+. ++|..++... ..+++..++.++.||+.||.|||+.+|+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 5799999998 5898887542 25899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+....++.+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH------- 230 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8654322111 1112234667999999866 578899999999999999999 8899987664433322211
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
... ......++..+.+||.+||+.||.+|||+.|++++
T Consensus 231 --------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 231 --------------------GNR---LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --------------------CCC---CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 100 11224567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=326.93 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=196.3
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEecCcccCh-hHHHHHHHHH---HHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008607 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-SDATRILREI---KLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-~~~~~i~rEi---~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV 105 (560)
+||+|+||.||+|.+..+++.||+|++....... ........|. .+++...||+|+.+++.+... ..+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CEEEEE
Confidence 4899999999999999999999999987532221 1122233444 344556799999999888433 468999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcc
Q 008607 106 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (560)
Q Consensus 106 ~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~ 184 (560)
|||+. ++|.+++...+.+++..++.|+.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99998 4899999888889999999999999999999999999999999999999999999999999987542221
Q ss_pred cccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHH
Q 008607 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264 (560)
Q Consensus 185 ~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 264 (560)
....+|+..|+|||++.+. ..++.++||||+||++|+|++|+.||.+...........
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-------------------- 209 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------------------- 209 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH--------------------
Confidence 1235799999999998642 458899999999999999999999997653221111000
Q ss_pred HHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
. ...... ......+..+.+||.+||..||.+|| +++++++||||+..
T Consensus 210 -~----~~~~~~---~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 210 -M----TLTMAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred -H----hhccCC---CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 0 000011 11234588999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.24 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=197.0
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCC-----cEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg-----~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~ 96 (560)
++|++.+.||+|+||.||+|++..+| ..||||++.... .......+.+|+.+|+.+ +|+||+++++.+...
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-- 114 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHG-- 114 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence 57999999999999999999865443 579999997432 223456788999999999 899999999988543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-------------------------------------------------------
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------- 120 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~------------------------------------------------------- 120 (560)
..+|+|||||. |+|.+++...
T Consensus 115 ---~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 115 ---GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred ---CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 46899999998 5999888542
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 121 ---------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 121 ---------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ ..
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~~ 270 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-VV 270 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-ee
Confidence 13788899999999999999999999999999999999999999999999999765332211 11
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 264 (560)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||........+..+..
T Consensus 271 ~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~------------------- 329 (374)
T cd05106 271 KGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK------------------- 329 (374)
T ss_pred ccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH-------------------
Confidence 122345667999999876 578999999999999999997 9999976543222111110
Q ss_pred HHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. .... ......++.+.+||.+||+.||.+|||++++++
T Consensus 330 ----~---~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 330 ----R---GYQM---SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ----c---ccCc---cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0000 011235789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=316.07 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=212.8
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||+|++|.||+|.+..+++.|++|++............+.+|+.+++.++|+||+++++.+.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 488999999999999999999999999999998754433455678889999999999999999999885442 24689
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 104 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
+|+||++ ++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999996 599999988778999999999999999999999999999999999999999999999999999876443321
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 262 (560)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+. ....+..+
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~---------------- 216 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKI---------------- 216 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhc----------------
Confidence 01234568889999999876 4588999999999999999999999987651 11111111
Q ss_pred HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.. ...........+..+.+||.+||..||.+||++.+++.||||
T Consensus 217 --------~~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 217 --------GS--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------cc--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 00 001112223457889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=369.11 Aligned_cols=264 Identities=32% Similarity=0.483 Sum_probs=205.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-------
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS------- 95 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~------- 95 (560)
+.|+.++.||+|+||.||+|+++-.|..||||+|.... .......+.+|+++|.+|+|||||+++..|....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 34688899999999999999999999999999998665 5566788999999999999999999988771000
Q ss_pred ---------------------------------------------------------------------c----------
Q 008607 96 ---------------------------------------------------------------------R---------- 96 (560)
Q Consensus 96 ---------------------------------------------------------------------~---------- 96 (560)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred ------------------C---C-------CccEEEEEecCCccHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHhCC
Q 008607 97 ------------------R---E-------FKDIYVVFELMESDLHQVIKANDDL--TPEHYQFFLYQLLRGLKYIHTAN 146 (560)
Q Consensus 97 ------------------~---~-------~~~i~lV~E~~~gdL~~~i~~~~~l--se~~~~~i~~Qll~aL~yLHs~g 146 (560)
+ + ...+||-||||+.+|.+.+...+.+ ..+.+|++|+||++||+|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 0 0247999999997655555554455 48899999999999999999999
Q ss_pred eeeccCCCCCeeeCCCCcEEEeccccccccc----C----------C-CCCcccccccccCccccccccccccc-CCCCC
Q 008607 147 VFHRDLKPKNILANADCKLKICDFGLARVAF----N----------D-TPTAIFWTDYVATRWYRAPELCGSFF-SKYTP 210 (560)
Q Consensus 147 IiHrDLKP~NILl~~~~~lKL~DFGla~~~~----~----------~-~~~~~~~~~~~gT~~Y~APEll~~~~-~~y~~ 210 (560)
||||||||.||++++++.|||+|||+|+... . . .......+..+||--|+|||++.+.. ..|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998721 0 0 01112346789999999999997742 26999
Q ss_pred ccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCC-CCCCCCCCHHH
Q 008607 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLA 289 (560)
Q Consensus 211 ~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~s~~~ 289 (560)
|+||||||+||+||+. ||... .+.... +.+++ +..++. ...+.+--+..
T Consensus 798 KiDmYSLGIVlFEM~y---PF~Ts--MERa~i------------------------L~~LR-~g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTS--MERASI------------------------LTNLR-KGSIPEPADFFDPEHPEE 847 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCch--HHHHHH------------------------HHhcc-cCCCCCCcccccccchHH
Confidence 9999999999999985 46432 222222 22333 222222 23333445677
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 290 LRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 290 ~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
..+|++||+.||.+||||.|+|++-||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 8999999999999999999999999986
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.15 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=209.0
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
..|+..+.||.|+||.||+|.+..++..||||.+... ........+.+|+.+++.+.|+||+++++++... ..+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEE
Confidence 4688899999999999999999999999999998642 2234456788999999999999999999988443 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+||||+++ +|.+++.. +.+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999985 89888865 4799999999999999999999999999999999999999999999999999976533221
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
......++..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 157 ---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---------------- 215 (277)
T cd06640 157 ---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK---------------- 215 (277)
T ss_pred ---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc----------------
Confidence 1133568889999999876 5678999999999999999999999976654332221100
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.. .......++..+.+||.+||..||.+||+++++++|+||...
T Consensus 216 -----------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 216 -----------NN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred -----------CC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 00 011223456789999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=342.44 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=197.6
Q ss_pred CceEEEEEEeecCCeEEEEEEE-----CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~ 96 (560)
++|++.+.||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 5799999999999999999964 4567789999986432 233456788999999999 799999999988543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC------------------------------------------------------
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 121 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~------------------------------------------------------ 121 (560)
...|+|||||+ |+|.+++....
T Consensus 112 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 112 ---GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ---CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 35899999998 59998886421
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 122 ---------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 122 ---------------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
.+++..+..|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 37788999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..+
T Consensus 269 ~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~---------------- 329 (375)
T cd05104 269 NY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM---------------- 329 (375)
T ss_pred cc-cccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH----------------
Confidence 11 11122345667999999976 578999999999999999998 88999765433221111
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
+... ... ......+..+.+||.+||+.||++|||+.|+++.
T Consensus 330 -------~~~~---~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 330 -------IKEG---YRM---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -------HHhC---ccC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1100 000 0112346789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.49 Aligned_cols=289 Identities=21% Similarity=0.267 Sum_probs=205.3
Q ss_pred EEEEeec--CCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008607 28 EEVIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 28 ~~~IG~G--~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV 105 (560)
...||+| +||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++... ..+|+|
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v 77 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVI 77 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEE
Confidence 3457777 999999999999999999999875443444557788999999999999999999998543 358999
Q ss_pred EecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 106 FELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 106 ~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
|||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++||+.+.........
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99998 4899988764 35899999999999999999999999999999999999999999999999866433221111
Q ss_pred c-cc---ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH----
Q 008607 183 A-IF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA---- 254 (560)
Q Consensus 183 ~-~~---~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~---- 254 (560)
. .. .....++..|+|||++.+....++.++|||||||++|+|++|++||.+......+..+...........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 0 00 011234567999999865334578999999999999999999999987765443322222111000000
Q ss_pred --HHHhhh--HHHHH-HHHhhcc-----CC--CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 255 --IARVRN--EKARR-YLSSMRK-----KK--PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 255 --~~~~~~--~~~~~-~l~~~~~-----~~--~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
.....+ ..... ....... .. ..........+++.+.+||++||+.||++|||++|+|+||||.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000000 00000 0000000 00 00000112345678999999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=318.50 Aligned_cols=251 Identities=28% Similarity=0.450 Sum_probs=209.8
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
+|++.+.||+|+||.||++.+..+++.+++|++............+.+|+.+++.++|+||+++++++... ...|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 58999999999999999999999999999999875444445566788999999999999999999988543 4689
Q ss_pred EEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 104 VVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 104 lV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 99999975 89988866 35689999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. .....++..|++||.+.+ ..++.++|+||||+++++|++|+.||...+.......+..
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------- 215 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 31 133568889999999876 5788899999999999999999999987664332221111
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
.. +......++..+.++|.+||..||.+|||+.++|+||++
T Consensus 216 --------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 --------------GK---YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------------CC---CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 00 111123567889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=321.10 Aligned_cols=245 Identities=23% Similarity=0.341 Sum_probs=197.3
Q ss_pred EEeecCCeEEEEEEE--CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008607 30 VIGKGSYGVVCSAYD--TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (560)
Q Consensus 30 ~IG~G~~G~Vy~a~d--~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E 107 (560)
.||+|+||.||+|.+ ..++..+|+|++............+.+|+.+++.+.|+||+++++++.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 589999999999964 4678899999987544444456778899999999999999999987632 24689999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccc
Q 008607 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (560)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (560)
|++ ++|.+++.....+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||+++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 998 5899999887789999999999999999999999999999999999999999999999999997654332211111
Q ss_pred cccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 187 ~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....++..|+|||.+.. ..++.++|||||||++|||++ |+.||.+.+..+....+..
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-------------------- 213 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-------------------- 213 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC--------------------
Confidence 22344678999999865 568889999999999999998 9999987665443333221
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ......+++.+.+||.+||+.||.+||++++|..
T Consensus 214 -------~~~---~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 214 -------GER---MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -------CCC---CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 111 1122457889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=326.85 Aligned_cols=263 Identities=21% Similarity=0.383 Sum_probs=208.3
Q ss_pred ceEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEecCcc--cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~ 97 (560)
.|++.+.||.|+||.||+|.+. .+|+.||+|.+.... .......++.+|+.+|+.+ +|+||+.+++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 3899999999999999999875 478999999986421 1223446678899999999 58999999988743
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
...+|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 77 -DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 246899999998 499999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
...... ......|+..|+|||.+.+....++.++|||||||++|+|++|..||...+.......+.+
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------- 222 (290)
T cd05613 156 HEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR----------- 222 (290)
T ss_pred cccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----------
Confidence 332211 1234678999999999865334577899999999999999999999965432221111111
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~~ 320 (560)
.+.... .+ ....+++.+.+||++||+.||.+|+ ++++++.||||+.+.
T Consensus 223 ------------~~~~~~-~~---~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 223 ------------RILKSE-PP---YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ------------HhhccC-CC---CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 110100 01 1234678899999999999999997 899999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=331.54 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=201.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcE----EEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~----vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
..+|++.+.||+|+||.||+|.+..+++. ||||++... ........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 35699999999999999999998766664 899998642 2234456788999999999999999999988543
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..++|+||+. |+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 3589999998 68999998754 689999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
........ ......++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.+.........+..
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (316)
T cd05108 159 LGADEKEY-HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------- 226 (316)
T ss_pred ccCCCcce-eccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC---------
Confidence 54332211 1122334678999999876 578899999999999999997 9999987654332211110
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.... ...+.++..+.+||.+||..||.+||++.+++.+
T Consensus 227 ------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 227 ------------------GERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------------------CCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011 1123467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=323.65 Aligned_cols=254 Identities=20% Similarity=0.365 Sum_probs=200.5
Q ss_pred CCCceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
..++|++.+.||+|+||+||+|.+. .++..||||++... ........+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-- 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-- 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 4578999999999999999999864 34578999998642 223345678899999999999999999998843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~~----------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~ 164 (560)
....++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.
T Consensus 81 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 81 ---GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred ---CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 246899999998 58999987532 2577889999999999999999999999999999999999999
Q ss_pred EEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHH
Q 008607 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIM 243 (560)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i 243 (560)
+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+....+..+
T Consensus 158 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred EEECCCCCccccCCcceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999987543322111 1122355778999999876 578899999999999999999 78999876654433322
Q ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 244 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.. ... .......+..+.+||.+||+.||.+|||+.|++++
T Consensus 235 ~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 ME---------------------------GGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred Hc---------------------------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 000 01123467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.96 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=199.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECC-----CCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~ 96 (560)
++|++++.||+|+||.||+|++.. +++.||+|++.... .......+.+|+.+++.+ +|+||+++++.+....
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~- 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG- 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC-
Confidence 689999999999999999997543 45789999987532 223446678999999999 7999999999875432
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhC-------------------------------------------------------
Q 008607 97 REFKDIYVVFELMES-DLHQVIKAN------------------------------------------------------- 120 (560)
Q Consensus 97 ~~~~~i~lV~E~~~g-dL~~~i~~~------------------------------------------------------- 120 (560)
..+++||||+.+ +|.+++...
T Consensus 85 ---~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 85 ---GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred ---CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 368999999984 898888542
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcc
Q 008607 121 ------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194 (560)
Q Consensus 121 ------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~ 194 (560)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .......++..
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~ 240 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLK 240 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCcc
Confidence 25789999999999999999999999999999999999999999999999999865332211 11233456778
Q ss_pred cccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccC
Q 008607 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKK 273 (560)
Q Consensus 195 Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~ 273 (560)
|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+.... . ..
T Consensus 241 y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~-----------------------~---~~ 292 (337)
T cd05054 241 WMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL-----------------------K---EG 292 (337)
T ss_pred ccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH-----------------------h---cc
Confidence 999999876 578999999999999999997 999998754322221110 0 00
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 274 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 274 ~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
... ......++.+.+|+.+||+.+|++||+++|+++|
T Consensus 293 ~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 293 TRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 1113467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=322.44 Aligned_cols=256 Identities=22% Similarity=0.382 Sum_probs=201.3
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCc--EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCcc
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGE--KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFKD 101 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~--~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~~~~~ 101 (560)
|.+.++||+|+||.||+|.+..++. .||+|.++...........+.+|+.+|+.++|+||+++++.+..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3577899999999999999887775 69999987654455567788899999999999999999998754321 22345
Q ss_pred EEEEEecCC-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 102 IYVVFELME-SDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~------~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.++||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 799999998 589888743 1248899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
......... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.......+.+..
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------- 229 (272)
T cd05075 161 KIYNGDYYR-QGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-------- 229 (272)
T ss_pred ccCccccee-cCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--------
Confidence 654322111 1122345678999999876 578899999999999999999 8899987654332222111
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.... ...+.++..+.+||.+||+.||.+|||+++++++
T Consensus 230 -------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 230 -------------------GNRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------------CCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1000 1123567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=325.36 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=202.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECC-----CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
..+|.+.+.||+|+||.||+|.+.. ++..||||++..... ......+.+|+++|+.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence 3568999999999999999998753 467899999875322 22456788999999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAND--------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 161 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~--------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~ 161 (560)
...|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 81 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 ---DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ---CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 46899999998 59999997643 3789999999999999999999999999999999999999
Q ss_pred CCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHH
Q 008607 162 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQL 240 (560)
Q Consensus 162 ~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~ 240 (560)
++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred CCeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999754322211 11123456788999999876 578999999999999999998 99999876654433
Q ss_pred HHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 241 ~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..+.. ... ......++..+.+||++||+.||.+|||++|+++
T Consensus 235 ~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQ---------------------------GRL---LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33221 000 1112356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=343.81 Aligned_cols=246 Identities=29% Similarity=0.440 Sum_probs=203.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.+++++.||+|-||.||++... ....||+|.++.. ....+.+++|+++|++|+|+|||++++++... ..+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----Cce
Confidence 45677899999999999999653 2348999998742 33456788999999999999999999999543 259
Q ss_pred EEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
|||||||. |+|.++++. ...+.......|+.||++|++||+++++|||||-..||||+++..+||+|||||+...++
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999998 899999987 446999999999999999999999999999999999999999999999999999954433
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
..... ...--..-|.|||.+.- ..++.++|||||||+|+||+| |+.||++.+..+.++.+.+...-|.
T Consensus 357 ~Y~~~--~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~------- 425 (468)
T KOG0197|consen 357 EYTAS--EGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR------- 425 (468)
T ss_pred ceeec--CCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC-------
Confidence 32211 11122334889999976 689999999999999999999 8899999998887777665433222
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL 311 (560)
.+.+++.+-+|+..||..+|++|||++.+.
T Consensus 426 -----------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 -----------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -----------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 246889999999999999999999999664
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.17 Aligned_cols=275 Identities=24% Similarity=0.308 Sum_probs=201.1
Q ss_pred CCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCC-ccH
Q 008607 35 SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDL 113 (560)
Q Consensus 35 ~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~-gdL 113 (560)
++|.||.+++..+++.||||++............+.+|+.+|+.++|+||+++++++... ...|++|||+. ++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEEeccCCCCH
Confidence 556677777788999999999976434455677899999999999999999999988543 45899999998 589
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC----ccccc
Q 008607 114 HQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT----AIFWT 187 (560)
Q Consensus 114 ~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~----~~~~~ 187 (560)
.+++... ..+++..++.+++||+.||+|||+++|+||||||+|||++.++.+||+|||.+......... .....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 9988763 46899999999999999999999999999999999999999999999999998754322111 11123
Q ss_pred ccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHH
Q 008607 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 267 (560)
Q Consensus 188 ~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l 267 (560)
...++..|+|||++......|+.++|||||||++|+|++|+.||........+ +....+..... +...... ...
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~-~~~~~~~---~~~ 240 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCL-LDKSTYP---LYE 240 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccc-cccCchh---hhc
Confidence 35678899999998653346889999999999999999999999876543322 11221211100 0000000 000
Q ss_pred Hhhcc--------CCCC-CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 268 SSMRK--------KKPI-PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 268 ~~~~~--------~~~~-~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
..+.. .... ........++..+.+||.+||..||.+|||++++|+||||+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00000 0000 00011123456789999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=362.93 Aligned_cols=147 Identities=24% Similarity=0.436 Sum_probs=132.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|+++++||+|+||.||+|++..+++.||||++... .........+.+|+.+++.++|+||+.++.++.. ...
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-----ANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-----CCE
Confidence 5799999999999999999999999999999999742 2233345678899999999999999999988743 346
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
+||||||+. ++|.+++...+.+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 899999997 5999999888889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.47 Aligned_cols=259 Identities=22% Similarity=0.374 Sum_probs=203.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECC-----CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.++|++.++||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-- 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 4689999999999999999997652 35589999886432 223445678999999999999999999987433
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcE
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~----------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~l 165 (560)
...|+||||+. |+|.+++.... .++...+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 82 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 ---QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred ---CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 35899999998 69999997532 34667889999999999999999999999999999999999999
Q ss_pred EEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHH
Q 008607 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (560)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~ 244 (560)
||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.++.+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred EECcCCcccccccccccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999997643322111 1122345678999999876 568899999999999999998 789998765443332221
Q ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------Cccccc
Q 008607 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA------DPYFKG 318 (560)
Q Consensus 245 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~------hp~f~~ 318 (560)
. .. ........++.+.+||.+||+.||++|||+.++++ ||||.+
T Consensus 236 ~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 236 D---------------------------GG---YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred c---------------------------CC---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 1 00 00111245788999999999999999999999987 999986
Q ss_pred c
Q 008607 319 L 319 (560)
Q Consensus 319 ~ 319 (560)
+
T Consensus 286 ~ 286 (288)
T cd05061 286 V 286 (288)
T ss_pred C
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=320.20 Aligned_cols=253 Identities=30% Similarity=0.505 Sum_probs=205.4
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008607 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (560)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~ 109 (560)
||.|+||.||++.+..+|+.|++|.+..... .......+.+|+++++.++|+||+++++.+.. ...+|+|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-----KKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-----CcEEEEEEecC
Confidence 6899999999999999999999999864321 22345678899999999999999999988743 34689999999
Q ss_pred Cc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC-----c
Q 008607 110 ES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-----A 183 (560)
Q Consensus 110 ~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~-----~ 183 (560)
.+ +|.+++.+.+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 84 99999988778999999999999999999999999999999999999999999999999998765332110 1
Q ss_pred ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHH
Q 008607 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (560)
Q Consensus 184 ~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 263 (560)
.......++..|+|||.+.. ..++.++|||||||++|+|++|..||...+.......+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------ 215 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------------ 215 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Confidence 11234568889999999876 4578899999999999999999999987664433322211
Q ss_pred HHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCcccccc
Q 008607 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA---EEALADPYFKGL 319 (560)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta---~elL~hp~f~~~ 319 (560)
....+.. ....+..+.+||++||+.||.+|||+ .++|+||||+++
T Consensus 216 ----------~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 216 ----------GKIEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred ----------CCcCCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 0001111 11247889999999999999999999 999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.19 Aligned_cols=255 Identities=28% Similarity=0.417 Sum_probs=206.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
..|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++.+... ..+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----TKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccC-----Cce
Confidence 35778889999999999999999999999999986432 223456788999999999999999999988543 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999985 88888764 4799999999999999999999999999999999999999999999999999876432211
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+.
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP----------------- 214 (277)
T ss_pred ---hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-----------------
Confidence 1233468889999999976 578889999999999999999999997544322211110
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
...+ ......++..+.+||.+||..+|.+||++.++|+||||..+
T Consensus 215 ----------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 215 ----------KNSP---PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ----------cCCC---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 0000 11123457789999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=329.26 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=212.8
Q ss_pred cccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecC
Q 008607 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (560)
Q Consensus 15 ~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~ 93 (560)
+|......+.|...+.||+|+||.||+|.+..+|..|++|++..... .......+.+|+.+++.++|+|++++++++..
T Consensus 13 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 13 LFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred HhccCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 34445555678888999999999999999999999999999864322 22334578899999999999999999999854
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccc
Q 008607 94 PSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGl 172 (560)
. ...|+||||+.++|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||+
T Consensus 93 ~-----~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 93 E-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred C-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCC
Confidence 3 46899999999998888865 44689999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
+..... .....|+..|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 168 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----- 235 (313)
T cd06633 168 ASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----- 235 (313)
T ss_pred CcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-----
Confidence 854211 1345788999999998421 145788999999999999999999999876654443322110
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
..+ ......++..+.+||.+||+.||.+||++.++|.||||..
T Consensus 236 ---------------------~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 236 ---------------------DSP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ---------------------CCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 000 0112345678999999999999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=312.36 Aligned_cols=251 Identities=31% Similarity=0.530 Sum_probs=207.9
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++|+||+.+++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence 38899999999999999999999999999999975322 3567888999999999999999999988544 4589
Q ss_pred EEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 104 VVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 104 lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
+++||++ ++|.+++... ..+++..++.++.|++.||++||++|++||||+|+||+++.++.++|+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 5999998776 5799999999999999999999999999999999999999999999999999876544332
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
.....++..|++||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 211 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---------------- 211 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------------
Confidence 234578899999999876 4578899999999999999999999987653333222111
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~ 315 (560)
.. .+.......++..+.+||.+||+.||++|||+.|+|+|||
T Consensus 212 -----------~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 -----------NG-PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -----------cC-CCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00 0000111124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.91 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=199.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.+.|++.+.||+|+||.||++... .+..+|+|.+... ......+.+|+.+|+.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 73 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KP 73 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CC
Confidence 357999999999999999999865 4568999987632 22345678899999999999999999988433 46
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|+||||++ ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 899999998 5899998753 46899999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+.+..+....
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~----------- 218 (256)
T cd05114 154 EYTS--SSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF----------- 218 (256)
T ss_pred ceec--cCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-----------
Confidence 2111 122345567999999876 578899999999999999999 899998877655544433210
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... ....+..+.+||.+||+.||.+||+++++++
T Consensus 219 ----------------~~~~---~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 219 ----------------RLYR---PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ----------------CCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000 1234678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=322.78 Aligned_cols=253 Identities=22% Similarity=0.373 Sum_probs=200.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECC-----CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.+.|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-- 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--
Confidence 4679999999999999999999987 78899999886422 223345688999999999999999999988543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC---cE
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KL 165 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~-------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~---~l 165 (560)
...|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+
T Consensus 82 ---~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 ---LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ---CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 35799999997 59999997653 489999999999999999999999999999999999998765 59
Q ss_pred EEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHH
Q 008607 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (560)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~ 244 (560)
||+|||+++......... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+.
T Consensus 159 kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 159 KIADFGMARDIYRASYYR-KGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred EeccCccccccCCcccee-cCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999998653221110 0112233567999999876 578999999999999999997 999998776544333221
Q ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 245 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.. .. ......++..+.+||++||+.||++|||+.++|+|
T Consensus 236 ~~---------------------------~~---~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 236 GG---------------------------GR---LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cC---------------------------Cc---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 10 00 01123567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.41 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=200.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|+++++||+|+||.||+|.+. .+..||+|.+... ......+.+|+.+++.++|+||+++++.+... ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-----EP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CC
Confidence 467999999999999999999864 5678999987632 22456788999999999999999999887432 45
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 899999997 5999998753 4689999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 156 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----------- 220 (261)
T cd05072 156 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG----------- 220 (261)
T ss_pred Ccee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----------
Confidence 2211 1123345678999999876 568889999999999999998 99999876644433322211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... .....++..+.+||.+||..||++||+++++++
T Consensus 221 ----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 221 ----------------YRM---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ----------------CCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011 122356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.90 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=197.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCc--EEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE--KVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~--~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (560)
++|++.+.||+|+||.||+|.+..++. .+++|.++. .........+.+|+.++..+ +||||+++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~----- 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACENR----- 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----
Confidence 579999999999999999999887775 468887763 22334456788999999999 699999999987433
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC
Q 008607 100 KDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~ 162 (560)
..+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 35899999998 59999997542 48899999999999999999999999999999999999999
Q ss_pred CcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHH
Q 008607 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241 (560)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~ 241 (560)
+.+||+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999864321111 111223456999999876 578899999999999999997 999998776544332
Q ss_pred HHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 242 ~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.+.. ... ......++..+.+||.+||..||.+|||++++++.
T Consensus 230 ~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLPQ---------------------------GYR---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHhc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2211 000 01123578899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=322.73 Aligned_cols=246 Identities=23% Similarity=0.365 Sum_probs=196.0
Q ss_pred CceEEEEEE--eecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008607 23 SRYKIEEVI--GKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 23 ~~Y~i~~~I--G~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (560)
+.|++.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.+...+ .|+||+++++.+...
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~----- 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL----- 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC-----
Confidence 456666666 99999999999999999999999986421111 133333333 699999999998543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC-cEEEeccccccccc
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAF 177 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~-~lKL~DFGla~~~~ 177 (560)
..+|+||||++ ++|.+++..+..++++.++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 36899999997 59999998888899999999999999999999999999999999999999998 99999999987643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhH-HHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ-LDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-~~~i~~~~g~p~~~~~~ 256 (560)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~------------- 219 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL------------- 219 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH-------------
Confidence 21 23468899999999976 5788999999999999999999999975432210 0000
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCcccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-AEEALADPYFK 317 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-a~elL~hp~f~ 317 (560)
.... . ......+..++.+.+||.+||+.||.+|++ ++|+|+||||.
T Consensus 220 ----------~~~~--~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 220 ----------LKRQ--Q---KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ----------HHhh--c---ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 0101 0 011223468899999999999999999996 59999999996
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.58 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=201.0
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||+|++..+++.||||++... .........+.+|+.+|+.++||||+++++.+... ..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence 5799999999999999999999999999999988642 22334456788999999999999999999988543 46
Q ss_pred EEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 102 IYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
+|+|+||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 8999999994 88887753 345899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ....+
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~------------- 217 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLC------------- 217 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHH-------------
Confidence 32221 1234568889999999876 56788999999999999999999999654321 00100
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..+...... .......+..+.+||.+||..||.+||++.++|+
T Consensus 218 -----------~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 218 -----------QKIEQCDYP--PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred -----------HHHhcCCCC--CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 000000000 0111245678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.19 Aligned_cols=254 Identities=28% Similarity=0.431 Sum_probs=207.3
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
-|++.+.||+|+||.||+|.+..+++.||||.+... ........+.+|+.+++.++|+||+++++.+... ...|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc-cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEE
Confidence 478899999999999999999999999999987642 2223456788999999999999999999988433 4689
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 104 lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 99999985 88888764 469999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 262 (560)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------------- 215 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK----------------- 215 (277)
T ss_pred -hhhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-----------------
Confidence 11234578899999999876 5678899999999999999999999976553322221110
Q ss_pred HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.. .......++..+.++|.+||..||.+||++.++++||||...
T Consensus 216 ----------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 216 ----------NN---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ----------CC---CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 00 011223567889999999999999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=328.11 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=196.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcE--EEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~--vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (560)
+.|++.+.||+|+||.||+|.+..++.. +++|.+... ........+.+|+.+|..+ +|+||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~----- 80 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----- 80 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-----
Confidence 5799999999999999999999888764 577776532 2233456788999999999 899999999988433
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC
Q 008607 100 KDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~ 162 (560)
..+|+||||+. ++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 46899999998 59999987542 47899999999999999999999999999999999999999
Q ss_pred CcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHH
Q 008607 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241 (560)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~ 241 (560)
+.+||+|||++......... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+..+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred CcEEeCccccCcccchhhhc----ccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 99999999998642211110 11234567999999866 568899999999999999998 999998766443322
Q ss_pred HHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 242 ~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.+. ..... ......++.+.+||.+||+.||++||+++++|++
T Consensus 235 ~~~---------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 235 KLP---------------------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHh---------------------------cCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 211 00000 1112467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.91 Aligned_cols=245 Identities=23% Similarity=0.406 Sum_probs=193.5
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEec
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~ 108 (560)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+++|+.++|+||+++++++... ..+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEee
Confidence 46999999999999999999999999886432 233456788999999999999999999988543 468999999
Q ss_pred CC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccc
Q 008607 109 ME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (560)
Q Consensus 109 ~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (560)
+. ++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-cC
Confidence 97 58999987644 68999999999999999999999999999999999999999999999999987543221110 00
Q ss_pred cccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 187 ~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+..
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------------------- 211 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------------------- 211 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc--------------------
Confidence 11123456999999876 568899999999999999997 8899965543222111111
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..... .....+..+.+||++||+.||++|||+.++++
T Consensus 212 -------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 212 -------GVRLP---CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCCCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111 12345788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.56 Aligned_cols=260 Identities=32% Similarity=0.527 Sum_probs=214.7
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
-...+.|++.+.||.|+||.||+|.+..++..|++|++..... ....+.+|+.+++.++|+||+++++.+...
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 87 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG---- 87 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC----
Confidence 3456779999999999999999999999999999999874322 456788999999999999999999988554
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+|+|+||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 88 -DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred -CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 46899999999 59999998876 8999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
..... ......++..|++||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+..
T Consensus 167 ~~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~----------- 230 (286)
T cd06614 167 TKEKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT----------- 230 (286)
T ss_pred ccchh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 32211 1123457889999999876 5688999999999999999999999987655433222211
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
... +.......++..+.+||.+||+.||.+|||+.++|+|+||++.
T Consensus 231 ----------------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 231 ----------------KGI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ----------------cCC-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 000 0111123467889999999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=317.76 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=201.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCC---CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.++|++.+.||+|+||+||+|.+..+ ...||||.+.... .......+.+|+.+|+.++|+||+++++.+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS---- 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC----
Confidence 46799999999999999999988654 4579999886432 233456788999999999999999999987432
Q ss_pred CccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+|+||||+.+ +|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 78 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 78 -RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred -CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 458999999985 899998764 46899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.+..
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 225 (266)
T cd05033 157 EDSEAT-YTTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-------- 225 (266)
T ss_pred cccccc-eeccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--------
Confidence 421111 11112345678999999876 578899999999999999998 999997655443333222110
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
..+ ....++..+.+|+.+||+.||.+||+++|++++
T Consensus 226 -------------------~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 226 -------------------RLP---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -------------------CCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 001 123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.20 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=201.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
...|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.+|+.++|+||+++++.+...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-- 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 467999999999999999999863 35567999988642 233456788999999999999999999988543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAND-------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~-------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~ 162 (560)
..+|+||||+. ++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.+
T Consensus 80 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 ---DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred ---CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 46899999998 59999987543 48999999999999999999999999999999999999999
Q ss_pred CcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHH
Q 008607 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241 (560)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~ 241 (560)
+.+||+|||+++....... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred CcEEeccCCccccccCCce-eecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999975432221 111233456778999999876 578899999999999999998 999998766544333
Q ss_pred HHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 242 ~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.+.. .... ......+..+.+||.+||+.||.+|||+.++++
T Consensus 234 ~i~~---------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 234 CITQ---------------------------GRVL---QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3221 1111 112246788999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.00 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=209.5
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.....|+..+.||+|+||.||++.+..++..||+|++.... ........+.+|+.+++.++|+|++++++++...
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 97 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE---- 97 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC----
Confidence 34455999999999999999999999999999999986432 2233446788999999999999999999988543
Q ss_pred CccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
...|+||||+.|+|.+.+.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus 98 -~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 98 -HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred -CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 35899999999998888765 4569999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.. ....++..|+|||.+... ...++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 177 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---------- 239 (317)
T cd06635 177 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------- 239 (317)
T ss_pred Cc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc----------
Confidence 21 235688999999997421 245788999999999999999999999776544333322210
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
..+ ......+++.+.+||.+||+.||.+||++.++++|+|+..
T Consensus 240 ----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 ----------------ESP---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ----------------cCC---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000 0112346778999999999999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.67 Aligned_cols=246 Identities=26% Similarity=0.429 Sum_probs=202.4
Q ss_pred EEEeecCCeEEEEEEECCC---CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV 105 (560)
+.||+|+||.||+|.+... +..|++|.+....... ....+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEE
Confidence 4699999999999999866 8999999997543332 46778899999999999999999998854 3468999
Q ss_pred EecCC-ccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 106 FELME-SDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 106 ~E~~~-gdL~~~i~~~---------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
|||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+..
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99995 6999999875 6799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
...... ........++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 222 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------- 222 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 543321 111234567889999999876 478899999999999999999 6999988755443332221
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.. .......++..+.++|.+||..||.+|||++|++++
T Consensus 223 ------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 ------------------GY---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------------CC---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00 111224558899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.56 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=199.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||.||+|.+. +++.||+|.+.... .....+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecC-----CC
Confidence 367999999999999999999875 45789999986422 2345688999999999999999999987432 46
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 899999995 69999997654 699999999999999999999999999999999999999999999999999987642
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
..... ......+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+...
T Consensus 156 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 220 (261)
T cd05068 156 DIYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG----------- 220 (261)
T ss_pred Ccccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 22111 111223457999999876 578899999999999999999 99999877654433332211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ......+..+.+||.+||+.||.+||++.++++
T Consensus 221 ----------------~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 221 ----------------YRM---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ----------------CCC---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 001 112356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=326.13 Aligned_cols=256 Identities=27% Similarity=0.516 Sum_probs=208.3
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.|....+||+|+||.||++.+..+|+.||||++... .......+.+|+.+++.++|+||+++++.+... ...|
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 93 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELW 93 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEE
Confidence 344457899999999999999999999999998632 223456688999999999999999999988543 4689
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 104 lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
+||||+++ +|.+++. ...+++..++.++.||+.||+|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 94 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~- 171 (292)
T cd06657 94 VVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 171 (292)
T ss_pred EEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence 99999985 7877664 45789999999999999999999999999999999999999999999999999875433221
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 262 (560)
......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+....+..+..
T Consensus 172 --~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~----------------- 230 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD----------------- 230 (292)
T ss_pred --cccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------------
Confidence 1234578899999999876 5678899999999999999999999987665443332221
Q ss_pred HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
..+.. ......+++.+.+||.+||+.||.+||++.++|+||||....
T Consensus 231 ----------~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 231 ----------NLPPK-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ----------hCCcc-cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 00111 112245688899999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.28 Aligned_cols=252 Identities=21% Similarity=0.383 Sum_probs=200.9
Q ss_pred CceEEEEEEeecCCeEEEEEEE----CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYD----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d----~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
+.|++.+.||+|+||+||+|.+ ..++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE---- 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC----
Confidence 4689999999999999999985 3456789999987432 233446788999999999999999999987543
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 99 FKDIYVVFELME-SDLHQVIKAN-----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~-----------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
...|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 -QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred -CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 35899999998 5999988532 2478899999999999999999999999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhH
Q 008607 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (560)
.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCccee-cccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999997653322111 1233455678999999876 568899999999999999998 9999987664433
Q ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 240 ~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
+..+.. .... .....+++.+.+||.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRK---------------------------RQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 332211 1111 1223567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=317.98 Aligned_cols=248 Identities=28% Similarity=0.397 Sum_probs=198.5
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.++||+|+||.||+|.+..+ ..||+|++.... .....+.+|+.+++.++|+||+++++.+.. .
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~ 73 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E 73 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEECC------C
Confidence 347899999999999999999988665 469999987422 233567899999999999999999887622 2
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..|+||||+. ++|.+++... ..++++.+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 4799999998 5999999763 358999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
...... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+...
T Consensus 154 ~~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~---------- 219 (262)
T cd05071 154 DNEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---------- 219 (262)
T ss_pred cccccc--ccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC----------
Confidence 322111 122346678999999866 578899999999999999999 88999876544433322110
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... .....++..+.+||.+||+.||.+||+++++++
T Consensus 220 -----------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 220 -----------------YRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----------------CCC---CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000 112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=325.35 Aligned_cols=258 Identities=27% Similarity=0.417 Sum_probs=208.2
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
...+|...+.||+|+||.||+|++..++..+|+|.+.... .......++.+|+++++.++|+|++++++++...
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----- 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----
Confidence 4456888999999999999999999999999999986422 2223445788999999999999999999988543
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
...|+||||+.++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 35899999999988887754 44689999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
. ....++..|+|||.+.+. ...++.++|||||||++|+|++|..||...+....+..+..
T Consensus 168 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------ 228 (308)
T cd06634 168 A-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------ 228 (308)
T ss_pred c-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh------------
Confidence 1 235688899999997431 13578899999999999999999999976543332221111
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
... + ......++..+.+||++||..+|.+||++++++.|||+...
T Consensus 229 --------------~~~--~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 229 --------------NES--P-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred --------------cCC--C-CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 000 0 01123567889999999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=318.18 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=202.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCc---EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
..+|++.+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS---- 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC----
Confidence 4689999999999999999999876554 79999886432 233456788999999999999999999988432
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 78 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 78 -KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred -CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 46899999998 5899999765 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
..............++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-------- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC--------
Confidence 433221111122233567999999976 578899999999999999886 999998766544433332211
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..+ ....+++.+.+|+.+||+.+|.+||++.++++
T Consensus 227 -------------------~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 227 -------------------RLP---APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------------cCC---CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 011 12346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=316.13 Aligned_cols=245 Identities=21% Similarity=0.322 Sum_probs=196.0
Q ss_pred EEEeecCCeEEEEEEECCCC---cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg---~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV 105 (560)
++||+|+||.||+|....++ ..+|+|.+...... .....+.+|+.+++.+.|+||+++++++.. ..+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence 46999999999999876554 78999998753322 455678899999999999999999997632 257999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcc
Q 008607 106 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (560)
Q Consensus 106 ~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~ 184 (560)
|||+. ++|.+++..+..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99998 59999998888899999999999999999999999999999999999999999999999999986543322111
Q ss_pred cccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHH
Q 008607 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (560)
Q Consensus 185 ~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 263 (560)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~------------------ 213 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES------------------ 213 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc------------------
Confidence 1111223457999999876 578899999999999999998 9999977665433322211
Q ss_pred HHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. .. ......++..+.+||.+||..||++||++.++++
T Consensus 214 ------~---~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 214 ------G---ER---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ------C---Cc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 00 1122456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=317.97 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=198.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
...|++.+.||+|+||.||++.+. ++..+|+|++.... .....+.+|+++++.++|+||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 73 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RP 73 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----Cc
Confidence 346899999999999999999875 56789999986422 2234678899999999999999999987433 46
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.|+||||++ ++|.+++..+ ..++++.++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 899999997 4899998764 46899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+...
T Consensus 154 ~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05059 154 QYTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG------------ 217 (256)
T ss_pred cccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC------------
Confidence 2111 111223457999999876 578899999999999999999 89999876544333222110
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
... .....++..+.+|+.+||..+|++|||++|+++.
T Consensus 218 ---------------~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 218 ---------------YRL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ---------------CcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 000 1123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=316.79 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=201.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCc---EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.+.|+..+.||+|+||.||+|.+..++. .+|+|++.... .......+.+|+++++.++|+||+++.+++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF---- 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC----
Confidence 4679999999999999999999887665 79999886432 233456788999999999999999999988433
Q ss_pred CccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
...|+||||+++ +|.+++... +.+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 79 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 79 -KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred -CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 458999999985 898888764 57899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...............+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~------- 228 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR------- 228 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC-------
Confidence 433221111111223457999999876 568899999999999999997 9999987665444443322110
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.+ ....++..+.+|+.+||+.||.+||++.++++
T Consensus 229 --------------------~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 229 --------------------LP---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred --------------------CC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01 11245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=319.29 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=202.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
..|++.++||.|+||.||+|.+.. +..+|+|++... .......+.+|+.+|+.++|+||+++++++... ..+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 77 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPV 77 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCe
Confidence 458999999999999999999987 899999998742 233456788999999999999999999987433 458
Q ss_pred EEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999985 999999763 36899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
... .....++..|+|||.+.. ..++.++|||||||++|+|++ |+.||.+.+..+.+..+.....
T Consensus 158 ~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 222 (261)
T cd05148 158 VYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR---------- 222 (261)
T ss_pred ccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc----------
Confidence 211 123345678999999876 578899999999999999998 8999988765444433321100
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. ......++.+.++|.+||+.||.+|||+.++++
T Consensus 223 -----------------~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 223 -----------------M---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -----------------C---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 112456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=316.68 Aligned_cols=247 Identities=27% Similarity=0.385 Sum_probs=198.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.+++.++|+||+++++.+.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC------CC
Confidence 457999999999999999999765 566799999874222 24568899999999999999999987632 24
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 799999998 5999998763 3589999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+...
T Consensus 155 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05070 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----------- 219 (260)
T ss_pred ccccc--ccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 22111 122345667999999866 578899999999999999999 89999877655444433211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ......+..+.+||.+||..||.+|||++++++
T Consensus 220 ----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 220 ----------------YRM---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ----------------CCC---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 011 112356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=314.82 Aligned_cols=253 Identities=28% Similarity=0.461 Sum_probs=201.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.. .........+.+|+++++.++|+||+.+++.+... ..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 5799999999999999999999999999999988632 22333456788999999999999999999988543 46
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 102 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
.++||||++ ++|.+++.. ...++++.++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 899999998 499988864 235899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ..+
T Consensus 157 ~~~~~~---~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~--------------- 215 (267)
T cd08224 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYS--------------- 215 (267)
T ss_pred cCCCcc---cceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHH---------------
Confidence 322211 234568899999999876 57889999999999999999999999654311 000
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..+.+......+. .....+..+.++|.+||..||.+|||+.++++
T Consensus 216 ---------~~~~~~~~~~~~~--~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 216 ---------LCKKIEKCDYPPL--PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---------HHhhhhcCCCCCC--ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0011100000000 01246778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=321.93 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=203.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCC----------------cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG----------------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg----------------~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv 85 (560)
.++|++++.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+++|+.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 357999999999999999999877644 457999987432 224566788999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 008607 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (560)
Q Consensus 86 ~l~~i~~~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~-----------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLK 153 (560)
++++++... ...++|||++. ++|.+++.... .+++..++.++.||+.||+|||+.||+|||||
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 83 RLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred EEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 999988543 46899999998 58999987765 68999999999999999999999999999999
Q ss_pred CCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh--CCCCC
Q 008607 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLF 231 (560)
Q Consensus 154 P~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt--G~~pF 231 (560)
|+|||++.++.++|+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 99999999999999999998764332211 11233456788999999876 578899999999999999998 67888
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008607 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (560)
Q Consensus 232 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL 311 (560)
...+....+..+.... ............+.++..+.+||.+||+.||.+|||+.|++
T Consensus 235 ~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 235 EHLTDQQVIENAGHFF-----------------------RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred CCcChHHHHHHHHhcc-----------------------ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 7655444333222111 00001111112245678999999999999999999999996
Q ss_pred c
Q 008607 312 A 312 (560)
Q Consensus 312 ~ 312 (560)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.06 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=201.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCC-----cEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg-----~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~ 95 (560)
.++|++.+.||+|+||.||++.+.... ..+|+|.+.... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE- 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC-
Confidence 368999999999999999999876443 789999987432 233456788999999999 799999999988433
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCee
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKA----------------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 158 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~----------------~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NIL 158 (560)
..+|+||||+. ++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 89 ----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 89 ----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred ----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 45899999997 599999864 235889999999999999999999999999999999999
Q ss_pred eCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChh
Q 008607 159 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVV 237 (560)
Q Consensus 159 l~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~ 237 (560)
++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999998654322111 1122334567999999866 578899999999999999997 99999877654
Q ss_pred hHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 238 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
+....+.. ... .......+..+.+||.+||..||++|||+.|++++
T Consensus 242 ~~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKE---------------------------GYR---MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 43332211 000 01123567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=315.34 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=198.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.+.|++.+.||+|+||+||++.+.. +..+|||.+.... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CC
Confidence 4579999999999999999997654 4569999886422 2345688999999999999999999988433 35
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||+.||+|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 799999997 58999987643 6899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 154 ~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05113 154 EYTS--SVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG------------ 217 (256)
T ss_pred ceee--cCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC------------
Confidence 2111 112335677999999976 568899999999999999998 99999776644333322211
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.... .....+..+.+|+.+||..||.+|||+.+++.+
T Consensus 218 ---------------~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 218 ---------------LRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------------CCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0000 112357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=317.79 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=200.6
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCc----EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
..++|++.++||+|+||+||+|.+..++. .||+|.+... ........+.+|+.+++.+.|+||+.+++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-- 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--
Confidence 45689999999999999999999877776 4899988643 2333456788999999999999999999988542
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
..++++||++ |+|.+++..+ +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ----~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 82 ----TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred ----CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 3689999998 6999999764 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------- 226 (279)
T cd05109 158 LLDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-------- 226 (279)
T ss_pred ecccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--------
Confidence 65332211 11122334678999999866 578899999999999999998 8999976553332221111
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... ......+..+.+||.+||..||++||++.+++.
T Consensus 227 -------------------~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 227 -------------------GERL---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -------------------CCcC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 112456788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=316.69 Aligned_cols=252 Identities=22% Similarity=0.370 Sum_probs=201.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCC-----cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg-----~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+|+.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc-cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--
Confidence 468999999999999999999886544 88999998643 2334456788999999999999999999988543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcE
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~----------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~l 165 (560)
...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 82 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 ---QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred ---CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 46899999997 6999998653 236788999999999999999999999999999999999999999
Q ss_pred EEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHH
Q 008607 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (560)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~ 244 (560)
||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+....+..+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999999765332211 11133456788999999865 568899999999999999998 999998766544332221
Q ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 245 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..... ......+..+.+||.+||+.||++|||+.++++
T Consensus 236 ---------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 ---------------------------DGGHL---DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ---------------------------cCCCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11111 112345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=321.05 Aligned_cols=262 Identities=24% Similarity=0.398 Sum_probs=205.4
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~ 99 (560)
..+.|++.+.||+|+||.||+|.+..+++.||||.+..... ......+.+|+.++..+. |+||+++++.+...
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~----- 86 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD----- 86 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecC-----
Confidence 34679999999999999999999999999999999874322 234456777888776665 99999999988543
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|+||||+++.|.+++.. ...+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 46899999999888888766 4579999999999999999999997 599999999999999999999999999987643
Q ss_pred CCCCCcccccccccCccccccccccccc--CCCCCccchhhHHHHHHHHhhCCCCCCCCChh-hHHHHHHHhcCCCCHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~~~~i~~~~g~p~~~~ 254 (560)
..... ....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||...... +.+..+.
T Consensus 167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------- 232 (296)
T cd06618 167 DSKAK----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL---------- 232 (296)
T ss_pred CCCcc----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh----------
Confidence 22211 2335788899999986521 34788999999999999999999999653221 1111110
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.. . ...+ .....++..+.+||.+||..||.+||+++++++||||..+.
T Consensus 233 -------------~~---~-~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 233 -------------QE---E-PPSL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred -------------cC---C-CCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 00 0 0000 11124678899999999999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=318.22 Aligned_cols=270 Identities=23% Similarity=0.395 Sum_probs=201.1
Q ss_pred CCceEEEEEEeecCCeEEEEEE----ECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
..+|++.+.||+|+||.||++. +..++..||||++... .......+.+|+++|+.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-- 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC--
Confidence 4589999999999999999987 4568899999998642 3344567889999999999999999999875432
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
...+++||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 -~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 79 -RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred -CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 235899999997 5999999764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...............++..|+|||.+.+ ..++.++|||||||++|||++|..++...... .. ...+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~----~~~~~~~~~~- 229 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FM----RMMGNDKQGQ- 229 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hh----hhcccccccc-
Confidence 5332221111112234456999999876 57889999999999999999998776443211 11 1111100000
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.......+.+...... .....++..+.+||.+||..||++|||+.|+++
T Consensus 230 -----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 230 -----MIVYHLIELLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred -----cchHHHHHHHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0000111111111111 123467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=357.75 Aligned_cols=256 Identities=27% Similarity=0.383 Sum_probs=200.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.++||+|+||.||+|++..+|+.||||++..... ......++.+|+.+++.++||||+++++++.. ...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence 579999999999999999999999999999999975332 23345678999999999999999999998843 346
Q ss_pred EEEEEecCCc-cHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEec
Q 008607 102 IYVVFELMES-DLHQVIKAN-----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~-----------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~D 169 (560)
.|+||||++| +|.+++... ..++...+..++.||+.||+|||+.||+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 8999999985 899888641 2355677889999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCC---------------cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCC
Q 008607 170 FGLARVAFNDTPT---------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (560)
Q Consensus 170 FGla~~~~~~~~~---------------~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~ 234 (560)
||+++........ .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999865211100 001123579999999999876 57899999999999999999999999775
Q ss_pred ChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 235 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 235 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
+....... .... .+... ..+..+++.+.+++.+||..||++|++..+.|.+
T Consensus 235 ~~~ki~~~--~~i~-------------------------~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYR--DVIL-------------------------SPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhh--hhcc-------------------------Chhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43221110 0000 00000 1124678889999999999999999887665543
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=313.92 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=200.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.++||+|+||.||+|.+. .+..||||.+... ......+.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPG---TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCC---ccCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCc
Confidence 468999999999999999999875 4578999998742 2334678899999999999999999998743 245
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.++||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 899999998 48999997643 689999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......
T Consensus 156 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 223 (261)
T cd05034 156 DEYTA--REGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------- 223 (261)
T ss_pred hhhhh--hhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 21110 112234567999999876 578899999999999999998 99999887655544443221110
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
......+..+.++|.+||..||.+||+++++++
T Consensus 224 ----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 ----------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 111344778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=317.72 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=201.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||+|++..+++.+|||++.... ........+.+|+.+++.++|+||+++++.+... ..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----Ce
Confidence 46899999999999999999999999999999886422 2333456788999999999999999999988543 46
Q ss_pred EEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 102 IYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
+++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 8999999985 89888863 346899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+...... . +
T Consensus 157 ~~~~~~---~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~-~------------- 216 (267)
T cd08229 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-S-L------------- 216 (267)
T ss_pred ccCCcc---cccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHH-H-H-------------
Confidence 332211 234578999999999876 5688899999999999999999999976442110 0 0
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
...+...... .......+..+.+||.+||..||.+|||++++++
T Consensus 217 ----------~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 217 ----------CKKIEQCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------hhhhhcCCCC--CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0000000000 0112346788999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.56 Aligned_cols=251 Identities=21% Similarity=0.350 Sum_probs=200.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCC-----CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~t-----g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
..|++.+.||+|+||.||+|.+..+ +..||||+++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--- 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--- 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC---
Confidence 4588899999999999999987543 5789999987432 223346688999999999999999999998544
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
..+++++||+. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 81 --~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 81 --QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred --CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 35899999998 5898888532 2478889999999999999999999999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhH
Q 008607 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (560)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCCceEecccccccccccchhe-eeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999998764322211 11233456788999999865 568899999999999999998 8899987665544
Q ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 240 ~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
+..+... ... .....++..+.+|+.+||+.||.+||+++++++
T Consensus 236 ~~~i~~~---------------------------~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 236 IEMIRNR---------------------------QVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHHcC---------------------------CcC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 4333221 111 112357788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=314.65 Aligned_cols=252 Identities=29% Similarity=0.501 Sum_probs=201.8
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc---cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~---~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
||.+.+.||+|+||.||++.+..++..+++|.++... ........+.+|+.+++.++||||+++++.+... .
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence 6999999999999999999999888877777765322 1223445677899999999999999999987543 3
Q ss_pred cEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 101 DIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..++|+||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++. +.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 58999999985 88887753 456999999999999999999999999999999999999975 5699999999876
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+.. .
T Consensus 155 ~~~~~~---~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---~------ 220 (260)
T cd08222 155 LMGSCD---LATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---G------ 220 (260)
T ss_pred cCCCcc---cccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---C------
Confidence 543222 1234568889999999865 5678899999999999999999999976554332222111 0
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
........++..+.+||.+||..||.+||+++|+++||||
T Consensus 221 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 221 ---------------------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ---------------------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0111123567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=313.60 Aligned_cols=247 Identities=28% Similarity=0.413 Sum_probs=199.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.+.|+++++||+|+||.||+|.+. +++.||+|.+.... .....+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CC
Confidence 467999999999999999999864 57789999987422 234578899999999999999999987632 24
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 799999997 5999988753 3689999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
..... .....++..|+|||.+.. ..++.++|||||||++|+|++ |++||.+.+..+....+....
T Consensus 155 ~~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 220 (260)
T cd05067 155 NEYTA--REGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY---------- 220 (260)
T ss_pred CCccc--ccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC----------
Confidence 22111 122345678999999876 568899999999999999999 999998776544433322111
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.. ......+..+.+||.+||..||++|||++++++
T Consensus 221 -----------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 221 -----------------RM---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------------CC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 112345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=314.33 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=201.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCc---EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.+.|++.+.||+|+||.||+|.+..+++ .||||.+.... .......+.+|+.+++.++||||+++++.+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 77 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS---- 77 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC----
Confidence 3569999999999999999999887765 59999987532 334456789999999999999999999988433
Q ss_pred CccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+++||||+++ +|.+++... +.+++..++.++.|++.||.|||++|++|+||||+|||++.++.+||+|||++...
T Consensus 78 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 78 -RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred -CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 458999999985 899888764 46899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccc--ccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 177 FNDTPTAIFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 177 ~~~~~~~~~~~~~--~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
............. ..+..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~------- 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD------- 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------
Confidence 4322211111111 12457999999876 578899999999999999886 99999876654433332211
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
...+ ....++..+.+|+.+||..||.+||++++++.
T Consensus 228 --------------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 --------------------YRLP---PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred --------------------CcCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0111 12356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=335.88 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=197.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCC-----CcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~t-----g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~ 95 (560)
.++|++.++||+|+||.||+|.+... +..||||++... ........+.+|+++|+.+. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~- 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS- 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence 46789999999999999999987433 457999998643 23344567899999999996 99999999998443
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~------------------------------------------------------ 120 (560)
..+|||||||. |+|.+++..+
T Consensus 114 ----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 114 ----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred ----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 46899999998 5898887542
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCee
Q 008607 121 ------------------------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 158 (560)
Q Consensus 121 ------------------------------------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NIL 158 (560)
..+++..+..++.||+.||+|||+.+|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 23778889999999999999999999999999999999
Q ss_pred eCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChh
Q 008607 159 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVV 237 (560)
Q Consensus 159 l~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~ 237 (560)
++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999999865332211 11123456788999999876 578999999999999999997 99999765432
Q ss_pred hHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 238 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..+... +...... .....++..+.+||.+||+.||++|||+.++.+
T Consensus 347 ~~~~~~--------------------------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNK--------------------------IKSGYRM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHH--------------------------HhcCCCC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 211110 0000000 112356788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=318.50 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=199.4
Q ss_pred CceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
..|.+.+.||+|+||.||+|.+. .++..+++|.+.. ........+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--- 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC---
Confidence 46999999999999999999754 3456789998864 2233446688999999999999999999988443
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
...++||||++ ++|.+++..+. .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 80 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 80 --DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 45899999997 59999997542 388999999999999999999999999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhH
Q 008607 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (560)
.++.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred cCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999976433221 111234567888999999876 578899999999999999998 9999977654433
Q ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 240 ~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
++.+.. .. ........+..+.+||.+||+.||++|||+.++++
T Consensus 235 ~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQ---------------------------GR---VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhC---------------------------CC---CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 322211 00 01112345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=319.52 Aligned_cols=258 Identities=22% Similarity=0.374 Sum_probs=198.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCC--------------cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTG--------------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg--------------~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~ 88 (560)
++|++.+.||+|+||.||+|++..++ ..||+|+++... .......+.+|+++|+.++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 58999999999999999999875432 358999987432 233445788999999999999999999
Q ss_pred eeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 008607 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKAND------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPK 155 (560)
Q Consensus 89 ~i~~~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~ 155 (560)
+.+... ..+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+
T Consensus 84 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 84 GVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred EEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 988543 45899999998 48999886532 3688899999999999999999999999999999
Q ss_pred CeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh--CCCCCCC
Q 008607 156 NILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPG 233 (560)
Q Consensus 156 NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt--G~~pF~~ 233 (560)
|||++.++.+||+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||..
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999764322211 11122345678999999876 568999999999999999988 6678877
Q ss_pred CChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 234 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.+....+..+... +..... ..+....+..++.+.+||.+||+.||.+||+++++++
T Consensus 236 ~~~~~~~~~~~~~--------------------~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEF--------------------FRNQGR---QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHh--------------------hhhccc---cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 6654433322211 111000 0111123346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=311.60 Aligned_cols=243 Identities=23% Similarity=0.395 Sum_probs=197.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
..+|++.+.||+|+||.||++.. .|..||+|.+... .....+.+|+.+++.++|+|++++++++... ...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~ 74 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 74 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCc
Confidence 35799999999999999999965 4888999988632 2345688999999999999999999876432 235
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+|+||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 899999998 59999997654 488999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus 155 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05082 155 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 214 (256)
T ss_pred cC------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------
Confidence 22 22344567999999876 578899999999999999997 9999976554332222111
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ....+.+++.+.+||.+||..||++|||+.++++
T Consensus 215 ---------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 215 ---------------GYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ---------------CCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 100 1122467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=317.54 Aligned_cols=267 Identities=25% Similarity=0.335 Sum_probs=198.7
Q ss_pred Cce-EEEEEEeecCCeEEEEEE----ECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 23 SRY-KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 23 ~~Y-~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
+|| ++++.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+|+.++||||+++++.+...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--- 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 456 999999999999998764 34578899999987432 223456778999999999999999999987432
Q ss_pred CCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 98 EFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 98 ~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
....+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 22468999999984 898888764 5999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHh-cCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL-LGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~-~g~p~~~~~ 255 (560)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... +..+... .+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~--- 230 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTV--- 230 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccch---
Confidence 432221111123345677999999876 56889999999999999999999998653311 1111110 000000
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
......+. .... ......++..+.+|+.+||+.||++|||++++++
T Consensus 231 -----~~~~~~~~---~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 231 -----VRLIELLE---RGMR---LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -----hhhhhhhh---cCCC---CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00001111 1111 1122456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.80 Aligned_cols=247 Identities=28% Similarity=0.393 Sum_probs=197.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
..+|++.+.||+|+||.||+|.+..+ ..+|+|.+... ......+.+|+.+++.++|+|++++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPG---TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccC---CccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CC
Confidence 46799999999999999999987655 46999987632 1234567889999999999999999887632 24
Q ss_pred EEEEEecCCc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.|+||||+.+ +|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+|||+++++.+||+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 7999999985 9999997643 489999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+....+....+...
T Consensus 155 ~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05069 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG----------- 219 (260)
T ss_pred Ccccc--cCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 22111 122345678999998876 568899999999999999999 89999876654433322210
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ......+..+.+||++||..||.+||+++++++
T Consensus 220 ----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 220 ----------------YRM---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ----------------CCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001 112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=341.79 Aligned_cols=243 Identities=31% Similarity=0.509 Sum_probs=200.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (560)
...|++...+|.|+|++|-.+.+..++...++|++.+. .....+|+.++... .|+||+++++++ .+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeeccee-----cCCc
Confidence 45688888899999999999999999999999999754 11223577665544 699999999998 4456
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee-CCCCcEEEecccccccccC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA-NADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl-~~~~~lKL~DFGla~~~~~ 178 (560)
++|+|||++.| .|.+.|.....+. ..+..|+.||+.|+.|||++||+||||||+|||+ +..+.|+|||||.++....
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 89999999996 6777776665555 7888899999999999999999999999999999 6889999999999987644
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
+ +.+-|-|..|.|||++.. ..|+.++||||||++||+||+|+.||...... ++++.. ++.+
T Consensus 469 ~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~-i~~~-------- 529 (612)
T KOG0603|consen 469 S------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTR-IQMP-------- 529 (612)
T ss_pred h------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHh-hcCC--------
Confidence 3 234578899999999986 78999999999999999999999999765443 111111 1111
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
+++ ..+|..+++||+.||++||.+|+++.+++.||||
T Consensus 530 ------------------~~s---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 530 ------------------KFS---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------------------ccc---cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 111 4679999999999999999999999999999999
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=318.43 Aligned_cols=263 Identities=22% Similarity=0.391 Sum_probs=205.4
Q ss_pred ceEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEecCcc--cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~ 97 (560)
.|++.+.||+|+||.||++.+. .+++.||||.+.+.. ........+.+|+.++..+ +|+||+.+++++...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--- 77 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--- 77 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC---
Confidence 4899999999999999999864 467899999986421 1223345678999999999 599999999887433
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+|+||||+. ++|.+++.....+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||+++..
T Consensus 78 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 78 --TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred --CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 46899999998 499999988778999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
...... ......|+..|+|||.+.+.....+.++|||||||++|+|++|..||...+.......+.+
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----------- 222 (288)
T cd05583 156 LAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------- 222 (288)
T ss_pred cccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-----------
Confidence 332211 1123468899999999865322367899999999999999999999965432211111110
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGLA 320 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt---a~elL~hp~f~~~~ 320 (560)
..... . ......+++.+.+||.+||+.||++||| +.++|+||||+.+.
T Consensus 223 --------~~~~~---~-----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 223 --------RILKS---K-----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred --------HHHcc---C-----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 00100 0 1112346788999999999999999998 57789999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.60 Aligned_cols=244 Identities=25% Similarity=0.438 Sum_probs=199.9
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..+.|++.+.||.|+||.||+|.+ .|+.||+|++..... ...++.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 73 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----N 73 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----C
Confidence 356799999999999999999976 488999999975322 467788999999999999999999988542 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..|+||||++ ++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence 5899999998 59999998765 69999999999999999999999999999999999999999999999999997652
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... .....+..|+|||.+.. ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 154 ~~~------~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----------- 214 (256)
T cd05039 154 QGQ------DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK----------- 214 (256)
T ss_pred ccc------ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-----------
Confidence 221 12334567999999865 568889999999999999997 9999976654332221111
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... .......++.+.+||.+||..+|.+|||++|+++
T Consensus 215 ----------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 215 ----------------GYR---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ----------------CCC---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 0112346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=317.02 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=200.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.++|.+.++||+|+||.||++... .++..+|+|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG-- 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--
Confidence 357899999999999999999743 35678999988642 334456788999999999999999999988543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAND---------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~---------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
...++||||+. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++
T Consensus 80 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 ---RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred ---CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 35899999998 58999987643 488999999999999999999999999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhH
Q 008607 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (560)
+++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 9999999999999754322211 11123345678999999876 578999999999999999998 9999977655443
Q ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 240 ~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
+..+.. .... .....+++.+.+||.+||+.||.+||+++|+++
T Consensus 234 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 234 IECITQ---------------------------GREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHc---------------------------CccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 332211 0000 112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.94 Aligned_cols=266 Identities=18% Similarity=0.205 Sum_probs=194.7
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCC---CcEEEEEEecCcccChhHH---------HHHHHHHHHHHhcCCCCccccc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDA---------TRILREIKLLRLLRHPDIVEIK 88 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~---------~~i~rEi~iL~~l~HpnIv~l~ 88 (560)
.+++|++.++||+|+||.||+|.+..+ +..+|+|+........... .....++..+..+.|+||+.++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 457899999999999999999998877 6677777643211111000 1122344455667899999999
Q ss_pred eeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEe
Q 008607 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (560)
Q Consensus 89 ~i~~~~~~~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~ 168 (560)
+....... .....+++++++..++.+.+.....+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRC-RMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecC-CceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 86543221 11245788998888888887776667899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCc----ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHH
Q 008607 169 DFGLARVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (560)
Q Consensus 169 DFGla~~~~~~~~~~----~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~ 244 (560)
|||+|+......... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+....
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999998653221110 11123479999999999877 578999999999999999999999998764322211111
Q ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 245 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. ..++..+.... ...+..+..+.++++.|+..||++||+.+++++
T Consensus 247 ~------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 K------------------CDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred H------------------HHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 11122211111 123456788999999999999999999999975
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=321.21 Aligned_cols=252 Identities=25% Similarity=0.419 Sum_probs=198.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECC-------CCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPP 94 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~-------tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~ 94 (560)
++|.+.+.||+|+||.||+|.+.. +...+|+|.+... ........+.+|+.+++.+ +|+||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 689999999999999999998643 3357999998743 2233456788999999999 799999999988433
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 008607 95 SRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 157 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NI 157 (560)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||
T Consensus 97 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 97 -----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 46899999998 59999997642 478899999999999999999999999999999999
Q ss_pred eeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCCh
Q 008607 158 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (560)
Q Consensus 158 Ll~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 236 (560)
|++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred EEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999998754322111 01112234568999999876 568899999999999999998 8899977654
Q ss_pred hhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 237 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.+....+.. ... ......++..+.+||.+||..+|.+|||+.+++++
T Consensus 249 ~~~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 EELFKLLKE---------------------------GHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHc---------------------------CCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 333222211 101 11223567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=324.14 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=221.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~ 99 (560)
...|.++.+||+|+||.|.+|..+.|.+.||||++++. .....+.+....|-++|.... -|.+++++..|.+.+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD---- 423 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD---- 423 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh----
Confidence 35688999999999999999999999999999999753 334456666778999998774 678999999886655
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|+||||+. |||...|+.-+++.|.++.+++.+|+-||-|||+.|||.||||.+|||++.+|.+||+|||+++....
T Consensus 424 -RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 424 -RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred -heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 4999999998 59999999999999999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
+.. ...++|||+.|+|||++.- .+|+.++|.||+||+|||||.|++||.|.+..+.+..|.+...
T Consensus 503 ~~~---TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv---------- 567 (683)
T KOG0696|consen 503 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV---------- 567 (683)
T ss_pred CCc---ceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC----------
Confidence 222 2357899999999999864 7999999999999999999999999999999888887765211
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~~ 320 (560)
.....+|.++.++++.+|.+.|.+|.. -.+|-.||||+.+.
T Consensus 568 ---------------------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 568 ---------------------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred ---------------------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 122357889999999999999999964 45788999998653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=309.28 Aligned_cols=245 Identities=29% Similarity=0.494 Sum_probs=202.6
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008607 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (560)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~ 109 (560)
||.|+||.||++.+..+++.+|+|.+.... ........+.+|+.+++.++|+||+++++.+.. ...+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-----EEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-----CCeeEEEEecC
Confidence 699999999999999999999999987532 222345678899999999999999999988743 34689999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccc
Q 008607 110 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188 (560)
Q Consensus 110 ~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 188 (560)
. ++|.+++.....+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 5 69999998887899999999999999999999999999999999999999999999999999976543321 1244
Q ss_pred cccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHH
Q 008607 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 268 (560)
Q Consensus 189 ~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~ 268 (560)
..++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------------- 207 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------------------- 207 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------------
Confidence 578889999999876 4578899999999999999999999977654222221111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCccc
Q 008607 269 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA---EEALADPYF 316 (560)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta---~elL~hp~f 316 (560)
... ......+..+.+||++||..||++||++ +++++||||
T Consensus 208 -----~~~---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 -----DPL---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -----CCC---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 000 1112347889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.04 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=197.7
Q ss_pred EEEeecCCeEEEEEEECC-CCc--EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTR-TGE--KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~-tg~--~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV 105 (560)
++||+|++|+||+|.+.. +++ .||||.+...... .....+.+|+.+++.++|+||+++++++.. ..+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence 468999999999999865 333 6999999764333 456788999999999999999999998854 468999
Q ss_pred EecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 106 FELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 106 ~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
|||++ ++|.+++..+. .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99997 69999998764 6899999999999999999999999999999999999999999999999999876432221
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE--------------- 216 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---------------
Confidence 111123456788999999876 578899999999999999998 99999876655443332210
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... ......+..+.+|+.+||..+|++||++.++++
T Consensus 217 -----------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 217 -----------GERL---ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -----------CCcC---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0000 011245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.90 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=197.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCc----EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.+|++.+.||+|+||+||+|.+..++. .+++|.+... ........+..|+.+++.+.||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~----- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG----- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----
Confidence 578999999999999999999887776 4777776532 122334567788999999999999999998632
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
...++|+||+. |+|.+++... +.+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 24689999998 6999999764 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
..... ........++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.......+.+..
T Consensus 160 ~~~~~-~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---------- 226 (279)
T cd05111 160 YPDDK-KYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK---------- 226 (279)
T ss_pred cCCCc-ccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----------
Confidence 33221 112234456778999999876 578999999999999999998 9999987664332222211
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..... ....++..+.+++.+||..||.+|||+.|+++
T Consensus 227 -----------------~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 227 -----------------GERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11111 11234667899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=317.16 Aligned_cols=271 Identities=24% Similarity=0.378 Sum_probs=203.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEE----CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYD----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d----~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
..-|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+|+.++|+||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG-- 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--
Confidence 44589999999999999999973 5678899999986432 2334567889999999999999999999875432
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
...+++||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 80 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 80 -GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred -CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence 245899999997 58999987653 589999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...............++..|+|||.+.+ ..++.++|||||||++|+|+++..|+.... ....+..+....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~-----~~~~~~~~~~~~~~~ 231 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPM-----TLFLKMIGPTHGQMT 231 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCcccc-----chhhhhccccccccc
Confidence 5432221112234556778999999876 578899999999999999999886653321 111122221111100
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
....+..+...... .....++..+.+||.+||+.||.+|||+++++++
T Consensus 232 -------~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 232 -------VTRLVRVLEEGKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred -------HHHHHHHHHcCccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00111111111111 1234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=337.04 Aligned_cols=259 Identities=25% Similarity=0.323 Sum_probs=207.6
Q ss_pred cccCCC-CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 17 TEYGEG-SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 17 ~~~~~~-~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
.+|.+. +...+.+.||+|+||+||+|++ --.||||+++...-+....+.|.+|+.+|++-+|.||+-+.+++..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 344443 6678999999999999999964 347999999877777778899999999999999999999999886543
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 96 RREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
+.||+.+|+| +|+.++.-. ..|.......|++||++|+.|||.++|||||||..||++.++++|||+||||+
T Consensus 462 ------~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 ------LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ------eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccce
Confidence 4899999998 899988654 36889999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccccccccc-ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHH-HhcCCCC
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT-DLLGTPS 251 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~-~~~g~p~ 251 (560)
.+.... ..........|...|||||++.. ...+|++.+|||||||++|||++|..||.. +..+|+-.+. ...+.|
T Consensus 536 tvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifmVGrG~l~p- 612 (678)
T KOG0193|consen 536 TVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFMVGRGYLMP- 612 (678)
T ss_pred eeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEEecccccCc-
Confidence 864322 11112233467888999999842 235799999999999999999999999994 4344432111 111111
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.......+++.++++|+..||.+++++||.+.+||.
T Consensus 613 -------------------------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 613 -------------------------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -------------------------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 122333566779999999999999999999999986
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.78 Aligned_cols=243 Identities=22% Similarity=0.343 Sum_probs=192.0
Q ss_pred EeecCCeEEEEEEEC--CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEec
Q 008607 31 IGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108 (560)
Q Consensus 31 IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~ 108 (560)
||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+|+.++|+||+++++++.. ...++||||
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~ 75 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM 75 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence 899999999999765 456679999986532 23344678899999999999999999998732 257999999
Q ss_pred CC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccc
Q 008607 109 ME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (560)
Q Consensus 109 ~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (560)
++ ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 98 589998875 4469999999999999999999999999999999999999999999999999997543332211111
Q ss_pred cccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 187 ~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------------------- 213 (257)
T cd05115 156 SAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ-------------------- 213 (257)
T ss_pred CCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC--------------------
Confidence 22233568999999875 568889999999999999996 9999987665443322211
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... ...+..++.+.+||.+||..||++||++.++++
T Consensus 214 -------~~~~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 214 -------GKRL---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred -------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 122456889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.78 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=199.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEE-----CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~ 95 (560)
.++|++.+.||+|+||.||++.+ ..++..||+|+++... .......+.+|+.+++.+ +|+||+++++.+...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-
Confidence 45899999999999999999975 3356689999887432 233456788999999999 799999999988443
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccc
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGl 172 (560)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||+
T Consensus 112 ----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 ----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 35899999998 69999997643 389999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+..
T Consensus 188 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~------ 258 (302)
T cd05055 188 ARDIMNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK------ 258 (302)
T ss_pred cccccCCCce-eecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH------
Confidence 9765332211 11122346788999999876 568899999999999999998 9999987654332211110
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. .... ......++.+.+||.+||..||++|||+.|+++
T Consensus 259 -----------------~---~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 259 -----------------E---GYRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -----------------c---CCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 0000 112345788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=367.98 Aligned_cols=262 Identities=29% Similarity=0.413 Sum_probs=215.0
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
-++.-...||.|.||.||.|.+..||+..|+|.|............+.+|+++|..|.|||+|+++++=++.. .+
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----kv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----KV 1309 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----HH
Confidence 3677778899999999999999999999999998743333445567889999999999999999999876543 48
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC-
Q 008607 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT- 180 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~- 180 (560)
||.||||+ |+|.+++...+..+|-..+.+..|++.||.|||+.||+||||||.|||++.+|.+|++|||.|....+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999998 5899999887778888889999999999999999999999999999999999999999999998765543
Q ss_pred CCcccccccccCccccccccccccc-CCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.-......++||+-|||||++.+.. .+..-+.|||||||++.||+||+.||...+..-++ |.++
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI--My~V------------- 1454 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI--MYHV------------- 1454 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH--HhHH-------------
Confidence 2222345789999999999996642 34567899999999999999999999765543332 2221
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
.+..+.++| ..++++..|||++||.-||+.|.++.|||+|-|-+.
T Consensus 1455 ---------~~gh~Pq~P-----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1455 ---------AAGHKPQIP-----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred ---------hccCCCCCc-----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 122222222 247899999999999999999999999999998653
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.20 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=198.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECC-------CCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPP 94 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~-------tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~ 94 (560)
.+|.+.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 589999999999999999998642 34579999887432 234456788999999999 599999999988433
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 008607 95 SRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 157 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NI 157 (560)
..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 91 -----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 91 -----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 35899999998 5999999753 2488899999999999999999999999999999999
Q ss_pred eeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCCh
Q 008607 158 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (560)
Q Consensus 158 Ll~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 236 (560)
|++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999997653222111 0112234467999999876 578899999999999999999 8899987665
Q ss_pred hhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 237 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.+.+..+.. ... ......++..+.+||.+||..||++|||+.|+++
T Consensus 243 ~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 EELFKLLRE---------------------------GHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 444332221 000 0112456778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.99 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=200.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC-------CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT-------RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~-------~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~ 93 (560)
..+|.+.+.||+|+||.||+|++. ..+..||+|.+.... .......+.+|+.+++.+ +||||+++++.+..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 568999999999999999999753 234579999886432 234456788999999999 79999999998843
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 008607 94 PSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~N 156 (560)
. ..+|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|
T Consensus 93 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 93 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred C-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 3 46899999998 5999998763 247788899999999999999999999999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 008607 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (560)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 235 (560)
||++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999765332211 11123345678999999876 578899999999999999998 789998776
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 236 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
..+....+.. ... ......++..+.+||.+||..+|.+|||+.|+++.
T Consensus 245 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKE---------------------------GHR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 5444332211 000 01123567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=312.76 Aligned_cols=254 Identities=21% Similarity=0.362 Sum_probs=202.2
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECC----CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTR----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~----tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.+++|++.++||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+|+.++|+||+++++++....
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~- 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG- 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence 45789999999999999999999876 3678999988642 34445677889999999999999999999875432
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEE
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAN--------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~--------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL 167 (560)
...+++++|+. ++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 82 ---~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 ---EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred ---CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 35799999998 6999988653 35899999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHh
Q 008607 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246 (560)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~ 246 (560)
+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus 159 ~d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~- 234 (280)
T cd05043 159 TDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD- 234 (280)
T ss_pred CCCCCcccccCCceEE-eCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-
Confidence 9999997654322111 1122345678999999876 578899999999999999998 9999987654332221111
Q ss_pred cCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 247 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... .....+++.+.+++.+||..||++|||+.++++
T Consensus 235 --------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 --------------------------GYRL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------------------------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 112345788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=314.15 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=195.0
Q ss_pred EEEEEEeecCCeEEEEEEEC----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 26 KIEEVIGKGSYGVVCSAYDT----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++.+.||.|+||.||+|... ..+..|+||.++. .........+.+|+++|+.++||||+++++++... ..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc-----cc
Confidence 57899999999999999887 4567899999964 23444578899999999999999999999999732 34
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+++|+|||. |+|.+++... ..+++..++.|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999998 6999999987 6799999999999999999999999999999999999999999999999999987632
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... ...........|+|||.+.+ ..++.++||||||+++|||++ |+.||.+.+..+.+..+.+.
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~----------- 221 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG----------- 221 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-----------
T ss_pred cccc-cccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccc-----------
Confidence 2211 11233456778999999976 458899999999999999999 78999877655444333211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... .....++..+.+||.+||..||.+|||+.++++
T Consensus 222 ----------------~~~---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 222 ----------------QRL---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ----------------EET---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ----------------ccc---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 000 112356888999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.11 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=197.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEE-----CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~ 95 (560)
.++|++.+.||+|+||+||+|.+ ..+++.||||+++... .......+.+|+.+|..+ +|+||+++++.+...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 35899999999999999999984 3567899999997432 223456788999999999 689999999987433
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC-----------------------------------------------------
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKAND----------------------------------------------------- 121 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~~----------------------------------------------------- 121 (560)
...+++|||||+ |+|.+++....
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 84 ---GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ---CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 235899999998 58998886431
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccccc
Q 008607 122 --------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187 (560)
Q Consensus 122 --------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~ 187 (560)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcC
Confidence 3677888999999999999999999999999999999999999999999999764322111 1112
Q ss_pred ccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Q 008607 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (560)
Q Consensus 188 ~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 266 (560)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+...
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----------------------- 294 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----------------------- 294 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-----------------------
Confidence 2345677999999876 578899999999999999997 99999765432211110
Q ss_pred HHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
+. ...... .....++.+.+++.+||+.||.+|||+.|+++|
T Consensus 295 ~~---~~~~~~---~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 295 LK---EGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred Hh---ccCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 000000 112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.49 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=196.4
Q ss_pred ceEEEEEEeecCCeEEEEEEECC-----CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+|+.++||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD---- 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC----
Confidence 48899999999999999998753 33578888876432 233456788999999999999999999987432
Q ss_pred CccEEEEEecCC-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 008607 99 FKDIYVVFELME-SDLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~------------------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLK 153 (560)
...|+|+||+. ++|.+++... ..+++..++.++.|++.||.|||++||+|||||
T Consensus 76 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 76 -GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred -CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 45899999998 5899888642 247889999999999999999999999999999
Q ss_pred CCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCC
Q 008607 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFP 232 (560)
Q Consensus 154 P~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~ 232 (560)
|+|||+++++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999764322211 11122345678999998866 578899999999999999998 999998
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 233 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
+.......+.+.. .... .....++..+.+||.+||+.||.+||++.|+++
T Consensus 232 ~~~~~~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 232 GIAPERLFNLLKT---------------------------GYRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCHHHHHHHHhC---------------------------CCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7664433222111 0000 112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=309.48 Aligned_cols=250 Identities=24% Similarity=0.412 Sum_probs=200.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCC---CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.++|.+.+.||+|+||.||+|.+... ...|+||.+.... .......+.+|+.+++.+.|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----
Confidence 35699999999999999999987654 3468999886432 23455678899999999999999999998743
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
...|+||||+. ++|.+++.... .+++..++.++.||+.||+|||+.|++||||||+|||++.++.+||+|||+++..
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 23689999998 59999998754 5899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... ..+...++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+.+..+..
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~---------- 223 (270)
T cd05056 158 EDESYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN---------- 223 (270)
T ss_pred ccccce--ecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc----------
Confidence 333211 1122334567999999865 578899999999999999986 9999987765544332211
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... ...+.++..+.+||.+||..+|.+|||+.+++.
T Consensus 224 -----------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 224 -----------------GERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred -----------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0111 123466889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=306.88 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=198.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
..+|++.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++.+.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 74 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CC
Confidence 568999999999999999999754 5567999988642 2345678899999999999999999988743 35
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 799999998 5999999763 3578899999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... ......++..|+|||++.. ..++.++|||||||++|+|++ |+.||.+.+..+....+...
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05073 155 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG----------- 219 (260)
T ss_pred CCcc--cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-----------
Confidence 2211 1122345677999999876 568889999999999999998 99999876654433322210
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.. .......+..+.+++.+||+.||.+||++.++++
T Consensus 220 ----------------~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 220 ----------------YR---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ----------------CC---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00 0122456788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.99 Aligned_cols=252 Identities=26% Similarity=0.426 Sum_probs=198.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCC-------CcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRT-------GEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPP 94 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~t-------g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~ 94 (560)
.+|++.+.||+|+||.||+|++... +..||+|.+... ........+.+|+++++.+ +|+||+++++.+...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 4799999999999999999986432 236899987642 2233456788999999999 799999999988433
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 008607 95 SRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 157 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NI 157 (560)
..+|+|+||+. ++|.+++.... .++...+..++.||+.||.|||++||+||||||+||
T Consensus 91 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 91 -----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 35899999998 59999987532 377888999999999999999999999999999999
Q ss_pred eeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCCh
Q 008607 158 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (560)
Q Consensus 158 Ll~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 236 (560)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999765332211 11122334567999999976 578899999999999999998 8899987765
Q ss_pred hhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 237 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.+.+..+.. ... .......+..+.+||.+||+.+|.+|||+.|+|++
T Consensus 243 ~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKE---------------------------GHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHc---------------------------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 444333221 000 01123567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=305.84 Aligned_cols=248 Identities=28% Similarity=0.482 Sum_probs=200.7
Q ss_pred eEEEEEEeecCCeEEEEEEECCCC----cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTG----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg----~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
+++.+.||.|+||.||++.+...+ ..||+|++.... .......+.+|+.+|+.+.|+||+++++.+... .
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----E 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----C
Confidence 357889999999999999998776 899999986432 222566788999999999999999999988543 4
Q ss_pred cEEEEEecCCc-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 101 DIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~--lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..|++|||+.+ +|.+++..... +++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 68999999984 99999976554 9999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
....... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+....+..+..
T Consensus 155 ~~~~~~~--~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~----------- 219 (258)
T smart00219 155 DDDYYKK--KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK----------- 219 (258)
T ss_pred ccccccc--ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 4321111 12236788999999865 578899999999999999998 8899987654443332221
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... ......+..+.+++.+||..||.+|||+.|+++
T Consensus 220 ----------------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 220 ----------------GYRL---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ----------------CCCC---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 1111 112346888999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=306.30 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=198.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
...|++.+.||+|+||.||++.+. .+..+|+|.+.... .....+.+|+++++.+.||||+++++.+... ..
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----Cc
Confidence 457999999999999999999875 46789999886422 2235678899999999999999999987433 36
Q ss_pred EEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|+||||+.+ +|.+++... +.++++.++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 8999999984 898888764 46899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||........+..+.+
T Consensus 154 ~~~~--~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 216 (256)
T cd05112 154 QYTS--STGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA------------- 216 (256)
T ss_pred cccc--cCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-------------
Confidence 2111 112334568999999876 568889999999999999998 9999977664433332211
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
..... .....+..+.+|+.+||+.||++|||+.+++++
T Consensus 217 --------------~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 217 --------------GFRLY---KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred --------------CCCCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00000 012347889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=311.03 Aligned_cols=242 Identities=25% Similarity=0.393 Sum_probs=190.4
Q ss_pred EEEeecCCeEEEEEEECCCCc--EEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGE--KVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~--~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~~i~lV 105 (560)
+.||+|+||.||+|.+..++. .+++|.+... ........+.+|+.++..+ +||||+++++++... ..+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEE
Confidence 368999999999999988876 4688887632 2233456788999999999 799999999988443 358999
Q ss_pred EecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEe
Q 008607 106 FELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (560)
Q Consensus 106 ~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~ 168 (560)
|||+. ++|.+++.... .++++.++.++.||+.||+|||+.||+||||||+|||++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99998 59999997543 47899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhc
Q 008607 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~ 247 (560)
|||++....... .......+..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 155 dfgl~~~~~~~~----~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--- 225 (270)
T cd05047 155 DFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 225 (270)
T ss_pred CCCCccccchhh----hccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh---
Confidence 999986322111 0111234567999999866 578899999999999999997 999997765433322211
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..... ......+..+.+||.+||..||.+|||+++++.
T Consensus 226 ------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 226 ------------------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------------------CCCCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 10000 112346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=340.29 Aligned_cols=279 Identities=20% Similarity=0.260 Sum_probs=186.1
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCC----CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRT----GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~t----g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
..++|++.+.||+|+||.||+|++..+ +..||||++.... .......| .++...+.++..+...+.....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 457899999999999999999999998 9999999986421 11111111 1222233334433333322211
Q ss_pred -CCCccEEEEEecCC-ccHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 008607 97 -REFKDIYVVFELME-SDLHQVIKANDD--------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 154 (560)
Q Consensus 97 -~~~~~i~lV~E~~~-gdL~~~i~~~~~--------------------lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP 154 (560)
.....++||+||++ ++|.+++..... ..+..++.++.||+.||.|||+.||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 34457899999998 489888865421 12345778999999999999999999999999
Q ss_pred CCeeeCC-CCcEEEecccccccccCCCCCcccccccccCccccccccccccc--------------------CCCCCccc
Q 008607 155 KNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 213 (560)
Q Consensus 155 ~NILl~~-~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~--------------------~~y~~~~D 213 (560)
+|||++. ++.+||+|||+|+....... .....+++|+.|+|||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 57999999999975432221 1224578999999999653210 12445679
Q ss_pred hhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCC---CCCCCCCHHHH
Q 008607 214 IWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS---QKFPNANPLAL 290 (560)
Q Consensus 214 IWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~s~~~~ 290 (560)
||||||+||||+++..++ .+...++..+....+..... +. ............ ..+......+.
T Consensus 362 VwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~-~~-----------~~~~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVA-WR-----------KLVEPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred cHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHH-HH-----------HhhccccchhhhhhhhhccccchHHH
Confidence 999999999999966543 34444444443333322111 10 000000000101 11122344567
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 291 RLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 291 dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
+||.+||++||.+|||+.|+|+||||++...
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 9999999999999999999999999987544
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=309.95 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=200.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCc----EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
..+|++.+.||+|+||.||+|.++.+|. .+|+|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 4689999999999999999999877765 58999876432 23445678899999999999999999998854
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
...++||||+. ++|.+++..+ ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 35899999998 5999998774 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
........ ......++..|+|||.+.. ..++.++|||||||++|||++ |+.||.+....+....+..
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 226 (279)
T cd05057 159 LDVDEKEY-HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK--------- 226 (279)
T ss_pred ccCcccce-ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC---------
Confidence 54322111 1111223567999998865 578899999999999999998 9999987664433222211
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... ......+..+.++|.+||..||.+|||+.++++
T Consensus 227 ------------------~~~~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 227 ------------------GERL---PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111 112345678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=313.59 Aligned_cols=259 Identities=22% Similarity=0.374 Sum_probs=197.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECC----------------CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTR----------------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~----------------tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv 85 (560)
.++|++.+.||+|+||.||++.+.. ++..||+|++... ........+.+|+.+|+.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3579999999999999999986433 3457999998643 2233456788999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 008607 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (560)
Q Consensus 86 ~l~~i~~~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~-----------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLK 153 (560)
++++.+... ..+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+|||||
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 83 RLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred eEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 999988543 35899999998 59999987642 36778999999999999999999999999999
Q ss_pred CCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh--CCCCC
Q 008607 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLF 231 (560)
Q Consensus 154 P~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt--G~~pF 231 (560)
|+|||++.++.+||+|||+++......... ......++..|++||.+.+ ..++.++|||||||++|||++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 999999999999999999997643322111 1122345678999998765 568899999999999999998 77888
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008607 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (560)
Q Consensus 232 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL 311 (560)
...+..+.+.... .++....... .......+++.+.+||.+||+.||.+||++.+++
T Consensus 235 ~~~~~~~~~~~~~--------------------~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 235 SQLSDEQVIENTG--------------------EFFRDQGRQV---YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred cccChHHHHHHHH--------------------HHHhhccccc---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 7655433222111 1111110000 1111234678899999999999999999999987
Q ss_pred c
Q 008607 312 A 312 (560)
Q Consensus 312 ~ 312 (560)
+
T Consensus 292 ~ 292 (296)
T cd05095 292 A 292 (296)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=312.00 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=198.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+.||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-- 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG-- 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--
Confidence 357999999999999999999875 367899999986432 223346688999999999999999999988543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAND----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~----------------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLK 153 (560)
...|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+|||||
T Consensus 81 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 81 ---KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred ---CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 35899999998 59999987431 37888999999999999999999999999999
Q ss_pred CCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCC
Q 008607 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFP 232 (560)
Q Consensus 154 P~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~ 232 (560)
|+|||++.++.+||+|||+++......... .......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999987543222111 0122344667999999876 578999999999999999997 888997
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 233 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
+.+..+.+..+.. ... .......+..+.+||.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 GMAHEEVIYYVRD---------------------------GNV---LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCHHHHHHHHhc---------------------------CCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7654433222211 110 1112356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=305.19 Aligned_cols=244 Identities=25% Similarity=0.411 Sum_probs=193.8
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEec
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~ 108 (560)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+++++.+.|+||+++++++... ...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEc
Confidence 469999999999999887 999999998753322 3456788999999999999999999987443 458999999
Q ss_pred CC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccc
Q 008607 109 ME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (560)
Q Consensus 109 ~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (560)
+. ++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.......... ..
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-SD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-cc
Confidence 97 589999866 3468999999999999999999999999999999999999999999999999997643221110 00
Q ss_pred cccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 187 ~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~------------------- 211 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG------------------- 211 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-------------------
Confidence 11233567999999866 578899999999999999999 88999776543322222110
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ......+..+.+||.+||..+|.+|||++|+|+
T Consensus 212 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 212 --------YRM---PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------CCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 012345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=309.40 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=199.7
Q ss_pred eEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC-Cc
Q 008607 25 YKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE-FK 100 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~-~~ 100 (560)
|++.+.||+|+||.||+|.+. .++..||||++............+.+|+++|+.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 46789999999765555556677899999999999999999999886543222 12
Q ss_pred cEEEEEecCC-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 101 DIYVVFELME-SDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
..+++++|+. ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578999998 6888877432 14789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
+......... ......++..|++||.+.+ ..++.++|||||||++|+|++ |++||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05074 161 KKIYSGDYYR-QGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK------- 230 (273)
T ss_pred ccccCCccee-cCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8653322111 1122345677999999876 567889999999999999999 8899987664433222211
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ....+..+..+.+|+.+||+.+|++||++.++++
T Consensus 231 --------------------~~~---~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 231 --------------------GNR---LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred --------------------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 0111356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=303.29 Aligned_cols=243 Identities=24% Similarity=0.416 Sum_probs=192.9
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEec
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~ 108 (560)
++||+|+||.||+|.+. .+..||+|++..... ......+.+|+.+++.++||||+++++++... ...++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEEC
Confidence 46999999999999864 688999999875432 23345688999999999999999999988443 358999999
Q ss_pred CC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccc
Q 008607 109 ME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (560)
Q Consensus 109 ~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (560)
++ ++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 98 5899888754 458999999999999999999999999999999999999999999999999987543222111 0
Q ss_pred cccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 187 ~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-------------------- 209 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-------------------- 209 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc--------------------
Confidence 12234567999999876 568889999999999999998 9999987654432222211
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ......++..+.+|+.+||..||++||++.|+++
T Consensus 210 -------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 210 -------GYR---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -------CCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 000 1122356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.62 Aligned_cols=238 Identities=28% Similarity=0.430 Sum_probs=196.7
Q ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008607 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
-++-||.|+.|-||+++ -.++.||||+++.. . ..+|+-|++|+|+||+.++++|... ..+||||
T Consensus 128 ELeWlGSGaQGAVF~Gr--l~netVAVKKV~el-------k--ETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiM 191 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGR--LHNETVAVKKVREL-------K--ETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIM 191 (904)
T ss_pred hhhhhccCcccceeeee--ccCceehhHHHhhh-------h--hhhHHHHHhccCcceeeEeeeecCC-----ceeEEee
Confidence 35779999999999995 45889999998631 1 2478889999999999999999543 4689999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccc
Q 008607 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (560)
|||. |-|..+++....++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++...... +
T Consensus 192 EfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-T--- 267 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-T--- 267 (904)
T ss_pred eccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh-h---
Confidence 9998 7999999999999999999999999999999999999999999999999999999999999987654332 1
Q ss_pred ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 186 ~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
.-.++||..|||||++.. ...+.|+|||||||+|||||||..||.+-+ +..+|..+ |+-+
T Consensus 268 kMSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVd---ssAIIwGV-GsNs-------------- 327 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVD---SSAIIWGV-GSNS-------------- 327 (904)
T ss_pred hhhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccc---hheeEEec-cCCc--------------
Confidence 246899999999999987 689999999999999999999999997533 22222111 1100
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~ 315 (560)
... .....++..++=||+.||.-.|..||++.+||.|-=
T Consensus 328 --------L~L---pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 328 --------LHL---PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred --------ccc---cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 001 122456777899999999999999999999999853
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=307.65 Aligned_cols=252 Identities=22% Similarity=0.371 Sum_probs=199.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECC-----CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
++|++.+.||+|+||.||+|+++. ..+.|++|.+... ........+.+|+.+|+.++|+||+++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--- 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC---
Confidence 579999999999999999999754 3467999987642 1222456788999999999999999999987432
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEE
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAND---------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~---------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL 167 (560)
...|+||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 --EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred --CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 45799999998 69999998765 6899999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHh
Q 008607 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246 (560)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~ 246 (560)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+.
T Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~-- 232 (275)
T cd05046 159 SLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-- 232 (275)
T ss_pred cccccccccCcccc--cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH--
Confidence 99999875432221 11233456778999998865 467889999999999999998 788997654332222111
Q ss_pred cCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 247 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.. ...+ .....++..+.++|.+||+.||.+|||+.|++.+
T Consensus 233 -------------------------~~-~~~~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 233 -------------------------AG-KLEL-PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------------------cC-CcCC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 0011 1123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=330.24 Aligned_cols=259 Identities=22% Similarity=0.379 Sum_probs=224.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
-+..+++..||-|+||.|=++.-......+|+|++++.. -+......+..|-+||..++.|.||++|..| ++.+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence 356788889999999999988766655569999997532 3444567789999999999999999999988 5667
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
++|++||-|- |+|+..+..++.|.+...++++..+++|++|||+.|||+|||||+|+|++.+|-+||.|||+|+....+
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 8999999986 699999999999999999999999999999999999999999999999999999999999999987665
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
..+ .++|||+.|.|||++.+ ...+.++|.||||+++||||+|.+||.+.+....++.|.+.+..
T Consensus 574 ~KT----wTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~---------- 637 (732)
T KOG0614|consen 574 RKT----WTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK---------- 637 (732)
T ss_pred Cce----eeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------
Confidence 544 67899999999999987 67899999999999999999999999999998888888653210
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~~ 320 (560)
-.....++..+.+||+++...+|.+|.. +.+|-.|.||.++.
T Consensus 638 -------------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 638 -------------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred -------------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 0111345677999999999999999975 89999999998754
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=304.42 Aligned_cols=240 Identities=26% Similarity=0.456 Sum_probs=195.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.|++.+.||+|+||.||++. .+++.||+|++... .....+.+|+.+++.++|+||+++++.+... ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------Cc
Confidence 569999999999999999984 57889999998642 2345788999999999999999999987432 36
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
|+||||+. ++|.+++.... .+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999998 59999997654 5899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+..+....+..
T Consensus 154 ~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 212 (254)
T cd05083 154 V------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK------------- 212 (254)
T ss_pred C------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------------
Confidence 1 12234567999999865 578889999999999999997 9999987664433222211
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... .....++..+.+||.+||+.+|.+||++++++.
T Consensus 213 --------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 213 --------------GYRM---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --------------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0001 112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=313.78 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=199.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCc----EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
.++|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++|+||+++++.+...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 4578999999999999999999988776 46888876422 223344678999999999999999999988542
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..++|+||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 ---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 3579999998 68999987754 589999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK--------- 226 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC---------
Confidence 5332211 11223456778999999876 578899999999999999997 8999977653332221111
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... ...+..+..+.++|.+||..||.+||+++++++
T Consensus 227 ------------------~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 227 ------------------GERL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred ------------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0001 112345778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=306.25 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=187.5
Q ss_pred EEeecCCeEEEEEEECC--CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008607 30 VIGKGSYGVVCSAYDTR--TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (560)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~--tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E 107 (560)
.||+|+||.||+|.... ....+++|.+... ........+.+|+.+++.++|+||+++++.+... ...|+|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLE 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEE
Confidence 59999999999996433 4457888877542 2233445678999999999999999999988543 35899999
Q ss_pred cCC-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 108 LME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 108 ~~~-gdL~~~i~~~~-----~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|++ ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 998 59999987643 246788899999999999999999999999999999999999999999999865322211
Q ss_pred CcccccccccCcccccccccccc-----cCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~-----~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
.. ......++..|+|||++... ...++.++|||||||++|+|++ |..||......+.+..+....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-------- 226 (269)
T cd05042 156 YI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ-------- 226 (269)
T ss_pred ee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc--------
Confidence 11 01223456779999987431 1356789999999999999999 788997765444333221110
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
....+.......++..+.+++..|+ .||++|||++++++
T Consensus 227 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 227 -----------------DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -----------------CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0111111223456788899999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=305.36 Aligned_cols=228 Identities=25% Similarity=0.364 Sum_probs=185.0
Q ss_pred cCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCC-cc
Q 008607 34 GSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SD 112 (560)
Q Consensus 34 G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~-gd 112 (560)
|.+|.||+|++..+++.||+|++.... ...+|...+....||||+++++.+... ..+|+||||++ ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCC
Confidence 899999999999999999999986421 123455555566799999999987433 46899999998 59
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccC
Q 008607 113 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192 (560)
Q Consensus 113 L~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT 192 (560)
|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcC
Confidence 99999887789999999999999999999999999999999999999999999999999876543221 234567
Q ss_pred cccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhcc
Q 008607 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRK 272 (560)
Q Consensus 193 ~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~ 272 (560)
..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... + . .
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------------------~---~ 191 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------------------N---T 191 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------------------c---c
Confidence 78999999865 56888999999999999999999887432110 0 0 0
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCccc
Q 008607 273 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYF 316 (560)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta-----~elL~hp~f 316 (560)
.... ...+.+++.+.+||.+||+.||++|+++ +++++||||
T Consensus 192 ~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 HTTL---NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccc---CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0000 1123468889999999999999999985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=328.83 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=212.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
-+-|..++.||-|+||.|++++...|...||+|.+.+. .........+..|-.||..-..+-||+|+-.|.+. .
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk-----d 702 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----D 702 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC-----C
Confidence 35588999999999999999999999999999998752 22334456778899999999999999999988544 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC-
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN- 178 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~- 178 (560)
.+|+||||+. ||+..++.+.+-|.|+.+++++.+|.+|+++.|+.|+|||||||+|||||.+|.|||.||||+.-...
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 6999999998 59999999999999999999999999999999999999999999999999999999999999964211
Q ss_pred --------CCCC------------------------------cccccccccCcccccccccccccCCCCCccchhhHHHH
Q 008607 179 --------DTPT------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (560)
Q Consensus 179 --------~~~~------------------------------~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~i 220 (560)
+... .......+||+.|+|||+|.. ..|+..+|.||.|||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVI 860 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHH
Confidence 0000 000124689999999999987 689999999999999
Q ss_pred HHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 008607 221 FAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300 (560)
Q Consensus 221 l~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~D 300 (560)
||||+.|++||-.....+...+|..+ +.++. ...-.+++.++.+||.++.. +
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw-----------------~~~l~----------~~~~~~ls~e~~~li~kLc~-s 912 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINW-----------------RNFLH----------IPYQGNLSKEALDLIQKLCC-S 912 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeeh-----------------hhccc----------cccccccCHHHHHHHHHHhc-C
Confidence 99999999999776544332222110 11111 01124789999999998765 6
Q ss_pred CCCCC---CHHHHhcCccccccc
Q 008607 301 PKDRP---TAEEALADPYFKGLA 320 (560)
Q Consensus 301 P~~Rp---ta~elL~hp~f~~~~ 320 (560)
++.|. .++|+..||||+++.
T Consensus 913 ad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 913 ADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred hhhhhcccchhhhhcCccccccc
Confidence 77886 478899999999764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=308.54 Aligned_cols=261 Identities=23% Similarity=0.404 Sum_probs=209.0
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHH-hcCCCCccccceeecCCCcCCCccEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR-LLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~-~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.+-+..||.|+||+|++..|+.+|+..|||+|+.... ..+..+++.|..... .-.+||||+++++.+.. ++.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcW 139 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCW 139 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----Ccee
Confidence 3445779999999999999999999999999985433 456678888988764 44699999999998654 4689
Q ss_pred EEEecCCccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 104 VVFELMESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 104 lV~E~~~gdL~~~i~-----~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
|.||+|+-+|..+.+ ....++|+.+-+|....+.||.||.. .+||||||||+|||++..|.+||||||.+-.+.
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999999987655543 24579999999999999999999975 589999999999999999999999999987654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHh-cCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL-LGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~-~g~p~~~~~~ 256 (560)
+.... +...|-+.|||||.+.....+|+.++|+||||++|||+.||+.|+.+-+. .++.+..+ .|.|+.
T Consensus 220 ~SiAk----T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~---- 289 (361)
T KOG1006|consen 220 DSIAK----TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPI---- 289 (361)
T ss_pred HHHHh----hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCe----
Confidence 33222 44578899999999976556799999999999999999999999976443 34433332 122221
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
..+...--+.+..+++||.-||.+|-.+||...+++.+||++-..
T Consensus 290 -------------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 290 -------------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred -------------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 112222235788999999999999999999999999999998654
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=326.03 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=198.7
Q ss_pred CceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR 96 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~ 96 (560)
++|.+.++||+|+||.||+|++. .+++.||||+++... .......+.+|+.+|..+. ||||+++++++...
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-- 113 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-- 113 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--
Confidence 56889999999999999999853 456789999997532 2233457889999999997 99999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC------------------------------------------------------
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 121 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~------------------------------------------------------ 121 (560)
..+|+|||||. |+|.+++..+.
T Consensus 114 ---~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 114 ---GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ---CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 35899999998 59999986532
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 008607 122 --------------------------------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 157 (560)
Q Consensus 122 --------------------------------------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NI 157 (560)
.+++..+..|+.||+.||.|||+.+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256778889999999999999999999999999999
Q ss_pred eeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCCh
Q 008607 158 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (560)
Q Consensus 158 Ll~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 236 (560)
|++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999764322211 11123457788999999976 568899999999999999998 8899976543
Q ss_pred hhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 237 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.+.+..... ... .. .....++..+.+||.+||..||.+||++.||++.
T Consensus 348 ~~~~~~~~~----------------------~~~----~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIK----------------------RGY----RM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHH----------------------cCC----CC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 332211110 000 00 1123568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.91 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=189.5
Q ss_pred EEEeecCCeEEEEEEECC---CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~---tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV 105 (560)
+.||+|+||.||+|.+.. .+..||||++... ........+.+|+.+++.++||||+++++++.... ...++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEE
Confidence 468999999999998653 3457999988532 23345567889999999999999999999775332 347899
Q ss_pred EecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 008607 106 FELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (560)
Q Consensus 106 ~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (560)
|||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99998 59999987643 46788889999999999999999999999999999999999999999999997543221100
Q ss_pred -ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 184 -IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 184 -~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
.......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~----------------- 216 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----------------- 216 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-----------------
Confidence 11123345778999999876 578899999999999999999 467787655433222111
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
....... ....+..+.+|+.+||..||++||++.+++.
T Consensus 217 ----------~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 217 ----------QGRRLLQ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ----------cCCCCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0111111 1234678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.42 Aligned_cols=263 Identities=24% Similarity=0.429 Sum_probs=217.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~ 100 (560)
...|+|.++||.|.||.||++.+++++...|+|++... ......+..|.++|+.+. |||++.++++|.-.......
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 46799999999999999999999999999999988642 233456778999999885 99999999999766556667
Q ss_pred cEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
++|||||||+ |+..++++. ..++.|+.+.+|++.++.||.+||.+.++|||||-.|||++.++.|||+|||.+....
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 8999999998 577777765 5579999999999999999999999999999999999999999999999999997663
Q ss_pred CCCCCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
. +.....+.+||+.|||||++... ...|+..+|+||||++..||.-|.+|+-+..... .+..+...|++
T Consensus 175 s---T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aLF~IpRNPPP-- 246 (953)
T KOG0587|consen 175 S---TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLIPRNPPP-- 246 (953)
T ss_pred c---ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hhccCCCCCCc--
Confidence 3 23344678999999999998532 1347778999999999999999999996654332 22222223322
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
-...+..++..+.+||..||.+|..+||+..++|.|||++.
T Consensus 247 -----------------------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 247 -----------------------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred -----------------------cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 22334567889999999999999999999999999999983
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=303.61 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=187.8
Q ss_pred EEEeecCCeEEEEEEEC--CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
+.||+|+||.||+|... .++..+|+|++..... ......+.+|+.+++.++||||+++++.+... ..+++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEE
Confidence 36899999999999754 4567899999875332 23345688999999999999999999987433 3589999
Q ss_pred ecCC-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 107 ELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~-----~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
||++ ++|.+++.... ..++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9998 69999986532 35677888999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccccCccccccccccccc-----CCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~-----~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
.. .......++..|+|||++.+.. ..++.++|||||||++|||++ |+.||......+.+.....
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 224 (269)
T cd05087 155 YY-VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--------- 224 (269)
T ss_pred ee-ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---------
Confidence 11 1112345778899999985421 135789999999999999996 9999976554332211100
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.. ....+........+..+.+|+++|+ .||.+|||++||+.
T Consensus 225 --------------~~--~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 225 --------------EQ--QLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------------cc--cCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00 0011111112245778999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.75 Aligned_cols=238 Identities=20% Similarity=0.279 Sum_probs=184.3
Q ss_pred EEEeecCCeEEEEEEECC------------CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 29 EVIGKGSYGVVCSAYDTR------------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~------------tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
+.||+|+||.||+|.... ....|++|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 468999999999997432 2346888887642 233445678899999999999999999988543
Q ss_pred CCCccEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc-------EEE
Q 008607 97 REFKDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-------LKI 167 (560)
Q Consensus 97 ~~~~~i~lV~E~~~g-dL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~-------lKL 167 (560)
...++||||+++ .|..++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||
T Consensus 77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 346999999995 77777765 346999999999999999999999999999999999999987664 899
Q ss_pred ecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHh-hCCCCCCCCChhhHHHHHHHh
Q 008607 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL-TGKPLFPGKNVVHQLDIMTDL 246 (560)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLl-tG~~pF~~~~~~~~~~~i~~~ 246 (560)
+|||++...... ....++..|+|||.+... ..++.++|||||||++|+|+ .|..||.+....+....
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---- 221 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---- 221 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH----
Confidence 999998654211 235678889999988632 56888999999999999998 58888876543221110
Q ss_pred cCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 247 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.... .......+..+.+||.+||+.||.+||++.+||++
T Consensus 222 --------------------~~~~--------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 222 --------------------YEGQ--------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --------------------HhcC--------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0000 00112235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=307.58 Aligned_cols=238 Identities=18% Similarity=0.277 Sum_probs=186.4
Q ss_pred EEEeecCCeEEEEEEECCCCcE-------EEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEK-------VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~-------vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.||+|+||.||+|.+...+.. ||+|.+... .......+.+|+.+|+.+.||||+++++++... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence 4699999999999998665543 888887532 233446788899999999999999999998543 35
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc--------EEEeccc
Q 008607 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--------LKICDFG 171 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~--------lKL~DFG 171 (560)
.++||||+. |+|.+++..++ .+++..+..++.||+.||+|||+.||+||||||+|||++.++. +||+|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 799999998 58999997654 5899999999999999999999999999999999999987764 6999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCC-CCCCCCChhhHHHHHHHhcCCC
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTP 250 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~~~~i~~~~g~p 250 (560)
++...... ....++..|+|||++.+. ..++.++|||||||++|+|++|. +||...+........
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------- 218 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------- 218 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------
Confidence 88654221 235688899999998652 35788999999999999999995 666544432221110
Q ss_pred CHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 251 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
. ... ......+..+.+||.+||+.||++|||++++++.
T Consensus 219 -----------------~---~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 219 -----------------E---DRH-----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -----------------H---ccc-----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0 000 0112345779999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.72 Aligned_cols=270 Identities=26% Similarity=0.424 Sum_probs=201.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
...|++.+.||+|+||.||+|... .+++.||||++...... .....+.+|+++++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~-- 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG-- 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC--
Confidence 356899999999999999999854 35889999998754332 34667899999999999999999998874422
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
....++||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 80 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 80 -GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred -CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 246899999997 59999997754 599999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...............++..|+|||.+.+ ..++.++|||||||++++|++|..||....... ....+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~- 230 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQM- 230 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----ccccccccccc-
Confidence 6422221111122345567999999876 478889999999999999999999986532211 11111100000
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. .......+......+ ....++..+.+|+.+||..||.+|||+.|+++
T Consensus 231 ---~---~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 231 ---I---VTRLLELLKEGERLP---RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ---c---HHHHHHHHHcCCcCC---CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 001111111111111 12345688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.10 Aligned_cols=236 Identities=18% Similarity=0.277 Sum_probs=186.8
Q ss_pred EEEeecCCeEEEEEEECCCC----------cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 29 EVIGKGSYGVVCSAYDTRTG----------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg----------~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+|+.++|+||+++++.+..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998777 357888765321 125678899999999999999999998854
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC-------cEEEec
Q 008607 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-------KLKICD 169 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~-------~lKL~D 169 (560)
...++||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 24699999998 58999998765 799999999999999999999999999999999999999888 799999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcC
Q 008607 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g 248 (560)
||++...... ....++..|+|||++.+....++.++|||||||++|+|++ |..||...+........
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~----- 219 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY----- 219 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-----
Confidence 9999764331 2345677899999987632368899999999999999999 57888665422211110
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. .....+ ......+.+||.+||..||.+|||+.++++
T Consensus 220 -------------------~---~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 220 -------------------Q---DQHRLP-----MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -------------------h---cCCCCC-----CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 000000 111267899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=302.73 Aligned_cols=249 Identities=27% Similarity=0.471 Sum_probs=198.6
Q ss_pred eEEEEEEeecCCeEEEEEEECC-CCcEEEEEEecCcc--------cChhHHHHHHHHHHHHHh-cCCCCccccceeecCC
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIF--------EHVSDATRILREIKLLRL-LRHPDIVEIKHILLPP 94 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~-tg~~vAiK~i~~~~--------~~~~~~~~i~rEi~iL~~-l~HpnIv~l~~i~~~~ 94 (560)
|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.+++. ++|+||+++++.+...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 8889999999999999999988 78899999886321 122334567789998865 7899999999988543
Q ss_pred CcCCCccEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEe
Q 008607 95 SRREFKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKIC 168 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~ 168 (560)
...++||||+++ +|.+++.. ...+++..++.++.||+.||.|||+ .+|+|+||||+|||++.++.+||+
T Consensus 82 -----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 82 -----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred -----CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence 468999999985 78777643 3469999999999999999999996 789999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcC
Q 008607 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g 248 (560)
|||++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...+.......+....
T Consensus 157 dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~- 229 (269)
T cd08528 157 DFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV- 229 (269)
T ss_pred cccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc-
Confidence 999997654322 2245678999999999976 568899999999999999999999997665443332222110
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
..+. .....++.+.+||++||+.||++||++.|+.++
T Consensus 230 ------------------------~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 230 ------------------------YEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ------------------------CCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0010 112457889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.02 Aligned_cols=237 Identities=19% Similarity=0.257 Sum_probs=183.4
Q ss_pred EEeecCCeEEEEEEECCC------------------------CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcc
Q 008607 30 VIGKGSYGVVCSAYDTRT------------------------GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85 (560)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~t------------------------g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv 85 (560)
.||+|+||.||+|....+ ...|++|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999974322 245888888632 223345688899999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC
Q 008607 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC 163 (560)
Q Consensus 86 ~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~ 163 (560)
++++++... ...|+||||+++ +|..++.. .+.+++..+..++.||+.||+|||+.||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 999988543 357999999995 78888865 45789999999999999999999999999999999999997654
Q ss_pred -------cEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHh-hCCCCCCCCC
Q 008607 164 -------KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL-TGKPLFPGKN 235 (560)
Q Consensus 164 -------~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLl-tG~~pF~~~~ 235 (560)
.+||+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|||+ +|+.||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4899999988643221 223577889999988653 46889999999999999985 6999997654
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 236 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
..+.... +.. ... .....++.+.+||.+||+.||++|||+.++|++
T Consensus 227 ~~~~~~~------------------------~~~---~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERF------------------------YEK---KHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHH------------------------HHh---ccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 3322111 110 000 012235679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.40 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=192.4
Q ss_pred EEEeecCCeEEEEEEECCCC------cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 29 EVIGKGSYGVVCSAYDTRTG------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg------~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.||+|+||.||+|.+.... ..+|||.+.... .......+.+|+.+|+.++||||+++++++... ...
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCe
Confidence 36999999999999876544 689999886432 123456788999999999999999999988543 358
Q ss_pred EEEEecCC-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC-----cEEEec
Q 008607 103 YVVFELME-SDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-----KLKICD 169 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~-------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~-----~lKL~D 169 (560)
|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.+|+|+||||+|||++.++ .+||+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999998 5999998642 2478899999999999999999999999999999999999887 899999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcC
Q 008607 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g 248 (560)
||++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--- 228 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA--- 228 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc---
Confidence 99997543322111 1122345678999999876 578899999999999999998 9999987665443322211
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... .......+..+.+||.+||..+|.+||+++++++
T Consensus 229 ------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 229 ------------------------GGR---LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------------------CCc---cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000 0112356788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.78 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=186.3
Q ss_pred EEeecCCeEEEEEEECCC--CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008607 30 VIGKGSYGVVCSAYDTRT--GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (560)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~t--g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E 107 (560)
.||+|+||.||++..... ...+++|.+... ........+.+|+.+++.++||||+++++.+... ..+|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEe
Confidence 599999999999975433 345677776532 2233456789999999999999999999988543 35899999
Q ss_pred cCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 108 LME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 108 ~~~-gdL~~~i~~~----~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
|+. ++|.+++... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 998 5999998764 24677788999999999999999999999999999999999999999999998643221110
Q ss_pred cccccccccCcccccccccccc-----cCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~-----~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
......+++..|+|||++... ...++.++|||||||++|||++ |..||...+..+.+..+..-
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---------- 224 (268)
T cd05086 156 -ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD---------- 224 (268)
T ss_pred -hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh----------
Confidence 111345688899999998531 1245789999999999999997 56788776654443332210
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. .....-......+++.+.+||..|| .||.+||+++++++
T Consensus 225 -------------~--~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 225 -------------Q--QVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -------------c--ccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0 0000011112346788999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=315.26 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=195.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.+.|.-..+||+|+||.||+|.-..+ ..||||++....... ...|.+|+.+|..++|||+|+|+++|..... .
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~ 146 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE----H 146 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc----e
Confidence 36777778999999999999986544 899999887533221 4459999999999999999999999964431 4
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~g---IiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
.+||+|||. |+|.+.+.... .++|.....|+.++++||+|||... |+|||||++|||+|++...||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 899999998 79999997755 7999999999999999999999865 99999999999999999999999999965
Q ss_pred ccCCCCCccccccc-ccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhh---HHHHHHHhcCCCC
Q 008607 176 AFNDTPTAIFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH---QLDIMTDLLGTPS 251 (560)
Q Consensus 176 ~~~~~~~~~~~~~~-~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~---~~~~i~~~~g~p~ 251 (560)
.... ....... .||..|+|||.+.. ...+.++|||||||+|.||++|+.+........ ........
T Consensus 227 ~~~~---~~~~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~----- 296 (361)
T KOG1187|consen 227 GPEG---DTSVSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL----- 296 (361)
T ss_pred CCcc---ccceeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH-----
Confidence 4321 1111222 79999999999865 578899999999999999999998876533111 11111111
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
+....+...++ ..... ..++ ..-..+..+..+|++.+|.+||++.|++.
T Consensus 297 ------~~~~~~~eiiD----~~l~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 297 ------LEEGKLREIVD----PRLKE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred ------HHCcchhheeC----CCccC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 00001111111 11000 1111 11223677889999999999999999754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.04 Aligned_cols=269 Identities=26% Similarity=0.443 Sum_probs=212.0
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEec--Cc---ccChhHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DI---FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~--~~---~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~ 94 (560)
....||-++.+||+|+|+.||+|.|....+.||||+-. +. ...........||..|-+.|.||.||+++++|.-.
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 34689999999999999999999999999999999743 11 01112235577999999999999999999998543
Q ss_pred CcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeCC---CCcEEEe
Q 008607 95 SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA---DCKLKIC 168 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~~---~~~lKL~ 168 (560)
. ..+|.|+|||+| ||.-+++.+.-++|.+++.|+.||+.||.||.... |||-||||.|||+.. -|.+||.
T Consensus 540 t----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 T----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred c----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 3 357999999998 89999999989999999999999999999999774 999999999999754 3779999
Q ss_pred cccccccccCCCCCc----ccccccccCccccccccccc--ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHH
Q 008607 169 DFGLARVAFNDTPTA----IFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (560)
Q Consensus 169 DFGla~~~~~~~~~~----~~~~~~~gT~~Y~APEll~~--~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (560)
||||+++...+.... ...+...||.||++||.+.- .-.+.+.++||||+|||||.++.|+.||..+.... ++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HH
Confidence 999999876554432 22345789999999998632 12457889999999999999999999996543222 11
Q ss_pred HHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 243 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
+.. +.+.+...+.|. .-|-+++++++||++||++--++|..+.++-.||||.
T Consensus 694 Lqe----------------------NTIlkAtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 694 LQE----------------------NTILKATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred Hhh----------------------hchhcceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 111 001111111111 1256799999999999999999999999999999996
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=298.22 Aligned_cols=263 Identities=23% Similarity=0.422 Sum_probs=212.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (560)
+.|.++++||+|+|..|.+++++.|.+.||+|++++.. ....+..-+..|-.+...- +||.+|.++..|.+.++
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr---- 325 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR---- 325 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce----
Confidence 67999999999999999999999999999999998643 3344556677888888766 59999999999977764
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+++|.||+. |||.-.+++..++++++++++...|+.||.|||+.|||.||||.+|+|+|..|.+||.|+|.++.-...
T Consensus 326 -lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 326 -LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred -EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 899999998 589888888889999999999999999999999999999999999999999999999999998753222
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCC--CCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP--GKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~--~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
....+++|||+.|.|||++.+ ..|+.++|.|+|||+++||+.|+.||. |.+..++
T Consensus 405 ---gd~tstfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~------------------ 461 (593)
T KOG0695|consen 405 ---GDTTSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM------------------ 461 (593)
T ss_pred ---CcccccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcceecCCCccc------------------
Confidence 223367899999999999998 689999999999999999999999995 1111110
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC------CHHHHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP------TAEEALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp------ta~elL~hp~f~~~~ 320 (560)
..++|+-.+.-.+.+.+ ...++-.+..+|+..|.+||++|. ...++-.|+||+.+.
T Consensus 462 ----ntedylfqvilekqiri---prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 462 ----NTEDYLFQVILEKQIRI---PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred ----chhHHHHHHHhhhcccc---cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 01122221111111111 123456677899999999999995 478999999998653
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.13 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=201.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCc---E-EEEEEecC-cccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE---K-VAIKKIND-IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~---~-vAiK~i~~-~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
++-.+.++||+|+||.||+|.-+..+. . ||+|..+. ..........+.+|.++++.++|||||+++|+.....
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~-- 234 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE-- 234 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--
Confidence 445666999999999999998765422 3 89998874 2345566788999999999999999999999986543
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~~-lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
-+|||||+|. |+|.+++++++. ++..+...++++.++||+|||++++|||||-..|+|++.++.+||+||||++.
T Consensus 235 ---Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 ---PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred ---ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 4899999998 599999999874 99999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
...-.... ...-....|+|||.+.. ..|+.++|||||||++||+++ |..||.+....+....|...
T Consensus 312 ~~~~~~~~---~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~-------- 378 (474)
T KOG0194|consen 312 GSQYVMKK---FLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN-------- 378 (474)
T ss_pred Ccceeecc---ccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc--------
Confidence 42111000 01124457999999987 589999999999999999999 78999998877655544220
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..+.+. ....+..+..++.+|+..||++|||+.++.+
T Consensus 379 ------------------~~r~~~---~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 379 ------------------GYRMPI---PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ------------------CccCCC---CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 000111 1245667888999999999999999999865
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=306.03 Aligned_cols=286 Identities=29% Similarity=0.449 Sum_probs=213.9
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECC---CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR 96 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~---tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~ 96 (560)
+.+.|.++++||.|+|++||++.+.. .++.||+|.|.. .+...++.+|+++|..+. +.||+++.+.+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~----ts~p~ri~~El~~L~~~gG~~ni~~~~~~~----- 104 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR----TSSPSRILNELEMLYRLGGSDNIIKLNGCF----- 104 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc----ccCchHHHHHHHHHHHhccchhhhcchhhh-----
Confidence 45779999999999999999999888 889999999874 345678999999999886 89999999988
Q ss_pred CCCccEEEEEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC-CcEEEecccccc
Q 008607 97 REFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLAR 174 (560)
Q Consensus 97 ~~~~~i~lV~E~~~gd-L~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-~~lKL~DFGla~ 174 (560)
+....+.+|+||++.+ ..+++ . .++...++.+++.++.||+++|.+|||||||||+|+|.+.. ++-.|+|||||.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~-~--~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLY-R--SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred ccCCeeEEEecccCccCHHHHH-h--cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 4445799999999974 44444 3 37789999999999999999999999999999999999864 778999999997
Q ss_pred cccCC--------------CC-----------------Cc----------ccccccccCcccccccccccccCCCCCccc
Q 008607 175 VAFND--------------TP-----------------TA----------IFWTDYVATRWYRAPELCGSFFSKYTPAID 213 (560)
Q Consensus 175 ~~~~~--------------~~-----------------~~----------~~~~~~~gT~~Y~APEll~~~~~~y~~~~D 213 (560)
..... .+ .. ...-...||++|+|||++... ...++++|
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiD 260 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAID 260 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccc
Confidence 21100 00 00 001246799999999999875 66789999
Q ss_pred hhhHHHHHHHHhhCCCCC-CCCChhhHHHHHHHhcCCCCHHHHHHhhh-------------HHHHHHH-----HhhccCC
Q 008607 214 IWSIGCIFAELLTGKPLF-PGKNVVHQLDIMTDLLGTPSPEAIARVRN-------------EKARRYL-----SSMRKKK 274 (560)
Q Consensus 214 IWSlG~il~eLltG~~pF-~~~~~~~~~~~i~~~~g~p~~~~~~~~~~-------------~~~~~~l-----~~~~~~~ 274 (560)
|||.|||+..+++++.|| ...+..+.+..|..++|.-.......... .+...-+ ..+.+..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999775 56677777777777776432222111100 0111111 1111111
Q ss_pred C--CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 275 P--IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 275 ~--~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
. ..........+..+.|||.+||..||.+|+||+++|.||||...
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 1 11111122345689999999999999999999999999999843
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=325.17 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=205.2
Q ss_pred CceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
+.-++.+.||+|+||.||+|+-. .....||||.+++. ........|.||+++|..|+|||||++++++...
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--- 561 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREG--- 561 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC---
Confidence 45677899999999999999753 23457999999853 2233567899999999999999999999999543
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAND----------D----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~----------~----lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~ 162 (560)
+-+|||||||. |||.++++.+. . |+..+...|+.||+.|+.||-++.++||||-..|+||.++
T Consensus 562 --~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 562 --DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred --CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 45899999999 89999997632 3 7889999999999999999999999999999999999999
Q ss_pred CcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHH
Q 008607 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241 (560)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~ 241 (560)
..|||+||||++...+.+.-... ....-...||+||-+.- .+|+.++||||+||+|||+++ |+-||.|....+-++
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~-~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVR-GNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred eEEEecccccchhhhhhhhhccc-CCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 99999999999875444332211 11223456999998865 689999999999999999998 889999988877766
Q ss_pred HHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 008607 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310 (560)
Q Consensus 242 ~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~el 310 (560)
.|..- + .-.+..+++.++-+|+..||+.+|++||++.||
T Consensus 717 ~i~~g---------------------------~---lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 717 CIRAG---------------------------Q---LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHHcC---------------------------C---cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 66531 1 123446789999999999999999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=279.75 Aligned_cols=242 Identities=39% Similarity=0.655 Sum_probs=197.5
Q ss_pred CCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCCc-cH
Q 008607 35 SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DL 113 (560)
Q Consensus 35 ~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL 113 (560)
+||.||+|.+..+|+.+++|++........ ...+.+|+.+++.++|+||+++++.+... ...++|+|++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCH
Confidence 589999999999999999999875322211 57888999999999999999999988543 468999999997 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCc
Q 008607 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193 (560)
Q Consensus 114 ~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~ 193 (560)
..++.....+++..++.++.+++.+|.+||+.+|+|+||+|.||+++.++.++|+|||++....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9999877669999999999999999999999999999999999999999999999999998764432 124467888
Q ss_pred ccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCC-ChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhcc
Q 008607 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRK 272 (560)
Q Consensus 194 ~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~-~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~ 272 (560)
.|++||.+.+ ..++.++||||||+++++|++|..||... +....++.+..
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------------------------- 201 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK--------------------------- 201 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---------------------------
Confidence 9999999875 56788999999999999999999999763 22222111110
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 273 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
...........++..+.+++.+||..||++||++.++++||||
T Consensus 202 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 202 -PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -cCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0111111111267889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.95 Aligned_cols=270 Identities=30% Similarity=0.450 Sum_probs=202.3
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~-~~~ 98 (560)
++..-+...+.||+|+||.||+++++.||+.||||.++... .....++..+|+++|++|+|+|||+++++=-+.. .-.
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 55667888999999999999999999999999999998643 4567788899999999999999999988753221 111
Q ss_pred CccEEEEEecCC-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC--CCC--cEEEecc
Q 008607 99 FKDIYVVFELME-SDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADC--KLKICDF 170 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~---~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~--~~~--~lKL~DF 170 (560)
...-.+|||||. |+|..++.+ ...|++.++..++..+..||.|||++||+||||||.||++- .+| ..||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 234589999998 599999975 33699999999999999999999999999999999999863 334 3799999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhH-HHHHH-HhcC
Q 008607 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ-LDIMT-DLLG 248 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-~~~i~-~~~g 248 (560)
|.|+....+. .+.+.+||+.|.+||++.. ...|+..+|.|||||++|+++||..||........ ...+. ...+
T Consensus 169 G~Arel~d~s----~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 169 GAARELDDNS----LFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred cccccCCCCC----eeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 9998765444 4578999999999999974 25788899999999999999999999964322210 11111 1112
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCC---CC----HHHHHHHHHhcccCCCCCCC
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPN---AN----PLALRLLERMLAFEPKDRPT 306 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---~s----~~~~dLI~~mL~~DP~~Rpt 306 (560)
.|+.-.+... .....|+.|+..+|- ++ ..+..+|..||..||.+|-.
T Consensus 244 kp~~v~i~~~-----------~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 244 KPSGVAIGAQ-----------EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred CCCceeEeee-----------cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 2222111100 111234444444432 22 23556889999999999983
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=307.86 Aligned_cols=277 Identities=18% Similarity=0.261 Sum_probs=187.5
Q ss_pred CCCceEEEEEEeecCCeEEEEEEEC----------------CCCcEEEEEEecCcccCh------------hHHHHHHHH
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDT----------------RTGEKVAIKKINDIFEHV------------SDATRILRE 72 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~----------------~tg~~vAiK~i~~~~~~~------------~~~~~i~rE 72 (560)
..++|++.++||+|+||+||+|.+. ..++.||||++....... ........|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 345679999986421110 011123346
Q ss_pred HHHHHhcCCCCc-----cccceeecCCCc---CCCccEEEEEecCC-ccHHHHHHhC-----------------------
Q 008607 73 IKLLRLLRHPDI-----VEIKHILLPPSR---REFKDIYVVFELME-SDLHQVIKAN----------------------- 120 (560)
Q Consensus 73 i~iL~~l~HpnI-----v~l~~i~~~~~~---~~~~~i~lV~E~~~-gdL~~~i~~~----------------------- 120 (560)
+.++..++|.++ +.+++++..... ......++|+||++ ++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776554 556665543211 12345899999998 5888887532
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCccccccc
Q 008607 121 -DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199 (560)
Q Consensus 121 -~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE 199 (560)
..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChh
Confidence 124567889999999999999999999999999999999999999999999997543322111 11234578999999
Q ss_pred ccccccC------------------CCC--CccchhhHHHHHHHHhhCCC-CCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 200 LCGSFFS------------------KYT--PAIDIWSIGCIFAELLTGKP-LFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 200 ll~~~~~------------------~y~--~~~DIWSlG~il~eLltG~~-pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.+..... .|+ .+.||||+|||+|+|++|.. ||.+....... . ...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~-----------~~~ 446 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---L-----------RQY 446 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---H-----------hhc
Confidence 8753100 122 24799999999999999985 77543211110 0 000
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCcccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP---KDRPTAEEALADPYFK 317 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP---~~Rpta~elL~hp~f~ 317 (560)
.+. ...+... ......+. .+...++.+.|||.+||..+| .+|+|++|+|+||||.
T Consensus 447 ~~~--~~~~r~~-~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 447 DND--LNRWRMY-KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred cch--HHHHHhh-cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 000 0001111 11122222 356678999999999999876 6899999999999996
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=326.10 Aligned_cols=252 Identities=23% Similarity=0.407 Sum_probs=204.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCC-----cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg-----~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
...-++.+.||+|+||.||.|.-.... ..||||.+.+. .+..+...|++|..+|+.+.|||||+++++++...
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~- 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG- 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC-
Confidence 356788999999999999999754432 34999999753 45567788999999999999999999999998743
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEe
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~-------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~ 168 (560)
..+|++|||+ |||..+|++. ..++......|+.||++|+.||+++++|||||...|+|++....+||+
T Consensus 769 ----~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 769 ----PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred ----CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 5799999999 5999999876 258999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhc
Q 008607 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~ 247 (560)
|||+|+.......-... ....--..|||||.+.. ..++.++|||||||++||+++ |..||++.+..+.+.....-
T Consensus 845 DFGlArDiy~~~yyr~~-~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g- 920 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKH-GEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG- 920 (1025)
T ss_pred ccchhHhhhhchheecc-CccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC-
Confidence 99999943322221110 01122346999999987 689999999999999999999 78999998876655432221
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
-+ -...+.++..+-+||..||+.+|++||++..|++
T Consensus 921 ----------------------gR-------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 921 ----------------------GR-------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ----------------------Cc-------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 10 0112466777889999999999999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=315.00 Aligned_cols=250 Identities=30% Similarity=0.452 Sum_probs=193.2
Q ss_pred EEEEEeecCCeE-EEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEEE
Q 008607 27 IEEVIGKGSYGV-VCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 27 i~~~IG~G~~G~-Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
-.+++|.|+.|+ ||+|. -.|+.||||.+-. .....+.||+.+|+.-. |||||++++.- .+...+||
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YI 580 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGV--YEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYI 580 (903)
T ss_pred cHHHcccCCCCcEEEEEe--eCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEE
Confidence 346789999996 69995 4688999998753 34456789999999885 99999987754 33356899
Q ss_pred EEecCCccHHHHHHhCC-C---CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC---C--CcEEEeccccccc
Q 008607 105 VFELMESDLHQVIKAND-D---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---D--CKLKICDFGLARV 175 (560)
Q Consensus 105 V~E~~~gdL~~~i~~~~-~---lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~---~--~~lKL~DFGla~~ 175 (560)
..|+|..+|.++++... . ......+.++.|++.||++||+.+|+||||||+||||.. + .+++|+|||+++.
T Consensus 581 alELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 581 ALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred EehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 99999999999998741 1 111455788999999999999999999999999999986 3 4689999999998
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhC-CCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
...+...-.......||-.|+|||++.. ..-+.++|||||||++|..++| ..||...- ..+.+++..
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~-~R~~NIl~~--------- 728 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-ERQANILTG--------- 728 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchH-HhhhhhhcC---------
Confidence 8776665555677889999999999977 3456799999999999999997 79995432 222221111
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.. .+...-+....++.|||.+||.+||..||+|.++|.||+|-...
T Consensus 729 ------------------~~--~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 729 ------------------NY--TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE 774 (903)
T ss_pred ------------------cc--ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence 00 01111112222899999999999999999999999999997543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=290.20 Aligned_cols=246 Identities=22% Similarity=0.434 Sum_probs=207.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
....+..+||-|-||.||.++.++-.-.||||.++ .+......|+.|..+|+.++|||+|+|+++|.... -+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PF 338 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PF 338 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----Ce
Confidence 34567789999999999999999999999999987 35567889999999999999999999999996543 48
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
|||+|||. |+|.++++..+ .++.-.+.+++.||..|+.||...++|||||-..|.|+.++..|||+||||++....+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999998 89999998755 4778888999999999999999999999999999999999999999999999998776
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
+.+.. ...--..-|.|||-|.- ..++.++|||+|||+|||+.| |-.||+|-+....+.++.+-+.
T Consensus 419 TYTAH--AGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR---------- 484 (1157)
T KOG4278|consen 419 TYTAH--AGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR---------- 484 (1157)
T ss_pred ceecc--cCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc----------
Confidence 65431 11122356899998854 578899999999999999998 7799999876665555443211
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~el 310 (560)
- ....++++.+-.|++.||+++|.+||++.|+
T Consensus 485 -------------M-------~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 485 -------------M-------DGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred -------------c-------cCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 0 1124788999999999999999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.83 Aligned_cols=263 Identities=27% Similarity=0.428 Sum_probs=218.3
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
+-..+|+++.+||.|+||.||+|+|+.+++..|+|+++.. -..+..-+..|+-+++..+|+||+.+++.+....
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~d---- 85 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD---- 85 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhc----
Confidence 4456799999999999999999999999999999999753 3345566778999999999999999999886443
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.++|+||||+| +|.+...--+.+++.++.+..+..++||+|||+.|-+|||||-.|||+++.|.+||+|||.+.....
T Consensus 86 -klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 86 -KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred -CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 48999999995 8888888888999999999999999999999999999999999999999999999999998865432
Q ss_pred CCCCcccccccccCccccccccc-ccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll-~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
+.....+++||++|||||+- -+....|...+|||++|+...||-.-++|.........+.+|++..-.|.
T Consensus 165 ---ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp------ 235 (829)
T KOG0576|consen 165 ---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP------ 235 (829)
T ss_pred ---hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC------
Confidence 22334678999999999985 22236799999999999999999988888765555544445544322221
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
.. ..-..+++.+-+|++.+|.++|++|||++.+|+|||...
T Consensus 236 -------------------~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 236 -------------------TL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred -------------------cc-cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 11 122356788999999999999999999999999999864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=301.28 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=207.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECC-CCc--EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTR-TGE--KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~-tg~--~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
++..+.|+||+|+||+|+.|..+. +|+ .||||+++...... ....|++|+.+|..|+|+|+++||++.++..
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~qp---- 184 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQP---- 184 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccch----
Confidence 455677899999999999997765 343 58999998543332 6678999999999999999999999997643
Q ss_pred ccEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 100 KDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
+.||||++. |+|++.+.+ ...|-....+.|+.||+.|+.||.++++|||||-..|||+-....||||||||.+.+
T Consensus 185 --~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 185 --AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred --hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 689999999 799999987 335888999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
.............-....|+|||.|.- ..++.++|+|++||+||||++ |..||.|.+....+++|.+.-.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er------- 333 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER------- 333 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-------
Confidence 655433222222233456999999976 578999999999999999999 6799999998877766542110
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
-...+.++..+-+++.+||..+|.+|||+..|.+.-++.
T Consensus 334 -----------------------LpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 334 -----------------------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred -----------------------CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 011245678899999999999999999999886544443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.37 Aligned_cols=246 Identities=26% Similarity=0.464 Sum_probs=196.5
Q ss_pred EEEEEEeecCCeEEEEEEECC--CCc--EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 26 KIEEVIGKGSYGVVCSAYDTR--TGE--KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~~--tg~--~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.+.++||.|-||.||.|.-.. .|+ .||||..+.. ....+.+.|+.|..+|+.+.||||+++++++... -
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P 464 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P 464 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence 345789999999999996432 333 5888877643 3344577899999999999999999999999654 3
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|||||++. |.|..+++.+. .++......+++||+.||.|||+.+++||||-..|||+.....|||+||||++....+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 799999999 89999998865 5899999999999999999999999999999999999999999999999999986544
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
..-.. +...-..-|||||-+.- ..++.++|||.|||++||++. |..||.|-...+.+..|.+
T Consensus 545 ~yYka--S~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn------------- 607 (974)
T KOG4257|consen 545 AYYKA--SRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN------------- 607 (974)
T ss_pred chhhc--cccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-------------
Confidence 32111 11122345999999864 578999999999999999776 8899988654443322221
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ..+.+++++.+-.|+.+||+.||.+||++.||..
T Consensus 608 --------------GeR---lP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 608 --------------GER---LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred --------------CCC---CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 111 1234788999999999999999999999988753
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.56 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=217.6
Q ss_pred ccccCCCCceEEEEEEeecCCeEEEEEEECCCCc---EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeec
Q 008607 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (560)
Q Consensus 16 ~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~ 92 (560)
|+.-...+...|.++||.|.||.||+++.+..|+ .||||.++. .-..+....|+.|..||-++.||||+.|.++..
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 3444556778999999999999999999987775 699999974 334556678999999999999999999999983
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecc
Q 008607 93 PPSRREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DF 170 (560)
- .+-+.||+|||+ |.|..+++.++ .|+.-++.-+++.|+.|++||-+.|.+||||-..|||||.+-.+|++||
T Consensus 701 k-----s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDF 775 (996)
T KOG0196|consen 701 K-----SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDF 775 (996)
T ss_pred c-----CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccc
Confidence 2 245899999999 79999998765 6999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCccccccccc--CcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhc
Q 008607 171 GLARVAFNDTPTAIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~g--T~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~ 247 (560)
||+|...++.+.. .++.-| ...|.|||.+.- .+++.++||||+|++|||.++ |..||-..+..+-++.|.+-+
T Consensus 776 GLSRvledd~~~~--ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy 851 (996)
T KOG0196|consen 776 GLSRVLEDDPEAA--YTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY 851 (996)
T ss_pred cceeecccCCCcc--ccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc
Confidence 9999876555322 122222 256899999865 588999999999999999776 889999999888888887766
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
+-|++ .+++..+-+|+..||++|-..||++.||+.
T Consensus 852 RLPpP------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 852 RLPPP------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CCCCC------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 65543 467888999999999999999999999886
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=291.62 Aligned_cols=261 Identities=24% Similarity=0.369 Sum_probs=204.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++..++++||+|-||.|.++.- ..+.+||+|+++-. .+......|.+|+++|.+|+||||+.++++|+... -+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----ch
Confidence 5678999999999999999963 44699999999743 23333478999999999999999999999997653 48
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
++|+|||+ |||.+++.++. .+.......|+.||+.|++||.+.+++||||-+.|+|++.++++||||||.++-+..+
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999 89999999874 3345566679999999999999999999999999999999999999999999976555
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh--CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt--G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
..-... ...+-...|||+|.+.- .+++.++|+|+||+++||+++ ...||......+..+....++..+...
T Consensus 691 ~yy~vq-gr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~---- 763 (807)
T KOG1094|consen 691 DYYRVQ-GRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ---- 763 (807)
T ss_pred Cceeee-cceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc----
Confidence 432211 22355678999998755 588999999999999999765 678887665554444433333322211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
-.....+-++..+.+||.+|+..|-++||+++++ |.+|++
T Consensus 764 -------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq~ 803 (807)
T KOG1094|consen 764 -------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL--HLFLQE 803 (807)
T ss_pred -------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH--HHHHHH
Confidence 1112234567788899999999999999999998 445543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=260.51 Aligned_cols=208 Identities=26% Similarity=0.465 Sum_probs=170.7
Q ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHH-hcCCCCccccceeecCCCcCCCccEEE
Q 008607 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR-LLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~-~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
.-++.||+|+||+|-+.+|..+|...|+|.+..... .....+.++|+.+.. ...+|.+|.+++.+.. ..+++|
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-----egdvwI 122 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-----EGDVWI 122 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-----cccEEE
Confidence 345679999999999999999999999999975433 455677889999865 4469999999998743 357999
Q ss_pred EEecCCccHHH----HHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 105 VFELMESDLHQ----VIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 105 V~E~~~gdL~~----~i~~~~~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.||.|..+|.. +++.++.++|..+-+|+..++.||.|||++ .|||||+||+|||||.+|++|+||||.+-.+.+.
T Consensus 123 cME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 123 CMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred eHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 99999987754 445677899999999999999999999976 8999999999999999999999999999776544
Q ss_pred CCCcccccccccCcccccccccccc--cCCCCCccchhhHHHHHHHHhhCCCCCCC-CChhhHHHHH
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIM 243 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~--~~~y~~~~DIWSlG~il~eLltG~~pF~~-~~~~~~~~~i 243 (560)
... +-..|--.|+|||.+... ...|+-++||||||+.++||.+++.||+. .+...|+..+
T Consensus 203 iAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 203 IAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred hHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 332 224577789999998432 24799999999999999999999999974 3444444443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-33 Score=290.36 Aligned_cols=199 Identities=24% Similarity=0.400 Sum_probs=173.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc------ChhHHHHHHHHHHHHHhcC---CCCccccceeecC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------HVSDATRILREIKLLRLLR---HPDIVEIKHILLP 93 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~------~~~~~~~i~rEi~iL~~l~---HpnIv~l~~i~~~ 93 (560)
..|..++.+|.|+||.|++|.|+.+...|+||.|.+... ...+...+-.||.||..|+ |+||++++++|
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF-- 638 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF-- 638 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee--
Confidence 459999999999999999999999999999999875311 1122344668999999997 99999999999
Q ss_pred CCcCCCccEEEEEecCC-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccc
Q 008607 94 PSRREFKDIYVVFELME-S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~-g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFG 171 (560)
++..++||+||.-+ | ||+++|.....++|.+++.||+|++.|+++||+.||+|||||-+|+.++.+|-+||+|||
T Consensus 639 ---Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 ---EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ---ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 55567999999987 5 999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCC
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~ 232 (560)
.|....++. +..++||..|.|||+|+|. ...+..-|||+||++||.++....||.
T Consensus 716 saa~~ksgp-----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGP-----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCC-----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 997765443 3568999999999999883 333567899999999999999988884
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=319.95 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=185.0
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
..|...++||+|+||.||+|.+..+|..||||++..... ....|+++++.++|||||++++++... ...
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCC
Confidence 346677899999999999999999999999999864221 112468899999999999999998543 357
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLH---s~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
|+|||||+ |+|.++++ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++..+++ ||.+.....
T Consensus 759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999998 59999985 3899999999999999999999 6799999999999999999888776 665543221
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChh-hHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~~~~i~~~~g~p~~~~~~~ 257 (560)
. ....+|..|+|||++.+ ..|+.++|||||||++|||++|+.||...... ..+..+.+..-.
T Consensus 835 ~-------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 897 (968)
T PLN00113 835 D-------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS-------- 897 (968)
T ss_pred C-------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC--------
Confidence 1 23468899999999876 57999999999999999999999999532211 011111110000
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
......+++.... ............+.+|+.+||+.||++|||+.|+++.
T Consensus 898 --~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 898 --DCHLDMWIDPSIR----GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred --ccchhheeCcccc----CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000000000000 0000001112357789999999999999999999863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=273.86 Aligned_cols=268 Identities=24% Similarity=0.313 Sum_probs=199.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHh--cCCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL--LRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~--l~HpnIv~l~~i~~~~~~~~~ 99 (560)
-.-.++.++||+|.||.||+|. -+++.||||++.. .+.+.+.+|-+|.+. ++|+||+++++.-...+.. .
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-R 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-c
Confidence 3456788999999999999994 5679999999863 566778888888775 4799999988765433322 4
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CeeeccCCCCCeeeCCCCcEEEec
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKICD 169 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~---------gIiHrDLKP~NILl~~~~~lKL~D 169 (560)
..++||++|.+ |+|.++++.+ .+++....+++..+++||+|||+- .|+|||||.+||||..|++.-|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 57899999998 8999999887 699999999999999999999964 599999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCC-----CccchhhHHHHHHHHhhCCCCCC-CCChhhHHHHH
Q 008607 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAELLTGKPLFP-GKNVVHQLDIM 243 (560)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~-----~~~DIWSlG~il~eLltG~~pF~-~~~~~~~~~~i 243 (560)
||||.....+.+.... ...+||+.|||||+|.+- .... .++||||+|.+|+||++.-..+. +.-..-++---
T Consensus 360 FGLAl~~~p~~~~~d~-~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDT-HGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred cceeEEecCCCCCcch-hhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 9999988765554433 348999999999999763 2222 35899999999999999765443 33222233223
Q ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHH
Q 008607 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEA 310 (560)
Q Consensus 244 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~s~~~~dLI~~mL~~DP~~Rpta~el 310 (560)
.++...|+-+.+..+ +- +++....+...|. ..-..+.+.|+.||+.|++-|.|+.=+
T Consensus 438 ~evG~hPt~e~mq~~--------VV--~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQEL--------VV--RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHhcCCCCHHHHHHH--------HH--hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 344446665544322 11 1111111222222 223458899999999999999997654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=265.58 Aligned_cols=273 Identities=25% Similarity=0.364 Sum_probs=201.7
Q ss_pred ccCCCcccccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHH--hcCCCCcc
Q 008607 8 KSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR--LLRHPDIV 85 (560)
Q Consensus 8 ~~~~~~~~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~--~l~HpnIv 85 (560)
-|..++.++-.-.+..+..+.+.||+|.||.||+| ...|+.||||++.. .+.....||.+|.+ .|+|+||+
T Consensus 196 GSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENIL 268 (513)
T KOG2052|consen 196 GSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENIL 268 (513)
T ss_pred CCCCCchhHhHHhhhheeEEEEEecCccccceeec--cccCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhh
Confidence 45567788888888999999999999999999999 56799999999863 35566778888876 56999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCCCCC
Q 008607 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKN 156 (560)
Q Consensus 86 ~l~~i~~~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~--------gIiHrDLKP~N 156 (560)
.++..-.... ....++|||++|.+ |+|++++.+ ..++.+.+.++++.++.||++||.. .|+|||||..|
T Consensus 269 gFIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 269 GFIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hhhhccccCC-CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 9877643222 34468999999999 899999988 4799999999999999999999954 49999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCC-CcccccccccCccccccccccccc-----CCCCCccchhhHHHHHHHHhhC---
Q 008607 157 ILANADCKLKICDFGLARVAFNDTP-TAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAELLTG--- 227 (560)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~-~~~~~~~~~gT~~Y~APEll~~~~-----~~y~~~~DIWSlG~il~eLltG--- 227 (560)
|||..++..-|+|+|||....++.. ........+||-.|||||+|...- ..| ..+||||||.++||++-.
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy-k~ADIYafgLVlWEiarRc~~ 425 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESY-KRADIYAFGLVLWEIARRCES 425 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhh-hHHHHHHHHHHHHHHHHHhhc
Confidence 9999999999999999987655532 233456789999999999986521 111 358999999999998762
Q ss_pred -------CCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCC--HHHHHHHHHhcc
Q 008607 228 -------KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN--PLALRLLERMLA 298 (560)
Q Consensus 228 -------~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s--~~~~dLI~~mL~ 298 (560)
++||.+--.. .|+-+.+.++- -++.++...+ .-|...+ ..+..|++.||.
T Consensus 426 ggi~eey~~Pyyd~Vp~-----------DPs~eeMrkVV------Cv~~~RP~ip----nrW~s~~~l~~m~klMkeCW~ 484 (513)
T KOG2052|consen 426 GGIVEEYQLPYYDVVPS-----------DPSFEEMRKVV------CVQKLRPNIP----NRWKSDPALRVMAKLMKECWY 484 (513)
T ss_pred CCEehhhcCCcccCCCC-----------CCCHHHHhcce------eecccCCCCC----cccccCHHHHHHHHHHHHhhc
Confidence 4666542211 11111111110 0011111111 1111111 235678999999
Q ss_pred cCCCCCCCHHHHh
Q 008607 299 FEPKDRPTAEEAL 311 (560)
Q Consensus 299 ~DP~~Rpta~elL 311 (560)
.||.-|.||--|-
T Consensus 485 ~Np~aRltALriK 497 (513)
T KOG2052|consen 485 ANPAARLTALRIK 497 (513)
T ss_pred CCchhhhHHHHHH
Confidence 9999999986653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=239.12 Aligned_cols=212 Identities=38% Similarity=0.646 Sum_probs=180.9
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCC
Q 008607 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME 110 (560)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~ 110 (560)
||.|++|.||++.+..+++.+++|++....... ....+.+|+.+++.++|++|+++++++... ...++|+|++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence 689999999999998889999999987532221 346788999999999999999999988544 46899999999
Q ss_pred -ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC-CCcEEEecccccccccCCCCCccccc
Q 008607 111 -SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWT 187 (560)
Q Consensus 111 -gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-~~~lKL~DFGla~~~~~~~~~~~~~~ 187 (560)
++|.+++... ..+++..++.++.+++.+|++||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 6999999876 47999999999999999999999999999999999999999 89999999999976543321 123
Q ss_pred ccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHH
Q 008607 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 267 (560)
Q Consensus 188 ~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l 267 (560)
...+...|++||.+... ..++.+.|+|+||+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 45678889999998762 3678899999999999998
Q ss_pred HhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008607 268 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (560)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp 314 (560)
..+.++|.+||..||.+||+++++++|+
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1256799999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=282.60 Aligned_cols=247 Identities=28% Similarity=0.466 Sum_probs=195.5
Q ss_pred EEEEEEeecCCeEEEEEEEC----C---CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcC
Q 008607 26 KIEEVIGKGSYGVVCSAYDT----R---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRR 97 (560)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~----~---tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~ 97 (560)
.+.+.||+|.||.|++|.-. . ....||||.++..... .+...+..|+++|+.+. |+||+.+++.+..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 67779999999999999632 1 1457999999865444 67788999999999885 9999999999855
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
...+++|+||+. |+|..+++.+. .++......+++||+.|++||++.+++||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 346899999998 79999998765 388999999999999999999999999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCcccccccccC--cccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCC-h
Q 008607 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVAT--RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN-V 236 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT--~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~-~ 236 (560)
.+..+||+|||+|+.......-.. ....++ ..|||||.+.. ..|+.++||||+|++||||++ |..||++-. .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999986433322111 111222 33999999987 689999999999999999998 679998733 2
Q ss_pred hhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 237 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.+.++ ++....+. .....+++++-++++.|+..+|++||++.++..
T Consensus 529 ~~l~~------------------------~l~~G~r~------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLE------------------------FLKEGNRM------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHH------------------------HHhcCCCC------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 22111 11211110 112356888999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-29 Score=240.64 Aligned_cols=200 Identities=38% Similarity=0.670 Sum_probs=172.6
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
|.+.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..++.++|+|++++++.+... ...++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEE
Confidence 67889999999999999999999999999998753222 2567888999999999999999999987443 45899
Q ss_pred EEecCCc-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 105 VFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 105 V~E~~~g-dL~~~i~~~~~-lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
++|++.+ +|.+++..... +++..++.++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999997 99999988766 899999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCC
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~ 233 (560)
......++..|++||.+.+ ...++.++|+|||||++++|++|+.||.+
T Consensus 155 --~~~~~~~~~~~~~pe~~~~-~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLLG-GKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhcC-CCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1234578889999999842 25778899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=300.95 Aligned_cols=208 Identities=16% Similarity=0.195 Sum_probs=148.1
Q ss_pred hcCC-CCccccceeecCCCc--CCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 008607 78 LLRH-PDIVEIKHILLPPSR--REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (560)
Q Consensus 78 ~l~H-pnIv~l~~i~~~~~~--~~~~~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLK 153 (560)
.++| .||..+++.|..... .....++++||+++++|.+++... ..+++.+++.|++||+.||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3444 577777776622211 122357889999999999999753 469999999999999999999999999999999
Q ss_pred CCCeeeCC-------------------CCcEEEecccccccccCCC-------------CCcccccccccCccccccccc
Q 008607 154 PKNILANA-------------------DCKLKICDFGLARVAFNDT-------------PTAIFWTDYVATRWYRAPELC 201 (560)
Q Consensus 154 P~NILl~~-------------------~~~lKL~DFGla~~~~~~~-------------~~~~~~~~~~gT~~Y~APEll 201 (560)
|+||||+. ++.+||+|||+++...... +........+||++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999965 4456666666665321100 000011235789999999998
Q ss_pred ccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCC
Q 008607 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 281 (560)
Q Consensus 202 ~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 281 (560)
.+ ..|+.++|||||||+||||++|.+||..... .+..+... . .+ ..
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~-----------------------~---~~----~~ 233 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR-----------------------V---LP----PQ 233 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh-----------------------h---cC----hh
Confidence 77 5789999999999999999999988753211 11111000 0 00 00
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 282 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 282 ~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.....+.+.+++.+||..||.+||++.|+|+||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 01123556789999999999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=249.61 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=196.8
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~ 99 (560)
..+.|.|.+.||+|.||.+.+|+|+.+...+++|.+... ......+.||...--.|. |.||+.-+++.+...
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~---- 94 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS---- 94 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC----
Confidence 356799999999999999999999999999999999864 345677889988866665 899999888765433
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC--CCcEEEecccccccc
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVA 176 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~--~~~lKL~DFGla~~~ 176 (560)
+.+++++||++ |||..-+..+ .+-|...+.++.||+.||.|||+.+|+|||||.+||||-. ..+|||||||+.+..
T Consensus 95 d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 35778999999 8999988775 4889999999999999999999999999999999999743 247999999998754
Q ss_pred cCCCCCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
.... .-.--+..|.+||++... .-...+.+|||.||+|+|.+|||.+||......++
T Consensus 174 g~tV------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-------------- 233 (378)
T KOG1345|consen 174 GTTV------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-------------- 233 (378)
T ss_pred Ccee------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc--------------
Confidence 2211 112234568999987432 12356789999999999999999999963222111
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEALADPYF 316 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~R---pta~elL~hp~f 316 (560)
...+++.-..++.+ .....|.-+++.+.++.++-|..++++| -++..-...-|.
T Consensus 234 --------~Y~~~~~w~~rk~~-~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 234 --------PYWEWEQWLKRKNP-ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred --------hHHHHHHHhcccCc-cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 11233333333322 4556777889999999999999999999 334433334443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=268.90 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=198.0
Q ss_pred EEEEEEeecCCeEEEEEEECCCCc----EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 26 KIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+..++||.|+||+||++...-.|+ +||||++.. +...+....+++|+-+|..|.|||+++|++++....
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 445789999999999998866665 578887753 344455678999999999999999999999997653
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+-||++||+ |.|.++++.+. .+-.+....|.+||++||.|||.++++||||-..||||..-..+||.|||+|+....+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 689999999 79999998754 6889999999999999999999999999999999999999999999999999987655
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
..... ....-..+-|+|=|.+.. ..|+.++||||+||++|||+| |..|+.+....+.-+.+.+
T Consensus 852 ~~ey~-~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~------------- 915 (1177)
T KOG1025|consen 852 EKEYS-APGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK------------- 915 (1177)
T ss_pred ccccc-ccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-------------
Confidence 43311 111122345778787765 689999999999999999998 8899988775443222211
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
-. + -...+.++-++--++-+||-.|+..||+++++..
T Consensus 916 -----------ge-R-----LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 916 -----------GE-R-----LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -----------cc-c-----CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 00 0 1234677888888999999999999999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=276.23 Aligned_cols=267 Identities=28% Similarity=0.352 Sum_probs=202.9
Q ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEecC---cccChhHH-HHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND---IFEHVSDA-TRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~---~~~~~~~~-~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
....++|.|++|.|+.+....-.+.++.|.... ........ ..+..|+.+-..|.|+|++..+.+++... .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----G 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----c
Confidence 446779999999999998888788777776542 11122222 23667888888899999988877764432 2
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 102 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
++-+||||++||+.++...+.++...+..++.||+.||+|||+.||.|||||++|+|++.+|.+||+|||.+.+......
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred chhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 34449999999999999988899999999999999999999999999999999999999999999999999987533322
Q ss_pred C-cccccccccCcccccccccccccCCCCC-ccchhhHHHHHHHHhhCCCCCCCCChhhHHH-HHHHhcCCCCHHHHHHh
Q 008607 182 T-AIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTPSPEAIARV 258 (560)
Q Consensus 182 ~-~~~~~~~~gT~~Y~APEll~~~~~~y~~-~~DIWSlG~il~eLltG~~pF~~~~~~~~~~-~i~~~~g~p~~~~~~~~ 258 (560)
. .......+|+-.|+|||++.+ ..|++ ..||||.|+++..|++|+.||.-....++.. .+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~------------- 540 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY------------- 540 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-------------
Confidence 1 233467899999999999977 57776 5799999999999999999997544332210 0000
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
....+........+..++...+.+|.+||+.||.+|.|+++|++.+||+.+...
T Consensus 541 ----------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 541 ----------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred ----------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 000111111222233456678899999999999999999999999999976543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=223.68 Aligned_cols=165 Identities=22% Similarity=0.276 Sum_probs=127.2
Q ss_pred ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccccccc
Q 008607 111 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189 (560)
Q Consensus 111 gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~ 189 (560)
|+|.+++..+ ..++++.++.|+.||+.||+|||+.+ ||+|||++.++.+|+ ||+++..... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 6899999874 45999999999999999999999998 999999999999999 9998765332 23
Q ss_pred ccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhH-HHHHHHhcCCCCHHHHHHhhhHHHHHHHH
Q 008607 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ-LDIMTDLLGTPSPEAIARVRNEKARRYLS 268 (560)
Q Consensus 190 ~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~l~ 268 (560)
.||+.|+|||++.+ ..|+.++|||||||++|||++|+.||........ +..+..
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~----------------------- 119 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN----------------------- 119 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH-----------------------
Confidence 68999999999977 5789999999999999999999999976543221 111111
Q ss_pred hhccCCCCCCCCCCCCCCH--HHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 269 SMRKKKPIPFSQKFPNANP--LALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~--~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
.+....+.. ......++. .+.+||.+||..||.+||++.|+++|+|+.
T Consensus 120 ~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 120 GMPADDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhccCCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 111000000 000111222 589999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-25 Score=222.28 Aligned_cols=265 Identities=34% Similarity=0.524 Sum_probs=204.5
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChh-HHHHHHHHHHHHHhcCCC-CccccceeecCCCcCCCccE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS-DATRILREIKLLRLLRHP-DIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~-~~~~i~rEi~iL~~l~Hp-nIv~l~~i~~~~~~~~~~~i 102 (560)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+.+++.+.... ..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-----SL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-----EE
Confidence 889999999999999999887 8899999986554443 567889999999999988 7999999983332 37
Q ss_pred EEEEecCCc-cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC-cEEEeccccccccc
Q 008607 103 YVVFELMES-DLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAF 177 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~---~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~-~lKL~DFGla~~~~ 177 (560)
+++++++.+ ++.+++.... .+++..+..++.|++.+|.|+|+.+++||||||+|||++..+ .++++|||+++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999995 7887777664 799999999999999999999999999999999999999998 79999999998543
Q ss_pred CCCCCc---ccccccccCccccccccccccc-CCCCCccchhhHHHHHHHHhhCCCCCCCCCh---hhHHHHHHHhcCCC
Q 008607 178 NDTPTA---IFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---VHQLDIMTDLLGTP 250 (560)
Q Consensus 178 ~~~~~~---~~~~~~~gT~~Y~APEll~~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~---~~~~~~i~~~~g~p 250 (560)
...... ......+||.+|+|||.+.+.. ..+....|+||+|++++++++|..||..... ......+......+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 332221 1346789999999999987621 3677899999999999999999999887664 22222222111111
Q ss_pred CHHHHHHhhhHHHHHHHHhhccCCCCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 251 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.......... ......+.+++.+|+..+|..|.+..+...++|....
T Consensus 234 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 ----------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ----------------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000000 1123578899999999999999999999988666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=232.55 Aligned_cols=168 Identities=21% Similarity=0.227 Sum_probs=129.5
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECC-CCcEEEEEEecCccc---ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~-tg~~vAiK~i~~~~~---~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
...+|++.+.||+|+||+||+|++.. ++..||||++..... .......+.+|+++|+.++|+||+..+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 35679999999999999999999886 778889998753211 222355688999999999999998533221
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC-CCCCeeeCCCCcEEEecccccc
Q 008607 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 97 ~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDL-KP~NILl~~~~~lKL~DFGla~ 174 (560)
...|||||||+| +|. .+... . ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ---~~~~LVmE~~~G~~L~-~~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLH-LARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred ---CCcEEEEEccCCCCHH-HhCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 236999999986 665 22211 1 1568899999999999999999999 9999999999999999999998
Q ss_pred cccCCCCCcc-----cccccccCccccccccccc
Q 008607 175 VAFNDTPTAI-----FWTDYVATRWYRAPELCGS 203 (560)
Q Consensus 175 ~~~~~~~~~~-----~~~~~~gT~~Y~APEll~~ 203 (560)
.......... ..+..++++.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 7643321111 1245678899999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-24 Score=220.88 Aligned_cols=255 Identities=21% Similarity=0.230 Sum_probs=188.3
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCC-cEEEEEEecCcccChhHHHHHHHHHHHHHhcCC----CCccccceeecCCCcCC
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKINDIFEHVSDATRILREIKLLRLLRH----PDIVEIKHILLPPSRRE 98 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg-~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~H----pnIv~l~~i~~~~~~~~ 98 (560)
+|++.+.||+|+||.||+|.+..++ ..+|+|......... ...+..|+.+|..+.. .++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 8999999999999999999998875 678888765422111 1256789999988873 57777777663 12
Q ss_pred CccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC-----CcEEEeccc
Q 008607 99 FKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-----CKLKICDFG 171 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-----~~lKL~DFG 171 (560)
...-||||++++.+|.++.+.. +.|+...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 2357999999999999988654 479999999999999999999999999999999999999865 469999999
Q ss_pred ccc--cccCCCCC-----cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHH
Q 008607 172 LAR--VAFNDTPT-----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (560)
Q Consensus 172 la~--~~~~~~~~-----~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~ 244 (560)
+++ ........ ........||..|+++....+ ...+.+.|+||++.++.+|+.|..||.+.........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 32222111 011134569999999999887 577899999999999999999999997655433222221
Q ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 245 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ..... .......+..+..++..+-..+...+|....+..
T Consensus 251 ~~~-----------------------~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 251 KDP-----------------------RKLLT---DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHh-----------------------hhhcc---ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 100 00000 0011223455666777666788888998887755
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=219.31 Aligned_cols=253 Identities=18% Similarity=0.317 Sum_probs=196.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCC-----CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~t-----g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
..|+++..++-+|.||.||.|+.... .+.|.+|.++.. ...-....++.|..+|..+.|||+..+.++...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie--- 358 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE--- 358 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee---
Confidence 35688889999999999999965533 234666766532 233455678899999999999999999998754
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEE
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAN--------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~--------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL 167 (560)
+...-++++.+++ |+|..++... +.++..+...++.||..|++|||+.||+|.||-..|.+|++.-++||
T Consensus 359 -~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 359 -DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred -ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 3345688889998 7999998721 24777888899999999999999999999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHh
Q 008607 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246 (560)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~ 246 (560)
+|=.|+|..+..+.....-. .-....||+||.+.. ..|+.++|+|||||+||||+| |+.|+..-+..+..
T Consensus 438 tDsaLSRDLFP~DYhcLGDn-EnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~------ 508 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDN-ENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME------ 508 (563)
T ss_pred ccchhccccCcccccccCCC-CCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH------
Confidence 99999998877665432111 123456899999977 689999999999999999998 78888665544332
Q ss_pred cCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 247 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.|++.-.+ + ...-++++++..++.-||..+|++||+.+|+..
T Consensus 509 ------------------~ylkdGyR-----l-aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 509 ------------------HYLKDGYR-----L-AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ------------------HHHhccce-----e-cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 23322111 0 112378899999999999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=198.64 Aligned_cols=214 Identities=26% Similarity=0.355 Sum_probs=168.8
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCC-CCccccceeecCCC
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPS 95 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~H-pnIv~l~~i~~~~~ 95 (560)
.++-.+..|+++++||.|+||.+|+|....+|+.||||.-... .....+..|.++.+.|++ ..|..+....
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~----a~hpqL~yEskvY~iL~~g~GiP~i~~y~---- 80 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK----AKHPQLLYESKVYRILQGGVGIPHIRHYG---- 80 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc----CCCcchhHHHHHHHHhccCCCCchhhhhc----
Confidence 3457789999999999999999999999999999999986532 223456789999999985 5565555544
Q ss_pred cCCCccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC---CcEEEeccc
Q 008607 96 RREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFG 171 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~---~~lKL~DFG 171 (560)
.+..+-.+||++++.+|.+++.- +..|+...+.-++-|++.-|+|+|..+++||||||+|+|..-+ ..+.|+|||
T Consensus 81 -~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 81 -TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred -cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence 22345689999999888887764 3469999999999999999999999999999999999996543 459999999
Q ss_pred ccccccCCCCCc-c---cccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHH
Q 008607 172 LARVAFNDTPTA-I---FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241 (560)
Q Consensus 172 la~~~~~~~~~~-~---~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~ 241 (560)
||+.+....... + .-....||..|++--...+ ..-+...|+-|+|.+|..+.-|..||.|-......+
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q 231 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ 231 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence 998764332211 1 1245679999998776655 355678999999999999999999999876554433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-25 Score=234.43 Aligned_cols=242 Identities=25% Similarity=0.396 Sum_probs=197.7
Q ss_pred EEeecCCeEEEEEEE---CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEEEE
Q 008607 30 VIGKGSYGVVCSAYD---TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 30 ~IG~G~~G~Vy~a~d---~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~i~lV 105 (560)
++|.|+||.|++++. ...|..+|+|+.++.........+...|-.++..++ ||.+|+++..+.+.+ .+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-----kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-----KLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-----chhHh
Confidence 379999999998753 356778999998865444444445567889999997 999999999886554 58999
Q ss_pred EecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcc
Q 008607 106 FELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (560)
Q Consensus 106 ~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~ 184 (560)
+++..| +|...+.....+.+...+.+...++.|++++|+.+|+|||+|++||+++.+|.+|+.|||+++......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999985 999999888889999999999999999999999999999999999999999999999999998653322
Q ss_pred cccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHH
Q 008607 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264 (560)
Q Consensus 185 ~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 264 (560)
..|||..|||||++. ....++|.||+|+++|+|++|..||.+ +....|.+.
T Consensus 152 ---~~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~------------------ 202 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA------------------ 202 (612)
T ss_pred ---hcccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh------------------
Confidence 228999999999986 356899999999999999999999977 333333220
Q ss_pred HHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccccccc
Q 008607 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLAKV 322 (560)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~~~~ 322 (560)
+ ......++..+.+++..|+..+|..|.. +.|+++|+||..+...
T Consensus 203 --------~-----~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 203 --------E-----LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred --------c-----cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 0 0112355778999999999999999964 5899999999876543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-23 Score=202.77 Aligned_cols=241 Identities=22% Similarity=0.314 Sum_probs=184.4
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~ 98 (560)
.+|-.|+|.++||+|+||+.+.+.+.-+++.||||.-.. .+++.++..|....+.|. .++|..++-+- .+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qe 95 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QE 95 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeec-----cc
Confidence 467789999999999999999999999999999997543 355667788999998886 67777765433 23
Q ss_pred CccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC-----cEEEecccc
Q 008607 99 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-----KLKICDFGL 172 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~-----~lKL~DFGl 172 (560)
..+-.||+|+++.+|.+++.-.+ +|+...+..++.|++.-++|+|++++|.|||||+|+||..-+ .|.|+|||+
T Consensus 96 G~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 96 GKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred cchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 34568999999988888887654 699999999999999999999999999999999999997643 499999999
Q ss_pred cccccCCCCC-cc---cccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCCh---hhHHHHHHH
Q 008607 173 ARVAFNDTPT-AI---FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---VHQLDIMTD 245 (560)
Q Consensus 173 a~~~~~~~~~-~~---~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~---~~~~~~i~~ 245 (560)
|+.+..-... .+ ...+..||-.||+=-...+ ..-+...|+-|||-+|...|-|.+||.|... -+.+++|-+
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 9976432221 11 1245689999999887766 4667889999999999999999999998543 344445544
Q ss_pred hcCCCCHHHHHHhhhHHHHHHHHhhc
Q 008607 246 LLGTPSPEAIARVRNEKARRYLSSMR 271 (560)
Q Consensus 246 ~~g~p~~~~~~~~~~~~~~~~l~~~~ 271 (560)
.-..-+.+.+..--.++...|+.-.+
T Consensus 254 ~Kr~T~i~~Lc~g~P~efa~Yl~yvR 279 (449)
T KOG1165|consen 254 TKRSTPIEVLCEGFPEEFATYLRYVR 279 (449)
T ss_pred ccccCCHHHHHhcCHHHHHHHHHHHH
Confidence 33333333333333444555555443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=233.32 Aligned_cols=230 Identities=27% Similarity=0.412 Sum_probs=175.2
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
...+.|..++.|..|+||-||+++|+.+..++|+ +|++. + -+ || ||..+-+
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq-----~--li------lR-----nilt~a~---------- 130 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQ-----N--LI------LR-----NILTFAG---------- 130 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhh-ccccc-----c--hh------hh-----ccccccC----------
Confidence 3456789999999999999999999999999999 55431 1 11 11 1222111
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
..++| ||-...++..+.++.+. +.+++|||+.||+|||+||+|+||+.-|++|+.|||+...-...
T Consensus 131 -npfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 131 -NPFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -Cccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 12333 66666676666666554 78899999999999999999999999999999999999763222
Q ss_pred CCCc------------ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc
Q 008607 180 TPTA------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 180 ~~~~------------~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~ 247 (560)
.... ..-...|||+.|+|||++.. ..|+..+|.|++|+|+||.+-|..||.|....+.+..+..-
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd- 273 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD- 273 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh-
Confidence 1111 11234699999999999876 68999999999999999999999999998877766544321
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCccccccccc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEALADPYFKGLAKV 322 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~R---pta~elL~hp~f~~~~~~ 322 (560)
.+.|.+.-....++++++|.++|+.+|..| ..+-++.+|+||+.+...
T Consensus 274 ---------------------------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 274 ---------------------------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ---------------------------hccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 122344445678999999999999999999 457788899999987543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=206.07 Aligned_cols=240 Identities=21% Similarity=0.276 Sum_probs=154.2
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCC----------CCccccceeec
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRH----------PDIVEIKHILL 92 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~H----------pnIv~l~~i~~ 92 (560)
.+...+.||.|+++.||.+.|..||+.+|+|++.... ......+.+.+|.-....+.+ -.++-.+++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 5678899999999999999999999999999975322 222344556666544444322 12222223221
Q ss_pred CCCc---------CCC---ccEEEEEecCCccHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 008607 93 PPSR---------REF---KDIYVVFELMESDLHQVIKA---NDD----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (560)
Q Consensus 93 ~~~~---------~~~---~~i~lV~E~~~gdL~~~i~~---~~~----lse~~~~~i~~Qll~aL~yLHs~gIiHrDLK 153 (560)
.... ... -+.+++|+-+.+||.+++.. ... +.......+..|+++.+++||+.||+|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1100 000 13478899999998888653 221 2233345566999999999999999999999
Q ss_pred CCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccc------cCCCCCccchhhHHHHHHHHhhC
Q 008607 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTG 227 (560)
Q Consensus 154 P~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~------~~~y~~~~DIWSlG~il~eLltG 227 (560)
|+|+|++.+|.++|+||+......... .....+..|.+||+.... ...++.+.|.|+||+++|.|+||
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999776542211 113455779999976431 13478899999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 008607 228 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 304 (560)
Q Consensus 228 ~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~R 304 (560)
..||........ ....|..|. +++..+++||+.||+.||.+|
T Consensus 247 ~lPf~~~~~~~~----------------------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEAD----------------------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGST----------------------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccc----------------------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999975442110 001355666 888999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=233.35 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=184.0
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc--cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~--~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.|...+.||++.|=.|++|.|. .| .|+||++-+.. ..-....+.++|++ ...+++||.+.+..+..+ .+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t-----~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT-----DKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh-----hHH
Confidence 7999999999999999999764 34 49999886432 12223344456666 677899999998776533 245
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc--cCC
Q 008607 102 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA--FND 179 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~--~~~ 179 (560)
-|||-+|...+|++.+..+.-+..-+.+.|+.||+.||.-+|..||+|||||.+||||+.=+-+.|+||..-+.. ..+
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 799999999999999988888889999999999999999999999999999999999999989999999765532 222
Q ss_pred CCCc--ccccccccCcccccccccccc---------cCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhc
Q 008607 180 TPTA--IFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 180 ~~~~--~~~~~~~gT~~Y~APEll~~~---------~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~ 247 (560)
.+.. .++.+...-.+|.|||.+... ....+++-||||+||+++||++ |++||.- .|+-....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~-- 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRS-- 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhc--
Confidence 2221 223333344579999987431 0125678999999999999988 6899942 11111100
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
| ........++.+. +...+.||..|++.||.+|.+|++.|+.
T Consensus 250 ~----------~~~~~e~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 G----------NADDPEQLLEKIE--------------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred c----------CccCHHHHHHhCc--------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 0011122222221 3357899999999999999999999975
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=195.19 Aligned_cols=140 Identities=24% Similarity=0.256 Sum_probs=109.0
Q ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhH------------------------HHHHHHHHHHHHhcCCCC
Q 008607 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD------------------------ATRILREIKLLRLLRHPD 83 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~------------------------~~~i~rEi~iL~~l~Hpn 83 (560)
.+.||+|+||.||+|.+. +|+.||||+++........ .....+|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 8999999999743211111 112345999999998877
Q ss_pred ccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCeeeccCCCCCeeeCC
Q 008607 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILANA 161 (560)
Q Consensus 84 Iv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yL-Hs~gIiHrDLKP~NILl~~ 161 (560)
+.....+.. ...+|||||++| ++...+.....+++..+..++.||+.+|.+| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 744332221 123899999996 4555444556799999999999999999999 799999999999999998
Q ss_pred CCcEEEecccccccc
Q 008607 162 DCKLKICDFGLARVA 176 (560)
Q Consensus 162 ~~~lKL~DFGla~~~ 176 (560)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=195.92 Aligned_cols=176 Identities=13% Similarity=0.139 Sum_probs=132.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhH-HHH------HHHHHHHHHhcCCCCccccceeecCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD-ATR------ILREIKLLRLLRHPDIVEIKHILLPP 94 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~-~~~------i~rEi~iL~~l~HpnIv~l~~i~~~~ 94 (560)
.++|++.++||.|+||.||++.+ ++..+|||.+......... ..+ +.+|+..+..+.|++|..+.+.+...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 68999999999999999999754 4778999999754332222 223 57899999999999999998886543
Q ss_pred CcCC---CccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecc
Q 008607 95 SRRE---FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (560)
Q Consensus 95 ~~~~---~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DF 170 (560)
.... ....+|||||++| +|.++. .++++ .+.+|+.+|..||..||+||||||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2211 2357999999997 787763 23332 466999999999999999999999999999998 999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHh
Q 008607 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLl 225 (560)
|..+........ -.+... ..|+.++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~---------------d~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK---------------DRIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH---------------HHHHHH--hHhcccccccceeEeehHHH
Confidence 988654211100 002222 34667899999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=187.27 Aligned_cols=141 Identities=24% Similarity=0.228 Sum_probs=111.3
Q ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhH------------------------HHHHHHHHHHHHhcCCC
Q 008607 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD------------------------ATRILREIKLLRLLRHP 82 (560)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~------------------------~~~i~rEi~iL~~l~Hp 82 (560)
+.+.||+|++|.||+|.+. +|+.||||+++........ ...+.+|+..+..+.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999998753211000 12245799999999999
Q ss_pred CccccceeecCCCcCCCccEEEEEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeC
Q 008607 83 DIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN 160 (560)
Q Consensus 83 nIv~l~~i~~~~~~~~~~~i~lV~E~~~gd-L~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~ 160 (560)
++.....+... ..||||||++|. +.........+++..+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 87554444321 138999999973 43333344578899999999999999999999 9999999999999999
Q ss_pred CCCcEEEecccccccc
Q 008607 161 ADCKLKICDFGLARVA 176 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~ 176 (560)
++.++|+|||+++..
T Consensus 153 -~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DGKPYIIDVSQAVEL 167 (190)
T ss_pred -CCCEEEEEcccceec
Confidence 889999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=196.91 Aligned_cols=255 Identities=27% Similarity=0.368 Sum_probs=173.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCC-----------------------------------cEEEEEEecCcccChhHHH
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTG-----------------------------------EKVAIKKINDIFEHVSDAT 67 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg-----------------------------------~~vAiK~i~~~~~~~~~~~ 67 (560)
+.|+|.+.||+|....||.|+-...| -..|||.+-+. +..+...
T Consensus 157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~-~~~s~~~ 235 (598)
T KOG4158|consen 157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNF-EHDSGDA 235 (598)
T ss_pred hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccc-ccCCchH
Confidence 46999999999999999998643211 02466665432 2223333
Q ss_pred HHHH----HH------HH--------HHh--------cCCCCccccceeecCCC----------------------cCCC
Q 008607 68 RILR----EI------KL--------LRL--------LRHPDIVEIKHILLPPS----------------------RREF 99 (560)
Q Consensus 68 ~i~r----Ei------~i--------L~~--------l~HpnIv~l~~i~~~~~----------------------~~~~ 99 (560)
.|++ |+ .+ .+. -+|||||.+...|.+.- ..+.
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 3332 21 11 111 25999999998874321 1234
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC--CC--cEEEeccccccc
Q 008607 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DC--KLKICDFGLARV 175 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~--~~--~lKL~DFGla~~ 175 (560)
..+|+||..+..+|.+++-.+ ..+.....-++.|+++|+.|||.+||.|||||.+|||+.- |+ .+.|+|||++-.
T Consensus 316 ~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA 394 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA 394 (598)
T ss_pred ceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence 569999999999999999776 4677778889999999999999999999999999999753 33 389999998754
Q ss_pred ccCCCCCccc---ccccccCcccccccccccccCC---C-CCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcC
Q 008607 176 AFNDTPTAIF---WTDYVATRWYRAPELCGSFFSK---Y-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 176 ~~~~~~~~~~---~~~~~gT~~Y~APEll~~~~~~---y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g 248 (560)
..+..-...+ .-+.-|.-..||||+....-.+ . -.++|.|+.|.+.||++....||.+......
T Consensus 395 d~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L--------- 465 (598)
T KOG4158|consen 395 DDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL--------- 465 (598)
T ss_pred ccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee---------
Confidence 3221111111 1234567788999987532111 1 1378999999999999999999976432110
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~ 308 (560)
+.+.|-+ ..+......+++.+++|+..+|+.||++|+++.
T Consensus 466 -------------~~r~Yqe-------~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 466 -------------DTRTYQE-------SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred -------------chhhhhh-------hhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 0011111 112233356789999999999999999999843
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=179.62 Aligned_cols=192 Identities=17% Similarity=0.038 Sum_probs=137.1
Q ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC--hhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccE
Q 008607 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH--VSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~--~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~i 102 (560)
.+...|++|+||+|+.+.. .+.+++.+.+.....- ......+.+|+++|+.|. |++|..+++.. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 4578899999999998843 6788887777532221 112235789999999996 57788887741 36
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC-CCCCeeeCCCCcEEEecccccccccCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDL-KP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
|++|||+.| +|.+.+.. . ...++.|++.+|++||++||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 74 ~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred EEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999999997 56544321 1 1357899999999999999999999 7999999999999999999998543222
Q ss_pred CC----c-cc-----ccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCC
Q 008607 181 PT----A-IF-----WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235 (560)
Q Consensus 181 ~~----~-~~-----~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~ 235 (560)
.. . .. ..-...++.|++|+.-.-....--...+.++.|+.+|.++|++.++-+.+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 0 00 00122567788887543211122256788899999999999998875543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=200.50 Aligned_cols=309 Identities=22% Similarity=0.253 Sum_probs=207.9
Q ss_pred HHhcCCCCccccceeecCCCcCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCe-eeccC
Q 008607 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANV-FHRDL 152 (560)
Q Consensus 76 L~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gI-iHrDL 152 (560)
|+.+.|.|+.+++++++.. ..+++|.+||. |+|.+.+.. ...+++-....+++.|+.||.|||..-| .|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4678999999999999765 46899999998 799999987 3468888999999999999999999877 99999
Q ss_pred CCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccc--cCC---CCCccchhhHHHHHHHHhhC
Q 008607 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF--FSK---YTPAIDIWSIGCIFAELLTG 227 (560)
Q Consensus 153 KP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~--~~~---y~~~~DIWSlG~il~eLltG 227 (560)
+..|.++|..+.+||.|||+........ .........-...|.|||++.+. ... .+.+.||||+|+|++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccc-cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998764311 10111222244568999998662 111 46679999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 008607 228 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA 307 (560)
Q Consensus 228 ~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta 307 (560)
+.||........-+.+.. . +.........+.-.......+.+..++++|+.-+|..||++
T Consensus 155 ~~~~~~~~~~~~~~eii~-----------~---------~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIIL-----------R---------VKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred cCccccccccCChHHHHH-----------H---------HHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 999986432221111110 0 11111111111111112455679999999999999999999
Q ss_pred HHHhcCcccccccccCCCCCC-CCCCcchhhHHhhcCCHHHHHHHHHHHHHhhChhHHHhhhcCCCCCCCCCCchhHHHH
Q 008607 308 EEALADPYFKGLAKVEREPSA-QPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFK 386 (560)
Q Consensus 308 ~elL~hp~f~~~~~~~~~~~~-~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (560)
+++-.. +..+..... .. ..+..+-...+......|+ .+.+...++..+..+......-|.|..|+
T Consensus 215 ~~i~~~--~~~~~~~~~--~~~nl~D~m~~~le~Y~~nLe~-------~v~eRt~~l~~e~~k~d~LL~~mLP~~VA--- 280 (484)
T KOG1023|consen 215 EQIRSK--LLTINKGGS--SKGNLMDSLFRMLESYADNLEK-------LVDERTAELEEEKKKTDTLLGQMLPKSVA--- 280 (484)
T ss_pred HHHHhh--hhhhccccc--ccchhHHHHHHHHHHHHhhhHH-------HHHHHHHHHHHHHHHHHHHHHHhcCHHHh---
Confidence 987431 111111000 00 1111111222222333333 23333333344444444555567787776
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCCCCCCCccccccCCCCCCCcccc
Q 008607 387 KQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVT 431 (560)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (560)
+..+.|..+.|.....+.+..++++.++.+..+++|-.
T Consensus 281 -------~~lk~G~~v~pe~~~~vti~fsDiv~fT~l~~~~~P~~ 318 (484)
T KOG1023|consen 281 -------ESLKLGKTVDPESFDSVTIYFSDIVGFTVLSSNSTPIQ 318 (484)
T ss_pred -------hHhhcCCcCCccccCceeeeeHHHHHHHHHHhcCCCce
Confidence 67888999999999999999999999998888776654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.1e-20 Score=178.37 Aligned_cols=136 Identities=20% Similarity=0.244 Sum_probs=107.3
Q ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-----CCCCccccceeecCCCcCCCccE
Q 008607 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-----RHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-----~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
.+.||+|+||.||. |..++.. +||++... .......+.+|+.+++.+ .||||+++++++.+.. ....+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 46899999999995 7777776 69988642 223456789999999999 5799999999996642 11344
Q ss_pred E-EEEecCC---ccHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCeeeccCCCCCeeeCCC----CcEEEeccccc
Q 008607 103 Y-VVFELME---SDLHQVIKANDDLTPEHYQFFLYQLLRGL-KYIHTANVFHRDLKPKNILANAD----CKLKICDFGLA 173 (560)
Q Consensus 103 ~-lV~E~~~---gdL~~~i~~~~~lse~~~~~i~~Qll~aL-~yLHs~gIiHrDLKP~NILl~~~----~~lKL~DFGla 173 (560)
+ +|+||++ ++|.++++.. .++++ ..++.|++.++ +|||+++|+||||||+|||++.+ +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899955 5999999764 57666 36688888888 99999999999999999999743 47999996543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.8e-20 Score=207.72 Aligned_cols=193 Identities=25% Similarity=0.358 Sum_probs=152.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR---HPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~---HpnIv~l~~i~~~~~~~~ 98 (560)
+..|.|.+.||+|+||.||.|.+.+ |+.||||+=+- ...+.+.=-.+++.+|+ -+.|+.+...++..+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P-----~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~--- 767 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKP-----PNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQN--- 767 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecC-----CCceeeeehHHHHHhhchhhhcchHHHHHHHccCC---
Confidence 4679999999999999999999887 99999997542 22233332334444444 244555554443322
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC-------CcEEEecc
Q 008607 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-------CKLKICDF 170 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-------~~lKL~DF 170 (560)
.-+||+||.+ |+|.+++..++.+++..+.+|..|+|+.|+.||..+|||+||||+|+||... --|+|+||
T Consensus 768 --~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 768 --ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred --cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 3589999999 8999999988899999999999999999999999999999999999998542 34999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCC
Q 008607 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~ 228 (560)
|.+-...-- +....+...++|-.+-.+|...| ..|+..+|.|.|+-+++.||.|+
T Consensus 846 G~siDm~lf-p~~~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLF-PDGTKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEc-CCCcEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 988653211 12234566788888999999988 68999999999999999999998
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=179.89 Aligned_cols=148 Identities=19% Similarity=0.147 Sum_probs=113.8
Q ss_pred CCCCceEEEEEEeecCCeEEEEEE-ECCCCcEEEEEEecCcccChh----------------------HHHHHHHHHHHH
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAY-DTRTGEKVAIKKINDIFEHVS----------------------DATRILREIKLL 76 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~-d~~tg~~vAiK~i~~~~~~~~----------------------~~~~i~rEi~iL 76 (560)
.-|.-|++.+.||+|+||.||+|. +..+|+.||||+++....... ....+.+|+.++
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 335568999999999999999999 778999999999874221000 112356899999
Q ss_pred HhcCCCCccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCC
Q 008607 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKP 154 (560)
Q Consensus 77 ~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~g-IiHrDLKP 154 (560)
..+.+. ++.+..++.. ...|+||||++| +|.........+....+..++.||+.+|.+||+.| |+||||||
T Consensus 105 ~~L~~~-~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp 177 (237)
T smart00090 105 QRLYEA-GVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSE 177 (237)
T ss_pred HHHHhc-CCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCCh
Confidence 999753 3333333311 124899999998 55555444455677778899999999999999999 99999999
Q ss_pred CCeeeCCCCcEEEeccccccc
Q 008607 155 KNILANADCKLKICDFGLARV 175 (560)
Q Consensus 155 ~NILl~~~~~lKL~DFGla~~ 175 (560)
+|||++ ++.++|+|||++..
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhc
Confidence 999999 88999999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-20 Score=195.69 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=167.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCC---CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccce-------eec
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH-------ILL 92 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~-------i~~ 92 (560)
..+.+.+.++..++|.+....-... .+.+.-+... ..+........+++-.+....|.+..-+.+ .+.
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~--~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRAD--VDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhh--ccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 4455556666666666654432222 2233333221 112233445556666666665544333333 111
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEe
Q 008607 93 PPSRREFKDIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~---~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~ 168 (560)
........++||.|++|. .+|.++|..+. ..+...++.|+.|+..|++| +|.+|+|+||.||+...++.+||.
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 111112236899999998 68999997543 46778899999999999999 999999999999999999999999
Q ss_pred cccccccccCCC---CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhC-CCCCCCCChhhHHHHHH
Q 008607 169 DFGLARVAFNDT---PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMT 244 (560)
Q Consensus 169 DFGla~~~~~~~---~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~~~~i~ 244 (560)
|||+........ +.....+..+||.|||+||.+.+ ..|+.++||||||+|||||+.- .-.| +.+..+
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~- 469 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLIQFSTQF------ERIATL- 469 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHHHhccHH------HHHHhh-
Confidence 999998765443 11223567899999999999988 6899999999999999999872 1111 111111
Q ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 245 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
..++... +...+..-.|...+||++||...|.+||++.+.--|.|.
T Consensus 470 -----------------------~d~r~g~---ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 470 -----------------------TDIRDGI---IPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred -----------------------hhhhcCC---CChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1111111 111111223556789999999999999987777666664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-20 Score=206.89 Aligned_cols=265 Identities=27% Similarity=0.373 Sum_probs=207.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECC-CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~-tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~ 99 (560)
...|.+.+.||+|+|+.|-++.... +...+|+|.+...........++..|..+-+.+. |.|++.+++....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~----- 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP----- 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----
Confidence 4568888999999999998887643 4556788887754434445566677888888887 99999998877443
Q ss_pred ccEEEEEecCCc-cHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCCCCeeeCCCC-cEEEecccccc
Q 008607 100 KDIYVVFELMES-DLHQVI-KAND-DLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADC-KLKICDFGLAR 174 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i-~~~~-~lse~~~~~i~~Qll~aL~yLH-s~gIiHrDLKP~NILl~~~~-~lKL~DFGla~ 174 (560)
...++++++..| ++...+ .... .++......++.|+..+|.|+| ..++.|+||||+|.+++..+ .+|+.|||+|.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 357899999775 888888 5554 6888899999999999999999 99999999999999999999 99999999998
Q ss_pred cccCCCCCccccccccc-CcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 175 VAFNDTPTAIFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~g-T~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
...............+| ++.|+|||.+.+. ....+..|+||+|+++..+++|..||......+.
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-------------- 238 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-------------- 238 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccc--------------
Confidence 87652223334456788 9999999998763 3456789999999999999999999865432221
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
.|...+. .....-...|...+..+.+++.++|..+|..|.+.+++-.++|+..
T Consensus 239 -----------~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 239 -----------RYSSWKS-NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----------cceeecc-cccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 1111111 1111123345677888999999999999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=166.47 Aligned_cols=135 Identities=22% Similarity=0.285 Sum_probs=109.4
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh------hHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV------SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~------~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.||+|++|.||+|++ .|..+++|+........ ....++.+|+.++..+.|++|.....++... ...
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence 5799999999999976 78889999865322111 1224577899999999999987766655332 246
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
++||||++| +|.+++..... ....++.+|+.+|.+||+.||+|||++|.|||++ ++.++|+|||++..
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 899999986 89888865432 7888999999999999999999999999999999 78999999999865
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-18 Score=167.14 Aligned_cols=242 Identities=17% Similarity=0.233 Sum_probs=181.6
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
...+.-+|.+.-.|..|+++ ..|..+++|++.-..........|..|.-.|+.+.||||+.+++.+..+ .++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgr--wqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGR--WQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLV 263 (448)
T ss_pred hhhhhhhhccCCCccccccc--ccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCce
Confidence 45566778899999999994 6788888888864333334445678899999999999999999999555 3589
Q ss_pred EEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeCCCCcEEEe--cccccccc
Q 008607 104 VVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKIC--DFGLARVA 176 (560)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~~--lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~~~~~lKL~--DFGla~~~ 176 (560)
++..||+ |+|+.++..... ++..++.+|+..+++|++|||+.. |.---|....++||++.+.+|. |--++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 9999999 799999987543 577888999999999999999985 3344678888999998765543 3222211
Q ss_pred cCCCCCcccccccccCcccccccccccccC-CCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~-~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
.....-.+.|++||.+..... ..-.++|+|||+++++||.|...||..-...+.-.+|
T Consensus 343 ---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------------ 401 (448)
T KOG0195|consen 343 ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------------ 401 (448)
T ss_pred ---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------------
Confidence 122345788999999864211 1235789999999999999999999876655432222
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL 311 (560)
.++.++. ...|+++.....|+.-|+.-||.+||.++.++
T Consensus 402 ----------aleglrv-------~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 402 ----------ALEGLRV-------HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------hhccccc-------cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1233332 23478899999999999999999999987764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=161.13 Aligned_cols=138 Identities=22% Similarity=0.185 Sum_probs=105.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh--------------------hHHHHHHHHHHHHHhcCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV--------------------SDATRILREIKLLRLLRHP 82 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~--------------------~~~~~i~rEi~iL~~l~Hp 82 (560)
..|.+.+.||+|+||.||++.+. +|+.||||++....... .......+|+.++..+.|.
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred chhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 34888999999999999999874 79999999875321000 0112356799999999877
Q ss_pred Cc--cccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee
Q 008607 83 DI--VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 159 (560)
Q Consensus 83 nI--v~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl 159 (560)
++ ...++. ...++||||++| +|..+.. ......++.+|+.++.++|..||+||||||+||++
T Consensus 94 ~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill 158 (198)
T cd05144 94 GFPVPKPIDW---------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV 158 (198)
T ss_pred CCCCCceeec---------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE
Confidence 53 222221 235899999997 6655432 13467789999999999999999999999999999
Q ss_pred CCCCcEEEecccccccc
Q 008607 160 NADCKLKICDFGLARVA 176 (560)
Q Consensus 160 ~~~~~lKL~DFGla~~~ 176 (560)
+.++.++|+|||++...
T Consensus 159 ~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 159 DDDEKIYIIDWPQMVST 175 (198)
T ss_pred cCCCcEEEEECCccccC
Confidence 99999999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-17 Score=159.79 Aligned_cols=131 Identities=28% Similarity=0.390 Sum_probs=102.2
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEecCc-ccCh-----hHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHV-----SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~-----~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.||+|+||.||++. .+|..+++|+.... .... ....++.+|+++++.++|+++....-++... ...+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 48999999999997 46788999985432 1111 1235677899999999988755443333222 2358
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 104 lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
+||||++| +|.+++..... .++.|++.+|.+||+.||+|||++|.|||++ ++.++|+|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999986 88887755321 7899999999999999999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.7e-17 Score=179.63 Aligned_cols=138 Identities=22% Similarity=0.309 Sum_probs=106.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEec-Cccc-----ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFE-----HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~-~~~~-----~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
..|...+.||+|+||+||++... +..+++|+.. +... ......++.+|+++++.++|++++.........
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 34566799999999999999754 3445554432 2111 112235688999999999999988766555332
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 97 ~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
...++||||++| +|.+++. ....++.||+.+|.+||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 409 ---~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 409 ---EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ---CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 236899999985 8888875 356789999999999999999999999999999 678999999999976
Q ss_pred c
Q 008607 176 A 176 (560)
Q Consensus 176 ~ 176 (560)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=152.08 Aligned_cols=136 Identities=25% Similarity=0.259 Sum_probs=96.1
Q ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHH----------------------HHHHHHHHHhcCCCC--
Q 008607 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR----------------------ILREIKLLRLLRHPD-- 83 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~----------------------i~rEi~iL~~l~Hpn-- 83 (560)
.+.||+|+||.||+|.+. +|+.||||++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 8999999998643221111111 135666666665433
Q ss_pred ccccceeecCCCcCCCccEEEEEecCCc-cHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeC
Q 008607 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLH-QVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN 160 (560)
Q Consensus 84 Iv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~-~~i~~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~ 160 (560)
+...+.. ...++||||+++ .+. ..+.... . ...++.++.+++.++.++|. .||+||||||+||+++
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 2222221 125899999997 211 1111111 1 16788999999999999999 9999999999999999
Q ss_pred CCCcEEEecccccccc
Q 008607 161 ADCKLKICDFGLARVA 176 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~ 176 (560)
++.++|+|||++...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.7e-17 Score=173.23 Aligned_cols=256 Identities=26% Similarity=0.268 Sum_probs=199.6
Q ss_pred ceEEEEEEee--cCCeEEEEEEE--CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCC
Q 008607 24 RYKIEEVIGK--GSYGVVCSAYD--TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 24 ~Y~i~~~IG~--G~~G~Vy~a~d--~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~ 98 (560)
.+.+.+.+|. |.+|.||.+.. ..++..+|+|+-+..+.......+-++|+...+.+. |+|.++.+..+ +.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----EG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----cc
Confidence 5777888999 99999999998 889999999986554454444555567888888776 99999866666 34
Q ss_pred CccEEEEEecCCccHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCeeeccCCCCCeeeCCC-CcEEEecccc
Q 008607 99 FKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLR----GLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGL 172 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~~-lse~~~~~i~~Qll~----aL~yLHs~gIiHrDLKP~NILl~~~-~~lKL~DFGl 172 (560)
....|+-+|+|+.+|..+...... +++..++..+.+... ||.++|+.+|+|-|+||.||++..+ +..+++|||+
T Consensus 190 ~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 190 SGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred CCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 456899999999999998877555 899999999999999 9999999999999999999999999 8899999999
Q ss_pred cccccCCCCCcccc--cccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCC--ChhhHHHHHHHhcC
Q 008607 173 ARVAFNDTPTAIFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK--NVVHQLDIMTDLLG 248 (560)
Q Consensus 173 a~~~~~~~~~~~~~--~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~--~~~~~~~~i~~~~g 248 (560)
........-...+. ....|..-|++||++.+ .++.+.||+++|.++.+..+|..++... +.+.+++.+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---- 342 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---- 342 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc----
Confidence 98765443222111 12256778999999976 5788999999999999999998776554 3333332211
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
++ .+.....+..+...+..|++.||..|++++.+++|+++...
T Consensus 343 ---------------------------ip-~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 343 ---------------------------IP-LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ---------------------------Cc-hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 00 11122334555669999999999999999999999998743
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.3e-15 Score=149.64 Aligned_cols=139 Identities=22% Similarity=0.284 Sum_probs=103.2
Q ss_pred EEEe-ecCCeEEEEEEECCCCcEEEEEEecCc------cc-----ChhHHHHHHHHHHHHHhcCCCCc--cccceeecCC
Q 008607 29 EVIG-KGSYGVVCSAYDTRTGEKVAIKKINDI------FE-----HVSDATRILREIKLLRLLRHPDI--VEIKHILLPP 94 (560)
Q Consensus 29 ~~IG-~G~~G~Vy~a~d~~tg~~vAiK~i~~~------~~-----~~~~~~~i~rEi~iL~~l~HpnI--v~l~~i~~~~ 94 (560)
..|| .|+.|+||.+.. .+..++||.+... .. ......++.+|+.++..|+|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888888865 3788999987421 01 11234568899999999998875 4555543222
Q ss_pred CcCCCccEEEEEecCCc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccc
Q 008607 95 SRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~g--dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGl 172 (560)
.. .....++|||+++| +|.+++.. ..+++.. +.||+.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 115 ~~-~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 HG-LFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cC-cceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 11 11123599999995 78888765 3566553 57899999999999999999999999999999999999998
Q ss_pred ccc
Q 008607 173 ARV 175 (560)
Q Consensus 173 a~~ 175 (560)
++.
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.9e-15 Score=132.96 Aligned_cols=131 Identities=23% Similarity=0.216 Sum_probs=105.8
Q ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCC--CCccccceeecCCCcCCCccEEE
Q 008607 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH--PDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~H--pnIv~l~~i~~~~~~~~~~~i~l 104 (560)
+++.||.|.++.||++.+.. ..+++|.+..... ...+.+|+.+++.++| .++.+++...... ...|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEE
Confidence 46789999999999998644 7899998864322 4567889999999986 4777777665322 45899
Q ss_pred EEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 105 VFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 105 V~E~~~gd-L~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~---gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
+|||+.|. +..+ +......++.+++.+|++||.. +|+|+||+|.|||++..+.++++|||+++.
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99999873 3332 5567778899999999999985 699999999999999989999999998854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-15 Score=168.27 Aligned_cols=264 Identities=23% Similarity=0.275 Sum_probs=199.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
...+.+.+-+-+|+++.++.+.-..+|...++|....... ...+...+.++-.++-..++|-++...--+. -..
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-----~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-----CRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-----CCC
Confidence 3457788889999999999998888887777776543211 1123445555666666666777765433321 123
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
..+||++|.. ++|...+...+..+.+-.+.++..+..+++|||+..+.|+|++|.|+|+..++..++.|||......-.
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 5799999997 599999988888999999999999999999999999999999999999999999999999954332110
Q ss_pred CC--------C------------------c--ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCC
Q 008607 180 TP--------T------------------A--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231 (560)
Q Consensus 180 ~~--------~------------------~--~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF 231 (560)
.+ . . ......++|+.|.+||.+.+ .....++|+|++|++++|.++|.+||
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 0 01123578999999999987 46678999999999999999999999
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH---
Q 008607 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE--- 308 (560)
Q Consensus 232 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~--- 308 (560)
........++.| . +..++|.......++.+.+++.++|..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni---------------------------~-~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~ 1087 (1205)
T KOG0606|consen 1036 NAETPQQIFENI---------------------------L-NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAA 1087 (1205)
T ss_pred CCcchhhhhhcc---------------------------c-cCCCCCCCCccccChhhhhhhhhhhccCchhccCccccc
Confidence 876654433222 1 223455555567789999999999999999998877
Q ss_pred HHhcCccccccc
Q 008607 309 EALADPYFKGLA 320 (560)
Q Consensus 309 elL~hp~f~~~~ 320 (560)
++-.|+||+...
T Consensus 1088 e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1088 EVKGHPFFQDVD 1099 (1205)
T ss_pred ccccCCccCCCC
Confidence 888999998754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-14 Score=143.93 Aligned_cols=246 Identities=20% Similarity=0.228 Sum_probs=160.9
Q ss_pred EEEEEEECCCCcEEEEEEecCcc-cChhHH-HHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCC-ccHH
Q 008607 38 VVCSAYDTRTGEKVAIKKINDIF-EHVSDA-TRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLH 114 (560)
Q Consensus 38 ~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~-~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~-gdL~ 114 (560)
.||++.+...|..|+.-.+.... .+.... .....-..-|-.+-|.|||+++.+|.+...++...+.++.|||+ |.|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 35677777777777665553110 011100 11111123344556999999999987766666677899999998 6888
Q ss_pred HHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeCCCCcEEEeccccccc--ccCCCCCcccc
Q 008607 115 QVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARV--AFNDTPTAIFW 186 (560)
Q Consensus 115 ~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~~~~~lKL~DFGla~~--~~~~~~~~~~~ 186 (560)
+++++ ...+.....++|+-||+.||.|||+.. |+|+++..+-|++..+|-+||+----... ..+.... ...
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~-~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE-AEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhH-hhh
Confidence 88865 235889999999999999999999885 99999999999999999888763221111 0000000 001
Q ss_pred cccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCC-CCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHH
Q 008607 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (560)
Q Consensus 187 ~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 265 (560)
.-..+-+.|.+||.=.. ...+.++|||++|.+..+|..|..- -.+.+...--..|..
T Consensus 240 ~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~-------------------- 297 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN-------------------- 297 (458)
T ss_pred hccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh--------------------
Confidence 12345678899986433 3456789999999999999887732 222211111011110
Q ss_pred HHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.+ +.--++.-+++|.+||+-.|..||++.++|.||.+-+++
T Consensus 298 ~i--------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 298 VI--------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred he--------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 00 011123345699999999999999999999999976554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.7e-12 Score=140.47 Aligned_cols=184 Identities=23% Similarity=0.340 Sum_probs=135.5
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
|.+ +..+-++.+..-.|..+.++..|.|.+.+.... .....+.+-++-|+.|+||||+++++.+. ....+||
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-----~~~~~yl 86 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTE-----EEGTLYL 86 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhc-----ccCceEE
Confidence 555 444445554333466678899999988875322 34456778899999999999999999873 3347999
Q ss_pred EEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCc
Q 008607 105 VFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (560)
Q Consensus 105 V~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLH-s~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (560)
|+|-+.. |..++++ +....+..-++||+.||.||| +.+++|++|.-+-|+|+..|..||++|.++.........
T Consensus 87 vTErV~P-l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~- 161 (690)
T KOG1243|consen 87 VTERVRP-LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP- 161 (690)
T ss_pred Eeecccc-HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-
Confidence 9998863 4445544 337788889999999999997 678999999999999999999999999988654322210
Q ss_pred ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhC
Q 008607 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 227 (560)
Q Consensus 184 ~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG 227 (560)
.....---.|..|+.+.. . +-..|.|.|||+++|++.|
T Consensus 162 --~~~~~~~~s~~~P~~~~~--s--~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 --AKSLYLIESFDDPEEIDP--S--EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cccchhhhcccChhhcCc--c--ccchhhhhHHHHHHHHhCc
Confidence 111222234677776643 1 2467999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-12 Score=125.04 Aligned_cols=139 Identities=22% Similarity=0.262 Sum_probs=98.9
Q ss_pred EEEEeecCCeEEEEEEECC------CCcEEEEEEecCc---c-------------c----ChhHHHHH----HHHHHHHH
Q 008607 28 EEVIGKGSYGVVCSAYDTR------TGEKVAIKKINDI---F-------------E----HVSDATRI----LREIKLLR 77 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~------tg~~vAiK~i~~~---~-------------~----~~~~~~~i----~rEi~iL~ 77 (560)
...||.|--+.||.|.... .+..+|||+.+-. + . +......+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3569999999999997653 3579999987411 1 0 01112222 38999999
Q ss_pred hcCC--CCccccceeecCCCcCCCccEEEEEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCeeeccCC
Q 008607 78 LLRH--PDIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLK 153 (560)
Q Consensus 78 ~l~H--pnIv~l~~i~~~~~~~~~~~i~lV~E~~~gd-L~~~i~~~~~lse~~~~~i~~Qll~aL~yL-Hs~gIiHrDLK 153 (560)
.+.. -++..++.+. .-+|||||++++ +..-..+...++++....++.|++.+|..| |..||+|+||+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 8864 3444444431 238999999863 322222233466677788899999999999 89999999999
Q ss_pred CCCeeeCCCCcEEEecccccccc
Q 008607 154 PKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 154 P~NILl~~~~~lKL~DFGla~~~ 176 (560)
+.|||+. ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 568999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.6e-13 Score=147.35 Aligned_cols=140 Identities=22% Similarity=0.332 Sum_probs=93.9
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh--------------------------------hHHHHHHHH
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV--------------------------------SDATRILRE 72 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~--------------------------------~~~~~i~rE 72 (560)
|+. +.||+|++|.||+|+.+.+|+.||||+++...... .....+.+|
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 444 67999999999999998889999999986321000 111223344
Q ss_pred HHHHHhc------C----CCCccccceeecCCCcCCCccEEEEEecCCc-cHHHH--HHhCC----CCCHHHHHHHHHHH
Q 008607 73 IKLLRLL------R----HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV--IKAND----DLTPEHYQFFLYQL 135 (560)
Q Consensus 73 i~iL~~l------~----HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~--i~~~~----~lse~~~~~i~~Ql 135 (560)
+.+++.. + +.+.+.+-.++..- ....+|||||++| .+.++ +.+.+ .+.+..+..++.|+
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 4444333 2 23333333333211 1235799999997 67653 33333 25566666677776
Q ss_pred HHHHHHHHhCCeeeccCCCCCeeeCCCC----cEEEecccccccc
Q 008607 136 LRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVA 176 (560)
Q Consensus 136 l~aL~yLHs~gIiHrDLKP~NILl~~~~----~lKL~DFGla~~~ 176 (560)
+ ..|++|+|+||.||+++.++ .++++|||++...
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 5 48999999999999999988 9999999998654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.3e-12 Score=120.30 Aligned_cols=126 Identities=20% Similarity=0.184 Sum_probs=92.0
Q ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCccEEEEE
Q 008607 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~~i~~~~~~~~~~~i~lV~ 106 (560)
++.|+.|.++.||++... +..|++|....... ....+.+|+.+++.+.+.+++ +++... . ..-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~-----~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--P-----ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--C-----CCCeEEE
Confidence 467899999999999754 78999998754211 122456899999988765544 333322 1 1237999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCe-----eeccCCCCCeeeCCCCcEEEecccccc
Q 008607 107 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV-----FHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 107 E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gI-----iHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
|+++| ++... .. ....++.+++++|+.||+.++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 71 e~i~G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99997 44322 11 123457899999999999985 9999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.5e-12 Score=136.10 Aligned_cols=140 Identities=21% Similarity=0.261 Sum_probs=92.2
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhH--------------------------------HH------HHH
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD--------------------------------AT------RIL 70 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~--------------------------------~~------~i~ 70 (560)
+.||.|++|.||+|+. .+|+.||||+.+......-. .. .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 4699999999999986 47999999998532100000 00 133
Q ss_pred HHHHHHHhc----CCCCccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHH
Q 008607 71 REIKLLRLL----RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLR-GLKYIH 143 (560)
Q Consensus 71 rEi~iL~~l----~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~-aL~yLH 143 (560)
+|...+..+ +|.+-+.+-.++..-+ ..-+|||||++| +|.++.... ..+. ...++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 444444444 2333333434442211 235899999997 666655421 1222 2345555655 478899
Q ss_pred hCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 144 TANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 144 s~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..|++|+|++|.||+++.++.++|+|||++...
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=140.26 Aligned_cols=250 Identities=22% Similarity=0.219 Sum_probs=176.8
Q ss_pred CceEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDT-RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~-~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.+|..+..||.|.|+.|+.+.-. .++..|++|.+.+......+...-+.|+-+...+ .|.+++++...|. ...
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-----~~r 339 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-----QLR 339 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-----ccc
Confidence 35788899999999999987644 6788999998876544444444445677777666 4889998877773 334
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC-CcEEEecccccccccC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-~~lKL~DFGla~~~~~ 178 (560)
+.||-.|||++ ++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||++....-
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 57899999975 444444434468899999999999999999999999999999999999886 7889999998863111
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
... ...-+++.|-..|++... ..+..+.|++|||.-+.+.++|.+.-...+....+
T Consensus 420 ~~~-----~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i------------------ 475 (524)
T KOG0601|consen 420 SSG-----VFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI------------------ 475 (524)
T ss_pred ecc-----cccccccccccchhhccc-cccccccccccccccccccccCcccCcccccceee------------------
Confidence 000 111233444224544432 56778999999999999999998543222211100
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
+. ......+.....+..+.+.|+..|+..|+.+.++..|.=|.
T Consensus 476 ------------~~----~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 ------------RS----GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ------------ec----ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 00 00011123346678899999999999999999998876654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.9e-10 Score=117.58 Aligned_cols=215 Identities=17% Similarity=0.195 Sum_probs=154.9
Q ss_pred CCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCCc--c
Q 008607 35 SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES--D 112 (560)
Q Consensus 35 ~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~g--d 112 (560)
.-.+.|++....+|..|++|.++... .........-++.++++.|+|+|.+.++|.+... ....+++|++|+++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCch
Confidence 34567999999999999999994211 1111122345788999999999999999985543 33468999999984 7
Q ss_pred HHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 113 LHQVIKA---------------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 113 L~~~i~~---------------~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
|.++.-. +...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+.+++|...|...+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 8776632 2247789999999999999999999999999999999999999999999998876654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCC-CCCCChhhH-HHHHHHhcCCCCHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQ-LDIMTDLLGTPSPEAI 255 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~-~~~i~~~~g~p~~~~~ 255 (560)
.+.. |.+.+ ..+-|.=.||.+++.|.||..- +........ ++.|
T Consensus 445 ~d~~-----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------ 490 (655)
T KOG3741|consen 445 EDPT-----------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------ 490 (655)
T ss_pred CCCC-----------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------
Confidence 4330 12222 2467999999999999999632 111111100 1111
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.+.++.++.++|.-+...++.+ -++++++.|
T Consensus 491 --------------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 --------------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --------------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1345667777888777777776 678888764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.3e-10 Score=104.61 Aligned_cols=142 Identities=23% Similarity=0.302 Sum_probs=104.6
Q ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEE-ecCcccCh-----hHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKK-INDIFEHV-----SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~-i~~~~~~~-----~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.+..|-+|+-+.|+++ ...|+..+||. +.+...+. -...+..+|+++|.+++--.|.-..-++.+..
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence 6788999999999998 46788888886 32322222 23466789999998886444433322332221
Q ss_pred cEEEEEecCCc--cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc---EEEeccccc
Q 008607 101 DIYVVFELMES--DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLA 173 (560)
Q Consensus 101 ~i~lV~E~~~g--dL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~---lKL~DFGla 173 (560)
.-.|+|||++| ++.+++.... ....+....++.+|-+.|.-||.++|+|+||..+||++..++. +.|+|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 23799999998 8888887632 2333444789999999999999999999999999999987653 589999998
Q ss_pred cc
Q 008607 174 RV 175 (560)
Q Consensus 174 ~~ 175 (560)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 65
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.5e-10 Score=104.90 Aligned_cols=130 Identities=22% Similarity=0.353 Sum_probs=92.8
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEE-ecCcccChh-----HHHHHHHHHHHHHhcCCCCc--cccceeecCCCcCCCc
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKK-INDIFEHVS-----DATRILREIKLLRLLRHPDI--VEIKHILLPPSRREFK 100 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~-i~~~~~~~~-----~~~~i~rEi~iL~~l~HpnI--v~l~~i~~~~~~~~~~ 100 (560)
..|++|+-+.++.+.. -|..+++|. +.+...+.. ...+..+|..+|+.++--.| ..++++. +.
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~----- 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PD----- 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CC-----
Confidence 3578999999998843 455566664 333333322 23456789999998864333 3334433 21
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
...|+|||++| .|.+++... .-.++..+-.-+.-||.+||+|+||.++||++..++ +.++||||+..
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 24799999998 566677665 145677777788899999999999999999998765 99999999964
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.7e-10 Score=107.48 Aligned_cols=142 Identities=18% Similarity=0.276 Sum_probs=100.7
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
+.|+.|.++.||++.... |+.+++|+....... .....+.+|+.+++.+++.+ +.+++....... .....++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEE
Confidence 568999999999997643 689999987542211 13456789999999997643 455555442211 113468999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 008607 107 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT----------------------------------------- 144 (560)
Q Consensus 107 E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs----------------------------------------- 144 (560)
||++| ++...+.. ..++++....++.+++++|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99997 45443321 346677777777777777777773
Q ss_pred ---------------CCeeeccCCCCCeeeCC--CCcEEEeccccccc
Q 008607 145 ---------------ANVFHRDLKPKNILANA--DCKLKICDFGLARV 175 (560)
Q Consensus 145 ---------------~gIiHrDLKP~NILl~~--~~~lKL~DFGla~~ 175 (560)
..++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.7e-11 Score=127.80 Aligned_cols=155 Identities=23% Similarity=0.335 Sum_probs=113.3
Q ss_pred HHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC-Cccccc-----ccccCcccccccccccccCC
Q 008607 135 LLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP-TAIFWT-----DYVATRWYRAPELCGSFFSK 207 (560)
Q Consensus 135 ll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~-~~~~~~-----~~~gT~~Y~APEll~~~~~~ 207 (560)
+..||.|+|. .+++|++|.|++|.+++++.+||+.|+.+........ ....++ -..-...|.|||++.+ ..
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--TT 185 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--cc
Confidence 3389999995 5999999999999999999999999998865433111 000011 1234567999999987 56
Q ss_pred CCCccchhhHHHHHHHHh-hCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCC
Q 008607 208 YTPAIDIWSIGCIFAELL-TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 286 (560)
Q Consensus 208 y~~~~DIWSlG~il~eLl-tG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s 286 (560)
.+.++|+|||||++|.+. .|+..|.+.+.......-...++ ......-.+++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~---------------------------~~~~~~s~~~p 238 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN---------------------------AGAFGYSNNLP 238 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc---------------------------cccccccccCc
Confidence 789999999999999999 67777766543322111110000 00111125778
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 287 PLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 287 ~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
+++++=|.++|..|+..||++.+++..|||.+
T Consensus 239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred HHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 99999999999999999999999999999985
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.7e-09 Score=106.65 Aligned_cols=135 Identities=15% Similarity=0.117 Sum_probs=93.1
Q ss_pred EEEEEEECCCCcEEEEEEecCcccCh---------hHHHHHHHHHHHHHhcCCCCcccc--ceeecCCCcCCCccEEEEE
Q 008607 38 VVCSAYDTRTGEKVAIKKINDIFEHV---------SDATRILREIKLLRLLRHPDIVEI--KHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 38 ~Vy~a~d~~tg~~vAiK~i~~~~~~~---------~~~~~i~rEi~iL~~l~HpnIv~l--~~i~~~~~~~~~~~i~lV~ 106 (560)
.|+.+ ...|+.|.||......... .-...+.+|...+..|..-+|... ..+...........-+|||
T Consensus 37 rvvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 35554 3457789999764221100 001136789999988865444433 2222111111123468999
Q ss_pred ecCCc--cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC-------CCcEEEecccccc
Q 008607 107 ELMES--DLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-------DCKLKICDFGLAR 174 (560)
Q Consensus 107 E~~~g--dL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-------~~~lKL~DFGla~ 174 (560)
|++++ +|.+++.. ....++.....++.+++..+.-||.+||+|+||++.|||++. +..+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99997 68888864 335667788899999999999999999999999999999975 4679999999774
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.9e-09 Score=101.35 Aligned_cols=129 Identities=23% Similarity=0.316 Sum_probs=93.7
Q ss_pred CCCcEEEEEEecCcc-----cChhHHHHHHHHHHHHHhcCCCCccc--cceeecCCCcCCCccEEEEEecCCc--cHHHH
Q 008607 46 RTGEKVAIKKINDIF-----EHVSDATRILREIKLLRLLRHPDIVE--IKHILLPPSRREFKDIYVVFELMES--DLHQV 116 (560)
Q Consensus 46 ~tg~~vAiK~i~~~~-----~~~~~~~~i~rEi~iL~~l~HpnIv~--l~~i~~~~~~~~~~~i~lV~E~~~g--dL~~~ 116 (560)
..++.+-+|...... .......+..+|...+..|..-.|.. .+.+..... ......++|+|++++ +|.++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHH
Confidence 345666666543211 11123456788999888886544433 233322211 111346899999986 79999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC---cEEEeccccccc
Q 008607 117 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARV 175 (560)
Q Consensus 117 i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~---~lKL~DFGla~~ 175 (560)
+.....++......++.++...++-||.+||+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 109 ~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 109 LQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 98755577888899999999999999999999999999999999987 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=4e-09 Score=100.71 Aligned_cols=127 Identities=28% Similarity=0.312 Sum_probs=81.2
Q ss_pred EEEEEEECCCCcEEEEEEecCc----------------cc------Chh--HHHHHHHHHHHHHhcCCCC--ccccceee
Q 008607 38 VVCSAYDTRTGEKVAIKKINDI----------------FE------HVS--DATRILREIKLLRLLRHPD--IVEIKHIL 91 (560)
Q Consensus 38 ~Vy~a~d~~tg~~vAiK~i~~~----------------~~------~~~--~~~~i~rEi~iL~~l~Hpn--Iv~l~~i~ 91 (560)
.||.|.. ..|..+|||+.+.. +. ... ......+|.+.|..+..-+ +.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888876 56779999986421 00 011 1234678999999998653 45554432
Q ss_pred cCCCcCCCccEEEEEecCC--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCeeeccCCCCCeeeCCCCcEEEe
Q 008607 92 LPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY-IHTANVFHRDLKPKNILANADCKLKIC 168 (560)
Q Consensus 92 ~~~~~~~~~~i~lV~E~~~--gdL~~~i~~~~~lse~~~~~i~~Qll~aL~y-LHs~gIiHrDLKP~NILl~~~~~lKL~ 168 (560)
.-+|||||++ |.....+... .++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---------CCEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 1279999999 6322223222 12245667788888885555 589999999999999999988 99999
Q ss_pred cccccccc
Q 008607 169 DFGLARVA 176 (560)
Q Consensus 169 DFGla~~~ 176 (560)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.2e-07 Score=91.47 Aligned_cols=143 Identities=16% Similarity=0.170 Sum_probs=101.9
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEecCc----ccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCccEEEE
Q 008607 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDI----FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFKDIYVV 105 (560)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~----~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~~~~~i~lV 105 (560)
-|+|+.+.|+.... .|..+-+|.-.+. .....-...+.+|+..|+.|..-+|.-..-++..... ...-.-+||
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 35688888988743 3457888876421 1112234678899999999975444322112211111 112246899
Q ss_pred EecCCc--cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc--EEEeccccccc
Q 008607 106 FELMES--DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARV 175 (560)
Q Consensus 106 ~E~~~g--dL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~--lKL~DFGla~~ 175 (560)
+|-++| +|.+++... .+.++.....++.++..+|+-||..|+.|+|+-+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998885 899988663 24678888899999999999999999999999999999987777 99999987654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.3e-07 Score=96.06 Aligned_cols=266 Identities=18% Similarity=0.196 Sum_probs=162.8
Q ss_pred ccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceee---
Q 008607 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHIL--- 91 (560)
Q Consensus 16 ~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~--- 91 (560)
|..||+. ....+-||+|+-+.+|..- .-+. .+.|+....--. ... .-+..|... .||.+-. --+|
T Consensus 6 ~~~~ge~--i~~gr~LgqGgea~ly~l~--e~~d-~VAKIYh~Pppa--~~a---qk~a~la~~p~~p~~~~-rvaWPqa 74 (637)
T COG4248 6 YDVYGEP--IPPGRPLGQGGEADLYTLG--EVRD-QVAKIYHAPPPA--AQA---QKVAELAATPDAPLLNY-RVAWPQA 74 (637)
T ss_pred ccccCcc--cCCCccccCCccceeeecc--hhhc-hhheeecCCCch--HHH---HHHHHhccCCCCcchhh-hhcccHH
Confidence 4455544 4556789999999999762 2222 344665532111 111 112223322 3554322 1111
Q ss_pred -cCCCcCCCccEEEEEecCCc--cHHHHHHh---C---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC
Q 008607 92 -LPPSRREFKDIYVVFELMES--DLHQVIKA---N---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (560)
Q Consensus 92 -~~~~~~~~~~i~lV~E~~~g--dL~~~i~~---~---~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~ 162 (560)
+... +...-+-+.|..+.| .+..++.. + ....++...+..+.|+.|.+.||..|-.-+|+.++|+|+.++
T Consensus 75 ~L~G~-~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~ 153 (637)
T COG4248 75 TLHGG-RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD 153 (637)
T ss_pred HhhCC-CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC
Confidence 1111 222337888988886 45555432 1 247789999999999999999999999999999999999999
Q ss_pred CcEEEecccccccccCCCCCcccccccccCcccccccccc-ccc--CCCCCccchhhHHHHHHHHhhC-CCCCCCCChhh
Q 008607 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG-SFF--SKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVH 238 (560)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~-~~~--~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~ 238 (560)
+.|.|.|=..-.+..++ ..+..-+|...|.+||+-. +.+ ..-+...|.|.||+++|+||.| +.||.|-..
T Consensus 154 ~~V~LVdsDsfqi~~ng----~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~-- 227 (637)
T COG4248 154 SKVVLVDSDSFQINANG----TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL-- 227 (637)
T ss_pred ceEEEEcccceeeccCC----ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc--
Confidence 99999985543332222 2334568999999999743 211 1345678999999999999997 899987321
Q ss_pred HHHHHHHhcCCCC--HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHHH
Q 008607 239 QLDIMTDLLGTPS--PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF--EPKDRPTAEE 309 (560)
Q Consensus 239 ~~~~i~~~~g~p~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~--DP~~Rpta~e 309 (560)
....|. ...|....-..+. +.-+..++.+..--|.-+++.+..|..+|+.. ++.-|||++-
T Consensus 228 -------~~~ap~p~E~~Ia~g~f~ya~---~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 228 -------ISDAPNPLETDIAHGRFAYAS---DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred -------cCCCCCcchhhhhcceeeech---hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 111111 1122211111111 11223344444445556788999999999975 3568999764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=9.6e-08 Score=94.45 Aligned_cols=137 Identities=27% Similarity=0.258 Sum_probs=98.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecC-------cc---------cChh----HHHHHHHHHHHHHhcCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND-------IF---------EHVS----DATRILREIKLLRLLRHP 82 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~-------~~---------~~~~----~~~~i~rEi~iL~~l~Hp 82 (560)
.-+.+...||-|--|.||.|.+. .|.++|||.=+. .. .+.+ ......+|.++|..|...
T Consensus 91 ~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 91 IVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred hHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 34567789999999999999875 789999996320 00 1111 123457899999998754
Q ss_pred --CccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee
Q 008607 83 --DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 159 (560)
Q Consensus 83 --nIv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl 159 (560)
.+.+.++. +.-.+|||+++| .|...- ++.+....++..|++-+.-+-..||+|+|+++=|||+
T Consensus 170 G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV 235 (304)
T COG0478 170 GVKVPKPIAW---------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV 235 (304)
T ss_pred CCCCCCcccc---------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE
Confidence 44444332 234899999998 333321 2344555667777777777779999999999999999
Q ss_pred CCCCcEEEecccccc
Q 008607 160 NADCKLKICDFGLAR 174 (560)
Q Consensus 160 ~~~~~lKL~DFGla~ 174 (560)
+++|.+.++||-.+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999998664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.8e-07 Score=86.29 Aligned_cols=143 Identities=20% Similarity=0.275 Sum_probs=89.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhH-HH------HHHHHHHHHHhcCCCCccccceeecC-
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD-AT------RILREIKLLRLLRHPDIVEIKHILLP- 93 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~-~~------~i~rEi~iL~~l~HpnIv~l~~i~~~- 93 (560)
.+.|++.+++-......|.+. ...|+.+++|..+........ .. ...+++..+..++...+..+-+.++.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 467899999988887777666 467899999987642211110 01 12344444444443333332222211
Q ss_pred --CCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecc
Q 008607 94 --PSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (560)
Q Consensus 94 --~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DF 170 (560)
....-....+|||||++| .|.+.. .++++ +.-.|..++.-||+.|++|+|..|.|++++.++ ++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE----DIDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch----hcCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 111111245689999998 554432 13332 445677889999999999999999999998654 999999
Q ss_pred ccccc
Q 008607 171 GLARV 175 (560)
Q Consensus 171 Gla~~ 175 (560)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 86643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.2e-06 Score=98.57 Aligned_cols=204 Identities=18% Similarity=0.234 Sum_probs=140.7
Q ss_pred HHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Q 008607 69 ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147 (560)
Q Consensus 69 i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gI 147 (560)
..-|+..+..++|+|++.++.+-+..-... -.+.+..++|.+ ++...+..-+.++.+.++.+..++++||+|+|+...
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 445777788889999999988765432111 123345577775 888888888889999999999999999999999977
Q ss_pred eeccCCCC---CeeeCCCCcEEEe--cccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHH
Q 008607 148 FHRDLKPK---NILANADCKLKIC--DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 222 (560)
Q Consensus 148 iHrDLKP~---NILl~~~~~lKL~--DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~ 222 (560)
.|.-|.-. +..++..+.+.+. ||+........... ........+.++|.+...........|+|++|..+.
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 66666555 5556667777777 88877654322211 223445567788887652222233479999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCH-HHHHHHHHhcccCC
Q 008607 223 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP-LALRLLERMLAFEP 301 (560)
Q Consensus 223 eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~-~~~dLI~~mL~~DP 301 (560)
.+..|..+-.... .+.. ..+..+. ...+++.+|+.-|+
T Consensus 384 ~~~~~~~i~~~~~------~~~~-----------------------------------~l~~~~~~~~~d~~~~~~~~~~ 422 (1351)
T KOG1035|consen 384 QLSQGEDISEKSA------VPVS-----------------------------------LLDVLSTSELLDALPKCLDEDS 422 (1351)
T ss_pred hhhhcCccccccc------chhh-----------------------------------hhccccchhhhhhhhhhcchhh
Confidence 9988874321100 0000 0011111 56789999999999
Q ss_pred CCCCCHHHHhcCccccc
Q 008607 302 KDRPTAEEALADPYFKG 318 (560)
Q Consensus 302 ~~Rpta~elL~hp~f~~ 318 (560)
++|+++.++|.|+|.+-
T Consensus 423 ~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 423 EERLSALELLTHPFLRF 439 (1351)
T ss_pred hhccchhhhhhchhccc
Confidence 99999999999999874
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.8e-06 Score=80.48 Aligned_cols=139 Identities=20% Similarity=0.218 Sum_probs=79.9
Q ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCccEEEE
Q 008607 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~i~~~~~~~~~~~i~lV 105 (560)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.|.... +..++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 5779999999999997655 49999987532 35567889999999886443 33444422111 122247999
Q ss_pred EecCCc-cHHH----------------HHH---hC----CCCCHHH------HHHH---------------HHHHHH-HH
Q 008607 106 FELMES-DLHQ----------------VIK---AN----DDLTPEH------YQFF---------------LYQLLR-GL 139 (560)
Q Consensus 106 ~E~~~g-dL~~----------------~i~---~~----~~lse~~------~~~i---------------~~Qll~-aL 139 (560)
|++++| .+.. .+. .. ..+.... ...+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999997 4444 111 11 0111000 0000 111222 33
Q ss_pred HHHH-------hCCeeeccCCCCCeeeC-CCCcEEEecccccc
Q 008607 140 KYIH-------TANVFHRDLKPKNILAN-ADCKLKICDFGLAR 174 (560)
Q Consensus 140 ~yLH-------s~gIiHrDLKP~NILl~-~~~~lKL~DFGla~ 174 (560)
..++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3333 24599999999999999 66777899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.6e-06 Score=94.81 Aligned_cols=151 Identities=21% Similarity=0.311 Sum_probs=91.5
Q ss_pred CCcccccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc----------------------cC-----h
Q 008607 11 ADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF----------------------EH-----V 63 (560)
Q Consensus 11 ~~~~~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~----------------------~~-----~ 63 (560)
+--+.|.+|+. +-|+.++-|.||.|+-+ +|+.||||+.+-.. .. .
T Consensus 120 ~iee~F~eF~~-------~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~ 191 (517)
T COG0661 120 PIEELFSEFEP-------EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDL 191 (517)
T ss_pred CHHHHHHHcCC-------CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCCh
Confidence 33456777774 66999999999999865 49999999874210 00 0
Q ss_pred -hH----HHH------HHHHHHHHHhcC----CCCccccceeecCCCcCCCccEEEEEecCCc-cHHHH--HHhCCCCCH
Q 008607 64 -SD----ATR------ILREIKLLRLLR----HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV--IKANDDLTP 125 (560)
Q Consensus 64 -~~----~~~------i~rEi~iL~~l~----HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~--i~~~~~lse 125 (560)
.. .+. +.+|...+..++ ...-+.+=.+|..-+ ..-.|+|||++| .+.+. +++ ..++.
T Consensus 192 ~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~ 266 (517)
T COG0661 192 VEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDR 266 (517)
T ss_pred HHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCH
Confidence 00 011 234444444442 222233334443211 234899999998 45544 444 33553
Q ss_pred HHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 126 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 126 ~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+...+.++. +..+=..|++|.|..|.||+++.+|++-+.|||+....
T Consensus 267 k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 267 KELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 33322222211 12222379999999999999999999999999987543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.29 E-value=9.2e-06 Score=80.13 Aligned_cols=132 Identities=18% Similarity=0.183 Sum_probs=77.9
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCc--cccceeecCCCcCCCccEEEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI--VEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI--v~l~~i~~~~~~~~~~~i~lV~ 106 (560)
..||.|..+.||+. .|..+++|..... .....+.+|.++++.+..-.+ .+++++.... ....+||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~-----~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDG-----GRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecC-----Ceeeeee
Confidence 56899999999984 2557888877531 233457889999998864333 4445444222 2367899
Q ss_pred ecCCcc--HHHHH---------------------HhC--CCCCHHH-HHHHHHH----------HHHH-HHHHH----hC
Q 008607 107 ELMESD--LHQVI---------------------KAN--DDLTPEH-YQFFLYQ----------LLRG-LKYIH----TA 145 (560)
Q Consensus 107 E~~~gd--L~~~i---------------------~~~--~~lse~~-~~~i~~Q----------ll~a-L~yLH----s~ 145 (560)
|+++|. +...+ ..- ....... ...+..+ +... ..+|. ..
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999983 11111 100 0111110 1111101 1111 12222 12
Q ss_pred CeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 146 NVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 146 gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999988 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.24 E-value=9.5e-06 Score=79.73 Aligned_cols=143 Identities=22% Similarity=0.180 Sum_probs=92.6
Q ss_pred CCceEEEEE---EeecCCeEEEEEEECCCCcEEEEEEecCccc--------------------ChhHH--HHHHHHHHHH
Q 008607 22 GSRYKIEEV---IGKGSYGVVCSAYDTRTGEKVAIKKINDIFE--------------------HVSDA--TRILREIKLL 76 (560)
Q Consensus 22 ~~~Y~i~~~---IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~--------------------~~~~~--~~i~rEi~iL 76 (560)
.++..+.+. |+.|--+.||+|.. ..+..+|+|+++.... +.... .-..+|..-|
T Consensus 44 ~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL 122 (268)
T COG1718 44 LSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNL 122 (268)
T ss_pred hcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHH
Confidence 344544444 55666668999863 5688999998852110 00011 1124567777
Q ss_pred HhcCC--CCccccceeecCCCcCCCccEEEEEecCCccH--HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecc
Q 008607 77 RLLRH--PDIVEIKHILLPPSRREFKDIYVVFELMESDL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRD 151 (560)
Q Consensus 77 ~~l~H--pnIv~l~~i~~~~~~~~~~~i~lV~E~~~gdL--~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrD 151 (560)
+.+.. -.+.+-+.+. .-.|||||++.+. .-.++ .-.+..+....+..++++.+.-|-. .+++|+|
T Consensus 123 ~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgD 192 (268)
T COG1718 123 KRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGD 192 (268)
T ss_pred HHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCccccc
Confidence 76642 2333333322 3489999998541 00111 1123444788888999999998876 9999999
Q ss_pred CCCCCeeeCCCCcEEEecccccccc
Q 008607 152 LKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 152 LKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
|+.=|||+. ++.+.|+|||.|...
T Consensus 193 LSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 193 LSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred chhhheEEE-CCeEEEEECcccccc
Confidence 999999999 889999999988643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.3e-05 Score=74.90 Aligned_cols=129 Identities=22% Similarity=0.310 Sum_probs=91.4
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
-++.+.|++|.+|+||++. ..|..+|+|+-+ ..+....+..|.++|..+.-.++..=+-.+ . ..++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr----~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g-------~~~i 89 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGE--WRGGEVALKVRR----RDSPRRNLEKEAKILEILAGEGVTPEVYFY-G-------EDFI 89 (201)
T ss_pred hhhhhhhhcccccEEEEee--ccCceEEEEEec----CCcchhhHHHHHHHHHHhhhcCCCceEEEe-c-------hhhh
Confidence 4567889999999999995 567799999764 234556788899999999866665432222 1 1356
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC-CC-CeeeCCCCcEEEeccccccc
Q 008607 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK-PK-NILANADCKLKICDFGLARV 175 (560)
Q Consensus 105 V~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLK-P~-NILl~~~~~lKL~DFGla~~ 175 (560)
.|||+.| .|..+.... +. +-+..++++---|-..||-|+.|. |. ||+++ ++.+.|+||..|+.
T Consensus 90 ~me~i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~ 155 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEec-CCcEEEEEccchhh
Confidence 7999998 676654321 22 234556666566778899999998 44 55555 45999999998874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=8.6e-07 Score=96.19 Aligned_cols=243 Identities=16% Similarity=0.132 Sum_probs=159.9
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC-ccccceeecCCCcCCCccEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD-IVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn-Iv~l~~i~~~~~~~~~~~i~ 103 (560)
|....-.++|+++.+++++...+...+ .+++... ..+.-++++|.+++||| .+..++ +.+...+.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~ 310 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLW 310 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc-----cCCcccccc
Confidence 344455789999999999877766655 6666431 33345899999999999 333222 334445789
Q ss_pred EEEecCCcc--HHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 104 VVFELMESD--LHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 104 lV~E~~~gd--L~~~i~-~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
++++++++. ....+. ..-.+.+-+...+.+.-+++|+++|+.-=+|+| |||..+ +..|+.||+.+..+....
T Consensus 311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc
Confidence 999999853 111111 111244455666777888999999998778998 777655 689999999887664433
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
......+|+.++|||+... ..+..+.|.|++|+--.+|--|-+|-...- .... ..|..... .
T Consensus 386 ----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~----~~g~~p~s--~---- 447 (829)
T KOG0576|consen 386 ----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLP----MIGNGPNS--P---- 447 (829)
T ss_pred ----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCCCc--cccC----CCCCCCCc--c----
Confidence 2256789999999998876 578889999999987777777776643310 0000 00100000 0
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.+.. ...|...+. .++...||..-|..|++..+++-|.+|.+-
T Consensus 448 --------~L~~--~~aw~~~~~------~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 448 --------MLTD--KSAWSPVFH------RDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred --------ccch--hhhcCcccc------cCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 0000 011111111 147788999999999999999999999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.3e-05 Score=74.71 Aligned_cols=133 Identities=12% Similarity=0.058 Sum_probs=75.5
Q ss_pred EEeecCC-eEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEEEEEe
Q 008607 30 VIGKGSY-GVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVVFE 107 (560)
Q Consensus 30 ~IG~G~~-G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~i~lV~E 107 (560)
.|..|.+ ..||++.. .+..+.||...... ...+.+|+.+++.+. +--+.+++...... ..-++|||
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e 72 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLTS 72 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEEE
Confidence 3555555 78899854 34678888765321 335678999998885 32333445444221 24689999
Q ss_pred cCCc-cHHHH----------------HHhCC-------CCCHH---HHHHH---H----------------HHHHHHHHH
Q 008607 108 LMES-DLHQV----------------IKAND-------DLTPE---HYQFF---L----------------YQLLRGLKY 141 (560)
Q Consensus 108 ~~~g-dL~~~----------------i~~~~-------~lse~---~~~~i---~----------------~Qll~aL~y 141 (560)
+++| .|... +.+-. .+... ..... + ..+...+..
T Consensus 73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T cd05150 73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE 152 (244)
T ss_pred eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence 9987 33322 11100 11100 00000 0 001111222
Q ss_pred H-------HhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 142 I-------HTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 142 L-------Hs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
| ....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2 12348999999999999998778999999763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.97 E-value=4.3e-05 Score=73.41 Aligned_cols=143 Identities=26% Similarity=0.327 Sum_probs=97.6
Q ss_pred CCCcccccccCCCCceEEEEEEeecCC-eEEEEEEECCCCcEEEEEEecC-----------cccC-h-------hHHHHH
Q 008607 10 SADVDFFTEYGEGSRYKIEEVIGKGSY-GVVCSAYDTRTGEKVAIKKIND-----------IFEH-V-------SDATRI 69 (560)
Q Consensus 10 ~~~~~~~~~~~~~~~Y~i~~~IG~G~~-G~Vy~a~d~~tg~~vAiK~i~~-----------~~~~-~-------~~~~~i 69 (560)
.+-++-|+-. +..++.++.||.|.- |.||++. -.|+.||||.+.. .+.. . .....|
T Consensus 26 gPKL~~F~~h--~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF 101 (207)
T PF13095_consen 26 GPKLEPFTHH--GDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF 101 (207)
T ss_pred CCCcCCcCCC--CCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence 3455656663 388999999999999 9999995 5688999999421 0000 0 112346
Q ss_pred HHHHHHHHhcC---CCCc--cccceeecCCCc-------------CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHH
Q 008607 70 LREIKLLRLLR---HPDI--VEIKHILLPPSR-------------REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF 131 (560)
Q Consensus 70 ~rEi~iL~~l~---HpnI--v~l~~i~~~~~~-------------~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i 131 (560)
..|.+..-.|+ +.++ |++++++.-... .......||.||+...- .++...
T Consensus 102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~---- 169 (207)
T PF13095_consen 102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD---- 169 (207)
T ss_pred HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH----
Confidence 77877766554 5566 888887643210 11123468888887532 233333
Q ss_pred HHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 132 ~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
+.+|++-|..+|..||+-+|+++.|.. .-||+|||.+
T Consensus 170 ~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 567888899999999999999999986 2489999964
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.0001 Score=86.20 Aligned_cols=146 Identities=16% Similarity=0.284 Sum_probs=88.7
Q ss_pred EEEEEeecCCeEEEEEEECCCC--cEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCc--cccceeecCCCcCCCcc
Q 008607 27 IEEVIGKGSYGVVCSAYDTRTG--EKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDI--VEIKHILLPPSRREFKD 101 (560)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg--~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnI--v~l~~i~~~~~~~~~~~ 101 (560)
-++.|+.|.++.+|+......+ ..+++|+..... .......+.+|+.+|+.|. |.++ .+++..+.+. .....
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 3577899999999998765432 468888764321 1123446789999999996 6664 5555544322 22235
Q ss_pred EEEEEecCCccH-H--------------------HHHH---hCC----C---------CCHHHHHHHHHH----------
Q 008607 102 IYVVFELMESDL-H--------------------QVIK---AND----D---------LTPEHYQFFLYQ---------- 134 (560)
Q Consensus 102 i~lV~E~~~gdL-~--------------------~~i~---~~~----~---------lse~~~~~i~~Q---------- 134 (560)
.|+||||++|.. . +.+. .-. . .-..++..|..+
T Consensus 119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~ 198 (822)
T PLN02876 119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP 198 (822)
T ss_pred ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence 689999999742 1 0111 100 0 111233333222
Q ss_pred -----HHHHHHHHHh-----------CCeeeccCCCCCeeeCCC-Cc-EEEeccccccc
Q 008607 135 -----LLRGLKYIHT-----------ANVFHRDLKPKNILANAD-CK-LKICDFGLARV 175 (560)
Q Consensus 135 -----ll~aL~yLHs-----------~gIiHrDLKP~NILl~~~-~~-lKL~DFGla~~ 175 (560)
+...+.+|.. ..++|+|+++.|||++.+ +. +-|.||+++..
T Consensus 199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2233566632 249999999999999853 33 58999999875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=8.6e-05 Score=79.41 Aligned_cols=176 Identities=26% Similarity=0.369 Sum_probs=119.1
Q ss_pred HHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 008607 65 DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144 (560)
Q Consensus 65 ~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs 144 (560)
....++--..+|+.+.|+|....+++..... ....+|+|+++.+|.+..+.+. +-.... + .
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~-------~-------~ 85 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESL-------L-------A 85 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhh-------c-------c
Confidence 4456677788999999999999888663322 2378999999999999987764 221111 1 2
Q ss_pred CCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHH
Q 008607 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224 (560)
Q Consensus 145 ~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eL 224 (560)
+|+.|- | .++++| -++ +. | | ....+++||||+|.++.++
T Consensus 86 ~~~~~~-----~-------~~~~td-~~~-------------t~------~--~-------~~~~pKsdVwsl~~i~~el 124 (725)
T KOG1093|consen 86 HGVLHL-----N-------IIYITD-HFL-------------TK------Y--P-------SPIGPKSDVWSLGFIILEL 124 (725)
T ss_pred ccccee-----h-------hhhccc-ccc-------------cc------C--C-------CCCCcchhhhhHHHHHHHH
Confidence 222221 2 233333 110 00 0 1 1122599999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 008607 225 LTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 304 (560)
Q Consensus 225 ltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~R 304 (560)
..|...|......+++..|.++...+.....-.... .+. -.++....+++++|+-..|..|
T Consensus 125 ~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~-----~~~--------------~~~d~~~~~~~~~c~~~~~~ir 185 (725)
T KOG1093|consen 125 YLGISLEAELTESEYLEILLKYYTDDQELLSTAMEH-----LIQ--------------LLADKKRLPLLKKCLWLEPIIR 185 (725)
T ss_pred HHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH-----HHH--------------HhhhHhHHHHhccCCccccccc
Confidence 999999999888888888887765554332221111 000 1345667889999999999999
Q ss_pred CCHHHHhcCcccccc
Q 008607 305 PTAEEALADPYFKGL 319 (560)
Q Consensus 305 pta~elL~hp~f~~~ 319 (560)
|...++..++-|...
T Consensus 186 ~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 186 PLPMELSKRCSFTEV 200 (725)
T ss_pred cchhHHhcCccHHHH
Confidence 999999999999765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00014 Score=72.02 Aligned_cols=30 Identities=33% Similarity=0.482 Sum_probs=25.6
Q ss_pred CCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 145 ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 145 ~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.+++|+|+.+.|||++.++..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 358999999999999877666799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.0004 Score=67.03 Aligned_cols=128 Identities=20% Similarity=0.251 Sum_probs=89.8
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcc--------------cChhHHHHHHHHHHHHHhcC------CCCccccc
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--------------EHVSDATRILREIKLLRLLR------HPDIVEIK 88 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~--------------~~~~~~~~i~rEi~iL~~l~------HpnIv~l~ 88 (560)
..||+|+.-.||.- .......||++.... ..........+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999854 334556888886432 11223456777888777776 77889999
Q ss_pred eeecCCCcCCCccEEEEEecCC---c----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC
Q 008607 89 HILLPPSRREFKDIYVVFELME---S----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 161 (560)
Q Consensus 89 ~i~~~~~~~~~~~i~lV~E~~~---g----dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~ 161 (560)
++..+. ...-+|+|.+. | +|.+++... .+++ .+ ...|-+-.+||-+++|+.+||+|.||++..
T Consensus 84 G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETN-----LGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecC-----CceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 988554 34788888874 3 688888554 4666 33 333444567888999999999999999865
Q ss_pred CC----cEEEec
Q 008607 162 DC----KLKICD 169 (560)
Q Consensus 162 ~~----~lKL~D 169 (560)
+. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 42 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=2.1e-05 Score=92.54 Aligned_cols=154 Identities=18% Similarity=0.107 Sum_probs=114.2
Q ss_pred HHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh
Q 008607 70 LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHT 144 (560)
Q Consensus 70 ~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~----~lse~~~~~i~~Qll~aL~yLHs 144 (560)
+.|...++...|+++.....-..+ .+....|.+++|+. |+++.+|.++- .+.+.-+.....+.+.+..-+|+
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 345555666789988765554322 22345689999998 69999987642 34444444444554777888776
Q ss_pred CC-----eeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHH
Q 008607 145 AN-----VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 219 (560)
Q Consensus 145 ~g-----IiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~ 219 (560)
.. .+|++||+-|.+|..+..+|++++|+.+...+. ..+....++++.|+.|++... -.++.++|+|..||
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~---~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV---LSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRSL 1428 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCch---HhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHHH
Confidence 52 689999999999999999999999999854322 233456778889999998866 46777799999999
Q ss_pred HHHHHhhCCCCC
Q 008607 220 IFAELLTGKPLF 231 (560)
Q Consensus 220 il~eLltG~~pF 231 (560)
-+|++..|..+|
T Consensus 1429 ~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHhcccHHH
Confidence 999999998776
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00029 Score=77.24 Aligned_cols=139 Identities=25% Similarity=0.299 Sum_probs=84.3
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh-----------------------------hHHHH------HHHHH
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-----------------------------SDATR------ILREI 73 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-----------------------------~~~~~------i~rEi 73 (560)
+-||.-+.|.|++|+.+. |+.||||+-+...... .-... +.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 569999999999999766 9999999864211110 00111 22333
Q ss_pred HHHH----hcCCCC---ccccceeecCCCcCCCccEEEEEecCCc----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 008607 74 KLLR----LLRHPD---IVEIKHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142 (560)
Q Consensus 74 ~iL~----~l~Hpn---Iv~l~~i~~~~~~~~~~~i~lV~E~~~g----dL~~~i~~~~~lse~~~~~i~~Qll~aL~yL 142 (560)
+-.. .+.|-+ -|.+=.++..-+ ..-.|+||||+| || +.|.+.+ ++...+..-+.+... .-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~i~~~l~~~~~--~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDL-DAIDKRG-ISPHDILNKLVEAYL--EQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCH-HHHHHcC-CCHHHHHHHHHHHHH--HHH
Confidence 3322 223444 122333443221 135899999997 55 5555553 555543333222221 223
Q ss_pred HhCCeeeccCCCCCeeeCC----CCcEEEecccccccc
Q 008607 143 HTANVFHRDLKPKNILANA----DCKLKICDFGLARVA 176 (560)
Q Consensus 143 Hs~gIiHrDLKP~NILl~~----~~~lKL~DFGla~~~ 176 (560)
=..|++|+|=.|.||+++. ++.+.+-|||+....
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 3468999999999999994 678999999998654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00068 Score=66.77 Aligned_cols=72 Identities=11% Similarity=0.178 Sum_probs=44.9
Q ss_pred EEEEeecCCeEEEEEEECC-CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCccEEEE
Q 008607 28 EEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFKDIYVV 105 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~-tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~~i~~~~~~~~~~~i~lV 105 (560)
++.|..|-...+|++.... .++.|++|+...... ......+|+.+++.+...+++ +++... . -.+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~-------~~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF--Q-------NGLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe--C-------CcEE
Confidence 4567889899999986433 357899997653211 112234799999988644443 333221 1 1479
Q ss_pred EecCCc
Q 008607 106 FELMES 111 (560)
Q Consensus 106 ~E~~~g 111 (560)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999986
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00026 Score=67.82 Aligned_cols=97 Identities=23% Similarity=0.217 Sum_probs=77.6
Q ss_pred HHHHHHHhcCC-CCccccceeecCCCcCCCccEEEEEecCCc-cHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 008607 71 REIKLLRLLRH-PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV---IKANDDLTPEHYQFFLYQLLRGLKYIHT- 144 (560)
Q Consensus 71 rEi~iL~~l~H-pnIv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~---i~~~~~lse~~~~~i~~Qll~aL~yLHs- 144 (560)
.|.-+|+.+++ +++.+++|.+ .-++|.||.+. .+... +..-..-++.....++.++++.+.+|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C---------G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC---------GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC---------CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 58889999986 6999999988 13678899883 44321 1111246799999999999999999987
Q ss_pred --CCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 145 --ANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 145 --~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+.-.|++++|+-+++++++|++|...+...
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 45888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00069 Score=69.84 Aligned_cols=150 Identities=17% Similarity=0.179 Sum_probs=86.6
Q ss_pred cccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC--ccccceeec
Q 008607 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILL 92 (560)
Q Consensus 15 ~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~i~~ 92 (560)
++..|+.+ .....+.|+.|....+|++.. ++..+++|+.... .....+..|+++++.|.... +.+++.
T Consensus 15 ~l~~y~~~-~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~----~~~~~i~~e~~~l~~L~~~g~pvp~~i~--- 84 (307)
T TIGR00938 15 FLDGYDLG-ELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKR----VKAEELPFFLALTTHLAARGLPVPKPVK--- 84 (307)
T ss_pred HHHhcCCC-CceeccccCCccccceEEEEe--CCCcEEEEEecCC----CCHHHHHHHHHHHHHHHHCCCCCCcccc---
Confidence 45556553 355577788888889998853 3446888876531 12345567888888885433 233322
Q ss_pred CCCc----CCCccEEEEEecCCcc-H-----H------HHH---Hh-CCCCC--------HHHHH---------------
Q 008607 93 PPSR----REFKDIYVVFELMESD-L-----H------QVI---KA-NDDLT--------PEHYQ--------------- 129 (560)
Q Consensus 93 ~~~~----~~~~~i~lV~E~~~gd-L-----~------~~i---~~-~~~ls--------e~~~~--------------- 129 (560)
+... ...+..++|++|++|. + . ..+ .. ...++ .....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 1111 1124578999999861 1 1 111 10 01110 01000
Q ss_pred HHHHHHHHHHHHHHh-------CCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 130 FFLYQLLRGLKYIHT-------ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 130 ~i~~Qll~aL~yLHs-------~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.....+...++++.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 001123334555542 589999999999999998877999999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0013 Score=68.09 Aligned_cols=150 Identities=16% Similarity=0.130 Sum_probs=79.5
Q ss_pred ccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 16 ~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
...|+.+ .-.-.+.|+.|....+|.... ++..+++|++.. .....+..|+.+++.|...++. +-.++.+.+
T Consensus 16 l~~y~~~-~~~~~~~l~~G~~n~~y~v~t--~~g~~vLK~~~~-----~~~~~l~~~~~~l~~L~~~glp-vP~~i~~~~ 86 (319)
T PRK05231 16 LAPYDLG-ELLSLKGIAEGIENSNFFLTT--TQGEYVLTLFER-----LTAEDLPFFLGLMQHLAARGVP-VPAPVARRD 86 (319)
T ss_pred HHhcCCc-hhhccchhccccccceEEEEe--CCCcEEEEEecc-----CChHHhHHHHHHHHHHHHCCCC-CCcceeCCC
Confidence 3456654 233345677888889998853 234789998751 1233445677777777533321 111121111
Q ss_pred c----CCCccEEEEEecCCcc-H-----------HHHHH----hCCCC--------C--H-HH-HH-----------HHH
Q 008607 96 R----REFKDIYVVFELMESD-L-----------HQVIK----ANDDL--------T--P-EH-YQ-----------FFL 132 (560)
Q Consensus 96 ~----~~~~~i~lV~E~~~gd-L-----------~~~i~----~~~~l--------s--e-~~-~~-----------~i~ 132 (560)
. ...+..++++++++|. + -+.+. ....+ . . .. .. ..+
T Consensus 87 G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 166 (319)
T PRK05231 87 GAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALL 166 (319)
T ss_pred CCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHH
Confidence 1 1123468999999873 1 11111 01111 0 0 00 00 111
Q ss_pred HHHH-HHHHHHH-------hCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 133 YQLL-RGLKYIH-------TANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 133 ~Qll-~aL~yLH-------s~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.+.+ ..++.+. ..+++|+|+.|.|||++.+...-|+||+.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 167 EAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 1122222 2379999999999999977666899999764
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0029 Score=67.54 Aligned_cols=77 Identities=21% Similarity=0.192 Sum_probs=51.8
Q ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEecCc----ccC-hhHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCCC
Q 008607 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI----FEH-VSDATRILREIKLLRLLR---HPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~----~~~-~~~~~~i~rEi~iL~~l~---HpnIv~l~~i~~~~~~~~~ 99 (560)
.+.||.|.+..||++.+...++.|+||.-... ... .....+...|.+.|+.+. -..+.+++.+- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~----- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E----- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C-----
Confidence 46799999999999998654468999984311 011 234567778999998874 23455555532 1
Q ss_pred ccEEEEEecCCc
Q 008607 100 KDIYVVFELMES 111 (560)
Q Consensus 100 ~~i~lV~E~~~g 111 (560)
...++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 235899999985
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00065 Score=68.03 Aligned_cols=130 Identities=15% Similarity=0.236 Sum_probs=74.1
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCccEEEEEecC
Q 008607 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFKDIYVVFELM 109 (560)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~~i~~~~~~~~~~~i~lV~E~~ 109 (560)
+..|-.+.+|+.. .++..+++|......... .....+|..+|+.+....++ +++... . -++|+||+
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~--~-------~~~v~e~i 70 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN--E-------HWLLVEWL 70 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe--C-------CEEEEEec
Confidence 5568888899885 557788898754321110 01245799999988754442 222221 1 26899999
Q ss_pred Cc-cHH--------------HHHHh---CC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCeee
Q 008607 110 ES-DLH--------------QVIKA---ND----DLTP-EHYQFFLYQL---------LRGLKYIHT--------ANVFH 149 (560)
Q Consensus 110 ~g-dL~--------------~~i~~---~~----~lse-~~~~~i~~Ql---------l~aL~yLHs--------~gIiH 149 (560)
+| .+. +.+.+ .. .++. +.+..+..++ ...+..+-. ..++|
T Consensus 71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 87 221 11111 10 1121 2222322222 111222221 25899
Q ss_pred ccCCCCCeeeCCCCcEEEecccccc
Q 008607 150 RDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 150 rDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
+|+.|.|||++.++ +.|+||+.|.
T Consensus 151 ~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 151 MDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CCCCcCcEEEeCCC-CEEEeccccC
Confidence 99999999999877 7899999774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0013 Score=67.28 Aligned_cols=150 Identities=17% Similarity=0.096 Sum_probs=84.9
Q ss_pred ccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC--ccccceeecC
Q 008607 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLP 93 (560)
Q Consensus 16 ~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~i~~~ 93 (560)
+..|+.++ ..-.+.|..|....+|++.. .+..+++|+... .....+..|+.+++.|.+.+ +.+++... .
T Consensus 8 l~~y~~~~-~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~-~ 78 (296)
T cd05153 8 LADYDLGE-LLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADR-D 78 (296)
T ss_pred HHHcCCCc-hhheecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCC-C
Confidence 34455432 23356677888889998843 345789998753 23455778899988886433 33332211 0
Q ss_pred CC--cCCCccEEEEEecCCc-cH--------HHH---H---Hh-CCCC----------CH--HHHH--------HHHHHH
Q 008607 94 PS--RREFKDIYVVFELMES-DL--------HQV---I---KA-NDDL----------TP--EHYQ--------FFLYQL 135 (560)
Q Consensus 94 ~~--~~~~~~i~lV~E~~~g-dL--------~~~---i---~~-~~~l----------se--~~~~--------~i~~Ql 135 (560)
.. ....+..++|+++++| .+ .++ + .. ...+ .+ .... .....+
T Consensus 79 g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 158 (296)
T cd05153 79 GEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL 158 (296)
T ss_pred CcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence 00 0112346899999986 21 111 1 00 0001 00 0000 011122
Q ss_pred HHHHHHHHh-------CCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 136 LRGLKYIHT-------ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 136 l~aL~yLHs-------~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
..++.++.+ .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 334444443 379999999999999998778999999763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.002 Score=66.04 Aligned_cols=72 Identities=17% Similarity=0.137 Sum_probs=44.2
Q ss_pred EEEEeecCCeEEEEEEECC------CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCc
Q 008607 28 EEVIGKGSYGVVCSAYDTR------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFK 100 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~------tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~~i~~~~~~~~~~ 100 (560)
++.|..|-...||++.... +++.+++|+..... .......+|+.+++.+....+. +++..+ ..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~----- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIF--PN----- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEe--CC-----
Confidence 3556668888899886433 36789999865321 2223456899999888644333 333333 11
Q ss_pred cEEEEEecCCc
Q 008607 101 DIYVVFELMES 111 (560)
Q Consensus 101 ~i~lV~E~~~g 111 (560)
.+|+||++|
T Consensus 73 --~~v~e~i~G 81 (302)
T cd05156 73 --GRIEEFIPS 81 (302)
T ss_pred --CchhheeCC
Confidence 357888775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0054 Score=63.37 Aligned_cols=145 Identities=18% Similarity=0.199 Sum_probs=83.3
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcc--ccceeecCCCcCCCccE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV--EIKHILLPPSRREFKDI 102 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv--~l~~i~~~~~~~~~~~i 102 (560)
-.+++.+..|..-.+|...+. ++++++. ...............+|+.+|+.+.--.+. ..++++.... ....
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~p 100 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTP 100 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCc
Confidence 445565655555556666543 8888888 332223334556677899999877542222 2233332221 3457
Q ss_pred EEEEecCCc-cH------------------HHHHHh-------C-------CCCCHHHHHHHHHHH--------------
Q 008607 103 YVVFELMES-DL------------------HQVIKA-------N-------DDLTPEHYQFFLYQL-------------- 135 (560)
Q Consensus 103 ~lV~E~~~g-dL------------------~~~i~~-------~-------~~lse~~~~~i~~Ql-------------- 135 (560)
|.||++++| .+ .+++.. . +.+...++..+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 999999998 11 111111 0 001111222222222
Q ss_pred HHHHHHHHhC--------CeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 136 LRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 136 l~aL~yLHs~--------gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..-..||+.+ .++|+|+.+.||+++.++.+=|.||+++..
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 2223444433 489999999999999999999999999865
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0069 Score=62.29 Aligned_cols=80 Identities=13% Similarity=0.127 Sum_probs=52.6
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCC---CCccccceeecCCCcCCCc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH---PDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~H---pnIv~l~~i~~~~~~~~~~ 100 (560)
.-.-.+.||.|..+.||...+ ++.++++|..+. ......+.+|...|+.|.. -.+.++++++... ...+
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g 86 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD--SQGNPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPG 86 (297)
T ss_pred hhheeeecCCccceeEEEEEc--CCCCEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCC
Confidence 344567899999999999843 233577776432 1123567789999998864 2456666655332 1123
Q ss_pred cEEEEEecCCc
Q 008607 101 DIYVVFELMES 111 (560)
Q Consensus 101 ~i~lV~E~~~g 111 (560)
.-+||||+++|
T Consensus 87 ~~~LVmE~i~G 97 (297)
T PRK10593 87 PDVLLLERLRG 97 (297)
T ss_pred CeEEEEeccCC
Confidence 47999999986
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0033 Score=65.24 Aligned_cols=144 Identities=24% Similarity=0.283 Sum_probs=96.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc----------------c------cChhHHHH--HHHHHHHHH
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI----------------F------EHVSDATR--ILREIKLLR 77 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~----------------~------~~~~~~~~--i~rEi~iL~ 77 (560)
|---.|...|..|--+.||.|. ...|..+|||+++-. | .+....-. ...|+.-|.
T Consensus 143 G~i~~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLk 221 (520)
T KOG2270|consen 143 GVIVEINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLK 221 (520)
T ss_pred CeeeecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHH
Confidence 3334566678889999999986 456788999987421 1 11111222 235677777
Q ss_pred hcCCCCccccceeecCCCcCCCccEEEEEecCCccHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCeeeccCCCC
Q 008607 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLH-QVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPK 155 (560)
Q Consensus 78 ~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~gdL~-~~i~~~~~lse~~~~~i~~Qll~aL~yL-Hs~gIiHrDLKP~ 155 (560)
.|..-.|.-..-+.+- .-.|||++++.+-+ .=..++-.++...+..+-.|++.-+.-| |..+++|.||+-=
T Consensus 222 Rl~~aGIP~PePIlLk-------~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEf 294 (520)
T KOG2270|consen 222 RLNNAGIPCPEPILLK-------NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEF 294 (520)
T ss_pred HHHhcCCCCCCceeee-------cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhh
Confidence 7766555433333321 23799999985311 1111233588888888888888888877 6779999999999
Q ss_pred CeeeCCCCcEEEecccccc
Q 008607 156 NILANADCKLKICDFGLAR 174 (560)
Q Consensus 156 NILl~~~~~lKL~DFGla~ 174 (560)
|+|+- +|.|.|+|-+.+.
T Consensus 295 N~Lyh-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 295 NLLYH-DGKLYIIDVSQSV 312 (520)
T ss_pred hheEE-CCEEEEEEccccc
Confidence 99985 6789999998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.01 Score=61.25 Aligned_cols=29 Identities=17% Similarity=0.139 Sum_probs=27.1
Q ss_pred CeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 146 NVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 146 gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
+|+|+|+.+.|||++.++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999774
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0067 Score=61.70 Aligned_cols=30 Identities=33% Similarity=0.570 Sum_probs=25.2
Q ss_pred CeeeccCCCCCeeeCCCCc-EEEeccccccc
Q 008607 146 NVFHRDLKPKNILANADCK-LKICDFGLARV 175 (560)
Q Consensus 146 gIiHrDLKP~NILl~~~~~-lKL~DFGla~~ 175 (560)
.++|+|+.|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 57999998743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.012 Score=61.69 Aligned_cols=82 Identities=17% Similarity=0.148 Sum_probs=52.4
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEec----Ccc-cChhHHHHHHHHHHHHHhcC--CCC-ccccceeecCCCcCCCcc
Q 008607 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIF-EHVSDATRILREIKLLRLLR--HPD-IVEIKHILLPPSRREFKD 101 (560)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~tg~~vAiK~i~----~~~-~~~~~~~~i~rEi~iL~~l~--Hpn-Iv~l~~i~~~~~~~~~~~ 101 (560)
.||.|.-..||++.+...++.|+||.-. ... .......+...|...|+... .|. +.+++. + ++ ..
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~-----e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-DT-----EM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-cc-----cc
Confidence 4799999999999986544789999743 111 22445667778999998764 343 333433 2 11 23
Q ss_pred EEEEEecCCc--cHHHHHH
Q 008607 102 IYVVFELMES--DLHQVIK 118 (560)
Q Consensus 102 i~lV~E~~~g--dL~~~i~ 118 (560)
..+|||+++. .|...+.
T Consensus 75 ~~~vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 75 AVTVMEDLSHHKIARKGLI 93 (370)
T ss_pred ceehHhhCccchHHHHHHH
Confidence 4689999973 4544443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0019 Score=66.04 Aligned_cols=136 Identities=19% Similarity=0.214 Sum_probs=92.2
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecC---cc---------------cChhHH--HHHHHHHHHHHhcCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND---IF---------------EHVSDA--TRILREIKLLRLLRHP 82 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~---~~---------------~~~~~~--~~i~rEi~iL~~l~Hp 82 (560)
.-|.+.+.||=|--+.||.+-+ ..|+..++|.=+. .| ...-.. -...+|...|+.|...
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 4577888999999999999976 4588888885210 00 001111 2245788888888632
Q ss_pred C--ccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee
Q 008607 83 D--IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 159 (560)
Q Consensus 83 n--Iv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl 159 (560)
. +...++ ...-++|||++.| .|.++-+-. ....+...|..-+.-|-.+|+||+|..-=||++
T Consensus 171 gfpVPkpiD---------~~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 171 GFPVPKPID---------HNRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCCCccc---------ccceeeHHHhhcccceeeeeecC------ChHHHHHHHHHHHHHHHHcCceecccchheeEE
Confidence 2 222222 2235899999997 665543221 123345556666777889999999999999999
Q ss_pred CCCCcEEEecccccc
Q 008607 160 NADCKLKICDFGLAR 174 (560)
Q Consensus 160 ~~~~~lKL~DFGla~ 174 (560)
.+++.++++||-...
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999997653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.022 Score=58.49 Aligned_cols=28 Identities=25% Similarity=0.393 Sum_probs=25.0
Q ss_pred CCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 145 ANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 145 ~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
.+++|+|+.+.|||++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47999999999999987 67899999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.024 Score=60.30 Aligned_cols=91 Identities=21% Similarity=0.257 Sum_probs=58.0
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEec---Ccc-cChhHHHHHHHHHHHHHhcC--CCCcc-ccceeec
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIF-EHVSDATRILREIKLLRLLR--HPDIV-EIKHILL 92 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~---~~~-~~~~~~~~i~rEi~iL~~l~--HpnIv-~l~~i~~ 92 (560)
...+.+. .+.||.|.-..||++.+...++.|+||.-. +.. +-.-...|...|.+.|+.+. .|..| +++. +
T Consensus 27 ~~~~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~- 103 (409)
T PRK12396 27 EHAKGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F- 103 (409)
T ss_pred CCcccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-
Confidence 4444455 567899999999999885446789999742 111 22445678888999998774 45443 3433 2
Q ss_pred CCCcCCCccEEEEEecCCc--cHHHHHH
Q 008607 93 PPSRREFKDIYVVFELMES--DLHQVIK 118 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~g--dL~~~i~ 118 (560)
++ ....+|||+++. .|.+.+.
T Consensus 104 D~-----e~~~~vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 104 DS-----VMNCCVMEDLSDHTILRTALI 126 (409)
T ss_pred Cc-----HHhhHHHHhCcccHHHHHHHH
Confidence 11 235789999863 4555443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.048 Score=56.96 Aligned_cols=146 Identities=14% Similarity=0.229 Sum_probs=79.3
Q ss_pred cccccC--CCCceEEEEEEeecCCeEEEEEEECCC---CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcc-ccc
Q 008607 15 FFTEYG--EGSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIK 88 (560)
Q Consensus 15 ~~~~~~--~~~~Y~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~ 88 (560)
+.++|. ..+..++..+.| |-...+|++..... +..|++|+...... ..-.-.+|..+++.+..-++. +++
T Consensus 5 ~~~~w~~~~~~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l 80 (330)
T PLN02421 5 LFKGWSDLDDSDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLL 80 (330)
T ss_pred hCCccccCCcCceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCcee
Confidence 344454 234566655544 88888998864332 34899997753211 111224788999888755543 334
Q ss_pred eeecCCCcCCCccEEEEEecCCcc-H--------------HHHHHh-C-CC------C-CHHHHHHHHHHH---------
Q 008607 89 HILLPPSRREFKDIYVVFELMESD-L--------------HQVIKA-N-DD------L-TPEHYQFFLYQL--------- 135 (560)
Q Consensus 89 ~i~~~~~~~~~~~i~lV~E~~~gd-L--------------~~~i~~-~-~~------l-se~~~~~i~~Ql--------- 135 (560)
+.+ .. .+|.+|++|. | ...+++ + .. . -...+..++.++
T Consensus 81 ~~~--~~-------G~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~ 151 (330)
T PLN02421 81 GVF--GN-------GMIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPE 151 (330)
T ss_pred EEe--CC-------cEeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHH
Confidence 433 11 1477777652 1 111111 0 01 1 123333333322
Q ss_pred -------------HHHHHH---HH-hCC----eeeccCCCCCeeeCC-CCcEEEeccccc
Q 008607 136 -------------LRGLKY---IH-TAN----VFHRDLKPKNILANA-DCKLKICDFGLA 173 (560)
Q Consensus 136 -------------l~aL~y---LH-s~g----IiHrDLKP~NILl~~-~~~lKL~DFGla 173 (560)
..-+.. +. +.+ ++|.||.+.|||++. ++.++++||..|
T Consensus 152 ~~~~~~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 152 KQKKYETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred HhhhhcccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 111222 21 112 799999999999975 578999999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.05 Score=57.14 Aligned_cols=141 Identities=14% Similarity=0.131 Sum_probs=79.0
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECC----CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcc-ccceeecCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTR----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPS 95 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~----tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~~i~~~~~ 95 (560)
..+...+.. |..|-...+|++.... +++.|++|...... ..... -.+|..+++.+..-++. ++++.+. .
T Consensus 35 ~~~~~~i~~-l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~--~ 108 (344)
T PLN02236 35 DDEALQVIP-LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRFP--N 108 (344)
T ss_pred CcCcEEEEE-cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEEC--C
Confidence 345566654 4448888999986322 34789999775421 11112 25689999888644443 3444431 1
Q ss_pred cCCCccEEEEEecCCc-cHH-----------HH---HH---hCC------CCCHHHHHHHHHHHH---------------
Q 008607 96 RREFKDIYVVFELMES-DLH-----------QV---IK---AND------DLTPEHYQFFLYQLL--------------- 136 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~g-dL~-----------~~---i~---~~~------~lse~~~~~i~~Qll--------------- 136 (560)
..|.+|+++ +|. .+ +. ... ....+.+..|+.++.
T Consensus 109 -------g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~ 181 (344)
T PLN02236 109 -------GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDS 181 (344)
T ss_pred -------ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHH
Confidence 257788775 221 11 11 100 011233434432221
Q ss_pred --HHHHHH----H----hCCeeeccCCCCCeeeCC-CCcEEEecccccc
Q 008607 137 --RGLKYI----H----TANVFHRDLKPKNILANA-DCKLKICDFGLAR 174 (560)
Q Consensus 137 --~aL~yL----H----s~gIiHrDLKP~NILl~~-~~~lKL~DFGla~ 174 (560)
..+..| . ...++|+|+++.|||++. ++.+.|+||..|.
T Consensus 182 l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 182 LEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 111112 1 225899999999999986 4789999998764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.09 Score=56.21 Aligned_cols=76 Identities=16% Similarity=0.134 Sum_probs=49.3
Q ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc--C---hhHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCC
Q 008607 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE--H---VSDATRILREIKLLRLLR---HPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~--~---~~~~~~i~rEi~iL~~l~---HpnIv~l~~i~~~~~~~~ 98 (560)
..+.||.|....||++.+ .+..|+||.-..... . .-...+...|+..|+.+. ...+.+++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de------ 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR------ 107 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC------
Confidence 367789999999999976 345799997541100 1 124556667788887664 235666666542
Q ss_pred CccEEEEEecCCc
Q 008607 99 FKDIYVVFELMES 111 (560)
Q Consensus 99 ~~~i~lV~E~~~g 111 (560)
..-++|||++++
T Consensus 108 -d~~vlvME~L~~ 119 (418)
T PLN02756 108 -TMALIGMRYLEP 119 (418)
T ss_pred -CCCEEEEeecCC
Confidence 124789999976
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.036 Score=57.75 Aligned_cols=74 Identities=23% Similarity=0.354 Sum_probs=58.9
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
+..+.|++|++-++.|.-. + .-..+++..|+++.+..+.-+... ..-|||+.-.||||+ +|.|-|+||-++|..
T Consensus 297 e~~y~yl~~kdhgt~is~i-k---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 297 ETLYLYLHFKDHGTPISII-K---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred CceEEEEEEecCCceeeee-e---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 4457889999888765422 1 234677888999988888877755 688999999999999 999999999999853
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.21 Score=53.22 Aligned_cols=28 Identities=32% Similarity=0.309 Sum_probs=23.4
Q ss_pred CCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 145 ANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 145 ~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
...+|.||-+.|||.++ ..++++||..|
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccc
Confidence 35799999999999765 46999999866
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.57 Score=48.74 Aligned_cols=72 Identities=15% Similarity=0.083 Sum_probs=40.6
Q ss_pred cCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC--ccccceeecCCC--cCCCccEEEEEecC
Q 008607 34 GSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPS--RREFKDIYVVFELM 109 (560)
Q Consensus 34 G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~i~~~~~--~~~~~~i~lV~E~~ 109 (560)
+.-..||.+.. ..|..+++|+.+. .......+..|+.++..|.... ++.... .... ....+..+.|++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~---~~~~~~~i~~E~~~l~~L~~~gipv~~p~~--~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRP---ERWSDAQILEEHAFALELAEAEIPVVAPLA--FNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCc---ccCCHHHHHHHHHHHHHHHHCCCCCCCCcc--CCCCEEEEECCEEEEEEeee
Confidence 44556888853 4566789987642 1124566778999988885322 222111 1110 01123467899998
Q ss_pred Cc
Q 008607 110 ES 111 (560)
Q Consensus 110 ~g 111 (560)
+|
T Consensus 110 ~G 111 (325)
T PRK11768 110 GG 111 (325)
T ss_pred CC
Confidence 86
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.16 Score=49.56 Aligned_cols=101 Identities=18% Similarity=0.223 Sum_probs=64.0
Q ss_pred cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCCc--cHHHHHHhCCCCCHH
Q 008607 49 EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPE 126 (560)
Q Consensus 49 ~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~g--dL~~~i~~~~~lse~ 126 (560)
-...+|++....-.. ...-+..+..++.++. .|+++.. .+.-.+-++.|.|-. .+.
T Consensus 86 G~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i~~------------ 143 (308)
T PF07387_consen 86 GPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKINF------------ 143 (308)
T ss_pred chhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCcccch------------
Confidence 345666665321111 2233467888887664 4555542 122357789999863 111
Q ss_pred HHHHHHHHHHHHHHHHHh--CCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 127 HYQFFLYQLLRGLKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 127 ~~~~i~~Qll~aL~yLHs--~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
..++..=+.+|.-.|+ .+.+|+|-.|+||+.|..|-+||.|-+.-
T Consensus 144 --~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 144 --SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred --hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 1112222566777884 37999999999999999999999998753
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.42 Score=57.39 Aligned_cols=31 Identities=42% Similarity=0.574 Sum_probs=26.3
Q ss_pred CCeeeccCCCCCeeeCCCC--cEE-Eeccccccc
Q 008607 145 ANVFHRDLKPKNILANADC--KLK-ICDFGLARV 175 (560)
Q Consensus 145 ~gIiHrDLKP~NILl~~~~--~lK-L~DFGla~~ 175 (560)
.+|||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 554 999998754
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.15 Score=52.63 Aligned_cols=76 Identities=26% Similarity=0.287 Sum_probs=47.3
Q ss_pred cEEEEEecCCcc---HHH-HHHhCCCC-CHHHHHHHHHHHHHHHHHHHh----CCeeeccCCCCCeeeCCCC--------
Q 008607 101 DIYVVFELMESD---LHQ-VIKANDDL-TPEHYQFFLYQLLRGLKYIHT----ANVFHRDLKPKNILANADC-------- 163 (560)
Q Consensus 101 ~i~lV~E~~~gd---L~~-~i~~~~~l-se~~~~~i~~Qll~aL~yLHs----~gIiHrDLKP~NILl~~~~-------- 163 (560)
.-.|||++..++ +.. .+.+.|-. -.+-+++++.||+.-.-.+-. .+.+|-||||+||||-+..
T Consensus 249 GnIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~ 328 (444)
T PHA03111 249 GNIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLK 328 (444)
T ss_pred CcEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEEC
Confidence 346788876542 211 22223322 346788899999876644432 3689999999999975443
Q ss_pred ----------cEEEecccccccc
Q 008607 164 ----------KLKICDFGLARVA 176 (560)
Q Consensus 164 ----------~lKL~DFGla~~~ 176 (560)
+.+|.||.++++.
T Consensus 329 ~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 329 DATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred CeEEEeccchhhhhcccCHHHHc
Confidence 2466677776653
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.35 E-value=0.14 Score=52.99 Aligned_cols=75 Identities=25% Similarity=0.301 Sum_probs=46.9
Q ss_pred EEEEEecCCcc-----HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCCCCeeeCCCC---------
Q 008607 102 IYVVFELMESD-----LHQVIKANDDLTPEHYQFFLYQLLRGLKYIH----TANVFHRDLKPKNILANADC--------- 163 (560)
Q Consensus 102 i~lV~E~~~gd-----L~~~i~~~~~lse~~~~~i~~Qll~aL~yLH----s~gIiHrDLKP~NILl~~~~--------- 163 (560)
-.|||++..++ +....+-+-.--.+-+++++.||+.-.-.+- -.+.+|-||||+||||-+..
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 35888887642 2222221112234667888899876442232 34689999999999975432
Q ss_pred ---------cEEEecccccccc
Q 008607 164 ---------KLKICDFGLARVA 176 (560)
Q Consensus 164 ---------~lKL~DFGla~~~ 176 (560)
..+|.||.++++.
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred eEEEecccceeeecccCHHHhc
Confidence 2677888888764
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.71 E-value=0.95 Score=49.22 Aligned_cols=27 Identities=33% Similarity=0.701 Sum_probs=23.2
Q ss_pred CeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 146 NVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 146 gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
.++|.|+-+.|||.+.++ ++|+||..|
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYA 311 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYS 311 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeeccc
Confidence 479999999999987554 999999866
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.68 E-value=0.97 Score=46.25 Aligned_cols=75 Identities=15% Similarity=0.135 Sum_probs=43.0
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCC---CCccccceeecCCCcCCCc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH---PDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~H---pnIv~l~~i~~~~~~~~~~ 100 (560)
.-+-.+.|+-|....+|... .+++.+.||+-.. .....+..|..-|+.|.. -.+.+++.+....+
T Consensus 18 ~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~----- 85 (288)
T PF03881_consen 18 KITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD----- 85 (288)
T ss_dssp ---EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-----
T ss_pred ceeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-----
Confidence 34556778889999999885 7888999997642 223446678888888842 23445555442221
Q ss_pred cEEEEEecCC
Q 008607 101 DIYVVFELME 110 (560)
Q Consensus 101 ~i~lV~E~~~ 110 (560)
.-||||||++
T Consensus 86 ~~fLlle~l~ 95 (288)
T PF03881_consen 86 DAFLLLEFLE 95 (288)
T ss_dssp CCEEEEE---
T ss_pred CceEEEEeec
Confidence 2389999987
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.80 E-value=0.19 Score=51.69 Aligned_cols=136 Identities=21% Similarity=0.293 Sum_probs=89.0
Q ss_pred EEEEEEeecCCeEEEEEEE-------CC---CCcEEEEEEecCc--------------------cc--ChhHHHHHH--H
Q 008607 26 KIEEVIGKGSYGVVCSAYD-------TR---TGEKVAIKKINDI--------------------FE--HVSDATRIL--R 71 (560)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d-------~~---tg~~vAiK~i~~~--------------------~~--~~~~~~~i~--r 71 (560)
.|..+|..|.-++|+-|+- .. ....+|||+++-. |. +......+. +
T Consensus 255 ~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk 334 (531)
T KOG2269|consen 255 SIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK 334 (531)
T ss_pred hhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence 3456788899999987742 11 3346899876411 11 111112222 3
Q ss_pred HHHHHHhcC-----CCCccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-Hh
Q 008607 72 EIKLLRLLR-----HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HT 144 (560)
Q Consensus 72 Ei~iL~~l~-----HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yL-Hs 144 (560)
|+.-|.+++ +|.+|.+.. -.|||-+++. .+..=-.++-.|+.++.+..-.|++.++.-| |.
T Consensus 335 EmhNL~RMq~~GlpcP~vV~lkk------------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~E 402 (531)
T KOG2269|consen 335 EMHNLSRMQKHGLPCPQVVKLKK------------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKE 402 (531)
T ss_pred HHHHHHHHHhcCCCCCceeeeec------------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHh
Confidence 444444443 566665543 2689999884 2221111233589999999999999998887 67
Q ss_pred CCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 145 ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 145 ~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.-++|-||+--|||.... .+.++|-..+.
T Consensus 403 c~LVHADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 403 CLLVHADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred hheeecchhhhhheecCC-ceEEEechhcc
Confidence 789999999999999876 89999987653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 560 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-86 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-85 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-81 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-81 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-81 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-81 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-81 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-81 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-81 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-81 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-81 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-81 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-81 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-81 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-80 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-80 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-80 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-79 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-79 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-79 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-79 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-79 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-79 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-78 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-78 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-77 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-75 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-74 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-74 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-74 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-74 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-74 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-74 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-74 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-74 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-74 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-74 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-74 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-74 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-74 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-74 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-74 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-74 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-74 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-74 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-74 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-74 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-74 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-74 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-74 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-74 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-74 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-74 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-74 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-74 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-74 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-74 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-74 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-74 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-74 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-74 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-74 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-74 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-74 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-74 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-74 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-74 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-73 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-73 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-73 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-73 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-73 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-73 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-73 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-73 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-73 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-73 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-73 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-73 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-73 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-73 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-73 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-73 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-73 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-73 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-72 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-72 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-72 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-71 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-70 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-70 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-65 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-65 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-65 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-62 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-62 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-58 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-57 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-56 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-56 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-56 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-56 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-56 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-56 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-56 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-56 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-55 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-55 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-55 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-55 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-55 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-55 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-55 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-55 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-55 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-55 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-55 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-54 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-54 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-54 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-54 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-54 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-54 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-54 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-54 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-54 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-53 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-53 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-53 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-53 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-49 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-49 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-47 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-47 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-47 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-41 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-41 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-40 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-40 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-40 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-40 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-40 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-40 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-40 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-40 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-40 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-40 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-40 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-40 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-40 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-40 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-40 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-40 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-40 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-40 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-40 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-40 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-40 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-40 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-40 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-40 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-40 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-40 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-40 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-40 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-40 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-40 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-40 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-40 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-40 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-40 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-40 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-40 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-40 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-39 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-39 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-39 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-39 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-38 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-37 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-37 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-37 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-37 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-37 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-37 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-37 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-37 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-37 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-37 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-37 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-37 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-36 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-36 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-36 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-36 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-36 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-36 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-36 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-36 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-36 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-36 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-36 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-36 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-34 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-34 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-34 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-34 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-34 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-34 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-34 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-34 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-34 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-31 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-31 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-31 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-31 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-29 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-29 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-29 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-28 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-24 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-23 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-23 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-23 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-23 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-23 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-23 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-23 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-23 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-22 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-22 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-22 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-22 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-22 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-22 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-22 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-22 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-21 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-21 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-21 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-21 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-21 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-21 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-21 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-21 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-21 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-21 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-21 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-21 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-21 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-21 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-21 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-21 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-21 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-21 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-21 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-21 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-21 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-21 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-20 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-19 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-19 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-19 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-19 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-19 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-19 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-19 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-18 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-15 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 8e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-07 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 584 bits (1508), Expect = 0.0
Identities = 145/351 (41%), Positives = 217/351 (61%), Gaps = 13/351 (3%)
Query: 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
Y S ++++ ++G+G+YGVVCSA TGE VAIKKI F+ A R LREIK+L
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKIL 63
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 136
+ +H +I+ I +I P S F ++Y++ ELM++DLH+VI L+ +H Q+F+YQ L
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTL 122
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-------TPTAIFWTDY 189
R +K +H +NV HRDLKP N+L N++C LK+CDFGLAR+ T ++
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
VATRWYRAPE+ + +KY+ A+D+WS GCI AEL +P+FPG++ HQL ++ ++GT
Sbjct: 183 VATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 250 PSPEA-IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308
P + + + + +AR Y+ S+ P + FP NP + LL+RML F+P R TA+
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 309 EALADPYFKGLAKVEREPSAQPVTKMEFEF--ERRRITKEDVRELIYREIL 357
EAL PY + EP +P+ FEF + +T +D+++LI+ EI
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 584 bits (1508), Expect = 0.0
Identities = 164/361 (45%), Positives = 229/361 (63%), Gaps = 5/361 (1%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
+ ++ + G RY IG+G+YG+VCSAYD +VAIKKI+ FE
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FE 64
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND 121
H + R LREIK+L RH +I+ I I+ P+ + KD+Y+V +LME+DL++++K
Sbjct: 65 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH 124
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
L+ +H +FLYQ+LRGLKYIH+ANV HRDLKP N+L N C LKICDFGLARVA D
Sbjct: 125 -LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
F T+YVATRWYRAPE+ + YT +IDIWS+GCI AE+L+ +P+FPGK+ + QL+
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 301
+ +LG+PS E + + N KAR YL S+ K +P+++ FPNA+ AL LL++ML F P
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 302
Query: 302 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
R E+ALA PY + EP A+ +F+ E + KE ++ELI+ E + P
Sbjct: 303 HKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQP 360
Query: 362 Q 362
Sbjct: 361 G 361
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 586 bits (1512), Expect = 0.0
Identities = 142/426 (33%), Positives = 214/426 (50%), Gaps = 52/426 (12%)
Query: 1 MQPDQRKKSSADVDFFTEYGE---GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN 57
M S + +F Y I+ +IG+GSYG V AYD T + VAIKK+N
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 58 DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI 117
+FE + D RILREI +L L+ I+ + +++P +F ++Y+V E+ +SDL ++
Sbjct: 61 RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF 120
Query: 118 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
K LT EH + LY LL G +IH + + HRDLKP N L N DC +K+CDFGLAR
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 178 NDTPTAI-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218
++ T I T +V TRWYRAPEL YT +IDIWS G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTG 239
Query: 219 CIFAELLTG-----------KPLFPG-----------------KNVVHQLDIMTDLLGTP 250
CIFAELL PLFPG K+ QL+I+ +++GTP
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
+ + + + + +Y+ +KPI QK+P+ + + LLE ML F P R T ++A
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA 359
Query: 311 LADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEG 370
L PY K + K + E + + F+ + +++ +R + +E+ +HP+++ +
Sbjct: 360 LDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFT 418
Query: 371 SEPTGF 376
F
Sbjct: 419 IHENNF 424
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 560 bits (1446), Expect = 0.0
Identities = 125/368 (33%), Positives = 185/368 (50%), Gaps = 21/368 (5%)
Query: 5 QRKKSSADVDFF-TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND----- 58
Q K +A D + S Y ++ I GSYG VC+ D+ G VAIK++ +
Sbjct: 3 QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDG 61
Query: 59 ----IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLH 114
I R+LREI+LL HP+I+ ++ I + +Y+V ELM +DL
Sbjct: 62 RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 115 QVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
QVI ++P+H Q+F+Y +L GL +H A V HRDL P NIL + + ICDF LA
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
R D T YV RWYRAPEL F +T +D+WS GC+ AE+ K LF G
Sbjct: 182 REDTADA----NKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL-SSMRKKKPIPFSQKFPNANPLALRL 292
+QL+ + +++GTP E + + AR YL +S+ ++ P A+P+AL L
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL 296
Query: 293 LERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELI 352
+ +ML F P+ R + E+AL PYF+ L F F+ D+ ++
Sbjct: 297 IAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLS---ERFHFDESVTDVYDMHKIF 353
Query: 353 YREILEYH 360
E+ ++
Sbjct: 354 TAEVERFN 361
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 559 bits (1442), Expect = 0.0
Identities = 142/372 (38%), Positives = 217/372 (58%), Gaps = 13/372 (3%)
Query: 3 PDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH 62
P + +V T + + Y+ + +G G+YG VCSA D RTG KVAIKK+ F+
Sbjct: 6 PARSGFYRQEV-TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS 64
Query: 63 VSDATRILREIKLLRLLRHPDIVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKAND 121
A R RE++LL+ +RH +++ + + P + +F D Y+V M +DL +++K
Sbjct: 65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 124
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
L + QF +YQ+L+GL+YIH A + HRDLKP N+ N DC+LKI DFGLAR A ++
Sbjct: 125 -LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-- 181
Query: 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
T YV TRWYRAPE+ ++ +YT +DIWS+GCI AE++TGK LF G + + QL
Sbjct: 182 ----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 236
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 301
+ + GTP E + R+++++A+ Y+ + + + F+ NA+PLA+ LLE+ML +
Sbjct: 237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 296
Query: 302 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
+ R TA EALA PYF+ L E EP Q + F+ T ++ + + Y+E+L + P
Sbjct: 297 EQRVTAGEALAHPYFESLHDTEDEPQVQK---YDDSFDDVDRTLDEWKRVTYKEVLSFKP 353
Query: 362 QMLKEFLEGSEP 373
E
Sbjct: 354 PRQLGARVSKET 365
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 557 bits (1438), Expect = 0.0
Identities = 139/346 (40%), Positives = 205/346 (59%), Gaps = 12/346 (3%)
Query: 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
T + Y +G G+YG VCSA D R+GEKVAIKK++ F+ A R RE+ LL
Sbjct: 18 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 77
Query: 77 RLLRHPDIVEIKHILLPPSR-REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 135
+ ++H +++ + + P S R F D Y+V M++DL +++ + E Q+ +YQ+
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQM 135
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L+GLKYIH+A V HRDLKP N+ N DC+LKI DFGLAR A + T YV TRWY
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWY 189
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
RAPE+ S+ Y +DIWS+GCI AE+LTGK LF GK+ + QL + + G P E +
Sbjct: 190 RAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
++ ++ A+ Y+ S+ + F+Q FP A+P A LLE+ML + R TA +AL P+
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308
Query: 316 FKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
F+ E E AQ + E ++T ++ ++ IY+EI+ + P
Sbjct: 309 FEPFRDPEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 557 bits (1438), Expect = 0.0
Identities = 138/387 (35%), Positives = 216/387 (55%), Gaps = 43/387 (11%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR- 80
+Y++ + +GKG+YG+V + D RTGE VA+KKI D F++ +DA R REI +L L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
H +IV + ++L + +D+Y+VF+ ME+DLH VI+AN L P H Q+ +YQL++ +K
Sbjct: 68 HENIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIK 123
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARV------------------AFNDTPT 182
Y+H+ + HRD+KP NIL NA+C +K+ DFGL+R N
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 183 AIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG + ++QL+
Sbjct: 184 QPILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF----------------PNA 285
+ ++ PS E + +++ A+ + S+++K I S K +
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 286 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITK 345
N AL LL+++L F P R +A +AL P+ EP+ + + + + +
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSI 360
Query: 346 EDVRELIYREILEYHPQMLKEFLEGSE 372
+D R L+Y EI +++ + +
Sbjct: 361 DDYRNLVYSEISRRKRELISNKHQNVQ 387
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 554 bits (1430), Expect = 0.0
Identities = 148/373 (39%), Positives = 221/373 (59%), Gaps = 18/373 (4%)
Query: 1 MQPDQRKKSSADVDFF------TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK 54
M S F+ T + RY+ +G G+YG VC+A+DT+TG +VA+K
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 55 KINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE-FKDIYVVFELMESDL 113
K++ F+ + A R RE++LL+ ++H +++ + + P E F D+Y+V LM +DL
Sbjct: 61 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
+ ++K LT +H QF +YQ+LRGLKYIH+A++ HRDLKP N+ N DC+LKI DFGLA
Sbjct: 121 NNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
R + T YVATRWYRAPE+ ++ Y +DIWS+GCI AELLTG+ LFPG
Sbjct: 180 RHTAD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 293
+ + QL ++ L+GTP E + ++ +E AR Y+ S+ + + F+ F ANPLA+ LL
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 294 ERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIY 353
E+ML + R TA +ALA YF + EP A P + E R + ++ + L Y
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSLESRDLLIDEWKSLTY 349
Query: 354 REILEYHPQMLKE 366
E++ + P L +
Sbjct: 350 DEVISFVPPPLDQ 362
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 556 bits (1435), Expect = 0.0
Identities = 149/417 (35%), Positives = 213/417 (51%), Gaps = 57/417 (13%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
Q K +++ +++ RY+I +IG GSYG VC AYD VAIKKI +FE
Sbjct: 32 QHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND 121
+ D RILREI +L L H +V++ I++P +F ++YVV E+ +SD ++ +
Sbjct: 92 DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV 151
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA----- 176
LT H + LY LL G+KY+H+A + HRDLKP N L N DC +K+CDFGLAR
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 177 -------------------FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217
+ T +V TRWYRAPEL YT AID+WSI
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSI 270
Query: 218 GCIFAELLT-----------GKPLFPGKNVV--------------------HQLDIMTDL 246
GCIFAELL PLFPG + QL+++ ++
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
LGTPS E I + E A+RY+ K++ +++FP ++ A+ LL+RML F P R T
Sbjct: 331 LGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390
Query: 307 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 363
E LA P+FK + E E +A ++ F + + + +R +EI YHP++
Sbjct: 391 INECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 535 bits (1380), Expect = 0.0
Identities = 128/378 (33%), Positives = 204/378 (53%), Gaps = 27/378 (7%)
Query: 1 MQPDQRKKS---SADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN 57
M ++ + S ++ + + RY+ + IG G+ G+VC+AYD VAIKK++
Sbjct: 1 MGSRSKRDNNFYSVEI-GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS 59
Query: 58 DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP-SRREFKDIYVVFELMESDLHQV 116
F++ + A R RE+ L++ + H +I+ + ++ P S EF+D+Y+V ELM+++L QV
Sbjct: 60 RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV 119
Query: 117 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176
I+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR A
Sbjct: 120 IQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177
Query: 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG +
Sbjct: 178 ----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231
Query: 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA----------- 285
+ Q + + + LGTP PE + ++ R Y+ + K F + FP+
Sbjct: 232 IDQWNKVIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290
Query: 286 -NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRIT 344
A LL +ML + R + +EAL PY + P + + + R T
Sbjct: 291 KASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPP-KIPDKQLDEREHT 349
Query: 345 KEDVRELIYREILEYHPQ 362
E+ +ELIY+E+++
Sbjct: 350 IEEWKELIYKEVMDLEHH 367
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 538 bits (1388), Expect = 0.0
Identities = 133/400 (33%), Positives = 214/400 (53%), Gaps = 29/400 (7%)
Query: 1 MQPDQRKKSSADVDFFT-EYGE-----GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK 54
+ KS D F++ E G+ RY+ + IG G+ G+VC+AYD VAIK
Sbjct: 34 AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 55 KINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP-PSRREFKDIYVVFELMESDL 113
K++ F++ + A R RE+ L++ + H +I+ + ++ P + EF+D+Y+V ELM+++L
Sbjct: 94 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 153
Query: 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
QVI+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLA
Sbjct: 154 CQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
R A T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG
Sbjct: 212 RTA----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA-------- 285
++ + Q + + + LGTP PE + ++ R Y+ + K + F + FP++
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 286 ----NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERR 341
A LL +ML +P R + ++AL PY A P + + + R
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDKQLDER 383
Query: 342 RITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSA 381
T E+ +ELIY+E++ + ++G ++
Sbjct: 384 EHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNS 423
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 524 bits (1351), Expect = 0.0
Identities = 125/315 (39%), Positives = 175/315 (55%), Gaps = 15/315 (4%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
GSRY + +G G G+V SA D ++VAIKKI + LREIK++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 82 PDIVEIKHILLPPSRR---------EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
+IV++ IL P + E +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
YQLLRGLKYIH+ANV HRDLKP N+ N D LKI DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
T+WYR+P L S + YT AID+W+ GCIFAE+LTGK LF G + + Q+ ++ + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
E + + Y+ + + P +Q P + A+ LE++L F P DR TAEEAL
Sbjct: 246 EEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 312 ADPYFKGLAKVEREP 326
+ PY + EP
Sbjct: 305 SHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 479 bits (1236), Expect = e-168
Identities = 115/351 (32%), Positives = 176/351 (50%), Gaps = 27/351 (7%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
E R+++E + G+G++G V + TG VAIKK+ + R L+ ++ L +L
Sbjct: 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLH 77
Query: 81 HPDIVEIKHILLPPSRREFKDIY--VVFELMESDLHQVIK----ANDDLTPEHYQFFLYQ 134
HP+IV+++ R+ +DIY VV E + LH+ + P + FL+Q
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 135 LLRGLKYIH--TANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
L+R + +H + NV HRD+KP N+L N AD LK+CDFG A+ P Y+
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN----VAYIC 193
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
+R+YRAPEL YT A+DIWS+GCIFAE++ G+P+F G N QL + +LG PS
Sbjct: 194 SRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKF----PNANPLALRLLERMLAFEPKDRPTA 307
E + ++ L K IP+S F A LL +L + P++R
Sbjct: 253 REVLRKLNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
Query: 308 EEALADPYFKGLAKVERE-PSAQPVTKMEFEFERR--RITKEDVRELIYRE 355
EAL PYF L + P+ + + + F F + E + + R+
Sbjct: 310 YEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 443 bits (1141), Expect = e-153
Identities = 119/399 (29%), Positives = 195/399 (48%), Gaps = 33/399 (8%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
+ + D T Y +VIG GS+GVV A + E VAIKK+
Sbjct: 18 LDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV---- 72
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RREFKDIYVVFELMESDLHQVI-- 117
+ D RE++++R+++HP++V++K +++ + +V E + +++
Sbjct: 73 --LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRH 130
Query: 118 --KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLAR 174
K + + ++YQLLR L YIH+ + HRD+KP+N+L + LK+ DFG A+
Sbjct: 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
Query: 175 VAFNDTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ P Y+ +R+YRAPEL G+ + YT IDIWS GC+ AEL+ G+PLFPG
Sbjct: 191 ILIAGEPN----VSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRL 292
++ + QL + +LGTPS E I + + +P PFS+ F P P A+ L
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFP---QIRPHPFSKVFRPRTPPDAIDL 301
Query: 293 LERMLAFEPKDRPTAEEALADPYFKGLAKVE-REPSAQPVTKM-EFEFERRRITKEDVRE 350
+ R+L + P R TA EAL P+F L E R P+ + + + + E + + +
Sbjct: 302 ISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISR 361
Query: 351 LIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQF 389
L+ H + + G + F P ++ K
Sbjct: 362 LVP-----QHAEA-ELLSRGIDVHNFQ-PIPLESLKVTL 393
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 441 bits (1136), Expect = e-152
Identities = 104/382 (27%), Positives = 178/382 (46%), Gaps = 67/382 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+Y + + +G GS+G+VC +D +G++ A+KK+ D RE+ ++++L H
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHV 60
Query: 83 DIVEIKHIL---------------------------------LPPSRREFKDIYVVFELM 109
+I+++ + + + K + V+ E +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 110 ESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCK 164
LH+V+ ++ + ++YQL R + +IH+ + HRD+KP+N+L N+ D
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFAE 223
LK+CDFG A+ P+ Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F E
Sbjct: 181 LKLCDFGSAKKLIPSEPS----VAYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFGE 234
Query: 224 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP 283
L+ GKPLF G+ + QL + ++GTP+ E + R+ K + + P
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP---TLKAKDWRKILP 291
Query: 284 NANP-LALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKME------- 335
P LA+ LLE++L +EP R EA+A P+F L
Sbjct: 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIP 351
Query: 336 --FEF---ERRRITKEDVRELI 352
F F E I + ++
Sbjct: 352 QLFNFSPYELSIIPGNVLNRIL 373
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 429 bits (1104), Expect = e-147
Identities = 110/339 (32%), Positives = 170/339 (50%), Gaps = 25/339 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 108
Query: 84 IVEIKHILLPPS-RREFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRG 138
IV +++ +++ + +V + + +++V + A L + + ++YQL R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 139 LKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L YIH+ + HRD+KP+N+L + D LK+CDFG A+ P Y+ +R+YRA
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----VSYICSRYYRA 224
Query: 198 PELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PEL G+ + YT +ID+WS GC+ AELL G+P+FPG + V QL + +LGTP+ E I
Sbjct: 225 PELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ + K P+++ F P P A+ L R+L + P R T EA A +
Sbjct: 283 EMNPNYTEFKFP---QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 316 FKGLAKVEREPSAQPVTKMEFEFERR--RITKEDVRELI 352
F L + T F F + LI
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 378
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 400 bits (1031), Expect = e-137
Identities = 87/318 (27%), Positives = 153/318 (48%), Gaps = 24/318 (7%)
Query: 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK 74
E+G Y++ +G+G Y V A + EKV +K + + +I REIK
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIK 82
Query: 75 LLRLLR-HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
+L LR P+I+ + I+ P V + +D Q+ + LT +F++Y
Sbjct: 83 ILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMY 137
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
++L+ L Y H+ + HRD+KP N++ + KL++ D+GLA + VA+
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVAS 193
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPS 251
R+++ PEL + Y ++D+WS+GC+ A ++ K P F G + QL + +LGT
Sbjct: 194 RYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 252 PEA-IARVRNEKARRYLSSMRKKKPIPFSQKFPNAN-----PLALRLLERMLAFEPKDRP 305
I + E R+ + + + + + N P AL L+++L ++ + R
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
Query: 306 TAEEALADPYFKGLAKVE 323
TA EA+ PYF + K +
Sbjct: 313 TAREAMEHPYFYTVVKDQ 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 366 bits (942), Expect = e-124
Identities = 104/309 (33%), Positives = 162/309 (52%), Gaps = 12/309 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y+ IG+GSYGVV + TG+ VAIKK + + LREI++L+ L+HP+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 142
+V + + R + +++VFE + + + + + +Q L+ + +
Sbjct: 64 LVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 201
H N HRD+KP+NIL +K+CDFG AR P+ + D VATRWYR+PE L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELLV 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
G ++Y P +D+W+IGC+FAELL+G PL+PGK+ V QL ++ LG P
Sbjct: 176 GD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
+ + + P KFPN + AL LL+ L +P +R T E+ L PYF+ + +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 322 VEREPSAQP 330
+E
Sbjct: 294 IEDLAKEHD 302
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-116
Identities = 96/296 (32%), Positives = 158/296 (53%), Gaps = 12/296 (4%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y+ ++G+GSYG+V + TG VAIKK + + +REIKLL+ LRH +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 142
+V + + ++ K Y+VFE ++ + ++ + L + Q +L+Q++ G+ +
Sbjct: 86 LVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC- 201
H+ N+ HRD+KP+NIL + +K+CDFG AR P ++ D VATRWYRAPEL
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELLV 197
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
G KY A+D+W+IGC+ E+ G+PLFPG + + QL + LG P
Sbjct: 198 GD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ K+ P +++P + + + L ++ L +P RP E L +F+
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-105
Identities = 99/309 (32%), Positives = 140/309 (45%), Gaps = 30/309 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI-----LREIKLLR 77
SRY+ IG G+YG V A D +G VA+K + + +RE+ LLR
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLR 66
Query: 78 LLR---HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFL 132
L HP++V + + + +VFE ++ DL + L E + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
Q LRGL ++H + HRDLKP+NIL + +K+ DFGLAR ++ T V T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA---LTPVVVT 182
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
WYRAPE L S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P
Sbjct: 183 LWYRAPEVLLQS---TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 252 PE---AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308
+ + + + P P P +LL ML F P R +A
Sbjct: 240 EDDWPRDVSLPR-------GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292
Query: 309 EALADPYFK 317
AL Y
Sbjct: 293 RALQHSYLH 301
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = e-104
Identities = 123/325 (37%), Positives = 174/325 (53%), Gaps = 24/325 (7%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
S+ + G +Y+ E +G+G+YGVV A D G VA+K+I +
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIR--LDAE 58
Query: 64 SDATRI--LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-N 120
+ +REI LL+ L HP+IV + ++ + +VFE ME DL +V+
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENK 113
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
L + +LYQLLRG+ + H + HRDLKP+N+L N+D LK+ DFGLAR AF
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI- 171
Query: 181 PTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239
P + T V T WYRAP+ L GS KY+ ++DIWSIGCIFAE++TGKPLFPG Q
Sbjct: 172 PVRSY-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228
Query: 240 LDIMTDLLGTPSPEA---IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296
L + +LGTP+P + + K R + + + P+S P + LL M
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIPGFCQEGIDLLSNM 284
Query: 297 LAFEPKDRPTAEEALADPYFKGLAK 321
L F+P R +A +A+ PYFK L
Sbjct: 285 LCFDPNKRISARDAMNHPYFKDLDP 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-104
Identities = 112/328 (34%), Positives = 168/328 (51%), Gaps = 24/328 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y + +G+G+Y V T VA+K+I E + T I RE+ LL+ L+H +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHAN 61
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 142
IV + I+ + +VFE ++ DL Q + + + + + FL+QLLRGL Y
Sbjct: 62 IVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 201
H V HRDLKP+N+L N +LK+ DFGLAR A + PT + + V T WYR P+ L
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPDILL 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA---IARV 258
GS + Y+ ID+W +GCIF E+ TG+PLFPG V QL + +LGTP+ E I
Sbjct: 174 GS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
K Y K + P + LL ++L FE ++R +AE+A+ P+F
Sbjct: 232 EEFKTYNY----PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287
Query: 319 L----AKVEREPSAQPVTKMEFEFERRR 342
L K+ S + +++ + E
Sbjct: 288 LGERIHKLPDTTSIFALKEIQLQKEASL 315
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-104
Identities = 114/298 (38%), Positives = 166/298 (55%), Gaps = 19/298 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRH 81
+Y E IG+G+YGVV A + GE A+KKI E + +REI +L+ L+H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLK 140
+IV++ ++ R + +VFE ++ DL +++ L + FL QLL G+
Sbjct: 60 SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
Y H V HRDLKP+N+L N + +LKI DFGLAR AF P + T + T WYRAP+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPDV 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
L GS KY+ IDIWS+GCIFAE++ G PLFPG + QL + +LGTP+ + V
Sbjct: 172 LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ +Y + +P+P+ + + LL +ML +P R TA++AL YFK
Sbjct: 230 --ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-104
Identities = 110/303 (36%), Positives = 157/303 (51%), Gaps = 24/303 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRI--LREIKLLRLL 79
RY+ + +G+G + V A D T + VAIKKI D LREIKLL+ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRG 138
HP+I+ + S I +VF+ ME+DL +IK N LTP H + ++ L+G
Sbjct: 70 SHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+Y+H + HRDLKP N+L + + LK+ DFGLA+ +F P + T V TRWYRAP
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRAP 181
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA--- 254
E L G+ Y +D+W++GCI AELL P PG + + QL + + LGTP+ E
Sbjct: 182 ELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+ + + + + IP F A L L++ + F P R TA +AL
Sbjct: 240 MCSLPDYV------TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293
Query: 315 YFK 317
YF
Sbjct: 294 YFS 296
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-103
Identities = 116/301 (38%), Positives = 163/301 (54%), Gaps = 19/301 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRH 81
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKH 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLK 140
+IV + +L + + +VFE + DL + + N DL PE + FL+QLL+GL
Sbjct: 61 KNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
+ H+ NV HRDLKP+N+L N + +LK+ +FGLAR AF P + + V T WYR P+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPDV 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
L G+ Y+ +ID+WS GCIFAEL G+PLFPG +V QL + LLGTP+ E +
Sbjct: 173 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
K Y P N LL+ +L P R +AEEAL PYF
Sbjct: 231 T--KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
Query: 319 L 319
Sbjct: 289 F 289
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-103
Identities = 105/326 (32%), Positives = 161/326 (49%), Gaps = 23/326 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRI--LREIKLLRLL 79
+Y+ IG+G+YG V A D + G VA+K++ + + + +RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 80 R---HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQ 134
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
LLRGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR ++ T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA---LTSVVVTLW 184
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
YRAPE L S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P E
Sbjct: 185 YRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
R + K P + + + L LL + L F P R +A AL+
Sbjct: 242 DWPRDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 314 PYFKGLAK-VEREPSAQPVTKMEFEF 338
PYF+ L + E S P ++ E
Sbjct: 298 PYFQDLERCKENLDSHLPPSQNTSEL 323
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-102
Identities = 111/306 (36%), Positives = 161/306 (52%), Gaps = 23/306 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
RY+ +G+G+YG V A DT T E VAIK+I EH + +RE+ LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
H +I+E+K ++ R ++++FE E+DL + + N D++ + FLYQL+ G+
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 141 YIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ H+ HRDLKP+N+L + LKI DFGLAR AF P F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
R PE L GS Y+ ++DIWSI CI+AE+L PLFPG + + QL + ++LG P
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNA-NPLALRLLERMLAFEPKDRPTAEEALAD 313
V + S K + + + L LL ML +P R +A+ AL
Sbjct: 262 WPGV--TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319
Query: 314 PYFKGL 319
PYF
Sbjct: 320 PYFSHN 325
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-101
Identities = 108/309 (34%), Positives = 168/309 (54%), Gaps = 25/309 (8%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S++K E +G G+Y V + TG VA+K++ E + +T I REI L++ L+H
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKELKHE 63
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN------DDLTPEHYQFFLYQLL 136
+IV + ++ ++ + +VFE M++DL + + + L ++F +QLL
Sbjct: 64 NIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
+GL + H + HRDLKP+N+L N +LK+ DFGLAR AF P F + V T WYR
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTLWYR 175
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
AP+ L GS Y+ +IDIWS GCI AE++TGKPLFPG N QL ++ D++GTP+
Sbjct: 176 APDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNA-----NPLALRLLERMLAFEPKDRPTAEEA 310
V K +Y +++++ P Q + + L +L P R +A++A
Sbjct: 234 PSV--TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291
Query: 311 LADPYFKGL 319
L P+F
Sbjct: 292 LHHPWFAEY 300
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-101
Identities = 108/338 (31%), Positives = 163/338 (48%), Gaps = 28/338 (8%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
S+Y+ IG+G++G V A +TG+KVA+KK+ + E+ + I LREIK+L+LL+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQLLK 74
Query: 81 HPDIV---EIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLL 136
H ++V EI P R IY+VF+ E DL ++ T + + LL
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY---VATR 193
GL YIH + HRD+K N+L D LK+ DFGLAR AF+ Y V T
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVVTL 192
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
WYR PE L G Y P ID+W GCI AE+ T P+ G HQL +++ L G+ +P
Sbjct: 193 WYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250
Query: 253 EA---IARVRNEKARRYLSSMRKKKPIPFSQKFPN--ANPLALRLLERMLAFEPKDRPTA 307
E + + K + + +P AL L++++L +P R +
Sbjct: 251 EVWPNVDNYELYEKLEL----VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306
Query: 308 EEALADPYFKGL---AKVEREPSAQPVTKMEFEFERRR 342
++AL +F + ++ S + E+ RR
Sbjct: 307 DDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 5e-88
Identities = 109/366 (29%), Positives = 173/366 (47%), Gaps = 56/366 (15%)
Query: 23 SRYKIE-EVIGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL 79
++ E +G+G+YG V A D + + A+K+I +S + REI LLR L
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLREL 75
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD---------LTPEHYQF 130
+HP+++ ++ + L + + ++++F+ E DL +IK + L +
Sbjct: 76 KHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVAFNDTPTAIF- 185
LYQ+L G+ Y+H V HRDLKP NIL + +KI D G AR FN P
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNS-PLKPLA 190
Query: 186 -WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-------- 235
V T WYRAPE L G+ YT AIDIW+IGCIFAELLT +P+F +
Sbjct: 191 DLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 236 -VVHQLDIMTDLLGTPS----------PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPN 284
QLD + +++G P+ PE +++ + Y + K +
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIK---YMEKHKVK 305
Query: 285 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRIT 344
+ A LL+++L +P R T+E+A+ DPYF P++ + + +R
Sbjct: 306 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL----PTSDVFAGCQIPYPKREFL 361
Query: 345 KEDVRE 350
E+ +
Sbjct: 362 TEEEPD 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 2e-75
Identities = 88/399 (22%), Positives = 155/399 (38%), Gaps = 65/399 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR-LLRHP 82
+ ++V+G G+ G + VA+K+I +D RE++LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 141
+++ + ++ + Y+ EL + L + ++ D L Q GL +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 142 IHTANVFHRDLKPKNIL-----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
+H+ N+ HRDLKP NIL A+ K I DFGL + + + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE L T +DI+S GC+F +++ GK++ Q +I+
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL------------ 241
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ + + +A L+E+M+A +P+ RP+A+ L P+
Sbjct: 242 ---------------LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 316 FKGLAK-----------VEREPSAQPVTKMEFEFERRRITKEDVRELIYREILE------ 358
F L K +E+E P+ K + E R + K D RE I +
Sbjct: 287 FWSLEKQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRKFR 345
Query: 359 -YHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHY 396
Y +++ L Y ++ L + +
Sbjct: 346 TYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDF 384
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 8e-69
Identities = 96/331 (29%), Positives = 157/331 (47%), Gaps = 46/331 (13%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
RY++ +VIGKGS+G V AYD + + VA+K + + + EI++L LR
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAE--EIRILEHLRK 152
Query: 82 PDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRG 138
D +++ F++ I + FEL+ +L+++IK N + + F + +L+
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 139 LKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L +H + H DLKP+NIL +K+ DFG + T Y+ +R+YR
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT------YIQSRFYR 266
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE + G+ +Y ID+WS+GCI AELLTG PL PG++ QL M +LLG PS + +
Sbjct: 267 APEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 256 ARVRN-------------------EKARRYLSSMRKK----KPIPFSQKFPNANPLALR- 291
+ L+ R + + P S+++ NA
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 292 ----LLERMLAFEPKDRPTAEEALADPYFKG 318
L++ L ++P R T +AL P+ +
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-68
Identities = 80/343 (23%), Positives = 122/343 (35%), Gaps = 51/343 (14%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
+ ++ F + +G Y I + IG G V + + AIK +N
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA 65
Query: 62 HVSDATRILREIKLLRLLRHP--DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA 119
EI L L+ I+ + + + IY+V E DL+ +K
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKK 120
Query: 120 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
+ P + + +L + IH + H DLKP N L D LK+ DFG+A D
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179
Query: 180 TPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
T T++ V T Y PE G SK +P D+WS+GCI + GK
Sbjct: 180 T-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 290
F +Q+ + AI + I F
Sbjct: 239 FQQII--NQISKL---------HAI--------------IDPNHEIEFP---DIPEKDLQ 270
Query: 291 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTK 333
+L+ L +PK R + E LA PY +++ P Q
Sbjct: 271 DVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQMAKG 309
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 4e-66
Identities = 54/350 (15%), Positives = 98/350 (28%), Gaps = 61/350 (17%)
Query: 9 SSADVDFFTEYGEGSR-YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDA 66
+A+ + +G R K+ E + G VV D E A+K S+
Sbjct: 47 QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106
Query: 67 TRILREIKLLRLLRHPDIVEIK---HILLPP------------------SRREFKDIYVV 105
R+ L E + +LLP + ++
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166
Query: 106 FELMESDLHQVIKANDDLTPEHY-------QFFLYQLLRGLKYIHTANVFHRDLKPKNIL 158
DL + D + QL+R + + + H P N+
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLF 226
Query: 159 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218
D +L + D P Y E + + +T A++ W +G
Sbjct: 227 IMPDGRLMLGDVSALWKVGTRGPA------SSVPVTYAPREFLNASTATFTHALNAWQLG 280
Query: 219 CIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF 278
+ F + L P +++ + P+P
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL-------------AFGSCTPLP- 326
Query: 279 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSA 328
L+ R L F+ + R EA+ P F +++ E S+
Sbjct: 327 --------DFVKTLIGRFLNFDRRRRLLPLEAMETPEFL---QLQNEISS 365
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-65
Identities = 78/332 (23%), Positives = 118/332 (35%), Gaps = 47/332 (14%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G Y I + IG G V + + AIK +N EI L L+
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 82 P--DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
I+ + + IY+V E DL+ +K + P + + +L +
Sbjct: 67 HSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
IH + H DLKP N L D LK+ DFG+A DT T++ V T Y PE
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT-TSVVKDSQVGTVNYMPPE 179
Query: 200 L---------CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
G SK +P D+WS+GCI + GK F +Q+ +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKL------- 230
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
AI + I F +L+ L +PK R + E
Sbjct: 231 --HAI--------------IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPEL 271
Query: 311 LADPYFKGLAKVEREPSAQPVTKMEFEFERRR 342
LA PY + + + +M++ +
Sbjct: 272 LAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 4e-65
Identities = 94/354 (26%), Positives = 159/354 (44%), Gaps = 57/354 (16%)
Query: 11 ADVDFFTEYGE--GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFEHVSDA 66
+ D+ + GE RY+I+ +IGKGS+G V AYD E VAIK I F + +
Sbjct: 40 DNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-- 97
Query: 67 TRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--L 123
E++LL L+ D +I+ F++ + +VFE++ +L+ +++ + +
Sbjct: 98 ---QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV 154
Query: 124 TPEHYQFFLYQLLRGLKYIHT--ANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFND 179
+ + F Q+ L ++ T ++ H DLKP+NIL +KI DFG +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214
Query: 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239
Y+ +R+YR+PE+ Y AID+WS+GCI E+ TG+PLF G N V Q
Sbjct: 215 IYQ------YIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 240 LDIMTDLLGTPSPEAIARVRNEK-----------ARRYLSSMRKKKPIPFSQKFPNANPL 288
++ + ++LG P + + + + +++ P ++K N +
Sbjct: 267 MNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGV 326
Query: 289 ALR----------------------LLERMLAFEPKDRPTAEEALADPYFKGLA 320
L+ RML ++PK R AL +FK A
Sbjct: 327 ETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 5e-64
Identities = 70/344 (20%), Positives = 135/344 (39%), Gaps = 65/344 (18%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+ + + +G G++G V + A+K + +I + + + +I E +L+ +++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKI--EADILKKIQN 90
Query: 82 PDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRG 138
D + +I+ + + D + ++FE + L+++I N+ E + + ++L+
Sbjct: 91 DD-INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 139 LKYIHTANVFHRDLKPKNIL-------------------------ANADCKLKICDFGLA 173
L Y+ ++ H DLKP+NIL +K+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-- 207
Query: 174 RVAFNDTPTAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
A F +D + TR YRAPE + + + D+WS GC+ AEL TG
Sbjct: 208 --------CATFKSDYHGSIINTRQYRAPEVILNL---GWDVSSDMWSFGCVLAELYTGS 256
Query: 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL-------------SSMRKKKP 275
LF + L +M ++ + +Y+ SS+ K
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316
Query: 276 IPFSQKFPNA--NPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ + L L +L +P RP+ E L + +
Sbjct: 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-63
Identities = 81/352 (23%), Positives = 127/352 (36%), Gaps = 49/352 (13%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
D K SS+ + + +G Y I + IG G V + + AIK +N
Sbjct: 37 TDDDDKASSSANECISV--KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA 93
Query: 62 HVSDATRILREIKLLRLLRHP--DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA 119
EI L L+ I+ + + + IY+V E DL+ +K
Sbjct: 94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKK 148
Query: 120 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
+ P + + +L + IH + H DLKP N L D LK+ DFG+A D
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207
Query: 180 TPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
T T++ V Y PE G SK +P D+WS+GCI + GK
Sbjct: 208 T-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
Query: 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 290
F ++ ++ L AI + I F
Sbjct: 267 FQ-----QIINQISKL------HAI--------------IDPNHEIEFP---DIPEKDLQ 298
Query: 291 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRR 342
+L+ L +PK R + E LA PY + + + +M++ +
Sbjct: 299 DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 350
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 4e-63
Identities = 88/345 (25%), Positives = 144/345 (41%), Gaps = 65/345 (18%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+RY+I + +G+G++G V D + G VA+K + ++ + +A R EI++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 81 HPDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 137
D + E I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 138 GLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVAFN 178
+ ++H+ + H DLKP+NIL + +K+ DFG
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG------- 182
Query: 179 DTPTAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+A + + V+TR YRAPE + ++ D+WSIGCI E G +FP
Sbjct: 183 ---SATYDDEHHSTLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEK--------------ARRYLSSMRKKKPIPFS 279
+ L +M +LG I + R K A RY + P
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRY----VSRACKPLK 292
Query: 280 QKFPNANP---LALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
+ + + L+++ML ++P R T EAL P+F L K
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-62
Identities = 92/352 (26%), Positives = 142/352 (40%), Gaps = 59/352 (16%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDT-RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
RY+I +G+G++G V D R +VA+K I ++ +A R+ EI +L+ ++
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARL--EINVLKKIK 74
Query: 81 HPDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 137
D +L F + + FEL+ + + +K N+ H + YQL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 138 GLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVAFN 178
L+++H + H DLKP+NIL + + +++ DFG
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG------- 187
Query: 179 DTPTAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+A F + VATR YR PE + + D+WSIGCI E G LF
Sbjct: 188 ---SATFDHEHHTTIVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQT 241
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEK------ARRYLSSMRKKKPIPFSQKFPNA-- 285
L +M +LG I R R +K +S + + +
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 286 -----NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER--EPSAQP 330
+ L+ RML F+P R T EAL P+F GL ER S P
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNP 353
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-61
Identities = 80/339 (23%), Positives = 129/339 (38%), Gaps = 49/339 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+RY + +G G + V A D VA+K + + ++A EIKLL+ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVNDA 75
Query: 83 DIVEIKHILLPPSRR-----EFKDIYV-----VFELMESDLHQVIKANDD--LTPEHYQF 130
D + + + K VFE++ +L +IK + + + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 131 FLYQLLRGLKYIHT-ANVFHRDLKPKNILAN------ADCKLKICDFGLARVAFNDTPTA 183
QLL GL Y+H + H D+KP+N+L ++KI D G A
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--- 192
Query: 184 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV------ 236
T+ + TR YR+PE L G+ + DIWS C+ EL+TG LF
Sbjct: 193 ---TNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 237 VHQLDIMTDLLGTPSPEAIARVR------NEKARRYLSSMRKKKP----IPFSQKFPNAN 286
+ + +LLG + + N + S K P + KF
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 287 PLALR-LLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324
+ L ML +P+ R A + P+ K +E
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEE 345
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 4e-60
Identities = 79/358 (22%), Positives = 137/358 (38%), Gaps = 52/358 (14%)
Query: 1 MQPDQRKKSSADVDFFTEYGEG-SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI 59
M S D+ Y + +Y + IG+GS+G T G + IK+IN
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN-- 58
Query: 60 FEHVSDATR--ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV 116
+S R RE+ +L ++HP+IV+ + S E +Y+V + E DL +
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKR 113
Query: 117 IK-ANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174
I L E + Q+ LK++H + HRD+K +NI D +++ DFG+AR
Sbjct: 114 INAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234
V + A + T +Y +PE+C + Y DIW++GC+ EL T K F
Sbjct: 174 VLNSTVELA---RACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAG 228
Query: 235 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP--FSQKFPNANPLALRL 292
++ + ++ + P+ +S + L
Sbjct: 229 SM---------------KNLVLKIISGSF----------PPVSLHYSYDLRS-------L 256
Query: 293 LERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRE 350
+ ++ P+DRP+ L + + P F + +
Sbjct: 257 VSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 4e-60
Identities = 74/323 (22%), Positives = 120/323 (37%), Gaps = 56/323 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S ++ V+G+G++G V A + AIKKI + IL E+ LL L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQ 62
Query: 83 DIVEIKH--------ILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPE-HYQFFL 132
+V + + ++ +++ E E L+ +I + + Y
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW------ 186
Q+L L YIH+ + HRDLKP NI + +KI DFGLA+
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 187 -----TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
T + T Y A E+ Y ID++S+G IF E++ P G V+
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN--- 236
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP-NANPLALRLLERMLAFE 300
I+ L + I F F N + +++ ++ +
Sbjct: 237 ILKKL-------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271
Query: 301 PKDRPTAEEALADPYFKGLAKVE 323
P RP A L + + E
Sbjct: 272 PNKRPGARTLLNSGWLPVKHQDE 294
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-59
Identities = 63/314 (20%), Positives = 119/314 (37%), Gaps = 26/314 (8%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + +++G+G+ V +TG+ AIK N+I + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGL 139
IV++ I + R ++ E L+ V++ L + L ++ G+
Sbjct: 69 IVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 140 KYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
++ + HR++KP NI+ + K+ DFG AR +D T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF----VSLYGTEEY 181
Query: 196 RAPEL------CGSFFSKYTPAIDIWSIGCIFAELLTGKPLF-PGKNVVHQLDIMTDLLG 248
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308
AI+ V+ + S S L +L +L + + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 309 EALADPYFKGLAKV 322
+ A+
Sbjct: 299 QFFAETSDILHRGN 312
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 8e-59
Identities = 75/321 (23%), Positives = 117/321 (36%), Gaps = 67/321 (20%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G +K E+IG G +G V A G+ IK++ + + RE+K L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 82 PDIVEIKH-----------ILLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEHY 128
+IV SR + K +++ E + L Q I+ + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 129 -QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
Q+ +G+ YIH+ + +RDLKP NI ++KI DFGL ND
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246
T Y +PE S Y +D++++G I AELL F L
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL------ 231
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIP--FSQKFPNANPLALRLLERMLAFEPKDR 304
+ I F +K LL+++L+ +P+DR
Sbjct: 232 -------------------------RDGIISDIFDKKEKT-------LLQKLLSKKPEDR 259
Query: 305 PTAEEALADPYFKGLAKVERE 325
P E L + + E
Sbjct: 260 PNTSEILRTLTVWKKSPEKNE 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-58
Identities = 85/313 (27%), Positives = 137/313 (43%), Gaps = 49/313 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLLR 77
Y + + +G G+ G V A++ +T +KVAI+ I+ A + EI++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 136
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 137 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
++Y+H + HRDLKP+N+L DC +KI DFG +++ + T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 305
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK----------- 354
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+ I F + + + AL L++++L +PK R T EEAL
Sbjct: 355 DQI----------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
Query: 312 ADPYFKGLAKVER 324
P+ + +
Sbjct: 399 RHPWLQDEDMKRK 411
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-58
Identities = 72/327 (22%), Positives = 119/327 (36%), Gaps = 55/327 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ ++ + +G+G +GVV A + AIK+I + +++RE+K L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 83 DIVEIKH-------ILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF---F 131
IV + +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------- 183
Q+ ++++H+ + HRDLKP NI D +K+ DFGL D
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 184 -IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242
T V T+ Y +PE + Y+ +DI+S+G I ELL P V
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQMERV----- 234
Query: 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 302
+ VRN K F F P +++ ML+ P
Sbjct: 235 ----------RTLTDVRNLK---------------FPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 303 DRPTAEEALADPYFKGLAKVEREPSAQ 329
+RP A + + F+ L + Q
Sbjct: 270 ERPEAINIIENAVFEDLDFPGKTVLRQ 296
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-58
Identities = 83/308 (26%), Positives = 129/308 (41%), Gaps = 56/308 (18%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRH 81
Y++ IG GSYG G+ + K+++ + +++A + ++ E+ LLR L+H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELKH 64
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHY-QFFLYQLL 136
P+IV ++ R +Y+V E E DL VI E + + QL
Sbjct: 65 PNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 137 RGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
LK H + V HRDLKP N+ + +K+ DFGLAR+ +DT A +V
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KTFVG 178
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
T +Y +PE Y DIWS+GC+ EL P F +
Sbjct: 179 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------------- 221
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIP--FSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
E ++R K + IP +S + ++ RML + RP+ EE
Sbjct: 222 KELAGKIREGKF----------RRIPYRYSDELNE-------IITRMLNLKDYHRPSVEE 264
Query: 310 ALADPYFK 317
L +P
Sbjct: 265 ILENPLIL 272
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 7e-58
Identities = 73/361 (20%), Positives = 140/361 (38%), Gaps = 29/361 (8%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + +++G+G+ V +TG+ AIK N+I + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGL 139
IV++ I + R ++ E L+ V++ L + L ++ G+
Sbjct: 69 IVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 140 KYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
++ + HR++KP NI+ + K+ DFG AR +D + T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEY 181
Query: 196 RAPEL------CGSFFSKYTPAIDIWSIGCIFAELLTGKPLF-PGKNVVHQLDIMTDLLG 248
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308
AI+ V+ + S S L +L +L + + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 309 EALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE--ILEYHPQMLKE 366
+ A+ V S Q +T + T EL+Y++ I+ + +++ E
Sbjct: 299 QFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYN-TATIFHELVYKQTKIISSNQELIYE 357
Query: 367 F 367
Sbjct: 358 G 358
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 8e-58
Identities = 70/297 (23%), Positives = 104/297 (35%), Gaps = 46/297 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRH 81
++ +G GSYG V G A+K+ F D R L E+ ++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 140
P V ++ + E +Y+ EL L Q +A PE +L L L
Sbjct: 117 PCCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
++H+ + H D+KP NI + K+ DFGL + Y APEL
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPEL 227
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
Y A D++S+G E+ L G QL
Sbjct: 228 LQ---GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-------------------- 264
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ P F+ + +L ML +PK R TAE LA P +
Sbjct: 265 ---------RQGYLPPEFTAGLSSE---LRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-57
Identities = 86/316 (27%), Positives = 139/316 (43%), Gaps = 49/316 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLLR 77
Y + + +G G+ G V A++ +T +KVAIK I+ A + EI++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 136
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 137 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
++Y+H + HRDLKP+N+L DC +KI DFG +++ + T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 180
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
Y APE L + Y A+D WS+G I L+G P F Q+ +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR--TQVSLK--------- 229
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+ I F + + + AL L++++L +PK R T EEAL
Sbjct: 230 DQI----------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
Query: 312 ADPYFKGLAKVEREPS 327
P+ + +
Sbjct: 274 RHPWLQDEDMKRKFQD 289
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-56
Identities = 77/338 (22%), Positives = 131/338 (38%), Gaps = 51/338 (15%)
Query: 3 PDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH 62
P + + + Y + ++IE+ IG+G + V A G VA+KK+ IF+
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ-IFDL 70
Query: 63 VSDATR--ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA 119
+ R ++EI LL+ L HP++++ S E ++ +V EL ++ DL ++IK
Sbjct: 71 MDAKARADCIKEIDLLKQLNHPNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKH 125
Query: 120 ---NDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175
L PE + QL L+++H+ V HRD+KP N+ A +K+ D GL R
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+ T A V T +Y +PE + Y DIWS+GC+ E+ + F G
Sbjct: 186 FSSKTTAA---HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240
Query: 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP---FSQKFPNANPLALRL 292
++ P+P +S++ L
Sbjct: 241 -------------MNLYSLCKKIEQCDY----------PPLPSDHYSEELRQ-------L 270
Query: 293 LERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 330
+ + +P+ RP
Sbjct: 271 VNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHH 308
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-54
Identities = 97/336 (28%), Positives = 144/336 (42%), Gaps = 53/336 (15%)
Query: 5 QRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS 64
SS + + + RY I ++GKGS+G V D T ++ A+K IN
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 65 DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKAN 120
D + ILRE++LL+ L HP+I+++ I +D Y+V EL +L I
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAF 177
+ + Q+ G+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ F
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-F 174
Query: 178 NDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
D + T +Y APE L G Y D+WS G I LL+G P F GKN
Sbjct: 175 QQNTK---MKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN- 226
Query: 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLER 295
+ DI+ + + + F ++ + A L+ +
Sbjct: 227 --EYDIL---------KRV----------------ETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 296 MLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPV 331
ML F P R TA + L P+ + + S P
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPS 295
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 7e-54
Identities = 75/361 (20%), Positives = 130/361 (36%), Gaps = 74/361 (20%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR-LLR 80
+ E+++G GS G V + G VA+K++ + L EIKLL
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDD 67
Query: 81 HPDIVEIKHILLPPSRREFKD---IYVVFELMESDLHQVIKANDDLTPEHYQF------- 130
HP+++ +Y+ EL +L ++++ +
Sbjct: 68 HPNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNIL-------------ANADCKLKICDFGLAR-VA 176
L Q+ G+ ++H+ + HRDLKP+NIL + ++ I DFGL + +
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 177 FNDTPTAIFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230
+ + T +RAPEL + T +IDI+S+GC+F +L+ GK
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 290
F K + + + A
Sbjct: 240 FGDKY-----------------SRESNIIRGI---------FSLDEMKCLHDRSLIAEAT 273
Query: 291 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRE 350
L+ +M+ +P RPTA + L P F +K + V+ E E R + +
Sbjct: 274 DLISQMIDHDPLKRPTAMKVLRHPLFWPKSK--KLEFLLKVSD-RLEIENRDPPSALLMK 330
Query: 351 L 351
Sbjct: 331 F 331
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 8e-54
Identities = 86/316 (27%), Positives = 142/316 (44%), Gaps = 52/316 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
RYK + V+GKGS+G V D TG++ A+K I+ + +D +LRE++LL+ L H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 82 PDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 137
P+I+++ F+D Y+V E+ +L I + + + Q+L
Sbjct: 86 PNIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 138 GLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
G+ Y+H + HRDLKP+N+L + D ++I DFGL+ F + D + T +
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-FEASKK---MKDKIGTAY 193
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
Y APE+ Y D+WS G I LL+G P F G N + DI+ +
Sbjct: 194 YIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDIL---------KK 238
Query: 255 IARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
+ +K F ++ + A L+ +ML + P R +A +AL
Sbjct: 239 V----------------EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282
Query: 314 PYFKGLAKVEREPSAQ 329
+ + K +
Sbjct: 283 EWIQTYTKEQISVDVP 298
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-53
Identities = 87/316 (27%), Positives = 140/316 (44%), Gaps = 51/316 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y+ + +G G+YG V D T + AIK I S +++L E+ +L+LL HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+I+++ F+D Y+V E + +L I + Q+L G
Sbjct: 97 NIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ Y+H N+ HRDLKP+N+L D +KI DFGL+ V F + + + T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV-FENQKK---MKERLGTAYY 204
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ KY D+WSIG I LL G P F G+ +I+ +
Sbjct: 205 IAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEIL---------RKV 249
Query: 256 ARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+K F S ++ N + A L+++ML F+ + R +A++AL P
Sbjct: 250 ----------------EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293
Query: 315 YFKGLAKVEREPSAQP 330
+ K + + P
Sbjct: 294 WIKEMCSKKESGIELP 309
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-53
Identities = 75/324 (23%), Positives = 132/324 (40%), Gaps = 45/324 (13%)
Query: 2 QPDQRKKSSADVDFFTEYGEGS---RY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN 57
Q ++ ++ + T+ S R+ K + IG+GS+ V DT T +VA ++
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 58 DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV 116
D S+ R E ++L+ L+HP+IV + + K I +V ELM S L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTY 119
Query: 117 IKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLA 173
+K + + + + Q+L+GL+++HT + HRDLK NI +KI D GLA
Sbjct: 120 LKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ A+ T + APE+ KY ++D+++ G E+ T + +
Sbjct: 180 TLKRASFAKAVIGTPE----FM-APEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSE 231
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 293
Q+ Y KP F + A P ++
Sbjct: 232 CQNAAQI-------------------------YRRVTSGVKPASFDK---VAIPEVKEII 263
Query: 294 ERMLAFEPKDRPTAEEALADPYFK 317
E + +R + ++ L +F+
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-53
Identities = 79/347 (22%), Positives = 126/347 (36%), Gaps = 81/347 (23%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLL 79
+Y ++ IG+GSYGVV A + +T AIK +N + D RI E++L++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQF-------- 130
HP+I + + + + I +V EL L + D +
Sbjct: 86 HHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 131 --------------------------------FLYQLLRGLKYIHTANVFHRDLKPKNIL 158
+ Q+ L Y+H + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 159 --ANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
N ++K+ DFGL++ + T T ++ APE+ + Y P D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 216 SIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 275
S G + LL G FPG N D + + K
Sbjct: 261 SAGVLLHLLLMGAVPFPGVN---DADTI---------SQV----------------LNKK 292
Query: 276 IPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
+ F + + +PLA LL +L +R A AL P+ +
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 7e-53
Identities = 89/361 (24%), Positives = 134/361 (37%), Gaps = 61/361 (16%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIF 60
P + + + RY +GKG + D T E A K + +
Sbjct: 20 APAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL 79
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA 119
++ EI + R L H +V ++VV EL L ++ K
Sbjct: 80 LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKR 134
Query: 120 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
LT +++L Q++ G +Y+H V HRDLK N+ N D ++KI DFGLA D
Sbjct: 135 RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194
Query: 180 ---------TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
TP +Y+ APE+ ++ +D+WSIGCI LL GKP
Sbjct: 195 GERKKVLCGTP------NYI------APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPP 240
Query: 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 290
F + E R++ Y IP + NP+A
Sbjct: 241 FETSCL---------------KETYLRIKK---NEY--------SIP-----KHINPVAA 269
Query: 291 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRE 350
L+++ML +P RPT E L D +F R P F + + +
Sbjct: 270 SLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKP 329
Query: 351 L 351
L
Sbjct: 330 L 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-52
Identities = 84/307 (27%), Positives = 123/307 (40%), Gaps = 61/307 (19%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLR 80
RY +GKG + D T E A K + + ++ EI + R L
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
H +V ++VV EL L ++ K LT +++L Q++ G
Sbjct: 74 HQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND---------TPTAIFWTDYV 190
+Y+H V HRDLK N+ N D ++KI DFGLA D TP +Y+
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI 182
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
APE+ ++ +D+WSIGCI LL GKP F +
Sbjct: 183 ------APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------------- 220
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
E R++ Y IP + NP+A L+++ML +P RPT E
Sbjct: 221 -KETYLRIKK---NEY--------SIP-----KHINPVAASLIQKMLQTDPTARPTINEL 263
Query: 311 LADPYFK 317
L D +F
Sbjct: 264 LNDEFFT 270
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-52
Identities = 65/305 (21%), Positives = 109/305 (35%), Gaps = 43/305 (14%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
Y + +G+G + V G A+K+I D RE + RL H
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNH 85
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLL 136
P+I+ + L + + +++ + L I+ + LT + + L +
Sbjct: 86 PNILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA------IFWTDYV 190
RGL+ IH HRDLKP NIL + + + D G A + W
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 191 ATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
T YRAPEL D+WS+GC+ ++ G+ +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV--------------- 249
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
+K +++ + IP S + +A +LL M+ +P RP
Sbjct: 250 ----------FQKGDSVALAVQNQLSIPQSPRHSSA---LWQLLNSMMTVDPHQRPHIPL 296
Query: 310 ALADP 314
L+
Sbjct: 297 LLSQL 301
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-52
Identities = 89/327 (27%), Positives = 131/327 (40%), Gaps = 64/327 (19%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-----------DIFEHVSDATRILR 71
Y +G G+YG V + + AIK I D I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 72 EIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEH 127
EI LL+ L HP+I+++ + F+D Y+V E E +L + I
Sbjct: 96 EISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAI 184
+ Q+L G+ Y+H N+ HRD+KP+NIL N+ +KI DFGL+ F+
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF-FSKDYK-- 204
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
D + T +Y APE L KY D+WS G I LL G P F G+N DI+
Sbjct: 205 -LRDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDII 256
Query: 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPK 302
+ + +K F + N + A L++ ML ++
Sbjct: 257 ---------KKV----------------EKGKYYFDFNDWKNISDEAKELIKLMLTYDYN 291
Query: 303 DRPTAEEALADPYFKGLAKVEREPSAQ 329
R TAEEAL + K A + +
Sbjct: 292 KRCTAEEALNSRWIKKYANNINKSDQK 318
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 5e-52
Identities = 78/350 (22%), Positives = 132/350 (37%), Gaps = 36/350 (10%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++++E +G G +G V TGE+VAIK+ + R EI++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73
Query: 84 IVEIKHILLPPSRREFKD-IYVVFELMES-DLHQVIKANDD---LTPEHYQFFLYQLLRG 138
+V + + + D + E E DL + + ++ L + L +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L+Y+H + HRDLKP+NI+ KI D G A+ T++V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTLQY 189
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APEL KYT +D WS G + E +TG F Q
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK------------ 235
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL-------ALRLLERMLAFEPKDRPTAE 308
VR + + + FS P N L R L+ ML + + R T
Sbjct: 236 --VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293
Query: 309 EALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILE 358
+ F+ L + + + +T+ + + + + +
Sbjct: 294 QNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQ 343
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 8e-52
Identities = 84/302 (27%), Positives = 124/302 (41%), Gaps = 49/302 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y +E IG+GS+G V A T + A KKI V D R +EI++++ L HP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHP 66
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ + + DIY+V EL +L + + + +L + Y
Sbjct: 67 NIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 142 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
H NV HRDLKP+N L + D LK+ DFGLA V T +Y +P
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPYYVSP 177
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
+ L G Y P D WS G + LL G P F ++M I
Sbjct: 178 QVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVM---------LKI-- 219
Query: 258 VRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
++ F + + N +P A L+ R+L PK R T+ +AL +F
Sbjct: 220 --------------REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265
Query: 317 KG 318
+
Sbjct: 266 EK 267
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-52
Identities = 96/328 (29%), Positives = 144/328 (43%), Gaps = 53/328 (16%)
Query: 5 QRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS 64
SS + + + RY I ++GKGS+G V D T ++ A+K IN
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 65 DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKAN 120
D + ILRE++LL+ L HP+I+++ I +D Y+V EL +L I
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAF 177
+ + Q+ G+ Y+H N+ HRDLKP+NIL DC +KI DFGL+
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 178 NDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
+T D + T +Y APE L G Y D+WS G I LL+G P F GKN
Sbjct: 176 QNT----KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN- 226
Query: 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLER 295
+ DI+ + + + F ++ + A L+ +
Sbjct: 227 --EYDIL---------KRV----------------ETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 296 MLAFEPKDRPTAEEALADPYFKGLAKVE 323
ML F P R TA + L P+ + + E
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-50
Identities = 85/313 (27%), Positives = 135/313 (43%), Gaps = 46/313 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y ++E +GKG++ VV TG + A K IN D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+IV + + +E Y+VF+L+ +L + I A + + + Q+L + Y
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 142 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T Y +P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTPGYLSP 176
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
E L Y+ +DIW+ G I LL G P F ++ Q + I
Sbjct: 177 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY---------AQI-- 219
Query: 258 VRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
K + S ++ P A L++ ML PK R TA++AL P+
Sbjct: 220 --------------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
Query: 317 KGLAKVEREPSAQ 329
+V Q
Sbjct: 266 CNRERVASAIHRQ 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-50
Identities = 79/323 (24%), Positives = 135/323 (41%), Gaps = 53/323 (16%)
Query: 5 QRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS 64
SS + + + + + +G G++G V + +G + IK IN
Sbjct: 4 HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN-KDRSQV 62
Query: 65 DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDL 123
+I EI++L+ L HP+I++I + ++ ++Y+V E E +L + I +
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQA- 116
Query: 124 TPEHY-----QFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARV 175
+ + Q++ L Y H+ +V H+DLKP+NIL + +KI DFGLA +
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 176 AFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234
+D T+ T Y APE T DIWS G + LLTG F G
Sbjct: 177 FKSDE----HSTNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGT 228
Query: 235 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 294
+ ++ + K ++ + P A+ LL+
Sbjct: 229 S---LEEVQ---------QKA----------------TYKEPNYAVECRPLTPQAVDLLK 260
Query: 295 RMLAFEPKDRPTAEEALADPYFK 317
+ML +P+ RP+A + L +FK
Sbjct: 261 QMLTKDPERRPSAAQVLHHEWFK 283
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 8e-50
Identities = 79/318 (24%), Positives = 131/318 (41%), Gaps = 51/318 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-------DIFEHVSDATRILREIKL 75
Y+ +E++G+G VV T ++ A+K I+ E L+E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 76 LRLL-RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLY 133
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTP 187
Query: 194 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
Y APE + S Y +D+WS G I LL G P F + Q+ ++
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML------ 238
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAE 308
I F S ++ + + L+ R L +P+ R TAE
Sbjct: 239 ---RMI----------------MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279
Query: 309 EALADPYFKGLAKVEREP 326
EALA P+F+ E
Sbjct: 280 EALAHPFFQQYVVEEVRH 297
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-49
Identities = 87/329 (26%), Positives = 138/329 (41%), Gaps = 52/329 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y ++E +GKG++ VV TG + A K IN D ++ RE ++ R L+HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
+IV + ++ Y+VF+L+ +L + I A + + + Q+L
Sbjct: 89 NIVRLHDS--------IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 140
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ Y H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T Y
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTPGY 196
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
+PE L Y+ +DIW+ G I LL G P F ++ Q +
Sbjct: 197 LSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY---------AQ 241
Query: 255 IARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
I K + S ++ P A L++ ML PK R TA++AL
Sbjct: 242 I----------------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285
Query: 314 PYFKGLAKVEREPSAQPVTKMEFEFERRR 342
P+ +V Q +F RR
Sbjct: 286 PWICNRERVASAIHRQDTVDCLKKFNARR 314
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-49
Identities = 70/320 (21%), Positives = 132/320 (41%), Gaps = 62/320 (19%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------------------------DI 59
+Y +++ IGKGSYGVV AY+ A+K ++
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 60 FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIK 118
+ ++ +EI +L+ L HP++V++ +L P+ +Y+VFEL+ + +V
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVPT 130
Query: 119 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178
L+ + +F+ L++G++Y+H + HRD+KP N+L D +KI DFG++
Sbjct: 131 -LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--NEF 187
Query: 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVV 237
A+ V T + APE ++ A+D+W++G + G+ F + +
Sbjct: 188 KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI- 245
Query: 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 297
++++++ P P+ L+ RML
Sbjct: 246 --------------MCLHSKIKSQALE-----------FP---DQPDIAEDLKDLITRML 277
Query: 298 AFEPKDRPTAEEALADPYFK 317
P+ R E P+
Sbjct: 278 DKNPESRIVVPEIKLHPWVT 297
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 9e-49
Identities = 75/318 (23%), Positives = 132/318 (41%), Gaps = 55/318 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
Y++ E +G G + +V TG++ A K I I RE+ +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 79 LRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
+RHP+I+ + I F++ + ++ EL+ +L + + LT + FL Q
Sbjct: 65 IRHPNIITLHDI--------FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ 116
Query: 135 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+L G+ Y+H+ + H DLKP+NI+ + ++K+ DFG+A + +
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIF 172
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T + APE+ + D+WSIG I LL+G F G+ + + +
Sbjct: 173 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGET---KQETL------- 220
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
I+ V F + F N + LA + R+L +PK R T +
Sbjct: 221 --TNISAVN----------------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQ 262
Query: 310 ALADPYFKGLAKVEREPS 327
+L + K + +
Sbjct: 263 SLEHSWIKAIRRRNVRGE 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 83/329 (25%), Positives = 132/329 (40%), Gaps = 51/329 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y++ E +GKG++ VV G++ A IN D ++ RE ++ RLL+HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
+IV + + Y++F+L+ +L + I A + + + Q+L
Sbjct: 71 NIVRLHDS--------ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ + H V HR+LKP+N+L +K+ DFGLA + W + T Y
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGY 179
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
+PE L Y +D+W+ G I LL G P F ++ Q + +
Sbjct: 180 LSPEVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLY---------QQ 224
Query: 255 IARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
I K F S ++ P A L+ +ML P R TA EAL
Sbjct: 225 I----------------KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268
Query: 314 PYFKGLAKVEREPSAQPVTKMEFEFERRR 342
P+ + V Q +F RR
Sbjct: 269 PWISHRSTVASCMHRQETVDCLKKFNARR 297
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-48
Identities = 76/326 (23%), Positives = 131/326 (40%), Gaps = 55/326 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
Y E +G G + VV + TG + A K I I RE+ +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 79 LRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
++HP+++ + + +++ + ++ EL+ +L + + LT E FL Q
Sbjct: 71 IQHPNVITLHEV--------YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 135 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+L G+ Y+H+ + H DLKP+NI+ ++KI DFGLA + +
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIF 178
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T + APE+ + D+WSIG I LL+G F G + + +
Sbjct: 179 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL------- 226
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
++ V F + F N + LA + R+L +PK R T ++
Sbjct: 227 --ANVSAVN----------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268
Query: 310 ALADPYFKGLAKVEREPSAQPVTKME 335
+L P+ K + ME
Sbjct: 269 SLQHPWIKPKDTQQALSRKASAVNME 294
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-48
Identities = 72/306 (23%), Positives = 127/306 (41%), Gaps = 62/306 (20%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
+K+ ++GKGS+ V A TG +VAIK I+ R+ E+K+ L+HP
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
I+E+ + + +Y+V E+ + ++++ +K + + F++Q++ G+
Sbjct: 72 SILELYNYFEDSNY-----VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND---------TPTAIFWTDYVA 191
Y+H+ + HRDL N+L + +KI DFGLA TP +Y+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP------NYI- 179
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
+PE+ S + D+WS+GC+F LL G+P F V
Sbjct: 180 -----SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTV--------------- 217
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+ +V +P + A L+ ++L P DR + L
Sbjct: 218 KNTLNKVVLADYE-----------MP-----SFLSIEAKDLIHQLLRRNPADRLSLSSVL 261
Query: 312 ADPYFK 317
P+
Sbjct: 262 DHPFMS 267
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-48
Identities = 73/326 (22%), Positives = 130/326 (39%), Gaps = 55/326 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
Y I E +G G + +V + TG + A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
+ H +++ + + +++ + ++ EL+ +L + + L+ E F+ Q
Sbjct: 72 VLHHNVITLHDV--------YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 135 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+L G+ Y+HT + H DLKP+NI+ +K+ DFGLA + + +
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIF 179
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T + APE+ + D+WSIG I LL+G F G + + +
Sbjct: 180 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL------- 227
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
I V F + F + + LA + ++L E + R T +E
Sbjct: 228 --ANITSVS----------------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQE 269
Query: 310 ALADPYFKGLAKVEREPSAQPVTKME 335
AL P+ + + + V +E
Sbjct: 270 ALRHPWITPVDNQQAMVRRESVVNLE 295
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-47
Identities = 59/324 (18%), Positives = 101/324 (31%), Gaps = 71/324 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL-RLLRH 81
+ + E IG G +G V G AIK+ D LRE+ L +H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLT---PEHY-QFFLYQLL 136
+V + E + + E L I N + E + L Q+
Sbjct: 71 SHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 137 RGLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVAF 177
RGL+YIH+ ++ H D+KP NI A+ KI D G
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-I 184
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
+ + A E+ ++ + P DI+++ +PL +
Sbjct: 185 SSPQV------EEGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQW 237
Query: 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 297
H++ R+ + Q LL+ M+
Sbjct: 238 HEI------------------------------RQGRLPRIPQVLS---QEFTELLKVMI 264
Query: 298 AFEPKDRPTAEEALADPYFKGLAK 321
+P+ RP+A + ++
Sbjct: 265 HPDPERRPSAMALVKHSVLLSASR 288
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-47
Identities = 75/326 (23%), Positives = 130/326 (39%), Gaps = 55/326 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
Y I E +G G + +V + TG + A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
+ HP+I+ + + +++ + ++ EL+ +L + + L+ E F+ Q
Sbjct: 72 VLHPNIITLHDV--------YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 135 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+L G+ Y+HT + H DLKP+NI+ +K+ DFGLA + + +
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIF 179
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T + APE+ + D+WSIG I LL+G F G + + +
Sbjct: 180 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL------- 227
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
I V F + F + LA + ++L E + R T +E
Sbjct: 228 --ANITAVS----------------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQE 269
Query: 310 ALADPYFKGLAKVEREPSAQPVTKME 335
AL P+ + + + V +E
Sbjct: 270 ALRHPWITPVDTQQAMVRRESVVNLE 295
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-47
Identities = 84/341 (24%), Positives = 149/341 (43%), Gaps = 58/341 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y++ + IGKG++ V A TG +VAIK I+ + + ++ RE++++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV++ ++ K +Y++ E ++ + A+ + + + Q++ ++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H + HRDLK +N+L +AD +KI DFG + F Y APEL
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF----CGAPPYAAPEL-- 184
Query: 203 SFFS--KYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
F KY P +D+WS+G I L++G F G+N+ E RV
Sbjct: 185 --FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---------------KELRERVL 227
Query: 260 NEKAR--RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
K R Y+S LL+R L P R T E+ + D +
Sbjct: 228 RGKYRIPFYMS------------------TDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269
Query: 318 -GLAKVEREPSAQPVTKMEFEF-----ERRRITKEDVRELI 352
G + E +P +P + + ++E+++E +
Sbjct: 270 AGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL 310
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-47
Identities = 73/311 (23%), Positives = 129/311 (41%), Gaps = 56/311 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLL 76
+Y ++VIG+G VV TG + A+K + + RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 77 RLLR-HPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFF 131
R + HP I+ + ++ +++VF+LM +L + L+ + +
Sbjct: 154 RQVAGHPHIITLIDS--------YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
+ LL + ++H N+ HRDLKP+NIL + + ++++ DFG + +
Sbjct: 206 MRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH-LEPGE---KLRELCG 261
Query: 192 TRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
T Y APE L S Y +D+W+ G I LL G P F + Q+ ++
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILML---- 314
Query: 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 306
I + F S ++ + + L+ R+L +P+ R T
Sbjct: 315 -----RMI----------------MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT 353
Query: 307 AEEALADPYFK 317
AE+AL P+F+
Sbjct: 354 AEQALQHPFFE 364
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-47
Identities = 75/306 (24%), Positives = 127/306 (41%), Gaps = 40/306 (13%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + + +G+G+YG V A + T E VA+K I D+ V I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ + Y+ E +L I+ + + Q F +QL+ G+ Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
++ +D+WS G + +L G+ + ++
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQP-------------------------SD 213
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF-KGLA 320
+ Y KK + +K L LL ++L P R T + D ++ K L
Sbjct: 214 SCQEYSDWKEKKTYLNPWKKID---SAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
Query: 321 KVEREP 326
K + P
Sbjct: 271 KGAKRP 276
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 7e-47
Identities = 79/336 (23%), Positives = 130/336 (38%), Gaps = 59/336 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLL 79
Y++ EVIGKG + VV + TG++ A+K ++ + RE + +L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 80 RHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVI----KANDDLTPEHYQFF 131
+HP IVE+ + +Y+VFE M+ +DL I A + +
Sbjct: 84 KHPHIVELLET--------YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 188
+ Q+L L+Y H N+ HRD+KP +L +K+ FG+A
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV---AGG 192
Query: 189 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
V T + APE + Y +D+W G I LL+G F G +
Sbjct: 193 RVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF---- 241
Query: 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 306
E I + + +++ + + A L+ RML +P +R T
Sbjct: 242 -----EGIIKGK----------------YKMNPRQWSHISESAKDLVRRMLMLDPAERIT 280
Query: 307 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRR 342
EAL P+ K + + + +F RR
Sbjct: 281 VYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-47
Identities = 65/320 (20%), Positives = 119/320 (37%), Gaps = 56/320 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRH 81
+Y + +++G+GSYG V D+ T + A+K + + + + +EI+LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLLRGL 139
+++++ +L + + +Y+V E + +++ + QL+ GL
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-----DYVATRW 194
+Y+H+ + H+D+KP N+L LKI G+A T +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ---- 178
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
PE+ + ++ +DIWS G + TG F G N+ +
Sbjct: 179 --PPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---------------YK 220
Query: 254 AIARVRNEKAR--RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+ P LL+ ML +EP R + +
Sbjct: 221 LFENIGKGSYAIPGDCG------------------PPLSDLLKGMLEYEPAKRFSIRQIR 262
Query: 312 ADPYF-KGLAKVEREPSAQP 330
+F K E P
Sbjct: 263 QHSWFRKKHPPAEAPVPIPP 282
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-46
Identities = 69/317 (21%), Positives = 122/317 (38%), Gaps = 55/317 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
+ I +GKG +G V A + + +A+K + E ++ REI++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P+I+ + + R IY++ E +L++ ++ + + F+ +L L
Sbjct: 74 PNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-----DYVATRWY 195
Y H V HRD+KP+N+L +LKI DFG + P+ T DY+
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRTMCGTLDYL----- 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
PE+ + +D+W G + E L G P F + E
Sbjct: 180 -PPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---------------TETH 221
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
R+ N + P P + + L+ ++L + P R + + P+
Sbjct: 222 RRIVNVDLK-----------FP-----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265
Query: 316 FKGLAKVEREPSAQPVT 332
K ++ P Q
Sbjct: 266 VKANSRRVLPPVYQSTQ 282
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 76/331 (22%), Positives = 126/331 (38%), Gaps = 52/331 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y I E +G G++GVV + TG K IN + D + EI ++ L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQLLR 137
++ + F+D + ++ E + +L I A D E ++ Q
Sbjct: 109 KLINLHDA--------FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 138 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
GLK++H ++ H D+KP+NI+ +KI DFGLA D AT +
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI----VKVTTATAEF 216
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ D+W+IG + LL+G F G++ L+ + + +
Sbjct: 217 AAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETL---------QNV 262
Query: 256 ARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
R F F + +P A ++ +L EP+ R T +AL P
Sbjct: 263 KRCD----------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
Query: 315 YFKGLAKVEREPSAQPVTKMEFEFERRRITK 345
+ KG + + +
Sbjct: 307 WLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-46
Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 61/305 (20%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
++I +GKG +G V A + ++ +A+K + E ++ RE+++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P+I+ + +R +Y++ E +++ ++ + ++ +L L
Sbjct: 69 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-------TPTAIFWTDYVATR 193
Y H+ V HRD+KP+N+L + +LKI DFG + A + T DY+
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL------DYL--- 174
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
PE+ + +D+WS+G + E L GKP F +
Sbjct: 175 ---PPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------------K 217
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPN-ANPLALRLLERMLAFEPKDRPTAEEALA 312
I+RV FP+ A L+ R+L P RP E L
Sbjct: 218 RISRVE--------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
Query: 313 DPYFK 317
P+
Sbjct: 258 HPWIT 262
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-46
Identities = 73/354 (20%), Positives = 136/354 (38%), Gaps = 52/354 (14%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
++ + +Y ++V+G G G V + RTG+K A+K + D
Sbjct: 12 LEVLFQGPEPKKYAVTDDYQLS-----KQVLGLGVNGKVLECFHRRTGQKCALKLLYD-- 64
Query: 61 EHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI- 117
+ + +E+ + P IV I + + + + ++ E ME +L I
Sbjct: 65 -----SPKARQEVDHHWQASGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQ 118
Query: 118 -KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLA 173
+ + T + + ++++H+ N+ HRD+KP+N+L D LK+ DFG A
Sbjct: 119 ERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ + T +Y APE+ G KY + D+WS+G I LL G P F
Sbjct: 179 KETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYS 231
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRL 292
I + R+R + F + ++ + A +L
Sbjct: 232 NT---GQAISPGMK--------RRIRLGQ-------------YGFPNPEWSEVSEDAKQL 267
Query: 293 LERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 346
+ +L +P +R T + + P+ V + P E + + +E
Sbjct: 268 IRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEE 321
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 74/306 (24%), Positives = 118/306 (38%), Gaps = 49/306 (16%)
Query: 18 EYGEGSR-YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
EY E + +G+GS+G V D +TG + A+KK+ E E+
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVAC 104
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQ 134
L P IV + + RE + + EL+E S L Q+IK L + ++L Q
Sbjct: 105 AGLSSPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLGQ 158
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARV--AFNDTPTAIFWTDYVA 191
L GL+Y+HT + H D+K N+L ++D + +CDFG A + +
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
T + APE+ +DIWS C+ +L G + + + + P
Sbjct: 219 TETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQ---YFRGPLCLKIASEPP 273
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
P + IP P+ PL + ++ L EP R +A E
Sbjct: 274 P--------------------IREIP-----PSCAPLTAQAIQEGLRKEPVHRASAMELR 308
Query: 312 ADPYFK 317
Sbjct: 309 RKVGKA 314
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-45
Identities = 73/345 (21%), Positives = 135/345 (39%), Gaps = 53/345 (15%)
Query: 12 DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILR 71
D F+ Y ++ +G+GS+ + ++ + A+K I+ +
Sbjct: 3 DSPFYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQK 54
Query: 72 EIKLLRLLR-HPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPE 126
EI L+L HP+IV++ + F D ++V EL+ +L + IK +
Sbjct: 55 EITALKLCEGHPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSET 106
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTA 183
+ + +L+ + ++H V HRDLKP+N+L N + ++KI DFG AR+ D
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165
Query: 184 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242
T Y APE L + Y + D+WS+G I +L+G+ F +
Sbjct: 166 --LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEP 301
+++ + I KK F + + N + A L++ +L +P
Sbjct: 221 AVEIM-----KKI----------------KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDP 259
Query: 302 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 346
R + + + +++ P P K
Sbjct: 260 NKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKA 304
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 90/361 (24%), Positives = 146/361 (40%), Gaps = 64/361 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
Y I E +G+GS+G V A +T +KVA+K I+ + + R+ REI L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+++ ++ P DI +V E +L I +T + + F Q++ ++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW-----YRA 197
H + HRDLKP+N+L + + +KI DFGL+ I Y A
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLS---------NIMTDGNFLKTSCGSPNYAA 175
Query: 198 PELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PE+ Y P +D+WS G + +L G+ F + + P
Sbjct: 176 PEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI---------------PNLFK 218
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
+V + +P +P A L+ RM+ +P R T +E DP+F
Sbjct: 219 KVNSCVYV-----------MP-----DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
Query: 317 KGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGF 376
V +P+ E + V +L E + + + E L E
Sbjct: 263 ----NVNLPDYLRPME----EVQGSYADSRIVSKLG--EAMGFSEDYIVEALRSDENNEV 312
Query: 377 M 377
Sbjct: 313 K 313
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 54/340 (15%), Positives = 114/340 (33%), Gaps = 58/340 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---------------DIFEHVSDATR 68
Y+I + +G + + + + A+KK D S
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 69 ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEH 127
E++++ +++ + + I+ ++Y+++E ME+ + + + L +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 128 YQ--------FFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFN 178
+ +L YIH N+ HRD+KP NIL + + ++K+ DFG +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES----E 200
Query: 179 DTPTAIFWT-----DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+++ PE + S +DIWS+G + F
Sbjct: 201 YMVDKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 293
K + +L I E + + + + L
Sbjct: 255 KISLVEL-----------FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303
Query: 294 ERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTK 333
+ L P +R T+E+AL + + ++ + K
Sbjct: 304 KLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 76/317 (23%), Positives = 128/317 (40%), Gaps = 44/317 (13%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + + +G+G+YG V A + T E VA+K I D+ V I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ + Y+ E +L I+ + + Q F +QL+ G+ Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL-- 178
Query: 203 SFFS--KYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
++ +D+WS G + +L G+ +
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP------------------------- 211
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF-KG 318
++ + Y KK + +K L LL ++L P R T + D ++ K
Sbjct: 212 SDSCQEYSDWKEKKTYLNPWKKID---SAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
Query: 319 LAKVEREPSAQPVTKME 335
L K + P E
Sbjct: 269 LKKGAKRPRVTSGGVSE 285
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-45
Identities = 70/314 (22%), Positives = 126/314 (40%), Gaps = 40/314 (12%)
Query: 24 RYKI-EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-H 81
Y++ E+V+G+G++ V + + T ++ A+K I + +R+ RE+++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGH 70
Query: 82 PDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 137
+++E+ F++ Y+VFE M + I + +
Sbjct: 71 RNVLELIEF--------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 138 GLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARV----AFNDTPTAIFWTDYV 190
L ++H + HRDLKP+NIL N +KICDF L +
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 191 ATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
+ Y APE+ S Y D+WS+G I LL+G P F G+ +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 306
++ K F + + + + A L+ ++L + K R +
Sbjct: 243 PACQNMLFESIQEGK-------------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLS 289
Query: 307 AEEALADPYFKGLA 320
A + L P+ +G A
Sbjct: 290 AAQVLQHPWVQGCA 303
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-45
Identities = 79/307 (25%), Positives = 123/307 (40%), Gaps = 65/307 (21%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
Y + + +G G++G V TG KVA+K +N + +I REI+ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
I+++ ++ P+ D ++V E + +L I + + + Q+L + Y
Sbjct: 72 HIIKLYQVISTPT-----DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND--------TPTAIFWTDYVATR 193
H V HRDLKP+N+L +A KI DFGL+ + + +P
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----------- 175
Query: 194 WYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
Y APE+ Y P +DIWS G I LL G F ++V P
Sbjct: 176 -YAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---------------P 217
Query: 253 EAIARVRNEKAR--RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
++R YL+ LL ML +P R T ++
Sbjct: 218 TLFKKIRGGVFYIPEYLN------------------RSVATLLMHMLQVDPLKRATIKDI 259
Query: 311 LADPYFK 317
+FK
Sbjct: 260 REHEWFK 266
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-45
Identities = 52/345 (15%), Positives = 98/345 (28%), Gaps = 82/345 (23%)
Query: 15 FFTEYGEGSR-YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK------------------- 54
+E GE R V+G+ A D TGE +
Sbjct: 64 VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 123
Query: 55 ----KINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME 110
++ ++ A LR I L++ P ++ + L + ++ M+
Sbjct: 124 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 183
Query: 111 SDLHQVIKANDDLTPEHYQF-------FLYQLLRGLKYIHTANVFHRDLKPKNILANADC 163
S+L + + H Q++R L +H + H L+P +I+ +
Sbjct: 184 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 243
Query: 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDI 214
+ + F + +R + PEL + T + D
Sbjct: 244 GVFLTGFEHLVRDGARVVS-------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296
Query: 215 WSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKK 274
W++G + + + R K
Sbjct: 297 WALGLVIYWIWCADLPITKDAALG--------------------------GSEWIFRSCK 330
Query: 275 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
IP LLE L + +DR +A+ P ++ L
Sbjct: 331 NIP---------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-45
Identities = 76/307 (24%), Positives = 122/307 (39%), Gaps = 55/307 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+++E +G+G+ +V T + A+K + D + EI +L L HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHP 108
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+I+++K I F+ I +V EL+ +L I + + Q+L
Sbjct: 109 NIIKLKEI--------FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ Y+H + HRDLKP+N+L D LKI DFGL+++ + T Y
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGY 216
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
APE L G Y P +D+WS+G I LL G F + +
Sbjct: 217 CAPEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF-----------RR 262
Query: 255 IARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
I F S + + A L+ +++ +PK R T +AL
Sbjct: 263 I----------------LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306
Query: 314 PYFKGLA 320
P+ G A
Sbjct: 307 PWVTGKA 313
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 64/333 (19%), Positives = 116/333 (34%), Gaps = 58/333 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR- 80
R ++ V+ +G + V A D +G + A+K++ I++E+ ++ L
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSG 84
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME---SDLHQVI---KANDDLTPEHYQFFLYQ 134
HP+IV+ L E L + + ++ L+ + YQ
Sbjct: 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 135 LLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA- 191
R ++++H + HRDLK +N+L + +K+CDFG A + +
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 192 --------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
T YR PE+ +S DIW++GCI L + F +
Sbjct: 205 EEEITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---- 259
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 301
I +Y IP L+ ML P
Sbjct: 260 ------------RIVNG------KY--------SIPPHDTQYTV---FHSLIRAMLQVNP 290
Query: 302 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKM 334
++R + E + + +A P+T++
Sbjct: 291 EERLSIAEVVHQL--QEIAAARNVNPKSPITEL 321
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-44
Identities = 69/328 (21%), Positives = 123/328 (37%), Gaps = 52/328 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDL-HQVIKANDDLTPEHYQFFLYQLLR 137
+V + F+D + +++E M +L +V ++ ++ + ++ Q+ +
Sbjct: 215 TLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 138 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
GL ++H N H DLKP+NI+ +LK+ DFGL T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEF 322
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ D+WS+G + LL+G F G+N + + +
Sbjct: 323 AAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETL---------RNV 368
Query: 256 ARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
F + + ++L +P R T +AL P
Sbjct: 369 KSCD----------------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412
Query: 315 YFKGLAKVEREPSAQPVTKMEFEFERRR 342
+ R+ + +
Sbjct: 413 WLTPGNAPGRDSQIPSSRYTKIRDSIKT 440
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-44
Identities = 67/308 (21%), Positives = 125/308 (40%), Gaps = 55/308 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+Y I E +G+G +G+V +T + + K + +D + +EI +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHR 61
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLH-QVIKANDDLTPEHYQFFLYQLLR 137
+I+ + F+ + ++FE + D+ ++ + +L +++Q+
Sbjct: 62 NILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 138 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L+++H+ N+ H D++P+NI+ +KI +FG AR + Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEY 169
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
APE + A D+WS+G + LL+G F + I+ E
Sbjct: 170 YAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAET---NQQII---------EN 214
Query: 255 IARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
I F + F + A+ ++R+L E K R TA EAL
Sbjct: 215 IMNAE----------------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258
Query: 314 PYFKGLAK 321
P+ K +
Sbjct: 259 PWLKQKIE 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 85/342 (24%), Positives = 129/342 (37%), Gaps = 58/342 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY + IG G++GV D T E VA+K I + + REI R LRHP+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPN 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV K ++L P+ + ++ E +L++ I + + +FF QLL G+ Y
Sbjct: 78 IVRFKEVILTPT-----HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 143 HTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTP--TAIFWTDYVATRWYRAP 198
H+ + HRDLK +N L + +LKICDFG ++ + + + V T Y AP
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 186
Query: 199 ELCGSFFS--KYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
E+ +Y D+WS G +L G F + I
Sbjct: 187 EV----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR-----------KTI 231
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
R+ + K IP + P L+ R+ +P R + E +
Sbjct: 232 QRILSVKYS-----------IPDDIRIS---PECCHLISRIFVADPATRISIPEIKTHSW 277
Query: 316 F-KGLAKVEREPSAQPVTKMEFEF------ERRRITKEDVRE 350
F K L S E E +I E
Sbjct: 278 FLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP 319
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 82/363 (22%), Positives = 139/363 (38%), Gaps = 57/363 (15%)
Query: 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREI 73
+Y +V+G G G V ++ RT EK A+K + D + RE+
Sbjct: 58 AIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREV 105
Query: 74 KLL-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHY--- 128
+L R + P IV I + K + +V E ++ +L I+ D + +
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD---QAFTER 161
Query: 129 --QFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTA 183
+ + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ +
Sbjct: 162 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-- 219
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
T T +Y APE+ G KY + D+WS+G I LL G P F +
Sbjct: 220 --LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH-------- 267
Query: 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPK 302
SP R+R + F + ++ + L+ +L EP
Sbjct: 268 ---GLAISPGMKTRIRMGQ-------------YEFPNPEWSEVSEEVKMLIRNLLKTEPT 311
Query: 303 DRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQ 362
R T E + P+ KV + P E + + +E L + +
Sbjct: 312 QRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIK 371
Query: 363 MLK 365
+ K
Sbjct: 372 IKK 374
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 4e-44
Identities = 77/321 (23%), Positives = 122/321 (38%), Gaps = 56/321 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHP 82
Y+++E IG GSY V T + A+K I+ EI+ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
+I+ +K + + D +YVV ELM+ +L I + L+ + +
Sbjct: 77 NIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 139 LKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
++Y+H V HRDLKP NIL + ++ICDFG A+ + T
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCYTAN 185
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
+ APE L Y A DIWS+G + +LTG F +I+
Sbjct: 186 FVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL---------A 233
Query: 254 AIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
I + + + A L+ +ML +P R TA L
Sbjct: 234 RI----------------GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277
Query: 313 DPYFKGLAKVEREPSAQPVTK 333
P+ ++ + +
Sbjct: 278 HPWIVHWDQLPQYQLNRQDAP 298
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-44
Identities = 84/311 (27%), Positives = 125/311 (40%), Gaps = 47/311 (15%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
E V+GKG+YG+V + D ++AIK+I + + EI L + L+
Sbjct: 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLK 77
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLL 136
H +IV+ S E I + E + S L + + F+ Q+L
Sbjct: 78 HKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 137 RGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRW 194
GLKY+H + HRD+K N+L N LKI DFG + R+A + T F T
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF----TGTLQ 188
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
Y APE+ Y A DIWS+GC E+ TGKP P + M
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAM----------- 235
Query: 255 IARVRNEKARRYLSSMRKKKP-IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
+ M K P IP + + A + + +P R A + L D
Sbjct: 236 -----------FKVGMFKVHPEIP-----ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279
Query: 314 PYFKGLAKVER 324
+ K +K ++
Sbjct: 280 EFLKVSSKKKK 290
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 49/344 (14%), Positives = 87/344 (25%), Gaps = 70/344 (20%)
Query: 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------------------ 61
V+G+ A D TGE +
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 62 -----HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQV 116
+ A LR I L++ P ++ + L + ++ M+S+L
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 117 IKANDDLTPEHYQ-------FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAELLT 226
F A A + + T A D W++G +
Sbjct: 255 FEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 227 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 286
+ E I R K IP
Sbjct: 313 ADLPNTDDAALG------------GSEWI--------------FRSCKNIP--------- 337
Query: 287 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 330
LLE L + +DR +A+ P ++ L
Sbjct: 338 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLY 381
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 68/305 (22%), Positives = 119/305 (39%), Gaps = 59/305 (19%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLL 79
+Y++ ++G G +G V S VAIK + + + + TR+ E+ LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 80 RH--PDIVEIKHILLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQL 135
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 136 LRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
L +++ H V HRD+K +NIL + + +LK+ DFG + DT +TD+ TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTV----YTDFDGTRV 213
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y PE + +Y + +WS+G + +++ G F +I+ +
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQVFFR--- 263
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
+ +S L+ LA P DRPT EE
Sbjct: 264 -----------QRVS------------------SECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 314 PYFKG 318
P+ +
Sbjct: 295 PWMQD 299
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 69/310 (22%), Positives = 125/310 (40%), Gaps = 60/310 (19%)
Query: 23 SRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+ Y + + +G+G + VV TG++ A K + IL EI +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 82 -PDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHY-----QFF 131
P ++ + + +++ I ++ E ++ + E
Sbjct: 88 CPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRL 136
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 188
+ Q+L G+ Y+H N+ H DLKP+NIL +KI DFG++R + +
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE----LRE 192
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248
+ T Y APE+ + T A D+W+IG I LLT F G++ +
Sbjct: 193 IMGTPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETY----- 242
Query: 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTA 307
I++V + + + F + + LA ++ +L P+ RPTA
Sbjct: 243 ----LNISQVN----------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA 282
Query: 308 EEALADPYFK 317
E L+ + +
Sbjct: 283 EICLSHSWLQ 292
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 74/328 (22%), Positives = 126/328 (38%), Gaps = 62/328 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
+ Y++ ++GKG +G V + + +VAIK I + +SD+ E+ LL
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 79 LR----HPDIVEIKHILLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFL 132
+ HP ++ + + +V E DL I L + F
Sbjct: 91 VGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVA 191
Q++ +++ H+ V HRD+K +NIL + K+ DFG + +D P +TD+
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEP----YTDFDG 200
Query: 192 TRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
TR Y PE +Y +WS+G + +++ G F +I+ L P
Sbjct: 201 TRVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILEAELHFP 253
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
++S P L+ R LA +P RP+ EE
Sbjct: 254 --------------AHVS------------------PDCCALIRRCLAPKPSSRPSLEEI 281
Query: 311 LADPYFK-GLAKVEREPSAQPVTKMEFE 337
L DP+ + V PS + +
Sbjct: 282 LLDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-43
Identities = 107/488 (21%), Positives = 173/488 (35%), Gaps = 81/488 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
Y + + +G G++G V TG KVA+K +N + +I REI+ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
I+++ ++ P DI++V E + +L I N L + + Q+L G+ Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW-----YR 196
H V HRDLKP+N+L +A KI DFGL+ + Y
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLS---------NMMSDGEFLRTSCGSPNYA 182
Query: 197 APELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ Y P +DIWS G I LL G F +V P
Sbjct: 183 APEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---------------PTLF 225
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
++ + P NP + LL+ ML +P R T ++ +
Sbjct: 226 KKICDGIFY-----------TP-----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269
Query: 316 FKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTG 375
FK P + + I E ++E+ E E + + L
Sbjct: 270 FKQDLPKYLFPE-------DPSYSSTMIDDEALKEVC--EKFECSEEEVLSCLYNRNHQ- 319
Query: 376 FMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLS 435
D + +L + A S P + T + V ++
Sbjct: 320 -------DPLAVAY-HLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVA 371
Query: 436 KCSIKEVEKPPMDRTSGIPMARLPIQVPQGMQGAARPGKVVSSVLRYNNCGAAAAAEALD 495
+ ++ + G++ +RP +++ V R A + LD
Sbjct: 372 ETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCR--------AIKQLD 423
Query: 496 QRRVVRNP 503
V NP
Sbjct: 424 YEWKVVNP 431
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 72/363 (19%), Positives = 129/363 (35%), Gaps = 72/363 (19%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLLR 77
+Y +G G++G V +A D ++V +K I D + ++ EI +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQL 135
+ H +I+++ I +V E S DL I + L + QL
Sbjct: 85 RVEHANIIKVLDIFENQ-----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ + Y+ ++ HRD+K +NI+ D +K+ DFG A +F+T + T Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYT-FCGTIEY 195
Query: 196 RAPELCGSFFS--KYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
APE+ Y P +++WS+G L+ + F
Sbjct: 196 CAPEV----LMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------------------- 232
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+ P S + L+ +L P+ R T E+ +
Sbjct: 233 -----LEETVEAAI------HPPYLVS-------KELMSLVSGLLQPVPERRTTLEKLVT 274
Query: 313 DPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSE 372
DP+ QPV ++ +E + ++ LE + L + + E
Sbjct: 275 DPWVT-----------QPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQE 323
Query: 373 PTG 375
G
Sbjct: 324 LCG 326
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 3e-42
Identities = 68/335 (20%), Positives = 116/335 (34%), Gaps = 45/335 (13%)
Query: 23 SRYKIEEVIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
Y++ VIGKG V A TGE V +++IN T + E+ + +L
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKA--NDDLTPEHYQFFLYQLL 136
HP+IV + + + +++VV M S +I D + + L +L
Sbjct: 85 HPNIVPYRATFIADN-----ELWVVTSFMAYGS-AKDLICTHFMDGMNELAIAYILQGVL 138
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTDYVAT 192
+ L YIH HR +K +IL + D K+ + + F V
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP----------LF----------P 232
+ +PE+ Y DI+S+G EL G L
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258
Query: 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP--FSQKFPNANPLAL 290
+ + ++ + + ++ R + P FS F +
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH------ 312
Query: 291 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 325
+E+ L P RP+A L +FK + + E
Sbjct: 313 -FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-42
Identities = 77/354 (21%), Positives = 131/354 (37%), Gaps = 75/354 (21%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
++ + K +A +D + +V+G G G V ++ RT EK A+K + D
Sbjct: 4 VKSGLQIKKNAIIDDY--------KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC- 54
Query: 61 EHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI- 117
+ RE++L R + P IV I + K + +V E ++ +L I
Sbjct: 55 ------PKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQ 107
Query: 118 -KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLA 173
+ + T + + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG
Sbjct: 108 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF- 166
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
A E G KY + D+WS+G I LL G P F
Sbjct: 167 -----------------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPPFYS 200
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRL 292
+ SP R+R + F + ++ + L
Sbjct: 201 NHG-----------LAISPGMKTRIRMGQ-------------YEFPNPEWSEVSEEVKML 236
Query: 293 LERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 346
+ +L EP R T E + P+ KV + P E + + +E
Sbjct: 237 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 290
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 76/316 (24%), Positives = 123/316 (38%), Gaps = 56/316 (17%)
Query: 23 SRYKIE--EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
S Y + E++G G +G V +T TG K+A K I + D + EI ++ L
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLD 144
Query: 81 HPDIVEIKHILLPPSRREF---KDIYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQL 135
H +++++ F DI +V E ++ +L I E F+ Q+
Sbjct: 145 HANLIQLYDA--------FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 136 LRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
G++++H + H DLKP+NIL ++KI DFGLAR T
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK----LKVNFGTP 252
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
+ APE + F + D+WS+G I LL+G F G N + +
Sbjct: 253 EFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETL--------- 297
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
I R ++F + + A + ++L E R +A EAL
Sbjct: 298 NNILACR----------------WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEAL 341
Query: 312 ADPYFKGLAKVEREPS 327
P+ R +
Sbjct: 342 KHPWLSDHKLHSRLSA 357
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 57/306 (18%), Positives = 101/306 (33%), Gaps = 52/306 (16%)
Query: 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVE 86
I + + + + S +I+ + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ---FFLYQLLRGLKYI 142
+Y+ +L +L + L + Q+ ++++
Sbjct: 126 QLQ-----PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFND---------TPTAIFWTDYVATR 193
H+ + HRDLKP NI D +K+ DFGL D P T V T+
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y +PE + Y+ +DI+S+G I ELL
Sbjct: 241 LYMSPEQIHG--NNYSHKVDIFSLGLILFELLY--SFSTQ-------------------- 276
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
E+ R K P+ F+QK+P + +++ ML+ P +RP A + + +
Sbjct: 277 ------MERVRIITDVRNLKFPLLFTQKYPQEH----MMVQDMLSPSPTERPEATDIIEN 326
Query: 314 PYFKGL 319
F+ L
Sbjct: 327 AIFENL 332
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-40
Identities = 63/307 (20%), Positives = 116/307 (37%), Gaps = 43/307 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
+ +G G+ G V +TG +A+K++ + + RIL ++ +L+ P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPY 85
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYI 142
IV+ + + D+++ ELM + ++ K PE +++ L Y+
Sbjct: 86 IVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 143 HTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-- 199
V HRD+KP NIL + ++K+CDFG++ + Y APE
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSAGCAAYMAPERI 196
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
Y D+WS+G EL TG+ + +++T +L P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVLQEEPP------ 248
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
+ FS F + ++ L + + RP + L + K
Sbjct: 249 ------------LLPGHMGFSGDFQS-------FVKDCLTKDHRKRPKYNKLLEHSFIKR 289
Query: 319 LAKVERE 325
+E +
Sbjct: 290 YETLEVD 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-40
Identities = 83/373 (22%), Positives = 137/373 (36%), Gaps = 91/373 (24%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
RY + +G G + V ++D + + VA+K + EH ++ EI+LL+ +R+
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRNS 93
Query: 83 DIVEIKHILLPPSRREFKD-------IYVVFELMESDLHQVIKANDD--LTPEHYQFFLY 133
D + ++ +FK I +VFE++ L + I ++ L + +
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 134 QLLRGLKYIHT-ANVFHRDLKPKNILANAD------------------------------ 162
Q+L+GL Y+HT + H D+KP+NIL + +
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 163 -------------------CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
K+KI D G A +T+ + TR YR+ E+
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL-- 265
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI------MTDLLGTPSPEAIAR 257
S Y DIWS C+ EL TG LF + + +LLG + I
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV- 324
Query: 258 VRNEKARRY------LSSMRKKKPIPFSQKFPNANPL-------ALRLLERMLAFEPKDR 304
+ ++ + L + K KP + L ML P+ R
Sbjct: 325 -AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383
Query: 305 PTAEEALADPYFK 317
TA E L P+
Sbjct: 384 ATAAECLRHPWLN 396
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-40
Identities = 66/298 (22%), Positives = 112/298 (37%), Gaps = 54/298 (18%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-----NDIFEHVSDATRILREIKLLRLLR 80
+ E+ IGKG +G+V + VAIK + E + RE+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI-KANDDLTPEHYQFFLYQLLRG 138
HP+IV++ ++ P +V E + DL+ + + + + G
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 139 LKYIHTAN--VFHRDLKPKNIL-----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
++Y+ N + HRDL+ NI NA K+ DFGL++ + + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSVSGLLGN---- 189
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
+W APE G+ YT D +S I +LTG+ F +
Sbjct: 190 FQW-MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------------- 235
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
+ I +R E R IP + P ++E + +PK RP
Sbjct: 236 IKFINMIREEGLR---------PTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSY 279
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 67/333 (20%), Positives = 122/333 (36%), Gaps = 53/333 (15%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
EV+GKG +G TGE + +K++ E L+E+K++R L HP+++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHPNVL 70
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
+ + ++ K + + E ++ L +IK+ D F + G+ Y+H
Sbjct: 71 K----FIGVLYKD-KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT-----------PTAIFWTDYVAT 192
+ N+ HRDL N L + + + DFGLAR+ ++ P V
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
++ APE+ Y +D++S G + E++ P P
Sbjct: 186 PYWMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNADPD--------------YLPRT 229
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+ P PN P + R +P+ RP+ +
Sbjct: 230 MDFGLNVRGFLD---------RYCP-----PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
Query: 313 --DPYFKGLAK-VEREPSAQPVTKMEFEFERRR 342
+ LA + P + + + +E RR
Sbjct: 276 WLETLRMHLAGHLPLGPQLEQLDRGFWETYRRG 308
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 66/315 (20%), Positives = 119/315 (37%), Gaps = 55/315 (17%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+I E+IGKG +G V GE VAI+ I+ ++ RE+ R RH ++V
Sbjct: 36 EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 86 E-IKHILLPPSRREFKDIYVVFELME-SDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYI 142
+ + PP + ++ L + L+ V+ A L + ++++G+ Y+
Sbjct: 93 LFMGACMSPP------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR--APEL 200
H + H+DLK KN+ + + K+ I DFGL ++ + W APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 201 -------CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
++ D++++G I+ EL + F + E
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP----------------AE 249
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR-LLERMLAFEPKDRPTAEEALA 312
AI + + + +L AFE ++RPT + +
Sbjct: 250 AIIWQMGTGMKP---------NLS-----QIGMGKEISDILLFCWAFEQEERPTFTKLMD 295
Query: 313 DPYFKGLAKVEREPS 327
+ L K R S
Sbjct: 296 --MLEKLPKRNRRLS 308
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 44/297 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+Y E IG+G+ G V +A D TG++VAI+++N + I+ EI ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+IV S +++VV E + L V+ + + L+ L++
Sbjct: 78 NIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEF 131
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+ V HRD+K NIL D +K+ DFG TP + V T ++ APE+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 202 GSFFSKYTPAIDIWSIGCIFA-ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
Y P +DIWS+G I A E++ G+P P N + L + + +P
Sbjct: 189 TR--KAYGPKVDIWSLG-IMAIEMIEGEP--PYLN-ENPLRALYLIATNGTP-------- 234
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ P S F + L R L + + R +A+E L + K
Sbjct: 235 ----------ELQNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 89/380 (23%), Positives = 146/380 (38%), Gaps = 80/380 (21%)
Query: 1 MQPDQRKKSSADVDFFTEYGEG---SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN 57
M R S D D + + + IG GS+G V A D R E VAIKK++
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 58 -DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQV 116
+ I++E++ L+ LRHP+ ++ + L ++V E +
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TAWLVMEYCLGSASDL 143
Query: 117 IKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-- 173
++ + E + L+GL Y+H+ N+ HRD+K NIL + +K+ DFG A
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 174 ---RVAFNDTPTAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA-ELLTGK 228
+F TP +W APE+ +Y +D+WS+G I EL K
Sbjct: 204 MAPANSFVGTP---YWM---------APEVILAMDEGQYDGKVDVWSLG-ITCIELAERK 250
Query: 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP------FSQKF 282
P P N A L + + + P +S+ F
Sbjct: 251 P----------------------PLF-----NMNAMSALYHIAQNES-PALQSGHWSEYF 282
Query: 283 PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRR 342
N ++ L P+DRPT+E L + +P T + +R +
Sbjct: 283 RN-------FVDSCLQKIPQDRPTSEVLLKHRFVL---------RERPPTVIMDLIQRTK 326
Query: 343 ITKEDVRELIYREILEYHPQ 362
++ L YR++ + Q
Sbjct: 327 DAVRELDNLQYRKMKKILFQ 346
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 83/374 (22%), Positives = 150/374 (40%), Gaps = 70/374 (18%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M D +S ++D +++ E++G G+YG V +TG+ AIK ++
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 61 EHVSDATRILREIKLLR-LLRHPDIVEIKHILLPPSRREFKD-IYVVFELME----SDLH 114
+ + I +EI +L+ H +I + + D +++V E +DL
Sbjct: 62 DEEEE---IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 115 QVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA- 173
+ K N L E + ++LRGL ++H V HRD+K +N+L + ++K+ DFG++
Sbjct: 119 KNTKGNT-LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 174 --------RVAFNDTPTAIFWTDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCIFA 222
R F TP +W APE C + Y D+WS+G I A
Sbjct: 178 QLDRTVGRRNTFIGTP---YWM---------APEVIACDENPDATYDFKSDLWSLG-ITA 224
Query: 223 -ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 281
E+ G P P + +H + + + P+P + K +S+K
Sbjct: 225 IEMAEGAP--PLCD-MHPMRALFLIPRNPAP-------------------RLKSKKWSKK 262
Query: 282 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERR 341
F + +E L RP E+ + P+ + Q +++ +R
Sbjct: 263 FQS-------FIESCLVKNHSQRPATEQLMKHPFIRDQPN-----ERQVRIQLKDHIDRT 310
Query: 342 RITKEDVRELIYRE 355
+ + + E Y
Sbjct: 311 KKKRGEKDETEYEY 324
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 44/302 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
K IG+G+YG V +G+ +A+K+I + ++L ++ ++R P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 84 IVEIKHILLPPSRREFKDIYVVFELM----ESDLHQVIKANDDLTPEHY-QFFLYQLLRG 138
IV+ L D ++ ELM + V DD+ PE ++
Sbjct: 83 IVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 139 LKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L ++ + HRD+KP NIL + +K+CDFG++ + +I T R Y A
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRDAGCRPYMA 193
Query: 198 PE--LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
PE + Y D+WS+G EL TG+ +P N V D +T ++ P
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGDPP--- 248
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ + FS F N + L + RP +E L P+
Sbjct: 249 -------------QLSNSEEREFSPSFIN-------FVNLCLTKDESKRPKYKELLKHPF 288
Query: 316 FK 317
Sbjct: 289 IL 290
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 62/288 (21%), Positives = 111/288 (38%), Gaps = 40/288 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ + IG GS+G V + VA+K +N E+ +LR RH +I+
Sbjct: 27 TVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
P + +V + E S L+ + A++ + Q RG+ Y+H
Sbjct: 84 LFMGYSTAP------QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCG 202
++ HRDLK NI + D +KI DFGLA + + + + + APE +
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ Y+ D+++ G + EL+TG+ + N + + I +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN---------------NRDQIIEMVGRG 241
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLAL-RLLERMLAFEPKDRPTAEE 309
+ P K + P + RL+ L + +RP+
Sbjct: 242 SLS-----------PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPR 278
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 68/301 (22%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
+ +G+G+YGVV +G+ +A+K+I + + R+L ++ +R + P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 84 IVEIKHILLPPSRREFKDIYVVFELM----ESDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
V L D+++ ELM + QVI + + +++ L
Sbjct: 68 TVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 140 KYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+++H+ +V HRD+KP N+L NA ++K+CDFG++ + + + Y AP
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKDIDAGCKPYMAP 178
Query: 199 E--LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
E Y+ DIWS+G EL + FP + + ++ PSP+
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSPQL-- 234
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
FS +F + + L K+RPT E + P+F
Sbjct: 235 -----------------PADKFSAEFVD-------FTSQCLKKNSKERPTYPELMQHPFF 270
Query: 317 K 317
Sbjct: 271 T 271
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-39
Identities = 76/292 (26%), Positives = 120/292 (41%), Gaps = 57/292 (19%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++EEV+G+G++GVVC A + VAIK+I S+ + E++ L + HP+IV
Sbjct: 11 EVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHYQFFLYQLLRGLKY 141
++ L P + +V E E L+ V+ + T H + Q +G+ Y
Sbjct: 65 KLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 142 IHTAN---VFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
+H+ + HRDLKP N+L A LKICDFG A T+ + + A
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM------TNNKGSAAWMA 171
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PE+ S Y+ D++S G I E++T + F I
Sbjct: 172 PEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIG--------------GPAFRIMW 215
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
+ R P+ N L+ R + +P RP+ EE
Sbjct: 216 AVHNGTRP---------PLI-----KNLPKPIESLMTRCWSKDPSQRPSMEE 253
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-39
Identities = 78/337 (23%), Positives = 131/337 (38%), Gaps = 32/337 (9%)
Query: 5 QRKKSSADVDFFTEYGEGSR--YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH 62
QRK+ A + + GE ++ +G G+ GVV +G +A K I +
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIK 71
Query: 63 VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKAND 121
+ +I+RE+++L P IV +I + E M+ L QV+K
Sbjct: 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAG 126
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
+ + +++GL Y+ + HRD+KP NIL N+ ++K+CDFG++ D+
Sbjct: 127 RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDS 185
Query: 181 PTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239
F V TR Y +PE L G + Y+ DIWS+G E+ G+ P +
Sbjct: 186 MANSF----VGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238
Query: 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP---IPFSQKFPNANPLALR----- 291
+ + + E R R M + P N P L
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 298
Query: 292 -----LLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323
+ + L P +R ++ + + K E
Sbjct: 299 LEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 51/289 (17%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
I+E IG GS+G V A + G VA+K + + H LRE+ +++ LRHP+I
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 85 VE-IKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGL 139
V + + PP ++ +V E + L++++ + L Y + +G+
Sbjct: 97 VLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 140 KYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
Y+H N + HR+LK N+L + +K+CDFGL+R+ + ++ T + A
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMA 207
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PE+ D++S G I EL T + + N + +A
Sbjct: 208 PEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLN---------------PAQVVAA 250
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
V + R IP N NP ++E EP RP+
Sbjct: 251 VGFKCKR---------LEIP-----RNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 75/303 (24%), Positives = 127/303 (41%), Gaps = 44/303 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
IG+GS G+VC A + +G +VA+K ++ + E+ ++R +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHF 102
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
++VE+ S ++++V+ E ++ L ++ L E +L+ L Y
Sbjct: 103 NVVEMYK-----SYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAY 156
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H V HRD+K +IL D ++K+ DFG + V T ++ APE+
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 202 GSFFSKYTPAIDIWSIGCIFA-ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
S Y +DIWS+G I E++ G+P P + + M L +P P
Sbjct: 214 SR--SLYATEVDIWSLG-IMVIEMVDGEP--PYFS-DSPVQAMKRLRDSPPP-------- 259
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320
+ K S + LERML +P++R TA+E L P+
Sbjct: 260 ----------KLKNSHKVSPVLRD-------FLERMLVRDPQERATAQELLDHPFLLQTG 302
Query: 321 KVE 323
E
Sbjct: 303 LPE 305
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 80/312 (25%), Positives = 131/312 (41%), Gaps = 39/312 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y+++EVIG G+ VV +AY EKVAIK+I ++ + + +L+EI+ + HP
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTP-----EHYQFFLY 133
+IV + ++++V +L+ D+ + I A + L
Sbjct: 74 NIVSYYTSFVVKD-----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVA 191
++L GL+Y+H HRD+K NIL D ++I DFG++ D +V
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
T + APE+ Y DIWS G EL TG + H+ M L+ T
Sbjct: 189 TPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY------HKYPPMKVLMLTL- 240
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+N+ K+ + + F ++ L +P+ RPTA E L
Sbjct: 241 -------QNDPPSLETGVQDKEMLKKYGKSFRK-------MISLCLQKDPEKRPTAAELL 286
Query: 312 ADPYFKGLAKVE 323
+F+ E
Sbjct: 287 RHKFFQKAKNKE 298
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 75/298 (25%), Positives = 118/298 (39%), Gaps = 58/298 (19%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPD 83
+EE+IG G +G V A G++VA+K + T + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ ++ + L + +V E L++V+ + P+ + Q+ RG+ Y+
Sbjct: 68 IIALRGVCLKEPN-----LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYL 121
Query: 143 HTAN---VFHRDLKPKNIL--------ANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
H + HRDLK NIL ++ LKI DFGLAR T +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA---- 177
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
W APE+ + S ++ D+WS G + ELLTG+ F G +
Sbjct: 178 YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID---------------G 219
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
V K PIP +L+E +P RP+
Sbjct: 220 LAVAYGVAMNKLA---------LPIP-----STCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 45/348 (12%), Positives = 96/348 (27%), Gaps = 74/348 (21%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAY-----DTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
+ ++G+G++ V A D + +K +K + + + ++ L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERL 121
Query: 77 RLLRHPDIVEIKHILLPPSRREFKD-IYVVFELME-SDLHQVIK-----ANDDLTPEHYQ 129
+ ++ F++ +V EL L I +
Sbjct: 122 KPSMQHMFMKFYSAH------LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 130 FFLYQLLRGLKYIHTANVFHRDLKPKNIL-----------ANADCKLKICDFGLARVAFN 178
F ++L ++ +H + H D+KP N + + L + D G +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 179 DTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
IF T ++ E L + ID + + +L G +
Sbjct: 236 FPKGTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMK------ 285
Query: 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 297
V+NE + ++ P + ML
Sbjct: 286 --------------------VKNEGGECKPEGLFRRLPHL---------DMWNEFFHVML 316
Query: 298 AFEPKDRPTAEEALA---DPYFKGLAKVEREPSAQPVTKMEFEFERRR 342
+ + L F+ + + + E +R R
Sbjct: 317 NIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSR 364
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 88/340 (25%), Positives = 127/340 (37%), Gaps = 80/340 (23%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M + + E + E IGKGS+G V D RT + VAIK I D+
Sbjct: 1 MAHSPVQSGLPGMQNLKADPE-ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLE 58
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQV 116
E + I +EI +L P + + L + ++++ E + DL +
Sbjct: 59 EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLWIIMEYLGGGSALDLLE- 112
Query: 117 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA--- 173
L L ++L+GL Y+H+ HRD+K N+L + ++K+ DFG+A
Sbjct: 113 ---PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169
Query: 174 ------RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-ELLT 226
R F TP FW APE+ S Y DIWS+G I A EL
Sbjct: 170 TDTQIKRNTFVGTP---FWM---------APEVIKQ--SAYDSKADIWSLG-ITAIELAR 214
Query: 227 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP-----FSQK 281
G+P +L M L P K P +S+
Sbjct: 215 GEPPH------SELHPMKVLFLIP----------------------KNNPPTLEGNYSKP 246
Query: 282 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
+E L EP RPTA+E L + AK
Sbjct: 247 LKE-------FVEACLNKEPSFRPTAKELLKHKFILRNAK 279
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 87/327 (26%), Positives = 142/327 (43%), Gaps = 51/327 (15%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
P +R+ D D T+ E + + E +G+GSYG V A TG+ VAIK++ +
Sbjct: 9 NPPRRQLKKLDEDSLTKQPE-EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVES 66
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVI 117
+ + I++EI +++ P +V+ + D+++V E SD+ ++
Sbjct: 67 DLQE---IIKEISIMQQCDSPHVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIIRLR 118
Query: 118 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
N LT + L L+GL+Y+H HRD+K NIL N + K+ DFG VA
Sbjct: 119 --NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG---VAG 173
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-ELLTGKPLFPGKNV 236
T T + T ++ APE+ Y DIWS+G I A E+ GKP P +
Sbjct: 174 QLTDTMAKRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLG-ITAIEMAEGKP--PYAD- 227
Query: 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296
+H + + + P P +KP +S F + +++
Sbjct: 228 IHPMRAIFMIPTNPPP------------------TFRKPELWSDNFTD-------FVKQC 262
Query: 297 LAFEPKDRPTAEEALADPYFKGLAKVE 323
L P+ R TA + L P+ + V
Sbjct: 263 LVKSPEQRATATQLLQHPFVRSAKGVS 289
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 67/317 (21%), Positives = 124/317 (39%), Gaps = 67/317 (21%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++I +G G++G V A + TG A K I + + + EI++L HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPY 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
IV++ ++++ E + +++ + LT Q Q+L L
Sbjct: 78 IVKLLGAYYHDG-----KLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLEAL 130
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVAFNDTPTAIFWTDYV 190
++H+ + HRDLK N+L + +++ DFG++ R +F TP +W
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP---YWM--- 184
Query: 191 ATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-ELLTGKPLFPGKNVVHQLDIMTDL 246
APE+ K Y DIWS+G I E+ +P P ++ + ++ +
Sbjct: 185 ------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP--PHHE-LNPMRVLLKI 234
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
+ P P +S +F + L+ L P+ RP+
Sbjct: 235 AKSDPP------------------TLLTPSKWSVEFRD-------FLKIALDKNPETRPS 269
Query: 307 AEEALADPYFKGLAKVE 323
A + L P+ + +
Sbjct: 270 AAQLLEHPFVSSITSNK 286
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 82/320 (25%), Positives = 128/320 (40%), Gaps = 63/320 (19%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT---RILREIKLLRL 78
RYKI + +G G V A DT KVAIK I R RE+
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQ 67
Query: 79 LRHPDIVEIKHILLPPSRREFKDI-------YVVFELME-SDLHQVIKANDDLTPEHYQF 130
L H +IV + D+ Y+V E +E L + I+++ L+ +
Sbjct: 68 LSHQNIVSMI------------DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN 115
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
F Q+L G+K+ H + HRD+KP+NIL +++ LKI DFG+A+ + T T++V
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ---TNHV 172
Query: 191 -ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
T Y +PE DI+SIG + E+L G+P F G
Sbjct: 173 LGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNG---------------- 214
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-TAE 308
+ +IA + ++ P + + ++ R + +R T +
Sbjct: 215 ETAVSIA----------IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQ 264
Query: 309 EALADPYFKGLAKVEREPSA 328
E D L+ V E A
Sbjct: 265 EMKDD-----LSSVLHENRA 279
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 46/289 (15%), Positives = 93/289 (32%), Gaps = 52/289 (17%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ + G + + G + +K + + E LR+ HP++
Sbjct: 13 NFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 85 VEIK-HILLPPSRREFKDIYVVFELMES-DLHQVI--KANDDLTPEHYQFFLYQLLRGLK 140
+ + PP+ ++ M L+ V+ N + F + RG+
Sbjct: 70 LPVLGACQSPPAPH----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 141 YIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
++HT + L ++++ + D +I + + + W AP
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM---YA----PAWV-AP 177
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
E L + D+WS + EL+T + F + + E +
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIGMK 222
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
V E R IP P +P +L++ + +P RP
Sbjct: 223 VALEGLR---------PTIP-----PGISPHVSKLMKICMNEDPAKRPK 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 75/303 (24%), Positives = 115/303 (37%), Gaps = 40/303 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++E IGKG +G V GE+VA+K + R EI +LRH +I+
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLRHENIL 99
Query: 86 -----EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
+ K +++V + E L + +T E GL
Sbjct: 100 GFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGL 152
Query: 140 KYIHTANVF--------HRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IFWTDYV 190
++H V HRDLK KNIL + I D GLA + T T I V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 191 ATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
T+ Y APE L S K+ + DI+++G +F E+ + G + +QL +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLV 271
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
PS E + +V E+ R IP + A + +++ R T
Sbjct: 272 PSDPSVEEMRKVVCEQKLR--------PNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 307 AEE 309
A
Sbjct: 324 ALR 326
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 76/300 (25%), Positives = 111/300 (37%), Gaps = 34/300 (11%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++ + IGKG YG V + GEKVA+K E S EI L+RH +I
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTT-EEASWFRE--TEIYQTVLMRHENI 93
Query: 85 VE-IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+ I + +Y++ + E+ L+ +K+ L + Y + GL ++
Sbjct: 94 LGFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHL 150
Query: 143 HTANVF--------HRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IFWTDYVATR 193
HT HRDLK KNIL + I D GLA +DT I V T+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 194 WYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
Y PE L S + + D++S G I E+ G +QL +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQLPYHDLVPSD 269
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
PS E + + K R P +L+ A P R TA
Sbjct: 270 PSYEDMREIVCIKKLR--------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 82/308 (26%), Positives = 129/308 (41%), Gaps = 59/308 (19%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT---RILREIKLLRL 78
RY++ E++G G V A D R VA+K + + D + R RE +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAA 68
Query: 79 LRHPDIVEI--------KHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ 129
L HP IV + LP Y+V E ++ L ++ +TP+
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 130 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189
+ + L + H + HRD+KP NI+ +A +K+ DFG+AR A D+ ++ T
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAA 178
Query: 190 V-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248
V T Y +PE D++S+GC+ E+LTG+P F G
Sbjct: 179 VIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGD-------------- 222
Query: 249 TPSPEAIA--RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP- 305
SP ++A VR + PIP S + + ++ + LA P++R
Sbjct: 223 --SPVSVAYQHVRED-------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQ 267
Query: 306 TAEEALAD 313
TA E AD
Sbjct: 268 TAAEMRAD 275
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 75/318 (23%), Positives = 115/318 (36%), Gaps = 53/318 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT---RILREIKLLRLLR 80
Y++ ++G+G G V A DT VA+K +++ SD R+ RE + L+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE--TLSSDPVFRTRMQREARTAGRLQ 92
Query: 81 HPDIVEIKHILLPPSRREFKDI-YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
P +V I H E YV L+ DL +++ L P + Q+
Sbjct: 93 EPHVVPI-H-----DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV-ATRWYRA 197
L H A HRD+KP+NIL +AD + DFG+A ++ T T +Y A
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ---LGNTVGTLYYMA 203
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PE S T DI+++ C+ E LTG P + G + A
Sbjct: 204 PERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLS---------------VMGAH 246
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-PTAEEALADPYF 316
+ S P ++ R +A P+DR T + A
Sbjct: 247 INQA-------------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA--- 290
Query: 317 KGLAKVEREPSAQPVTKM 334
T +
Sbjct: 291 --AHAALATADQDRATDI 306
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 63/305 (20%), Positives = 107/305 (35%), Gaps = 40/305 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ E +GKG YG V + GE VA+K + R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 86 -----EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
++ ++++ E L+ ++ L + + GL
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 140 KYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYV 190
++H + HRDLK KNIL + + I D GLA + + + + V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 191 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
T+ Y APE L + +DIW+ G + E+ G ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVV 237
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
PS E + +V +R IP +L++ P R T
Sbjct: 238 PNDPSFEDMRKVVCVDQQR--------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 307 AEEAL 311
A
Sbjct: 290 ALRIK 294
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 70/313 (22%), Positives = 114/313 (36%), Gaps = 61/313 (19%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+Y+++ I G G + A D G V +K + + + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
HP IV+I + + R Y+V E + L + L +L ++L L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
Y+H+ + + DLKP+NI+ + +LK+ D G N T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY------GTPGFQAPE 247
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
+ + T A DI+++G A L P G+ V P + + +
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPEDDPVLKT- 293
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLAL-RLLERMLAFEPKDRP-TAEEALADPYFK 317
+ RLL R + +P+ R TAEE A
Sbjct: 294 ---------------------------YDSYGRLLRRAIDPDPRQRFTTAEEMSAQ---- 322
Query: 318 GLAKVEREPSAQP 330
L V RE AQ
Sbjct: 323 -LTGVLREVVAQD 334
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 68/304 (22%), Positives = 114/304 (37%), Gaps = 42/304 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++ EV +G +G V A E VA+K + + E+ L ++H +I+
Sbjct: 27 QLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 86 -----EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
E + D++++ E L +KAN ++ + RGL
Sbjct: 82 QFIGAEKR------GTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGL 134
Query: 140 KYIHTA----------NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189
Y+H + HRD+K KN+L + I DFGLA F +A
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHGQ 193
Query: 190 VATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
V TR Y APE+ +F ID++++G + EL + G + L ++
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL-RLLERMLAFEPKDRP 305
PS E + V K +R P+ +A L +E + + R
Sbjct: 254 GQHPSLEDMQEVVVHKKKR---------PVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 306 TAEE 309
+A
Sbjct: 305 SAGC 308
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 29/240 (12%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK--KINDI 59
P Q +K + DF K +++G+GS+ V A + T + AIK + I
Sbjct: 20 PPPQPRKKRPE-DF----------KFGKILGEGSFSTVVLARELATSREYAIKILEKRHI 68
Query: 60 FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQ 115
+ + + RE ++ L HP V++ F+D +Y ++ +L +
Sbjct: 69 IKE-NKVPYVTRERDVMSRLDHPFFVKLYF--------TFQDDEKLYFGLSYAKNGELLK 119
Query: 116 VIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175
I+ +F+ +++ L+Y+H + HRDLKP+NIL N D ++I DFG A+V
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV 179
Query: 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
++ A + +V T Y +PEL + D+W++GCI +L+ G P F N
Sbjct: 180 LSPESKQARANS-FVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGN 236
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 49/298 (16%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K + +GKG++G V TGE VA+KK+ REI++L+ L+H
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQH 70
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
+IV+ K + RR ++ ++ E + L ++ + + + + Q+ +G+
Sbjct: 71 DNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
+Y+ T HRDL +NIL + ++KI DFGL +V D +
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF------FKVKEPGESPI 181
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
WY APE SK++ A D+WS G + EL T + K+ + M +
Sbjct: 182 FWY-APE--SLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQG 234
Query: 253 EAIARVRNEKARRYLSS-MRKKKPIPFSQKFPNANPLALRLLERML---AFEPKDRPT 306
+ + L + R +P P + ++ M RP+
Sbjct: 235 Q----MIVFHLIELLKNNGRLPRP-------DGC-PDEIYMI--MTECWNNNVNQRPS 278
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 49/298 (16%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K + +GKG++G V TGE VA+KK+ REI++L+ L+H
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQH 101
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
+IV+ K + RR ++ ++ E + L ++ + + + + Q+ +G+
Sbjct: 102 DNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
+Y+ T HRDL +NIL + ++KI DFGL +V D Y
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY------YKVKEPGESPI 212
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
WY APE SK++ A D+WS G + EL T + K+ + M +
Sbjct: 213 FWY-APE--SLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQG 265
Query: 253 EAIARVRNEKARRYLSS-MRKKKPIPFSQKFPNANPLALRLLERML---AFEPKDRPT 306
+ + L + R +P P + ++ M RP+
Sbjct: 266 Q----MIVFHLIELLKNNGRLPRP-------DGC-PDEIYMI--MTECWNNNVNQRPS 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 68/302 (22%), Positives = 117/302 (38%), Gaps = 57/302 (18%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLL 79
K +G+G +G V TGE+VA+K + + +EI++LR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIEILRNL 80
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 137
H +IV+ K I + I ++ E + S L + + N + + + + Q+ +
Sbjct: 81 YHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT----- 192
G+ Y+ + HRDL +N+L ++ ++KI DFGL + D Y
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVKDDRDS 191
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
WY APE SK+ A D+WS G ELLT + + + ++G
Sbjct: 192 PVFWY-APE--CLMQSKFYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPT 243
Query: 251 SPEAIARVRNEKARRYLSS---MRKKKPIPFSQKFPNANPLALRLLERML---AFEPKDR 304
+ + + L + P P + L M F+P +R
Sbjct: 244 HGQ----MTVTRLVNTLKEGKRLPC----------PPNCPDEVYQL--MRKCWEFQPSNR 287
Query: 305 PT 306
+
Sbjct: 288 TS 289
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 45/239 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ ++ +G G YG V + VA+K + E + L+E +++ ++HP
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 69
Query: 83 DIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLY 133
++V+ LL PP Y++ E M +L ++ + +++ +
Sbjct: 70 NLVQ----LLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFW 186
Q+ ++Y+ N HRDL +N L + +K+ DFGL+R+ DT TA I W
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
T APE ++K++ D+W+ G + E+ T G +PG + V L+
Sbjct: 179 T---------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 72/299 (24%), Positives = 119/299 (39%), Gaps = 52/299 (17%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K +GKG++G V TG VA+K++ REI++L+ L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQILKALHS 83
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
IV+ + + P R + + +V E + S L ++ + L + Q+ +G+
Sbjct: 84 DFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
+Y+ + HRDL +NIL ++ +KI DFGLA++ D YV
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY------YVVREPGQSPI 194
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVVHQLDIMTDLLGTP 250
WY APE + ++ D+WS G + EL T K P + + D
Sbjct: 195 FWY-APE--SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD--VPA 249
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML---AFEPKDRPT 306
+ + E+ +R + P A P + L M A P+DRP+
Sbjct: 250 LSRLLELL--EEGQR----LPA----------PPACPAEVHEL--MKLCWAPSPQDRPS 290
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 35/231 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
K+ + IGKG +G V G KVA+K I + DAT L E ++ LR
Sbjct: 21 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 72
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 137
H ++V+ LL E +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQ----LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF---WTDYVATRW 194
++Y+ N HRDL +N+L + D K+ DFGL + A + T WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 66/312 (21%), Positives = 120/312 (38%), Gaps = 49/312 (15%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
K+ E+IG+G YG V D VA+K + + + + I + L+ H +I
Sbjct: 16 KLLELIGRGRYGAVYKGSLD---ERPVAVKVFSF--ANRQNFIN-EKNIYRVPLMEHDNI 69
Query: 85 V-----EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+ + + + +V E + L + + + + + RG
Sbjct: 70 ARFIVGDER-----VTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH-SVTRG 123
Query: 139 LKYIHTANVF---------HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189
L Y+HT HRDL +N+L D I DFGL+ + D
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 190 -----VATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVV- 237
V T Y APE L G+ +D++++G I+ E+ LFPG++V
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS-QKFPNANPLALRLLERM 296
+Q+ T++ P+ E + + + + +R P + ++ A +E
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQR--------PKFPEAWKENSLAVRSLKETIEDC 295
Query: 297 LAFEPKDRPTAE 308
+ + R TA+
Sbjct: 296 WDQDAEARLTAQ 307
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K +V+G G++G V GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ +G+
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------R 193
Y+ + HRDL +N+L +KI DFGLA++ + Y A +
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE------YHAEGGKVPIK 184
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
W A E YT D+WS G EL+T G + G + L+
Sbjct: 185 WM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 34/234 (14%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGE--KVAIKKI-NDIFEHVSDATRILREIKLLRLLRH 81
++ E +G GS+GVV +D +G+ VA+K + D+ +RE+ + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
+++ + ++L P + +V EL L ++ + + Q+ G+
Sbjct: 81 RNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
Y+ + HRDL +N+L +KI DFGL R + YV
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEHRKVPF 188
Query: 193 RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
W APE S ++ A D W G E+ T G+ + G N ++H++D
Sbjct: 189 AWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 66/298 (22%), Positives = 124/298 (41%), Gaps = 49/298 (16%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
IGKGS+G VC T + A+K +N E ++ + +E+++++ L HP +V +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEHPFLVNL 80
Query: 88 KHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
+ F+D +++V +L+ DL ++ N E + F+ +L+ L Y+
Sbjct: 81 WY--------SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCG 202
+ HRD+KP NIL + + I DF +A + +T T+ Y APE
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM----AGTKPYMAPEMFSS 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ Y+ A+D WS+G ELL G+ + +R+
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPY-------------------------HIRSST 223
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-PTAEEALADPYFKGL 319
+ + + + + + + + LL+++L P R + PY +
Sbjct: 224 SSKEIVHTFETTVVTYPSAWS---QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 69/301 (22%), Positives = 106/301 (35%), Gaps = 57/301 (18%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLL 79
K +G+G +G V + TGE VA+K + R +EI +LR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQHRSGWKQEIDILRTL 90
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
H I++ K + +V E + L + + + F Q+ G
Sbjct: 91 YHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEG 146
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------ 192
+ Y+H + HRDL +N+L + D +KI DFGLA+ Y
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY------YRVREDGDSP 200
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
WY APE K+ A D+WS G ELLT + +L+G
Sbjct: 201 VFWY-APE--CLKEYKFYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIAQ 252
Query: 252 PEAIARVRNEKARRYLSS---MRKKKPIPFSQKFPNANPLALRLLERML---AFEPKDRP 305
+ + + L + + P+ P + L M E RP
Sbjct: 253 GQ----MTVLRLTELLERGERLPR----------PDKCPAEVYHL--MKNCWETEASFRP 296
Query: 306 T 306
T
Sbjct: 297 T 297
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 53/233 (22%), Positives = 103/233 (44%), Gaps = 33/233 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ ++ +G G YG V + VA+K + E + L+E +++ ++HP
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 276
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGL 139
++V++ + Y++ E M +L ++ + +++ + Q+ +
Sbjct: 277 NLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVAT 192
+Y+ N HR+L +N L + +K+ DFGL+R+ DT TA I WT
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----- 386
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 387 ----APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 45/235 (19%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ + +G G +GVV + VA+K I E +E + + L HP +V
Sbjct: 11 TLLKELGSGQFGVVKLGK-WKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 86 EIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLR 137
+ P IY+V E + + L ++++ L P Y +
Sbjct: 67 K----FYGVCSKEYP-------IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCE 115
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT----- 192
G+ ++ + HRDL +N L + D +K+ DFG+ R +D YV++
Sbjct: 116 GMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKF 167
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W APE + KY+ D+W+ G + E+ + GK + VV ++
Sbjct: 168 PVKWS-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 33/229 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ IG G +G+V Y +KVAIK I E + E +++ L HP +V
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
+ L + I +V E ME L ++ E + G+ Y+
Sbjct: 67 Q----LYGVCLEQ-APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWYR 196
A V HRDL +N L + +K+ DFG+ R +D Y ++ +W
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFPVKWA- 172
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+PE FS+Y+ D+WS G + E+ + GK + ++ VV +
Sbjct: 173 SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 33/231 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHPD 83
+ E IG+G++G V S VA+K E + + L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 84 IVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQL 135
IV L+ P IY+V EL++ D ++ L + +
Sbjct: 174 IVR----LIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
G++Y+ + HRDL +N L LKI DFG++R + A V +W
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282
Query: 196 RAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE + + +Y+ D+WS G + E + G +P + ++
Sbjct: 283 -APE---ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 75/343 (21%), Positives = 123/343 (35%), Gaps = 63/343 (18%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKI-------NDIFEHVSDATRILREIKLLRLLRHP 82
+IG+G +G V TG+ A+K + + +L + P
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD---CP 252
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
IV + + P + + + +LM DLH + + + +F+ +++ GL++
Sbjct: 253 FIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVL 362
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
Y + D +S+GC+ +LL G F R
Sbjct: 363 QK-GVAYDSSADWFSLGCMLFKLLRGHSPF-------------------------RQHKT 396
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYF 316
K + + M + F P LLE +L + R A+E P+F
Sbjct: 397 KDKHEIDRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
Query: 317 KGL--AKVER---EPSAQPVTKM---EFEFERRRITKEDVREL 351
+ L V P P F+ +ED + +
Sbjct: 454 RSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGI 496
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 9e-28
Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 29/228 (12%)
Query: 28 EEVIGKGSYGVVCSA-YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++ +G G++G V Y + VA+K + + + +L E +++ L +P IV
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ I S +V E+ E L++ ++ N + ++ ++Q+ G+KY+
Sbjct: 82 RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWYRA 197
+N HRDL +N+L KI DFGL++ D Y A +WY A
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY------YKAQTHGKWPVKWY-A 188
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
PE + K++ D+WS G + E + G+ + G V L+
Sbjct: 189 PE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 33/233 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
IE++IG G G VC G+ VAIK + ++ R L E ++
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFD 108
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 138
HP+I+ ++ ++ + +V E ME+ L ++ +D T L + G
Sbjct: 109 HPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------ 192
++Y+ HRDL +N+L +++ K+ DFGL+RV +D A Y T
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTGGKIPI 218
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
RW APE F ++ A D+WS G + E+L G+ + V+ ++
Sbjct: 219 RWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 69/299 (23%), Positives = 118/299 (39%), Gaps = 47/299 (15%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + L E ++L + +V +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 89 HILLPPSRREFKDIYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ + +V LM DL H F+ ++ GL+ +H
Sbjct: 251 YAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
+ +RDLKP+NIL + ++I D GLA V T Y APE+ +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKN-- 359
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265
+YT + D W++GC+ E++ G+ F + + + +
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-------------------- 399
Query: 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFKGL 319
+ K+ P +S++F A L ++L +P +R +A E P FK L
Sbjct: 400 ----LVKEVPEEYSERFSPQ---ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 40/235 (17%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
++ IG+G +G V VAIK SD+ R L+E +R
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFD 74
Query: 81 HPDIVEIKHILL-PPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 137
HP IV++ ++ P ++++ EL +L ++ L + YQL
Sbjct: 75 HPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT----- 192
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + Y
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKL 179
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 180 PIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 66/338 (19%), Positives = 130/338 (38%), Gaps = 59/338 (17%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEE-------VIGKGSYGVVCSAYDTRTGEKVAIK 54
P Q S F ++ + E V+G+G +G V + TG+ A K
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACK 216
Query: 55 KIN--DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES- 111
K+N + + + E K+L + IV + + + + +V +M
Sbjct: 217 KLNKKRLKKR-KGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGG 270
Query: 112 DL----HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167
D+ + V + N F+ Q++ GL+++H N+ +RDLKP+N+L + D ++I
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRI 330
Query: 168 CDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
D GLA + T T + T + APEL +Y ++D +++G E++
Sbjct: 331 SDLGLAVELKAGQTKTKGY----AGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIA 384
Query: 227 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 286
+ F + + + + ++ + + KF
Sbjct: 385 ARGPFRARGEKVENKELKQRV------------------------LEQAVTYPDKFS--- 417
Query: 287 PLALRLLERMLAFEPKDR-----PTAEEALADPYFKGL 319
P + E +L +P+ R + + P F+ +
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 52/236 (22%), Positives = 92/236 (38%), Gaps = 34/236 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRL 78
+ + +V+G G +G V GE V IK I D + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGS 71
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLL 136
L H IV + + S + +V + + L ++ + L P+ + Q+
Sbjct: 72 LDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT---- 192
+G+ Y+ + HR+L +N+L + ++++ DFG+A + D +
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSEAK 178
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W A E F KYT D+WS G EL+T G + G V L+
Sbjct: 179 TPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 56/235 (23%), Positives = 102/235 (43%), Gaps = 40/235 (17%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEK--VAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
+ ++G+G +G V Y GEK VA+K + + + + E +++ L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLD 71
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 138
HP IV++ I+ +++ EL +L ++ N + L + Q+ +
Sbjct: 72 HPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------ 192
+ Y+ + N HRD+ +NIL + +K+ DFGL+R ++ DY
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKASVTRLP 177
Query: 193 -RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 178 IKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 33/236 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRI--LREIKLLR 77
+ I++V+G G +G VCS +K VAIK + ++ R L E ++
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMG 101
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQL 135
HP+I+ ++ ++ + K + +V E ME+ L ++ +D T L +
Sbjct: 102 QFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT--- 192
G+KY+ HRDL +NIL N++ K+ DFGL RV +D A Y
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA-----YTTRGGK 211
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
RW +PE + K+T A D+WS G + E+++ G+ + + V+ +D
Sbjct: 212 IPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
++E +G+G +G V T +VAIK + L+E ++++ LRH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 239
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 139
+V++ ++ + IY+V E M L +K L Q+ G+
Sbjct: 240 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVAT 192
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ TA I WT
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----- 348
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE + + ++T D+WS G + EL T G+ +PG + V+ Q++
Sbjct: 349 ----APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 50/229 (21%), Positives = 91/229 (39%), Gaps = 33/229 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ +G G +GVV R VAIK I E + E K++ L H +V
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
++ + + + I+++ E M + L ++ + + ++Y+
Sbjct: 83 QLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWYR 196
+ HRDL +N L N +K+ DFGL+R +D +Y ++ RW
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--------EYTSSVGSKFPVRWS- 188
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
PE +SK++ DIW+ G + E+ + GK + +
Sbjct: 189 PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 60/237 (25%), Positives = 108/237 (45%), Gaps = 34/237 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRI--LREIKLL 76
S ++VIG G +G V + VAIK + ++ R+ L E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIM 100
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQ 134
H +I+ ++ ++ ++K + ++ E ME+ L + ++ D + L
Sbjct: 101 GQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-- 192
+ G+KY+ N HRDL +NIL N++ K+ DFGL+RV +D Y +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGG 210
Query: 193 ----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
RW APE + K+T A D+WS G + E++T G+ + + V+ ++
Sbjct: 211 KIPIRWT-APE--AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-27
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
K+ + IGKG +G V G KVA+K I + DAT L E ++ LR
Sbjct: 193 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 244
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 137
H ++V+ LL E +Y+V E M L +++ L + F +
Sbjct: 245 HSNLVQ----LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
++Y+ N HRDL +N+L + D K+ DFGL + A + T +W A
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT-A 354
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
PE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 355 PE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K +V+G G++G V GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ +G+
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------R 193
Y+ + HRDL +N+L +KI DFGLA++ + Y A +
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE------YHAEGGKVPIK 184
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
W A E YT D+WS G EL+T G + G + L+
Sbjct: 185 WM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
++E +G+G +G V T +VAIK + L+E ++++ LRH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 322
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 139
+V++ ++ + IY+V E M L +K L Q+ G+
Sbjct: 323 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVAT 192
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ TA I WT
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----- 431
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE + + ++T D+WS G + EL T G+ +PG + V+ Q++
Sbjct: 432 ----APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 67/238 (28%), Positives = 99/238 (41%), Gaps = 45/238 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
K+ E +G G +G V Y KVA+K + + L E L++ L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68
Query: 83 DIVEIKHILL-----PPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQ 134
+V L P IY++ E ME+ L +K LT Q
Sbjct: 69 RLVR----LYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWT 187
+ G+ +I N HRDL+ NIL + KI DFGLAR+ ++ TA I WT
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE + +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 178 ---------APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 64/306 (20%), Positives = 116/306 (37%), Gaps = 55/306 (17%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
VIG+G++ V +TG+ A+K +N D+ + + + E +L I ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR-GEVSCFREERDVLVNGDRRWITQL 126
Query: 88 KHILLPPSRREFKD---IYVVFELMES-DL-HQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
F+D +Y+V E DL + K + + E +F+L +++ + +
Sbjct: 127 HF--------AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPEL- 200
H HRD+KP NIL + +++ DFG ++ + T + V T Y +PE+
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS--LV-AVGTPDYLSPEIL 235
Query: 201 ----CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
G Y P D W++G E+ G+ F +
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------------------- 276
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEALAD 313
Y + K+ + A ++R+L P+ R A +
Sbjct: 277 -------ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328
Query: 314 PYFKGL 319
P+F GL
Sbjct: 329 PFFFGL 334
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 33/231 (14%)
Query: 27 IEEVIGKGSYGVVCSA-YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ +G G++G V Y R + VAIK + E +D ++RE +++ L +P I
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYI 72
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 142
V + + + + +V E+ LH+ + + + + L+Q+ G+KY+
Sbjct: 73 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWY 195
N HRDL +N+L KI DFGL++ D Y A +WY
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 180
Query: 196 RAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 181 -APE---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
EVIG+G +G V K A+K +N I + + ++ L E +++ HP
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHP 86
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
+++ LL R VV M+ DL I+ + T + F Q+ +G+K
Sbjct: 87 NVLS----LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------- 192
Y+ + HRDL +N + + +K+ DFGLAR ++ +Y +
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNKTGAKL 194
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W A E K+T D+WS G + EL+T G P +P N + L
Sbjct: 195 PVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 49/241 (20%), Positives = 93/241 (38%), Gaps = 33/241 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLL 79
+ + +++G+G +G V + KVA+K + + L E ++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHYQFFL 132
HP+++ + + + S + V+ M+ DLH + + + + F+
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD-YVA 191
+ G++Y+ N HRDL +N + D + + DFGL++ I+ D Y
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYYRQ 205
Query: 192 T-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQL 240
+W A E YT D+W+ G E+ T G +PG + L
Sbjct: 206 GRIAKMPVKWI-AIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
Query: 241 D 241
Sbjct: 263 L 263
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 35/230 (15%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+E+ +G G +G V A + KVA+K + L E +++ L+H +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYI 142
++ ++ + IY++ E M L +K+++ F Q+ G+ +I
Sbjct: 247 KLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWY 195
N HRDL+ NIL +A KI DFGLARV ++ TA I WT
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT-------- 352
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE F +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 353 -APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 57/230 (24%), Positives = 100/230 (43%), Gaps = 31/230 (13%)
Query: 27 IEEVIGKGSYGVVCSA-YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ +G G++G V Y R + VAIK + E +D ++RE +++ L +P I
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYI 398
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 142
V + + + + +V E+ LH+ + + + + L+Q+ G+KY+
Sbjct: 399 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWY 195
N HR+L +N+L KI DFGL++ D Y A +WY
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 506
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 507 -APE--CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 39/291 (13%), Positives = 68/291 (23%), Gaps = 65/291 (22%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLR 80
RY++ G A DT +VA+ ++ L L +
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
P + + ++ + VV E + L +V + +P + L
Sbjct: 90 KPGVARVLDVVHTRAG-----GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAA 142
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
H A V P + + D + + A
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------- 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
P DI IG LL + P V L A
Sbjct: 180 ---------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------AERDTA 219
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
+ PI + + + R + + R +
Sbjct: 220 GQ-------------PIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 65/307 (21%), Positives = 121/307 (39%), Gaps = 59/307 (19%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
VIG+G++G V + A+K +N ++ + ++ E +L I +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR-AETACFREERDVLVNGDSKWITTL 139
Query: 88 KHILLPPSRREFKD---IYVVFELMES-DL-HQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+ F+D +Y+V + DL + K D L E +F+L +++ + +
Sbjct: 140 HY--------AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPEL- 200
H + HRD+KP NIL + + +++ DFG ++ + T + V T Y +PE+
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS--SV-AVGTPDYISPEIL 248
Query: 201 --CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
+Y P D WS+G E+L G+ F +++V
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------------------- 287
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT------AEEALA 312
Y M K+ F + + + A L+ R++ R E+
Sbjct: 288 -----ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLI----CSREHRLGQNGIEDFKK 338
Query: 313 DPYFKGL 319
P+F G+
Sbjct: 339 HPFFSGI 345
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ VIGKG +GVV + + AIK ++ I E LRE L+R L HP
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMRGLNHP 82
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
+++ L+ +V+ M DL Q I++ + T + F Q+ RG++
Sbjct: 83 NVLA----LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------- 192
Y+ HRDL +N + + +K+ DFGLAR I +Y +
Sbjct: 139 YLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD--------ILDREYYSVQQHRHARL 190
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W A E ++T D+WS G + ELLT G P + + + H L
Sbjct: 191 PVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
EVIG+G +G V K A+K +N I + + ++ L E +++ HP
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHP 150
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
+++ LL R VV M+ DL I+ + T + F Q+ +G+K
Sbjct: 151 NVLS----LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------- 192
++ + HRDL +N + + +K+ DFGLAR ++ ++ +
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEFDSVHNKTGAKL 258
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W A E K+T D+WS G + EL+T G P +P N + L
Sbjct: 259 PVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
VIG+G++G V T + A+K ++ ++ + SD+ E ++ P +V++
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-SDSAFFWEERDIMAFANSPWVVQL 134
Query: 88 KHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
+ F+D +Y+V E M DL ++ N D+ + +F+ +++ L IH
Sbjct: 135 FY--------AFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIH 185
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE--LC 201
+ HRD+KP N+L + LK+ DFG N T V T Y +PE
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDT-AVGTPDYISPEVLKS 243
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
Y D WS+G E+L G F ++V
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 8e-25
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 48/239 (20%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
++ IG+G +G V VAIK SD+ R L+E +R
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFD 449
Query: 81 HPDIVEIKHILL-----PPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLY 133
HP IV+ L+ P ++++ EL +L ++ L + Y
Sbjct: 450 HPHIVK----LIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT- 192
QL L Y+ + HRD+ +N+L +++ +K+ DFGL+R + Y
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKAS 550
Query: 193 ------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 551 KGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 56/242 (23%), Positives = 102/242 (42%), Gaps = 34/242 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLL 79
++ + ++GKG +G V A + KVA+K + SD LRE ++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 80 RHPDIVEIKHI-LLPPSRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHYQFF 131
HP + ++ + L ++ V+ M+ DLH + A+ +L + F
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-- 189
+ + G++Y+ + N HRDL +N + D + + DFGL+R I+ DY
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDYYR 194
Query: 190 ------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQ 239
+ +W A E + YT D+W+ G E++T G+ + G + +
Sbjct: 195 QGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 240 LD 241
L
Sbjct: 252 LI 253
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 65/243 (26%), Positives = 109/243 (44%), Gaps = 32/243 (13%)
Query: 30 VIGKGSYG---VVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDI 84
V+GKG YG V TG+ A+K + I + D E +L ++HP I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 85 VEIKHILLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
V++ + + +Y++ EL + ++ + F+L ++
Sbjct: 84 VDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAEISMA 133
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L ++H + +RDLKP+NI+ N +K+ DFGL + + +D + T Y AP
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIEYMAP 190
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPE 253
E L S + A+D WS+G + ++LTG P F G+N +D I+ L P + E
Sbjct: 191 EILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE 247
Query: 254 AIA 256
A
Sbjct: 248 ARD 250
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 37/239 (15%), Positives = 76/239 (31%), Gaps = 40/239 (16%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGE-------KVAIKKINDIFEHVSDATRILREIKLLRL 78
E +G+G++ + G+ +V +K ++ H + + ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAASMMSK 68
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLL 136
L H +V + + + +V E ++ L +K N + + QL
Sbjct: 69 LSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKL--------KICDFGLARVAFNDTPTAIFWTD 188
+ ++ + H ++ KNIL + K+ D G++ D
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------D 175
Query: 189 Y--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
W PE C A D WS G E+ + G + + +
Sbjct: 176 ILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/245 (23%), Positives = 106/245 (43%), Gaps = 38/245 (15%)
Query: 7 KKSSADVDFFTEYGEGSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIK--KINDI 59
K+ D E + ++++ +G GS+G V +G A+K +
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 60 F-----EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELME- 110
EH + RIL+ + P +V+++ FKD +Y+V E +
Sbjct: 80 VKLKQIEHTLNEKRILQAV------NFPFLVKLEF--------SFKDNSNLYMVMEYVAG 125
Query: 111 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170
++ ++ + H +F+ Q++ +Y+H+ ++ +RDLKP+N+L + +++ DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
G A+ T WT T APE+ S Y A+D W++G + E+ G P
Sbjct: 186 GFAKRVKGRT-----WT-LCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 231 FPGKN 235
F
Sbjct: 238 FFADQ 242
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 61/238 (25%), Positives = 112/238 (47%), Gaps = 26/238 (10%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
++GKG++G V + TG A+K + I + + E ++L+ RHP + +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTESRVLQNTRHPFLTAL 70
Query: 88 KHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
K+ R + V E +L + T E +F+ +++ L+Y+H+ +
Sbjct: 71 KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 147 VFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPE-LCGS 203
V +RD+K +N++ + D +KI DFGL + ++ T F T Y APE L
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTF----CGTPEYLAPEVLED- 179
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL--DIMTDLLGTP---SPEAIA 256
+ Y A+D W +G + E++ G+ F ++ +L I+ + + P SPEA +
Sbjct: 180 --NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKS 234
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHP 82
++I +G GS+G V G A+K K + E +L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHP 66
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
I+ + F+D I+++ + +E +L +++ + +F+ ++
Sbjct: 67 FIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-----DYVATR 193
L+Y+H+ ++ +RDLKP+NIL + + +KI DFG A+ + T +T DY+
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYI--- 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
APE+ + Y +ID WS G + E+L G F N
Sbjct: 171 ---APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 66/269 (24%), Positives = 112/269 (41%), Gaps = 42/269 (15%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI----- 56
+P + K + DF + +++GKGS+G V A +T + AIK +
Sbjct: 7 RPSLQIKLKIE-DF----------ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV 55
Query: 57 --NDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DL 113
+D E T + + + L HP + + ++ V E + DL
Sbjct: 56 LMDDDVEC----TMVEKRV-LSLAWEHPFLTHMFCTFQTKEN-----LFFVMEYLNGGDL 105
Query: 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
I++ F+ +++ GL+++H+ + +RDLK NIL + D +KI DFG+
Sbjct: 106 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
Query: 174 R--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ + + T F T Y APE+ KY ++D WS G + E+L G+ F
Sbjct: 166 KENMLGDAK-TNTF----CGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPF 218
Query: 232 PGKNVVHQLD-IMTDLLGTP---SPEAIA 256
G++ I D P EA
Sbjct: 219 HGQDEEELFHSIRMDNPFYPRWLEKEAKD 247
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 67/273 (24%), Positives = 114/273 (41%), Gaps = 48/273 (17%)
Query: 9 SSADVDFFTEYGEGSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIKKI------- 56
++ V F G R K+ + V+GKGS+G V + T E A+K +
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60
Query: 57 NDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE------LME 110
+D E T + + + L + P + ++ R +Y V E LM
Sbjct: 61 DDDVEC----TMVEKRV-LALPGKPPFLTQLHSCFQTMDR-----LYFVMEYVNGGDLM- 109
Query: 111 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170
H I+ H F+ ++ GL ++ + + +RDLK N++ +++ +KI DF
Sbjct: 110 --YH--IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 165
Query: 171 GLAR--VAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTG 227
G+ + + T T F T Y APE + Y ++D W+ G + E+L G
Sbjct: 166 GMCKENIWDGVT-TKTF----CGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAG 217
Query: 228 KPLFPGKNVVHQLD-IMTDLLGTP---SPEAIA 256
+ F G++ IM + P S EA+A
Sbjct: 218 QAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 62/255 (24%), Positives = 105/255 (41%), Gaps = 56/255 (21%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
++ +G+G++G V Y+ + VA+K + D + A R RE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD----PTLAARKDFQREAEL 70
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN-------------- 120
L L+H IV+ + +VFE M+ DL++ ++A+
Sbjct: 71 LTNLQHEHIVK----FYGVCGDG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 121 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178
+L Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--- 182
Query: 179 DTPTAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 229
++ TDY RW PE + K+T D+WS G I E+ T GK
Sbjct: 183 -----VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 230 LFPGKN---VVHQLD 241
+ + V+ +
Sbjct: 235 PWFQLSNTEVIECIT 249
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-22
Identities = 58/234 (24%), Positives = 109/234 (46%), Gaps = 17/234 (7%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
++GKG++G V + TG A+K + ++ + L E ++L+ RHP + +K
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-N 146
+ R + V E +L + + + +F+ +++ L Y+H+ N
Sbjct: 215 YSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
V +RDLK +N++ + D +KI DFGL + D T + T Y APE+ +
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED--N 324
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEAIA 256
Y A+D W +G + E++ G+ F ++ + I+ + + P PEA +
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 378
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 7e-22
Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 33/242 (13%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKI-------NDIFEHVSDATRILREIKLLRLLRHP 82
V+GKGS+G V + T E A+K + +D E T + + + L + P
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC----TMVEKRV-LALPGKPP 402
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+ ++ R +Y V E + DL I+ H F+ ++ GL +
Sbjct: 403 FLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPE 199
+ + + +RDLK N++ +++ +KI DFG+ + + T T F T Y APE
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTF----CGTPDYIAPE 512
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEA 254
+ Y ++D W+ G + E+L G+ F G++ IM + P S EA
Sbjct: 513 IIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569
Query: 255 IA 256
+A
Sbjct: 570 VA 571
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 55/254 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
++ +G+G++G V ++ + VA+K + + S++ R RE +L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAEL 96
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD------------ 122
L +L+H IV + + +VFE M DL++ ++++
Sbjct: 97 LTMLQHQHIVR----FFGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 123 ---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
L Q+ G+ Y+ + HRDL +N L +KI DFG++R
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD---- 207
Query: 180 TPTAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230
I+ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ----IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
Query: 231 FPGKN---VVHQLD 241
+ + + +
Sbjct: 261 WYQLSNTEAIDCIT 274
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 56/242 (23%), Positives = 91/242 (37%), Gaps = 63/242 (26%)
Query: 23 SRYKIEEVIGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
S + E +G+ +G V + GE VAIK + + R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAML 65
Query: 76 LRLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 120
L+HP++V LL P + ++F DLH+ +
Sbjct: 66 RARLQHPNVVC----LLGVVTKDQP-------LSMIFSYCSHGDLHEFLVMRSPHSDVGS 114
Query: 121 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
L P + + Q+ G++Y+ + +V H+DL +N+L +KI D GL
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 173 ARVAFNDTPTAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224
R ++ DY RW APE + K++ DIWS G + E+
Sbjct: 175 FRE--------VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEV 223
Query: 225 LT 226
+
Sbjct: 224 FS 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 58/247 (23%), Positives = 92/247 (37%), Gaps = 66/247 (26%)
Query: 26 KIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKLLRL 78
+ +G+GS+G+V A E +VAIK +N E S RI L E +++
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKE 84
Query: 79 LRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN----------D 121
+V LL P V+ ELM DL +++
Sbjct: 85 FNCHHVVR----LLGVVSQGQP-------TLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
+ ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD------ 187
Query: 182 TAIFWTDYVATRWYR------------APELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 228
I+ TDY YR +PE +T D+WS G + E+ T +
Sbjct: 188 --IYETDY-----YRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAE 238
Query: 229 PLFPGKN 235
+ G +
Sbjct: 239 QPYQGLS 245
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 65/244 (26%), Positives = 111/244 (45%), Gaps = 36/244 (14%)
Query: 30 VIGKGSYG---VVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPDI 84
V+G+GS+G +V + + A+K K + D R E +L + HP I
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFI 88
Query: 85 VEIKHILLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
V++ + + +Y++ +L + T E +F+L +L
Sbjct: 89 VKLHYAFQTEGK-----LYLILDFLRGGDLF---TR--LSKEVMFTEEDVKFYLAELALA 138
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L ++H+ + +RDLKP+NIL + + +K+ DFGL++ + + A + T Y AP
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYMAP 195
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL--DIMTDLLGTP---SP 252
E + +T + D WS G + E+LTG F GK+ + I+ LG P SP
Sbjct: 196 EVVNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMILKAKLGMPQFLSP 251
Query: 253 EAIA 256
EA +
Sbjct: 252 EAQS 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 64/242 (26%), Positives = 104/242 (42%), Gaps = 33/242 (13%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKI-------NDIFEHVSDATRILREIKLLRLLRHP 82
V+GKGS+G V A TG+ A+K + +D E T + I L HP
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVEC----TMTEKRI-LSLARNHP 84
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+ ++ P R ++ V E + DL I+ + +F+ +++ L +
Sbjct: 85 FLTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLA--RVAFNDTPTAIFWTDYVATRWYRAPE 199
+H + +RDLK N+L + + K+ DFG+ + T TA F T Y APE
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TATF----CGTPDYIAPE 194
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEA 254
L Y PA+D W++G + E+L G F +N + I+ D + P +A
Sbjct: 195 ILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDA 251
Query: 255 IA 256
Sbjct: 252 TG 253
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 70/318 (22%), Positives = 125/318 (39%), Gaps = 54/318 (16%)
Query: 20 GEGSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILRE 72
G +++ VIG+GSY V +T A+K K + + D + E
Sbjct: 1 GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTE 59
Query: 73 IK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF 130
+ HP +V + SR ++ V E + DL ++ L EH +F
Sbjct: 60 KHVFEQASNHPFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARF 114
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTD 188
+ ++ L Y+H + +RDLK N+L +++ +K+ D+G+ + + DT T+ F
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTF--- 170
Query: 189 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
T Y APE L G Y ++D W++G + E++ G+ F D
Sbjct: 171 -CGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------ 220
Query: 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR--- 304
+ YL + +K I + A +L+ L +PK+R
Sbjct: 221 -------------QNTEDYLFQVILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLGC 264
Query: 305 ---PTAEEALADPYFKGL 319
+ P+F+ +
Sbjct: 265 HPQTGFADIQGHPFFRNV 282
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 64/281 (22%), Positives = 108/281 (38%), Gaps = 48/281 (17%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIKK 55
M + + K + VIGKGS+G V A A+K
Sbjct: 11 MNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV 70
Query: 56 I-------NDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF-- 106
+ +H R + LL+ ++HP +V + + +Y V
Sbjct: 71 LQKKAILKKKEEKH----IMSERNV-LLKNVKHPFLVGLHFSFQTADK-----LYFVLDY 120
Query: 107 ----ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162
EL H ++ +F+ ++ L Y+H+ N+ +RDLKP+NIL ++
Sbjct: 121 INGGELF---YH--LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175
Query: 163 CKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220
+ + DFGL + + N T T+ F T Y APE+ Y +D W +G +
Sbjct: 176 GHIVLTDFGLCKENIEHNST-TSTF----CGTPEYLAPEVLHK--QPYDRTVDWWCLGAV 228
Query: 221 FAELLTGKPLFPGKNVVHQL--DIMTDLLGTP---SPEAIA 256
E+L G P F +N ++ +I+ L + A
Sbjct: 229 LYEMLYGLPPFYSRN-TAEMYDNILNKPLQLKPNITNSARH 268
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 92.6 bits (229), Expect = 1e-20
Identities = 51/349 (14%), Positives = 87/349 (24%), Gaps = 75/349 (21%)
Query: 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI------NDIFEHVSDATRI 69
F+ + + E IG+G +G V T VAIK I H I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 70 LREIKLLRLL---------RHPDIVEIKHILL-------------------------PPS 95
L EI + + L R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF-HRDLKP 154
+ +++V E + + + L+QL L + F HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 155 KNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
N+L K+ + + + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV------------------SIIDYTLSRLE 232
Query: 215 WSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK-------ARRYL 267
+F ++ + LF G +Q DI L+ + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFDI-YRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 268 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
K + ML F +A + L
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 60/247 (24%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIK-LLRLLRHPDIVE 86
VIG+GSY V +T A++ K + + D + E + HP +V
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVG 117
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 118 LHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPE-LCG 202
+ +RDLK N+L +++ +K+ D+G+ + + DT T+ F T Y APE L G
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTF----CGTPNYIAPEILRG 227
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD----------IMTDLLGTP-- 250
Y ++D W++G + E++ G+ F D I+ + P
Sbjct: 228 ---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284
Query: 251 -SPEAIA 256
S +A +
Sbjct: 285 LSVKAAS 291
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 51/249 (20%), Positives = 88/249 (35%), Gaps = 49/249 (19%)
Query: 23 SRYKIEEVIGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ +G G++G V +VA+K + E S+ + L E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALI 86
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 134
+ H +IV + S + +++ ELM DL ++ + +
Sbjct: 87 ISKFNHQNIVR----CIGVSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 135 LL-------RGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAI 184
LL G +Y+ + HRD+ +N L KI DFG+AR I
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------I 193
Query: 185 FWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235
+ Y +W PE +T D WS G + E+ + G +P K+
Sbjct: 194 YRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250
Query: 236 ---VVHQLD 241
V+ +
Sbjct: 251 NQEVLEFVT 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 52/252 (20%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
R K+ + +G+G++G V A+ VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 76 L-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN------------- 120
L + H ++V LL + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 121 ---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD-- 197
Query: 178 NDTPTAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 228
I+ YV +W APE F YT D+WS G + E+ + G
Sbjct: 198 ------IYKDPDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 229 PLFPGKNVVHQL 240
+PG + +
Sbjct: 249 SPYPGVKIDEEF 260
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 70/336 (20%), Positives = 135/336 (40%), Gaps = 57/336 (16%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEE-----VIGKGSYG---VVCSAYDTRTGEKVAIKK 55
+Q ++ G + IE V+G G+YG +V TG+ A+K
Sbjct: 30 EQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV 89
Query: 56 IN--DIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSRREFKDIYVVFELMES- 111
+ I + E ++L +R P +V + + ++ ++++ + +
Sbjct: 90 LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK-----LHLILDYINGG 144
Query: 112 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171
+L + + T Q ++ +++ L+++H + +RD+K +NIL +++ + + DFG
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 172 LAR--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
L++ VA F T Y AP++ S + A+D WS+G + ELLTG
Sbjct: 205 LSKEFVADETERAYDF----CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
Query: 230 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPL 288
F + ++ +S K P+ Q+ A L
Sbjct: 261 PFTVDG------------------------EKNSQAEISRRILKSEPPYPQEMSALAKDL 296
Query: 289 ALRLLERMLAFEPKDR----PT-AEEALADPYFKGL 319
RLL + +PK R P A+E +F+ +
Sbjct: 297 IQRLLMK----DPKKRLGCGPRDADEIKEHLFFQKI 328
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 51/249 (20%), Positives = 88/249 (35%), Gaps = 49/249 (19%)
Query: 23 SRYKIEEVIGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ +G G++G V +VA+K + E S+ + L E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALI 127
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 134
+ H +IV + S + +++ ELM DL ++ + +
Sbjct: 128 ISKFNHQNIVR----CIGVSLQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 135 LL-------RGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAI 184
LL G +Y+ + HRD+ +N L KI DFG+AR I
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------I 234
Query: 185 FWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235
+ Y +W PE +T D WS G + E+ + G +P K+
Sbjct: 235 YRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291
Query: 236 ---VVHQLD 241
V+ +
Sbjct: 292 NQEVLEFVT 300
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 62/231 (26%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHVSDATRI--LREIKLL-R 77
+ K ++VIG+G++G V A + G + AIK++ E+ S E+++L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCK 81
Query: 78 LLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN---------- 120
L HP+I+ LL +Y+ E +L ++ +
Sbjct: 82 LGHHPNIIN----LLGACEHRGY-------LYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 121 ------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
Query: 175 VAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIG 218
+ YV RW A E +S YT D+WS G
Sbjct: 191 --GQEV--------YVKKTMGRLPVRWM-AIE--SLNYSVYTTNSDVWSYG 228
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 56/247 (22%), Positives = 91/247 (36%), Gaps = 81/247 (32%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ + IG+G++G V A E VA+K + E S + RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 76 LRLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKANDD------ 122
+ +P+IV+ LL P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVK----LLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSL 152
Query: 123 ------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164
L+ Q+ G+ Y+ HRDL +N L +
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV 212
Query: 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYR------------APELCGS-FFSKYTPA 211
+KI DFGL+R I+ DY Y+ PE S F+++YT
Sbjct: 213 VKIADFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTE 256
Query: 212 IDIWSIG 218
D+W+ G
Sbjct: 257 SDVWAYG 263
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 58/255 (22%), Positives = 98/255 (38%), Gaps = 61/255 (23%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ + + +G G++G V +A+ + KVA+K + + + E+K+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKI 102
Query: 76 L-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELME---------------SDL 113
+ L +H +IV LL P + V+ E
Sbjct: 103 MSHLGQHENIVN----LLGACTHGGP-------VLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
AN + F Q+ +G+ ++ + N HRD+ +N+L KI DFGLA
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 174 RVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
R ND ++Y+ +W APE F YT D+WS G + E+ +
Sbjct: 212 RDIMND-------SNYIVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFS 261
Query: 227 -GKPLFPGKNVVHQL 240
G +PG V +
Sbjct: 262 LGLNPYPGILVNSKF 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 73/243 (30%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ + +G+G +G V +A+ + VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 76 LRLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 120
L+ + HP +++ L P + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQDGP-------LLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 121 ----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164
LT F +Q+ +G++Y+ + HRDL +NIL K
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 165 LKICDFGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIW 215
+KI DFGL+R ++ D YV +W A E S F YT D+W
Sbjct: 189 MKISDFGLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVW 236
Query: 216 SIG 218
S G
Sbjct: 237 SFG 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 68/260 (26%), Positives = 96/260 (36%), Gaps = 67/260 (25%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+R + +G G++G V +AY + VA+K + R + E+K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79
Query: 76 L-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN------- 120
L L H +IV LL P V+ E DL ++
Sbjct: 80 LSYLGNHMNIVN----LLGACTIGGP-------TLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 121 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
L E F YQ+ +G+ ++ + N HRDL +NIL KICD
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 170 FGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
FGLAR I YV +W APE F YT D+WS G
Sbjct: 189 FGLARD--------IKNDSNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFL 237
Query: 222 AELLT-GKPLFPGKNVVHQL 240
EL + G +PG V +
Sbjct: 238 WELFSLGSSPYPGMPVDSKF 257
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 40/167 (23%), Positives = 68/167 (40%), Gaps = 30/167 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL-REIKLLRLLR 80
G +++ + IG G++G + + T E VAIK E + L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 81 H-PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL------- 132
I ++ + K +V EL+ L + D F L
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSLEDLFDLCD------RTFSLKTVLMIA 111
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 174
QL+ ++Y+H+ N+ +RD+KP+N L + I DF LA+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 61/263 (23%), Positives = 106/263 (40%), Gaps = 70/263 (26%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE-----KVAIKKINDIFEHVSDATRI--LREI 73
+ + + +G+G++G V A + VA+K + + ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 74 KLL-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN----- 120
+++ + +H +I+ LL P +YV+ E +L + ++A
Sbjct: 92 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGM 140
Query: 121 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
+ +T + YQL RG++Y+ + HRDL +N+L + +KI D
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 170 FGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
FGLAR I D Y T +W APE F YT D+WS G +
Sbjct: 201 FGLARD--------INNIDYYKKTTNGRLPVKWM-APE--ALFDRVYTHQSDVWSFGVLM 249
Query: 222 AELLT-GK---PLFPGKNVVHQL 240
E+ T G P P + + L
Sbjct: 250 WEIFTLGGSPYPGIPVEELFKLL 272
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 61/261 (23%), Positives = 106/261 (40%), Gaps = 72/261 (27%)
Query: 26 KIEEVIGKGSYGVV--CSAYDTRTGE-----KVAIKKINDIFEHVSDATRI--LREIKLL 76
+ + +G+G +G V A + VA+K + + ++ + E++++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMM 140
Query: 77 -RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 120
+ +H +I+ LL P +YV+ E +L + ++A
Sbjct: 141 KMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 121 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
+ +T + YQL RG++Y+ + HRDL +N+L + +KI DFGL
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 173 ARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAE 223
AR I D Y T +W APE + F YT D+WS G + E
Sbjct: 250 ARD--------INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLMWE 297
Query: 224 LLT-GKPLFPG---KNVVHQL 240
+ T G +PG + + L
Sbjct: 298 IFTLGGSPYPGIPVEELFKLL 318
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 63/264 (23%), Positives = 107/264 (40%), Gaps = 72/264 (27%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE-----KVAIKKINDIFEHVSDATRI--LREI 73
R + + +G+G++G V A + KVA+K + ++ + E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEM 125
Query: 74 KLL-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN----- 120
+++ + +H +I+ LL P +YV+ E +L + ++A
Sbjct: 126 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGL 174
Query: 121 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
+ L+ + YQ+ RG++Y+ + HRDL +N+L D +KI D
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 170 FGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 220
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 235 FGLARD--------IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVL 282
Query: 221 FAELLT-GK---PLFPGKNVVHQL 240
E+ T G P P + + L
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLL 306
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-SDATRILREIKLLRLLR 80
G+RY++ IG GS+G + D GE+VAIK E V + ++ E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 81 H-PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRG 138
I I+ E +V EL+ L + + + Q++
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 174
++YIH+ N HRD+KP N L + I DFGLA+
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 66/266 (24%), Positives = 105/266 (39%), Gaps = 74/266 (27%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ +V+G G++G V +AY +VA+K + E + R + E+K+
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKM 101
Query: 76 L-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELME------------------ 110
+ +L H +IV LL P IY++FE
Sbjct: 102 MTQLGSHENIVN----LLGACTLSGP-------IYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 111 ------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164
+ + + LT E F YQ+ +G++++ + HRDL +N+L
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210
Query: 165 LKICDFGLAR-VAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFF-SKYTPAIDIW 215
+KICDFGLAR + + YV +W APE S F YT D+W
Sbjct: 211 VKICDFGLARDIMSDSN--------YVVRGNARLPVKWM-APE---SLFEGIYTIKSDVW 258
Query: 216 SIGCIFAELLT-GKPLFPGKNVVHQL 240
S G + E+ + G +PG V
Sbjct: 259 SYGILLWEIFSLGVNPYPGIPVDANF 284
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 35/170 (20%), Positives = 73/170 (42%), Gaps = 21/170 (12%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G+++ + + IG G +G++ A+ T EK A + E+ + + E+K + +
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAK 92
Query: 82 PDIVE-------IKHILLP-------PSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 127
D ++ + ++ +P + ++V E + DL ++ N
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152
Query: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 174
++L L+YIH H D+K N+L N D ++ + D+GL+
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 81.1 bits (199), Expect = 4e-16
Identities = 89/493 (18%), Positives = 156/493 (31%), Gaps = 151/493 (30%)
Query: 44 DTRTGE-KVAIKKINDIFE----------HVSDATR-ILREIKLLRLLRHPDIVEIKHIL 91
D TGE + K I +FE V D + IL + EI HI+
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK------------EEIDHII 55
Query: 92 LPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQL--------LRGLKY 141
+ +F + S ++++ + L Y+F + + + Y
Sbjct: 56 MSKDAVS--GTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTRMY 112
Query: 142 IHTANVFHRD-----------LKPKNILANADCKLK----ICDFG--------LARVAFN 178
I + + D L+P L A +L+ + G +A
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL 172
Query: 179 DT------PTAIFWTDYVATRWYRAPE--------LCGSFFSKYTPAIDIWS-----IGC 219
IFW + + +PE L +T D S I
Sbjct: 173 SYKVQCKMDFKIFW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 220 IFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA------RV----RNEKARRYLSS 269
I AEL + L K + L ++ ++ + +A ++ R ++ +LS+
Sbjct: 230 IQAEL---RRLLKSKPYENCLLVLLNVQ---NAKAWNAFNLSCKILLTTRFKQVTDFLSA 283
Query: 270 MRKKKP--IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA-DPYFKGL-AKVERE 325
S LL + L P+D P E L +P + A+ R+
Sbjct: 284 ATTTHISLDHHSMTLTPDE--VKSLLLKYLDCRPQDLP--REVLTTNPRRLSIIAESIRD 339
Query: 326 PSAQPVTKMEFEFER-RRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDH 384
A ++ + + + + +I + L EP
Sbjct: 340 GLAT--------WDNWKHVNCDKLTTII------------ESSLNVLEP---------AE 370
Query: 385 FKKQFAYLEEHYGKGTTVAPPERQHASLPRP--CVLYSDKTVQNSAAVTDDLSKCSIKEV 442
++K F L +V PP A +P +++ D + V + L K S+ V
Sbjct: 371 YRKMFDRL--------SVFPP---SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL--V 417
Query: 443 EKPPMDRTSGIPM 455
EK P + T IP
Sbjct: 418 EKQPKESTISIPS 430
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 21/178 (11%), Positives = 54/178 (30%), Gaps = 50/178 (28%)
Query: 337 EFERRRITKEDVRELI---------YR--EILEYHP-QMLKEFLEGSEPTGFMYPSAVDH 384
+ + ++KE++ +I R L +M+++F+E
Sbjct: 40 DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVL------------ 87
Query: 385 FKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEK 444
+ + +L E++ S+ + + N V + ++ K
Sbjct: 88 -RINYKFLMSPIKT-------EQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK 139
Query: 445 PPMDRTSGIPMARLPIQVPQGMQGAARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRN 502
R + + + + G+ G+ GK + + A + +V
Sbjct: 140 L---RQALLELRPAKNVLIDGVLGS---GK---TWV---------ALDVCLSYKVQCK 179
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 30/167 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL-REIKLLRLLR 80
G YK+ IG+GS+GV+ + ++VAIK FE L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 81 H-PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL------- 132
I + + +E +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 174
Q+L ++ IH ++ +RD+KP N L + + + DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 16/159 (10%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-SDATRILREIKLLRLLR 80
G+++++ IG GS+G + + +T E+VAIK E+V + ++L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 81 -HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRG 138
I ++ E +V +L+ L + L+ + Q++
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 174
++++H+ + HRD+KP N L ++ I DFGLA+
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 8e-16
Identities = 57/235 (24%), Positives = 90/235 (38%), Gaps = 76/235 (32%)
Query: 30 VIGKGSYGVVCSAYD--TRTGEKVAIKKINDI-------FEHVSDATRILREIKLLRLLR 80
+IG G +G V Y R G KVA+K+ F EI+ L R
Sbjct: 46 LIGHGVFGKV---YKGVLRDGAKVALKRRTPESSQGIEEF---------ETEIETLSFCR 93
Query: 81 HPDIV-------EIKHILLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHY 128
HP +V E ++L +++ M + L+ ++ E
Sbjct: 94 HPHLVSLIGFCDERNEMIL------------IYKYMENGNLKRHLYGSDLPTMSMSWE-- 139
Query: 129 QFFLYQLL-------RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
Q L RGL Y+HT + HRD+K NIL + + KI DFG+++
Sbjct: 140 -----QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 182 TAIFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAELLTGKP 229
T +++T Y PE +F + T D++S G + E+L +
Sbjct: 195 T------HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 65/230 (28%)
Query: 30 VIGKGSYGVVCSAYD-TRTGEKVAIKKINDIFEHVSD--ATRILREIKLLRLLRHPDIV- 85
+G+G +GVV Y VA+KK+ + + ++ + +EIK++ +H ++V
Sbjct: 38 KMGEGGFGVV---YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 86 ------EIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL--- 136
+ + L V+ M N L L L
Sbjct: 95 LLGFSSDGDDLCL------------VYVYMP---------NGSL-----LDRLSCLDGTP 128
Query: 137 ---------------RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
G+ ++H + HRD+K NIL + KI DFGLAR +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 182 TAIFWTDYVA-TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
T + T + T Y APE L G + TP DI+S G + E++TG P
Sbjct: 189 TVM--TSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 36/176 (20%), Positives = 72/176 (40%), Gaps = 30/176 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+ +K+ IG+G +G + A D + E V + SD + E+K +
Sbjct: 34 AAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAK 92
Query: 82 PDIVE-------IKHILLPP-------SRREFKDIYVVFELMESDLHQVIKANDDLTPEH 127
P+ ++ +K++ +P + +++ + SDL ++ +AN
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------ 146
Query: 128 YQFFL-------YQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLAR 174
+F ++L L+YIH H D+K N+L ++ + D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 26/176 (14%), Positives = 63/176 (35%), Gaps = 30/176 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG--------EKVAIKKINDIFEHVSDATRILREI 73
G ++K++ + + G++ A T T +K ++K + R+ E
Sbjct: 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKD--GRLFNEQ 93
Query: 74 KLL-RLLRHPDIVEIKHILLPPS----------RREFKDIYVVFELMESDLHQVIKANDD 122
R + + + K + P + K ++V + L + +
Sbjct: 94 NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPK 153
Query: 123 LT-PEHYQFFL-YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI--CDFGLAR 174
E + +LL L+++H H ++ +NI + + + ++ +G A
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 18/140 (12%)
Query: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
+E + D LT EH + +Q+ +G++++ + HRDL +NIL + +KIC
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 169 DFGLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 222 AELLT-GKPLFPGKNVVHQL 240
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 45/220 (20%)
Query: 30 VIGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPDIV- 85
++G+G +G V Y G VA+K++ + E E++++ + H +++
Sbjct: 37 ILGRGGFGKV---YKGRLADGTLVAVKRLKE--ERTQGGELQFQTEVEMISMAVHRNLLR 91
Query: 86 ------EIKHILLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLT-PEHYQFFLY 133
LL V+ M S L + ++ L P+ + L
Sbjct: 92 LRGFCMTPTERLL------------VYPYMANGSVASCLRERPESQPPLDWPKRQRIAL- 138
Query: 134 QLLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
RGL Y+H + HRD+K NIL + + + + DFGLA++ + T + T
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVT-TAVR 196
Query: 191 ATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
T + APE G K + D++ G + EL+TG+
Sbjct: 197 GTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 560 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.57 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.44 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.17 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.37 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.31 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.24 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.05 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.01 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.92 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.81 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.81 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.73 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.71 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.62 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.74 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.87 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.98 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-68 Score=568.48 Aligned_cols=343 Identities=50% Similarity=0.888 Sum_probs=300.2
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS- 95 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~- 95 (560)
..|.++++|++++.||+|+||+||+|+++.+|+.||||+|++.........++.+|+++|+.|+|||||++++++....
T Consensus 48 ~~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 48 VTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp CCCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 3467789999999999999999999999999999999999876666677788999999999999999999999986542
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..+...+|||||||+|+|.+++..++.+++..++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 128 ~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 128 YGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp TTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 34557899999999999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCC-CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 176 AFNDT-PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 176 ~~~~~-~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
..... .......+.+||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|....|+|..+.
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 54322 222334678999999999998763 4679999999999999999999999999999999999999999999988
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKM 334 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~ 334 (560)
+..........++..+....+.++...+++++++++|||++||++||.+|||++|+|+||||+.......++...+ .+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~--~~ 364 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP--PF 364 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--CC
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--CC
Confidence 8777777788888888888888888889999999999999999999999999999999999999887777766544 34
Q ss_pred hhhHHhhcCCHHHHHHHHHHHHHhhChh
Q 008607 335 EFEFERRRITKEDVRELIYREILEYHPQ 362 (560)
Q Consensus 335 ~~~~e~~~~~~e~~~e~i~~ei~~~~p~ 362 (560)
++.++...++.+++++.|++|+.++|..
T Consensus 365 ~~~~~~~~~~~~~~k~~i~~ei~~~~~~ 392 (398)
T 4b99_A 365 DFAFDREALTRERIKEAIVAEIEDFHAR 392 (398)
T ss_dssp CCHHHHSCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCccchhhcCHHHHHHHHHHHHHHHHHH
Confidence 6677888899999999999999988753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-60 Score=512.36 Aligned_cols=347 Identities=42% Similarity=0.756 Sum_probs=289.7
Q ss_pred ccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 16 ~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
...|.+.++|+++++||+|+||+||+|++..+|+.||||++...........++.+|+.+|+.++||||+++++++....
T Consensus 46 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 46 HSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CSSCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCcCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 34577889999999999999999999999999999999999877777777889999999999999999999999997766
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
......+|+||||++++|.+++.....+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 126 ~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 126 VEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 66667899999999999999999988899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCC------------------------cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-----
Q 008607 176 AFNDTPT------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT----- 226 (560)
Q Consensus 176 ~~~~~~~------------------------~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt----- 226 (560)
....... ....+.++||++|+|||++... ..|+.++||||||||||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 5422111 1134667999999999986432 579999999999999999999
Q ss_pred ------CCCCCCCCC--------------------hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCC
Q 008607 227 ------GKPLFPGKN--------------------VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 280 (560)
Q Consensus 227 ------G~~pF~~~~--------------------~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 280 (560)
|+++|+|.+ ..+++..|.+++|+|..+.+..+....+..++..+.......+..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 889998865 368899999999999999999999999999999998888888999
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhhHHhhcCCHHHHHHHHHHHHHhhC
Q 008607 281 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360 (560)
Q Consensus 281 ~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~ 360 (560)
.++.+++.+++||++||.+||.+|||++|+|+||||+++.....++.......+.++ +...++.+++++.+++||..|+
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~ 443 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYH 443 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTC
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999999999998776666544332233332 3357889999999999999999
Q ss_pred hhHH
Q 008607 361 PQML 364 (560)
Q Consensus 361 p~~~ 364 (560)
|++.
T Consensus 444 ~~~~ 447 (458)
T 3rp9_A 444 PEIQ 447 (458)
T ss_dssp TTCC
T ss_pred cccc
Confidence 8743
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-59 Score=505.72 Aligned_cols=351 Identities=39% Similarity=0.698 Sum_probs=302.2
Q ss_pred CCcccccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcccccee
Q 008607 11 ADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90 (560)
Q Consensus 11 ~~~~~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i 90 (560)
..-..+..+.+.++|++++.||+|+||.||+|++..+|+.||||++...+.......++.+|+.+|+.++|+||++++++
T Consensus 14 ~~~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 93 (432)
T 3n9x_A 14 LYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93 (432)
T ss_dssp CCTTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 34456778899999999999999999999999999999999999998777777778899999999999999999999999
Q ss_pred ecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecc
Q 008607 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (560)
Q Consensus 91 ~~~~~~~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DF 170 (560)
+..........+|+|||||+++|.+++.....+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 94 IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp CCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred EecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccC
Confidence 97766555678999999999999999999888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC-------------------cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-----
Q 008607 171 GLARVAFNDTPT-------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT----- 226 (560)
Q Consensus 171 Gla~~~~~~~~~-------------------~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt----- 226 (560)
|+|+........ ....+.++||++|+|||++... ..|+.++||||||||+|||++
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccc
Confidence 999875433211 0234678999999999986432 579999999999999999998
Q ss_pred ------CCCCCCCCC-----------------hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCC
Q 008607 227 ------GKPLFPGKN-----------------VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP 283 (560)
Q Consensus 227 ------G~~pF~~~~-----------------~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 283 (560)
|.++|.|.+ ..+++..|.+++|+|..+.+..+....+..++..+....+.++...++
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 667777765 478999999999999999999999999999999998888888888889
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhhHHhhcCCHHHHHHHHHHHHHhhChhH
Q 008607 284 NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 363 (560)
Q Consensus 284 ~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~~ 363 (560)
.+++.+.+||++||++||.+|||++|+|+||||+++.....++.........|+ +...++.+++++.+++|+..++|++
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~ 411 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPEL 411 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTC
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCccc
Confidence 999999999999999999999999999999999998877766544332222332 2357899999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-61 Score=496.89 Aligned_cols=257 Identities=28% Similarity=0.511 Sum_probs=222.2
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.|+++++||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+|+.++|||||+++++|.+. ..+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ 146 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DEL 146 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence 569999999999999999999999999999999975322 2345678999999999999999999999554 469
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|||||||+| +|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.......
T Consensus 147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999985 89998876 4699999999999999999999999999999999999999999999999999987643322
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
..++.+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|.+..
T Consensus 226 ---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------- 286 (346)
T 4fih_A 226 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 286 (346)
T ss_dssp ---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS--------------
T ss_pred ---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--------------
Confidence 2356899999999999977 689999999999999999999999999988777666554311
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.+....+..+++.+++||.+||++||++|||++|+|+||||++..
T Consensus 287 --------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 287 --------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp --------------CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 011123456899999999999999999999999999999998643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-61 Score=491.68 Aligned_cols=260 Identities=27% Similarity=0.469 Sum_probs=224.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|+++++||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.|+|||||+++++|.+. .
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----E 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence 356999999999999999999999999999999997432 2233456789999999999999999999999543 4
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|||||||+| +|.++|.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 69999999985 99999999889999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. .....+.|||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+....+..|...
T Consensus 186 ~~-~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------------- 249 (311)
T 4aw0_A 186 SK-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL------------- 249 (311)
T ss_dssp TT-CCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------
T ss_pred CC-cccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------
Confidence 22 223456899999999999987 68999999999999999999999999998877666555431
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE------ALADPYFKGLA 320 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~e------lL~hp~f~~~~ 320 (560)
...+ ...+++.+++||++||++||.+|||++| +++||||+++.
T Consensus 250 ---------------~~~~---p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 250 ---------------EYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp ---------------CCCC---CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ---------------CCCC---CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 0111 2367899999999999999999999987 68999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=482.04 Aligned_cols=254 Identities=32% Similarity=0.545 Sum_probs=206.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++++.||+|+||+||+|+++.+|+.||||++++... ......++.+|+.+|+.++|||||++++++.+. ..
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CE
Confidence 479999999999999999999999999999999975432 233456789999999999999999999999543 46
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 102 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
+|||||||+|+|.+++.+++.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 88 ~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998654322
Q ss_pred CcccccccccCcccccccccccccCCC-CCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
...+.+||+.|+|||++.+ ..| +.++|||||||++|+|++|++||.+.+....+..|...
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~-------------- 227 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG-------------- 227 (275)
T ss_dssp -----------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------
T ss_pred ---ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------------
Confidence 2356799999999999976 444 68999999999999999999999988766555444321
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
. .. ....+++.+++||++||++||.+|||++|+|+||||+.
T Consensus 228 ------------~--~~---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 228 ------------V--YT---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ------------C--CC---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ------------C--CC---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 0 11 12457899999999999999999999999999999973
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-61 Score=498.37 Aligned_cols=269 Identities=26% Similarity=0.445 Sum_probs=220.2
Q ss_pred CCCcccccc---cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccc
Q 008607 10 SADVDFFTE---YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVE 86 (560)
Q Consensus 10 ~~~~~~~~~---~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~ 86 (560)
|+++|+=++ |..-++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.|+|||||+
T Consensus 8 ssgvd~gten~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~ 87 (350)
T 4b9d_A 8 SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87 (350)
T ss_dssp -------CCCCBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCccCCCcccCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 445554332 23347999999999999999999999999999999999866556666788999999999999999999
Q ss_pred cceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC
Q 008607 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC 163 (560)
Q Consensus 87 l~~i~~~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~ 163 (560)
+++++.+. ..+|||||||+ |+|.++|...+ .+++..++.|+.||+.||+|||++||+||||||+||||+.+|
T Consensus 88 ~~~~~~~~-----~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g 162 (350)
T 4b9d_A 88 YRESFEEN-----GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG 162 (350)
T ss_dssp EEEEEEET-----TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC
T ss_pred EEEEEEEC-----CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC
Confidence 99999543 46999999998 59999997643 579999999999999999999999999999999999999999
Q ss_pred cEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHH
Q 008607 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243 (560)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i 243 (560)
.+||+|||+|+..... ....+..+||++|+|||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|
T Consensus 163 ~vKl~DFGla~~~~~~---~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i 237 (350)
T 4b9d_A 163 TVQLGDFGIARVLNST---VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237 (350)
T ss_dssp CEEECSTTEESCCCHH---HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CEEEcccccceeecCC---cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 9999999999865321 112356789999999999987 68999999999999999999999999998877766555
Q ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 244 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
... . +......+++.+.+||.+||++||.+|||++|+|+||||++
T Consensus 238 ~~~--------------------------~----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 238 ISG--------------------------S----FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHT--------------------------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HcC--------------------------C----CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 431 0 11223567999999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=498.64 Aligned_cols=256 Identities=28% Similarity=0.509 Sum_probs=222.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+|+.|+|||||+++++|... ..+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ 223 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DEL 223 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEE
Confidence 56999999999999999999999999999999997532 23345688999999999999999999999654 469
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|||||||+| +|.++++.. .+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.......
T Consensus 224 ~iVmEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEEEECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EEEEeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999985 899988754 699999999999999999999999999999999999999999999999999987643322
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
.....+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|....
T Consensus 303 ---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------- 363 (423)
T 4fie_A 303 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 363 (423)
T ss_dssp ---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------------
T ss_pred ---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--------------
Confidence 2366899999999999987 689999999999999999999999999988777666554311
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.+....+..+++.+++||.+||++||.+|||++|||+||||+..
T Consensus 364 --------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 364 --------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp --------------CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred --------------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 11123345789999999999999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-59 Score=475.49 Aligned_cols=260 Identities=27% Similarity=0.381 Sum_probs=217.7
Q ss_pred CCce-EEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y-~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..+| ++.++||+|+||+||+|+++.++..||||++...........++.+|+++|+.|+|||||+++++|.... ....
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCc
Confidence 3455 8889999999999999999999999999999865556666788999999999999999999999985422 2234
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeCC-CCcEEEecccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVA 176 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~~-~~~lKL~DFGla~~~ 176 (560)
.+|||||||+ |+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+||||+. ++.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 6899999998 599999999889999999999999999999999999 999999999999985 799999999999864
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... ...+.+||+.|||||++.+ .|+.++|||||||+||||+||++||.+.+...++......
T Consensus 183 ~~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~---------- 244 (290)
T 3fpq_A 183 RAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS---------- 244 (290)
T ss_dssp CTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT----------
T ss_pred CCC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc----------
Confidence 322 2356799999999999865 6999999999999999999999999876654433222110
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
...+ .......++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 245 ---------------~~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 245 ---------------GVKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ---------------TCCC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ---------------CCCC---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0001 1112356789999999999999999999999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=484.53 Aligned_cols=335 Identities=42% Similarity=0.777 Sum_probs=286.7
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS- 95 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~- 95 (560)
+.|...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++....
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 3467789999999999999999999999999999999999876666667788999999999999999999999997653
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
......+|+||||++++|.+++.. +.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 99 LDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 234456899999998899999977 4799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
.... .+.+++|++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|+|..+.+
T Consensus 178 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 5322 2557899999999998653 47899999999999999999999999999999999999999999999999
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcch
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKME 335 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~ 335 (560)
..+.......++..+.......+...++.+++.+.+||++||++||.+|||++|+|+||||+.+.....++... .++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~---~~~ 327 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYD 327 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCC
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC---CCC
Confidence 99999999999999988888888888999999999999999999999999999999999999988777666554 345
Q ss_pred hhHHhhcCCHHHHHHHHHHHHHhhChh
Q 008607 336 FEFERRRITKEDVRELIYREILEYHPQ 362 (560)
Q Consensus 336 ~~~e~~~~~~e~~~e~i~~ei~~~~p~ 362 (560)
+.++....+.+++++.+++|++.++|+
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (367)
T 1cm8_A 328 DSFDDVDRTLDEWKRVTYKEVLSFKPP 354 (367)
T ss_dssp CC-----CCHHHHHHHHHHHHHTCCC-
T ss_pred CChhhhcCCHHHHHHHHHHHHHHhccc
Confidence 667777889999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-60 Score=484.46 Aligned_cols=258 Identities=26% Similarity=0.442 Sum_probs=215.6
Q ss_pred CCCceEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
.+++|++++.||+|+||+||+|++. .+++.||||++++.........++.+|+.+|+.++|||||++++++.+.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--- 98 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE--- 98 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET---
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC---
Confidence 3578999999999999999999984 4788999999976443333445688999999999999999999999543
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+|||||||+ |+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 99 --~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 99 --GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp --TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred --CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 46999999998 599999999889999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
..... ...+.+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..|.+.
T Consensus 177 ~~~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------- 241 (304)
T 3ubd_A 177 IDHEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA---------- 241 (304)
T ss_dssp ----C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred cCCCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC----------
Confidence 33221 2356799999999999977 68999999999999999999999999998877766655431
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~ 319 (560)
. . .....+++.+.+||++||++||.+||| ++|+|+||||+++
T Consensus 242 ----------------~--~---~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 242 ----------------K--L---GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp ----------------C--C---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred ----------------C--C---CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 0 1 112457999999999999999999998 5899999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-58 Score=484.47 Aligned_cols=340 Identities=39% Similarity=0.725 Sum_probs=274.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.+. ||||+++++++.... ..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---DR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---SS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---CC
Confidence 36899999999999999999999999999999999877777778888999999999997 999999999986532 34
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 101 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
.+|+|||||+++|.+++..+ .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp CEEEEEECCSEEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEEecccCcCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 68999999999999999874 79999999999999999999999999999999999999999999999999998653211
Q ss_pred ------------------CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHH
Q 008607 181 ------------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (560)
Q Consensus 181 ------------------~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (560)
......+.++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111224567999999999998653 5789999999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHhhhHHHHHHHHhhccCC---CCCCCCCCC-------------CCCHHHHHHHHHhcccCCCCCCC
Q 008607 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKK---PIPFSQKFP-------------NANPLALRLLERMLAFEPKDRPT 306 (560)
Q Consensus 243 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~~-------------~~s~~~~dLI~~mL~~DP~~Rpt 306 (560)
|...++.|..+.+..+.......++..+.... ...+...++ .+++.+.+||++||++||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 99999999999988877776666666654433 222333332 77899999999999999999999
Q ss_pred HHHHhcCcccccccccCCCCCCCCCCcchhhHHhhcCCHHHHHHHHHHHHHhhChhHHHhh
Q 008607 307 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEF 367 (560)
Q Consensus 307 a~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~~~~~~ 367 (560)
++|+|+||||+.+.....++.+.......+. .....+.+++++.+|+++.++++++..+.
T Consensus 323 ~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 382 (388)
T 3oz6_A 323 ANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELISNK 382 (388)
T ss_dssp HHHHTTSTTTTTTCCGGGCCCCSSCCCCC-------CCHHHHHHHHHHHHHHHHHHHTCC-
T ss_pred HHHHhCCHHHHHhcCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhhhhhhhhc
Confidence 9999999999999888777766554333332 23467899999999999999998876543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-58 Score=482.91 Aligned_cols=335 Identities=43% Similarity=0.822 Sum_probs=282.3
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-c
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-R 96 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~-~ 96 (560)
.|...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.... .
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp EEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred ccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence 466789999999999999999999999999999999999876666667788999999999999999999999986542 2
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 97 ~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
.....+|+|+|+++++|.+++.. +.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 104 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp GGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred ccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 34467899999999999998876 57999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... .+..+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|+|..+.+.
T Consensus 183 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 183 ADE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp --------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ccc------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 322 2457899999999998653 468999999999999999999999999999999999999999999999999
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchh
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 336 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 336 (560)
.+.....+.++..+.......+...++++++.+.+||++||++||.+|||++|+|+||||+.+.....++...+ +++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~~ 332 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQ 332 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CCG
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CCc
Confidence 99999999999988887777888888899999999999999999999999999999999999887776665543 456
Q ss_pred hHHhhcCCHHHHHHHHHHHHHhhChhH
Q 008607 337 EFERRRITKEDVRELIYREILEYHPQM 363 (560)
Q Consensus 337 ~~e~~~~~~e~~~e~i~~ei~~~~p~~ 363 (560)
.++......+++++++|+|+..++|+.
T Consensus 333 ~~~~~~~~~~~~~~~~~~e~~~~~~~~ 359 (367)
T 2fst_X 333 SLESRDLLIDEWKSLTYDEVISFVPPP 359 (367)
T ss_dssp GGSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred chhhccCCHHHHHHHHHHHHHHhccCc
Confidence 667778899999999999999998874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=477.05 Aligned_cols=258 Identities=26% Similarity=0.357 Sum_probs=216.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.|+|||||++++++.+. ..
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~-----~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREG-----PW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEET-----TE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 4679999999999999999999999999999999974321 24799999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC-cEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~-~lKL~DFGla~~~~~~ 179 (560)
+|||||||+ |+|.++|+..+.+++..++.|+.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+....+
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999998 59999999988999999999999999999999999999999999999999997 6999999999876443
Q ss_pred CCCcc--cccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 180 TPTAI--FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 180 ~~~~~--~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
..... .....+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+....+..|..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------------ 270 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------------ 270 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------------
Confidence 22111 1234689999999999987 6899999999999999999999999998776555444432
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH-------------hcCcccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA-------------LADPYFKGLAK 321 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~el-------------L~hp~f~~~~~ 321 (560)
.+.++....+.+++.+.+||.+||++||.+|||+.|+ |+|||+.....
T Consensus 271 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 271 ----------------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp ----------------SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred ----------------CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 1112234456889999999999999999999999997 57999986543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=477.95 Aligned_cols=286 Identities=27% Similarity=0.440 Sum_probs=223.8
Q ss_pred CCCceEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~ 96 (560)
..++|++.++||+|+||+||+|+++ .+++.||||++... ....++.+|+++|+.+ .||||++++++|...
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-- 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-- 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--
Confidence 4578999999999999999999875 46889999998642 3456788999999988 599999999999543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC-CcEEEecccccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLAR 174 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-~~lKL~DFGla~ 174 (560)
.++|||||||+ |+|.+++. .+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 93 ---~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 93 ---DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp ---TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred ---CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 47999999998 59999883 59999999999999999999999999999999999999987 799999999998
Q ss_pred cccCCCCC-------------------------cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCC
Q 008607 175 VAFNDTPT-------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229 (560)
Q Consensus 175 ~~~~~~~~-------------------------~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~ 229 (560)
........ ....++.+||++|+|||++.+. ..|+.++||||+|||+|||++|+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCC
Confidence 64322110 1123457899999999998763 468999999999999999999998
Q ss_pred CC-CCCChhhHHHHHHHhcCCCCHHHHHHhhh-----------HHHHHHHHhhcc---CC---------CCCCCCCCCCC
Q 008607 230 LF-PGKNVVHQLDIMTDLLGTPSPEAIARVRN-----------EKARRYLSSMRK---KK---------PIPFSQKFPNA 285 (560)
Q Consensus 230 pF-~~~~~~~~~~~i~~~~g~p~~~~~~~~~~-----------~~~~~~l~~~~~---~~---------~~~~~~~~~~~ 285 (560)
|| .+.+..+++..|..++|++.......... ...+.....+.. .. .......+..+
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 87 57788899999999999765433322110 001111111110 00 01112345678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 286 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 286 s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
+++++|||++||++||.+|+|++|+|+||||+++
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-57 Score=489.08 Aligned_cols=333 Identities=37% Similarity=0.696 Sum_probs=267.3
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-RE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~~ 98 (560)
...++|++++.||+|+||+||+|++..+|+.||||++...........++.+|+.+|+.++||||+++++++..... .+
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 34589999999999999999999999999999999998766677778889999999999999999999999976532 44
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
...+|||||||+++|.+.+.. .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 567999999999999988854 499999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. ..+..+||++|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+++..|.+.+|+|.++.+..+
T Consensus 217 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 217 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp CC----CC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred Cc----ccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 22 2356899999999999987 58999999999999999999999999999999999999999999999888776
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCC------------CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCC
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNA------------NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 326 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~------------s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~ 326 (560)
. ...+.++..........+...++.. ++.+++||++||++||.+|||++|+|+||||+.+.......
T Consensus 291 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~ 369 (464)
T 3ttj_A 291 Q-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE 369 (464)
T ss_dssp C-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHS
T ss_pred c-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCccccc
Confidence 4 4456666655544444444443332 57799999999999999999999999999999876544322
Q ss_pred CCCCCCcchhhHHhhcCCHHHHHHHHHHHHHhhChh
Q 008607 327 SAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQ 362 (560)
Q Consensus 327 ~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~ 362 (560)
. .+....++.++....+.+++++.+++|+..++..
T Consensus 370 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 404 (464)
T 3ttj_A 370 A-PPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEK 404 (464)
T ss_dssp C-CC-----------CCCHHHHHHHHHHHHHC----
T ss_pred C-CCCccCCcchhhccCCHHHHHHHHHHHHHHhhhc
Confidence 2 1222345566777888999999999999865543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=460.86 Aligned_cols=340 Identities=48% Similarity=0.864 Sum_probs=292.8
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
.+..+++|++++.||+|+||.||+|++..++..||||++.. .........+.+|+++|+.++||||+++++++......
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc-ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 36778999999999999999999999999999999999974 23444557889999999999999999999999776655
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
....+|+||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEcccCcCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 56679999999999999999764 69999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
............+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|...+|.|..+.+..
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 433333334567899999999987542 4689999999999999999999999999999999999999999999999998
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhh
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (560)
..+.....+...+......++...++.+++.+.+||.+||++||.+|||++|+|+||||+.......++.... .+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~--~~~~~ 336 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFD 336 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CCCCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC--cCCcc
Confidence 8888888888888877778888888899999999999999999999999999999999998765554443332 23444
Q ss_pred HHhhcCCHHHHHHHHHHHHHhhChh
Q 008607 338 FERRRITKEDVRELIYREILEYHPQ 362 (560)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p~ 362 (560)
.+...+.++++++++++|+..++|.
T Consensus 337 ~~~~~~~~~~~~~~~~~e~~~~~~~ 361 (364)
T 3qyz_A 337 MELDDLPKEKLKELIFEETARFQPG 361 (364)
T ss_dssp -----CCHHHHHHHHHHHTGGGCC-
T ss_pred cccccCCHHHHHHHHHHHHHHhhhh
Confidence 5667888999999999999988876
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-56 Score=452.76 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=200.7
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-------
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR------- 96 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~------- 96 (560)
.|++++.||+|+||+||+|+++.+|+.||||+++.. .......++.+|+++|+.|+|||||+++++|.....
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 599999999999999999999999999999999743 233455678999999999999999999999865332
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~~---lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGl 172 (560)
....++|||||||+ |+|.+++..... ..+..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 12335899999998 599999987664 45567899999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCc---------ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHH
Q 008607 173 ARVAFNDTPTA---------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243 (560)
Q Consensus 173 a~~~~~~~~~~---------~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i 243 (560)
|+......... ...+..+||+.|||||++.+ ..|+.++|||||||+||||++ ||.+. .+....+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~ 237 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL 237 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence 98764432211 12345789999999999987 689999999999999999996 77542 2333333
Q ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 244 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
..+.....+ ..++..++.+.+||++||+.||.+|||++|+|+||||+++.
T Consensus 238 ~~~~~~~~p---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 238 TDVRNLKFP---------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHTTCCC---------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHhcCCCC---------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 222111111 11223467788999999999999999999999999998764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=447.49 Aligned_cols=332 Identities=42% Similarity=0.766 Sum_probs=282.3
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (560)
|...++|++.+.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 556789999999999999999999999999999999998766666667888999999999999999999999965432 2
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
....+|+||||++++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 118 NFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp TCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred cceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 223459999999999998874 359999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.. ....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.|..+.+..
T Consensus 196 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 196 AE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cC------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 22 2456899999999998652 4789999999999999999999999999999999999999999999998888
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhh
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (560)
+.......++..+.......+...++.+++.+.+||++||+.||.+|||++|+|+||||+.+.....+..... .+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~--~~~~~ 346 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDS 346 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccccccc--CcCcc
Confidence 8777777888877776666677777889999999999999999999999999999999998765544433222 12223
Q ss_pred HHhhcCCHHHHHHHHHHHHHhhCh
Q 008607 338 FERRRITKEDVRELIYREILEYHP 361 (560)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p 361 (560)
.+....+.+++++.+++|+.+|+|
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 347 LEHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp TSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred hhhcccchHHHHHHHHHHHHhccc
Confidence 345678899999999999999876
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=479.51 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=225.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++++.||+|+||+||+|+++.+|+.||||++... ...+...+.+|+.+|+.|+|||||+++++|... ..+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 229 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEM 229 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-----SEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEE
Confidence 5899999999999999999999999999999999753 345567789999999999999999999999543 579
Q ss_pred EEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC--CcEEEecccccccccC
Q 008607 103 YVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFN 178 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~--~~lKL~DFGla~~~~~ 178 (560)
|||||||+ |+|.++|.. .+.|++..++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999998 599999964 4579999999999999999999999999999999999999865 8999999999987643
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. .....+||++|+|||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|......+
T Consensus 310 ~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 375 (573)
T 3uto_A 310 KQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-------- 375 (573)
T ss_dssp TS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC--------
T ss_pred CC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC--------
Confidence 32 2356799999999999987 689999999999999999999999999998877776664421111
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
....++.+++.+++||++||++||.+|||++|+|+||||+.....
T Consensus 376 -------------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 376 -------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp -------------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred -------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 123346789999999999999999999999999999999865443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=440.84 Aligned_cols=332 Identities=42% Similarity=0.766 Sum_probs=282.5
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (560)
+...++|++.+.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 445689999999999999999999999999999999998665555666788999999999999999999999865432 1
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
....+|+||||++++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 100 NFYDFYLVMPFMQTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp GCCCCEEEEECCSEEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cceeEEEEeccccCCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 2335699999999998887743 59999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.. ....++|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..+.+.+|.|..+.+..
T Consensus 178 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 178 AE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp ------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CC------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 22 2456899999999998652 4688999999999999999999999999999999999999999999998888
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhh
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (560)
+.......++..+.......+...++.+++.+.+||.+||+.||.+|||++|+|+||||+.+...+.+..... .+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~--~~~~~ 328 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDS 328 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC--CCccc
Confidence 8877777888877776666777778899999999999999999999999999999999998766554433322 23344
Q ss_pred HHhhcCCHHHHHHHHHHHHHhhCh
Q 008607 338 FERRRITKEDVRELIYREILEYHP 361 (560)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p 361 (560)
.+...++.+++++.|++|+.++.|
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 329 LEHEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp TTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred hhhccCCHHHHHHHHHHHHHhhcc
Confidence 456788999999999999998765
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-54 Score=475.31 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=212.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHH---HHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRIL---REIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~---rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
+.|+++++||+|+||.||+|+++.+|+.||||+|.+... .......+. +++.+++.++|||||+++++|.+.
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~---- 264 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---- 264 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS----
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC----
Confidence 679999999999999999999999999999999964211 111122333 446667778899999999999554
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|||||||. |+|.++|...+.|++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+...
T Consensus 265 -~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 265 -DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred -CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 46999999998 5999999998999999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... ..+.|||+.|+|||++.+. ..|+.++||||||||||||++|++||.+.+..+....+...+
T Consensus 344 ~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~---------- 407 (689)
T 3v5w_A 344 KKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---------- 407 (689)
T ss_dssp SCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH----------
T ss_pred CCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc----------
Confidence 332 2457999999999999531 479999999999999999999999998755433322111110
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~~ 320 (560)
. ... .....+++.+++||.+||++||.+|++ ++||++||||+++.
T Consensus 408 --------------~-~~~---~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 408 --------------T-MAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp --------------H-CCC---CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred --------------C-CCC---CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 0 011 123468999999999999999999998 89999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=435.41 Aligned_cols=337 Identities=42% Similarity=0.808 Sum_probs=277.0
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
.+...++|++.+.||+|+||.||+|.+..+|+.||||++.. .........+.+|+.+|+.++||||+++++++......
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc-cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 45678999999999999999999999999999999999963 23444566788999999999999999999988765555
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
....+|+||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 85 NFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp TCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 5678999999999999999977 469999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCc-------ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCC
Q 008607 178 NDTPTA-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (560)
Q Consensus 178 ~~~~~~-------~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p 250 (560)
...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...+|.|
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 322111 112346899999999987542 468899999999999999999999999999999999999999887
Q ss_pred CHH-HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCC
Q 008607 251 SPE-AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQ 329 (560)
Q Consensus 251 ~~~-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~ 329 (560)
... ............++..+.......+...++.+++.+.+||++||+.||.+|||++|+|+||||+.......++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~ 322 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGE 322 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccC
Confidence 632 2233333445566666555544555556678999999999999999999999999999999999887766555554
Q ss_pred CCCc--chhhHHhhcCCHHHHHHHHHHHHH
Q 008607 330 PVTK--MEFEFERRRITKEDVRELIYREIL 357 (560)
Q Consensus 330 ~~~~--~~~~~e~~~~~~e~~~e~i~~ei~ 357 (560)
++.. +++......++.+++++++++||.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 323 PIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred CCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 4443 445556678899999999999884
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=435.84 Aligned_cols=257 Identities=23% Similarity=0.301 Sum_probs=207.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.+++++.++||+|+||+||+|++. ..||||+++...........+.+|+.+|+.++|||||++++++.. ..
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence 478999999999999999999753 369999997655556667889999999999999999999998732 24
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 799999998 6999999764 57999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
... ......+||+.|||||++.+. ...|+.++|||||||+||||+||+.||.+.+....+..+...
T Consensus 186 ~~~-~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~------------ 252 (307)
T 3omv_A 186 SGS-QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR------------ 252 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT------------
T ss_pred Ccc-eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc------------
Confidence 221 123557899999999998542 246899999999999999999999999987765544333211
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
...........+++++.+.+||.+||+.||++|||+.|++++
T Consensus 253 -------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 253 -------------GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp -------------TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred -------------CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111112334456789999999999999999999999988653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=435.82 Aligned_cols=266 Identities=24% Similarity=0.358 Sum_probs=216.3
Q ss_pred cccccccCCCCceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcccc
Q 008607 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEI 87 (560)
Q Consensus 13 ~~~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l 87 (560)
+|=|...-..++|.+.+.||+|+||+||+|++. .++..||||+++.. .......+.+|+++|+.|+|||||++
T Consensus 3 ~d~~~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l 80 (299)
T 4asz_A 3 MDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKF 80 (299)
T ss_dssp GGGSCCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred chhhhcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccE
Confidence 343444455678999999999999999999875 46889999999753 34456789999999999999999999
Q ss_pred ceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 008607 88 KHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (560)
Q Consensus 88 ~~i~~~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~-------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLK 153 (560)
++++... ..+|||||||+ |+|.+++...+ .+++..+..|+.||+.||+|||+++|+|||||
T Consensus 81 ~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlK 155 (299)
T 4asz_A 81 YGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLA 155 (299)
T ss_dssp EEEECSS-----SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEeeC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccC
Confidence 9999543 46899999998 69999997642 59999999999999999999999999999999
Q ss_pred CCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCC
Q 008607 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFP 232 (560)
Q Consensus 154 P~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~ 232 (560)
|+|||++.++.+||+|||+|+........ ......+||+.|+|||++.+ ..|+.++|||||||+||||+| |+.||.
T Consensus 156 p~NILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~ 232 (299)
T 4asz_A 156 TRNCLVGENLLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWY 232 (299)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred HhhEEECCCCcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999865433221 11234579999999999977 689999999999999999998 899999
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 233 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
+.+..+.+..+... ... .....+++.+.+||.+||+.||++|||++|+
T Consensus 233 ~~~~~~~~~~i~~~---------------------------~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i-- 280 (299)
T 4asz_A 233 QLSNNEVIECITQG---------------------------RVL---QRPRTCPQEVYELMLGCWQREPHMRKNIKGI-- 280 (299)
T ss_dssp TSCHHHHHHHHHHT---------------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--
T ss_pred CCCHHHHHHHHHcC---------------------------CCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHH--
Confidence 88866655444321 001 1124678999999999999999999999999
Q ss_pred Cccccccc
Q 008607 313 DPYFKGLA 320 (560)
Q Consensus 313 hp~f~~~~ 320 (560)
|+||+.+.
T Consensus 281 ~~~L~~~~ 288 (299)
T 4asz_A 281 HTLLQNLA 288 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 45776554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=441.82 Aligned_cols=330 Identities=38% Similarity=0.695 Sum_probs=255.9
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~-~~~~ 99 (560)
..++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.... ..+.
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 357899999999999999999999999999999999865556666778899999999999999999999986543 2344
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
..+|+|||||+++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred cceEEEEEcCCCCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 57899999999999999863 5999999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+++..+.+.++.|.++.+..+.
T Consensus 181 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 181 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp -------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 2345789999999999987 578999999999999999999999999999999999999999999988776553
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCC------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCC
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPN------------ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPS 327 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~------------~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~ 327 (560)
. ....++..........+...++. .++.+++||++||++||.+|||++|+|+||||+.+........
T Consensus 255 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~ 333 (371)
T 2xrw_A 255 P-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA 333 (371)
T ss_dssp H-HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC
T ss_pred h-HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC
Confidence 3 23334433222211111111111 1567999999999999999999999999999987654322111
Q ss_pred CCCCCcchhhHHhhcCCHHHHHHHHHHHHHhhC
Q 008607 328 AQPVTKMEFEFERRRITKEDVRELIYREILEYH 360 (560)
Q Consensus 328 ~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~ 360 (560)
..+ .......+.+..+.++++++++.++..+.
T Consensus 334 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 334 PPP-KIPDKQLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp CCC-CCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred CCC-CCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence 111 11223344567788999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=434.36 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=203.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.+.|.+.++||+|+||+||+|++. .++..||||+++. ........+.+|+++|+.|+|||||++++++...
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-- 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-- 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence 367999999999999999999865 4688999999975 3445567899999999999999999999999543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAN---------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~---------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
..+|||||||+ |+|.+++... +.+++..+..|+.||+.||+|||+.+|+||||||+||||+
T Consensus 116 ---~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 ---RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp ---SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred ---CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 46899999998 6999999764 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhH
Q 008607 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (560)
.++.+||+|||+|+........ ...+..+||+.|+|||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999865433221 12245689999999999987 689999999999999999999 8999998887665
Q ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 240 ~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
+..|... ... .....+++.+.+||.+||+.||++|||++||++
T Consensus 270 ~~~i~~g---------------------------~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 270 IDCITQG---------------------------REL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHHHHHT---------------------------CCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HHHHHcC---------------------------CCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 5544321 011 112467899999999999999999999999976
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=428.34 Aligned_cols=299 Identities=39% Similarity=0.667 Sum_probs=238.9
Q ss_pred CCCcccccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccce
Q 008607 10 SADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH 89 (560)
Q Consensus 10 ~~~~~~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~ 89 (560)
++..+-.+..+..++|++++.||+|+||+||+|.+. +|+.||||++............+.+|+.+|+.++||||+++++
T Consensus 8 ~~~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 86 (311)
T 3niz_A 8 SSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86 (311)
T ss_dssp -------CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeee
Confidence 334444456688899999999999999999999985 5999999999765444445577889999999999999999999
Q ss_pred eecCCCcCCCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEe
Q 008607 90 ILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (560)
Q Consensus 90 i~~~~~~~~~~~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~ 168 (560)
++... ..+|+|||||+++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 87 ~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~ 161 (311)
T 3niz_A 87 VIHSE-----RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLA 161 (311)
T ss_dssp EECCS-----SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEccC-----CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEc
Confidence 98533 4689999999999999988754 59999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcC
Q 008607 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g 248 (560)
|||+++....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++
T Consensus 162 Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 237 (311)
T 3niz_A 162 DFGLARAFGIPVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237 (311)
T ss_dssp CCTTCEETTSCCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHC
T ss_pred cCcCceecCCCcc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHC
Confidence 9999986533221 22456899999999998652 4689999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhhHHHHHHHH-hhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 249 TPSPEAIARVRNEKARRYLS-SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.+.+..+........ +.. ........++....+.+++.+.+||.+||++||.+|||++|+|+||||+++.
T Consensus 238 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 238 TPNPREWPQVQELPL--WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCCTTTSGGGTTSHH--HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred CCChHHhhhhhccch--hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 887765544332111 111 0111122233344567889999999999999999999999999999999753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=429.10 Aligned_cols=252 Identities=21% Similarity=0.351 Sum_probs=208.6
Q ss_pred CceEEEEEEeecCCeEEEEEEE-----CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
+.+++.+.||+|+||+||+|.. ..+++.||||+++... .......+.+|+.+|+.|+|||||++++++...
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--- 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--- 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC---
Confidence 5789999999999999999985 3577899999997532 233456799999999999999999999999543
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
..+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||+++|+||||||+||||+
T Consensus 102 --~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 102 --QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp --SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred --CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 35899999998 6999999753 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhH
Q 008607 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (560)
+++.+||+|||+|+........ ...+..+||+.|+|||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999865433221 12345689999999999977 689999999999999999998 8999999887665
Q ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 240 ~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
+..|... ... ....++++.+.+||.+||+.||.+|||+.||+++
T Consensus 257 ~~~i~~~---------------------------~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNR---------------------------QVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTT---------------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcC---------------------------CCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5444321 111 1234678999999999999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=416.31 Aligned_cols=287 Identities=38% Similarity=0.616 Sum_probs=235.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++... ..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEE
Confidence 579999999999999999999999999999999986555555667888999999999999999999998543 468
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+|||||+++|.+.+.. ++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988887766 56799999999999999999999999999999999999999999999999999986532221
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCC-CCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+..+++..+.+.++.|..+.+.....
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22456899999999998662 3489999999999999999987755 788888889999999999887665433221
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.. .+................+.+++.+.+||++||+.||.+|||++|+|+||||+++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cc--cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 00 00000000011122344567899999999999999999999999999999998753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=425.23 Aligned_cols=332 Identities=36% Similarity=0.670 Sum_probs=265.2
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc---------ChhHHHHHHHHHHHHHhcCCCCcccccee
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---------HVSDATRILREIKLLRLLRHPDIVEIKHI 90 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~---------~~~~~~~i~rEi~iL~~l~HpnIv~l~~i 90 (560)
...++|++.+.||+|+||.||+|.+.. |..||||++..... .......+.+|+.+|+.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 346789999999999999999999865 99999999864322 22234778999999999999999999999
Q ss_pred ecCCCcCCCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEec
Q 008607 91 LLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (560)
Q Consensus 91 ~~~~~~~~~~~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~D 169 (560)
+..........+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 8765544556799999999999999998654 699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCC
Q 008607 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (560)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~ 249 (560)
||+++....... ....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.
T Consensus 178 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 178 FNLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp TTC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cCcccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999975433222 2456899999999998653 46889999999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccC-CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCC
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKK-KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSA 328 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~ 328 (560)
|..+............++...... ....+....+..++.+.+||.+||+.||.+|||++|+|+||||+.+.........
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 332 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG 332 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc
Confidence 998887777666666665443322 2233444556789999999999999999999999999999999987544332211
Q ss_pred CCCCcchhhHHhhcCCHHHHHHHHHHHHHhhC
Q 008607 329 QPVTKMEFEFERRRITKEDVRELIYREILEYH 360 (560)
Q Consensus 329 ~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~ 360 (560)
. ...+.+++...+.+++++.++.|+.+++
T Consensus 333 ~---~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 333 L---SERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp C---CCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred c---ccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 1 1123455567788999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=421.95 Aligned_cols=259 Identities=27% Similarity=0.471 Sum_probs=224.1
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.-++|++++.||+|+||.||+|++..+|+.||||++...........++.+|+++|+.++||||+++++++... .
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-----K 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----C
Confidence 34679999999999999999999999999999999987666666778899999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+|||||+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 6999999997 599999998889999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCcccccccccccccCCC-CCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
. .....+||++|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 168 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------ 229 (328)
T 3fe3_A 168 G----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------------ 229 (328)
T ss_dssp C----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred C----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 2 2356789999999999976 344 47899999999999999999999998866555444321
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
... ....+++.+.+||++||.+||.+|||++|+|+||||+....
T Consensus 230 --------------~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 230 --------------KYR-----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp --------------CCC-----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred --------------CCC-----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 111 11246899999999999999999999999999999986543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=415.48 Aligned_cols=284 Identities=38% Similarity=0.657 Sum_probs=231.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++++.||+|+||.||+|.+ .+|+.||||++............+.+|+.+|+.++||||+++++++... ..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence 5799999999999999999998 7899999999975433333446788999999999999999999998543 468
Q ss_pred EEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+||||++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999999874 5799999999999999999999999999999999999999999999999999986532211
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..+...++.+....+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 12456789999999998652 46899999999999999999999999999999999999888887765443322110
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
..+...+....+.++......+++.+.+||++||+.||.+|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0011112222334455556778999999999999999999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=428.31 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=209.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCC-----CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCC-CCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~t-----g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~H-pnIv~l~~i~~~~~ 95 (560)
.++|++.+.||+|+||+||+|.+..+ ++.||||++... ........+.+|+++|..++| ||||++++++....
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 36899999999999999999987654 468999999743 233456779999999999975 89999999985432
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCee
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 158 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NIL 158 (560)
..+|||||||+ |+|.++|+.. ..+++..+..|+.||+.||+|||+++|+||||||+|||
T Consensus 142 ----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 142 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp ----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 35899999998 6999999763 24899999999999999999999999999999999999
Q ss_pred eCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChh
Q 008607 159 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVV 237 (560)
Q Consensus 159 l~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~ 237 (560)
++.++.+||+|||+|+....+... ......+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999876443321 22345789999999999987 689999999999999999998 99999987654
Q ss_pred hHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 238 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
..+..+.. . .... .....+++.+.+||.+||+.||.+|||+.||++|
T Consensus 295 ~~~~~~i~-----------------------~---g~~~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLK-----------------------E---GTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHH-----------------------H---TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHH-----------------------c---CCCC---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 43322211 0 0001 1124578999999999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=418.67 Aligned_cols=288 Identities=34% Similarity=0.568 Sum_probs=232.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc---ChhHHHHHHHHHHHHHhcC---CCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLR---HPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~---~~~~~~~i~rEi~iL~~l~---HpnIv~l~~i~~~~~ 95 (560)
.++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 5789999999999999999999999999999999864321 1112345667888877665 999999999987654
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 96 RREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~gdL~~~i~~~~~--lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
......+++||||++++|.+++..... +++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 334446899999999999999988654 999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
+....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..+.+.++.+...
T Consensus 168 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 168 RIYSYQMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp TTSTTCCC----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccCCCcc----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 86533222 255789999999999976 578999999999999999999999999999999999999988877654
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.+....... -..+....+.+.....+.+++.+.+||.+||++||.+|||++|+|+||||++.
T Consensus 242 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVSLP----RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TSCSSCSSC----GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccchhhcc----ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 332111000 00111122233334456789999999999999999999999999999999853
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=423.44 Aligned_cols=269 Identities=28% Similarity=0.451 Sum_probs=228.5
Q ss_pred cccccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh----hHHHHHHHHHHHHHhcCCCCccccc
Q 008607 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLRHPDIVEIK 88 (560)
Q Consensus 13 ~~~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~----~~~~~i~rEi~iL~~l~HpnIv~l~ 88 (560)
++.|..-...++|++.+.||+|+||+||+|+++.+|+.||||++....... .....+.+|+.+|+.++||||++++
T Consensus 2 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp --CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 455666677889999999999999999999999999999999997533221 1356788999999999999999999
Q ss_pred eeecCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC----
Q 008607 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---- 163 (560)
Q Consensus 89 ~i~~~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~---- 163 (560)
+++... ..+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 82 DVYENR-----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp EEEECS-----SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSC
T ss_pred EEEEeC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCcc
Confidence 998543 46999999997 69999998888899999999999999999999999999999999999998877
Q ss_pred cEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHH
Q 008607 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243 (560)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i 243 (560)
.+||+|||+++...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|
T Consensus 157 ~vkl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i 230 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (361)
T ss_dssp CEEECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CEEEEecCCceEcCCCC----ccccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 79999999998754332 2245789999999999976 57899999999999999999999999998877766665
Q ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 244 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
......... ..+..+++.+.+||++||..||.+|||++|+|+||||+..
T Consensus 231 ~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 231 TAVSYDFDE---------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HTTCCCCCH---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HhcCCCCCc---------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 543222221 1234678999999999999999999999999999999854
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=410.37 Aligned_cols=288 Identities=36% Similarity=0.666 Sum_probs=229.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++... ..+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeE
Confidence 579999999999999999999999999999999976544545567788999999999999999999998543 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
++||||+++ +|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999996 6777777777899999999999999999999999999999999999999999999999999986542221
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++...+.........
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 158 ---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp -----------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 22456899999999998652 56899999999999999999999999999999999999888887766543222111
Q ss_pred HHHHHHHhhccCC---CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 262 KARRYLSSMRKKK---PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 262 ~~~~~l~~~~~~~---~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
. ++....... ..+....++++++.+.+||.+||+.||.+|||++|+|+||||+++...
T Consensus 234 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 234 Q---YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp G---GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred c---ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 0 111110000 011122346789999999999999999999999999999999987644
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=427.76 Aligned_cols=288 Identities=36% Similarity=0.660 Sum_probs=234.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~~~~ 100 (560)
..+|++.++||+|+||+||+|++..+++ ||+|++..... ...+|+.+|+.++||||+++++++..... .+..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3579999999999999999999987776 88888753211 12379999999999999999999865432 3334
Q ss_pred cEEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC-CCCcEEEeccccccc
Q 008607 101 DIYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARV 175 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~-~~~~lKL~DFGla~~ 175 (560)
.+|+|||||++++.+.+.. ...+++..++.|++||+.||+|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 5889999999887766542 56799999999999999999999999999999999999999 799999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
....... ..++||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|+|..+.+
T Consensus 192 ~~~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEPN----VSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCCC----CSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCCCC----cccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 6443322 457899999999998652 46899999999999999999999999999999999999999999998877
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCC
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~ 324 (560)
......... ..+....+.++...+ +.+++.+.+||.+||++||.+|||+.|+|+||||+++.....
T Consensus 267 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 267 KTMNPNYME---HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp HHHCGGGSS---SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred HhhChhhhh---hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence 654321100 011111222222222 358899999999999999999999999999999998866543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=427.89 Aligned_cols=287 Identities=35% Similarity=0.624 Sum_probs=232.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~~~~~ 101 (560)
.+|++.++||+|+||+||+|++..+|+.||||++.... ....+|+++|+.++||||+++++++..... .+..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 47999999999999999999999999999999986421 123479999999999999999998864321 23345
Q ss_pred EEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC-CcEEEecccccccc
Q 008607 102 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVA 176 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-~~lKL~DFGla~~~ 176 (560)
+++||||++++|.+++.. ...+++..++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 789999999988777653 5679999999999999999999999999999999999999965 67899999999875
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
..... ...++||++|+|||++.+. ..|+.++||||||||||||++|++||.+.+..+++..|.+.+|+|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 44332 2457899999999998652 478999999999999999999999999999999999999999999987765
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccC
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQ-KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~ 323 (560)
...... ..+ .+......+|.. ..+.+++.+++||++||++||.+|||+.|+|+||||+++....
T Consensus 283 ~~~~~~-~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 283 EMNPNY-TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347 (420)
T ss_dssp HHCSCC-CCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hhChhh-hhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence 432110 000 000001111111 1246789999999999999999999999999999999876544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=418.86 Aligned_cols=288 Identities=35% Similarity=0.624 Sum_probs=230.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++... ..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEE
Confidence 579999999999999999999999999999999964221 11112355799999999999999999998543 468
Q ss_pred EEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+||||++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 9999999999999998754 59999999999999999999999999999999999999999999999999997643222
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
......+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..+...++.|..+.+......
T Consensus 155 --~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 155 --KTYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred --cccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 122456889999999998653 46899999999999999999999999999999999999999999887766544332
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
...... ..............+.+++.+.+||.+||++||.+|||++|+|+||||.++..
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTY-NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHT-CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhccc-ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 211111 11111222223345678999999999999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=417.12 Aligned_cols=277 Identities=37% Similarity=0.613 Sum_probs=223.0
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..-++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN----- 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-----
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-----
Confidence 345689999999999999999999999999999999976544444456778999999999999999999998543
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC-----CCCcEEEecccccc
Q 008607 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-----ADCKLKICDFGLAR 174 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~-----~~~~lKL~DFGla~ 174 (560)
..+|+||||++++|.+++..+..+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 106 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 106 HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp TEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred CEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 4689999999999999999998999999999999999999999999999999999999994 45569999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..+...++.|....
T Consensus 186 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 186 AFGIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccCCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 7532221 22456789999999998652 4589999999999999999999999999999999999998888876544
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCC-------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFP-------------NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------------~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
+...... ..+...++ .+++.+.+||++||++||.+|||++|+|+||||++.
T Consensus 262 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 262 WPGVTAL--------------PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp STTGGGS--------------TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhh--------------hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 3222110 00111111 167899999999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=413.14 Aligned_cols=289 Identities=33% Similarity=0.607 Sum_probs=219.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTE-----NK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-----TE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-----Ce
Confidence 468999999999999999999999999999999997432 223346678999999999999999999998543 46
Q ss_pred EEEEEecCCccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 102 IYVVFELMESDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~~------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 8999999999999998753 3599999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..|.+.+|.|....+
T Consensus 158 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 158 FGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 532221 12456899999999998652 46899999999999999999999999999999999999999988876544
Q ss_pred HHhhhHHHHHHHHhhccCCCCCC-----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPF-----SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
...... ..+...+....+..+ ......+++.+.+||.+||+.||.+|||++|+|+||||++....
T Consensus 234 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 234 PSVTKL--PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGGGGC--TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhh--hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 322110 000000000000000 01123578899999999999999999999999999999986543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=422.30 Aligned_cols=286 Identities=34% Similarity=0.685 Sum_probs=231.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-----
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR----- 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~----- 96 (560)
.++|++++.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++||||+++++++.....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4689999999999999999999999999999999864211 12379999999999999999999865432
Q ss_pred ----------------------------CCCccEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh
Q 008607 97 ----------------------------REFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHT 144 (560)
Q Consensus 97 ----------------------------~~~~~i~lV~E~~~gdL~~~i~----~~~~lse~~~~~i~~Qll~aL~yLHs 144 (560)
.....+++|||||+++|.+.+. .+..+++..++.+++||+.||+|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 2334589999999998777765 35679999999999999999999999
Q ss_pred CCeeeccCCCCCeeeC-CCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHH
Q 008607 145 ANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223 (560)
Q Consensus 145 ~gIiHrDLKP~NILl~-~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~e 223 (560)
.||+||||||+|||++ .++.+||+|||+++....... ....++|+.|+|||++.+. ..|+.++|||||||++|+
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHH
Confidence 9999999999999998 688999999999986543332 2456899999999998652 458999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCC-CCCCCCHHHHHHHHHhcccCCC
Q 008607 224 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ-KFPNANPLALRLLERMLAFEPK 302 (560)
Q Consensus 224 LltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~s~~~~dLI~~mL~~DP~ 302 (560)
|++|++||.+.+..+++..|.+.+|+|..+.+......... ..+.......+.. .....++.+.+||.+||+.||.
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE---VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc---ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999999999999999999998876554321100 0000011111111 1235789999999999999999
Q ss_pred CCCCHHHHhcCcccccccc
Q 008607 303 DRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 303 ~Rpta~elL~hp~f~~~~~ 321 (560)
+|||+.|+|+||||+.+..
T Consensus 312 ~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GSCCHHHHHTSGGGHHHHH
T ss_pred hCCCHHHHhcCHHHHHHHh
Confidence 9999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=410.32 Aligned_cols=256 Identities=24% Similarity=0.443 Sum_probs=218.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----SE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----CE
Confidence 579999999999999999999999999999999974211 223456788999999999999999999998543 46
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+||||++| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999985 999999988889999999999999999999999999999999999999999999999999997533222
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..|..
T Consensus 160 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--------------- 219 (337)
T 1o6l_A 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------- 219 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------------
T ss_pred C---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 2356789999999999977 5789999999999999999999999998776554443322
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
.. .. ....+++.+.+||++||+.||.+|| +++|+++||||+++
T Consensus 220 -----------~~--~~---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 220 -----------EE--IR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -----------CC--CC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -----------CC--CC---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 00 01 1235789999999999999999999 99999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=416.92 Aligned_cols=257 Identities=24% Similarity=0.429 Sum_probs=215.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (560)
-++|+++++||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.+ +||||+++++++...
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~----- 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP----- 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-----
Confidence 368999999999999999999999999999999997421 1233456688999999988 699999999998543
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+|||||.| +|..++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 469999999984 9999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..|...
T Consensus 177 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 239 (353)
T 3txo_A 177 NG---VTTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------------ 239 (353)
T ss_dssp ------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CC---ccccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence 21 12355789999999999976 57899999999999999999999999998877666555431
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCcccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA------EEALADPYFKGL 319 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta------~elL~hp~f~~~ 319 (560)
. . .....+++.+.+||++||+.||.+||++ +|+++||||+++
T Consensus 240 --------------~--~---~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 240 --------------E--V---VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp --------------C--C---CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred --------------C--C---CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 0 0 1123478999999999999999999998 999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=424.51 Aligned_cols=262 Identities=28% Similarity=0.450 Sum_probs=222.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++.. ...
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----EGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-----SSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-----CCE
Confidence 357999999999999999999999999999999997654444566778999999999999999999999853 346
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC---CCCcEEEeccccccccc
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVAF 177 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~---~~~~lKL~DFGla~~~~ 177 (560)
+|+|||||.| +|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 8999999985 9999999988999999999999999999999999999999999999998 46789999999997654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 165 ~~~---~~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~----------- 228 (444)
T 3soa_A 165 GEQ---QAWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG----------- 228 (444)
T ss_dssp TTC---CBCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----------
T ss_pred CCC---ceeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-----------
Confidence 332 22355789999999999976 57899999999999999999999999988766655544321
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
........++.+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 229 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~ 275 (444)
T 3soa_A 229 ----------------AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 275 (444)
T ss_dssp ----------------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHH
T ss_pred ----------------CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCc
Confidence 11112234567899999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=409.45 Aligned_cols=300 Identities=34% Similarity=0.550 Sum_probs=236.0
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc--
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-- 96 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-- 96 (560)
.+..++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp SCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred cccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 455689999999999999999999999999999999987554444445677899999999999999999999865431
Q ss_pred -CCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 97 -REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 97 -~~~~~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.....+|+||||++++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ----CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 113468999999999999888764 479999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 175 VAFNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 175 ~~~~~~~-~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
....... ........+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....+.+..+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 6542221 12233567899999999998652 468999999999999999999999999999999999999998887765
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.+...........+.... .........+ ...++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp TSTTGGGCGGGTSSCCCS-SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred hccccccchhhccccccc-ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 544332211000000000 0000000000 01367899999999999999999999999999998643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=404.14 Aligned_cols=301 Identities=41% Similarity=0.644 Sum_probs=235.4
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC--
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-- 95 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~-- 95 (560)
.+..+++|++++.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+|+.++||||+++++++....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 45668899999999999999999999999999999999864 24455678899999999999999999999885432
Q ss_pred -------cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC-CCCcEEE
Q 008607 96 -------RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKI 167 (560)
Q Consensus 96 -------~~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~-~~~~lKL 167 (560)
..+...+|+||||++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 123457899999999999999864 5799999999999999999999999999999999999997 5679999
Q ss_pred ecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc
Q 008607 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~ 247 (560)
+|||+++................+|++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998754332222223456789999999988542 468899999999999999999999999999988888888877
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccC
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~ 323 (560)
..+..+........ ...++.........++....+.+++.+.+||++||+.||.+|||++|+|+||||+......
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 242 PVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CCCCHHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred CCCchhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 77766554433221 1112222222233334445567899999999999999999999999999999998765443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=420.42 Aligned_cols=281 Identities=32% Similarity=0.562 Sum_probs=232.0
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc------CCCCccccceeecCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL------RHPDIVEIKHILLPP 94 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l------~HpnIv~l~~i~~~~ 94 (560)
...+|+++++||+|+||.||+|++..+++.||||++.. .......+.+|+.+|+.+ .|+||+.+++.+...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 45789999999999999999999999999999999974 234456677899998887 467999999988543
Q ss_pred CcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc--EEEecc
Q 008607 95 SRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDF 170 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~--lKL~DF 170 (560)
..+|+||||++++|.+++.... .+++..++.|+.||+.||+|||+.||+||||||+|||++.++. +||+||
T Consensus 172 -----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 -----NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp -----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred -----CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 4689999999999999998764 4999999999999999999999999999999999999999987 999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCC
Q 008607 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p 250 (560)
|+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..|.+.+|.|
T Consensus 247 G~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 247 GSSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp TTCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999764322 245689999999999977 579999999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhHHHHHHHHhhccCCC-----------------------------CCCCC-CCCCCCHHHHHHHHHhcccC
Q 008607 251 SPEAIARVRNEKARRYLSSMRKKKP-----------------------------IPFSQ-KFPNANPLALRLLERMLAFE 300 (560)
Q Consensus 251 ~~~~~~~~~~~~~~~~l~~~~~~~~-----------------------------~~~~~-~~~~~s~~~~dLI~~mL~~D 300 (560)
..+.+...... ..++..-..... ..+.. .....++.+.+||++||++|
T Consensus 319 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 319 SQKLLDASKRA--KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CHHHHHTBTTH--HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CHHHHHhhhhh--hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 98877654322 222221110000 00000 11234788999999999999
Q ss_pred CCCCCCHHHHhcCcccccc
Q 008607 301 PKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 301 P~~Rpta~elL~hp~f~~~ 319 (560)
|.+|||++|+|+||||+..
T Consensus 397 P~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 397 PAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TTTSCCHHHHHTSTTTC--
T ss_pred hhhCCCHHHHhCChhhccC
Confidence 9999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=405.24 Aligned_cols=262 Identities=28% Similarity=0.460 Sum_probs=222.6
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh----hHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~----~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~ 94 (560)
-...++|++.+.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+|+.++||||+++++++...
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 344578999999999999999999999999999999997533221 2356788999999999999999999998543
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC----cEEEec
Q 008607 95 SRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICD 169 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~----~lKL~D 169 (560)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|
T Consensus 87 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 87 -----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp -----SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred -----CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 46899999997 59999998888899999999999999999999999999999999999999887 799999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCC
Q 008607 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (560)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~ 249 (560)
||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 162 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 162 FGLAHKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235 (326)
T ss_dssp CTTCEECCTTSC----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred CCCCeECCCCCc----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence 999987543221 245689999999999976 57899999999999999999999999988876666555432221
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
... ..++.+++.+.+||++||+.||.+|||++|+|+||||+.
T Consensus 236 ~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 236 FED---------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp CCH---------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred cCc---------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 111 122467889999999999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=412.88 Aligned_cols=260 Identities=29% Similarity=0.480 Sum_probs=222.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CE
Confidence 3579999999999999999999999999999999976555555667889999999999999999999998543 46
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC---cEEEeccccccccc
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAF 177 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~---~lKL~DFGla~~~~ 177 (560)
+|+|||||.| +|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 8999999985 9999998888899999999999999999999999999999999999998754 59999999997654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..+....
T Consensus 183 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~---------- 246 (362)
T 2bdw_A 183 DSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA---------- 246 (362)
T ss_dssp TCC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----------
T ss_pred CCc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----------
Confidence 322 2345789999999999977 579999999999999999999999999887655544443211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.......+..+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 247 -----------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 247 -----------------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp -----------------CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred -----------------CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 011112335678999999999999999999999999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=414.07 Aligned_cols=298 Identities=23% Similarity=0.319 Sum_probs=222.0
Q ss_pred cCCCCceEEEEEEeec--CCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 19 YGEGSRYKIEEVIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G--~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.+.+++|+++++||+| +||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 98 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-- 98 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--
Confidence 4678899999999999 999999999999999999999986555555667888999999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
..+|+|||||+ ++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 99 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 ---NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp ---TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred ---CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 46899999998 5999999875 67999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCC----CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc--
Q 008607 174 RVAFNDTP----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL-- 247 (560)
Q Consensus 174 ~~~~~~~~----~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~-- 247 (560)
........ ........+||+.|+|||++.+....|+.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 65432211 111123358999999999997633468999999999999999999999999877666554332110
Q ss_pred ------CCCCHHHHHHhhhH-HHHHHHHhhc------cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008607 248 ------GTPSPEAIARVRNE-KARRYLSSMR------KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (560)
Q Consensus 248 ------g~p~~~~~~~~~~~-~~~~~l~~~~------~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp 314 (560)
..+..+........ ........+. .....+.......+++.+.+||++||+.||.+|||++|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 00000000000000 0000000000 0001111223456789999999999999999999999999999
Q ss_pred ccccccc
Q 008607 315 YFKGLAK 321 (560)
Q Consensus 315 ~f~~~~~ 321 (560)
||+++..
T Consensus 336 ~f~~~~~ 342 (389)
T 3gni_B 336 FFKQIKR 342 (389)
T ss_dssp GGGGC--
T ss_pred HHHHHhh
Confidence 9997654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=408.20 Aligned_cols=255 Identities=31% Similarity=0.521 Sum_probs=214.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC-hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+|+.++||||+++++++... ..
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 83 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----TD 83 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CE
Confidence 5799999999999999999999999999999998642211 12235688999999999999999999998544 46
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 102 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
+|+||||++|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred EEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 8999999999999999988899999999999999999999999999999999999999999999999999997653322
Q ss_pred CcccccccccCcccccccccccccCCC-CCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|+.||.+.+....+
T Consensus 163 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------------- 217 (336)
T 3h4j_B 163 ---FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------------- 217 (336)
T ss_dssp ---TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--------------------
T ss_pred ---ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--------------------
Confidence 2355789999999999976 344 68999999999999999999999875532211
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.............+++.+.+||++||+.||.+|||++|+++||||+..
T Consensus 218 -----------~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 218 -----------KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -----------CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -----------HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 111111112234578999999999999999999999999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=399.81 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=218.4
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++++.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~ 90 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVG-----D 90 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----T
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----C
Confidence 3568999999999999999999999999999999986432 23356788999999999999999999998543 3
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+|||||+ ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 5899999997 5999999775 6999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..+.... .
T Consensus 170 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~---------- 233 (297)
T 3fxz_A 170 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-T---------- 233 (297)
T ss_dssp TC---CBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-S----------
T ss_pred cc---ccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-C----------
Confidence 22 2345689999999999977 578999999999999999999999998887665544332210 0
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
+.......+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 234 -----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 234 -----------------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -----------------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----------------CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 0011124578899999999999999999999999999999853
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=403.56 Aligned_cols=254 Identities=24% Similarity=0.444 Sum_probs=218.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~ 80 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQ 80 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-----CE
Confidence 579999999999999999999999999999999974221 123456678999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999998 499999999889999999999999999999999999999999999999999999999999999865322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..|...
T Consensus 160 -----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------------- 218 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 218 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred -----cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 235689999999999977 57899999999999999999999999988766555444321
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~~ 320 (560)
. . ...+.+++.+.+||++||..||.+|| +++|+++||||+++.
T Consensus 219 ------------~--~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 219 ------------E--L---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp ------------C--C---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ------------C--C---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 0 0 11235789999999999999999999 999999999998653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=405.23 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=221.3
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+..+++.||+|++.. .......+.+|+.+|+.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~ 74 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFESM-----E 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----T
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec---CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----C
Confidence 45789999999999999999999999999999999874 234556788999999999999999999998543 4
Q ss_pred cEEEEEecCCc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC--CCcEEEecccccccc
Q 008607 101 DIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVA 176 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~--~~~lKL~DFGla~~~ 176 (560)
.+|+|||||+| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 69999999985 9999997654 6999999999999999999999999999999999999997 789999999999875
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+......+..
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 224 (321)
T 1tki_A 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE---- 224 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH----
T ss_pred CCCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh----
Confidence 4322 2345689999999999976 46789999999999999999999999998877666655543222221
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..++.+++.+.+||++||..||.+|||++|+|+||||+..
T Consensus 225 -----------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 225 -----------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -----------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -----------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 1234678999999999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=408.11 Aligned_cols=281 Identities=22% Similarity=0.412 Sum_probs=229.9
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-----CCCccccceeecC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-----HPDIVEIKHILLP 93 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-----HpnIv~l~~i~~~ 93 (560)
....++|+++++||+|+||.||+|++..+++.||||++.. .......+.+|+.+|+.++ ||||+++++++..
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 4446899999999999999999999999999999999974 2344566778999999997 9999999999854
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC----------
Q 008607 94 PSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---------- 161 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~---------- 161 (560)
. ..+|+||||++++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 108 ~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 108 Y-----DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp T-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred C-----CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 3 4689999999889999998765 5999999999999999999999999999999999999975
Q ss_pred ---------------CCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh
Q 008607 162 ---------------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226 (560)
Q Consensus 162 ---------------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt 226 (560)
++.+||+|||+++...... ...+||+.|+|||++.+ ..|+.++|||||||++|+|++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHH
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcC--CCCCCccchHHHHHHHHHHHH
Confidence 7889999999998643222 45689999999999987 579999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCC-----------------CCCCCHHH
Q 008607 227 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK-----------------FPNANPLA 289 (560)
Q Consensus 227 G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-----------------~~~~s~~~ 289 (560)
|+.||.+.+..+.+..+....+.++...+..........++..... ...+... ....++.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDEL--KLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTT--EECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccc--eecCcccccchhhhhhhhhcccccccchHHHH
Confidence 9999999999999999999888887766544332111111100000 0000000 01234778
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 290 LRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 290 ~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
.+||.+||+.||.+|||++|+|+||||+
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 8999999999999999999999999995
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=410.46 Aligned_cols=275 Identities=23% Similarity=0.238 Sum_probs=193.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
..+|.+.++||+|+||+||+|++ +|+.||||+++.. ........+|+..+..++|||||++++++.... .....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceE
Confidence 46799999999999999999976 6899999998642 112222334666667889999999999986432 12236
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCCCCCeeeCCCCcEEEecccc
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGL 172 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~--------gIiHrDLKP~NILl~~~~~lKL~DFGl 172 (560)
+|||||||+ |+|.++++.. .++++.+..|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 899999998 6999999765 699999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCc-ccccccccCccccccccccccc----CCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc
Q 008607 173 ARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 173 a~~~~~~~~~~-~~~~~~~gT~~Y~APEll~~~~----~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~ 247 (560)
|+......... ......+||++|+|||++.+.. ..|+.++|||||||+||||+||.+||........-. .....
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~ 233 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVP 233 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhccc
Confidence 98764433221 1223568999999999986521 136779999999999999999998875433211000 00000
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..+..+.+ ...+..-.....++.......+...+.+||.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~--------~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 234 SDPSVEEM--------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHH--------HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHH--------HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11111111 1111000001111111111123356889999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=399.28 Aligned_cols=266 Identities=27% Similarity=0.452 Sum_probs=224.6
Q ss_pred ccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh----hHHHHHHHHHHHHHhcCCCCccccceee
Q 008607 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLRHPDIVEIKHIL 91 (560)
Q Consensus 16 ~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~----~~~~~i~rEi~iL~~l~HpnIv~l~~i~ 91 (560)
+..-...++|++.+.||+|+||.||+|++..+|+.||||++....... .....+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (321)
T 2a2a_A 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY 84 (321)
T ss_dssp CBCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 334455678999999999999999999999999999999997533221 1356788999999999999999999998
Q ss_pred cCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC----cEE
Q 008607 92 LPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLK 166 (560)
Q Consensus 92 ~~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~----~lK 166 (560)
... ..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+|
T Consensus 85 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 85 ENR-----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp ECS-----SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred ecC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEE
Confidence 543 46899999997 59999999888899999999999999999999999999999999999999988 799
Q ss_pred EecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHh
Q 008607 167 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246 (560)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~ 246 (560)
|+|||++........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 160 l~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp ECCCTTCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred EccCccceecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 999999987543322 245679999999999976 57899999999999999999999999988876666555443
Q ss_pred cCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 247 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
...... ..+..+++.+.+||++||..||.+|||++|+|+||||+..
T Consensus 234 ~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 234 SYDFDE---------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CCCCCH---------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ccccCh---------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 222111 1124578899999999999999999999999999999854
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=408.19 Aligned_cols=288 Identities=33% Similarity=0.615 Sum_probs=230.4
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
|..-++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 96 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK---- 96 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC----
Confidence 3456799999999999999999999999999999999876555555566788999999999999999999998533
Q ss_pred CccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|+||||+++ +|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 97 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 97 -KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp -TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred -CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 468999999997 566666667789999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... .....+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++...+.....
T Consensus 176 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 176 APGE---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred CCcc---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 3221 22456799999999998652 4688999999999999999999999999999999998888888776654322
Q ss_pred hhhHHHHHHHHhhc---cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 258 VRNEKARRYLSSMR---KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 258 ~~~~~~~~~l~~~~---~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
...... +.... .....+....++.+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 252 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 252 FNKNPV---FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCGG---GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhccc---cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 211100 00000 00111222334578999999999999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=426.82 Aligned_cols=259 Identities=31% Similarity=0.502 Sum_probs=216.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++++.||+|+||+||+|++..++..||||++............+.+|+.+|+.++||||+++++++... ..+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-----RNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEE
Confidence 479999999999999999999999999999999976544444466788999999999999999999998543 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC---CcEEEecccccccccC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFN 178 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~---~~lKL~DFGla~~~~~ 178 (560)
|+|||||.+ +|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999985 999999888889999999999999999999999999999999999999764 4599999999987543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. .....+||++|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 192 ~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------- 254 (494)
T 3lij_A 192 QK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY---------- 254 (494)
T ss_dssp TB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------
T ss_pred Cc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 32 2345789999999999864 689999999999999999999999999887666555543211
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
......+..+++.+.+||++||+.||.+|||++|+|+||||+...
T Consensus 255 -----------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 255 -----------------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp -----------------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred -----------------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 111233467899999999999999999999999999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=409.94 Aligned_cols=288 Identities=37% Similarity=0.608 Sum_probs=228.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh---hHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV---SDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~---~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.++|++.+.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 84 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK---- 84 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT----
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC----
Confidence 468999999999999999999999999999999987432211 1124678999999999999999999998543
Q ss_pred CccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 85 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 85 -SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp -TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred -CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 4589999999999999987654 69999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... .....+||++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+++..+...++.|..+.+..
T Consensus 164 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 164 SPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp SCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred CCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 3221 23456899999999998652 4588999999999999999999999999999999999988888876554322
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
..... .++ .+......++...+..+++.+.+||++||+.||.+|||++|+|+||||+....
T Consensus 240 ~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 240 MCSLP--DYV-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp TTSST--TCC-CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hccCc--ccc-cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 21100 000 00011112222334677899999999999999999999999999999987543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=408.49 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=219.2
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~ 98 (560)
..++|++.+.||+|+||.||+|+++.+|+.||||++++.. ........+.+|..+|+.+ +||||+++++++...
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~---- 90 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK---- 90 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS----
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC----
Confidence 3468999999999999999999999999999999997421 1123355678899999876 899999999998543
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 91 -~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 91 -ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp -SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred -CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 46999999997 5999999988889999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..|...
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 233 (345)
T 1xjd_A 170 LGDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD----------- 233 (345)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cCCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 2221 2356789999999999977 57899999999999999999999999988866555444320
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE-EALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~-elL~hp~f~~~~ 320 (560)
.+ .....+++.+.+||++||+.||.+||++. ++++||||+++.
T Consensus 234 ----------------~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 234 ----------------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp ----------------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ----------------CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 00 11235789999999999999999999998 999999998763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=386.88 Aligned_cols=265 Identities=29% Similarity=0.478 Sum_probs=224.7
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----S 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-----C
Confidence 35789999999999999999999999999999999976555556677889999999999999999999998543 4
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc---EEEecccccccc
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVA 176 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~---lKL~DFGla~~~ 176 (560)
..|+||||+.+ +|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 68999999985 99999988888999999999999999999999999999999999999987655 999999999765
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 159 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 223 (284)
T 3kk8_A 159 NDSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--------- 223 (284)
T ss_dssp CSSC----BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------
T ss_pred ccCc----cccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc---------
Confidence 4322 2245689999999999977 578999999999999999999999998877655544433211
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccC
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~ 323 (560)
.......+..+++.+.+||.+||+.||.+|||++|+|+||||++.....
T Consensus 224 ------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 224 ------------------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272 (284)
T ss_dssp ------------------CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred ------------------ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence 1111223457789999999999999999999999999999998765443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=402.91 Aligned_cols=267 Identities=22% Similarity=0.392 Sum_probs=215.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (560)
.++|++++.||+|+||.||+|+++.+++.||||++.+.. ........+.+|+.+|+.+ +||||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~----- 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE----- 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-----
Confidence 357999999999999999999999999999999997543 2344556788999999987 899999999998543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 46999999997 59999999888899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+......... ..
T Consensus 163 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------~~------- 223 (345)
T 3a8x_A 163 PG---DTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NT------- 223 (345)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------C-------
T ss_pred CC---CcccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-------cc-------
Confidence 21 12356789999999999987 5789999999999999999999999975321110000 00
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA------EEALADPYFKGLA 320 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta------~elL~hp~f~~~~ 320 (560)
. ......+... ... ....+++.+.+||++||+.||.+||++ +|+++||||+++.
T Consensus 224 -~---~~~~~~i~~~-~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 224 -E---DYLFQVILEK-QIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp -H---HHHHHHHHHC-CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred -H---HHHHHHHHcC-CCC---CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 0 0000111111 111 124678999999999999999999995 8999999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=429.28 Aligned_cols=261 Identities=34% Similarity=0.536 Sum_probs=221.2
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|+++++||+|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++... .
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----S 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-----C
Confidence 45789999999999999999999999999999999975433334567789999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC---CCCcEEEecccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVA 176 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~---~~~~lKL~DFGla~~~ 176 (560)
.+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 6899999998 59999998888899999999999999999999999999999999999995 4567999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|++||.+.+..+.+..+.....
T Consensus 175 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-------- 239 (486)
T 3mwu_A 175 QQNT----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY-------- 239 (486)
T ss_dssp CCC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------
T ss_pred CCCC----ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 4332 2245689999999999875 588999999999999999999999999887766655543111
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
......+..+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 240 -------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 240 -------------------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp -------------------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred -------------------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 111123456789999999999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=405.93 Aligned_cols=255 Identities=20% Similarity=0.377 Sum_probs=219.8
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
.-++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 113 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN----- 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----
Confidence 3468999999999999999999999999999999986421 1223456788999999999999999999998543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 46999999997 59999999888899999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
. ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 194 ~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 253 (350)
T 1rdq_E 194 R------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------------ 253 (350)
T ss_dssp C------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred C------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC------------
Confidence 2 135689999999999977 57899999999999999999999999988766555444321
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~ 319 (560)
. . .....+++.+.+||++||+.||.+||+ ++|+++||||+++
T Consensus 254 --------------~--~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 254 --------------K--V---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp --------------C--C---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred --------------C--C---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 0 0 112357899999999999999999998 9999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=410.64 Aligned_cols=267 Identities=21% Similarity=0.393 Sum_probs=213.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (560)
.++|+++++||+|+||.||+|+++.+++.||||++++... .......+.+|..+|+.+ +||||+++++++...
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~----- 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE----- 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-----
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-----
Confidence 4689999999999999999999999999999999975432 223345678899999877 899999999998543
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+|||||.| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 469999999985 9999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+....+.... ...
T Consensus 206 ~~---~~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~------ 267 (396)
T 4dc2_A 206 PG---DTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTE------ 267 (396)
T ss_dssp TT---CCBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCH------
T ss_pred CC---CccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhH------
Confidence 22 12356789999999999987 6789999999999999999999999975432111000 000
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA------EEALADPYFKGLA 320 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta------~elL~hp~f~~~~ 320 (560)
. .....+... .. .....+++.+.+||++||+.||.+||++ +|+++||||+++.
T Consensus 268 --~---~~~~~i~~~-~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 268 --D---YLFQVILEK-QI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp --H---HHHHHHHHC-CC---CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred --H---HHHHHHhcc-cc---CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 0 000111111 11 1224578999999999999999999984 8999999998763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=397.81 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=210.2
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEecCccc--ChhHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFE--HVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~~--~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~ 94 (560)
-..++|++.+.||+|+||.||+|++. .+|+.||||+++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 34578999999999999999999985 6899999999975321 223445678999999999999999999998543
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 95 SRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
..+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 94 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 94 -----GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp -----SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred -----CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 46899999998 599999998888999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
+....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 169 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------- 236 (327)
T 3a62_A 169 KESIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC------- 236 (327)
T ss_dssp -------------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-------
T ss_pred cccccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-------
Confidence 75432221 2245689999999999976 57899999999999999999999999988766555444321
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
. ....+.+++.+.+||++||..||.+|| +++|+|+||||+++
T Consensus 237 -------------------~-----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 237 -------------------K-----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp -------------------C-----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred -------------------C-----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 0 011245789999999999999999999 89999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=405.63 Aligned_cols=258 Identities=21% Similarity=0.381 Sum_probs=218.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (560)
.++|+++++||+|+||.||+|+++.+|+.||||++.+... .......+.+|..+|..+ +||+|+.+++++...
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~----- 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM----- 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-----
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-----
Confidence 4679999999999999999999999999999999974211 123456678999999887 799999999998543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 46999999998 59999999888899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..|...
T Consensus 174 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 236 (353)
T 2i0e_A 174 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------ 236 (353)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------------
Confidence 221 2355789999999999976 57899999999999999999999999988866655544321
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~~ 320 (560)
. . .....+++.+.+||++||..||.+|| +++++++||||+++.
T Consensus 237 --------------~--~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 237 --------------N--V---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp --------------C--C---CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred --------------C--C---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 0 0 11236789999999999999999999 479999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=398.39 Aligned_cols=292 Identities=34% Similarity=0.591 Sum_probs=235.2
Q ss_pred CCCceEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc---CCCCccccceeecCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDT-RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSR 96 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~-~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l---~HpnIv~l~~i~~~~~~ 96 (560)
..++|++++.||+|+||.||+|++. .+|+.||||++............+.+|+.+++.+ +||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3478999999999999999999995 6789999999875333322233556788877766 89999999999863322
Q ss_pred CCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 97 REFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 97 ~~~~~i~lV~E~~~gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.....+++||||++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 3445789999999999999998754 49999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.|..+.
T Consensus 169 ~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCGGG----GGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCCC----CccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 643221 2345689999999999976 5789999999999999999999999999999999999988888776543
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
+....... -..+............+.++..+.+||.+||+.||.+|||+.|+|+||||+++...
T Consensus 243 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 243 WPRDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp SCTTCSSC----GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred Cccccccc----hhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 32110000 00111122233445567789999999999999999999999999999999977543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=405.67 Aligned_cols=291 Identities=35% Similarity=0.616 Sum_probs=224.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc--CCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR--REFK 100 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~--~~~~ 100 (560)
++|++.+.||+|+||.||+|.+..+|+.||||++... .....+..+|+..|+.++||||+++++++..... ....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECC---TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC---ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 5799999999999999999999999999999998642 1223355678888999999999999999865332 2233
Q ss_pred cEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCCCCeeeCC-CCcEEEeccccc
Q 008607 101 DIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILANA-DCKLKICDFGLA 173 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~----~~~~lse~~~~~i~~Qll~aL~yLH--s~gIiHrDLKP~NILl~~-~~~lKL~DFGla 173 (560)
.+++||||++++|...+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 478999999998776654 4557999999999999999999999 999999999999999997 899999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
+....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+...++..+...++.|..+
T Consensus 180 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 180 KKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp BCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 86543322 2456799999999998652 458999999999999999999999999999999999999999999987
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCC
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQK----FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~ 324 (560)
.+..+....... ........++... ....++.+.+||.+||+.||.+|||+.|+|+||||+++.....
T Consensus 255 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 255 VLRKLNPSHTDV---DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHHCTTCCCG---GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HHHhcccchhhc---cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 766543211000 0011111222222 2236788999999999999999999999999999998865443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=420.80 Aligned_cols=266 Identities=22% Similarity=0.387 Sum_probs=221.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|+++++||+|+||.||+|+++.+++.||||++.+... .......+.+|+.+|..++||||+++++++... .
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-----~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD-----N 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS-----S
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----C
Confidence 4789999999999999999999999999999999864211 111223477899999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|||||||. |+|.+++.. .+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 6999999997 699999987 56899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccccCccccccccccc---ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~---~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
... ......+||++|+|||++.. ....|+.++|||||||++|||++|++||.+.+..+.+..|....
T Consensus 228 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------- 297 (437)
T 4aw2_A 228 DGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-------- 297 (437)
T ss_dssp TSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--------
T ss_pred CCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc--------
Confidence 222 12245689999999999862 11468999999999999999999999999988777766654310
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGLA 320 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--Rpta~elL~hp~f~~~~ 320 (560)
....+......+++.+++||++||..+|++ |++++|+++||||+++.
T Consensus 298 ------------------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 298 ------------------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp ------------------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred ------------------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 011223334568999999999999998888 99999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=408.78 Aligned_cols=262 Identities=26% Similarity=0.440 Sum_probs=218.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
-++|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++||||+++++++... .
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----E 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence 478999999999999999999999999999999986421 1223456788999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+|||||. |+|..++..+..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 6899999997 599999999889999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
. .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.+.......+..+
T Consensus 169 ~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------ 232 (384)
T 4fr4_A 169 T----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF------------ 232 (384)
T ss_dssp C----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH------------
T ss_pred C----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH------------
Confidence 2 23567899999999998642 145889999999999999999999999865433222111110
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-AEEALADPYFKGLA 320 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-a~elL~hp~f~~~~ 320 (560)
.. . . ......+++.+.+||++||+.||.+||+ ++++++||||+++.
T Consensus 233 ---------~~---~-~---~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 233 ---------ET---T-V---VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp ---------HH---C-C---CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred ---------hh---c-c---cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 00 0 0 1122467899999999999999999998 99999999998753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=419.21 Aligned_cols=292 Identities=33% Similarity=0.581 Sum_probs=215.3
Q ss_pred CCceEE-EEEEeecCCeEEEEEEEC--CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKI-EEVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i-~~~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.+.|++ .++||+|+||.||+|+++ .+++.||||++.... ....+.+|+.+|+.++||||+++++++....
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 91 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHA--- 91 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---
Confidence 356777 458999999999999976 578999999997432 2345779999999999999999999986432
Q ss_pred CccEEEEEecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee----CCCCcE
Q 008607 99 FKDIYVVFELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKL 165 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~---------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl----~~~~~l 165 (560)
...+||||||++++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 2468999999999999888632 149999999999999999999999999999999999999 677899
Q ss_pred EEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCCh---------
Q 008607 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--------- 236 (560)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~--------- 236 (560)
||+|||+++...............+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+.
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999998764332222233567899999999998762 4589999999999999999999999987654
Q ss_pred hhHHHHHHHhcCCCCHHHHHHhhhH-HHHHHHHhhccCCCCC------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 008607 237 VHQLDIMTDLLGTPSPEAIARVRNE-KARRYLSSMRKKKPIP------FSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309 (560)
Q Consensus 237 ~~~~~~i~~~~g~p~~~~~~~~~~~-~~~~~l~~~~~~~~~~------~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~e 309 (560)
.+++..|...+|.|....+..+... ........+....... +.......++.+.+||++||++||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 4788999999999987665544321 1112222221110000 00112234778999999999999999999999
Q ss_pred HhcCcccccccc
Q 008607 310 ALADPYFKGLAK 321 (560)
Q Consensus 310 lL~hp~f~~~~~ 321 (560)
+|+||||.+...
T Consensus 331 ~L~hp~f~~~~~ 342 (405)
T 3rgf_A 331 AMQDPYFLEDPL 342 (405)
T ss_dssp HHTSGGGTSSSC
T ss_pred HhcChhhccCCC
Confidence 999999987543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=408.17 Aligned_cols=260 Identities=28% Similarity=0.434 Sum_probs=212.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc---cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~---~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.++|++.+.||+|+||+||+|+++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 98 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD---- 98 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC----
Confidence 468999999999999999999999999999999986321 1112356788999999999999999999998543
Q ss_pred CccEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc---EEEecc
Q 008607 99 FKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDF 170 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~----~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~---lKL~DF 170 (560)
..+|+|||||+ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 99 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 99 -GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp -TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred -CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 46899999998 5998877542 35899999999999999999999999999999999999987654 999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCC
Q 008607 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p 250 (560)
|+++....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+. ..+..+.......
T Consensus 178 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 178 GVAIQLGESGL---VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKM 251 (351)
T ss_dssp TTCEECCTTSC---BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCC
T ss_pred cceeEecCCCe---eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCC
Confidence 99987543221 2345689999999999976 5789999999999999999999999987532 2222222111011
Q ss_pred CHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 251 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
....+..+++.+.+||++||+.||.+|||+.|+|+||||+..
T Consensus 252 ---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 252 ---------------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ---------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ---------------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 111234678999999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=420.41 Aligned_cols=261 Identities=31% Similarity=0.494 Sum_probs=223.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|++.++||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----KG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 4689999999999999999999999999999999864322 23456788999999999999999999999854 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee---CCCCcEEEecccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVA 176 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl---~~~~~lKL~DFGla~~~ 176 (560)
.+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 6899999998 5999999998899999999999999999999999999999999999999 56789999999999875
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 180 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------- 245 (484)
T 3nyv_A 180 EASK----KMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT------- 245 (484)
T ss_dssp CCCC----SHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred cccc----ccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 4332 2245689999999999865 5899999999999999999999999998877666555432111
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
.....+..+++.+.+||++||+.||.+|||++|+|+||||+....
T Consensus 246 --------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 246 --------------------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp --------------------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred --------------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 111233567899999999999999999999999999999987643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=396.47 Aligned_cols=288 Identities=30% Similarity=0.575 Sum_probs=225.2
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPS 95 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~ 95 (560)
.+++..++|++++.||+|+||.||+|++..+++.||||++.. .....+.+|+.+|+.++ ||||+++++++....
T Consensus 30 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp CCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred hcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 346778999999999999999999999999999999999863 23467889999999997 999999999986532
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC-cEEEeccccc
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLA 173 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~-~lKL~DFGla 173 (560)
....++||||+. ++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 105 ---~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 105 ---SRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp ---TCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ---CCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 346899999998 48888774 389999999999999999999999999999999999999777 8999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCC-CCCChhhHHHHHHHhcCCCCH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF-PGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF-~~~~~~~~~~~i~~~~g~p~~ 252 (560)
+....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+..+++..+...++.+..
T Consensus 179 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~ 253 (330)
T 3nsz_A 179 EFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253 (330)
T ss_dssp EECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred eEcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence 86543332 2456899999999998653 46899999999999999999999888 456677777777776664332
Q ss_pred HHH-HHhhhHHHHHHHHhhccCCCCCCCCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 253 EAI-ARVRNEKARRYLSSMRKKKPIPFSQK-----FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 253 ~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~-----~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
... ..........+...........+... ...+++.+.+||.+||++||.+|||++|+|+||||+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 111 11000000001111111111111111 123789999999999999999999999999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=403.38 Aligned_cols=263 Identities=29% Similarity=0.428 Sum_probs=204.3
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
.....++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 88 (361)
T 3uc3_A 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTP--- 88 (361)
T ss_dssp CCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred CCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeC---
Confidence 3456789999999999999999999999999999999997532 2235678999999999999999999999644
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc--EEEecccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLAR 174 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~--lKL~DFGla~ 174 (560)
..+|+|||||. ++|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++. +||+|||+++
T Consensus 89 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 89 --THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp --SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred --CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 46899999997 599999988888999999999999999999999999999999999999988765 9999999997
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCC-ccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~-~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
...... .....+||++|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 167 ~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~------- 233 (361)
T 3uc3_A 167 SSVLHS----QPKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR------- 233 (361)
T ss_dssp ------------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH-------
T ss_pred cccccC----CCCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH-------
Confidence 432222 1245689999999999876 45544 489999999999999999999876543322221110
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.+. .... ......+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 234 ------------~~~---~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 234 ------------ILS---VKYS---IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ------------HHT---TCCC---CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ------------Hhc---CCCC---CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 000 0000 01123578999999999999999999999999999999654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=391.67 Aligned_cols=260 Identities=27% Similarity=0.481 Sum_probs=207.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC------------------------hhHHHHHHHHHHHHH
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH------------------------VSDATRILREIKLLR 77 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~------------------------~~~~~~i~rEi~iL~ 77 (560)
.++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999999999999999998643211 112356889999999
Q ss_pred hcCCCCccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 008607 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (560)
Q Consensus 78 ~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~N 156 (560)
.++||||+++++++.... ...+|+||||+++ +|.+++ ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999986432 3468999999984 776654 34579999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCC-CCCccchhhHHHHHHHHhhCCCCCCCCC
Q 008607 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKN 235 (560)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~-y~~~~DIWSlG~il~eLltG~~pF~~~~ 235 (560)
||++.++.+||+|||+++...... ......+||+.|+|||++.+.... ++.++|||||||++|+|++|+.||.+.+
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999998654322 123456899999999998762111 3678999999999999999999998876
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008607 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (560)
Q Consensus 236 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~ 315 (560)
.......+... . ..+ ...+.+++.+.+||.+||+.||.+|||++|+|+|||
T Consensus 245 ~~~~~~~~~~~--------------------------~--~~~-~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 245 IMCLHSKIKSQ--------------------------A--LEF-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHHHC--------------------------C--CCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHHHHhcc--------------------------c--CCC-CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 54433322210 0 011 123567899999999999999999999999999999
Q ss_pred cc
Q 008607 316 FK 317 (560)
Q Consensus 316 f~ 317 (560)
|+
T Consensus 296 ~~ 297 (298)
T 2zv2_A 296 VT 297 (298)
T ss_dssp HH
T ss_pred cc
Confidence 96
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=405.59 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=219.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++++.||+|+||.||+|.+..+|+.||+|++... ...+...+.+|+.+|+.++||||+++++++... ..
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-----CE
Confidence 36799999999999999999999999999999998753 233456788999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC--CCcEEEeccccccccc
Q 008607 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAF 177 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~--~~~lKL~DFGla~~~~ 177 (560)
+|+|||||. ++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 899999998 59999997654 6999999999999999999999999999999999999974 4779999999998754
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 203 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~----------- 265 (387)
T 1kob_A 203 PDE----IVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC----------- 265 (387)
T ss_dssp TTS----CEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCc----ceeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 322 1244689999999999976 57889999999999999999999999988766655444321
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
........+..+++.+.+||++||+.||.+|||++|+|+||||++..
T Consensus 266 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 266 ----------------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp ----------------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ----------------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 11111234467899999999999999999999999999999998643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=413.59 Aligned_cols=264 Identities=24% Similarity=0.363 Sum_probs=218.1
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..++|+++++||+|+||.||+|+++.+++.||||++.+.. ........+.+|+.+|+.++||||+++++++...
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----- 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD----- 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----
Confidence 4578999999999999999999999999999999986421 1111223477899999999999999999998543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|||||||+ |+|.+++... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 46999999997 5999998764 699999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccccccccccc--CCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.. .......+||+.|+|||++.+.. ..|+.++|||||||++|||++|++||.+.+....+..|.....
T Consensus 221 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-------- 290 (410)
T 3v8s_A 221 EG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-------- 290 (410)
T ss_dssp TS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--------
T ss_pred CC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--------
Confidence 22 11234678999999999986521 1178899999999999999999999999887777665543100
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGL 319 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--Rpta~elL~hp~f~~~ 319 (560)
. ..+ .....+++.+++||++||..+|.+ |++++||++||||+++
T Consensus 291 ------------~------~~~-p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 291 ------------S------LTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp ------------H------CCC-CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred ------------c------ccC-CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 0 000 112467999999999999999988 9999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=405.22 Aligned_cols=259 Identities=26% Similarity=0.444 Sum_probs=211.7
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHH-HHhcCCCCccccceeecCCCcCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKL-LRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~i-L~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
..++|++++.||+|+||.||+|+++.+++.||||++.+... .......+.+|..+ ++.++||||+++++++...
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~---- 111 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA---- 111 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS----
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC----
Confidence 34789999999999999999999999999999999975332 23344567778777 5778999999999998543
Q ss_pred CccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|+|||||+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 112 -~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 112 -DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred -CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 469999999985 999999988889999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+..|...
T Consensus 191 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------- 254 (373)
T 2r5t_A 191 EHNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----------- 254 (373)
T ss_dssp CCCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-----------
T ss_pred cCCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------
Confidence 2221 2256789999999999977 67999999999999999999999999988876655544320
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta----~elL~hp~f~~~~ 320 (560)
.. ...+.+++.+.+||++||+.||.+||++ +++++||||+++.
T Consensus 255 -----------------~~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 255 -----------------PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp -----------------CC---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred -----------------cc---CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 11 1224678999999999999999999986 6999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=415.81 Aligned_cols=258 Identities=25% Similarity=0.443 Sum_probs=210.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|+++++||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+.+++++... .
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----D 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----T
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----C
Confidence 468999999999999999999999999999999997432 2333446678999999999999999999998543 4
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|||||||++ +|.+++...+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 68999999985 999999888889999999999999999999998 9999999999999999999999999999975332
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 302 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 364 (446)
T 4ejn_A 302 DG---ATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------ 364 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CC---cccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------
Confidence 22 12356789999999999976 67999999999999999999999999988766555444321
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~~ 320 (560)
. . .....+++.+.+||.+||+.||.+|| |++|+|+||||+++.
T Consensus 365 --------------~--~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 365 --------------E--I---RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp --------------C--C---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred --------------C--C---CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 0 0 11235789999999999999999999 999999999999763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=397.34 Aligned_cols=263 Identities=25% Similarity=0.370 Sum_probs=213.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++++.||+|+||.||+|++..+++.||||++..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 79 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-----NI 79 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----Ce
Confidence 4679999999999999999999999999999999864221 22335678999999999999999999998543 46
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+|||||++ +|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 8999999985 999999888789999999999999999999999999999999999999999999999999997653222
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 160 ~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--------------- 222 (323)
T 3tki_A 160 R-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--------------- 222 (323)
T ss_dssp E-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH---------------
T ss_pred c-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---------------
Confidence 1 1123457899999999999762 2346789999999999999999999987654322111100
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
. . ......+..+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 223 -------~---~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 223 -------E---K---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp -------T---T---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -------c---c---cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 0 0 011122346789999999999999999999999999999998653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=393.22 Aligned_cols=252 Identities=26% Similarity=0.304 Sum_probs=206.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|+++++||+|+||+||+|++..+|+.||||++..............+|+..+..+ +|+||+++++++.. ...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence 679999999999999999999999999999999876555555666666777766555 89999999999843 346
Q ss_pred EEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+|||||+++|.+++...+ .+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 89999999999999887644 69999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. ....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+...... +.. +...
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~--------- 270 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLP--------- 270 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCC---------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCC---------
Confidence 2 244679999999999875 688999999999999999999877655332211 110 0000
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
......+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 271 ------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 ------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 0112356899999999999999999999999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=412.32 Aligned_cols=267 Identities=22% Similarity=0.345 Sum_probs=218.3
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..++|+++++||+|+||.||+|+++.+|+.||||++++.. ........+.+|+.+|..++||||+++++++...
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~----- 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE----- 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS-----
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----
Confidence 3578999999999999999999999999999999996421 1112234577899999999999999999998543
Q ss_pred ccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 100 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|||||||. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 46999999996 6999999875 479999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCcccccccccccc-----cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~-----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
.... ......+||+.|+|||++... ...|+.++|||||||++|||++|+.||.+.+..+.+..|....
T Consensus 214 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----- 286 (412)
T 2vd5_A 214 ADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK----- 286 (412)
T ss_dssp TTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-----
T ss_pred CCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----
Confidence 3221 112346899999999998621 1468899999999999999999999999988777666554310
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCcccccccc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEALADPYFKGLAK 321 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~R---pta~elL~hp~f~~~~~ 321 (560)
. ...+......+++.+++||++||. ||.+| ++++|+++||||+++..
T Consensus 287 ---------------~------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 287 ---------------E------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp ---------------H------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred ---------------c------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 0 001111224679999999999999 99998 59999999999997643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=381.67 Aligned_cols=257 Identities=31% Similarity=0.477 Sum_probs=219.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+|+.++||||+++++++... ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 80 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-----TD 80 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----Ce
Confidence 4679999999999999999999999999999999975332 3456788999999999999999999998543 46
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee---CCCCcEEEeccccccccc
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF 177 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl---~~~~~lKL~DFGla~~~~ 177 (560)
+|+||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 8999999985 999999888889999999999999999999999999999999999999 788999999999997654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+.........
T Consensus 161 ~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 228 (277)
T 3f3z_A 161 PGK----MMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE----- 228 (277)
T ss_dssp TTS----CBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH-----
T ss_pred Ccc----chhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence 332 2245679999999999865 4889999999999999999999999988876665555443222221
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..+..+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 229 ----------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 229 ----------------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ----------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ----------------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 1123568899999999999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=390.86 Aligned_cols=283 Identities=31% Similarity=0.519 Sum_probs=229.4
Q ss_pred CCCceEEEEEEeecCCeEEEEEEE-CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC------ccccceeecC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYD-TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD------IVEIKHILLP 93 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d-~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn------Iv~l~~i~~~ 93 (560)
..++|++.+.||+|+||.||+|.+ ..+++.||||++.. .......+.+|+.+++.++|++ |+++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 457999999999999999999999 56889999999974 2344567889999999987654 8899888843
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC----------
Q 008607 94 PSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---------- 161 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~---------- 161 (560)
. ..+|+||||++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 89 ~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 H-----GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp T-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred C-----CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 3 4689999999889999998876 6899999999999999999999999999999999999988
Q ss_pred ---------CCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCC
Q 008607 162 ---------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (560)
Q Consensus 162 ---------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~ 232 (560)
++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEHH------STLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSCC------CSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccCCCceEeeCcccccCcccc------ccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 6689999999997643221 34689999999999976 578999999999999999999999999
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHHhhhHH--------------HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 008607 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEK--------------ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 298 (560)
Q Consensus 233 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~--------------~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~ 298 (560)
+.+..+.+..+...++.++...+....... ...++..... ....+.......++.+.+||++||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc-chhhhcccchhhHHHHHHHHHHHhC
Confidence 999999999999988887776655432210 1111111110 0011111222345779999999999
Q ss_pred cCCCCCCCHHHHhcCccccccc
Q 008607 299 FEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 299 ~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.||.+|||++|+|+||||+.+.
T Consensus 315 ~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 315 YDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp SSTTTSCCHHHHTTSGGGGGGG
T ss_pred cCcccccCHHHHhcCHHHHHHh
Confidence 9999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=399.63 Aligned_cols=261 Identities=28% Similarity=0.437 Sum_probs=211.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|++.+.||+|+||.||+|.++.+|+.||||++..... ...+|+++|..+ +||||+++++++.. ..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~ 89 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDD-----GK 89 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEEC-----SS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEc-----CC
Confidence 4579999999999999999999999999999999975322 234688888877 79999999999854 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC----CcEEEeccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARV 175 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~----~~lKL~DFGla~~ 175 (560)
.+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++.
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 6999999998 5999999988899999999999999999999999999999999999998543 3599999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+
T Consensus 170 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~------------ 232 (342)
T 2qr7_A 170 LRAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL------------ 232 (342)
T ss_dssp CBCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH------------
T ss_pred CcCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH------------
Confidence 543322 2245689999999999976 46888999999999999999999999864321111111
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
..+...........++.+++.+.+||++||..||.+|||++|+|+||||.++...
T Consensus 233 ------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~ 287 (342)
T 2qr7_A 233 ------------ARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287 (342)
T ss_dssp ------------HHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGS
T ss_pred ------------HHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccc
Confidence 1111111112223456789999999999999999999999999999999876543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=416.06 Aligned_cols=261 Identities=31% Similarity=0.444 Sum_probs=219.6
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh-----------hHHHHHHHHHHHHHhcCCCCccccce
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-----------SDATRILREIKLLRLLRHPDIVEIKH 89 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-----------~~~~~i~rEi~iL~~l~HpnIv~l~~ 89 (560)
+.++|+++++||+|+||+||+|.++.++..||||++....... .....+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4688999999999999999999999999999999997532211 23567889999999999999999999
Q ss_pred eecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC---cE
Q 008607 90 ILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KL 165 (560)
Q Consensus 90 i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~---~l 165 (560)
++.. ...+|+|||||+| +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+
T Consensus 114 ~~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFED-----KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEEC-----SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEc-----CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccE
Confidence 9854 3468999999985 9999998888899999999999999999999999999999999999999876 69
Q ss_pred EEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHH
Q 008607 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245 (560)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~ 245 (560)
||+|||+++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 189 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp EECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 999999998754332 2355789999999999864 689999999999999999999999999887776666554
Q ss_pred hcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 246 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 246 ~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
....... ..+..+++.+.+||++||++||.+|||++|+|+||||+...
T Consensus 262 ~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 262 GKYYFDF---------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CCCCCCH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCCCCc---------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 2211111 12356789999999999999999999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=398.96 Aligned_cols=263 Identities=24% Similarity=0.448 Sum_probs=193.2
Q ss_pred ceEEE---EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 008607 24 RYKIE---EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 24 ~Y~i~---~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~ 99 (560)
+|++. +.||+|+||.||+|.+..+|+.||||++.. .....+.+|+.+|+.+. ||||+++++++...
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~----- 78 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQ----- 78 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-----
Confidence 47775 789999999999999999999999999864 23456779999999997 99999999998543
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC---cEEEeccccccc
Q 008607 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARV 175 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~---~lKL~DFGla~~ 175 (560)
..+|+|||||++ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 468999999985 9999999988999999999999999999999999999999999999998766 899999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+...... .
T Consensus 159 ~~~~~---~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------~----- 220 (325)
T 3kn6_A 159 KPPDN---QPLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT--------S----- 220 (325)
T ss_dssp CCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC--------C-----
T ss_pred cCCCC---CcccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc--------c-----
Confidence 53322 12345688999999999976 578999999999999999999999998754321100 0
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
....+..+...........+..+++.+.+||.+||+.||.+|||++|+|+||||++...
T Consensus 221 -------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 221 -------AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp -------HHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred -------HHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 00111111111111111223467899999999999999999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=381.68 Aligned_cols=263 Identities=26% Similarity=0.346 Sum_probs=219.0
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
-..+..|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~ 100 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KG 100 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SS
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CC
Confidence 34567899999999999999999999999999999999865556667788999999999999999999999875432 23
Q ss_pred CccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeC-CCCcEEEecccccc
Q 008607 99 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLAR 174 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~-~~~~lKL~DFGla~ 174 (560)
...+|+||||+++ +|.+++.....+++..++.|+.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 4568999999974 99999998888999999999999999999999999 99999999999998 78999999999997
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+......
T Consensus 181 ~~~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-------- 244 (290)
T 1t4h_A 181 LKRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-------- 244 (290)
T ss_dssp GCCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--------
T ss_pred cccccc-----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc--------
Confidence 543221 244679999999998865 5889999999999999999999999875544332211110
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
... ........++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 245 -----------------~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 245 -----------------GVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------TCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------cCC---ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 000 11112345788999999999999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=383.58 Aligned_cols=258 Identities=30% Similarity=0.470 Sum_probs=210.0
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
.+.++|++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+++|+.++||||+++++++.. .
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----Y 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheec-----C
Confidence 34578999999999999999999999999999999987543 23345778899999999999999999999843 3
Q ss_pred ccEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee---CCCCcEEEeccc
Q 008607 100 KDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFG 171 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl---~~~~~lKL~DFG 171 (560)
..+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 468999999985 89888854 3679999999999999999999999999999999999999 456889999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
++........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 173 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~----- 240 (285)
T 3is5_A 173 LAELFKSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK----- 240 (285)
T ss_dssp CCCC--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----
T ss_pred cceecCCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-----
Confidence 9976543221 245679999999999864 6789999999999999999999999987754433322110
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
...+......+++.+.+||++||+.||.+|||++|+|+||||++
T Consensus 241 -----------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 241 -----------------------EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -----------------------CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -----------------------CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 11112223347899999999999999999999999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=413.64 Aligned_cols=257 Identities=32% Similarity=0.512 Sum_probs=218.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++... .
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----S 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence 367999999999999999999999999999999996421 1122346788999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+|||||+ ++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 6899999997 599999988888999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 170 ~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------ 232 (476)
T 2y94_A 170 E----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------------ 232 (476)
T ss_dssp C----CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC------------
T ss_pred c----cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------------
Confidence 2 23557899999999999762 223679999999999999999999999887665554443210
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
......+++.+.+||++||+.||.+|||++|+++||||+..
T Consensus 233 -------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 -------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 01123568999999999999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=398.82 Aligned_cols=283 Identities=28% Similarity=0.424 Sum_probs=225.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC--------CCCccccceeecC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--------HPDIVEIKHILLP 93 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~--------HpnIv~l~~i~~~ 93 (560)
.++|++.++||+|+||+||+|++..+++.||||++.. .......+.+|+.+|+.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4789999999999999999999999999999999974 2345567889999999996 7789999998853
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeCCCC-------
Q 008607 94 PSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADC------- 163 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~~~~------- 163 (560)
.. .....+|+||||++++|.+.+... ..+++..++.|+.||+.||+|||++ ||+||||||+|||++.++
T Consensus 113 ~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 21 133578999999999988888765 4699999999999999999999998 999999999999999875
Q ss_pred ------------------------------------------cEEEecccccccccCCCCCcccccccccCccccccccc
Q 008607 164 ------------------------------------------KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201 (560)
Q Consensus 164 ------------------------------------------~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll 201 (560)
.+||+|||+++..... ....+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence 7999999999865432 2456899999999999
Q ss_pred ccccCCCCCccchhhHHHHHHHHhhCCCCCCCCC------hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCC
Q 008607 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN------VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 275 (560)
Q Consensus 202 ~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~------~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~ 275 (560)
.+ ..|+.++|||||||++|+|++|+.||.+.+ ..+++..+...+|.++...+....... .++........
T Consensus 266 ~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~ 341 (397)
T 1wak_A 266 IG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK--EFFTKKGDLKH 341 (397)
T ss_dssp HT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG--GTBCTTSSBSS
T ss_pred cC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc--cccCCcccccc
Confidence 77 579999999999999999999999998765 567788888899988776654322110 00000000000
Q ss_pred CCC-------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 276 IPF-------------SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 276 ~~~-------------~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
... .......++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000 0001123467889999999999999999999999999973
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=400.15 Aligned_cols=280 Identities=32% Similarity=0.547 Sum_probs=227.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCC-----ccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPD-----IVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-Hpn-----Iv~l~~i~~~~~ 95 (560)
.++|++.+.||+|+||+||+|++..+++.||||++.. .......+.+|+.+++.++ |++ |+.+++.+...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR- 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-
Confidence 4789999999999999999999999999999999974 2344566778999998886 554 88888887543
Q ss_pred cCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCCCCeeeC--CCCcEEEec
Q 008607 96 RREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILAN--ADCKLKICD 169 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLH--s~gIiHrDLKP~NILl~--~~~~lKL~D 169 (560)
..+||||||++++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 129 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 ----NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ----TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ----CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 468999999999999999875 36999999999999999999999 57999999999999995 478899999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCC
Q 008607 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (560)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~ 249 (560)
||+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..|...++.
T Consensus 205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999875322 245689999999999987 57999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCC---------CCCC-CCC------------------CC-------CCHHHHHHHH
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKP---------IPFS-QKF------------------PN-------ANPLALRLLE 294 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~---------~~~~-~~~------------------~~-------~s~~~~dLI~ 294 (560)
|....+... ...+.++..+..... ..+. ... .+ .++.+++||+
T Consensus 277 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 277 PPAHILDQA--PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CCHHHHTTC--TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCHHHHHhh--HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 887765432 223344433221100 0000 000 00 0147899999
Q ss_pred HhcccCCCCCCCHHHHhcCcccccc
Q 008607 295 RMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 295 ~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
+||++||.+|||++|+|+||||++.
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HhcCCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=397.09 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=201.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 122 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TE 122 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEecC-----Ce
Confidence 46799999999999999999999999999999998742 2345677899999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC---CCcEEEeccccccccc
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAF 177 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~---~~~lKL~DFGla~~~~ 177 (560)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 899999998 599999988888999999999999999999999999999999999999976 8899999999998653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhh-HHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~-~~~~i~~~~g~p~~~~~~ 256 (560)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... .+..+..
T Consensus 203 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~----------- 265 (349)
T 2w4o_A 203 HQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN----------- 265 (349)
T ss_dssp --------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT-----------
T ss_pred ccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh-----------
Confidence 322 2245689999999999977 578999999999999999999999997765433 2221111
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.........+..++..+.+||++||+.||.+|||+.|+|+||||.+..
T Consensus 266 ----------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 266 ----------------CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ----------------TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ----------------CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 111112234567899999999999999999999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=393.46 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=206.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc------
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR------ 96 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~------ 96 (560)
++|++++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46999999999999999999999999999999997432 33456788999999999999999999998854321
Q ss_pred ----------------------------------------------CCCccEEEEEecCCc-cHHHHHHhCCC---CCHH
Q 008607 97 ----------------------------------------------REFKDIYVVFELMES-DLHQVIKANDD---LTPE 126 (560)
Q Consensus 97 ----------------------------------------------~~~~~i~lV~E~~~g-dL~~~i~~~~~---lse~ 126 (560)
.....+|+|||||++ +|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 112248999999985 99999987653 5667
Q ss_pred HHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCc---------ccccccccCccccc
Q 008607 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA---------IFWTDYVATRWYRA 197 (560)
Q Consensus 127 ~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~---------~~~~~~~gT~~Y~A 197 (560)
.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 799999999999999999999999999999999999999999999998764432111 12245689999999
Q ss_pred ccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCC
Q 008607 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP 277 (560)
Q Consensus 198 PEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~ 277 (560)
||++.+ ..++.++|||||||++|+|++|..|+. +....+........
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~-------------------------- 291 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKF-------------------------- 291 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCC--------------------------
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCC--------------------------
Confidence 999977 578999999999999999999876652 11111111111111
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 278 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 278 ~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
...+...++.+.+||.+||+.||.+|||++|+|+||||+++
T Consensus 292 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 292 -PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp -CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred -CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 11112346778999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=392.76 Aligned_cols=274 Identities=24% Similarity=0.405 Sum_probs=225.0
Q ss_pred cCCCcccccccCCCCceEEE-EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccc
Q 008607 9 SSADVDFFTEYGEGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVE 86 (560)
Q Consensus 9 ~~~~~~~~~~~~~~~~Y~i~-~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~ 86 (560)
+.+.+-|...-...++|.+. +.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.+. ||||++
T Consensus 14 ~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~ 93 (327)
T 3lm5_A 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93 (327)
T ss_dssp --CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred cchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEE
Confidence 33445555555566789998 8999999999999999999999999999865555555678899999999995 699999
Q ss_pred cceeecCCCcCCCccEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC--
Q 008607 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-- 161 (560)
Q Consensus 87 l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-- 161 (560)
+++++.. ...+|+|||||.+ +|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 94 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 94 LHEVYEN-----TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY 168 (327)
T ss_dssp EEEEEEC-----SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT
T ss_pred EEEEEEe-----CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC
Confidence 9999843 3468999999985 898888553 57999999999999999999999999999999999999998
Q ss_pred -CCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHH
Q 008607 162 -DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240 (560)
Q Consensus 162 -~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~ 240 (560)
++.+||+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 242 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY 242 (327)
T ss_dssp TBCCEEECCGGGCEEC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCcEEEeeCccccccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 78999999999987543322 244689999999999976 57899999999999999999999999988876655
Q ss_pred HHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 241 ~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
..+...... .....+..+++.+.+||.+||+.||.+|||++|+|+||||+++.
T Consensus 243 ~~i~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 243 LNISQVNVD---------------------------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HHHHHTCCC---------------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred HHHHhcccc---------------------------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 544432211 12233457889999999999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=380.81 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=214.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
-++|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++... .
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----T 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----C
Confidence 357999999999999999999999999999999986421 1122345688999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 6899999998 599999988888999999999999999999999999999999999999999999999999998653322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 163 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 223 (279)
T 3fdn_A 163 R-----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------ 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------------
T ss_pred c-----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC------------
Confidence 1 245689999999999976 578899999999999999999999999887665554443211
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
......+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 224 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 224 -------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred -------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 011234688999999999999999999999999999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=394.30 Aligned_cols=268 Identities=28% Similarity=0.439 Sum_probs=214.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc---cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~---~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.++|++.+.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 100 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE---- 100 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC----
Confidence 478999999999999999999999999999999986421 1334567889999999999999999999998543
Q ss_pred CccEEEEEecCC-ccHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHH
Q 008607 99 FKDIYVVFELME-SDLHQVIKA----------------------------------------NDDLTPEHYQFFLYQLLR 137 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~----------------------------------------~~~lse~~~~~i~~Qll~ 137 (560)
..+|+|||||+ ++|.+++.. ...+++..++.++.||+.
T Consensus 101 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 101 -QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp -SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 46899999997 599998842 112467889999999999
Q ss_pred HHHHHHhCCeeeccCCCCCeeeCCCC--cEEEecccccccccCCCC-CcccccccccCcccccccccccccCCCCCccch
Q 008607 138 GLKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (560)
Q Consensus 138 aL~yLHs~gIiHrDLKP~NILl~~~~--~lKL~DFGla~~~~~~~~-~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DI 214 (560)
||+|||+.||+||||||+|||++.++ .+||+|||+++....... ........+||+.|+|||++.+....++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999998776 899999999986533221 111234568999999999986533578999999
Q ss_pred hhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHH
Q 008607 215 WSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 294 (560)
Q Consensus 215 WSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~ 294 (560)
|||||++|+|++|+.||.+.+..+.+..+.... .......+..+++.+.+||+
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~li~ 312 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK---------------------------LCFENPNYNVLSPLARDLLS 312 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------------------CCTTSGGGGGSCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcc---------------------------cccCCcccccCCHHHHHHHH
Confidence 999999999999999999888766555443211 11111223457899999999
Q ss_pred HhcccCCCCCCCHHHHhcCcccccccc
Q 008607 295 RMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 295 ~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
+||+.||.+|||+.|+|+||||+++..
T Consensus 313 ~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 313 NLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHcCCChhHCCCHHHHhcChhhccChH
Confidence 999999999999999999999987653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=392.67 Aligned_cols=270 Identities=25% Similarity=0.362 Sum_probs=215.5
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
...++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CC
Confidence 346789999999999999999999999999999999975432 3344567889999999999999999999885432 12
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
....|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 234699999997 5999999988889999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~---------- 235 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED---------- 235 (311)
T ss_dssp --------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC----------
T ss_pred ccccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC----------
Confidence 43322222345679999999999976 578999999999999999999999999887665544333211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..+.......+++.+.+||.+||+.||.+||++.++|.|+|++..
T Consensus 236 -----------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 236 -----------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -----------------CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----------------CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 111112235678999999999999999999999999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=378.72 Aligned_cols=261 Identities=28% Similarity=0.486 Sum_probs=217.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC----hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH----VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~----~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
++|++.+.||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 80 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK---- 80 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC----
Confidence 5799999999999999999999999999999998753222 12357788999999999999999999998543
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC----cEEEeccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLA 173 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~----~lKL~DFGla 173 (560)
..+|+||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 81 -TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred -CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 46899999997 69999998888899999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.........
T Consensus 160 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 232 (283)
T 3bhy_A 160 HKIEAGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE- 232 (283)
T ss_dssp EECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-
T ss_pred eeccCCCc----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-
Confidence 86533221 244679999999999976 57899999999999999999999999988766655544332211111
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
..++..++.+.+||++||..||.+|||++|+|+||||+.+..
T Consensus 233 --------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 233 --------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp --------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred --------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 122466889999999999999999999999999999987643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=382.63 Aligned_cols=259 Identities=28% Similarity=0.443 Sum_probs=216.9
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+|+.++||||+++++++... .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 79 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYEST-----T 79 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccC-----C
Confidence 3468999999999999999999999999999999997432 22345688999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee---CCCCcEEEecccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVA 176 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl---~~~~~lKL~DFGla~~~ 176 (560)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 6899999997 5999999888889999999999999999999999999999999999999 78899999999998754
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 160 ~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--------- 223 (304)
T 2jam_A 160 QNG-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY--------- 223 (304)
T ss_dssp CCB-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC---------
T ss_pred CCC-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC---------
Confidence 321 1244679999999999976 578899999999999999999999998877655544443211
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.......+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 224 ------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 224 ------------------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ------------------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ------------------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 1111223457789999999999999999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=392.21 Aligned_cols=262 Identities=27% Similarity=0.373 Sum_probs=207.9
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCC--CCccccceeecCCCcCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH--PDIVEIKHILLPPSRRE 98 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~H--pnIv~l~~i~~~~~~~~ 98 (560)
.+++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|+.++| +||+++++++...
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~---- 81 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD---- 81 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC----
Confidence 467899999999999999999987 468999999997655555666788999999999986 9999999998543
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|||||+++++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++....
T Consensus 82 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 82 -QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp -SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred -CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 4689999988889999999998999999999999999999999999999999999999997 67899999999986543
Q ss_pred CCCCcccccccccCcccccccccccc---------cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCC
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~---------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~ 249 (560)
.... ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... +..+...
T Consensus 160 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~--- 233 (343)
T 3dbq_A 160 DTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAI--- 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHH---
T ss_pred cccc-ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHH---
Confidence 3221 122456899999999998531 146788999999999999999999999764321 1111111
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
+...... ......+..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 234 --------------------~~~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 234 --------------------IDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp --------------------HCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred --------------------hcCCccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 0011111 112345678999999999999999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=399.45 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=211.9
Q ss_pred CceEE--EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 23 SRYKI--EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 23 ~~Y~i--~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
+.|.+ .+.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.+|+.++||||+++++++... .
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----N 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----C
Confidence 44555 67899999999999999999999999999752 334567789999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee--CCCCcEEEecccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA--NADCKLKICDFGLARVA 176 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl--~~~~~lKL~DFGla~~~ 176 (560)
.+|||||||+ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 6899999998 5898888664 369999999999999999999999999999999999999 56789999999999875
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|......
T Consensus 240 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------- 306 (373)
T 2x4f_A 240 KPREK----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD------- 306 (373)
T ss_dssp CTTCB----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------
T ss_pred CCccc----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Confidence 43322 244679999999999976 57889999999999999999999999998877666555432111
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.....++.+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 307 --------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 307 --------------------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp --------------------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred --------------------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1122345789999999999999999999999999999999854
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=385.69 Aligned_cols=255 Identities=28% Similarity=0.514 Sum_probs=214.4
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.|+..+.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+|+.++||||+++++++... ..+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEE
Confidence 4889999999999999999999999999999986432 23456788999999999999999999998543 3689
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 104 lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
+||||+++ +|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 99999985 88888754 47999999999999999999999999999999999999999999999999999865433222
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 262 (560)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---------------- 256 (321)
T 2c30_A 198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---------------- 256 (321)
T ss_dssp ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------------
T ss_pred ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------------
Confidence 245689999999999976 57899999999999999999999999887765544433221
Q ss_pred HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
. .+.......+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 257 -----------~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 257 -----------P-PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp -----------S-CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred -----------C-CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 0 00111123568899999999999999999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=400.33 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=203.7
Q ss_pred CCceEEE-EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHH-HhcCCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~-~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL-~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
.+.|.+. ++||+|+||+||+|++..+|+.||||++.. ...+.+|+.++ +.++||||+++++++.... .+.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCC
Confidence 4568877 799999999999999999999999999863 23466889887 5568999999999874311 223
Q ss_pred ccEEEEEecCCc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC---CCcEEEeccccc
Q 008607 100 KDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLA 173 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~---~~~lKL~DFGla 173 (560)
..+|||||||+| +|.+++...+ .+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 568999999985 9999998754 5999999999999999999999999999999999999998 789999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhh----HHHHHHHhcCC
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH----QLDIMTDLLGT 249 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~----~~~~i~~~~g~ 249 (560)
+...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+... ....+.
T Consensus 212 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----- 280 (400)
T 1nxk_A 212 KETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----- 280 (400)
T ss_dssp EECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH-----
T ss_pred cccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH-----
Confidence 8643222 2356789999999999976 689999999999999999999999998765322 111111
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
. .........+..+++.+.+||++||+.||.+|||++|+|+||||.+..
T Consensus 281 -------------------~---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 281 -------------------M---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp -------------------H---TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred -------------------c---CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 0 001111223467899999999999999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=387.95 Aligned_cols=282 Identities=31% Similarity=0.519 Sum_probs=227.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCC-cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC------ccccceeecCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD------IVEIKHILLPP 94 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg-~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn------Iv~l~~i~~~~ 94 (560)
.++|++.+.||+|+||.||+|++..++ ..||||++.. .......+.+|+.+|+.++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-
Confidence 579999999999999999999998877 6899999874 2344567888999999998766 7777777743
Q ss_pred CcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee-------------
Q 008607 95 SRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA------------- 159 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl------------- 159 (560)
...+|+||||++++|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 94 ----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 94 ----HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp ----TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred ----CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 34689999999999998887754 69999999999999999999999999999999999999
Q ss_pred ------CCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCC
Q 008607 160 ------NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233 (560)
Q Consensus 160 ------~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~ 233 (560)
+.++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCcEEEeecCccccccccc------cCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 567899999999997643222 44689999999999976 5789999999999999999999999999
Q ss_pred CChhhHHHHHHHhcCCCCHHHHHHhhhHH--------------HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 008607 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEK--------------ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 299 (560)
Q Consensus 234 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~--------------~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~ 299 (560)
.+..+.+..+.+.++.++...+....... ...++....... ..........++.+.+||++||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcc-cccccccchhHHHHHHHHHHHhcC
Confidence 99999999999999888776654432211 011111111000 000111122356789999999999
Q ss_pred CCCCCCCHHHHhcCccccccc
Q 008607 300 EPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 300 DP~~Rpta~elL~hp~f~~~~ 320 (560)
||.+|||++|+|+||||+++.
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGCC
T ss_pred ChhhCcCHHHHhcChhhcCCC
Confidence 999999999999999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=384.98 Aligned_cols=281 Identities=25% Similarity=0.389 Sum_probs=208.4
Q ss_pred CCCceEEE-EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 008607 21 EGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 21 ~~~~Y~i~-~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~ 98 (560)
..++|++. +.||+|+||.||+|.+..+++.||||++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~---- 83 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE---- 83 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC----
Confidence 35689995 7899999999999999999999999999753 223456788999999885 799999999998543
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc---EEEecccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLAR 174 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~---lKL~DFGla~ 174 (560)
..+|+|||||+ ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 84 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 84 -DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp -TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred -CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 46899999998 699999998888999999999999999999999999999999999999998876 9999999997
Q ss_pred cccCCCC----CcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc
Q 008607 175 VAFNDTP----TAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 175 ~~~~~~~----~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~ 247 (560)
....... ........+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---- 238 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---- 238 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc----
Confidence 6432111 11112345799999999998631 124788999999999999999999999876532200000
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
...... .....+..+...........+..+++.+.+||++||+.||.+|||++|+|+||||++..
T Consensus 239 ~~~~~~--------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 239 GEACPA--------CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp --CCHH--------HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred cccchh--------HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 000000 00011111111111111112346789999999999999999999999999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=379.10 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=198.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.++..+++.++||||+++++++... ..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----GD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----CC
Confidence 4689999999999999999999999999999999975433333334444555668888999999999998543 46
Q ss_pred EEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 102 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
+|+||||++++|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 899999999988777653 56799999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccccccccc--ccCCCCCccchhhHHHHHHHHhhCCCCCCCCCh-hhHHHHHHHhcCCCCHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~--~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~-~~~~~~i~~~~g~p~~~ 253 (560)
..... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+... ...+..+..
T Consensus 161 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------- 228 (290)
T 3fme_A 161 VDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 228 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH--------
T ss_pred ccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc--------
Confidence 43322 133579999999999631 114688899999999999999999999986332 222211111
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
...+ ......+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 229 ------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 229 ------------------EPSP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ------------------SCCC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ------------------cCCC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 0111 11124578999999999999999999999999999999853
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=392.47 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=216.1
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC-hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
...++|++++.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+|+.++||||+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 126 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE---- 126 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC----
Confidence 3346799999999999999999999999999999999753222 23346788999999999999999999998543
Q ss_pred CccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|+||||+.|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 127 -~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 127 -HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp -TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred -CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 46899999999999988864 5579999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCccccccccccc-ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.. ...+||+.|+|||++.+ ....++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 206 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~---------- 268 (348)
T 1u5q_A 206 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------- 268 (348)
T ss_dssp SB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------
T ss_pred CC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----------
Confidence 21 34689999999999842 1256889999999999999999999999887765544333221
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
..+. .....+++.+.+||.+||+.||.+|||++++|+||||..
T Consensus 269 ----------------~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 269 ----------------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ----------------CCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ----------------CCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 1110 112456889999999999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=376.80 Aligned_cols=263 Identities=30% Similarity=0.440 Sum_probs=222.3
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.-...++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 87 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-- 87 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--
Confidence 3466789999999999999999999999999999999987533 2344567788999999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..+|+||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 88 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 88 ---DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp ---SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ---CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 46899999998 59999998888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 165 ~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------- 229 (294)
T 2rku_A 165 VEYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK---------- 229 (294)
T ss_dssp CCSTTCC---BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----------
T ss_pred cccCccc---cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh----------
Confidence 5432221 244679999999999976 5788999999999999999999999988775544332211
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
.. ......+++.+.+||++||+.||.+|||++|+|+||||.....
T Consensus 230 ----------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 230 ----------------NE-----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp ----------------TC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ----------------cc-----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 00 0112357889999999999999999999999999999986543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=408.69 Aligned_cols=257 Identities=17% Similarity=0.193 Sum_probs=202.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHH---HHHhcCCCCccccc-------ee
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIK---LLRLLRHPDIVEIK-------HI 90 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~---iL~~l~HpnIv~l~-------~i 90 (560)
.++|++.+.||+|+||.||+|++..+|+.||||++... .........+.+|+. +|+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47899999999999999999999999999999999743 233445678889995 45555799999998 44
Q ss_pred ecCCCc---------CCC---ccEEEEEecCCccHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCeeecc
Q 008607 91 LLPPSR---------REF---KDIYVVFELMESDLHQVIKANDDLTP-------EHYQFFLYQLLRGLKYIHTANVFHRD 151 (560)
Q Consensus 91 ~~~~~~---------~~~---~~i~lV~E~~~gdL~~~i~~~~~lse-------~~~~~i~~Qll~aL~yLHs~gIiHrD 151 (560)
+..... ... ...||||||++|+|.+++...+.+++ ..++.|+.||+.||+|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 432210 000 13799999999999999987655655 88889999999999999999999999
Q ss_pred CCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccc---------cCCCCCccchhhHHHHHH
Q 008607 152 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFA 222 (560)
Q Consensus 152 LKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~---------~~~y~~~~DIWSlG~il~ 222 (560)
|||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. ...|+.++|||||||++|
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 999999999999999999999985321 2245678 999999999761 016899999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCC
Q 008607 223 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 302 (560)
Q Consensus 223 eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~ 302 (560)
||++|+.||.+.+....+.. .....+.+++.+.+||.+||+.||.
T Consensus 305 elltg~~Pf~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~L~~dp~ 349 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEW-----------------------------------IFRSCKNIPQPVRALLEGFLRYPKE 349 (377)
T ss_dssp HHHHSSCCC------CCSGG-----------------------------------GGSSCCCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHCCCCCcccccccchhh-----------------------------------hhhhccCCCHHHHHHHHHHcCCCch
Confidence 99999999976543221110 1112357789999999999999999
Q ss_pred CCCCHHHHhcCccccccc
Q 008607 303 DRPTAEEALADPYFKGLA 320 (560)
Q Consensus 303 ~Rpta~elL~hp~f~~~~ 320 (560)
+|||+.|+|+||||+++.
T Consensus 350 ~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 350 DRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp GCCCHHHHHTSHHHHHHH
T ss_pred hCCCHHHHhhChHHHHHH
Confidence 999999999999998643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=389.53 Aligned_cols=259 Identities=27% Similarity=0.489 Sum_probs=216.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh------hHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV------SDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~------~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~ 95 (560)
++|++.+.||+|+||.||+|++..+|+.||||++....... .....+.+|+.+|+.+ +||||+.+++++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS- 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS-
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC-
Confidence 57999999999999999999999999999999986432211 1235678999999999 799999999988443
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 96 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
..+|+||||++| +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 173 ----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 173 ----SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp ----SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 468999999985 999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCcccccccccccc----cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCC
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p 250 (560)
....... ....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus 249 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 249 HLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp ECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 6543322 2457899999999998531 1357889999999999999999999998877665555443321111
Q ss_pred CHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 251 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
. ...+...++.+.+||++||+.||.+|||++|+|+||||+
T Consensus 325 ~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 325 S---------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp C---------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred C---------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 1 111245688899999999999999999999999999997
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=385.18 Aligned_cols=264 Identities=30% Similarity=0.433 Sum_probs=223.2
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
......++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++|+||+++++++...
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 113 (335)
T 2owb_A 35 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN- 113 (335)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred cCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-
Confidence 34556789999999999999999999999999999999987532 2344567788999999999999999999998543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
..+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 114 ----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 114 ----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp ----SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ----CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 46899999998 5999999888889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 190 ~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------- 256 (335)
T 2owb_A 190 KVEYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------- 256 (335)
T ss_dssp ECCSTTCC---BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--------
T ss_pred ecccCccc---ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--------
Confidence 65432221 244679999999999976 57889999999999999999999999887755443332210
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
.. .....+++.+.+||++||+.||.+|||++|+|+||||.....
T Consensus 257 ------------------~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 257 ------------------EY-----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp ------------------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ------------------CC-----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 00 112356889999999999999999999999999999986543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=424.33 Aligned_cols=258 Identities=21% Similarity=0.381 Sum_probs=220.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (560)
.++|+++++||+|+||.||+|+++.+++.||||++.+.. ........+.+|..+|..+ +||+|+.+++++...
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~----- 414 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM----- 414 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-----
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-----
Confidence 468999999999999999999999999999999997421 1223446678899999887 699999999988543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+||||||++ |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+||+|||+++....
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 46999999998 59999999888999999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
... .....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..|...
T Consensus 495 ~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~------------ 557 (674)
T 3pfq_A 495 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------ 557 (674)
T ss_dssp TTC---CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS------------
T ss_pred CCc---ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------------
Confidence 221 2356789999999999976 68999999999999999999999999998877666555321
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYFKGLA 320 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta-----~elL~hp~f~~~~ 320 (560)
. . .....+++.+.+||++||+.||.+|+++ +||++||||+++.
T Consensus 558 --------------~--~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 558 --------------N--V---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp --------------C--C---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred --------------C--C---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 0 1 1124678999999999999999999997 9999999999753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=376.33 Aligned_cols=257 Identities=24% Similarity=0.414 Sum_probs=217.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++... .
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-----K 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-----C
Confidence 468999999999999999999999999999999986421 1122345788999999999999999999998543 4
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+||||+++ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 68999999985 99999998888999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 168 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------- 227 (284)
T 2vgo_A 168 R-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------- 227 (284)
T ss_dssp C-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------
T ss_pred c-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-------------
Confidence 1 234679999999999977 57889999999999999999999999887755543333210
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
. . ...+.++..+.+||.+||+.||.+|||++|+|+||||+....
T Consensus 228 -------------~--~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 228 -------------D--L---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp -------------C--C---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred -------------c--c---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 0 0 112457899999999999999999999999999999986543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=396.02 Aligned_cols=261 Identities=28% Similarity=0.371 Sum_probs=208.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC--CCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--HPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~--HpnIv~l~~i~~~~~~~~~ 99 (560)
+.+|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|+.++ |+||+++++++...
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~----- 128 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----- 128 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----
Confidence 4679999999999999999999865 999999999765445566778999999999997 59999999988543
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
..+|||||+++++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++.....
T Consensus 129 ~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 3599999977789999999988999999999999999999999999999999999999995 589999999999865432
Q ss_pred CCCcccccccccCcccccccccccc---------cCCCCCccchhhHHHHHHHHhhCCCCCCCCChh-hHHHHHHHhcCC
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGT 249 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~---------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~~~~i~~~~g~ 249 (560)
... ......+||+.|+|||++.+. ...|+.++||||||||||+|++|+.||.+.... ..+..+..
T Consensus 208 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~---- 282 (390)
T 2zmd_A 208 TTS-VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---- 282 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC----
T ss_pred Ccc-ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC----
Confidence 211 123456899999999998541 135888999999999999999999999764321 11111110
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
...... .....+..+.+||++||+.||.+|||+.|+|+||||+..
T Consensus 283 ----------------------~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 283 ----------------------PNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp ----------------------TTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ----------------------ccccCC---CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 011111 112347889999999999999999999999999999853
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=375.57 Aligned_cols=264 Identities=28% Similarity=0.430 Sum_probs=218.8
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC-------hhHHHHHHHHHHHHHhcC-CCCccccceeec
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-------VSDATRILREIKLLRLLR-HPDIVEIKHILL 92 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-------~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~ 92 (560)
..++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+|+.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 356899999999999999999999999999999998643211 123456789999999996 999999999984
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccc
Q 008607 93 PPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFG 171 (560)
.. ..+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 95 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TN-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cC-----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 43 46899999998 5999999988889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccc----cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~ 247 (560)
++........ ....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 170 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (298)
T 1phk_A 170 FSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245 (298)
T ss_dssp TCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred chhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence 9986543322 2456799999999998521 2467889999999999999999999998877655444333211
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.......+..++..+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 246 ---------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 246 ---------------------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp ---------------------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ---------------------------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 1111122346788999999999999999999999999999998653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=392.72 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=210.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh------hHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV------SDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~------~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
.++|++++.||+|+||.||+|++..+++.||||++....... .....+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 368999999999999999999999999999999997532211 133456789999999999999999999844
Q ss_pred cCCCccEEEEEecCC-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 96 RREFKDIYVVFELME-S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
...+++||||+. | +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 346899999986 5 99999999889999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCC-CCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
+....... ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+....
T Consensus 178 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 178 AYLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp EECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred eECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 87543322 245689999999999876 344 78899999999999999999999652210
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
.... ......+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 237 -----------------~~~~-----~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 237 -----------------VEAA-----IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp -----------------TTTC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred -----------------Hhhc-----cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 0000 0112347899999999999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=379.29 Aligned_cols=267 Identities=23% Similarity=0.398 Sum_probs=217.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc--cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~--~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+|+.++||||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE---K 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---C
Confidence 368999999999999999999999999999999997421 11234567889999999999999999999985432 2
Q ss_pred ccEEEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 100 KDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 46899999999888888876 3469999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
..... .......||+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 161 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----------- 228 (305)
T 2wtk_C 161 PFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG----------- 228 (305)
T ss_dssp TTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------
T ss_pred ccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-----------
Confidence 32221 223456799999999998753223467899999999999999999999987755444333210
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccC
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~ 323 (560)
. ......+++.+.+||++||+.||.+|||++|+|+||||+......
T Consensus 229 ---------------~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 229 ---------------S-----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ---------------C-----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ---------------C-----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 0 012246788999999999999999999999999999998765443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=403.30 Aligned_cols=260 Identities=32% Similarity=0.535 Sum_probs=204.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC------hhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH------VSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~------~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 46899999999999999999999999999999998743211 1122347899999999999999999998732
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC---cEEEeccc
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFG 171 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~---~lKL~DFG 171 (560)
..+|+|||||+ ++|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 212 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 24799999998 59999998888999999999999999999999999999999999999997654 59999999
Q ss_pred ccccccCCCCCcccccccccCccccccccccc-ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHH-HHHHHhcCC
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGT 249 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~-~~i~~~~g~ 249 (560)
+++...... .....+||+.|+|||++.+ ....|+.++|||||||++|+|++|++||.+......+ ..+...
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~--- 360 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG--- 360 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT---
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC---
Confidence 998753322 2245789999999999853 1246788999999999999999999999875433222 222111
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
........+..+++.+.+||++||+.||.+|||++|+|+||||++
T Consensus 361 ------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 361 ------------------------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ------------------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ------------------------CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 111111223567899999999999999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=416.20 Aligned_cols=262 Identities=26% Similarity=0.417 Sum_probs=216.5
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..++|++.++||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++...
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~----- 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK----- 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-----
Confidence 4578999999999999999999999999999999996421 1222345678999999999999999999998543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 100 KDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~--lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+|+|||||+ |+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 46999999997 599999987553 999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+..
T Consensus 337 ~~~~~----~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~----------- 399 (576)
T 2acx_A 337 PEGQT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----------- 399 (576)
T ss_dssp CTTCC----EECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-----------
T ss_pred ccCcc----ccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-----------
Confidence 43321 245689999999999976 5789999999999999999999999987653211111111
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~~ 320 (560)
.+... +.. ....+++.+.+||++||+.||.+|| +++|+++||||+++.
T Consensus 400 ---------~i~~~----~~~---~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 400 ---------LVKEV----PEE---YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp ---------HHHHC----CCC---CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred ---------Hhhcc----ccc---CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 11111 111 1246789999999999999999999 899999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=388.89 Aligned_cols=287 Identities=25% Similarity=0.371 Sum_probs=224.7
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-----------CCCccccce
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-----------HPDIVEIKH 89 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-----------HpnIv~l~~ 89 (560)
..++|++.+.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.++ |+||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 35789999999999999999999999999999999974 3344567889999999886 889999999
Q ss_pred eecCCCcCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeC------
Q 008607 90 ILLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILAN------ 160 (560)
Q Consensus 90 i~~~~~~~~~~~i~lV~E~~~gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~------ 160 (560)
++.... .+...+++|||+++++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 986432 223468999999988999999874 4599999999999999999999998 999999999999994
Q ss_pred CCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCC-----
Q 008607 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN----- 235 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~----- 235 (560)
..+.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4458999999999765432 244589999999999977 578999999999999999999999998764
Q ss_pred -hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCC-------------CCCCCCCHHHHHHHHHhcccCC
Q 008607 236 -VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS-------------QKFPNANPLALRLLERMLAFEP 301 (560)
Q Consensus 236 -~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-------------~~~~~~s~~~~dLI~~mL~~DP 301 (560)
..+.+..+.+.+|.++...+...... ..++........+... ......+..+.+||.+||+.||
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchh--hhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 55677788888888877655433221 1111111000000000 0112345778999999999999
Q ss_pred CCCCCHHHHhcCcccccccc
Q 008607 302 KDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 302 ~~Rpta~elL~hp~f~~~~~ 321 (560)
.+|||++|+|+||||++...
T Consensus 323 ~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCTT
T ss_pred cccCCHHHHhhChhhhcccC
Confidence 99999999999999997543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=378.81 Aligned_cols=266 Identities=28% Similarity=0.335 Sum_probs=212.8
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
...++|++++.||+|+||.||+|++..++..||||++.... .......++.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----- 82 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE----- 82 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-----
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-----
Confidence 34678999999999999999999999999999999986432 334455788999999999999999999999843
Q ss_pred CccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
...+|+||||++| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 3468999999985 999999988889999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 163 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~------------ 226 (294)
T 4eqm_A 163 ETSLT--QTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ------------ 226 (294)
T ss_dssp --------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS------------
T ss_pred ccccc--ccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh------------
Confidence 32211 1244679999999999977 5788999999999999999999999998776544322211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
...+.......+.+++.+.+||.+||+.||.+||+..+.+.+.|..-+.
T Consensus 227 --------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 227 --------------DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp --------------SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred --------------ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1111111223456789999999999999999999666666667655443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=372.78 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=207.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.++..+ +||||+++++++... ..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----DH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----TE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 579999999999999999999999999999999986555556677889999999999 899999999998543 46
Q ss_pred EEEEEecCCc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC--------------
Q 008607 102 IYVVFELMES-DLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-------------- 162 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~----~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-------------- 162 (560)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 8999999975 999999764 579999999999999999999999999999999999999844
Q ss_pred -----CcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChh
Q 008607 163 -----CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237 (560)
Q Consensus 163 -----~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~ 237 (560)
..+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++|.++|......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred ccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 47999999999865332 224699999999998762 35667999999999999999999877543321
Q ss_pred hHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 238 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
. .+. ... .......+++.+.+||.+||+.||.+|||+.|+|+||||.
T Consensus 238 ~---~~~---------------------------~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 238 H---EIR---------------------------QGR---LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp H---HHH---------------------------TTC---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred H---HHH---------------------------cCC---CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 1 111 000 1122346789999999999999999999999999999998
Q ss_pred cc
Q 008607 318 GL 319 (560)
Q Consensus 318 ~~ 319 (560)
..
T Consensus 285 ~~ 286 (289)
T 1x8b_A 285 SA 286 (289)
T ss_dssp --
T ss_pred hh
Confidence 53
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=376.78 Aligned_cols=260 Identities=34% Similarity=0.551 Sum_probs=219.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----Ce
Confidence 4689999999999999999999999999999999976554455677889999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC---CcEEEeccccccccc
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAF 177 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~---~~lKL~DFGla~~~~ 177 (560)
+|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 899999997 5999999887889999999999999999999999999999999999999764 469999999998654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... .....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 176 ~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------- 237 (287)
T 2wei_A 176 QNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG----------- 237 (287)
T ss_dssp CCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 3321 234578999999999875 4889999999999999999999999988765544433321
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
........+..+++.+.+||++||..||.+|||++|+|+||||+++.
T Consensus 238 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 238 ----------------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp ----------------CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred ----------------CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 00001122356789999999999999999999999999999998653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=396.69 Aligned_cols=276 Identities=17% Similarity=0.145 Sum_probs=198.4
Q ss_pred ccccCCC-CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhc--CCCCccccc---
Q 008607 16 FTEYGEG-SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL--RHPDIVEIK--- 88 (560)
Q Consensus 16 ~~~~~~~-~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l--~HpnIv~l~--- 88 (560)
-+.++.. ..|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.| +||||++++
T Consensus 54 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~ 133 (371)
T 3q60_A 54 DSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133 (371)
T ss_dssp EETTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CB
T ss_pred EecCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeE
Confidence 3444444 349999999999999999999999999999999986433 233445677885555544 699988755
Q ss_pred ----eeecCCCcC------------CCccEEEEEecCCccHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHhC
Q 008607 89 ----HILLPPSRR------------EFKDIYVVFELMESDLHQVIKAND-DLTPEHY------QFFLYQLLRGLKYIHTA 145 (560)
Q Consensus 89 ----~i~~~~~~~------------~~~~i~lV~E~~~gdL~~~i~~~~-~lse~~~------~~i~~Qll~aL~yLHs~ 145 (560)
+++...... ....+|||||||+++|.+++...+ .+.+... ..++.||+.||+|||++
T Consensus 134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 333222110 114589999999999999998743 3455555 67779999999999999
Q ss_pred CeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHh
Q 008607 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225 (560)
Q Consensus 146 gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLl 225 (560)
||+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+....|+.++|||||||++|+|+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 9999999999999999999999999999864321 1245677999999999652246899999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 008607 226 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305 (560)
Q Consensus 226 tG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp 305 (560)
+|+.||.+......- ..... ...............+.+++.+.+||.+||+.||.+||
T Consensus 288 tg~~Pf~~~~~~~~~-----~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 345 (371)
T 3q60_A 288 CLFLPFGLVTPGIKG-----SWKRP-----------------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345 (371)
T ss_dssp HSSCSTTBCCTTCTT-----CCCBC-----------------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCC
T ss_pred hCCCCCCCcCccccc-----chhhh-----------------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCC
Confidence 999999876422100 00000 00000001111122357899999999999999999999
Q ss_pred CHHHHhcCcccccc
Q 008607 306 TAEEALADPYFKGL 319 (560)
Q Consensus 306 ta~elL~hp~f~~~ 319 (560)
|++|+|+||||+++
T Consensus 346 t~~e~l~hp~f~~~ 359 (371)
T 3q60_A 346 LPLEAMETPEFLQL 359 (371)
T ss_dssp CHHHHTTSHHHHHH
T ss_pred CHHHHhcCHHHHHH
Confidence 99999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=373.74 Aligned_cols=257 Identities=27% Similarity=0.465 Sum_probs=191.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 85 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-----NY 85 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-----SE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-----Ce
Confidence 579999999999999999999999999999999864211 112246788999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 899999997 5999999875 57999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.
T Consensus 166 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------------- 225 (278)
T 3cok_A 166 HE---KHYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--------------- 225 (278)
T ss_dssp -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC---------------
T ss_pred CC---cceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh---------------
Confidence 21 1234679999999999976 578899999999999999999999998765433221110
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.. .......++..+.+||.+||+.||.+|||++++|+||||....
T Consensus 226 ------------~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 226 ------------LA----DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp ------------SS----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred ------------hc----ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 00 0112235788999999999999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=390.11 Aligned_cols=285 Identities=22% Similarity=0.346 Sum_probs=219.8
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++++.||+|+||.||+|.+..++..||+|++... ........+.+|+.+|+.++||||+++++++... .
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 104 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----G 104 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----T
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----C
Confidence 357899999999999999999999999999999998753 2344567789999999999999999999998543 4
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|+||||+++ +|.+++...+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 68999999985 9999999888899999999999999999999996 999999999999999999999999999975432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc-CCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL-GTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~-g~p~~~~~~~ 257 (560)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... +.+.......
T Consensus 185 ~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 SM-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HC---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cc-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 21 234689999999999977 578999999999999999999999999877554433221111 1111000000
Q ss_pred --------------hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 258 --------------VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 258 --------------~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.........+..+........ ....++..+.+||++||+.||.+|||++|+|+||||++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCC--CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCC--CcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 000001112222222211111 1234688999999999999999999999999999998643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=407.64 Aligned_cols=262 Identities=23% Similarity=0.356 Sum_probs=215.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|++.++||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++... .
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-----T 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-----C
Confidence 4789999999999999999999999999999999964221 122346788999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~----~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
.+|+|||||+ |+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 6999999998 5999999764 3699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
....... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+..
T Consensus 339 ~~~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---------- 403 (543)
T 3c4z_A 339 LKAGQTK---TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---------- 403 (543)
T ss_dssp CCTTCCC---BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH----------
T ss_pred ccCCCcc---cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH----------
Confidence 5433221 245689999999999987 6799999999999999999999999987642211111110
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~~ 320 (560)
..+. . .. .....+++.+.+||++||+.||.+||+ ++++++||||+++.
T Consensus 404 ---------~i~~----~-~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 404 ---------RVLE----Q-AV---TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp ---------HHHH----C-CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred ---------HHhh----c-cc---CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 0000 0 01 112467899999999999999999995 58999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=378.26 Aligned_cols=276 Identities=22% Similarity=0.401 Sum_probs=213.1
Q ss_pred cCCCcccccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCcccc
Q 008607 9 SSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEI 87 (560)
Q Consensus 9 ~~~~~~~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l 87 (560)
+..++++-..-...++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+|+.+ +||||+++
T Consensus 10 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~ 86 (326)
T 2x7f_A 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATY 86 (326)
T ss_dssp ------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCE
T ss_pred cchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeee
Confidence 3344444444456789999999999999999999999999999999986432 2346788999999999 79999999
Q ss_pred ceeecCCCc-CCCccEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC
Q 008607 88 KHILLPPSR-REFKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC 163 (560)
Q Consensus 88 ~~i~~~~~~-~~~~~i~lV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~ 163 (560)
++++..... .....+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC
T ss_pred eeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC
Confidence 999865321 113578999999985 999999874 4699999999999999999999999999999999999999999
Q ss_pred cEEEecccccccccCCCCCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHH
Q 008607 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240 (560)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~ 240 (560)
.+||+|||++........ .....+||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+....+
T Consensus 167 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp CEEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CEEEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 999999999876532211 12446799999999998621 146889999999999999999999999877655443
Q ss_pred HHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 241 ~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..+... ..+ ......+++.+.+||++||..||.+|||++++|+||||+..
T Consensus 244 ~~~~~~--------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 244 FLIPRN--------------------------PAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHHHS--------------------------CCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HHhhcC--------------------------ccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 322210 000 11124678999999999999999999999999999999853
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=371.12 Aligned_cols=257 Identities=29% Similarity=0.454 Sum_probs=206.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++... .
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----T 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence 468999999999999999999999999999999986421 1122345788999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 6899999997 599999988888999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. .....++|+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 165 ~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------- 226 (276)
T 2h6d_A 165 E----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG------------- 226 (276)
T ss_dssp ----------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred c----ceecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-------------
Confidence 2 12446799999999998762 22357899999999999999999999887654443333210
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
. ......++..+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 227 -------------~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 227 -------------V-----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -------------C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------------c-----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 0 01123468899999999999999999999999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=371.08 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=214.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEE
Confidence 56999999999999999999999999999999986432 223457788999999999999999999988543 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+||||+++ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999985 9999998777899999999999999999999999999999999999999999999999999976533221
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhH-HHHHHHhcCCCCHHHHHHhhh
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ-LDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.... +..+..
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 223 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------------- 223 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---------------
T ss_pred -hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---------------
Confidence 1123456899999999998762 2246789999999999999999999987654322 111110
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.. .....+..+++.+.+||++||+.||.+|||++|+|+||||++..
T Consensus 224 -----------~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 224 -----------KK---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp -----------TC---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -----------cc---cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 00 01112346789999999999999999999999999999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=382.94 Aligned_cols=260 Identities=32% Similarity=0.531 Sum_probs=208.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc------ChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------HVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~------~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
.++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 4689999999999999999999999999999999874321 112234578999999999999999999988432
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc---EEEeccc
Q 008607 96 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFG 171 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~---lKL~DFG 171 (560)
.+|+||||+++ +|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 88 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 -----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -----SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -----ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 37999999985 99999988888999999999999999999999999999999999999987664 9999999
Q ss_pred ccccccCCCCCcccccccccCccccccccccc-ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHH-HHHHHhcCC
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGT 249 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~-~~i~~~~g~ 249 (560)
+++..... ......+||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+......+ ..+......
T Consensus 163 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 163 HSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp TCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred cceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 99765322 12245679999999999742 1256889999999999999999999999875533222 222111000
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
.....+..+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 239 ---------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 239 ---------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp ---------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred ---------------------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 011123467889999999999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=373.96 Aligned_cols=265 Identities=22% Similarity=0.383 Sum_probs=212.9
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
.+...++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+|+.++||||+++++++...
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 88 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD--- 88 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC---
Confidence 356678999999999999999999999999999999998743 234467788999999999999999999998543
Q ss_pred CCccEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~g-dL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 89 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 89 --GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred --CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 368999999985 88888875 45799999999999999999999999999999999999999999999999999764
Q ss_pred ccCCCCCcccccccccCccccccccccc---ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~---~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
...... .....+||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 237 (302)
T 2j7t_A 167 NLKTLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------ 237 (302)
T ss_dssp HHHHHH---C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------
T ss_pred cccccc---ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc------
Confidence 321110 1134579999999999831 1156889999999999999999999999887755443332221
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.. +.......++..+.+||.+||+.||.+|||++++|+||||+.+.
T Consensus 238 --------------------~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 238 --------------------DP--PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp --------------------CC--CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred --------------------CC--cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 00 00111235688999999999999999999999999999998654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=371.84 Aligned_cols=260 Identities=30% Similarity=0.461 Sum_probs=215.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++... ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 4689999999999999999999999999999999976544555667889999999999999999999987532 2246
Q ss_pred EEEEEecCCc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCCCCeeeCCCCcEEEeccc
Q 008607 102 IYVVFELMES-DLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFG 171 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~----~~lse~~~~~i~~Qll~aL~yLHs~g-----IiHrDLKP~NILl~~~~~lKL~DFG 171 (560)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 8999999985 999998753 34999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 162 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----- 231 (279)
T 2w5a_A 162 LARILNHDT---SFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----- 231 (279)
T ss_dssp HHHHC---C---HHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----
T ss_pred hheeecccc---ccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-----
Confidence 998653322 11234679999999999976 57889999999999999999999999887754443333210
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
. .......+++.+.+||.+||+.||.+|||++|+|+|+|+.+-
T Consensus 232 ----------------------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 232 ----------------------K---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ----------------------C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ----------------------c---cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 0 011223578999999999999999999999999999999853
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=390.68 Aligned_cols=263 Identities=23% Similarity=0.390 Sum_probs=211.4
Q ss_pred CceEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEecCcc--cChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~ 96 (560)
++|++++.||+|+||.||+|++. .+|+.||||+++... ........+.+|+.+|+.+ +||||+.+++++...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 131 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 131 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC--
Confidence 68999999999999999999984 589999999987422 1122334567899999999 699999999988543
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 97 ~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..+|+|||||++ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 132 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 132 ---TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp ---TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ---ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 468999999984 9999999888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... ......+||+.|+|||++.+....++.++|||||||++|+|++|+.||...+.......+..
T Consensus 209 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------- 276 (355)
T 1vzo_A 209 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 276 (355)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH----------
T ss_pred cccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH----------
Confidence 432221 12245689999999999975334578999999999999999999999976543222211111
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
..+. .. ......++..+.+||.+||..||.+|| |++|+++||||+.+
T Consensus 277 ---------~~~~----~~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 277 ---------RILK----SE----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp ---------HHHH----CC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ---------HHhc----cC----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 0111 00 112346789999999999999999999 99999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=378.50 Aligned_cols=278 Identities=22% Similarity=0.374 Sum_probs=211.3
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
...++|++.++||+|+||.||+|.+..+|+.||||++..... ......+.+|+++|+.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 81 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---T 81 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---T
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---C
Confidence 456789999999999999999999999999999999974322 233566789999999999999999999886433 2
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee----CCCCcEEEeccc
Q 008607 100 KDIYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFG 171 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~---lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl----~~~~~lKL~DFG 171 (560)
..+|+||||++ ++|.+++..... +++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 46899999997 599999986543 9999999999999999999999999999999999999 788889999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccc------cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhh-HHHHHH
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMT 244 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~-~~~~i~ 244 (560)
+++....... ....+||+.|+|||++... ...++.++|||||||++|+|++|+.||....... ....+.
T Consensus 162 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 162 AARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp TCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred CceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 9987544332 2456799999999988521 1578899999999999999999999997543322 122222
Q ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008607 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS-------QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (560)
Q Consensus 245 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-------~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~ 315 (560)
.++.......+..+.. ....+..+. .....++..+.+||++||+.||.+|||++|+|+||=
T Consensus 238 ~~~~~~p~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 238 KIITGKPSGAISGVQK----------AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHCCTTCCEEEEC----------STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHhcCCCcccchhhhc----------ccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2211111000000000 000011111 111234567899999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=372.98 Aligned_cols=250 Identities=27% Similarity=0.403 Sum_probs=202.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||+||+|.+ +|..||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-----PN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-----TC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Cc
Confidence 46899999999999999999976 688999999986555556667899999999999999999999998543 35
Q ss_pred EEEEEecCCc-cHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 102 IYVVFELMES-DLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~---lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
+|+||||+++ +|.+++...+. +++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 8999999985 99999987654 999999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 189 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~--------- 254 (309)
T 3p86_A 189 KASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK--------- 254 (309)
T ss_dssp ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS---------
T ss_pred cccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------
Confidence 433221 1245689999999999977 57899999999999999999999999887755443332211
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ......+++.+.+||++||+.||.+|||++++++
T Consensus 255 -----------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 255 -----------------CKR---LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp -----------------CCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001 1123467899999999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=372.54 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=209.7
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+|+.++||||+++++++... .
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----T 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----C
Confidence 357899999999999999999999999999999998742 2345688999999999999999999998543 4
Q ss_pred cEEEEEecCCc-cHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELMES-DLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~-~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|+||||+++ +|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 68999999985 9999987 456799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 178 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 239 (314)
T 3com_A 178 TMA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT------------- 239 (314)
T ss_dssp TBS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred hcc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-------------
Confidence 221 1245679999999999977 5789999999999999999999999987665443322211
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
... ........++..+.+||.+||..||.+|||++++|+||||+..
T Consensus 240 --------------~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 240 --------------NPP-PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp --------------SCC-CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred --------------CCC-cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 000 1111223468899999999999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=375.16 Aligned_cols=273 Identities=27% Similarity=0.419 Sum_probs=194.6
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
...++|++.+.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 85 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK----- 85 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS-----
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----
Confidence 34678999999999999999999999999999999986432 123456688999999999999999999998544
Q ss_pred ccEEEEEecCC-ccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecc
Q 008607 100 KDIYVVFELME-SDLHQVIKA--------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~--------~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DF 170 (560)
..+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 35899999997 599998874 456999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCC--CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcC
Q 008607 171 GLARVAFNDTP--TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 171 Gla~~~~~~~~--~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g 248 (560)
|++........ ........+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+.......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~- 243 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 243 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS-
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC-
Confidence 99976533211 11122346799999999998642 358899999999999999999999998876655433222110
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.+.. ............+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 244 ~~~~--------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 244 PPSL--------------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCCT--------------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CCcc--------------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 0000 000111233456789999999999999999999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=376.00 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=209.3
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcE---EEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~---vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
-..++|++.+.||+|+||.||+|.+..++.. ||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 121 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--- 121 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG---
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe---
Confidence 3567999999999999999999999876654 9999997532 34456778999999999999999999999843
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 97 REFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 97 ~~~~~i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
...+|+||||+++ +|.+++... +.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 122 --GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp --GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred --CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 3468999999975 999999765 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
................+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.....
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----- 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR----- 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-----
T ss_pred ccccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC-----
Confidence 76544333333344567889999999976 578899999999999999999 9999988776655444332111
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
......+++.+.+||.+||..||.+|||+.|+++
T Consensus 273 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 273 -------------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1122467899999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=367.95 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=216.3
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
...++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 92 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD----- 92 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence 44577999999999999999999999999999999987432 234567789999999999999999999998543
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..+|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 468999999985 89988864 5799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 172 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 233 (303)
T 3a7i_A 172 TQI---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------------- 233 (303)
T ss_dssp TBC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred ccc---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-------------
Confidence 221 1245689999999999976 5788999999999999999999999987665443322211
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
..+ ......++..+.+||.+||..||.+|||++|+|+||||..
T Consensus 234 --------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 234 --------------NNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp --------------SCC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred --------------CCC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 111 1123467889999999999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=374.37 Aligned_cols=267 Identities=22% Similarity=0.353 Sum_probs=196.7
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCc---EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
...++|++.+.||+|+||.||+|.+..++. .||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 446789999999999999999999887775 89999997655455667889999999999999999999999865432
Q ss_pred C-CCccEEEEEecCCc-cHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEe
Q 008607 97 R-EFKDIYVVFELMES-DLHQVIKAND------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (560)
Q Consensus 97 ~-~~~~i~lV~E~~~g-dL~~~i~~~~------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~ 168 (560)
. .....++||||+.+ +|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 1 11235999999985 9999986532 59999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhc
Q 008607 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~ 247 (560)
|||+++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 180 Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 180 DFGLSRKIYSGDYYR-QGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp CCCC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred ecccccccccccccc-ccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 999998654332211 1234457889999999977 578999999999999999999 999999887666554433210
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCcccccc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-------AEEALADPYFKGL 319 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-------a~elL~hp~f~~~ 319 (560)
.....+.+++.+.+||.+||+.||.+||| +++++.|||+...
T Consensus 257 ------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 257 ------------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp ------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ------------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 01123467899999999999999999999 7888899999753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=368.22 Aligned_cols=263 Identities=21% Similarity=0.338 Sum_probs=195.1
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.-++|++++.||+|+||.||+|.+..+|+.||||++............+.++..+++.++||||+++++++... .
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----T 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----S
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----C
Confidence 34789999999999999999999999999999999975433322333444555678888999999999998543 4
Q ss_pred cEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|+||||+++.+..+... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 6899999997777666654 56799999999999999999999995 999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccccccccc---ccCCCCCccchhhHHHHHHHHhhCCCCCCCCC-hhhHHHHHHHhcCCCCHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~---~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~~~~i~~~~g~p~~~~ 254 (560)
... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.. ..+.+..+..
T Consensus 178 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (318)
T 2dyl_A 178 DKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--------- 244 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH---------
T ss_pred Ccc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc---------
Confidence 221 234579999999999852 11468899999999999999999999998643 2222222211
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
..+ +.......+++.+.+||.+||+.||.+|||++|+|+||||+++.
T Consensus 245 ------------------~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 245 ------------------EEP-PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp ------------------SCC-CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred ------------------cCC-CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 111 11112346789999999999999999999999999999998654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=375.06 Aligned_cols=262 Identities=25% Similarity=0.419 Sum_probs=191.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~-iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+. +++.++||||+++++++... .
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~ 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----G 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----S
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----C
Confidence 478999999999999999999999999999999997532 2334455666666 67788999999999998543 4
Q ss_pred cEEEEEecCCccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 101 DIYVVFELMESDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~~-----~~~lse~~~~~i~~Qll~aL~yLHs~-gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.+|+||||++++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 6899999999998888864 56799999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCccccccccccc--ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~--~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
....... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.+... ..+
T Consensus 175 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~--------- 239 (327)
T 3aln_A 175 QLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQL--------- 239 (327)
T ss_dssp C----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------
T ss_pred ecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHH---------
Confidence 6533221 234579999999999832 11468899999999999999999999997644211 000
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIP-FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.......+.. .......+++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 240 ---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 240 ---------------TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ---------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ---------------HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 1111111111 122234688999999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=377.46 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=208.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC-------CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT-------RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~-------~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~ 93 (560)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 468999999999999999999874 35568999999753 2344567789999999999 89999999999854
Q ss_pred CCcCCCccEEEEEecCCc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 008607 94 PSRREFKDIYVVFELMES-DLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~g-dL~~~i~~~~----------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~N 156 (560)
. ..+|+||||+++ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 159 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 159 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred C-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 3 458999999985 9999998753 48999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 008607 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (560)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 235 (560)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999865432221 11234567889999999976 578999999999999999999 999999877
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 236 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..+.+..+... .. ......+++.+.+||.+||+.||.+|||+.|+++
T Consensus 311 ~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 311 VEELFKLLKEG---------------------------HR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp GGGHHHHHHTT---------------------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcC---------------------------CC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 65544333221 00 1122467889999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=361.69 Aligned_cols=263 Identities=27% Similarity=0.414 Sum_probs=202.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-----
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR----- 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~----- 96 (560)
.++|++++.||+|+||.||+|++..+|+.||||++.. .......+.+|+.+|+.++||||+++++++.....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3579999999999999999999999999999999863 23455778899999999999999999998754321
Q ss_pred ---CCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccc
Q 008607 97 ---REFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (560)
Q Consensus 97 ---~~~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFG 171 (560)
.....+|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 22457899999998 59999998654 58899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC-----------CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCC-ChhhH
Q 008607 172 LARVAFNDTP-----------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-NVVHQ 239 (560)
Q Consensus 172 la~~~~~~~~-----------~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~-~~~~~ 239 (560)
++........ ........+||+.|+|||++.+. ..++.++|||||||++|+|++ ||... +....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9976532210 01122456799999999998752 468899999999999999998 55321 11111
Q ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 240 ~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
+..+ ...............++.+.+||++||+.||.+|||++++|+||||+.
T Consensus 238 ~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 238 LKKL---------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHH---------------------------HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHhc---------------------------cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 1111 111111111223456788999999999999999999999999999974
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=380.58 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=209.7
Q ss_pred CCceEEEEEEeecCCeEEEEEE-----ECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAY-----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~-----d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 4789999999999999999999 5567889999999643 3344556788999999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC---cE
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KL 165 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~-------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~---~l 165 (560)
...|+|||||+ |+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 147 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 ---LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ---CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 35799999997 59999998643 489999999999999999999999999999999999999655 59
Q ss_pred EEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHH
Q 008607 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (560)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~ 244 (560)
||+|||+++........ ......++|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999854322111 11234678999999999976 578999999999999999998 999999887665554443
Q ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 245 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
... . ......+++.+.+||.+||+.||.+|||+++++++.++-
T Consensus 301 ~~~---------------------------~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGG---------------------------R---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTC---------------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC---------------------------C---CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 211 0 011245788999999999999999999999999988764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=366.84 Aligned_cols=265 Identities=27% Similarity=0.348 Sum_probs=207.9
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC--CCCccccceeecCCCc
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--HPDIVEIKHILLPPSR 96 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~--HpnIv~l~~i~~~~~~ 96 (560)
-..+++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+|+.++ |+||+++++++...
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-- 100 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-- 100 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS--
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC--
Confidence 445678999999999999999999885 5889999999765455566778899999999997 59999999988543
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 97 ~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+|+|||+.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++..
T Consensus 101 ---~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 101 ---QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp ---SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred ---CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 3689999987889999999988999999999999999999999999999999999999996 489999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccc---------cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~---------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~ 247 (560)
...... ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+..... ..+..
T Consensus 177 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~-- 251 (313)
T 3cek_A 177 QPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHA-- 251 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHH--
T ss_pred cCcccc-ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--HHHHH--
Confidence 432221 122346799999999998641 1357889999999999999999999997643211 11111
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.+ ...... ......+..+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 252 ------------------~~---~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 252 ------------------II---DPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp ------------------HH---CTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ------------------HH---hccccc---CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 01 011111 1123457889999999999999999999999999999854
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=364.34 Aligned_cols=260 Identities=24% Similarity=0.418 Sum_probs=209.8
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.++||+|+||.||+|.+..+++.||+|++.. ........+.+|+.+|+.++||||+++++++... .
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~ 80 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----K 80 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----T
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----C
Confidence 45789999999999999999999999999999999864 3455667889999999999999999999998543 4
Q ss_pred cEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|+||||+++ +|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 68999999985 99999987 45799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCc-----------ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc
Q 008607 179 DTPTA-----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 179 ~~~~~-----------~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~ 247 (560)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------ 232 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------ 232 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------
Confidence 32211 11125689999999999977 678999999999999999999999987543211000
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
. ......+.. ...+.+++.+.+||.+||+.||.+|||++++++ |+..+
T Consensus 233 ~------------~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 233 G------------LNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp S------------BCHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred h------------hhhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 0 000111111 012466788999999999999999999999986 55543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=361.56 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=202.9
Q ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008607 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
...+||+|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++++... ..+++||
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 98 (295)
T 2clq_A 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIFM 98 (295)
T ss_dssp SBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred CcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEEE
Confidence 334899999999999999999999999998753 234456788999999999999999999998543 4689999
Q ss_pred ecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC-CCcEEEecccccccccCCCC
Q 008607 107 ELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 107 E~~~-gdL~~~i~~~~---~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-~~~lKL~DFGla~~~~~~~~ 181 (560)
||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9997 59999998752 4679999999999999999999999999999999999988 89999999999986533221
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
......||+.|+|||++.+....++.++|||||||++|+|++|+.||.+...........
T Consensus 179 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----------------- 238 (295)
T 2clq_A 179 ---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV----------------- 238 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-----------------
T ss_pred ---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-----------------
Confidence 124567999999999986532347889999999999999999999997543222110000
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
...... ......+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 239 -------~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 239 -------GMFKVH----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp -------HHHCCC----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred -------cccccc----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 000000 112346789999999999999999999999999999998543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=373.81 Aligned_cols=255 Identities=26% Similarity=0.432 Sum_probs=208.7
Q ss_pred CCceEEEEEEeecCCeEEEEEE-----ECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAY-----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~-----d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~ 95 (560)
.++|++.+.||+|+||.||+|. +..+++.||||++... ........+.+|+.+|+.+ +||||+++++++....
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 4789999999999999999998 5667899999999743 2334556789999999999 7899999999985432
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhCCC----------------------------------------------------
Q 008607 96 RREFKDIYVVFELMES-DLHQVIKANDD---------------------------------------------------- 122 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~g-dL~~~i~~~~~---------------------------------------------------- 122 (560)
..+++|||||.+ +|.+++.....
T Consensus 100 ----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 100 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp ----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 347999999985 99999987543
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccc
Q 008607 123 --------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188 (560)
Q Consensus 123 --------------lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 188 (560)
+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~ 254 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGD 254 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC--
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhccc
Confidence 89999999999999999999999999999999999999999999999999986533322 122345
Q ss_pred cccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHH
Q 008607 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 267 (560)
Q Consensus 189 ~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l 267 (560)
..||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+......
T Consensus 255 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--------------------- 311 (359)
T 3vhe_A 255 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--------------------- 311 (359)
T ss_dssp CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---------------------
T ss_pred cCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---------------------
Confidence 678999999999976 578999999999999999998 99999887654433222110
Q ss_pred HhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 268 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
... ......+++.+.+||.+||+.||.+|||++|+++|
T Consensus 312 -----~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 312 -----GTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCC---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 001 11124578899999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=375.90 Aligned_cols=272 Identities=19% Similarity=0.311 Sum_probs=211.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh---------------hHHHHHHHHHHHHHhcCCCCccc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV---------------SDATRILREIKLLRLLRHPDIVE 86 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~---------------~~~~~i~rEi~iL~~l~HpnIv~ 86 (560)
.++|++.+.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.+|+.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 36899999999999999999998 89999999986422111 11277889999999999999999
Q ss_pred cceeecCCCcCCCccEEEEEecCCc-cHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCC
Q 008607 87 IKHILLPPSRREFKDIYVVFELMES-DLHQV------IKA--NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKN 156 (560)
Q Consensus 87 l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~------i~~--~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~N 156 (560)
+++++... ..+|+||||+++ +|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 108 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 99998543 468999999986 99888 655 5679999999999999999999999 999999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCC-ccchhhHHHHHHHHhhCCCCCCCCC
Q 008607 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGKPLFPGKN 235 (560)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~-~~DIWSlG~il~eLltG~~pF~~~~ 235 (560)
||++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|||||||++|+|++|+.||.+.+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999865332 23456899999999999762 25555 8999999999999999999998876
Q ss_pred h-hhHHHHHHHhcC-CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 236 V-VHQLDIMTDLLG-TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 236 ~-~~~~~~i~~~~g-~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
. .+.+..+..... .|.... .++ ..............+++.+.+||.+||+.||.+|||++|+|+|
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~~----------~~~---~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDRN----------HFL---YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSSS----------SST---TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cHHHHHHHHhccCcCCccchh----------hhh---ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 5 333333322100 000000 000 0000000111225688999999999999999999999999999
Q ss_pred cccccc
Q 008607 314 PYFKGL 319 (560)
Q Consensus 314 p~f~~~ 319 (560)
|||++.
T Consensus 324 p~f~~~ 329 (348)
T 2pml_X 324 EWLADT 329 (348)
T ss_dssp GGGTTC
T ss_pred ccccCC
Confidence 999854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=358.43 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=206.9
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+|+.++||||+++++++... .
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 78 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----A 78 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----S
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----C
Confidence 3578999999999999999999986 57789999997532 2345688999999999999999999998543 4
Q ss_pred cEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 58999999985 899999764 4599999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+....
T Consensus 159 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~---------- 224 (269)
T 4hcu_A 159 DQY--TSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------- 224 (269)
T ss_dssp HHH--HSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----------
T ss_pred ccc--ccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc----------
Confidence 211 11234567888999999976 578999999999999999999 999998877655544333210
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
. .......++.+.+||.+||+.||.+|||+.|+++|
T Consensus 225 -----------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 -----------------R---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -----------------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------c---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 01123468899999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=365.59 Aligned_cols=271 Identities=23% Similarity=0.372 Sum_probs=206.6
Q ss_pred CCCceEEEEEEeecCCeEEEEEE----ECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
..++|++++.||+|+||.||+|+ +..+++.||||++.. ........+.+|+.+|+.++||||+++++++....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG- 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH-
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 56799999999999999999998 677899999999974 24455677899999999999999999999985432
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
...+|+||||++ ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 85 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 85 --RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp --HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred --CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 235799999997 59999998765 49999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQ 235 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-----HHHHHHCTTCCTH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChH-----HHHhhhcCccccc
Confidence 76443322222344567888999999976 5789999999999999999999999865321 1111122111110
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. ........+......+ ....+++.+.+||++||+.||.+|||+.|+++
T Consensus 236 ~------~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 236 M------IVFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp H------HHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h------hHHHHHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 0011112222221111 23467899999999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=368.85 Aligned_cols=259 Identities=19% Similarity=0.234 Sum_probs=206.3
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~ 97 (560)
...+++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+|+.+ +||||+.+++++...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--- 77 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG--- 77 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEET---
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecC---
Confidence 345789999999999999999999999999999999986432 223577899999999 899999999988543
Q ss_pred CCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc-----EEEeccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFG 171 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~-----lKL~DFG 171 (560)
...|+||||++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||
T Consensus 78 --~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 78 --KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp --TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred --CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 468999999988999999874 57999999999999999999999999999999999999999887 9999999
Q ss_pred ccccccCCCCCcc----cccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc
Q 008607 172 LARVAFNDTPTAI----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 172 la~~~~~~~~~~~----~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~ 247 (560)
+++.......... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..+.
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 233 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence 9987543322111 1245789999999999987 578999999999999999999999999855433322222110
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. ... +.+....... .+.+.+||.+||+.||.+||+++++++
T Consensus 234 ~------------~~~-----------~~~~~~~~~~-~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 234 D------------TKR-----------ATPIEVLCEN-FPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp H------------HHH-----------HSCHHHHTTT-CHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred h------------hhc-----------cCCHHHHhcc-ChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 000 0000000112 238999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=374.24 Aligned_cols=268 Identities=25% Similarity=0.383 Sum_probs=188.5
Q ss_pred ccccCCCCceEEEE-EEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 008607 16 FTEYGEGSRYKIEE-VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (560)
Q Consensus 16 ~~~~~~~~~Y~i~~-~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~ 94 (560)
...+...++|++.+ +||+|+||.||+|++..+|+.||||++... . ....+....++.+.||||+++++++...
T Consensus 21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 45577788999965 699999999999999999999999998641 1 1122233446778999999999998542
Q ss_pred CcCCCccEEEEEecCCc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC---CcEEEe
Q 008607 95 SRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKIC 168 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~g-dL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~---~~lKL~ 168 (560)
. .....+|+|||||++ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+
T Consensus 95 ~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 95 H-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp E-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred c-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 1 223458999999985 9999998764 69999999999999999999999999999999999999864 559999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcC
Q 008607 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g 248 (560)
|||+++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 174 Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--- 243 (336)
T 3fhr_A 174 DFGFAKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--- 243 (336)
T ss_dssp CCTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred ccccceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH---
Confidence 999997653222 234678999999999866 5688899999999999999999999976553322111100
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.+...........+..+++.+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 244 --------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 244 --------------------RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ---------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred --------------------hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0000011111223457899999999999999999999999999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=372.67 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=209.7
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh----hHHHHHHHHHHHHHhcC--CCCccccceeecC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLR--HPDIVEIKHILLP 93 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~----~~~~~i~rEi~iL~~l~--HpnIv~l~~i~~~ 93 (560)
...++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.+|+.++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 45678999999999999999999999999999999987432211 12245668999999996 5999999999854
Q ss_pred CCcCCCccEEEEEecCC--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC-CCCcEEEecc
Q 008607 94 PSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 170 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~--gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~-~~~~lKL~DF 170 (560)
. ..+++|||++. ++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++ .++.+||+||
T Consensus 120 ~-----~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 120 P-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp S-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred C-----CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 3 46899999997 69999999888899999999999999999999999999999999999999 7899999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCC
Q 008607 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p 250 (560)
|+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +.
T Consensus 195 g~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~------ 256 (320)
T 3a99_A 195 GSGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II------ 256 (320)
T ss_dssp TTCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH------
T ss_pred cccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh------
Confidence 9998754322 2446799999999998652 2346789999999999999999999965321 00
Q ss_pred CHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 251 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
. .. ......+++.+.+||++||+.||.+|||++|+|+||||++.
T Consensus 257 -----------------~---~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 257 -----------------R---GQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp -----------------H---CC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----------------c---cc-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 0 00 01124678999999999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=359.43 Aligned_cols=258 Identities=18% Similarity=0.245 Sum_probs=207.8
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (560)
.+++|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+++.+ +|+|++.+++++.. .
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~ 78 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----G 78 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----T
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC----CccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----C
Confidence 467899999999999999999999999999999998642 2233567899999999 79999999998743 3
Q ss_pred ccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc-----EEEeccccc
Q 008607 100 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLA 173 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~-----lKL~DFGla 173 (560)
...|+||||++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 4689999999889999998754 5999999999999999999999999999999999999988776 999999999
Q ss_pred ccccCCCCCc----ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCC
Q 008607 174 RVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (560)
Q Consensus 174 ~~~~~~~~~~----~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~ 249 (560)
+......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-- 234 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG-- 234 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH--
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH--
Confidence 8764432211 11245689999999999977 578999999999999999999999998854332222221110
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ...+.....+.+++.+.+||.+||+.||.+|||++++++
T Consensus 235 ----------~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 235 ----------EKK-----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ----------HHH-----------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------hhc-----------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 000 000111223467899999999999999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=355.31 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=206.1
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CC
Confidence 3578999999999999999999775 57789999997532 234568899999999999999999999843 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 6899999997 58999998754 599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+....
T Consensus 157 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------- 222 (268)
T 3sxs_A 157 DQY--VSSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---------- 222 (268)
T ss_dssp TCE--EECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC----------
T ss_pred hhh--hcccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC----------
Confidence 321 11234556788999999976 568899999999999999999 999998877655443332210
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
. .......++.+.+||.+||+.||.+|||+.|++++
T Consensus 223 -----------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 223 -----------------R---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -----------------C---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------C---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 01113457889999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=363.44 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=209.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-- 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC--
Confidence 578999999999999999999983 45689999999743 2345567889999999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCeeecc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKANDD------------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRD 151 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~~------------------------lse~~~~~i~~Qll~aL~yLHs~gIiHrD 151 (560)
..+|+||||++ ++|.+++..... +++..++.++.||+.||.|||++||+|||
T Consensus 99 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 99 ---GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ---CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 45899999998 699999987543 89999999999999999999999999999
Q ss_pred CCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCC
Q 008607 152 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230 (560)
Q Consensus 152 LKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~p 230 (560)
|||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cchheEEEcCCCCEEEccccccccccccccc-eeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999865432211 11234567889999999976 568899999999999999999 9999
Q ss_pred CCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 008607 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310 (560)
Q Consensus 231 F~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~el 310 (560)
|.+.+.......+... . .......+++.+.+||.+||+.||.+|||++|+
T Consensus 253 ~~~~~~~~~~~~~~~~---------------------------~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTG---------------------------H---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp STTCCGGGHHHHHHTT---------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHhhcC---------------------------C---cCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9887765544333211 0 011234678999999999999999999999999
Q ss_pred hcC
Q 008607 311 LAD 313 (560)
Q Consensus 311 L~h 313 (560)
+++
T Consensus 303 ~~~ 305 (314)
T 2ivs_A 303 SKD 305 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=358.92 Aligned_cols=250 Identities=20% Similarity=0.308 Sum_probs=204.4
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++++.||+|+||.||+|.+. ++..||||++.... .....+.+|+.+|+.++|+||+++++++.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QR 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CC
Confidence 4589999999999999999999875 67789999997532 234568899999999999999999999843 34
Q ss_pred cEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 6899999997 599999987 45799999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+......
T Consensus 173 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 240 (283)
T 3gen_A 173 DEY--TSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------- 240 (283)
T ss_dssp HHH--HSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred ccc--ccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------
Confidence 211 11233457788999999976 578999999999999999998 99999887765554444321110
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
......++.+.+||.+||+.||.+|||++|+|+|
T Consensus 241 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 ----------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1123457889999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=358.05 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=198.1
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCC---CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
..++|++.+.||+|+||.||+|++..+ +..||+|++... ........+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 87 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---- 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc----
Confidence 357999999999999999999998754 457999998643 234456778999999999999999999998732
Q ss_pred CCccEEEEEecCCc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~g-dL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..+|+||||+++ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 88 --NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred --CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 247999999985 9999998754 699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+...
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-------- 233 (281)
T 1mp8_A 166 MEDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-------- 233 (281)
T ss_dssp ---------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--------
T ss_pred cCccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC--------
Confidence 5432211 1233467789999999976 578899999999999999996 99999987766554443221
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.. ....+.+++.+.+||.+||+.||.+|||+.|+++
T Consensus 234 -------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 234 -------------------ER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp -------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 1123567899999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=354.77 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=204.3
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHH-----HHHHHHHHHHHhcCCCCccccceeecCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-----TRILREIKLLRLLRHPDIVEIKHILLPP 94 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~-----~~i~rEi~iL~~l~HpnIv~l~~i~~~~ 94 (560)
...++|++.+.||+|+||.||+|++..+++.||||++.......... ..+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34578999999999999999999999999999999986433222221 6788999999999999999999998543
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeCCCCc-----E
Q 008607 95 SRREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCK-----L 165 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~~~~~-----l 165 (560)
. ++||||+. ++|.+.+.... .+++..++.++.||+.||+|||+.| |+||||||+|||++.++. +
T Consensus 96 ~-------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 P-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp T-------EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred C-------eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 2 79999998 69988887644 6999999999999999999999999 999999999999988776 9
Q ss_pred EEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhH--HHHH
Q 008607 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ--LDIM 243 (560)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~--~~~i 243 (560)
||+|||+++.... .....+||+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+.... ...+
T Consensus 169 kl~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 169 KVADFGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp EECCCTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred EeCCCCccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 9999999974322 1245689999999999854335678899999999999999999999987553322 1111
Q ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 244 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.. .... ......+++.+.+||.+||+.||.+|||++|+++
T Consensus 243 ~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 RE--------------------------EGLR---PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HH--------------------------SCCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc--------------------------cCCC---CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 10 0000 1123467899999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=358.05 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=208.0
Q ss_pred cCCCCceEEEE-EEeecCCeEEEEEE--ECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 19 YGEGSRYKIEE-VIGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 19 ~~~~~~Y~i~~-~IG~G~~G~Vy~a~--d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
+...++|++.+ .||+|+||.||+|. +..+++.||||++............+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-- 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC--
Confidence 34567899999 99999999999995 46678999999998654444556789999999999999999999998822
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
..+|+||||++ ++|.+++..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 90 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 90 ----ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp ----SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ----CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 35899999998 5999999998889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
................+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------- 235 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------- 235 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------
T ss_pred eeccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------
Confidence 75443322222233456788999999976 567889999999999999999 9999988775543332221
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 236 -------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 236 -------------------GER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -------------------TCC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 1123467899999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=371.27 Aligned_cols=276 Identities=23% Similarity=0.245 Sum_probs=210.0
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
+...++|++.++||+|+||.||+|.+. ++.||||++... ........+|+.+|+.++||||+++++++.... ..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 93 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SV 93 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SS
T ss_pred ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CC
Confidence 456689999999999999999999875 899999998642 234455667999999999999999999986533 12
Q ss_pred CccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CeeeccCCCCCeeeCCCCcEEE
Q 008607 99 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------NVFHRDLKPKNILANADCKLKI 167 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~----------gIiHrDLKP~NILl~~~~~lKL 167 (560)
...+|+|||||++ +|.+++... .+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 3458999999985 999999775 599999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCccccccccccccc---CCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHH
Q 008607 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (560)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~---~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~ 244 (560)
+|||+++........ ......+||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.+......+....
T Consensus 173 ~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 173 ADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp CCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred ccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999875443322 1224468999999999986521 134567899999999999999999998865543333333
Q ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 245 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.....|....+... +. .......+...+. ..++.+.+||++||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~--------~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEV--------VV--HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHH--------HT--TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhh--------hh--cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 33444443332211 11 1111111111111 22456999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=361.86 Aligned_cols=260 Identities=20% Similarity=0.311 Sum_probs=201.7
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECC---CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~---tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
..++|++.+.||+|+||.||+|.+.. ++..||||++............+.+|+.+|+.++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45899999999999999999998765 566899999976555555667889999999999999999999998765543
Q ss_pred CCccEEEEEecCC-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~------~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DF 170 (560)
.....|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3446799999998 499999853 346999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCC
Q 008607 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 249 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~ 249 (560)
|+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 192 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--- 265 (313)
T 3brb_A 192 GLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG--- 265 (313)
T ss_dssp SCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---
T ss_pred Ccceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC---
Confidence 999765332211 11233567889999999976 578999999999999999999 89999887765544433221
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.. ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 266 ------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 ------------------------HR---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ------------------------CC---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CC---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 11224678899999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=360.75 Aligned_cols=254 Identities=28% Similarity=0.375 Sum_probs=200.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
-++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++... .
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----G 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----T
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----C
Confidence 4689999999999999999999999999999999975432 233457788999999999999999999998543 4
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|+||||+++ +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 68999999985 99999998888999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 188 ~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------------- 248 (309)
T 2h34_A 188 KL--TQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN--------------- 248 (309)
T ss_dssp -----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH---------------
T ss_pred cc--ccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc---------------
Confidence 21 12245679999999999976 578899999999999999999999998765432111111
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHhc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-TAEEALA 312 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-ta~elL~ 312 (560)
..........+++++.+.+||.+||+.||.+|| +++++++
T Consensus 249 -------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 249 -------------QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -------------SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -------------cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 111112233467889999999999999999999 7888774
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=357.32 Aligned_cols=250 Identities=21% Similarity=0.427 Sum_probs=211.6
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+..++..||||++.. .......+.+|+.+|+.++||||+++++++... .
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----P 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----S
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----C
Confidence 56789999999999999999999999999999999974 334567788999999999999999999998443 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
.+|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 5899999998 59999998744 49999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus 163 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~--------- 229 (288)
T 3kfa_A 163 GDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------- 229 (288)
T ss_dssp SSSS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---------
T ss_pred CCcc--ccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC---------
Confidence 3322 22244567889999999976 578999999999999999999 999998877655444332210
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. ......+++.+.+||.+||..||.+|||++|+++
T Consensus 230 ------------------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 ------------------R---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------C---CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0 1122467899999999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=386.33 Aligned_cols=260 Identities=27% Similarity=0.383 Sum_probs=195.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..+|++.++||+|+||+||. ....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++.. ..
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~ 91 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKD-----RQ 91 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEE-----TT
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEec-----CC
Confidence 35799999999999999763 4467899999999864221 2245899999999 79999999998843 34
Q ss_pred cEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC-----CCcEEEecccccc
Q 008607 101 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLAR 174 (560)
Q Consensus 101 ~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-----~~~lKL~DFGla~ 174 (560)
.+|||||||+|+|.+++.... .+.+..++.++.||+.||+|||++||+||||||+|||++. ...+||+|||+++
T Consensus 92 ~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 92 FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 689999999999999998764 4666677899999999999999999999999999999953 2358899999998
Q ss_pred cccCCCCCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
...............+||++|+|||++.+. ...++.++|||||||++|+|++ |..||...... +...+. +.
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-~~~~~~---~~--- 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANILL---GA--- 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-HHHHHT---TC---
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-HHHHHh---cc---
Confidence 765433222233567899999999998632 2467789999999999999999 89999654322 211111 10
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
............+..+.+||.+||+.||.+|||++|+|+||||..+.
T Consensus 245 ---------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 245 ---------------------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp ---------------------CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred ---------------------CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 01111111122356689999999999999999999999999998643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=366.27 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=201.2
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEE----EEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKV----AIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~v----AiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
-..++|++.++||+|+||.||+|++..+++.+ |+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 45678999999999999999999998888765 77776532 2233456788999999999999999999998643
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
..++|+||+. |+|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 90 -----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 90 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -----SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred -----CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 3688999998 6999999874 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
+........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+....
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----- 236 (327)
T 3poz_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----- 236 (327)
T ss_dssp HHHTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----
T ss_pred eEccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-----
Confidence 876433322 12234567889999999976 678999999999999999999 999998877655433332211
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
. ....+.++..+.+||.+||+.||.+|||+.|++++
T Consensus 237 ----------------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 237 ----------------------R---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ----------------------C---CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ----------------------C---CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 11234578899999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=370.69 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=209.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCC-------CcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-------GEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~t-------g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~ 93 (560)
.++|++.+.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+|+.+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 47899999999999999999997543 357999999753 3445567889999999999 89999999999854
Q ss_pred CCcCCCccEEEEEecCCc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 008607 94 PSRREFKDIYVVFELMES-DLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~g-dL~~~i~~~~----------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~N 156 (560)
. ..+|+||||+++ +|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|
T Consensus 147 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 147 D-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred C-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 3 358999999985 9999998754 49999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 008607 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (560)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 235 (560)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999865432211 12234567889999999976 578999999999999999999 999998877
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 236 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
..+.+..+... .. ......+++.+.+||.+||+.||.+|||++|++++
T Consensus 299 ~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKEG---------------------------HR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTT---------------------------CC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcC---------------------------CC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 65544333221 01 11124678999999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=364.93 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=201.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh----hHHHHHHHHHHHHHhc----CCCCccccceeecC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLL----RHPDIVEIKHILLP 93 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~----~~~~~i~rEi~iL~~l----~HpnIv~l~~i~~~ 93 (560)
.++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.+++.+ +|+||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 568999999999999999999999999999999996432211 1233456899999999 89999999998844
Q ss_pred CCcCCCccEEEEEec-CC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC-CCCcEEEecc
Q 008607 94 PSRREFKDIYVVFEL-ME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 170 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~-~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~-~~~~lKL~DF 170 (560)
. ..+++|||+ +. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 110 ~-----~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 110 Q-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp --------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred C-----CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 3 357999998 55 69999999888899999999999999999999999999999999999999 8899999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCC
Q 008607 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p 250 (560)
|+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+... +.
T Consensus 185 g~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~------ 246 (312)
T 2iwi_A 185 GSGALLHDEP-----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE------IL------ 246 (312)
T ss_dssp SSCEECCSSC-----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH------
T ss_pred chhhhcccCc-----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hh------
Confidence 9998754322 2456799999999998652 2234589999999999999999999965221 00
Q ss_pred CHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 251 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.. . ......+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 247 -----------------~~---~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 247 -----------------EA---E-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -----------------HT---C-----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -----------------hh---c-----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 00 0 011246789999999999999999999999999999998643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=364.94 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=208.1
Q ss_pred CCCceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
..++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG- 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-
Confidence 3578999999999999999999987 456899999997532 334456789999999999999999999998543
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 008607 96 RREFKDIYVVFELMES-DLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~g-dL~~~i~~~------------------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHr 150 (560)
..+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 123 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 123 ----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ----CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 458999999985 999999874 469999999999999999999999999999
Q ss_pred cCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCC
Q 008607 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 229 (560)
Q Consensus 151 DLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~ 229 (560)
||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999865332211 11234578899999999876 578999999999999999999 999
Q ss_pred CCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 008607 230 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309 (560)
Q Consensus 230 pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~e 309 (560)
||.+.+..+.+..+.+ ... ......+++.+.+||++||+.||.+|||+.+
T Consensus 276 p~~~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRD---------------------------GNI---LACPENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp TTTTSCHHHHHHHHHT---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCChHHHHHHHhC---------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 9988775544333321 111 1122467889999999999999999999999
Q ss_pred Hhc
Q 008607 310 ALA 312 (560)
Q Consensus 310 lL~ 312 (560)
+++
T Consensus 326 ~~~ 328 (343)
T 1luf_A 326 IHR 328 (343)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=355.69 Aligned_cols=258 Identities=24% Similarity=0.313 Sum_probs=199.5
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
-..++|++.++||+|+||.||+|.+. ..||||+++...........+.+|+.+|+.++||||+.++++...
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------ 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------
Confidence 34678999999999999999999753 359999998665666677889999999999999999999996522
Q ss_pred ccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 100 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+++||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 34799999998 5999998654 469999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.... ........||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 172 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------- 240 (289)
T 3og7_A 172 RWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR---------- 240 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH----------
T ss_pred cccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc----------
Confidence 2221 1123456799999999998521 146788999999999999999999999886655443322211
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
......+......+++.+.+||.+||+.||.+|||++++++
T Consensus 241 ---------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 241 ---------------GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ---------------TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11122233445678899999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=364.82 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=190.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCc---C
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR---R 97 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~---~ 97 (560)
..+|++.++||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+|+.+. ||||+++++++..... .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 4689999999999999999999999999999999853 23455667889999999996 9999999998853221 3
Q ss_pred CCccEEEEEecCCccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeCCCCcEEEecccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGL 172 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~---~~~lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~~~~~lKL~DFGl 172 (560)
....+++||||++|+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 3456899999999999998865 557999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc---------ccccccccCccccccccccc-ccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHH
Q 008607 173 ARVAFNDTPTA---------IFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (560)
Q Consensus 173 a~~~~~~~~~~---------~~~~~~~gT~~Y~APEll~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (560)
++......... ......+||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~- 263 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN- 263 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc-
Confidence 98754322211 01124569999999999831 11567889999999999999999999997644321110
Q ss_pred HHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008607 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (560)
Q Consensus 243 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~ 315 (560)
.... .......+..+.+||++||+.||.+|||++|+++|.+
T Consensus 264 -----------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 264 -----------------------------GKYS---IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------------------------CC---CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred -----------------------------Cccc---CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0000 0112345677899999999999999999999998643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=365.90 Aligned_cols=276 Identities=22% Similarity=0.343 Sum_probs=215.2
Q ss_pred ccccCCCCceEEEEEEeecCCeEEEEEE----ECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceee
Q 008607 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHIL 91 (560)
Q Consensus 16 ~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~ 91 (560)
..++-..++|++++.||+|+||.||+|+ +..+++.||||++... .......+.+|+.+|+.++|+||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 4556677899999999999999999998 5778999999999752 344566789999999999999999999988
Q ss_pred cCCCcCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEec
Q 008607 92 LPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (560)
Q Consensus 92 ~~~~~~~~~~i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~D 169 (560)
... +...+|+||||++ ++|.+++.. ...+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|
T Consensus 94 ~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 94 YGP---GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp ECS---SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred ecC---CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcc
Confidence 643 2356899999996 599999987 34699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCC
Q 008607 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (560)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~ 249 (560)
||+++................+|..|+|||++.+ ..++.++|||||||++|+|++|..||........ .....
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~ 243 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGC 243 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHCC-
T ss_pred cccceecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-----hhccc
Confidence 9999876444332223345678999999999876 5678899999999999999999999965332111 11100
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
... ..........+...... ...+.+++.+.+||.+||+.||.+|||++|++++
T Consensus 244 ~~~-------~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 244 ERD-------VPALSRLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp ----------CCHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccc-------cccHHHHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 00011111222222211 1235778999999999999999999999999763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=361.67 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=203.2
Q ss_pred ccccCCCCceEEEEEEeecCCeEEEEEEECCCC----cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceee
Q 008607 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTG----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHIL 91 (560)
Q Consensus 16 ~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg----~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~ 91 (560)
|..--..++|++.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+|+.++||||+++++++
T Consensus 37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 444456789999999999999999999887654 359999997432 334556788999999999999999999998
Q ss_pred cCCCcCCCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEec
Q 008607 92 LPPSRREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (560)
Q Consensus 92 ~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~D 169 (560)
.. ...+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 116 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 116 SK-----YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp CS-----SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred ec-----CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECC
Confidence 43 3468999999985 999999865 5799999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcC
Q 008607 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g 248 (560)
||+++................+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-- 266 (333)
T 1mqb_A 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-- 266 (333)
T ss_dssp CCC-----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--
T ss_pred CCcchhhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC--
Confidence 9999875433222222233456889999999976 578899999999999999999 99999877655444333221
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
... .....+++.+.+||.+||+.||.+||++.+++++
T Consensus 267 -------------------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 267 -------------------------FRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -------------------------CCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------------------CcC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001 1124578899999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=366.49 Aligned_cols=258 Identities=20% Similarity=0.322 Sum_probs=205.8
Q ss_pred ccccCCCCceEEEEEEeecCCeEEEEEEECCCCcE----EEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceee
Q 008607 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHIL 91 (560)
Q Consensus 16 ~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~----vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~ 91 (560)
+......++|++++.||+|+||.||+|.+..+++. ||+|.+.... .......+.+|+.+++.++||||+++++++
T Consensus 6 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 6 LARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp CCCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 33445668899999999999999999999988876 6777765322 122234567899999999999999999987
Q ss_pred cCCCcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEec
Q 008607 92 LPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (560)
Q Consensus 92 ~~~~~~~~~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~D 169 (560)
.. ..+++||||+. ++|.+++... +.+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|
T Consensus 85 ~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~D 158 (325)
T 3kex_A 85 PG------SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVAD 158 (325)
T ss_dssp CB------SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECS
T ss_pred cC------CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECC
Confidence 32 35899999998 5999999875 4799999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcC
Q 008607 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g 248 (560)
||+++........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 159 fg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-- 233 (325)
T 3kex_A 159 FGVADLLPPDDKQ-LLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-- 233 (325)
T ss_dssp CSGGGGSCCCTTC-CC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT--
T ss_pred CCcccccCccccc-ccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC--
Confidence 9999876443322 22345678889999999976 578999999999999999999 99999887655443333221
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
... .....+++.+.+||.+||..||.+|||+.|+++|
T Consensus 234 -------------------------~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 234 -------------------------ERL---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -------------------------CBC---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -------------------------CCC---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 1112356678899999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=357.62 Aligned_cols=257 Identities=20% Similarity=0.251 Sum_probs=202.4
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..+++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++++..+..+.. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecC----CC
Confidence 56789999999999999999999999999999999875422 22347789999999999988887776643 23
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee---CCCCcEEEeccccccc
Q 008607 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARV 175 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl---~~~~~lKL~DFGla~~ 175 (560)
...++||||++++|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 46899999998899999985 4579999999999999999999999999999999999999 7889999999999987
Q ss_pred ccCCCCCc----ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhh---HHHHHHHhcC
Q 008607 176 AFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH---QLDIMTDLLG 248 (560)
Q Consensus 176 ~~~~~~~~----~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~---~~~~i~~~~g 248 (560)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... .+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 233 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-- 233 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH--
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc--
Confidence 64433211 11235689999999999987 578999999999999999999999998754332 11111110
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.. ..+.......+++.+.+||.+||+.||.+|||++++++
T Consensus 234 -------------~~-----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 234 -------------KM-----------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------------HH-----------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------------cc-----------cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 00 00111122456889999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=353.44 Aligned_cols=257 Identities=20% Similarity=0.245 Sum_probs=206.1
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..+++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.++|++++..+..+.. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~ 77 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----EG 77 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEE----ET
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccC----CC
Confidence 457899999999999999999999999999999999864322 2357899999999999988877766533 23
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee---CCCCcEEEeccccccc
Q 008607 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARV 175 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl---~~~~~lKL~DFGla~~ 175 (560)
...|+||||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 46899999998899999984 4579999999999999999999999999999999999999 4788999999999987
Q ss_pred ccCCCCCc----ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChh---hHHHHHHHhcC
Q 008607 176 AFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV---HQLDIMTDLLG 248 (560)
Q Consensus 176 ~~~~~~~~----~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~---~~~~~i~~~~g 248 (560)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 64433211 11245689999999999987 57899999999999999999999999874422 22222211000
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. .+.......+++.+.+||++||+.||.+|||++++++
T Consensus 236 ~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 S--------------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp H--------------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred C--------------------------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0 0001112457889999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=357.97 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=211.6
Q ss_pred cccccCC-CCceEEEEEEeecCCeEEEEEEE-----CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCcccc
Q 008607 15 FFTEYGE-GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEI 87 (560)
Q Consensus 15 ~~~~~~~-~~~Y~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l 87 (560)
+...|.. .++|++.+.||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|+.+ +||||+++
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence 3334444 47999999999999999999985 467889999999743 2334567789999999999 89999999
Q ss_pred ceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCee
Q 008607 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANVF 148 (560)
Q Consensus 88 ~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~------------------~lse~~~~~i~~Qll~aL~yLHs~gIi 148 (560)
++++... ...|+||||+++ +|.+++.... .+++..++.++.||+.||.|||++||+
T Consensus 93 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 167 (313)
T 1t46_A 93 LGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167 (313)
T ss_dssp EEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9998543 357999999985 9999998754 389999999999999999999999999
Q ss_pred eccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-C
Q 008607 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-G 227 (560)
Q Consensus 149 HrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G 227 (560)
||||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |
T Consensus 168 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g 244 (313)
T 1t46_A 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLG 244 (313)
T ss_dssp CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTT
T ss_pred cCCCccceEEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999875443321 12234567889999999876 578999999999999999999 9
Q ss_pred CCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 008607 228 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA 307 (560)
Q Consensus 228 ~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta 307 (560)
+.||.+......+..+.. ... . ......+++.+.+||.+||+.||.+|||+
T Consensus 245 ~~p~~~~~~~~~~~~~~~-----------------------~~~---~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 295 (313)
T 1t46_A 245 SSPYPGMPVDSKFYKMIK-----------------------EGF---R---MLSPEHAPAEMYDIMKTCWDADPLKRPTF 295 (313)
T ss_dssp CCSSTTCCSSHHHHHHHH-----------------------HTC---C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCcccchhHHHHHhc-----------------------cCC---C---CCCcccCCHHHHHHHHHHcCCCchhCcCH
Confidence 999988765443322211 000 0 01124578899999999999999999999
Q ss_pred HHHhcC
Q 008607 308 EEALAD 313 (560)
Q Consensus 308 ~elL~h 313 (560)
+|++++
T Consensus 296 ~ell~~ 301 (313)
T 1t46_A 296 KQIVQL 301 (313)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999873
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=355.24 Aligned_cols=274 Identities=24% Similarity=0.381 Sum_probs=211.5
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEE----ECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecC
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~ 93 (560)
......+|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 33456779999999999999999998 67799999999997432 23345678899999999999999999999865
Q ss_pred CCcCCCccEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccc
Q 008607 94 PSRREFKDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~g-dL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFG 171 (560)
.. ...+|+||||+++ +|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 95 ~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 95 DG---GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp ------CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CC---CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence 32 2458999999985 99999954 4579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
++.................+|..|+|||++.+ ..++.++|||||||++|+|++|..||... ...+....+...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~ 244 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTH 244 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCC
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCcc
Confidence 99876544332223345678999999999876 56788999999999999999999886432 122222222222
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ........+...... ...+.+++.+.+||.+||+.||.+|||++|+++
T Consensus 245 ~~~-------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 245 GQM-------TVTRLVNTLKEGKRL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GGG-------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccc-------CHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 111 111222222222222 223567899999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=363.15 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=205.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEE-----CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~ 95 (560)
.++|++.+.||+|+||.||+|.+ ..++..||||++.... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence 47899999999999999999997 3466789999997432 233456788999999999 899999999998543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 151 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~~-----------------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrD 151 (560)
..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+|||
T Consensus 122 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 122 ----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 35899999997 59999998653 279999999999999999999999999999
Q ss_pred CCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCC
Q 008607 152 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230 (560)
Q Consensus 152 LKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~p 230 (560)
|||+|||++.++.+||+|||++......... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999865443321 22344567889999999876 578999999999999999998 9999
Q ss_pred CCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 008607 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310 (560)
Q Consensus 231 F~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~el 310 (560)
|.+......+..+.. .... ......+++.+.+||.+||+.||.+|||+.|+
T Consensus 275 ~~~~~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQ--------------------------NGFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp STTCCCSHHHHHHHH--------------------------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cccCCcHHHHHHHHh--------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 988765443322211 0100 11124568999999999999999999999999
Q ss_pred hcCc
Q 008607 311 LADP 314 (560)
Q Consensus 311 L~hp 314 (560)
++|.
T Consensus 326 ~~~l 329 (344)
T 1rjb_A 326 TSFL 329 (344)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9853
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=372.62 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=196.8
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
-..++|++.+.||+|+||.||+|++. .++..||||+++... .......+.+|+.+|+.++||||+++++++...
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 118 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-- 118 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--
Confidence 34578999999999999999999877 467789999997532 344567789999999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
..+|+|||||+ ++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 119 ---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 119 ---KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred ---CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 45899999997 59999998754 69999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
................+|..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~------ 267 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY------ 267 (373)
T ss_dssp ------------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE------
T ss_pred ccccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence 76433222111223345778999999976 578999999999999999998 999998877655443332211
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. . .....++..+.+||.+||+.||.+||+++++++
T Consensus 268 -----------------~--~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 -----------------R--L-----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -----------------E--C-----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------C--C-----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0 0 112356788999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=348.36 Aligned_cols=249 Identities=14% Similarity=0.195 Sum_probs=206.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||.||+|.+. ++.||||++............+.+|+.+|+.++||||+++++++.... ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence 368999999999999999999874 889999999865555566678999999999999999999999986542 246
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
+++||||++ ++|.+++.... .+++..++.++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 899999998 59999998765 4899999999999999999999999 999999999999999999999999987542
Q ss_pred cCCCCCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
.. ...+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 164 ~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------- 226 (271)
T 3kmu_A 164 QS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE--------- 226 (271)
T ss_dssp SC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS---------
T ss_pred cc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc---------
Confidence 11 335789999999998652 122334799999999999999999999887765543332211
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ......+++.+.+||.+||+.||.+|||++|+++
T Consensus 227 -----------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 227 -----------------GLR---PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 1123467899999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=359.92 Aligned_cols=253 Identities=21% Similarity=0.371 Sum_probs=208.2
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.++|++.+.||+|+||.||+|.+. .+++.||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC--
Confidence 478999999999999999999876 46789999999743 2334556788999999999999999999998443
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcE
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~----------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~l 165 (560)
..+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 101 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 ---QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ---CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 35899999998 5999998752 357999999999999999999999999999999999999999999
Q ss_pred EEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHH
Q 008607 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (560)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~ 244 (560)
||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 178 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EECcCcccccccccccc-ccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 99999999765332211 11234567899999999976 578999999999999999999 899998877554443332
Q ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 245 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
. .. .......+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 255 ~---------------------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 E---------------------------GG---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp T---------------------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c---------------------------CC---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 00 111234678999999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=372.40 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=206.4
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+..+++.||||+++.. ........+.+|+.+|+.++||||+++++++... .
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 185 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----Q 185 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----C
Confidence 357899999999999999999999999999999998743 2233445688999999999999999999998543 3
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|+|||||+ |+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 5899999998 69999998654 599999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
..... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.......+..
T Consensus 266 ~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~------------ 330 (377)
T 3cbl_A 266 GVYAA-SGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK------------ 330 (377)
T ss_dssp SEEEC-CSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT------------
T ss_pred Cceee-cCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 21110 0012235678999999976 568899999999999999998 9999988765443332221
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
....+ ....+++.+.+||.+||+.||.+|||++++++
T Consensus 331 ---------------~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 331 ---------------GGRLP---CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---------------TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11111 12356889999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=353.09 Aligned_cols=256 Identities=22% Similarity=0.334 Sum_probs=209.3
Q ss_pred CCCceEEEE-EEeecCCeEEEEEEEC--CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 21 EGSRYKIEE-VIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 21 ~~~~Y~i~~-~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
..++|.+.+ .||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 81 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 81 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC----
Confidence 456788887 9999999999999864 46888999999753 234566788999999999999999999999832
Q ss_pred CCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 82 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp --SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred --CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 248999999985 999998654 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~--------- 228 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------- 228 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---------
T ss_pred eccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc---------
Confidence 6433322222234467899999999976 568899999999999999998 9999988775544333321
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~ 315 (560)
... ....+.+++.+.+||.+||+.||.+||++.+++++.+
T Consensus 229 ------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 229 ------------------GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ------------------TCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ------------------CCc---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111 1123467899999999999999999999999998644
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=361.53 Aligned_cols=258 Identities=21% Similarity=0.323 Sum_probs=206.1
Q ss_pred CCCceEEEEEEeecCCeEEEEEE-----ECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAY-----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~-----d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
..++|++.+.||+|+||.||+|. +..++..||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS- 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-
Confidence 45799999999999999999998 6678899999999643 2344566788999999999999999999998543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC---CCc
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCK 164 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~~-------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~---~~~ 164 (560)
..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. +..
T Consensus 106 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 106 ----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred ----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 35799999996 59999998753 4899999999999999999999999999999999999995 446
Q ss_pred EEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHH
Q 008607 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIM 243 (560)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i 243 (560)
+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EEECcccccccccccccc-ccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 999999999764332211 11234578999999999876 578999999999999999998 99999887765444333
Q ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 244 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
... .. ......+++.+.+||.+||+.||.+|||++++++|.|+-
T Consensus 259 ~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSG---------------------------GR---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcC---------------------------CC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 221 00 112246788999999999999999999999999998864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=368.32 Aligned_cols=268 Identities=16% Similarity=0.145 Sum_probs=202.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCC-----CcEEEEEEecCcccChhH---------HHHHHHHHHHHHhcCCCCcccc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSD---------ATRILREIKLLRLLRHPDIVEI 87 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~t-----g~~vAiK~i~~~~~~~~~---------~~~i~rEi~iL~~l~HpnIv~l 87 (560)
.++|++.+.||+|+||.||+|.+..+ ++.||||++......... ...+.+|+..++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 46899999999999999999998765 588999998642110000 0123455666777889999999
Q ss_pred ceeecCCCcCCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC--CCCc
Q 008607 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCK 164 (560)
Q Consensus 88 ~~i~~~~~~~~~~~i~lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~--~~~~ 164 (560)
++++.... .....+|||||||+++|.+++... +.+++..++.|+.||+.||+|||+.||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 99986532 223468999999977999999876 5799999999999999999999999999999999999999 8899
Q ss_pred EEEecccccccccCCCCCc----ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHH
Q 008607 165 LKICDFGLARVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240 (560)
Q Consensus 165 lKL~DFGla~~~~~~~~~~----~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~ 240 (560)
+||+|||+++......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 9999999997654322111 11234569999999999977 57899999999999999999999999864332222
Q ss_pred HHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 241 ~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
....... ........+.... ...++++.+.+||.+||..||.+||+++++++
T Consensus 271 ~~~~~~~-----------~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIR-----------YRENIASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHH-----------HHHCHHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHH-----------hhhhHHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 2111100 0001111111110 01467889999999999999999999999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=347.95 Aligned_cols=248 Identities=28% Similarity=0.457 Sum_probs=193.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC--hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH--VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~--~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
.++|++.+.||+|+||.||+|.+. |+.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE----- 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----
Confidence 468999999999999999999874 899999998643221 22346788999999999999999999998543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCCCCeeeCC--------CCcEEE
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANA--------DCKLKI 167 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~g---IiHrDLKP~NILl~~--------~~~lKL 167 (560)
..+|+||||++ ++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 35899999997 58888774 557999999999999999999999999 999999999999986 778999
Q ss_pred ecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc
Q 008607 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~ 247 (560)
+|||+++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 158 ~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-- 228 (271)
T 3dtc_A 158 TDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-- 228 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT--
T ss_pred ccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc--
Confidence 99999976533221 34579999999999976 5789999999999999999999999988765443322211
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.... ......+++.+.+||.+||+.||.+|||+.|++++
T Consensus 229 ------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 229 ------------------------NKLA---LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------------------------SCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCC---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 1111 11224678899999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=360.91 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=201.5
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEE----EEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKV----AIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~v----AiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
-..++|+++++||+|+||.||+|++..+++.| |+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-
Confidence 45678999999999999999999999888865 66666432 2334567789999999999999999999998643
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
..++|++++. ++|.+++... +.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 90 -----~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 90 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -----SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred -----CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 3788999998 5999999874 46999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
+........ .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |+.||.+.+.......+....
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----- 236 (327)
T 3lzb_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----- 236 (327)
T ss_dssp ----------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----
T ss_pred eEccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 875432221 12234567889999999976 578999999999999999999 999998877655444332211
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. ....+.+++.+.+||++||..||.+|||+.|+++
T Consensus 237 ----------------------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 237 ----------------------R---LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ----------------------C---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------C---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 1122457889999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=347.90 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=206.3
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 76 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----A 76 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----S
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----C
Confidence 3578999999999999999999986 678899999975322 345788999999999999999999998543 3
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 5899999998 5999999875 4699999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.. ........+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 157 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~----------- 221 (267)
T 3t9t_A 157 DQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG----------- 221 (267)
T ss_dssp HH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----------
T ss_pred cc--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-----------
Confidence 11 111133567889999999976 578899999999999999999 89999887765544333221
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.. .......++.+.+||.+||+.||.+|||+.+++++
T Consensus 222 ----------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 222 ----------------FR---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ----------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------Cc---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 01123468899999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=365.26 Aligned_cols=268 Identities=16% Similarity=0.161 Sum_probs=201.7
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECC---CCcEEEEEEecCcccChh---------HHHHHHHHHHHHHhcCCCCcccc
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVS---------DATRILREIKLLRLLRHPDIVEI 87 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~---tg~~vAiK~i~~~~~~~~---------~~~~i~rEi~iL~~l~HpnIv~l 87 (560)
..+++|++.+.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 346899999999999999999999987 888999999874321110 11235678899999999999999
Q ss_pred ceeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC--cE
Q 008607 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC--KL 165 (560)
Q Consensus 88 ~~i~~~~~~~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~--~l 165 (560)
++++.... .....+|+|||||+++|.+++...+.+++..++.|+.||+.||+|||+.||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred eccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 99986522 2245789999999779999998877899999999999999999999999999999999999999887 99
Q ss_pred EEecccccccccCCCC----CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCC--ChhhH
Q 008607 166 KICDFGLARVAFNDTP----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK--NVVHQ 239 (560)
Q Consensus 166 KL~DFGla~~~~~~~~----~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~--~~~~~ 239 (560)
||+|||+++....... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+. +....
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 9999999986533211 1112245689999999999977 57899999999999999999999999653 22211
Q ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 240 ~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.............. +.... ....+++.+.+||.+||..||.+|||++++++
T Consensus 271 ~~~~~~~~~~~~~~-------------~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 271 QTAKTNLLDELPQS-------------VLKWA---------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHTTTHH-------------HHHHS---------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhcccccHH-------------HHhhc---------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11111111111100 00000 01267889999999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=351.04 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=203.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEECC---CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~---tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---- 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC----
Confidence 4789999999999999999998654 3446999998753 2344567889999999999999999999987432
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 86 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 --PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred --CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 3589999998 59999997654 5999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-------- 231 (281)
T 3cc6_A 164 EDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-------- 231 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC--------
T ss_pred cccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC--------
Confidence 432211 1234567889999999976 578899999999999999998 999998766555443332210
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.. .....+++.+.+||.+||..||.+|||+.|++++
T Consensus 232 -------------------~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 232 -------------------RL---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CC---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 00 1123568899999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=358.99 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=206.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC-------CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT-------RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~-------~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~ 93 (560)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 579999999999999999999986 46778999999743 2344567789999999999 89999999999854
Q ss_pred CCcCCCccEEEEEecCCc-cHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 008607 94 PSRREFKDIYVVFELMES-DLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~g-dL~~~i~~~~----------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~N 156 (560)
. ..+|+||||+++ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 113 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 113 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp S-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred C-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 3 458999999985 9999998754 38999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 008607 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (560)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 235 (560)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-cccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999999865432211 11234567889999999876 568899999999999999999 999998877
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 236 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
..+....+... .. ......+++.+.+||.+||+.||.+|||+.|++++
T Consensus 265 ~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 265 VEELFKLLKEG---------------------------HR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcC---------------------------CC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55444333221 00 11224678999999999999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=356.55 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=208.8
Q ss_pred CCCceEEEEEEeecCCeEEEEEEE-----CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPP 94 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~ 94 (560)
..++|++.+.||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|+.+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 357999999999999999999985 457789999999753 2334556788999999999 699999999998543
Q ss_pred CcCCCccEEEEEecCCc-cHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 008607 95 SRREFKDIYVVFELMES-DLHQVIKANDD----------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 157 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~g-dL~~~i~~~~~----------------lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NI 157 (560)
. ..+|+||||+++ +|.+++..... +++..++.++.||+.||.|||+.||+||||||+||
T Consensus 104 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 104 G----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp T----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred C----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 2 358999999985 99999987654 89999999999999999999999999999999999
Q ss_pred eeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCCh
Q 008607 158 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (560)
Q Consensus 158 Ll~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 236 (560)
|++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999986543322 122345678899999999976 578999999999999999998 9999987664
Q ss_pred hhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 237 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
...+..... . ... ......+++.+.+||.+||+.||.+|||++|+++|
T Consensus 257 ~~~~~~~~~-----------------------~---~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLK-----------------------E---GTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHH-----------------------H---TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhc-----------------------c---Ccc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333221111 0 001 11123568899999999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=355.19 Aligned_cols=246 Identities=17% Similarity=0.279 Sum_probs=200.7
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCC-------cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTG-------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg-------~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~ 93 (560)
..++|++.+.||+|+||.||+|++..++ ..||+|++... .......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3578999999999999999999998887 47999998643 33455778999999999999999999999854
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc-------
Q 008607 94 PSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK------- 164 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~-gdL~~~i~~~~~-lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~------- 164 (560)
. ...|+||||++ ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 84 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 G-----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp T-----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred C-----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 3 35799999998 599999988664 999999999999999999999999999999999999998887
Q ss_pred -EEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCC-CCCCCCChhhHHHH
Q 008607 165 -LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDI 242 (560)
Q Consensus 165 -lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~~~~ 242 (560)
+||+|||++..... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|. +||...+.......
T Consensus 159 ~~kl~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLP-------KDILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeeeccCcccccccC-------ccccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 99999999865321 1335688999999998652 46889999999999999999954 56655443332221
Q ss_pred HHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 243 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
+.. . .......++.+.+||.+||+.||.+|||++|+++|
T Consensus 231 ~~~---------------------------~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 231 YED---------------------------R-----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHT---------------------------T-----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhc---------------------------c-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111 0 01112346678999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=357.93 Aligned_cols=263 Identities=24% Similarity=0.314 Sum_probs=197.8
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHh--cCCCCccccceeecCCCcCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL--LRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~--l~HpnIv~l~~i~~~~~~~~ 98 (560)
..++|++.+.||+|+||.||+|.+ +|+.||||++.. .....+.+|.+++.. ++||||+++++++.... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CC
Confidence 467899999999999999999987 689999999863 344556678888877 78999999999875422 23
Q ss_pred CccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeeccCCCCCeeeCCCCcEEEec
Q 008607 99 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADCKLKICD 169 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLH--------s~gIiHrDLKP~NILl~~~~~lKL~D 169 (560)
...+|+||||+++ +|.++++. ..+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 3568999999984 99999954 47999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCCCCc-ccccccccCcccccccccccccC----CCCCccchhhHHHHHHHHhhC----------CCCCCCC
Q 008607 170 FGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTG----------KPLFPGK 234 (560)
Q Consensus 170 FGla~~~~~~~~~~-~~~~~~~gT~~Y~APEll~~~~~----~y~~~~DIWSlG~il~eLltG----------~~pF~~~ 234 (560)
||+++......... ......+||+.|+|||++.+... .++.++|||||||++|||++| +.||.+.
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654332221 11234589999999999876211 344689999999999999999 8888653
Q ss_pred Chhh-HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 235 NVVH-QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 235 ~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... ....+.. .+.........+........++.+.+||.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRK--------------------VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHH--------------------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhH--------------------HHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2111 0111110 00000011111111111224577999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=376.37 Aligned_cols=262 Identities=27% Similarity=0.393 Sum_probs=194.3
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~ 98 (560)
...+.|.+.++||+|+||+||.+ ...+|+.||||++.. .....+.+|+.+|+.+ +||||+++++++...
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~-----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~---- 81 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSETTD---- 81 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEG-----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECS----
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcH-----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecC----
Confidence 45678899999999999999875 456899999999864 2345678999999876 899999999988433
Q ss_pred CccEEEEEecCCccHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC---------
Q 008607 99 FKDIYVVFELMESDLHQVIKANDDL-------TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--------- 162 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~~l-------se~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~--------- 162 (560)
..+|||||||+|+|.+++...... ++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 82 -~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 82 -RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp -SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred -CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 468999999999999999876533 233457899999999999999999999999999999754
Q ss_pred ----CcEEEecccccccccCCCCC-cccccccccCcccccccccccc-----cCCCCCccchhhHHHHHHHHhh-CCCCC
Q 008607 163 ----CKLKICDFGLARVAFNDTPT-AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GKPLF 231 (560)
Q Consensus 163 ----~~lKL~DFGla~~~~~~~~~-~~~~~~~~gT~~Y~APEll~~~-----~~~y~~~~DIWSlG~il~eLlt-G~~pF 231 (560)
+.+||+|||+++........ .......+||+.|+|||++.+. ...++.++|||||||++|||++ |+.||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 48999999999876443221 1122456899999999998641 1468899999999999999999 99999
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008607 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (560)
Q Consensus 232 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL 311 (560)
.+..... ...+... ....... ......+++.+.+||.+||+.||.+|||+.|+|
T Consensus 241 ~~~~~~~-~~i~~~~------------------------~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 241 GDKYSRE-SNIIRGI------------------------FSLDEMK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp CSTTTHH-HHHHHTC------------------------CCCCCCT-TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCchhhH-HHHhcCC------------------------CCccccc-ccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 7654322 1111110 0000000 000113457899999999999999999999999
Q ss_pred cCccccc
Q 008607 312 ADPYFKG 318 (560)
Q Consensus 312 ~hp~f~~ 318 (560)
+||||..
T Consensus 295 ~hp~f~~ 301 (434)
T 2rio_A 295 RHPLFWP 301 (434)
T ss_dssp TSGGGSC
T ss_pred hCCccCC
Confidence 9999974
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=362.29 Aligned_cols=261 Identities=24% Similarity=0.376 Sum_probs=206.4
Q ss_pred CCCcccccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEE--EEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccc
Q 008607 10 SADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKV--AIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVE 86 (560)
Q Consensus 10 ~~~~~~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~v--AiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~ 86 (560)
......|+... .++|++.+.||+|+||.||+|++..+|..+ |+|.+... ........+.+|+.+|+.+ +||||++
T Consensus 13 ~~~~~~~p~~~-~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~ 90 (327)
T 1fvr_A 13 NPDPTIYPVLD-WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIIN 90 (327)
T ss_dssp ---CCCSSBCC-GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCC
T ss_pred CCCCccccccc-HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhh
Confidence 33444455533 368999999999999999999999999865 99988642 2333456788999999999 8999999
Q ss_pred cceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeee
Q 008607 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFH 149 (560)
Q Consensus 87 l~~i~~~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~Qll~aL~yLHs~gIiH 149 (560)
+++++... ..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+|
T Consensus 91 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 165 (327)
T 1fvr_A 91 LLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH 165 (327)
T ss_dssp EEEEEEET-----TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hceeeeeC-----CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 99998443 46899999997 59999998754 6999999999999999999999999999
Q ss_pred ccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CC
Q 008607 150 RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 228 (560)
Q Consensus 150 rDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~ 228 (560)
|||||+|||++.++.+||+|||+++...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |+
T Consensus 166 ~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~ 239 (327)
T 1fvr_A 166 RDLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGG 239 (327)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCccceEEEcCCCeEEEcccCcCccccccc----cccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCC
Confidence 9999999999999999999999997432211 1133467889999999976 568899999999999999998 99
Q ss_pred CCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 008607 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308 (560)
Q Consensus 229 ~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~ 308 (560)
.||.+.+..+....+.. ... ......+++.+.+||.+||+.||.+|||++
T Consensus 240 ~pf~~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 289 (327)
T 1fvr_A 240 TPYCGMTCAELYEKLPQ---------------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFA 289 (327)
T ss_dssp CTTTTCCHHHHHHHGGG---------------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCcHHHHHHHhhc---------------------------CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 99988775543332211 100 112246789999999999999999999999
Q ss_pred HHhcC
Q 008607 309 EALAD 313 (560)
Q Consensus 309 elL~h 313 (560)
|++++
T Consensus 290 ell~~ 294 (327)
T 1fvr_A 290 QILVS 294 (327)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=349.82 Aligned_cols=254 Identities=23% Similarity=0.361 Sum_probs=202.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCC---cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg---~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
..+|++.++||+|+||.||+|.+..++ ..||+|.+.. .........+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE--- 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS---
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC---
Confidence 467999999999999999999976443 3689999875 234455678899999999999999999999875432
Q ss_pred CccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
...|+||||+++ +|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 100 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 100 -GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp -SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred -CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 357999999985 999999864 46899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCC-CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 177 FNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 177 ~~~~~-~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
..... .........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~------- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-------
T ss_pred cccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-------
Confidence 33221 1112244678889999999976 578999999999999999999 668887776555443332210
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. ......+++.+.+||.+||+.||.+|||+.|+++
T Consensus 250 --------------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 250 --------------------R---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp --------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------C---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0112346788999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=356.81 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=206.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCc-----EEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE-----KVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~-----~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~ 95 (560)
.++|++.+.||+|+||.||+|.+..++. .||+|++... ........+.+|+.+|+.+ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGACTHG- 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-
Confidence 5789999999999999999999987665 7999998743 2334567789999999999 899999999998543
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 96 RREFKDIYVVFELMES-DLHQVIKAN--------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~g-dL~~~i~~~--------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
..+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++
T Consensus 123 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 123 ----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred ----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 358999999985 999998752 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhH
Q 008607 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (560)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (560)
.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CCCeEEECccccccccccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9999999999999865433221 12234567889999999876 578999999999999999998 9999987665443
Q ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 240 ~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
+..+.. .. .. .......++.+.+||.+||+.||.+|||++|+++
T Consensus 276 ~~~~~~-----------------------~~---~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 276 FYKLVK-----------------------DG---YQ---MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHH-----------------------HT---CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHh-----------------------cC---CC---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 322211 00 00 0112346789999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=357.76 Aligned_cols=262 Identities=23% Similarity=0.384 Sum_probs=204.4
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+++.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence 46799999999999999999999999999999999864 34456678889999999999999999999986321 2234
Q ss_pred cEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 101 DIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
.+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 68999999985 99998876 45799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCc------ccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcC
Q 008607 176 AFNDTPTA------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 176 ~~~~~~~~------~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g 248 (560)
........ ..+....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------- 253 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---------- 253 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT----------
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc----------
Confidence 42211100 012345679999999998652 1236889999999999999999999994311000
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
......+.. ... ....+.+++.+.+||.+||+.||.+|||+++++++
T Consensus 254 ------------~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 254 ------------DSVALAVQN---QLS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ------------SCHHHHHHC---C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------chhhHHhhc---cCC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 000000111 111 11235678999999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=364.30 Aligned_cols=261 Identities=13% Similarity=0.176 Sum_probs=201.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCC--------CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRT--------GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~t--------g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~ 93 (560)
+++|++.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+.+|+.++||||+++++.+..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 68999999999999999999999884 889999998642 357789999999999999985432211
Q ss_pred CC-----------cCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 94 PS-----------RREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 94 ~~-----------~~~~~~i~lV~E~~~gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
.. ......+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 00 0123578999999977999999986 6899999999999999999999999999999999999999
Q ss_pred CCC--cEEEecccccccccCCCCC----cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCC
Q 008607 161 ADC--KLKICDFGLARVAFNDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (560)
Q Consensus 161 ~~~--~lKL~DFGla~~~~~~~~~----~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~ 234 (560)
.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 998 8999999999765432211 112244589999999999977 57899999999999999999999999875
Q ss_pred C-hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 235 N-VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 235 ~-~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. ....+..... .+.... .........+..+++.+.+||++||+.||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~-------------------~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQ-------------------KFVDKP--GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHH-------------------HHHHSC--CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHH-------------------hccCCh--hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 2222111110 010100 0000011122357899999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.39 Aligned_cols=249 Identities=28% Similarity=0.389 Sum_probs=204.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-----
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR----- 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~----- 96 (560)
+.+|++++.||+|+||.||+|.+..+|+.||||++.... ..+.+|+++|+.++||||+++++++.....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 467999999999999999999999999999999986421 245689999999999999999998743111
Q ss_pred ------CCCccEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEE
Q 008607 97 ------REFKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (560)
Q Consensus 97 ------~~~~~i~lV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL 167 (560)
.....+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 123458999999995 999999764 57999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc
Q 008607 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~ 247 (560)
+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .
T Consensus 164 ~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~------ 226 (284)
T 2a19_B 164 GDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETS-----K------ 226 (284)
T ss_dssp CCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----H------
T ss_pred Ccchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHH-----H------
Confidence 99999987544322 244679999999999976 578999999999999999999998873210 0
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
....+.... ....++..+.+||.+||..||.+|||+.|+++|.|.-
T Consensus 227 ------------------~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 227 ------------------FFTDLRDGI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ------------------HHHHHHTTC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------HHHHhhccc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011111110 1235688899999999999999999999999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=351.22 Aligned_cols=256 Identities=25% Similarity=0.423 Sum_probs=195.4
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCc-ccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
...++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+|+.++||||+++++++...
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 104 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED---- 104 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----
Confidence 4557899999999999999999999999999999999742 23445567788999999999999999999998543
Q ss_pred CccEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 99 FKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
..+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 105 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 105 -NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp -TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred -CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 468999999985 99998864 456999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... ....
T Consensus 184 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~---------- 247 (310)
T 2wqm_A 184 RFFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC---------- 247 (310)
T ss_dssp ------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHH----------
T ss_pred eeecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHH----------
Confidence 76533221 1234679999999999976 578899999999999999999999997643211 0000
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..+.. ..... .....+++.+.+||.+||..||.+|||++++++
T Consensus 248 -----------~~~~~---~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 248 -----------KKIEQ---CDYPP--LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp -----------HHHHT---TCSCC--CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------HHhhc---ccCCC--CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00110 00000 112467889999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=346.96 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=203.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCc---EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
-+|++.++||+|+||.||+|.+..++. .||+|++.. .........+.+|+.+|+.++||||+++++++....
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE---- 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence 467888999999999999999765554 799999874 234455678899999999999999999999986433
Q ss_pred ccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 100 KDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
...++||||+. ++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 23489999997 699999987 4469999999999999999999999999999999999999999999999999997543
Q ss_pred CCCC-CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 178 NDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 178 ~~~~-~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
.... .........+|+.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-------- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-------- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC--------
T ss_pred CCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC--------
Confidence 2211 1112234578899999999977 578999999999999999999 456666655544433332211
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. ......+++.+.+||.+||+.||.+|||++++++
T Consensus 246 -------------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 246 -------------------R---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------C---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 1112356889999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=378.09 Aligned_cols=262 Identities=18% Similarity=0.189 Sum_probs=199.3
Q ss_pred ccccCCC-CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCC-CCcccc-----
Q 008607 16 FTEYGEG-SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRH-PDIVEI----- 87 (560)
Q Consensus 16 ~~~~~~~-~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~H-pnIv~l----- 87 (560)
.++.+.. ..|++.++||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+++.++| .|+..+
T Consensus 70 ~s~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 70 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp EESSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred eccCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 3344443 34899999999999999999999999999999987322 222335678899999999987 332211
Q ss_pred ----ceeec------------CCCcCCCccEEEEEecCCccHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 008607 88 ----KHILL------------PPSRREFKDIYVVFELMESDLHQVIKA-------NDDLTPEHYQFFLYQLLRGLKYIHT 144 (560)
Q Consensus 88 ----~~i~~------------~~~~~~~~~i~lV~E~~~gdL~~~i~~-------~~~lse~~~~~i~~Qll~aL~yLHs 144 (560)
.++.. .........++++|+++.++|.+++.. ...+++..+..++.||+.||+|||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 11111 111111335789999999999998852 2247888999999999999999999
Q ss_pred CCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCccccccccccc--------ccCCCCCccchhh
Q 008607 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWS 216 (560)
Q Consensus 145 ~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~--------~~~~y~~~~DIWS 216 (560)
+||+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+ ....|+.++||||
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 99999999999999999999999999998764322 245678 99999999831 1145788999999
Q ss_pred HHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHh
Q 008607 217 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296 (560)
Q Consensus 217 lG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~m 296 (560)
|||++|+|++|+.||.+.+....... .......+++.+.+||.+|
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~ 347 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGGSEW-----------------------------------IFRSCKNIPQPVRALLEGF 347 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSCSGG-----------------------------------GGSSCCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCcchhhhHHH-----------------------------------HHhhcccCCHHHHHHHHHH
Confidence 99999999999999987653321110 0112246789999999999
Q ss_pred cccCCCCCCCHHHHhcCcccccc
Q 008607 297 LAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 297 L~~DP~~Rpta~elL~hp~f~~~ 319 (560)
|+.||.+|||+.++|+||||+.+
T Consensus 348 l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 348 LRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp TCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccCChhhCcCHHHHHhCHHHHHH
Confidence 99999999999999999999753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=346.62 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=204.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++++.||+|+||.||+|.+. ++..||||++.... .....+.+|+++|+.++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CC
Confidence 478999999999999999999875 56789999987432 235678899999999999999999998742 24
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 799999997 59999987543 699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+...
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~----------- 226 (279)
T 1qpc_A 162 NEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG----------- 226 (279)
T ss_dssp SCEE--CCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred cccc--cccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-----------
Confidence 2211 1234567889999999976 568899999999999999999 99999887765444333211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.. ......+++.+.+||.+||..||.+|||++++++
T Consensus 227 ----------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 227 ----------------YR---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ----------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------cC---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 0112467889999999999999999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=379.66 Aligned_cols=249 Identities=21% Similarity=0.420 Sum_probs=209.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
..+|++.+.||+|+||.||+|.+..++..||||+++.. ......+.+|+.+|+.++||||+++++++... ..
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc---ccchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----Cc
Confidence 46899999999999999999999999999999999743 23456789999999999999999999998543 35
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+|||||||. |+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 899999998 6999999874 3599999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+....+..+...
T Consensus 371 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 435 (495)
T 1opk_A 371 DTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----------- 435 (495)
T ss_dssp CCEE--CCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----------
T ss_pred Ccee--ecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 2211 1233456788999999976 578899999999999999999 99999987765544333211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 436 ----------------~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 436 ----------------YRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ----------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCC---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 000 122467899999999999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=350.33 Aligned_cols=259 Identities=22% Similarity=0.335 Sum_probs=200.8
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEECC-CCc--EEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeec
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTR-TGE--KVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~-tg~--~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~ 92 (560)
+.....++|++.+.||+|+||.||+|.+.. +++ .||||++.... ........+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 334567899999999999999999998643 343 68999987432 23345678899999999999999999999985
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecc
Q 008607 93 PPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DF 170 (560)
.. ..++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 92 ~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Df 165 (291)
T 1u46_A 92 TP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 165 (291)
T ss_dssp SS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred cC------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccc
Confidence 43 3699999998 5999998764 46999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCC
Q 008607 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 249 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~ 249 (560)
|++.................+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+...
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--- 240 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--- 240 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS---
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc---
Confidence 999876443332222334567889999999976 567889999999999999999 99999887765544333211
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ......++..+.+||.+||..||.+|||+.++++
T Consensus 241 -----------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 241 -----------------------GER---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -----------------------CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCC---CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 1123467899999999999999999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=370.24 Aligned_cols=244 Identities=23% Similarity=0.397 Sum_probs=203.0
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+. |+.||||+++.. .....+.+|+.+|+.++||||+++++++.... .
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~ 260 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----G 260 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----S
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----C
Confidence 3578999999999999999999774 789999999753 24567889999999999999999999975432 3
Q ss_pred cEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~--lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
.+|||||||+ |+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 5899999998 599999987553 7999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+...
T Consensus 341 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---------- 402 (450)
T 1k9a_A 341 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---------- 402 (450)
T ss_dssp ------------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT----------
T ss_pred ccc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------
Confidence 221 22367889999999976 578999999999999999998 99999887655544333221
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... .....+++.+.+||++||+.||.+|||+.++++
T Consensus 403 -----------------~~~---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 403 -----------------YKM---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -----------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 001 122467899999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=347.07 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=197.0
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+ +|+.||||++... .....+.+|+.+++.++||||+++++++.... .
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~ 88 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----G 88 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----C
Confidence 347999999999999999999976 4889999998642 34567889999999999999999999875432 3
Q ss_pred cEEEEEecCCc-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 101 DIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~--lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
.+|+||||+++ +|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 58999999985 99999987543 8999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+..
T Consensus 169 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~----------- 229 (278)
T 1byg_A 169 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 229 (278)
T ss_dssp -------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-----------
T ss_pred ccc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 221 23467889999999976 578899999999999999998 9999987765444332211
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ......+++.+.+||++||+.||.+|||+.|+++
T Consensus 230 ----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 230 ----------------GYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 101 1123467899999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=385.62 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=204.4
Q ss_pred CceEEE-EEEeecCCeEEEEEEE--CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 23 SRYKIE-EVIGKGSYGVVCSAYD--TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 23 ~~Y~i~-~~IG~G~~G~Vy~a~d--~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..+.+. +.||+|+||.||+|.+ ..+++.||||+++...........+.+|+.+|+.++||||+++++++..
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------ 441 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ 441 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 334444 4899999999999954 5677899999998655555567889999999999999999999998842
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..++||||||+ |+|.+++..+..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 24799999998 59999999888999999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
............+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~----------- 588 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG----------- 588 (635)
T ss_dssp -------------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred CccccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 3322222344567889999999976 578999999999999999998 99999988765544443321
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.. ......+++.+.+||.+||+.||.+|||++++++
T Consensus 589 ----------------~~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 589 ----------------ER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----------------CC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------CC---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11 1122467899999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=365.37 Aligned_cols=267 Identities=23% Similarity=0.315 Sum_probs=206.0
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
...++|++.+.||+|+||.||+|.+ .+|+.||||++... .......+.+|+.+|+.++||||+++++++...
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDER----- 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-----
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----
Confidence 3468999999999999999999986 47899999998653 334567789999999999999999999988433
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 100 KDIYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~----~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 46899999998 59999886543 58999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+...
T Consensus 188 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-------- 256 (321)
T 2qkw_B 188 KGTELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-------- 256 (321)
T ss_dssp ECSSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT--------
T ss_pred cccccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh--------
Confidence 64322211 12244578999999999876 57899999999999999999999999875433221111000
Q ss_pred HHHhhhHHHHHHHH--hhccC-CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008607 255 IARVRNEKARRYLS--SMRKK-KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (560)
Q Consensus 255 ~~~~~~~~~~~~l~--~~~~~-~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp 314 (560)
..... .+... .+.......+..+..+.+||.+||+.||.+|||+.|++++.
T Consensus 257 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 257 ---------VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp ---------HHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---------hhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00000 00000 00000111223456789999999999999999999999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=370.38 Aligned_cols=275 Identities=23% Similarity=0.376 Sum_probs=206.3
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..+++|++.++||+|+||.||+|++..+|+.||||++.... .......+.+|+++|+.++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~ 81 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---T 81 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---T
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---C
Confidence 34678999999999999999999999999999999997432 1233567789999999999999999999986432 2
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee----CCCCcEEEeccc
Q 008607 100 KDIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFG 171 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~---~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl----~~~~~lKL~DFG 171 (560)
..+|+|||||+ ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 46899999997 59999997643 39999999999999999999999999999999999999 778889999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccc------cCCCCCccchhhHHHHHHHHhhCCCCCCCCChh-hHHHHHH
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMT 244 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~~~~i~ 244 (560)
+++...... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... .....+.
T Consensus 162 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 162 AARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp GCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred CceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 998653322 22456799999999998531 024677999999999999999999999753321 1112222
Q ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS-------QKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 245 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-------~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
+++...+...+..... .......|. .....++..+.+||++||+.||.+|||++|+++
T Consensus 238 ~~~~~~p~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 238 KIITGKPSGAISGVQK----------AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHSCCTTCCEEEEC----------STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHhcCCCcccchhhee----------ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2221111110000000 000001111 111234567889999999999999999999865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=344.95 Aligned_cols=244 Identities=27% Similarity=0.433 Sum_probs=190.9
Q ss_pred CCCCceEEE-EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHH-HhcCCCCccccceeecCCCcC
Q 008607 20 GEGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 20 ~~~~~Y~i~-~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL-~~l~HpnIv~l~~i~~~~~~~ 97 (560)
..-++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +.++||||+++++++.... .
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~ 85 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-A 85 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-C
Confidence 445678887 889999999999999999999999999863 23466899988 6678999999999885311 2
Q ss_pred CCccEEEEEecCCc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC---CCcEEEeccc
Q 008607 98 EFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFG 171 (560)
Q Consensus 98 ~~~~i~lV~E~~~g-dL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~---~~~lKL~DFG 171 (560)
....+|+||||+++ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 23568999999985 9999998764 6999999999999999999999999999999999999998 7889999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
++.... + ..|+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 166 ~a~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~------ 212 (299)
T 3m2w_A 166 FAKETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------ 212 (299)
T ss_dssp TCEECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC------
T ss_pred cccccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH------
Confidence 885421 1 3467899999999999999999999977553221100000
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
.+...........+..+++.+.+||.+||+.||.+|||++|+|+||||++...
T Consensus 213 -----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 213 -----------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp -----------------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred -----------------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 00000000000112467899999999999999999999999999999987554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.96 Aligned_cols=269 Identities=25% Similarity=0.352 Sum_probs=205.8
Q ss_pred CCce-EEEEEEeecCCeEEEEEE----ECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRY-KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y-~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.++| ++++.||+|+||.||++. +..+++.||||++... ........+.+|+.+|+.++||||+++++++....
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG- 106 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC-
Confidence 3445 999999999999997774 4568899999999753 33445677899999999999999999999986532
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
...+|+||||++ ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 107 --~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 107 --AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp --TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred --CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 246899999998 4999999765 599999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...............+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~~ 256 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQMT 256 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccchh
Confidence 6543322222345678899999999976 56788999999999999999999999653211 1111122111110
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.......+...... .....+++.+.+||++||+.||.+|||++|+++
T Consensus 257 -------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 257 -------VLRLTELLERGERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -------HHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------HHHHHHHHhcccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01111111112111 223567899999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=371.80 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=204.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||.||+|.+. ++..||||+++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Cc
Confidence 478999999999999999999885 46789999997532 346778999999999999999999998842 34
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+|||||||. |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 799999998 59999997543 689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... .......+|..|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+.+..+.....
T Consensus 337 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------- 403 (454)
T 1qcf_A 337 NEY--TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--------- 403 (454)
T ss_dssp HHH--HTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC---------
T ss_pred Cce--eccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 211 11123456788999999976 578999999999999999999 9999998876655444332110
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
. .....+++.+.+||.+||+.||.+|||++++++
T Consensus 404 ------------------~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 404 ------------------M---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ------------------C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------C---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 0 112467889999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.75 Aligned_cols=243 Identities=30% Similarity=0.469 Sum_probs=193.6
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
..++|++.+.||+|+||.||+|.+ +++.||||++.. ......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------- 72 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN------- 72 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------
Confidence 347899999999999999999976 478999999863 2456778899999999999999999998742
Q ss_pred cEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCCCCeeeCCCCc-EEEecccc
Q 008607 101 DIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHT---ANVFHRDLKPKNILANADCK-LKICDFGL 172 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~---~lse~~~~~i~~Qll~aL~yLHs---~gIiHrDLKP~NILl~~~~~-lKL~DFGl 172 (560)
.+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 3699999998 59999998765 37899999999999999999999 89999999999999998886 79999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..+.
T Consensus 153 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~-------- 215 (307)
T 2eva_A 153 ACDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMW-------- 215 (307)
T ss_dssp ------------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHH--------
T ss_pred ccccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHH--------
Confidence 9754322 134579999999999976 5789999999999999999999999975432211 0000
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
....... ......+++.+.+||.+||+.||.+|||++|+++
T Consensus 216 ----------------~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 216 ----------------AVHNGTR---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ----------------HHHTTCC---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------HHhcCCC---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0000111 1223567899999999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=358.88 Aligned_cols=264 Identities=20% Similarity=0.333 Sum_probs=204.1
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
....++|++.+.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+|+.++||||+++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 99 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP---- 99 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS----
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC----
Confidence 34568999999999999999999974 46899999998753211 1223578999999999999999999998543
Q ss_pred CccEEEEEecCCc-cHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCCCCeeeCCCCcEEEecc
Q 008607 99 FKDIYVVFELMES-DLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDF 170 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~~----~lse~~~~~i~~Qll~aL~yLHs~---gIiHrDLKP~NILl~~~~~lKL~DF 170 (560)
...++|||||++ +|.+++.... .+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+||
T Consensus 100 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 100 -TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp -SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred -CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 357999999985 9999998653 399999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCC-----hhhHHHHHHH
Q 008607 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-----VVHQLDIMTD 245 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-----~~~~~~~i~~ 245 (560)
|+++....... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .....+
T Consensus 179 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---- 250 (326)
T 3uim_A 179 GLAKLMDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD---- 250 (326)
T ss_dssp SSCEECCSSSS--CEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH----
T ss_pred ccccccCcccc--cccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH----
Confidence 99986543222 22345679999999999976 568899999999999999999999995211 111111
Q ss_pred hcCCCCHHHHHHhhhHHHHHHHHhhccCCCCC------C-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 246 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIP------F-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 246 ~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~------~-~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
++.......... . .......+..+.+||.+||+.||.+|||+.|+++|-.-.
T Consensus 251 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 251 --------------------WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp --------------------HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred --------------------HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 111111110000 0 011122346799999999999999999999999976543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=360.70 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=196.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCC---cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg---~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+... ........+.+|+.+|+.++||||+++++++....
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--- 163 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE--- 163 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS---
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC---
Confidence 346899999999999999999875432 46899988742 34456678999999999999999999999875432
Q ss_pred CccEEEEEecCCc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~g-dL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
...|+||||+++ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 164 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 164 -GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp -SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred -CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 357999999985 9999998654 5899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCC-cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 177 FNDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 177 ~~~~~~-~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
...... ........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-------- 312 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-------- 312 (373)
T ss_dssp ---------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--------
T ss_pred cccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--------
Confidence 332211 111234567889999999976 578999999999999999999 78899876654443322210
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.. ......+++.+.+||.+||+.||.+|||++|++++
T Consensus 313 -------------------~~---~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 313 -------------------RR---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 01123578899999999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=348.86 Aligned_cols=272 Identities=22% Similarity=0.363 Sum_probs=209.3
Q ss_pred CCCCceEEEEEEeecCCeEEEEEE----ECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~ 95 (560)
...++|++++.||+|+||.||+|. +..+|+.||||++.. ........+.+|+.+|+.++||||+++++++....
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS--CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 345789999999999999999998 467899999999975 23455678899999999999999999999886532
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccc
Q 008607 96 RREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~g-dL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla 173 (560)
...+++||||+++ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 116 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 ---RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp -----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ---CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 2357999999985 9999998764 5999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
+................++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+.+..+.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~ 265 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQG 265 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCT
T ss_pred hhccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccch
Confidence 876443322112234567888999999976 467889999999999999999999885421 1112222222111
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... .......+......+ ....+++.+.+||++||+.||.+|||+.|+++
T Consensus 266 ~~~------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 266 QMI------VFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHH------HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhh------HHHHHHHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 011111111111111 23567899999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=348.72 Aligned_cols=268 Identities=23% Similarity=0.336 Sum_probs=205.8
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc--cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~--~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
|.....|...+.||+|+||.||+|.+ +++.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 27 f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 102 (307)
T 2nru_A 27 FDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG-- 102 (307)
T ss_dssp TCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred cccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC--
Confidence 55566677779999999999999975 68899999987432 2334567788999999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~---~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGl 172 (560)
..+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 103 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 179 (307)
T 2nru_A 103 ---DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 179 (307)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ---CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 35899999997 599999874 34699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
++........ ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+.........
T Consensus 180 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 255 (307)
T 2nru_A 180 ARASEKFAQT-VMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK 255 (307)
T ss_dssp CEECCSCSSC-EECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC
T ss_pred cccccccccc-ccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh
Confidence 9865432211 12234679999999999865 4788999999999999999999999876544332222211100000
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
....++. . .+.......+..+.+||.+||+.||.+|||+.+++++
T Consensus 256 ---------~~~~~~~----~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 256 ---------TIEDYID----K---KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ---------CHHHHSC----S---SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------hhhhhcc----c---cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0001110 0 0111122345678999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=371.01 Aligned_cols=260 Identities=19% Similarity=0.255 Sum_probs=205.0
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..+++|+++++||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.|+|++++..+..+.. ..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~ 75 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGV----EG 75 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEE----ET
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEe----eC
Confidence 356889999999999999999999999999999998864322 2346789999999998665555554432 23
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee---CCCCcEEEeccccccc
Q 008607 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARV 175 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl---~~~~~lKL~DFGla~~ 175 (560)
...||||||++++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 76 ~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 46899999998899999985 4579999999999999999999999999999999999999 6889999999999987
Q ss_pred ccCCCCCc----ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 176 AFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 176 ~~~~~~~~----~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
........ ......+||+.|+|||++.+ ..++.++||||||||||+|++|+.||.+.........+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i----- 228 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----- 228 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH-----
T ss_pred ccCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH-----
Confidence 65433211 11235789999999999987 57899999999999999999999999886543333222211
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
........+.. ....++..+.+||.+||+.||.+||++++|++
T Consensus 229 -------~~~~~~~~~~~-----------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 229 -------SEKKVATSIEA-----------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -------HHHHHHSCHHH-----------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -------hhccccccHHH-----------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00111101111 11356889999999999999999999999876
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=353.06 Aligned_cols=273 Identities=22% Similarity=0.277 Sum_probs=195.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHH--HHhcCCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKL--LRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~i--L~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
-++|++++.||+|+||.||+|.+ +++.||||++.. .....+..|.++ +..++|+||+++++.+........
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSF-----ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEG-----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeec-----cchhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 47899999999999999999965 789999999863 223344445555 455899999999986543333444
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CeeeccCCCCCeeeCCCCcEEEec
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKICD 169 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~---------gIiHrDLKP~NILl~~~~~lKL~D 169 (560)
..+|+|||||+ |+|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred ceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 56899999997 5999999765 469999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCC-----CcccccccccCccccccccccccc-----CCCCCccchhhHHHHHHHHhhCCCCC-CCCChhh
Q 008607 170 FGLARVAFNDTP-----TAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAELLTGKPLF-PGKNVVH 238 (560)
Q Consensus 170 FGla~~~~~~~~-----~~~~~~~~~gT~~Y~APEll~~~~-----~~y~~~~DIWSlG~il~eLltG~~pF-~~~~~~~ 238 (560)
||+++....... ........+||+.|+|||++.+.. ..++.++|||||||++|||++|..|| .+.....
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999986543221 111223568999999999986521 23556899999999999999996554 4433222
Q ss_pred HHHHH-HHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCC---CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 239 QLDIM-TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP---NANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 239 ~~~~i-~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~---~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
....+ ......|..+.+. ..+.. ......+...+. .+++.+.+||.+||+.||.+|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQ--------VLVSR--EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHH--------HHHTT--SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhcccCCCchHHHHH--------hhhcc--cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 11111 1122233322221 11111 111112222222 24567999999999999999999999964
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=357.40 Aligned_cols=244 Identities=15% Similarity=0.192 Sum_probs=194.1
Q ss_pred CCceEEEEEEeecCCeEEEEE-----EECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC---CCCccccceeecC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSA-----YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR---HPDIVEIKHILLP 93 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a-----~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~---HpnIv~l~~i~~~ 93 (560)
.++|++.++||+|+||+||+| .+..+++.||||++.. .....+.+|+.+++.++ |+||+.+++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS-----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC-----CChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 578999999999999999999 4778999999999864 23456778888888887 8999999999854
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC------
Q 008607 94 PSRREFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA------ 161 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~-gdL~~~i~~-----~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~------ 161 (560)
. ...|||||||+ |+|.+++.. ...+++..++.|+.||+.||+|||+.||+||||||+|||++.
T Consensus 139 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 139 Q-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp S-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred C-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 4 35899999998 699999974 457999999999999999999999999999999999999998
Q ss_pred -----CCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCCh
Q 008607 162 -----DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236 (560)
Q Consensus 162 -----~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~ 236 (560)
++.+||+|||+|+....... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999976432222 223456789999999999987 5689999999999999999999999964331
Q ss_pred hhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 237 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
... ... ..+.. ...++.+.+|+.+||+.+|.+|++..+.|.+
T Consensus 291 ~~~-------------------------------~~~--~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 291 GEC-------------------------------KPE--GLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp TEE-------------------------------EEC--SCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred Cce-------------------------------eec--hhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 100 000 00000 1235678899999999999999665444443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=366.38 Aligned_cols=247 Identities=27% Similarity=0.390 Sum_probs=199.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||.||+|.+.. +..||||+++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 4789999999999999999999865 4679999997532 234678899999999999999999998843 34
Q ss_pred EEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+|||||||+ |+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 799999998 599999964 34699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+....
T Consensus 333 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 398 (452)
T 1fmk_A 333 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 398 (452)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred Ccee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 2211 1133457788999999876 578999999999999999999 999999877655444332210
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.. ...+.+++.+.+||.+||+.||.+|||++++++
T Consensus 399 -----------------~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 399 -----------------RM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01 112467889999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.85 Aligned_cols=269 Identities=25% Similarity=0.333 Sum_probs=195.8
Q ss_pred cccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc--CCCCccccceeec
Q 008607 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL--RHPDIVEIKHILL 92 (560)
Q Consensus 15 ~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l--~HpnIv~l~~i~~ 92 (560)
....-...++|++.+.||+|+||.||+|.+. |+.||||++.. .......+|.+++..+ +||||+++++++.
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFT-----TEEASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEG-----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEec-----cccchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 3333445679999999999999999999874 89999999853 2334455666666554 8999999999886
Q ss_pred CCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCCCCCeeeCCCC
Q 008607 93 PPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADC 163 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~--------gIiHrDLKP~NILl~~~~ 163 (560)
... .....+|+||||+++ +|.++++.. .+++..++.++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 102 ~~~-~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 102 KGT-GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp ESC-GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred cCC-CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 542 222568999999985 999999765 699999999999999999999999 999999999999999999
Q ss_pred cEEEecccccccccCCCCCc-ccccccccCcccccccccccccCCCCCc------cchhhHHHHHHHHhhC---------
Q 008607 164 KLKICDFGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPA------IDIWSIGCIFAELLTG--------- 227 (560)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~-~~~~~~~gT~~Y~APEll~~~~~~y~~~------~DIWSlG~il~eLltG--------- 227 (560)
.+||+|||+++......... ......+||+.|+|||++.+ ..++.. +|||||||++|||++|
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 99999999997654332211 11235689999999999976 344444 8999999999999999
Q ss_pred -CCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 008607 228 -KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306 (560)
Q Consensus 228 -~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt 306 (560)
+.||....... +....+ ...+.........+.......+++.+.+||.+||+.||.+|||
T Consensus 258 ~~~p~~~~~~~~-----------~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 318 (337)
T 3mdy_A 258 YQLPYHDLVPSD-----------PSYEDM--------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318 (337)
T ss_dssp CCCTTTTTSCSS-----------CCHHHH--------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred ccccHhhhcCCC-----------Cchhhh--------HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC
Confidence 66665432111 000000 0001000000111111111245667999999999999999999
Q ss_pred HHHHhcC
Q 008607 307 AEEALAD 313 (560)
Q Consensus 307 a~elL~h 313 (560)
+.|+++|
T Consensus 319 ~~ell~~ 325 (337)
T 3mdy_A 319 ALRVKKT 325 (337)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=376.46 Aligned_cols=253 Identities=22% Similarity=0.335 Sum_probs=201.2
Q ss_pred CCCceEEEE-EEeecCCeEEEEEEECC--CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 21 EGSRYKIEE-VIGKGSYGVVCSAYDTR--TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 21 ~~~~Y~i~~-~IG~G~~G~Vy~a~d~~--tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
...+|.+.+ .||+|+||.||+|.+.. ++..||||+++.. ........+.+|+++|+.++||||+++++++..
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---- 407 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 407 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES----
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc----
Confidence 345666666 89999999999998753 5667999999754 233456789999999999999999999999853
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..+|||||||+ |+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 408 --~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp --SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred --CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 24899999998 5899998754 4599999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
...............+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+...
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-------- 555 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-------- 555 (613)
T ss_dssp CC--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT--------
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------
Confidence 5433221111223346688999999976 578999999999999999998 99999987765544433221
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... .....+++.+.+||.+||..||.+||+++++++
T Consensus 556 -------------------~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 556 -------------------KRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -------------------CCC---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -------------------CCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 122467899999999999999999999999854
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=372.96 Aligned_cols=247 Identities=27% Similarity=0.387 Sum_probs=203.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||.||+|.+.. +..||||+++... .....+.+|+.+|+.++|+||+++++++.. ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence 4789999999999999999999865 4679999997532 234678999999999999999999998843 34
Q ss_pred EEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 102 IYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
+|||||||.+ +|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 7999999984 999999642 4699999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... .......++..|+|||++.. ..++.++|||||||+||||++ |+.||.+.+..+.+..+....
T Consensus 416 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 481 (535)
T 2h8h_A 416 NEY--TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 481 (535)
T ss_dssp HHH--HTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred Cce--ecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 110 11123456788999999876 578999999999999999999 999999877655444332210
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.. .....++..+.+||.+||+.||++|||+++|++
T Consensus 482 -----------------~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 482 -----------------RM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp -----------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01 112467889999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=385.61 Aligned_cols=281 Identities=26% Similarity=0.342 Sum_probs=211.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~-~~~~~~ 101 (560)
++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++.... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 6899999999999999999999999999999998753 24455677899999999999999999999875422 122456
Q ss_pred EEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc---EEEecccccc
Q 008607 102 IYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLAR 174 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~---~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~---lKL~DFGla~ 174 (560)
.|+|||||+ ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999997 59999998754 5999999999999999999999999999999999999997765 9999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ ..........
T Consensus 173 ~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~---~~i~~~~~~~ 243 (676)
T 3qa8_A 173 ELDQGEL----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH---GKVREKSNEH 243 (676)
T ss_dssp BTTSCCC----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSS---TTCC------
T ss_pred ccccccc----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhh---hhhhcccchh
Confidence 7543322 245689999999999976 678999999999999999999999998754332110 0000000000
Q ss_pred HHHhhhHHHHHHHHhhccC----CC-CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 255 IARVRNEKARRYLSSMRKK----KP-IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~----~~-~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
+ ......... .. .........+++.+.+||.+||.+||.+|||++|+|+||||+.+...
T Consensus 244 ~---------~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 244 I---------VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307 (676)
T ss_dssp C---------CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred h---------hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence 0 000000000 00 00112223467889999999999999999999999999999976543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.28 Aligned_cols=265 Identities=23% Similarity=0.302 Sum_probs=204.7
Q ss_pred cccccCC-CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecC
Q 008607 15 FFTEYGE-GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (560)
Q Consensus 15 ~~~~~~~-~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~ 93 (560)
+..+|.+ .++|++.+.||+|+||.||+|.+.. .||+|++............+.+|+.+++.++|+||+++++++..
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 4455544 4899999999999999999998754 49999987544444444567789999999999999999999854
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccc
Q 008607 94 PSRREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFG 171 (560)
. ..+++||||++ ++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++ ++.+||+|||
T Consensus 101 ~-----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 101 P-----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp S-----SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred C-----CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecC
Confidence 3 35899999998 59999997755 699999999999999999999999999999999999998 7899999999
Q ss_pred ccccccCCCC--CcccccccccCcccccccccccc-------cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHH
Q 008607 172 LARVAFNDTP--TAIFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (560)
Q Consensus 172 la~~~~~~~~--~~~~~~~~~gT~~Y~APEll~~~-------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (560)
+++....... .........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9875422111 11122345699999999998642 13578899999999999999999999988765544332
Q ss_pred HHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 243 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
+... ..+ ......++..+.+||.+||..||.+|||+.++++ .|+.+
T Consensus 255 ~~~~--------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l 300 (319)
T 2y4i_B 255 MGTG--------------------------MKP---NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKL 300 (319)
T ss_dssp HHTT--------------------------CCC---CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC
T ss_pred hccC--------------------------CCC---CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHH
Confidence 2210 000 0111256778999999999999999999999987 34443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=347.68 Aligned_cols=268 Identities=22% Similarity=0.277 Sum_probs=201.7
Q ss_pred cccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHh--cCCCCccccceeec
Q 008607 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL--LRHPDIVEIKHILL 92 (560)
Q Consensus 15 ~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~--l~HpnIv~l~~i~~ 92 (560)
+.......++|++.+.||+|+||.||+|.+ +|+.||||++.. .....+.+|+++++. ++||||+++++++.
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 333334457899999999999999999987 589999999863 344567889999988 78999999999986
Q ss_pred CCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeeccCCCCCeeeCCCC
Q 008607 93 PPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADC 163 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLH--------s~gIiHrDLKP~NILl~~~~ 163 (560)
... .....+|+||||+++ +|.+++... .+++..++.++.||+.||.||| +.||+||||||+|||++.++
T Consensus 107 ~~~-~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 107 KDN-GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCC-SSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred ccC-CccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 543 222468999999985 999999765 6999999999999999999999 89999999999999999999
Q ss_pred cEEEecccccccccCCCCCc-ccccccccCcccccccccccccC----CCCCccchhhHHHHHHHHhhC----------C
Q 008607 164 KLKICDFGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTG----------K 228 (560)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~-~~~~~~~gT~~Y~APEll~~~~~----~y~~~~DIWSlG~il~eLltG----------~ 228 (560)
.+||+|||++.......... ......+||+.|+|||++.+... .++.++|||||||++|+|++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999998754433211 11244689999999999865211 123689999999999999999 7
Q ss_pred CCCCCCChhh-HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCC--CCCCCHHHHHHHHHhcccCCCCCC
Q 008607 229 PLFPGKNVVH-QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK--FPNANPLALRLLERMLAFEPKDRP 305 (560)
Q Consensus 229 ~pF~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~--~~~~s~~~~dLI~~mL~~DP~~Rp 305 (560)
.||......+ ....+.. .+. .......+... ...++..+.+||.+||+.||.+||
T Consensus 265 ~p~~~~~~~~~~~~~~~~--------------------~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 322 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRK--------------------VVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322 (342)
T ss_dssp CTTTTTSCSSCCHHHHHH--------------------HHT--TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred cCccccCcCcccHHHHHH--------------------HHH--HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC
Confidence 7886543211 0000100 000 00001111111 112345789999999999999999
Q ss_pred CHHHHhcC
Q 008607 306 TAEEALAD 313 (560)
Q Consensus 306 ta~elL~h 313 (560)
|++|+++|
T Consensus 323 s~~~i~~~ 330 (342)
T 1b6c_B 323 TALRIKKT 330 (342)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.48 Aligned_cols=257 Identities=19% Similarity=0.153 Sum_probs=192.0
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc------ChhHHHHHHHHHHHHHhcC---------CC
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------HVSDATRILREIKLLRLLR---------HP 82 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~------~~~~~~~i~rEi~iL~~l~---------Hp 82 (560)
.....++|++.+.||+|+||+||+|++ +|+.||||++..... .......+.+|+.+|+.++ |+
T Consensus 15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ 92 (336)
T 2vuw_A 15 HCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE 92 (336)
T ss_dssp HHSCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred hhcccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence 334467899999999999999999988 789999999975321 2233467889999999886 66
Q ss_pred CccccceeecCCC-------------------------cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHH
Q 008607 83 DIVEIKHILLPPS-------------------------RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLL 136 (560)
Q Consensus 83 nIv~l~~i~~~~~-------------------------~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll 136 (560)
||+++.+++.... ......+|||||||. |++.+.+.. +.+++..++.|+.||+
T Consensus 93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLT 171 (336)
T ss_dssp CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHH
T ss_pred chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHH
Confidence 6666666543110 012457999999997 445555533 5699999999999999
Q ss_pred HHHHHHH-hCCeeeccCCCCCeeeCCCC--------------------cEEEecccccccccCCCCCcccccccccCccc
Q 008607 137 RGLKYIH-TANVFHRDLKPKNILANADC--------------------KLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195 (560)
Q Consensus 137 ~aL~yLH-s~gIiHrDLKP~NILl~~~~--------------------~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y 195 (560)
.||+||| +.||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y 243 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCT
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecc
Confidence 9999999 99999999999999999987 899999999987542 235899999
Q ss_pred ccccccccccCCCCCccchhhHHHH-HHHHhhCCCCCCCCChhh-HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccC
Q 008607 196 RAPELCGSFFSKYTPAIDIWSIGCI-FAELLTGKPLFPGKNVVH-QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKK 273 (560)
Q Consensus 196 ~APEll~~~~~~y~~~~DIWSlG~i-l~eLltG~~pF~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~ 273 (560)
+|||++.+. . +.++||||||++ .++++.|..||.+..... ..+.+. .... .
T Consensus 244 ~aPE~~~g~--~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~-----------------------~~~~-~ 296 (336)
T 2vuw_A 244 MDEDLFTGD--G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKML-----------------------KQMT-F 296 (336)
T ss_dssp TCSGGGCCC--S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHH-----------------------HTCC-C
T ss_pred cChhhhcCC--C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhh-----------------------hhhc-c
Confidence 999999762 3 789999998777 778999999984321111 111111 1100 1
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh-cCcccc
Q 008607 274 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL-ADPYFK 317 (560)
Q Consensus 274 ~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL-~hp~f~ 317 (560)
........++.+++.+.+||++||++| |++|+| +||||+
T Consensus 297 ~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 297 KTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred CcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 111111122346788999999999987 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=370.17 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=204.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCC---CcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
.++|++.+.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 46899999999999999999998654 457999988642 234455778999999999999999999998732
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..+|+||||++ |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 24799999998 69999998654 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 542 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~--------- 608 (656)
T 2j0j_A 542 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------- 608 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT---------
T ss_pred CCCcce--eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Confidence 332211 1234567889999999976 578999999999999999997 99999987766554443321
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ...+.+++.+.+||.+||..||.+|||+.|+++
T Consensus 609 ------------------~~~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 609 ------------------ERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 123467899999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=331.60 Aligned_cols=229 Identities=17% Similarity=0.101 Sum_probs=185.2
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC-hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
-.+++|++.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~---- 103 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR---- 103 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC----
Confidence 4567899999999999999999999999999999999754332 34457789999999999999999999998543
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|+||||++ ++|.++++.+ .....+..|+.||+.||+|||++||+||||||+|||++.++.+||+++|.
T Consensus 104 -~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~----- 175 (286)
T 3uqc_A 104 -AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT----- 175 (286)
T ss_dssp -TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-----
T ss_pred -CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-----
Confidence 46899999998 4999998543 46667899999999999999999999999999999999999999985542
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
++ .++.++|||||||++|+|++|+.||.+.+....+.......
T Consensus 176 ------------------~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------- 218 (286)
T 3uqc_A 176 ------------------MP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT---------- 218 (286)
T ss_dssp ------------------CT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT----------
T ss_pred ------------------cC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh----------
Confidence 22 36789999999999999999999999876433110000000
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
...........+++++.+.+||.+||+.||.+| |++|+++
T Consensus 219 --------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 219 --------------AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp --------------TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred --------------ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 001111122335788999999999999999999 9999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=374.63 Aligned_cols=246 Identities=25% Similarity=0.363 Sum_probs=198.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECC-CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~-tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|++.+.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.+|+.++||||+++++++.........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4799999999999999999999986 7999999998642 2334556788999999999999999999998654432223
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|||||||+| +|.+++.. .+++..++.|+.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 37999999985 88887654 79999999999999999999999999999999999999986 8999999999865322
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
...+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.... +.+...
T Consensus 235 -------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~------ 288 (681)
T 2pzi_A 235 -------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPEDD------ 288 (681)
T ss_dssp -------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTTC------
T ss_pred -------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccc----------cccccc------
Confidence 34679999999999865 3478999999999999999999998753211 001000
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
.....++.+.+||.+||+.||.+||+..+++.|+|+.-
T Consensus 289 ---------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 289 ---------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00012467889999999999999999999999998764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-33 Score=308.72 Aligned_cols=187 Identities=18% Similarity=0.112 Sum_probs=133.7
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEecCccc--------ChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008607 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE--------HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~--------~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++.|+.|.+..++...+|+.||+|++.+... .......+.+|+++|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 35678888888888888999999999864321 123345689999999999 699999999998 4445
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|||||||+| +|.++|...+.+++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 79999999996 999999999889875 47899999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCC
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~p 230 (560)
.. ...+.+||+.|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 393 ~~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C---CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred Cc---cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 22 2356799999999999976 466789999999999988776533
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=263.28 Aligned_cols=190 Identities=21% Similarity=0.253 Sum_probs=141.7
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC-h-----hHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-V-----SDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-~-----~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
+...++||+|+||.||+| ...+..+++|++...... . ....++.+|+++|+.++||||+.+..+....
T Consensus 338 ~~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~---- 411 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL---- 411 (540)
T ss_dssp ----------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET----
T ss_pred CCCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC----
Confidence 345679999999999999 567889999986532211 1 1234578999999999999999544444322
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
...|||||||+ ++|.+++.. +..|+.||+.||+|||++||+||||||+|||++. .+||+|||+++...
T Consensus 412 -~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 412 -DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp -TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred -CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 23599999998 699999865 5789999999999999999999999999999998 99999999998753
Q ss_pred CCCCCc----ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCC
Q 008607 178 NDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231 (560)
Q Consensus 178 ~~~~~~----~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF 231 (560)
...... ......+||++|+|||++......|+..+|+||..+-..+.+-++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 321110 012457899999999999764456888899999999888888777655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=219.21 Aligned_cols=161 Identities=19% Similarity=0.197 Sum_probs=123.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh----------------hHHHHHHHHHHHHHhcCCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----------------SDATRILREIKLLRLLRHPDIV 85 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~----------------~~~~~i~rEi~iL~~l~HpnIv 85 (560)
+..|++.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 45667779999999999999999 889999999986321110 13456889999999999 5 6
Q ss_pred ccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCc
Q 008607 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164 (560)
Q Consensus 86 ~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~ 164 (560)
.+.+++.. ...|+|||||+| +|.+ +. ......++.||+.||.|||+.||+||||||+|||++ ++.
T Consensus 165 ~v~~~~~~------~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 165 AVPKVYAW------EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp SSCCEEEE------ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE
T ss_pred CcCeEEec------cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc
Confidence 66665522 246999999985 8887 42 123557999999999999999999999999999999 999
Q ss_pred EEEecccccccccCCCCCcccccccccCcccccccccccc--------cCCCCCccchhh
Q 008607 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF--------FSKYTPAIDIWS 216 (560)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~--------~~~y~~~~DIWS 216 (560)
+||+|||+|+. +..|.|||++... ...|+..+|+|.
T Consensus 231 vkl~DFG~a~~----------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 231 IWIIDFPQSVE----------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEECCCTTCEE----------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEEEECCCCeE----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999999853 3457899987431 123455566665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-21 Score=192.27 Aligned_cols=144 Identities=17% Similarity=0.158 Sum_probs=110.9
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcE--EEEEEecCcccCh----------------------hHHHHHHHHHHHH
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHV----------------------SDATRILREIKLL 76 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~--vAiK~i~~~~~~~----------------------~~~~~i~rEi~iL 76 (560)
.+.-|++.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|
T Consensus 45 ~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 45 KGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp TTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred CCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 345689999999999999999998788999 9999875321110 1123578999999
Q ss_pred HhcCCCCccccceeecCCCcCCCccEEEEEecCCc------cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCeee
Q 008607 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES------DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-TANVFH 149 (560)
Q Consensus 77 ~~l~HpnIv~l~~i~~~~~~~~~~~i~lV~E~~~g------dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLH-s~gIiH 149 (560)
+.+.|+++.-..-+.. ...+|||||+++ .|.++... +++..+..++.||+.||.||| +.||+|
T Consensus 125 ~~l~~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givH 194 (258)
T 1zth_A 125 ERAKEAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVH 194 (258)
T ss_dssp HHHHHTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred HHHHhCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 9998876522211111 135899999953 67766432 345678899999999999999 999999
Q ss_pred ccCCCCCeeeCCCCcEEEecccccccc
Q 008607 150 RDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 150 rDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-17 Score=173.67 Aligned_cols=139 Identities=16% Similarity=0.160 Sum_probs=97.5
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc------------ChhHHHH--------HHHHHHHHHhcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------------HVSDATR--------ILREIKLLRLLRH 81 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~------------~~~~~~~--------i~rEi~iL~~l~H 81 (560)
+.-|+|.+.||.|++|.||+|.+. +|+.||||+++.... ....... ..+|...|..+.+
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 445999999999999999999974 699999998752110 0000111 2346666666644
Q ss_pred CCccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC
Q 008607 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (560)
Q Consensus 82 pnIv~l~~i~~~~~~~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~ 160 (560)
.++.-..-+.. ...+|||||++| .|.++. ..+....++.||+.+|.+||++|||||||||.|||++
T Consensus 173 ~gv~vp~p~~~-------~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 173 EGFPVPEPIAQ-------SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR 239 (397)
T ss_dssp TTCSCCCEEEE-------ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred cCCCCCeeeec-------cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 43321111111 113799999997 554432 2234567889999999999999999999999999999
Q ss_pred CCC----------cEEEecccccc
Q 008607 161 ADC----------KLKICDFGLAR 174 (560)
Q Consensus 161 ~~~----------~lKL~DFGla~ 174 (560)
.++ .+.|+||+.+.
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCCcccccccccceEEEEeCCcc
Confidence 877 38999999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.3e-11 Score=122.00 Aligned_cols=137 Identities=12% Similarity=0.108 Sum_probs=104.8
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccE
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~i 102 (560)
.|++...++.|+.+.||++.. .+..+++|....... .....+.+|+.+|+.|. +..+.++++.... ....
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~ 85 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWS 85 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCce
Confidence 488999999999999999964 478999999864221 12235788999999985 5667777776632 2457
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT------------------------------------- 144 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs------------------------------------- 144 (560)
|+|||+++| +|.+.+. +......++.++..+|+.||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999998 6766521 222345788999999999998
Q ss_pred ----------------------CCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 145 ----------------------ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 145 ----------------------~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876667899999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=1.2e-10 Score=114.17 Aligned_cols=132 Identities=15% Similarity=0.109 Sum_probs=94.4
Q ss_pred ceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCcc
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSRREFKD 101 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~i~~~~~~~~~~~ 101 (560)
.|.+..+.+.|..+.||++. ..+|..+++|..... ....+.+|+.+|+.+.+.+ +.+++...... +.
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~ 89 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GR 89 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SC
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CC
Confidence 46665555567779999995 456788999987542 2234678999999986544 44566655322 35
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN---------------------------------- 146 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~g---------------------------------- 146 (560)
.|+|||+++| +| . . ...+. ..++.++...|..||+..
T Consensus 90 ~~~v~e~i~G~~l-~-~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 90 DWLLLGEVPGQDL-L-S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEEEECCSSEET-T-T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred CEEEEEecCCccc-C-c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 7999999997 55 3 1 11222 356777888888888753
Q ss_pred ------------------------eeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 147 ------------------------VFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 147 ------------------------IiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667899999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.12 E-value=8.6e-11 Score=119.10 Aligned_cols=184 Identities=17% Similarity=0.251 Sum_probs=119.4
Q ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCc--cccceeecCCCcCCCccEEE
Q 008607 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDI--VEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnI--v~l~~i~~~~~~~~~~~i~l 104 (560)
++.++.|....||++. ..+++|+... ......+.+|..+|+.+. +..+ ..++... .........|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceE
Confidence 3559999999999872 5689998643 234567889999999884 3332 2222221 11111223489
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 008607 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------------------------------------- 144 (560)
Q Consensus 105 V~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs--------------------------------------- 144 (560)
||++++| .|..... ..++.+....++.|+...|+.||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999998 5544332 247888888889999999998886
Q ss_pred -------------------CCeeeccCCCCCeeeCC--CCcEEEecccccccccCCCCCcccccccccCccc---ccccc
Q 008607 145 -------------------ANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY---RAPEL 200 (560)
Q Consensus 145 -------------------~gIiHrDLKP~NILl~~--~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y---~APEl 200 (560)
..++|+|++|.|||++. .+.+.|+||+.+...... .+......+ ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-------~Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-------NDFISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-------HHHHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-------HHHHHHHhhccccCHHH
Confidence 13799999999999998 456899999998653111 001111111 23332
Q ss_pred cccccCCCC------------CccchhhHHHHHHHHhhCCCCC
Q 008607 201 CGSFFSKYT------------PAIDIWSIGCIFAELLTGKPLF 231 (560)
Q Consensus 201 l~~~~~~y~------------~~~DIWSlG~il~eLltG~~pF 231 (560)
+......|. .-.+.|++|.+++.+.+|..+|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111101111 1258999999999999999766
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=7.1e-10 Score=114.97 Aligned_cols=144 Identities=14% Similarity=0.200 Sum_probs=103.1
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEec--CcccChhHHHHHHHHHHHHHhcCC--CCccccceeecCCCcCCCc
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRH--PDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~--~~~~~~~~~~~i~rEi~iL~~l~H--pnIv~l~~i~~~~~~~~~~ 100 (560)
...++.|+.|.++.||++.. .+..+++|+.. ... .......+.+|+.+|+.|.. ..+.+++..+... ...+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g 114 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIG 114 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTS
T ss_pred CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccC
Confidence 34467799999999999864 35688998765 211 11223467889999999974 4567777766432 1223
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT----------------------------------- 144 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs----------------------------------- 144 (560)
..|+|||+++| .+.+. ....+++.....++.+++.+|..||+
T Consensus 115 ~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 47999999997 33221 12247888889999999999999997
Q ss_pred -----------------------CCeeeccCCCCCeeeCCCCc--EEEeccccccc
Q 008607 145 -----------------------ANVFHRDLKPKNILANADCK--LKICDFGLARV 175 (560)
Q Consensus 145 -----------------------~gIiHrDLKP~NILl~~~~~--lKL~DFGla~~ 175 (560)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999998753 69999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=7.5e-07 Score=90.27 Aligned_cols=133 Identities=21% Similarity=0.186 Sum_probs=90.0
Q ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC---ccccceeecCCCcCCCccEEE
Q 008607 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD---IVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn---Iv~l~~i~~~~~~~~~~~i~l 104 (560)
++.++.|....||+. |..+++|+.. .......+.+|..+|+.|.+.. +..++..... ..+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEE
Confidence 456889999999988 6778998753 2234567889999999997532 3333333321 1234689
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 008607 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-------------------------------------- 145 (560)
Q Consensus 105 V~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~-------------------------------------- 145 (560)
|||+++| .|....- ..++......++.|+...|+.||+.
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999998 4544221 1245555555556666665555542
Q ss_pred ----------------------CeeeccCCCCCeeeCC---CCc-EEEeccccccc
Q 008607 146 ----------------------NVFHRDLKPKNILANA---DCK-LKICDFGLARV 175 (560)
Q Consensus 146 ----------------------gIiHrDLKP~NILl~~---~~~-lKL~DFGla~~ 175 (560)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999998 455 48999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=2.4e-06 Score=84.25 Aligned_cols=131 Identities=20% Similarity=0.265 Sum_probs=90.7
Q ss_pred EEeecCCe-EEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCC-CCccccceeecCCCcCCCccEEEEEe
Q 008607 30 VIGKGSYG-VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSRREFKDIYVVFE 107 (560)
Q Consensus 30 ~IG~G~~G-~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~H-pnIv~l~~i~~~~~~~~~~~i~lV~E 107 (560)
.+..|..| .||+......+..+++|.-.. .....+.+|..+|+.|.. --+.+++.+.... ..-|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEE
Confidence 35556555 689888777788899997642 345678899999998862 2244555554322 35799999
Q ss_pred cCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 008607 108 LMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------------------------------------- 145 (560)
Q Consensus 108 ~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~----------------------------------------- 145 (560)
+++| ++.+..... ......+..++...|.-||+.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9997 566554332 122334556666666666642
Q ss_pred -----------------CeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 146 -----------------NVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 146 -----------------gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 17999999999999987777899999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=5.7e-06 Score=86.64 Aligned_cols=78 Identities=19% Similarity=0.147 Sum_probs=48.2
Q ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc--C---hhHHHHHHHHHHHHHhcCC--CCcc-ccceeecCCCcCC
Q 008607 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE--H---VSDATRILREIKLLRLLRH--PDIV-EIKHILLPPSRRE 98 (560)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~--~---~~~~~~i~rEi~iL~~l~H--pnIv-~l~~i~~~~~~~~ 98 (560)
-.+.||.|..+.||++.+..+++.++||....... . .....++.+|.++|+.+.. +.++ .++... .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~---- 107 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T---- 107 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T----
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C----
Confidence 35679999999999997666778999998652111 0 1123456789999988742 3333 343321 1
Q ss_pred CccEEEEEecCCc
Q 008607 99 FKDIYVVFELMES 111 (560)
Q Consensus 99 ~~~i~lV~E~~~g 111 (560)
...++|||++++
T Consensus 108 -~~~~lvmE~l~g 119 (397)
T 2olc_A 108 -EMAVTVMEDLSH 119 (397)
T ss_dssp -TTTEEEECCCTT
T ss_pred -CccEEEEEeCCC
Confidence 124899999986
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.17 E-value=6e-06 Score=83.88 Aligned_cols=30 Identities=20% Similarity=0.324 Sum_probs=27.1
Q ss_pred CCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 145 ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 145 ~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
..++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999663
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=9.4e-06 Score=83.49 Aligned_cols=85 Identities=11% Similarity=0.150 Sum_probs=51.8
Q ss_pred eEEEEEE-eecCCeEEEEEEECC------CCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCC---CCccccceeecC
Q 008607 25 YKIEEVI-GKGSYGVVCSAYDTR------TGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRH---PDIVEIKHILLP 93 (560)
Q Consensus 25 Y~i~~~I-G~G~~G~Vy~a~d~~------tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~H---pnIv~l~~i~~~ 93 (560)
....+.| +.|....+|++.... ++..+++|....... .......+.+|+.+|+.|.. -.+.+++.....
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 889999999886431 266889987643110 00012346789999888853 235556655432
Q ss_pred CCcCCCccEEEEEecCCc
Q 008607 94 PSRREFKDIYVVFELMES 111 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~g 111 (560)
.. .....|+|||+++|
T Consensus 102 ~~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GD--VLGTPFFLMDYVEG 117 (357)
T ss_dssp ST--TTSSCEEEEECCCC
T ss_pred CC--ccCCceEEEEecCC
Confidence 21 11345899999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00046 Score=72.69 Aligned_cols=32 Identities=16% Similarity=0.313 Sum_probs=28.0
Q ss_pred HhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 143 HTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 143 Hs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999999876 99999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0012 Score=66.11 Aligned_cols=68 Identities=15% Similarity=0.063 Sum_probs=42.1
Q ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCccEEEEE
Q 008607 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~~i~~~~~~~~~~~i~lV~ 106 (560)
++.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++. +++... .. .-++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~-----~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PA-----TGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT-----TCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CC-----CCEEEE
Confidence 678999999999998 56889887532111 11224688888877533333 343332 11 136899
Q ss_pred ecC-Cc
Q 008607 107 ELM-ES 111 (560)
Q Consensus 107 E~~-~g 111 (560)
||+ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00082 Score=67.68 Aligned_cols=152 Identities=15% Similarity=0.165 Sum_probs=81.6
Q ss_pred cccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCc--cccceeec
Q 008607 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI--VEIKHILL 92 (560)
Q Consensus 15 ~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI--v~l~~i~~ 92 (560)
+...|+.+ ...-++.|+.|....+|++... +..+++|..... .....+..|+.+++.|...++ .+++...
T Consensus 15 ~l~~~~~~-~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~- 86 (322)
T 2ppq_A 15 FLTQYDVG-SLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK- 86 (322)
T ss_dssp HHTTBCCC-CEEEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-
T ss_pred HHHhCCCC-cceEeeccCCCcccceEEEEeC--CccEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCC-
Confidence 34456663 3444567888988999998643 337889987642 122345678888887753232 2222110
Q ss_pred CCCc--CCCccEEEEEecCCcc-H-----H------HH---HH-hCCCC--------CHHHHHHH---------------
Q 008607 93 PPSR--REFKDIYVVFELMESD-L-----H------QV---IK-ANDDL--------TPEHYQFF--------------- 131 (560)
Q Consensus 93 ~~~~--~~~~~i~lV~E~~~gd-L-----~------~~---i~-~~~~l--------se~~~~~i--------------- 131 (560)
.... ...+..++||++++|. + . .. +. ....+ ........
T Consensus 87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 0000 0113468999999862 1 0 01 11 11111 11111100
Q ss_pred HHHHHHHHHHHHh-------CCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 132 LYQLLRGLKYIHT-------ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 132 ~~Qll~aL~yLHs-------~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
-..+...++.++. .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0113444555553 369999999999999987666899999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0018 Score=61.86 Aligned_cols=98 Identities=18% Similarity=0.103 Sum_probs=65.2
Q ss_pred cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCCccccccc
Q 008607 112 DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189 (560)
Q Consensus 112 dL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLH-s~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~ 189 (560)
+|.+++.. +.+++|+++|.+++|.+.+|.-+- .+.-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 79999976 558999999999999999988872 22212333456899999999987764 2110
Q ss_pred ccCcccccccccccccCCCCCccchhhHHHHHHHHhhCC
Q 008607 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (560)
Q Consensus 190 ~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~ 228 (560)
.....+.+||... ...+.+.=|+|||+++|.-+--.
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcC
Confidence 1122356888763 24456789999999999987644
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0028 Score=62.86 Aligned_cols=78 Identities=13% Similarity=0.018 Sum_probs=52.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC---ccccceeecCCCcCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD---IVEIKHILLPPSRRE 98 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn---Iv~l~~i~~~~~~~~ 98 (560)
|.+..-++.+|.|..+.||++.. .+|+.|++|+-... .......+.+|...|+.|.... +.+++..-
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~--~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------- 83 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDD--APALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------- 83 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTT--CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-------
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCC--CcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-------
Confidence 34567788999999999999974 56889999986532 1122234678999999885322 23333321
Q ss_pred CccEEEEEecCCc
Q 008607 99 FKDIYVVFELMES 111 (560)
Q Consensus 99 ~~~i~lV~E~~~g 111 (560)
.-++|||++.+
T Consensus 84 --~~~lv~e~l~~ 94 (288)
T 3f7w_A 84 --DRTLAMEWVDE 94 (288)
T ss_dssp --TTEEEEECCCC
T ss_pred --CceEEEEeecc
Confidence 12789999873
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0028 Score=63.89 Aligned_cols=76 Identities=13% Similarity=0.072 Sum_probs=46.0
Q ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC--ccccceeecCCCc--CCCccEEE
Q 008607 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSR--REFKDIYV 104 (560)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~i~~~~~~--~~~~~i~l 104 (560)
+.|+ |....||++.. ..|+.+++|..... ......+.+|..+++.|.... +..++.. .... ...+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~---~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCC---CCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence 4566 88889998743 34668999988621 113456677999988885322 3333332 1100 01234688
Q ss_pred EEecCCc
Q 008607 105 VFELMES 111 (560)
Q Consensus 105 V~E~~~g 111 (560)
||++++|
T Consensus 105 l~~~i~G 111 (328)
T 1zyl_A 105 VFPSVGG 111 (328)
T ss_dssp EEECCCC
T ss_pred EEEecCC
Confidence 9999986
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0023 Score=64.78 Aligned_cols=74 Identities=18% Similarity=0.130 Sum_probs=53.1
Q ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCC---CCccccceeecCCCcCCCccE
Q 008607 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH---PDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~H---pnIv~l~~i~~~~~~~~~~~i 102 (560)
.-.+.|+.|....+|+... .+..+++|.... .....+.+|...|+.|.. ..+.+++..... ....
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCce
Confidence 3457789999999999863 577899997653 235667889999988852 345555555422 1357
Q ss_pred EEEEecCCc
Q 008607 103 YVVFELMES 111 (560)
Q Consensus 103 ~lV~E~~~g 111 (560)
|+|||+++|
T Consensus 107 ~lvme~l~G 115 (312)
T 3jr1_A 107 FLLLEALNK 115 (312)
T ss_dssp EEEEECCCC
T ss_pred EEEEEeccC
Confidence 999999986
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0065 Score=64.21 Aligned_cols=72 Identities=14% Similarity=0.109 Sum_probs=48.0
Q ss_pred EEEEEeecCCeEEEEEEECC-------CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCC
Q 008607 27 IEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPPSRRE 98 (560)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~-------tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI-v~l~~i~~~~~~~~ 98 (560)
-++.|+.|....||++.... .+..+++|+.... . ....+.+|+.+++.|...++ .++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~ 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TESHLVAESVIFTLLSERHLGPKLYGIFS-----G 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C
Confidence 35668889999999997643 3578999987421 1 12345589999998864444 44555441 1
Q ss_pred CccEEEEEecCCc
Q 008607 99 FKDIYVVFELMES 111 (560)
Q Consensus 99 ~~~i~lV~E~~~g 111 (560)
.+|+||++|
T Consensus 148 ----g~v~e~l~G 156 (429)
T 1nw1_A 148 ----GRLEEYIPS 156 (429)
T ss_dssp ----EEEECCCCE
T ss_pred ----CEEEEEeCC
Confidence 389999986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0017 Score=66.96 Aligned_cols=73 Identities=10% Similarity=0.034 Sum_probs=42.3
Q ss_pred EEEEEeecCCeEEEEEEECC--------CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCc-cccceeecCCCcC
Q 008607 27 IEEVIGKGSYGVVCSAYDTR--------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPPSRR 97 (560)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~--------tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI-v~l~~i~~~~~~~ 97 (560)
-.+.|+.|....+|++.... .+..+++|+.... ........+|..+|+.|...++ .+++... .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T---
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEec--C---
Confidence 34567889889999997543 1368888876531 1111123578888888864343 3455433 1
Q ss_pred CCccEEEEEecCCc
Q 008607 98 EFKDIYVVFELMES 111 (560)
Q Consensus 98 ~~~~i~lV~E~~~g 111 (560)
-++||||++|
T Consensus 109 ----~~~v~e~i~G 118 (369)
T 3c5i_A 109 ----GGRIEEWLYG 118 (369)
T ss_dssp ----TEEEEECCCS
T ss_pred ----CcEEEEEecC
Confidence 1689999986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0029 Score=64.07 Aligned_cols=31 Identities=26% Similarity=0.470 Sum_probs=26.9
Q ss_pred CCeeeccCCCCCeeeCCC----CcEEEeccccccc
Q 008607 145 ANVFHRDLKPKNILANAD----CKLKICDFGLARV 175 (560)
Q Consensus 145 ~gIiHrDLKP~NILl~~~----~~lKL~DFGla~~ 175 (560)
..++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6899999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0086 Score=62.28 Aligned_cols=139 Identities=13% Similarity=0.199 Sum_probs=81.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECC-------CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCc-cccceeecCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPP 94 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~-------tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI-v~l~~i~~~~ 94 (560)
+..++ +.|..|-...+|++.... .+..|++|+.... ......+.+|..+++.|...++ .+++..+.
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-- 124 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFP-- 124 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--
Confidence 34443 457778888999987532 3578999986321 1234455689999988863333 34444441
Q ss_pred CcCCCccEEEEEecCCc-cH-----------H---HHHH---hCC-----CC--CHHHHHHHHHHHHH------------
Q 008607 95 SRREFKDIYVVFELMES-DL-----------H---QVIK---AND-----DL--TPEHYQFFLYQLLR------------ 137 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~g-dL-----------~---~~i~---~~~-----~l--se~~~~~i~~Qll~------------ 137 (560)
+ .+||||++| .| . +.+. ... .. -+..+..|+.++-.
T Consensus 125 ---~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~ 197 (379)
T 3feg_A 125 ---E----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLL 197 (379)
T ss_dssp ---T----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHH
T ss_pred ---C----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhh
Confidence 1 289999986 21 1 1111 111 11 24566667655532
Q ss_pred -------HHHHHH----h----CCeeeccCCCCCeeeCCC----CcEEEecccccc
Q 008607 138 -------GLKYIH----T----ANVFHRDLKPKNILANAD----CKLKICDFGLAR 174 (560)
Q Consensus 138 -------aL~yLH----s----~gIiHrDLKP~NILl~~~----~~lKL~DFGla~ 174 (560)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 198 ~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 198 EMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 2 258999999999999876 789999999774
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0063 Score=62.11 Aligned_cols=31 Identities=19% Similarity=0.326 Sum_probs=27.4
Q ss_pred CCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 145 ANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 145 ~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3689999999999999888899999987754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.038 Score=58.83 Aligned_cols=72 Identities=18% Similarity=0.202 Sum_probs=46.0
Q ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCCCccEEEEE
Q 008607 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI-v~l~~i~~~~~~~~~~~i~lV~ 106 (560)
++.|+.|-...+|++.....+..+++|+........-+ ..+|+.+|+.|...++ .++++++ .. .+||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~--~~-------G~v~ 180 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFF--TN-------GRIE 180 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEE--TT-------EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEe--CC-------eEEE
Confidence 45688899999999977554588999987432111111 1479999999975555 3455554 11 2599
Q ss_pred ecCCc
Q 008607 107 ELMES 111 (560)
Q Consensus 107 E~~~g 111 (560)
||++|
T Consensus 181 e~I~G 185 (458)
T 2qg7_A 181 EFMDG 185 (458)
T ss_dssp ECCCS
T ss_pred EeeCC
Confidence 99986
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.87 E-value=0.22 Score=52.42 Aligned_cols=75 Identities=12% Similarity=0.070 Sum_probs=46.0
Q ss_pred ceEEEEEEeecCCeEEEEEEECC-------CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCc-cccceeecCCC
Q 008607 24 RYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPPS 95 (560)
Q Consensus 24 ~Y~i~~~IG~G~~G~Vy~a~d~~-------tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI-v~l~~i~~~~~ 95 (560)
..+ ++.|..|-...+|++.... .+..|++++....... .....+|..+++.|...++ .++++.+ .
T Consensus 72 ~~~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~--~- 144 (424)
T 3mes_A 72 YIE-VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF--P- 144 (424)
T ss_dssp GEE-EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE--T-
T ss_pred ceE-EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc--C-
Confidence 344 4556678888999997652 1678999886432111 1123478888888863333 3344433 1
Q ss_pred cCCCccEEEEEecCCc
Q 008607 96 RREFKDIYVVFELMES 111 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~g 111 (560)
-++|+||++|
T Consensus 145 ------~~~I~efI~G 154 (424)
T 3mes_A 145 ------EGRIEEFIDG 154 (424)
T ss_dssp ------TEEEEECCCS
T ss_pred ------CCEEEEEeCC
Confidence 1689999987
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.98 E-value=0.27 Score=51.15 Aligned_cols=29 Identities=31% Similarity=0.421 Sum_probs=24.7
Q ss_pred eeeccCCCCCeee------CCCCcEEEeccccccc
Q 008607 147 VFHRDLKPKNILA------NADCKLKICDFGLARV 175 (560)
Q Consensus 147 IiHrDLKP~NILl------~~~~~lKL~DFGla~~ 175 (560)
++|+|+.+.|||+ +.+..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 560 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-101 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-92 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-91 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-81 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-80 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-77 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-74 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-74 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-73 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-72 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-71 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-69 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-69 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-69 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-69 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-68 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-68 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-67 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-67 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-66 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-65 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-63 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-61 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-60 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-59 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-58 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-58 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-56 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-55 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-53 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-51 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-50 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-41 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-25 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 307 bits (788), Expect = e-101
Identities = 163/341 (47%), Positives = 223/341 (65%), Gaps = 5/341 (1%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G RY IG+G+YG+VCSAYD +VAIKKI+ FEH + R LREIK+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRH 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ I I+ P+ + KD+Y+V LM +DL++++K L+ +H +FLYQ+LRGLKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
IH+ANV HRDLKP N+L N C LKICDFGLARVA D F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+ YT +IDIWS+GCI AE+L+ +P+FPGK+ + QL+ + +LG+PS E + + N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
KAR YL S+ K +P+++ FPNA+ AL LL++ML F P R E+ALA PY +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 322 VEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQ 362
EP A+ +F+ E + KE ++ELI+ E + P
Sbjct: 304 PSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPG 342
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 284 bits (728), Expect = 3e-92
Identities = 147/346 (42%), Positives = 217/346 (62%), Gaps = 12/346 (3%)
Query: 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
T + RY+ +G G+YG VC+A+DT+TG +VA+KK++ F+ + A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 77 RLLRHPDIVEIKHILLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 135
+ ++H +++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
LRGLKYIH+A++ HRDLKP N+ N DC+LKI DFGLAR T T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
RAPE+ + + Y +DIWS+GCI AELLTG+ LFPG + + QL ++ L+GTP E +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
++ +E AR Y+ S+ + + F+ F ANPLA+ LLE+ML + R TA +ALA Y
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 316 FKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
F + EP A P + FE R + ++ + L Y E++ + P
Sbjct: 304 FAQYHDPDDEPVADP---YDQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 282 bits (721), Expect = 3e-91
Identities = 140/346 (40%), Positives = 214/346 (61%), Gaps = 12/346 (3%)
Query: 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
T + + Y+ + +G G+YG VCSA D RTG KVAIKK+ F+ A R RE++LL
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 77 RLLRHPDIVEIKHILLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 135
+ +RH +++ + + P + F D Y+V M +DL +++K ++ L + QF +YQ+
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQM 130
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L+GL+YIH A + HRDLKP N+ N DC+LKI DFGLAR A ++ T YV TRWY
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
RAPE+ + + +YT +DIWS+GCI AE++TGK LF G + + QL + + GTP E +
Sbjct: 185 RAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
R+++++A+ Y+ + + + F+ NA+PLA+ LLE+ML + + R TA EALA PY
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303
Query: 316 FKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
F+ L E EP Q K + F+ T ++ + + Y+E+L + P
Sbjct: 304 FESLHDTEDEPQVQ---KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (656), Expect = 1e-81
Identities = 126/347 (36%), Positives = 195/347 (56%), Gaps = 23/347 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ + IG G+ G+VC+AYD VAIKK++ F++ + A R RE+ L++ + H +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 84 IVEIKHILLPPSR-REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ + ++ P EF+D+Y+V ELM+++L QVI+ D E + LYQ+L G+K++
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQMLCGIKHL 135
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ +DC LKI DFGLAR A T YV TR+YRAPE+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYYRAPEVIL 191
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y +DIWS+GCI E++ K LFPG++ + Q + + + LGTP PE + ++
Sbjct: 192 GM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-QPT 248
Query: 263 ARRYLSSMRKKKPIPFSQKFPNA------------NPLALRLLERMLAFEPKDRPTAEEA 310
R Y+ + K + F + FP++ A LL +ML +P R + ++A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 311 LADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREIL 357
L PY E A P + + + R T E+ +ELIY+E++
Sbjct: 309 LQHPYINVWYD-PAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (643), Expect = 5e-80
Identities = 101/301 (33%), Positives = 154/301 (51%), Gaps = 7/301 (2%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S+Y+ IG+G++G V A +TG+KVA+KK+ E LREIK+L+LL+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELMESDLHQV-IKANDDLTPEHYQFFLYQLLRG 138
++V + I + + IY+VF+ E DL + T + + LL G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRA 197
L YIH + HRD+K N+L D LK+ DFGLAR + +T+ V T WYR
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PEL Y P ID+W GCI AE+ T P+ G HQL +++ L G+ +PE
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 258 VRNEKARRYLSSMR-KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
V N + L ++ +K+ + K +P AL L++++L +P R +++AL +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 317 K 317
Sbjct: 309 W 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 4e-77
Identities = 106/331 (32%), Positives = 167/331 (50%), Gaps = 21/331 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 84 IVEIKHILLPPSRREFKD-IYVVFELMESDLHQVI----KANDDLTPEHYQFFLYQLLRG 138
IV +++ ++ + + +V + + +++V +A L + + ++YQL R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 139 LKYIHTANVFHRDLKPKNILANADCKL-KICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L YIH+ + HRD+KP+N+L + D + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PEL YT +ID+WS GC+ AELL G+P+FPG + V QL + +LGTP+ E I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
+ + K P+++ F P P A+ L R+L + P R T EA A +F
Sbjct: 250 MNPNYTEFKFPQI---KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 317 KGLAKVEREPSAQPVTKMEFEFERRRITKED 347
L + T F F + ++
Sbjct: 307 DELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 1e-74
Identities = 100/306 (32%), Positives = 154/306 (50%), Gaps = 16/306 (5%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRT-GEKVAIKKINDIFEHVSDATRILREIKLLRLL--- 79
+Y+ IG+G+YG V A D + G VA+K++ +RE+ +LR L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 137
HP++V + + + +VFE ++ DL + + + E + ++QLLR
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ T V T WYRA
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYRA 183
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PE+ S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P E R
Sbjct: 184 PEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ + K P + + + L LL + L F P R +A AL+ PYF+
Sbjct: 242 DVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
Query: 318 GLAKVE 323
L + +
Sbjct: 298 DLERCK 303
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 6e-74
Identities = 101/310 (32%), Positives = 149/310 (48%), Gaps = 22/310 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT---RILREIKLLRLLRHPDIV 85
+ +G+G + V A D T + VAIKKI + LREIKLL+ L HP+I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 86 EIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ +I +VF+ ME+D + + LTP H + ++ L+GL+Y+H
Sbjct: 64 GLLDA-----FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ HRDLKP N+L + + LK+ DFGLA+ + +T V TRWYRAPEL
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL-FG 174
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264
Y +D+W++GCI AELL P PG + + QL + + LGTP+ E + +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324
+ IP F A L L++ + F P R TA +AL YF
Sbjct: 235 VT---FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN------ 285
Query: 325 EPSAQPVTKM 334
P P ++
Sbjct: 286 RPGPTPGCQL 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 7e-74
Identities = 64/310 (20%), Positives = 120/310 (38%), Gaps = 28/310 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++ +G G+ GVV +G +A K I+ + + +I+RE+++L P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPY 65
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV +I + E M+ L QV+K + + +++GL Y+
Sbjct: 66 IVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 143 HTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+ + HRD+KP NIL N+ ++K+CDFG++ + +V TR Y +PE
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERL 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+ Y+ DIWS+G E+ G+ P + + + + E R R
Sbjct: 176 --QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 262 KARRYLSSMRKKKPIPFSQKFPNA-------------NPLALRLLERMLAFEPKDRPTAE 308
M + P+ + + + + L P +R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 309 EALADPYFKG 318
+ + + K
Sbjct: 294 QLMVHAFIKR 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 3e-73
Identities = 110/300 (36%), Positives = 162/300 (54%), Gaps = 13/300 (4%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++ E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKY 141
IV++ + +Y+VFE + DL + + A+ + + +L+QLL+GL +
Sbjct: 63 IVKLLDV-----IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
H+ V HRDLKP+N+L N + +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEIL 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
Y+ A+DIWS+GCIFAE++T + LFPG + + QL + LGTP
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP--GVT 231
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
Y S K FS+ P + LL +ML ++P R +A+ ALA P+F+ + K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 229 bits (585), Expect = 6e-72
Identities = 106/295 (35%), Positives = 157/295 (53%), Gaps = 13/295 (4%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+YGVV A + GE A+KKI E + +REI +L+ L+H +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 84 IVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV++ ++ K + +VFE + + + L + FL QLL G+ Y
Sbjct: 62 IVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H V HRDLKP+N+L N + +LKI DFGLAR +T + T WYRAP++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLM 173
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
KY+ IDIWS+GCIFAE++ G PLFPG + QL + +LGTP+ + V +
Sbjct: 174 G-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--E 230
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+Y + +P+P+ + + LL +ML +P R TA++AL YFK
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 6e-71
Identities = 107/297 (36%), Positives = 149/297 (50%), Gaps = 11/297 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV + +L + K V + N DL PE + FL+QLL+GL + H
Sbjct: 63 IVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ NV HRDLKP+N+L N + +LK+ +FGLAR ++ V T WYR P++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFG 175
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y+ +ID+WS GCIFAEL PLFPG +V QL + LLGTP+ E + K
Sbjct: 176 -AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--K 232
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
Y P N LL+ +L P R +AEEAL PYF
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 225 bits (574), Expect = 1e-69
Identities = 92/328 (28%), Positives = 163/328 (49%), Gaps = 27/328 (8%)
Query: 5 QRKKSSADVDFFT-EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
R + D + E+G Y++ +G+G Y V A + EKV +K + + +
Sbjct: 16 HRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK- 74
Query: 64 SDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND 121
+I REIK+L LR P+I+ + I+ P R +VFE + +D Q+ +
Sbjct: 75 ----KIKREIKILENLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT-- 125
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDT 180
LT +F++Y++L+ L Y H+ + HRD+KP N++ + + KL++ D+GLA
Sbjct: 126 -LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQ 239
+ VA+R+++ PEL + Y ++D+WS+GC+ A ++ K P F G + Q
Sbjct: 185 E----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239
Query: 240 LDIMTDLLGTPSP-EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN-----PLALRLL 293
L + +LGT + I + E R+ + + + + + N P AL L
Sbjct: 240 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 299
Query: 294 ERMLAFEPKDRPTAEEALADPYFKGLAK 321
+++L ++ + R TA EA+ PYF + K
Sbjct: 300 DKLLRYDHQSRLTAREAMEHPYFYTVVK 327
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 224 bits (571), Expect = 2e-69
Identities = 78/327 (23%), Positives = 136/327 (41%), Gaps = 43/327 (13%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y +V+G G++ V A D RT + VAIK I + EI +L ++HP+
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPN 68
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV + I +Y++ +L+ +L I T ++Q+L +KY+
Sbjct: 69 IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 143 HTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
H + HRDLKP+N+L + D K+ I DFGL+++ + + T Y APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL----STACGTPGYVAPE 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
+ Y+ A+D WSIG I LL G P F +N +
Sbjct: 180 VLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE------------------ 219
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
+ K + S + + + A + ++ +P+ R T E+AL P+ G
Sbjct: 220 ---------QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270
Query: 320 AKVEREPSAQPVTKMEFEFERRRITKE 346
+++ +++ F + + +
Sbjct: 271 TALDKNIHQSVSEQIKKNFAKSKWKQA 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 2e-69
Identities = 68/294 (23%), Positives = 121/294 (41%), Gaps = 40/294 (13%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAI+++N + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV +++VV E + + + + L+ L+++H
Sbjct: 79 IVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ V HRD+K NIL D +K+ DFG + + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 190
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
Y P +DIWS+G + E++ G+P + +N + L
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---------------------- 226
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ P Q + + L R L + + R +A+E L + K
Sbjct: 227 ------LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 2e-69
Identities = 68/295 (23%), Positives = 116/295 (39%), Gaps = 37/295 (12%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + + +G+G+YG V A + T E VA+K + D+ V I +EI + ++L H +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHEN 64
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLH-QVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ + Y+ E I+ + + Q F +QL+ G+ Y+
Sbjct: 65 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V F T Y APEL
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ +D+WS G + +L G+ + + Q
Sbjct: 179 R-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------------------- 216
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
K+ + + + L LL ++L P R T + D ++
Sbjct: 217 -------SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 221 bits (563), Expect = 2e-68
Identities = 76/345 (22%), Positives = 131/345 (37%), Gaps = 45/345 (13%)
Query: 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILRE 72
+ F + + IG GS+G V A D R E VAIKK++ + I++E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFF 131
++ L+ LRHP+ ++ + L ++V E S + L
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
+ L+GL Y+H+ N+ HRD+K NIL + +K+ DFG A + +V
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVG 173
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T ++ APE + +Y +D+WS+G EL KP N + L +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------- 226
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
+ + P S + ++ L P+DRPT+E
Sbjct: 227 -------------------AQNESPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVL 264
Query: 311 LADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE 355
L + TK E + +++++++E
Sbjct: 265 LKHRFVLRERPPTVIMDLIQRTKDAVR-ELDNLQYRKMKKILFQE 308
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 5e-68
Identities = 84/359 (23%), Positives = 146/359 (40%), Gaps = 46/359 (12%)
Query: 24 RYKI-EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRH 81
YK+ +V+G G G V ++ RT EK A+K + D + RE++ R +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQC 64
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRG 138
P IV I + K + +V E ++ +L I+ D T + +
Sbjct: 65 PHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ + T T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYY 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ G KY + D+WS+G I LL G P F + + M
Sbjct: 180 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------ 225
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ +R + + ++ + L+ +L EP R T E + P+
Sbjct: 226 -----------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274
Query: 316 FKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPT 374
KV + P ++ + ER KE++ + ++Y +K+ + S P
Sbjct: 275 IMQSTKVPQTPL-HTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPL 332
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 218 bits (556), Expect = 1e-67
Identities = 75/307 (24%), Positives = 127/307 (41%), Gaps = 49/307 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-------TRILREIKLL 76
Y+ +E++G+G VV T ++ A+K I+ A L+E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 77 RLLR-HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 195 YRAPELC----GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
Y APE+ Y +D+WS G I LL G P F + + L +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-------- 226
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
+ S ++ + + L+ R L +P+ R TAEEA
Sbjct: 227 -------------------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 311 LADPYFK 317
LA P+F+
Sbjct: 268 LAHPFFQ 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 3e-67
Identities = 70/327 (21%), Positives = 137/327 (41%), Gaps = 47/327 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y I E +G+G +G+V +T + + K + +D + +EI +L + RH +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRN 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKY 141
I+ + +++ ++FE + D+ + I + +L +++Q+ L++
Sbjct: 63 ILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 142 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+H+ N+ H D++P+NI+ +KI +FG AR + +T Y APE
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT----APEYYAPE 173
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
+ + A D+WS+G + LL+G F + ++
Sbjct: 174 VHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------------------ 213
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
++ + + F + A+ ++R+L E K R TA EAL P+ K
Sbjct: 214 ---------NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ- 263
Query: 320 AKVEREPSAQPVTKMEFEFERRRITKE 346
K+ER + T + I K+
Sbjct: 264 -KIERVSTKVIRTLKHRRYYHTLIKKD 289
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 5e-67
Identities = 66/298 (22%), Positives = 116/298 (38%), Gaps = 45/298 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
++I +GKG +G V A + ++ +A+K + E ++ RE+++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P+I+ + +R +Y++ E +++ ++ + ++ +L L
Sbjct: 66 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y H+ V HRD+KP+N+L + +LKI DFG + A + T T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-----TTLCGTLDYLPPEM 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
+ +D+WS+G + E L GKP F +
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------- 216
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
R + P A L+ R+L P RP E L P+
Sbjct: 217 ---------SRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 218 bits (555), Expect = 1e-66
Identities = 71/299 (23%), Positives = 122/299 (40%), Gaps = 44/299 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y I E +G G++GVV + TG K IN + D + EI ++ L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPK 87
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKY 141
++ + + ++ ++ E + +L I A D ++ ++ Q GLK+
Sbjct: 88 LINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 142 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+H ++ H D+KP+NI+ +KI DFGLA D AT + APE
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAPE 198
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
+ D+W+IG + LL+G F G++ + L
Sbjct: 199 IVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ------------------ 238
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
++++ F + +P A ++ +L EP+ R T +AL P+ KG
Sbjct: 239 ---------NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 217 bits (554), Expect = 2e-66
Identities = 68/311 (21%), Positives = 120/311 (38%), Gaps = 44/311 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPT 84
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI-KANDDLTPEHYQFFLYQLLRGLKY 141
+V + + ++ +++E M +L + + ++ ++ + ++ Q+ +GL +
Sbjct: 85 LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 142 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+H N H DLKP+NI+ +LK+ DFGL T + APE
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV----KVTTGTAEFAAPE 195
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
+ D+WS+G + LL+G F G+N L + A
Sbjct: 196 VA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA----- 248
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
F + + ++L +P R T +AL P+
Sbjct: 249 ----------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286
Query: 320 AKVEREPSAQP 330
R+
Sbjct: 287 NAPGRDSQIPS 297
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-66
Identities = 62/300 (20%), Positives = 105/300 (35%), Gaps = 43/300 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++I +G G++G V A + T A K I+ + + + EI +L HP+
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPN 70
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLKY 141
IV++ +++++ E + + LT Q Q L L Y
Sbjct: 71 IVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H + HRDLK NIL D +K+ DFG++ ++ T ++ APE+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVV 182
Query: 202 GSFFSK---YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
SK Y D+WS+G E+ +P N + L
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL----------------- 225
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
K P + + L++ L R T + L P+
Sbjct: 226 -----------KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 6e-66
Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 41/301 (13%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+G K + IG+GS+ V DT T +VA ++ D S+ R E ++L+ L+
Sbjct: 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
HP+IV + + K I +V ELM S L +K + + + + Q+L+GL
Sbjct: 67 HPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGL 125
Query: 140 KYIHTAN--VFHRDLKPKNIL-ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
+++HT + HRDLK NI +KI D GLA + A+ + T +
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-----IGTPEFM 180
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
APE+ + KY ++D+++ G E+ T + + Q+
Sbjct: 181 APEM---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------- 221
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
Y KP F + P ++E + +R + ++ L +F
Sbjct: 222 ---------YRRVTSGVKPASFDKVAI---PEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
Query: 317 K 317
+
Sbjct: 270 Q 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 3e-65
Identities = 78/301 (25%), Positives = 119/301 (39%), Gaps = 48/301 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y++ IG GSYG G+ + K+++ ++ ++ E+ LLR L+HP+I
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 85 VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD----LTPEHYQFFLYQLLRGL 139
V ++ + +Y+V E E DL VI L E + QL L
Sbjct: 66 VRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 140 KYIH-----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
K H V HRDLKP N+ + +K+ DFGLAR+ +DT A +V T +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVGTPY 179
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
Y +PE Y DIWS+GC+ EL P F +
Sbjct: 180 YMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------------- 224
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+R+ K ++ ++ RML + RP+ EE L +P
Sbjct: 225 --------------KIREGKFRRIPYRYS---DELNEIITRMLNLKDYHRPSVEEILENP 267
Query: 315 Y 315
Sbjct: 268 L 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 5e-63
Identities = 72/304 (23%), Positives = 124/304 (40%), Gaps = 47/304 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
V++ + +Y + +L + I+ +F+ +++ L+Y
Sbjct: 69 FFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H + HRDLKP+NIL N D ++I DFG A+V ++ A +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+ D+W++GCI +L+ G P F N +
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------ 222
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA------LADPY 315
K F +KF P A L+E++L + R EE A P+
Sbjct: 223 ----------IKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 316 FKGL 319
F+ +
Sbjct: 270 FESV 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 9e-61
Identities = 75/304 (24%), Positives = 120/304 (39%), Gaps = 47/304 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLL 79
Y E +G G + VV + TG + A K I I RE+ +L+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRG 138
+HP+++ + + D+ ++ EL+ L + + LT E FL Q+L G
Sbjct: 71 QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 139 LKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
+ Y+H+ + H DLKP+NI+ ++KI DFGLA + T
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPE 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
+ APE+ D+WSIG I LL+G F G L ++ + E
Sbjct: 182 FVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE- 238
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
F N + LA + R+L +PK R T +++L P
Sbjct: 239 --------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272
Query: 315 YFKG 318
+ K
Sbjct: 273 WIKP 276
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-60
Identities = 65/293 (22%), Positives = 109/293 (37%), Gaps = 38/293 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ + + IG GS+G V Y + VA+K +N E+ +LR RH
Sbjct: 8 GQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 140
+I+ + +V + E S L+ + + Q +G+
Sbjct: 65 NILLFMGY------STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
Y+H ++ HRDLK NI + D +KI DFGLA V + + F + + APE
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEV 177
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
+ + Y+ D+++ G + EL+TG+ + N Q+ M
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--------------- 222
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
R S+ N RL+ L + +RP + LA
Sbjct: 223 ----------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 196 bits (500), Expect = 2e-59
Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 33/293 (11%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
RY++ E++G G V A D R VA+K + D+ S R RE + L HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
IV + + Y+V E ++ L ++ +TP+ + + L +
Sbjct: 68 AIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
H + HRD+KP NI+ +A +K+ DFG+AR + + + T Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
D++S+GC+ E+LTG+P F G + V
Sbjct: 187 RG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-------------------- 224
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-TAEEALAD 313
++ PIP S + + ++ + LA P++R TA E AD
Sbjct: 225 -------QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-58
Identities = 66/306 (21%), Positives = 118/306 (38%), Gaps = 57/306 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
S+Y++ ++G G +G V S VAIK + + + + TR+ E+ LL+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 79 LR--HPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQ 134
+ ++ + P ++ E E DL I L E + F +Q
Sbjct: 64 VSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
+L +++ H V HRD+K +NIL + + +LK+ DFG + + +TD+ TR
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTR 173
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y PE + + + +WS+G + +++ G F +
Sbjct: 174 VYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------------- 216
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
+ + F Q+ L+ LA P DRPT EE
Sbjct: 217 ------------------IRGQVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQNH 255
Query: 314 PYFKGL 319
P+ + +
Sbjct: 256 PWMQDV 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-58
Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 45/300 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLL-RLLRH 81
+ + +++GKGS+G V A +T + AIK + D+ D + E ++L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P + + ++ V E + DL I++ F+ +++ GL+
Sbjct: 63 PFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
++H+ + +RDLK NIL + D +KI DFG+ + + T Y APE+
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEI 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
KY ++D WS G + E+L G+ F G++ +
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----------------- 215
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE-EALADPYFKGL 319
+ + + A LL ++ EP+ R + P F+ +
Sbjct: 216 -----------RMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-56
Identities = 65/302 (21%), Positives = 126/302 (41%), Gaps = 48/302 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPD 83
+ +++GKG++G V + TG A+K + ++ + + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+ +K+ R + V E L + T E +F+ +++ L+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ +V +RD+K +N++ + D +KI DFGL + +D T + T Y APE+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLE 178
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ Y A+D W +G + E++ G+ F ++ +++
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------- 217
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFK 317
+ I F + P A LL +L +PK R A+E + +F
Sbjct: 218 ---------LMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 318 GL 319
+
Sbjct: 266 SI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 188 bits (479), Expect = 2e-55
Identities = 68/306 (22%), Positives = 117/306 (38%), Gaps = 49/306 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLL 79
+ + +IG+G +G V TG+ A+K ++ + + + A + L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
P IV + + P + + + +LM DLH + + + +F+ +++ G
Sbjct: 65 DCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+++H V +RDLKP NIL + ++I D GLA P A T Y AP
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMAP 174
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
E+ Y + D +S+GC+ +LL G F + +I
Sbjct: 175 EVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------- 218
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALAD 313
M + F P LLE +L + R A+E
Sbjct: 219 ----------RMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265
Query: 314 PYFKGL 319
P+F+ L
Sbjct: 266 PFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 182 bits (463), Expect = 1e-53
Identities = 63/302 (20%), Positives = 117/302 (38%), Gaps = 51/302 (16%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPD 83
++I +G GS+G V G A+K + +I + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYI 142
I+ + ++ + I+++ + +E + P +F+ ++ L+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+NIL + + +KI DFG A+ + T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ Y +ID WS G + E+L G F N + + +
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFK 317
+ + P P N LL R++ + R E+ P+FK
Sbjct: 214 -------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
Query: 318 GL 319
+
Sbjct: 262 EV 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (452), Expect = 3e-52
Identities = 55/307 (17%), Positives = 99/307 (32%), Gaps = 44/307 (14%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G+RY++ IG GS+G + D GE+VAIK +H ++ E K+ ++++
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQG 61
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
+ E +V EL+ S + + + Q++ ++
Sbjct: 62 GVGIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 141 YIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVAFNDTPTAIFW----TDYVATR 193
YIH+ N HRD+KP N L + I DFGLA+ + + T
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y + + + D+ S+G + G + G +
Sbjct: 178 RYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK----------- 224
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE---EA 310
Y KK P L + D+P +
Sbjct: 225 ------------YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272
Query: 311 LADPYFK 317
+ + +
Sbjct: 273 FRNLFHR 279
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 9e-52
Identities = 62/293 (21%), Positives = 111/293 (37%), Gaps = 52/293 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
K+ + IGKG +G V G KVA+K I + + A L E ++ LRH
Sbjct: 7 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHS 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGL 139
++V++ +++ E +Y+V E M L +++ L + F + +
Sbjct: 61 NLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+Y+ N HRDL +N+L + D K+ DFGL + A + T + APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPE 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
K++ D+WS G + E+ + G+ +P + + + RV
Sbjct: 171 AL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------------KDVVPRV 213
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
K P P +++ + RP+ +
Sbjct: 214 EKGY----------KMDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-51
Identities = 58/299 (19%), Positives = 115/299 (38%), Gaps = 45/299 (15%)
Query: 28 EEVIGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++ +G G++G V Y + + VA+K + + + +L E +++ L +P IV
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ I E + +V E+ E L++ ++ N + ++ ++Q+ G+KY+
Sbjct: 72 RMIGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+N HRDL +N+L KI DFGL++ D T + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY- 184
Query: 205 FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
K++ D+WS G + E + G+ + G +
Sbjct: 185 -YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--------------------- 222
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE---ALADPYFKGL 319
+ K + + P L+ ++ ++RP L + Y+ +
Sbjct: 223 ------LEKGERMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 176 bits (447), Expect = 1e-51
Identities = 49/298 (16%), Positives = 98/298 (32%), Gaps = 43/298 (14%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G YK+ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 140
+ + +E +V +L+ L ++ + + Q+L ++
Sbjct: 60 CTGIPNVYYFG----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 141 YIHTANVFHRDLKPKNILANADC-----KLKICDFGLARVAFNDTPTAIFW----TDYVA 191
IH ++ +RD+KP N L + + DFG+ + + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
T Y + + + D+ ++G +F L G + G
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----------- 222
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
+ R+ KK+ P + + + P +
Sbjct: 223 -QKYERI-----------GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-51
Identities = 59/307 (19%), Positives = 124/307 (40%), Gaps = 44/307 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKIN--DIFEHVSDATRILREIKLLRL 78
+++ +V+G G+YG V TG+ A+K + I + E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 137
+R + + L + + ++++ + + +L + + T Q ++ +++
Sbjct: 85 IRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L+++H + +RD+K +NIL +++ + + DFGL++ F T + +
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMAP 199
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
+ G S + A+D WS+G + ELLTG F + ++ + P
Sbjct: 200 DIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP----- 253
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALA 312
P P + LA L++R+L +PK R A+E
Sbjct: 254 -----------------PYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
Query: 313 DPYFKGL 319
+F+ +
Sbjct: 292 HLFFQKI 298
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-51
Identities = 69/302 (22%), Positives = 113/302 (37%), Gaps = 30/302 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++E IGKG +G V GE+VA+K + + EI +LRH +
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHEN 58
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ + + +++V + E L + +T E GL ++
Sbjct: 59 ILGFIAADNKDNGT-WTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHL 116
Query: 143 HTA--------NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IFWTDYVATR 193
H + HRDLK KNIL + I D GLA + T T I V T+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 194 WYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
Y APE+ + + DI+++G +F E+ + G + +QL +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSD 235
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
PS E + +V E+ R IP + A + +++ R TA
Sbjct: 236 PSVEEMRKVVCEQKLR--------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
Query: 310 AL 311
Sbjct: 288 IK 289
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-51
Identities = 74/314 (23%), Positives = 116/314 (36%), Gaps = 55/314 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
++E +G+G +G V +VAIK + L+E ++++ LRH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 72
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME---SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
+V++ ++ + IY+V E M + L Q+ G+
Sbjct: 73 KLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ TA + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTAPE 184
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
++T D+WS G + EL T G+ +PG LD + P P
Sbjct: 185 AALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP------ 236
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYF 316
P L+ + EP++RPT E A + YF
Sbjct: 237 ------------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
Query: 317 KGLAKVEREPSAQP 330
EP QP
Sbjct: 273 TST-----EPQYQP 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 175 bits (445), Expect = 1e-50
Identities = 70/340 (20%), Positives = 116/340 (34%), Gaps = 47/340 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+RY + +G G + V A D VA+K + EIKLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDA 69
Query: 83 DIVE------------IKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 130
D + + H + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 131 FLYQLLRGLKYIHT-ANVFHRDLKPKNILANAD------CKLKICDFGLARVAFNDTPTA 183
QLL GL Y+H + H D+KP+N+L ++KI D G A
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 185
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV------V 237
+T+ + TR YR+PE+ + + DIWS C+ EL+TG LF
Sbjct: 186 --YTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 238 HQLDIMTDLLGTPSPEAIARVRNEK----ARRYLSSMRKKKPIPFSQKF-------PNAN 286
+ + +LLG + + + +R L ++ K K P +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 287 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 326
L ML +P+ R A + P+ K +E
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (443), Expect = 2e-50
Identities = 53/301 (17%), Positives = 110/301 (36%), Gaps = 49/301 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
++ + +G GS+G V +G A+K ++ + L E ++L+ + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ L + V+ + ++ ++ + H +F+ Q++ +Y+
Sbjct: 102 FLVK----LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+N+L + +++ DFG A+ T T APE+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP------EALAPEIIL 211
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
S Y A+D W++G + E+ G P F + + +
Sbjct: 212 S--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------- 250
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFK 317
+ K P + + LL +L + R + +F
Sbjct: 251 -------VSGKVRFP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 318 G 318
Sbjct: 299 T 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 3e-50
Identities = 66/309 (21%), Positives = 119/309 (38%), Gaps = 48/309 (15%)
Query: 24 RYKIEEV-IGKGSYGVVCSAYD--TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
I ++ +G G++G V + VAIK + E +D ++RE +++ L
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLD 67
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRG 138
+P IV + + + + + +V E+ LH+ + +++ + L+Q+ G
Sbjct: 68 NPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+KY+ N HRDL +N+L KI DFGL++ D + + AP
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
E K++ D+WS G E L+ G+ + PE +A
Sbjct: 182 ECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---------------GPEVMAF 224
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE---ALADP 314
+ K+ P P P L+ ++ +DRP +
Sbjct: 225 IEQ----------GKRMECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
Query: 315 YFKGLAKVE 323
Y+ +KVE
Sbjct: 270 YYSLASKVE 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 1e-49
Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 46/304 (15%)
Query: 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILRE 72
F + + S KIE+VIG G +G VCS + G++ VAIK + + L E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSE 77
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQF 130
++ HP+++ ++ ++ + + ++ E ME+ +D T
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVG 132
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT--PTAIFWTD 188
L + G+KY+ N HRDL +NIL N++ K+ DFGL+R +DT PT
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247
+ AP + K+T A D+WS G + E+++ G+ + ++ +
Sbjct: 193 GKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250
Query: 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA 307
P P + +L+ + RP
Sbjct: 251 RLPPPM------------------------------DCPSALHQLMLDCWQKDRNHRPKF 280
Query: 308 EEAL 311
+ +
Sbjct: 281 GQIV 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 7e-49
Identities = 59/295 (20%), Positives = 107/295 (36%), Gaps = 44/295 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAY---DTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLL 79
++ E +G GS+GVV + VA+K + D+ +RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 137
H +++ + ++ + +V EL S L ++ K + Q+
Sbjct: 69 DHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
G+ Y+ + HRDL +N+L +KI DFGL R + + + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PE + ++ A D W G E+ T G+ + G N + +
Sbjct: 183 PESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---------------QILH 225
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
++ E R P P + ++ + A +P+DRPT
Sbjct: 226 KIDKEGERL---------PRP-----EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 8e-49
Identities = 55/292 (18%), Positives = 104/292 (35%), Gaps = 46/292 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ +G G +GVV R VAIK I E + E K++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 85 VEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
V++ + + + I+++ E M L+ + + + + ++Y+
Sbjct: 62 VQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ HRDL +N L N +K+ DFGL+R +D T+ + PE+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWSPPEVLM 174
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
SK++ DIW+ G + E+ + GK + + + L P
Sbjct: 175 Y--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH-------- 224
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
A+ ++ + +RPT + L++
Sbjct: 225 ----------------------LASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-48
Identities = 66/300 (22%), Positives = 112/300 (37%), Gaps = 50/300 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
K+ E +G G +G V Y KVA+K + + L E L++ L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDL---HQVIKANDDLTPEHYQFFLYQLLRGL 139
+V + ++ + IY++ E ME+ + LT Q+ G+
Sbjct: 69 RLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+I N HRDL+ NIL + KI DFGLAR+ ++ TA + APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA--REGAKFPIKWTAPE 180
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
+ +T D+WS G + E++T G+ +PG +
Sbjct: 181 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN---------------- 222
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYF 316
+ + + P +L+ P+DRPT + + + +F
Sbjct: 223 -----------LERGYRMVRPDNCP---EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-48
Identities = 64/321 (19%), Positives = 122/321 (38%), Gaps = 69/321 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE-----KVAIKKINDIFEHVSDATRILREIKLL- 76
+ +V+G G++G V +A + +VA+K + + + S+ ++ E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMT 95
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD------------- 122
+L H +IV + IY++FE DL +++ +
Sbjct: 96 QLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 123 ----------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
LT E F YQ+ +G++++ + HRDL +N+L +KICDFGL
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLF 231
AR +D+ + + + APE F YT D+WS G + E+ + G +
Sbjct: 211 ARDIMSDS-NYVVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 291
PG V + ++ +
Sbjct: 268 PGIPVDANFYKL--------------------------IQNGFKMDQPFYAT---EEIYI 298
Query: 292 LLERMLAFEPKDRPTAEEALA 312
+++ AF+ + RP+ +
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTS 319
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (423), Expect = 3e-48
Identities = 54/290 (18%), Positives = 111/290 (38%), Gaps = 40/290 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ ++ +G G YG V + VA+K + E + L+E +++ ++HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 73
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++V++ + ++ + + L + +++ + Q+ ++Y+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYL 131
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
N HRDL +N L + +K+ DFGL+R+ DT TA + APE
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPESLA 189
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+K++ D+W+ G + E+ T G +PG ++ +++
Sbjct: 190 Y--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL------------------ 229
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
K + + P L+ + P DRP+ E
Sbjct: 230 ---------EKDYRMERPEGCP---EKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 6e-48
Identities = 65/292 (22%), Positives = 111/292 (38%), Gaps = 46/292 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S + IG G +G+V Y +KVAIK I E + E +++ L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 140
+V++ + L + I +VFE ME L ++ L + G+
Sbjct: 61 KLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+ A V HRDL +N L + +K+ DFG+ R +D T T + +PE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFPVKWASPEV 173
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
FS+Y+ D+WS G + E+ + GK + ++ ++ ++ P
Sbjct: 174 F--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR------ 225
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
A+ +++ P+DRP L
Sbjct: 226 ------------------------LASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-46
Identities = 61/319 (19%), Positives = 112/319 (35%), Gaps = 48/319 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+K +V+G G++G V GE VAIK++ + ++ IL E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMASVD 69
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
+P + + I L + + + L V + D++ ++ + Q+ +G+
Sbjct: 70 NPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+ + HRDL +N+L +KI DFGLA++ + A E
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMALES 184
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
YT D+WS G EL+T G + G I+ P P
Sbjct: 185 ILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP------- 235
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
P ++ + + RP E + +
Sbjct: 236 -----------------------PICTIDVYMIMVKCWMIDADSRPKFRELIIE-----F 267
Query: 320 AKVEREPSAQPVTKMEFEF 338
+K+ R+P V + +
Sbjct: 268 SKMARDPQRYLVIQGDERM 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-45
Identities = 60/296 (20%), Positives = 113/296 (38%), Gaps = 43/296 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRL 78
S ++VIG G +G V + K VAIK + + L E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQ 65
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLL 136
H +I+ ++ + ++K + ++ E ME + + + + + + L +
Sbjct: 66 FSHHNIIRLEGV-----ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
G+KY+ N HRDL +NIL N++ K+ DFGL+RV +D + +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
APE K+T A D+WS G + E++T + H++
Sbjct: 181 APEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------- 222
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+ ++ +P P +L+ + E RP + ++
Sbjct: 223 ----------MKAINDGFRLPTPMDCP---SAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-45
Identities = 58/296 (19%), Positives = 111/296 (37%), Gaps = 44/296 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYD---TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
EVIG+G +G V A+K +N I + + ++ L E +++
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFS 86
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ--FFLYQLLRG 138
HP+++ + I L VV M+ + N+ P F Q+ +G
Sbjct: 87 HPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRA 197
+K++ + HRDL +N + + +K+ DFGLAR + + + T + A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
E + K+T D+WS G + EL+T G P +P N
Sbjct: 203 LESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV--------------- 245
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+ + + + + P+ ++ + + + RP+ E ++
Sbjct: 246 ------------YLLQGRRLLQPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-45
Identities = 70/313 (22%), Positives = 118/313 (37%), Gaps = 52/313 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLL 79
R ++ IG+G +G V VAIK + S + L+E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQF 65
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 137
HP IV++ ++ ++++ EL + L + YQL
Sbjct: 66 DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + T + + A
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKWMA 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PE ++T A D+W G E+L G F G + + I
Sbjct: 178 PESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVK---------------NNDVIG 220
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
R+ N ++ P+P PN P L+ + A++P RP E A
Sbjct: 221 RIEN----------GERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ--- 262
Query: 317 KGLAKVEREPSAQ 329
L+ + E AQ
Sbjct: 263 --LSTILEEEKAQ 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-44
Identities = 66/315 (20%), Positives = 113/315 (35%), Gaps = 64/315 (20%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLL- 76
+R + +G G++G V A VA+K + H+++ ++ E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLS 81
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD------------- 122
L H +IV + V+ E DL ++ D
Sbjct: 82 YLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 123 -----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
L E F YQ+ +G+ ++ + N HRDL +NIL KICDFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236
ND+ + + +W + YT D+WS G EL + G +PG V
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296
+ M +++ + + P +++
Sbjct: 254 DSKFYKM--------------------------IKEGFRMLSPEHAP---AEMYDIMKTC 284
Query: 297 LAFEPKDRPTAEEAL 311
+P RPT ++ +
Sbjct: 285 WDADPLKRPTFKQIV 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-44
Identities = 61/311 (19%), Positives = 109/311 (35%), Gaps = 63/311 (20%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHVSDATRILREIKLL-RLL 79
+ K ++VIG+G++G V A + G + AIK++ + D E+++L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLG 68
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------------- 122
HP+I+ + +Y+ E +L ++ +
Sbjct: 69 HHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 123 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241
T + A E S YT D+WS G + E+++ G + G +
Sbjct: 184 ----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 301
+ P N + L+ + +P
Sbjct: 238 KLPQGYRLEKPL------------------------------NCDDEVYDLMRQCWREKP 267
Query: 302 KDRPTAEEALA 312
+RP+ + L
Sbjct: 268 YERPSFAQILV 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 3e-44
Identities = 56/320 (17%), Positives = 105/320 (32%), Gaps = 70/320 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLR 77
+ + IG+G++G V A VA+K + + RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-------------- 122
+P+IV++ + K + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGV-----CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 123 ----------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
L+ Q+ G+ Y+ HRDL +N L + +KI DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLF 231
+R ++ D + RW + + +YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 291
G + +R + + P
Sbjct: 244 YGMAHEEVIY---------------------------YVRDGNILACPENCP---LELYN 273
Query: 292 LLERMLAFEPKDRPTAEEAL 311
L+ + P DRP+
Sbjct: 274 LMRLCWSKLPADRPSFCSIH 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 9e-43
Identities = 59/317 (18%), Positives = 115/317 (36%), Gaps = 65/317 (20%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE-------KVAIKKINDIFEHVSDATRILREIKL 75
R + + +G+G++G V A + KVA+K + D + ++ E+++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71
Query: 76 L-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIK--------------- 118
+ + +H +I+ + + +YV+ E +L + ++
Sbjct: 72 MKMIGKHKNIINLLGA-----CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 119 -ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
+ L+ + YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236
+ + +W L YT D+WS G + E+ T G +PG V
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296
+ +++ + N ++
Sbjct: 244 EELFKL---------------------------LKEGHRMDKPSNCTNE---LYMMMRDC 273
Query: 297 LAFEPKDRPTAEEALAD 313
P RPT ++ + D
Sbjct: 274 WHAVPSQRPTFKQLVED 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-42
Identities = 65/312 (20%), Positives = 116/312 (37%), Gaps = 59/312 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLR 77
R K+ + +G+G++G V A T T VA+K + + H + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN---------------- 120
+ H ++V + P + V+ E + +L +++
Sbjct: 73 IGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR + D
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD- 187
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQ 239
P + D + APE YT D+WS G + E+ + +PG + +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 299
+++ + P + +
Sbjct: 246 F--------------------------CRRLKEGTRMRAPDYTT---PEMYQTMLDCWHG 276
Query: 300 EPKDRPTAEEAL 311
EP RPT E +
Sbjct: 277 EPSQRPTFSELV 288
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-41
Identities = 54/318 (16%), Positives = 107/318 (33%), Gaps = 62/318 (19%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLR 77
+ + +G+GS+G+V +VAIK +N+ + L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMK 78
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD----------LTPE 126
+V + ++ V+ ELM DL +++ +
Sbjct: 79 EFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186
++ G+ Y++ HRDL +N + D +KI DFG+ R +T
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKG 192
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTD 245
+ + +PE +T D+WS G + E+ T + + G + L
Sbjct: 193 GKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--- 247
Query: 246 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305
+ + + P + L+ + PK RP
Sbjct: 248 ------------------------VMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRP 280
Query: 306 TAEEALA------DPYFK 317
+ E ++ +P F+
Sbjct: 281 SFLEIISSIKEEMEPGFR 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (252), Expect = 2e-25
Identities = 27/203 (13%), Positives = 62/203 (30%), Gaps = 27/203 (13%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--------NDIFEHVSDATRILREIKLL 76
I +++G+G V + Y + +K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 136
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD-YVATRWY 195
+ + + H DL N+L ++ + I DF + + I D ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIG 218
Y DI S
Sbjct: 173 S---------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 560 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.34 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.81 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.01 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.82 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.42 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-61 Score=501.85 Aligned_cols=333 Identities=42% Similarity=0.781 Sum_probs=281.8
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR- 96 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~- 96 (560)
.|...++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+++|+.++|||||+++++|.....
T Consensus 13 ~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 13 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 4667899999999999999999999999999999999998766666677889999999999999999999999976542
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 97 ~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
....++|||||||+.+|..+++. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 93 ~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 93 DDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp TTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 23456899999998888888765 47999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
... .+..+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....+.++.+.+.
T Consensus 172 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 172 DSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 332 2557899999999998653 467899999999999999999999999999999999999999999999998
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchh
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 336 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 336 (560)
.........+...+.......+...++++++.+++||.+||.+||.+|||++|||+||||+.+...+.++..+ +.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~---~~~~ 321 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYDD 321 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCCC
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC---CCCC
Confidence 8888888888888887777888888899999999999999999999999999999999999987766665443 3445
Q ss_pred hHHhhcCCHHHHHHHHHHHHHhhCh
Q 008607 337 EFERRRITKEDVRELIYREILEYHP 361 (560)
Q Consensus 337 ~~e~~~~~~e~~~e~i~~ei~~~~p 361 (560)
.++....+.+++++++++|+++++|
T Consensus 322 ~~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 322 SFDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp C-----CCHHHHHHHHHHHHHTCCC
T ss_pred chhhhhcCHHHHHHHHHHHhhcCCC
Confidence 5566677899999999999999886
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-60 Score=489.89 Aligned_cols=340 Identities=48% Similarity=0.849 Sum_probs=287.3
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
.|.++++|++++.||+|+||+||+|++..+|+.||||++... .......++.+|+.+|+.++||||+++++++...+..
T Consensus 3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 378899999999999999999999999999999999999743 3445567889999999999999999999999776655
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
....+||++++++++|.+++..+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 55678899888888999999765 69999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
............+||+.|+|||++... ..|+.++||||+||++|+|++|+.||.+.+..++...+...++.+..+....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 444333344667899999999998553 5688999999999999999999999999999999999999999999888777
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchhh
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (560)
........+..........++...++.+++.+++||.+||+.||.+|||++|+|+||||+.......++..... ..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~--~~~~ 317 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP--FKFD 317 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSC--C---
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCc--cCCC
Confidence 77777777777777777777888889999999999999999999999999999999999977665555443332 3445
Q ss_pred HHhhcCCHHHHHHHHHHHHHhhChh
Q 008607 338 FERRRITKEDVRELIYREILEYHPQ 362 (560)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p~ 362 (560)
.+......+++++++++|...++|+
T Consensus 318 ~~~~~~~~~~l~~l~~~e~~~~~~~ 342 (345)
T d1pmea_ 318 MELDDLPKEKLKELIFEETARFQPG 342 (345)
T ss_dssp -----CCHHHHHHHHHHHSGGGSTT
T ss_pred hhhhhCCHHHHHHHHHHHHHhcCCC
Confidence 5667888999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=487.24 Aligned_cols=334 Identities=43% Similarity=0.825 Sum_probs=287.2
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR- 96 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~- 96 (560)
.|.+++||++++.||+|+||+||+|++..+|+.||||++.+...+.....++.+|+.+|+.++|||||++++++.....
T Consensus 13 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred cccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 3567889999999999999999999999999999999998766666777889999999999999999999999875543
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 97 ~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
++...+|+++++++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred ccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence 33345666766666899998854 47999999999999999999999999999999999999999999999999999654
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......|.+..+.+..+...
T Consensus 172 ~~------~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 172 DD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp TG------GGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred Cc------ccccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 22 23557899999999987652 457899999999999999999999999999999999999999999998887
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCCCCCCCCcchh
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 336 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 336 (560)
.........+...+.......+...+.++++.++|||++||++||.+|||++|+|+||||+++.....++...+ ...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~---~~~ 321 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQ 321 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCC---CCC
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCC---CCC
Confidence 77777777777777776667777777889999999999999999999999999999999999887776665544 356
Q ss_pred hHHhhcCCHHHHHHHHHHHHHhhChh
Q 008607 337 EFERRRITKEDVRELIYREILEYHPQ 362 (560)
Q Consensus 337 ~~e~~~~~~e~~~e~i~~ei~~~~p~ 362 (560)
.++....+.+++++++++|+.++.|.
T Consensus 322 ~~~~~~~~~~~~k~~~~~e~~~~~p~ 347 (348)
T d2gfsa1 322 SFESRDLLIDEWKSLTYDEVISFVPP 347 (348)
T ss_dssp GGGGCCCCHHHHHHHHHHHHHTCCCC
T ss_pred cccchhcCHHHHHHHHHHHhhccCCC
Confidence 67788999999999999999998773
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-58 Score=460.03 Aligned_cols=253 Identities=25% Similarity=0.443 Sum_probs=219.2
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.++|||||++++++... ..
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CE
Confidence 46999999999999999999999999999999986422 2223456788999999999999999999999543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999998 5999999988899999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 161 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-------------- 219 (263)
T d2j4za1 161 -----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------- 219 (263)
T ss_dssp -----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------------
T ss_pred -----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Confidence 245689999999999987 57999999999999999999999999988876665544321
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
. .. ....+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 220 -------------~-~~---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -------------E-FT---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------C-CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------C-CC---CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 0 01 12357899999999999999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=464.09 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=214.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+|+++|+.++|||||++++++... +.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~ 78 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 78 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----cee
Confidence 469999999999999999999999999999999975321 22345688999999999999999999999543 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|||||||+| +|.+++..++.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999984 9999998888899999999999999999999999999999999999999999999999999987543322
Q ss_pred CcccccccccCcccccccccccccCC-CCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~-y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
....+..+||+.|+|||++.+ .. ++.++|||||||++|||++|++||.+.+...+......
T Consensus 159 -~~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~--------------- 220 (271)
T d1nvra_ 159 -ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--------------- 220 (271)
T ss_dssp -ECCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH---------------
T ss_pred -cccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh---------------
Confidence 122356789999999999976 34 46789999999999999999999987664433221111
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
. .......+..+++.+.+||++||+.||++|||++|+|+||||+.
T Consensus 221 -----------~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 221 -----------E--KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp -----------T--TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -----------c--CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0 01112223567899999999999999999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=474.53 Aligned_cols=329 Identities=37% Similarity=0.689 Sum_probs=257.1
Q ss_pred CCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 008607 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-RE 98 (560)
Q Consensus 20 ~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~~ 98 (560)
.+-++|+++++||+|+||+||+|+|+.+|+.||||++.....+.....++.+|+.+|+.++||||++++++|..... +.
T Consensus 14 ~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 34478999999999999999999999999999999998766666677889999999999999999999999975533 34
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..++|+|||||.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 57899999999998888774 4699999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. ..+..++|+.|+|||++.+ ..+++++||||+||++|+|++|++||.+.+...++..+...++.+.++.+...
T Consensus 172 ~~----~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 172 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp -------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cc----ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 22 2356789999999999987 68999999999999999999999999999999999999999999988877665
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccccCCCC
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKF------------PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 326 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~------------~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~~~~~ 326 (560)
.. ....+...........+...+ ...++.+++||++||.+||++||||+|||+||||+.........
T Consensus 246 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~ 324 (355)
T d2b1pa1 246 QP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE 324 (355)
T ss_dssp CH-HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHT
T ss_pred hh-hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCccccc
Confidence 43 234444433322222211111 12356799999999999999999999999999999765433332
Q ss_pred CCCCCCcchhhHHhhcCCHHHHHHHHHHHHHh
Q 008607 327 SAQPVTKMEFEFERRRITKEDVRELIYREILE 358 (560)
Q Consensus 327 ~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~ 358 (560)
...+ ...+.+.+++..+.++++++|++|+++
T Consensus 325 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (355)
T d2b1pa1 325 APPP-QIYDKQLDEREHTIEEWKELIYKEVMN 355 (355)
T ss_dssp CCCC--------CCCCCCHHHHHHHHHHHHHC
T ss_pred CCCC-CCCCcchhhhhcCHHHHHHHHHHHhcC
Confidence 2222 233456677888999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=463.15 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=219.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+|+.++|||||++++++... ..
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CE
Confidence 358999999999999999999999999999999987532 23456789999999999999999999999543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|||||||+ |+|.+++..+ .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999998 5899887664 69999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+....
T Consensus 171 ~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~------------- 232 (293)
T d1yhwa1 171 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG------------- 232 (293)
T ss_dssp C---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-------------
T ss_pred c---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 2 2356789999999999987 679999999999999999999999999888766655443210
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
.. .....+.+++.+++||.+||+.||.+|||++|+|+||||+.
T Consensus 233 ------------~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 233 ------------TP---ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ------------SC---CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------------CC---CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 00 11223467899999999999999999999999999999973
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-57 Score=453.79 Aligned_cols=256 Identities=27% Similarity=0.385 Sum_probs=215.2
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~l 104 (560)
|++.++||+|+||+||+|++..++..||+|++............+.+|+++|+.++|||||++++++.... .....+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 48889999999999999999999999999999865556666778999999999999999999999985432 23356899
Q ss_pred EEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeeeC-CCCcEEEecccccccccCCC
Q 008607 105 VFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 105 V~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~g--IiHrDLKP~NILl~-~~~~lKL~DFGla~~~~~~~ 180 (560)
|||||+ |+|.+++.+...++++.++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 999998 599999999889999999999999999999999999 99999999999997 4789999999999864322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+......+...... +
T Consensus 169 ----~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~------------ 228 (270)
T d1t4ha_ 169 ----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G------------ 228 (270)
T ss_dssp ----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T------------
T ss_pred ----ccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-C------------
Confidence 2245789999999999865 6899999999999999999999999876544433211110 0
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~ 317 (560)
..+ .......++.+.+||++||+.||++|||++|+|+||||+
T Consensus 229 ------------~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 229 ------------VKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ------------CCC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ------------CCC---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 011 111235688999999999999999999999999999996
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=467.25 Aligned_cols=283 Identities=36% Similarity=0.582 Sum_probs=227.8
Q ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChh---HHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008607 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS---DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (560)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~---~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i~ 103 (560)
.+++||+|+||+||+|+++.+|+.||||+++....... ....+.+|+.+|+.++|||||++++++... ..+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Ccee
Confidence 57899999999999999999999999999974322211 134688999999999999999999999544 4689
Q ss_pred EEEecCCccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCCC
Q 008607 104 VVFELMESDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (560)
Q Consensus 104 lV~E~~~gdL~~~i~-~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (560)
||||||.+++...+. .+..+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 999999976555554 455799999999999999999999999999999999999999999999999999976543322
Q ss_pred cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhHH
Q 008607 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (560)
Q Consensus 183 ~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 262 (560)
.....+||++|+|||++... ..|+.++|||||||++|||++|++||.+.+..+++..|.+.+|+|..+.+.......
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred --cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 22457899999999998652 568999999999999999999999999999999999999999998876443221110
Q ss_pred HHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
. ...+......++...++.+++.+++||++||++||++|||++|+|+||||++...
T Consensus 233 ~---~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 233 D---YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp T---CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred h---hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 0 0011111223334455678999999999999999999999999999999986543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-57 Score=463.03 Aligned_cols=260 Identities=29% Similarity=0.464 Sum_probs=206.7
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
+.++|++.+.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++|||||++++++... .
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 80 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESG-----G 80 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence 346799999999999999999999999999999999753322 2335678999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC---CCCcEEEecccccccc
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVA 176 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~---~~~~lKL~DFGla~~~ 176 (560)
.+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+..
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 6999999998 69999999988999999999999999999999999999999999999995 5789999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
.... .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+.......|...
T Consensus 161 ~~~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~---------- 224 (307)
T d1a06a_ 161 DPGS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------- 224 (307)
T ss_dssp ----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT----------
T ss_pred cCCC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc----------
Confidence 4332 2245789999999999987 67999999999999999999999999988876655544321
Q ss_pred HhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
........++++++.+.+||++||++||.+|||++|+|+||||++.
T Consensus 225 -----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 225 -----------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -----------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -----------------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1111223446789999999999999999999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=454.04 Aligned_cols=256 Identities=30% Similarity=0.478 Sum_probs=208.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.|++++.||+|+||+||+|+++.+|+.||||++............+.+|+++|+.++|||||++++++.... ...+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCEE
Confidence 4699999999999999999999999999999999876556666778999999999999999999999986432 2468
Q ss_pred EEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCCCCeeeCCCCcEEEecccc
Q 008607 103 YVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGL 172 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~Qll~aL~yLHs~g-----IiHrDLKP~NILl~~~~~lKL~DFGl 172 (560)
|||||||+ |+|.+++.+ +..+++..++.|+.||+.||+|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 99999998 599998864 457999999999999999999999976 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 008607 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (560)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (560)
|+....... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..|...
T Consensus 161 a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~------ 229 (269)
T d2java1 161 ARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG------ 229 (269)
T ss_dssp HHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT------
T ss_pred eeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC------
Confidence 987643322 2356789999999999976 67999999999999999999999999988766554444321
Q ss_pred HHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008607 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (560)
Q Consensus 253 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f 316 (560)
. +......+++.+.+||++||+.||.+|||++|+|+|||+
T Consensus 230 ---------------------~---~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 230 ---------------------K---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ---------------------C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------------------C---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0 111224678999999999999999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-58 Score=469.60 Aligned_cols=283 Identities=22% Similarity=0.363 Sum_probs=218.6
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++++.||+|+||+||+|+++.+|+.||+|+++... ......++.+|+.+|+.++|||||+++++|... ..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 467999999999999999999999999999999997543 334557889999999999999999999999654 46
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|||||||+| +|.+++.+++.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999995 999999988899999999999999999999997 59999999999999999999999999999865432
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhh-HHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~-~~~~i~~~~g~p~~~~~~~~ 258 (560)
. .++.+||++|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+... +...+....|.+........
T Consensus 159 ~-----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 159 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp T-----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred c-----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 2 245799999999999987 689999999999999999999999998866443 22223333333221110000
Q ss_pred h--------------hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 259 R--------------NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 259 ~--------------~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
. .......+.......+.... ....++++.|||++||++||.+|||++|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0 00011111222222111111 12468899999999999999999999999999999853
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-57 Score=456.03 Aligned_cols=265 Identities=28% Similarity=0.447 Sum_probs=225.6
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc----ChhHHHHHHHHHHHHHhcCCCCccccceeec
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE----HVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~----~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~ 92 (560)
..-.+.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||++++++.
T Consensus 4 ~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (293)
T d1jksa_ 4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83 (293)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 334566789999999999999999999999999999999964322 1223577899999999999999999999995
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC----cEEE
Q 008607 93 PPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKI 167 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~----~lKL 167 (560)
.. ..+|||||||+ |+|.+++..++.+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||
T Consensus 84 ~~-----~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 84 NK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp CS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred EC-----CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEe
Confidence 43 46999999998 59999999888999999999999999999999999999999999999999876 4999
Q ss_pred ecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhc
Q 008607 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (560)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~ 247 (560)
+|||+|+...... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..|...-
T Consensus 159 ~DfG~a~~~~~~~----~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 159 IDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232 (293)
T ss_dssp CCCTTCEECTTSC----BCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred cchhhhhhcCCCc----cccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence 9999998754332 2245689999999999987 578999999999999999999999999988777766655432
Q ss_pred CCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 248 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..... ..++++++.+.+||++||+.||.+|||++|+|+||||+..
T Consensus 233 ~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 233 YEFED---------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp CCCCH---------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCCc---------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 22211 1224678999999999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=460.10 Aligned_cols=259 Identities=26% Similarity=0.464 Sum_probs=218.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.++||||+++++++... ..
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----EK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-----SE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-----CE
Confidence 56999999999999999999999999999999996422 1223456789999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|||||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999998 5999999998899999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 163 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-------------- 225 (288)
T d1uu3a_ 163 KQ-ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------------- 225 (288)
T ss_dssp --------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--------------
T ss_pred cc-cccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 21 22355789999999999977 67999999999999999999999999998876665544321
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE------ALADPYFKGLA 320 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~e------lL~hp~f~~~~ 320 (560)
... ....+++.+++||++||+.||.+|||++| +++||||+++.
T Consensus 226 --------------~~~---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 226 --------------EYD---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp --------------CCC---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred --------------CCC---CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 011 12367899999999999999999999988 58899998763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-57 Score=459.17 Aligned_cols=290 Identities=34% Similarity=0.607 Sum_probs=236.8
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCC-CcEEEEEEecCcccChhHHHHHHHHHHHHHhc---CCCCccccceeecCCCcC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-GEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~t-g~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l---~HpnIv~l~~i~~~~~~~ 97 (560)
.++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999766 56799999975444433344566788887766 799999999998655444
Q ss_pred CCccEEEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
....+|++||||++++..+... ...++++.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 5567999999999876555443 34699999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..|...++.|....+
T Consensus 166 ~~~~----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hccc----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 4322 23356789999999999977 68999999999999999999999999999999999999999998876544
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~ 321 (560)
....... -..+......+.......+++.+++||++||++||.+|||++|+|+||||+++..
T Consensus 240 ~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSC----GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccch----hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 3211100 0111223333444556788999999999999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=462.71 Aligned_cols=256 Identities=24% Similarity=0.439 Sum_probs=221.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++... ..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----SE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-----cc
Confidence 46999999999999999999999999999999997532 1223457788999999999999999999999543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+|||||+ |+|.+++...+.++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999998 5999999998899999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+...
T Consensus 160 ~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-------------- 220 (337)
T d1o6la_ 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------- 220 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred c---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--------------
Confidence 2 2356799999999999987 68999999999999999999999999998876655444321
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
.. .....+++.+++||++||++||.+|+ +++|+++||||+++
T Consensus 221 --------------~~---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 221 --------------EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp --------------CC---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred --------------CC---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 11 11246799999999999999999999 49999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-56 Score=466.26 Aligned_cols=261 Identities=25% Similarity=0.405 Sum_probs=223.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
-++|++++.||+|+||+||+|+++.+|+.||||++... .......+.+|+.+|+.++|||||++++++... ..
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~ 97 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NE 97 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 35799999999999999999999999999999999753 345567889999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC--CCcEEEeccccccccc
Q 008607 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAF 177 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~--~~~lKL~DFGla~~~~ 177 (560)
+|||||||+ |+|.+++.. .+.+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999998 599999854 457999999999999999999999999999999999999964 5789999999998754
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|......+
T Consensus 178 ~~~----~~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------- 244 (350)
T d1koaa2 178 PKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM------- 244 (350)
T ss_dssp TTS----CEEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-------
T ss_pred ccc----ccceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence 332 2356789999999999977 678999999999999999999999999988777766654422111
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
....++.+++.+++||++||+.||.+|||++|+|+||||+.....
T Consensus 245 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 245 --------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp --------------------CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred --------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 122335678999999999999999999999999999999876443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-57 Score=459.09 Aligned_cols=289 Identities=38% Similarity=0.638 Sum_probs=234.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++++.||+|+||+||+|++..+|+.||||+++..........++.+|+++|+.++|||||++++++... ..+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence 479999999999999999999999999999999975443334457889999999999999999999999543 469
Q ss_pred EEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 103 YVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
|+|||||++++..++.. ...+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999887777654 3469999999999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
......+||+.|+|||++... ..++.++|||||||++|+|++|+.||.+.+..+++..+....+.|....+.....
T Consensus 157 ---~~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 ---RTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp ---BCTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---ccceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 223557899999999988652 4468899999999999999999999999999999999998888877654433211
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
. ..+...........+...++.+++.+.+||++||++||.+|||++|+|+||||+++.++
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 M--PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp S--TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred c--cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 1 01111111122222333456789999999999999999999999999999999977543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-57 Score=455.92 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=217.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
+.|++++.||+|+||+||+|+++.+|+.||||++... .......+.+|+++|+.++|||||++++++... ..+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeE
Confidence 3599999999999999999999999999999999753 334556788999999999999999999998543 469
Q ss_pred EEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 103 YVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
|||||||+ |+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999998 589998765 4579999999999999999999999999999999999999999999999999997542211
Q ss_pred CCcccccccccCcccccccccccc---cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
......+||+.|+|||++... ...|+.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 165 ---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~----------- 230 (288)
T d2jfla1 165 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS----------- 230 (288)
T ss_dssp ---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-----------
T ss_pred ---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 122457899999999998421 246899999999999999999999999988877665544321
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
.+ +.......+++.+.+||++||+.||.+|||++|+|+||||+.
T Consensus 231 ----------------~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 231 ----------------EP-PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ----------------CC-CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ----------------CC-CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00 111223467899999999999999999999999999999973
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.7e-56 Score=464.10 Aligned_cols=258 Identities=28% Similarity=0.434 Sum_probs=223.0
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
-++|++++.||+|+||+||+|+++.+|+.||||+++.. ...+...+.+|+.+|+.|+|||||+++++|... ..
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~ 100 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YE 100 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 35799999999999999999999999999999999753 334556788999999999999999999999543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeC--CCCcEEEeccccccccc
Q 008607 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCKLKICDFGLARVAF 177 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~--~~~~lKL~DFGla~~~~ 177 (560)
+|||||||+ |+|.+.+...+ .+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999998 59998876654 699999999999999999999999999999999999998 57899999999998764
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.....
T Consensus 181 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--------- 245 (352)
T d1koba_ 181 PDE----IVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW--------- 245 (352)
T ss_dssp TTS----CEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC---------
T ss_pred CCC----ceeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 432 2355789999999999987 6799999999999999999999999999887777665543211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
......++.+++.+.+||++||++||.+|||++|+|+||||++.
T Consensus 246 ------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 246 ------------------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ------------------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ------------------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11223456789999999999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-55 Score=453.12 Aligned_cols=253 Identities=25% Similarity=0.448 Sum_probs=220.5
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||++++++... ..
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-----Ce
Confidence 46999999999999999999999999999999997432 2233457788999999999999999999999543 46
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+|||||+| +|..++.....++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 9999999985 899999999899999999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|...
T Consensus 159 ------~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 216 (316)
T d1fota_ 159 ------YTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 216 (316)
T ss_dssp ------CCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred ------ccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 45789999999999977 57999999999999999999999999998876665544321
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
.. ...+.+++.+.+||++||.+||.+|+ |++|+|+||||+++
T Consensus 217 ------------~~-----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 217 ------------EL-----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp ------------CC-----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ------------CC-----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 00 11246789999999999999999996 99999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.1e-56 Score=452.59 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=216.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC-hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.+|++++.||+|+||+||+|++..+|+.||||++...... ......+.+|+++|+.++|||||++++++... ..
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CE
Confidence 4699999999999999999999999999999999754332 33446789999999999999999999998543 46
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|||||||.+ +|..++..++.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999996 5666667777899999999999999999999999999999999999999999999999999976432
Q ss_pred CCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
....+||+.|+|||++.+. ...|+.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~------------- 229 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------- 229 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------------
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-------------
Confidence 1346899999999998642 246899999999999999999999999988766655444321
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
..+. .....+++.+.+||++||+.||.+|||++|+|+||||..
T Consensus 230 -------------~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 230 -------------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------------CCCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------CCCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 1111 112457899999999999999999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.3e-56 Score=448.55 Aligned_cols=284 Identities=38% Similarity=0.660 Sum_probs=234.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|+++++||+|+||+||+|+++ +|+.||||+++..........++.+|+.+|+.++||||+++++++... ..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence 58999999999999999999985 789999999976544444467889999999999999999999999654 468
Q ss_pred EEEEecCCccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~gdL~~~i~-~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
|+|||++.+++...+. ..+.+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9999999986655554 466799999999999999999999999999999999999999999999999999987543222
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhhH
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 261 (560)
.....++++.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+++..+...+|.|....+......
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 22456799999999998653 56799999999999999999999999999999999999999998876654332211
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
..+........+.++....+.+++.+.|||++||++||++|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1111222333445556667889999999999999999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-55 Score=459.21 Aligned_cols=253 Identities=21% Similarity=0.386 Sum_probs=220.3
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.++|||||++++++... ..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----cc
Confidence 57999999999999999999999999999999986422 2233456788999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCC
Q 008607 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (560)
+|+||||+. |+|..++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 899999998 5899999988899999999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..|...
T Consensus 196 ------~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 253 (350)
T d1rdqe_ 196 ------WTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-------------- 253 (350)
T ss_dssp ------CCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred ------ccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--------------
Confidence 45689999999999987 67999999999999999999999999998876665554331
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~ 319 (560)
. ......+++.+.+||++||++||.+|+ |++|||+||||++.
T Consensus 254 -------------~----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 254 -------------K----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp -------------C----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred -------------C----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 0 011246789999999999999999995 99999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.1e-55 Score=440.58 Aligned_cols=261 Identities=28% Similarity=0.441 Sum_probs=221.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh-------hHHHHHHHHHHHHHhcC-CCCccccceeecC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-------SDATRILREIKLLRLLR-HPDIVEIKHILLP 93 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-------~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~ 93 (560)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+..... ....++.+|+.+|+.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 357999999999999999999999999999999997532211 12346889999999997 9999999999954
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccc
Q 008607 94 PSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGl 172 (560)
. ..+|||||||+ |+|.++|+.++.++++.++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 82 ~-----~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 N-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp S-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred C-----cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 3 47999999998 59999999988999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccc----cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcC
Q 008607 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g 248 (560)
++...... ..+..+||+.|+|||++.+. ...++.++||||+||++|+|++|+.||.+.+..+.+..|...
T Consensus 157 a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~-- 230 (277)
T d1phka_ 157 SCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-- 230 (277)
T ss_dssp CEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--
T ss_pred eeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--
Confidence 98754332 22557899999999998531 235788999999999999999999999998876665554431
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
........++++|+.+++||.+||+.||.+|||++|+|+||||++
T Consensus 231 -------------------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 231 -------------------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -------------------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -------------------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 111112234578999999999999999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=456.12 Aligned_cols=286 Identities=36% Similarity=0.612 Sum_probs=233.4
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~-~~~~~ 101 (560)
-+|+.+++||+|+||+||+|++..+|+.||||++..... .+.+|+.+|+.++||||++++++|..... .+..+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 379999999999999999999999999999999975321 12379999999999999999999865432 34457
Q ss_pred EEEEEecCCccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC-cEEEecccccccc
Q 008607 102 IYVVFELMESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVA 176 (560)
Q Consensus 102 i~lV~E~~~gdL~~~i----~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~-~lKL~DFGla~~~ 176 (560)
+|||||||++++...+ .....+++..++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999998765554 3455799999999999999999999999999999999999999875 8999999999875
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~ 256 (560)
..... ....+||+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+++..|.+.+|.|..+.+.
T Consensus 174 ~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTTSC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cCCcc----cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 43322 2457899999999988652 578999999999999999999999999999999999999999999988776
Q ss_pred HhhhHHHHHHHHhhccCCCCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccccc
Q 008607 257 RVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (560)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~~~ 322 (560)
.......... +......++ ....+..++.+.+||.+||++||.+|||++|+|+||||+++...
T Consensus 249 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 249 EMNPNYTEFK---FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HHCC---CCC---CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hhccchhhcc---ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 5433211100 011111111 12345689999999999999999999999999999999987654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-55 Score=447.27 Aligned_cols=255 Identities=25% Similarity=0.438 Sum_probs=219.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+...+.+|+++|+.++|||||++++++... ..+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~ 76 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM-----EEL 76 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEE
Confidence 5799999999999999999999999999999999752 23445688999999999999999999999543 469
Q ss_pred EEEEecCCc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC--CcEEEecccccccccC
Q 008607 103 YVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFN 178 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~--~~lKL~DFGla~~~~~ 178 (560)
|||||||+| +|.++|...+ .+++++++.|+.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999985 9999998765 79999999999999999999999999999999999999854 5899999999987533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. .....++|+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|...-..+..
T Consensus 157 ~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~------ 224 (321)
T d1tkia_ 157 GD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE------ 224 (321)
T ss_dssp TC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH------
T ss_pred CC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh------
Confidence 22 2345689999999999977 57899999999999999999999999999887776666543222221
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
..++.+++.+++||++||+.||.+|||++|+|+||||++
T Consensus 225 ---------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 225 ---------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ---------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ---------------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 223567899999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-54 Score=452.82 Aligned_cols=259 Identities=26% Similarity=0.392 Sum_probs=213.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHH---HHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRIL---REIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~---rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
+.|+++++||+|+||.||+|+++.+|+.||||++.+... .......+. +|+.+++.++|||||++++++...
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~---- 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---- 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS----
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC----
Confidence 569999999999999999999999999999999864211 111122233 456777777899999999998543
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~ 177 (560)
..+|||||||+ |+|.+++.....+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 80 -~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 80 -DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred -CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 46999999998 5999999998899999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
... ....+||+.|+|||++... ..|+.++|||||||+||||++|+.||.+.+..+....+....
T Consensus 159 ~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~---------- 222 (364)
T d1omwa3 159 KKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---------- 222 (364)
T ss_dssp SSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS----------
T ss_pred CCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------
Confidence 332 2456899999999998642 468999999999999999999999998866544332221111
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpt-----a~elL~hp~f~~~~ 320 (560)
..+ ......+++.+.+||.+||++||.+||| ++|+|+||||+++.
T Consensus 223 ---------------~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 223 ---------------TMA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp ---------------SCC---CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred ---------------cCC---CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 111 1223468999999999999999999999 89999999999753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-55 Score=447.59 Aligned_cols=296 Identities=34% Similarity=0.561 Sum_probs=229.3
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc---C
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR---R 97 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~---~ 97 (560)
.-++|++++.||+|+||+||+|++..+|+.||||++...........++.+|+++|+.++||||+++++++..... .
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 3479999999999999999999999999999999987654455556778899999999999999999999865432 2
Q ss_pred CCccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 98 EFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 98 ~~~~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
....+|+|||||++++...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 2346899999999876665544 457999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCC-CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~-~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
..... ........+||++|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+.+..+.+.++.+..+..
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 32221 11223456899999999998653 57899999999999999999999999999999999999999998877654
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
...........+...... .......+ ...++.++|||.+||++||++|||++|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTCCCC-------CCSSC-CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cccchhhhhhhhcccccc-cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 433322222111111100 00000000 123678999999999999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=444.38 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=218.0
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcc-cChhHHHHHHHHHHHHH-hcCCCCccccceeecCCCcCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLR-LLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~rEi~iL~-~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
+.|++++.||+|+||+||+|.++.+|+.||||++++.. ........+.+|..++. .++|||||++++++... .
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----E 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----S
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----C
Confidence 46999999999999999999999999999999996421 12233456677777764 78999999999999544 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|||||||+ |+|.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 6999999998 599999999889999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
. ...+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|.. +
T Consensus 157 ~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~----------- 218 (320)
T d1xjda_ 157 D---AKTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--D----------- 218 (320)
T ss_dssp T---CCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--C-----------
T ss_pred c---ccccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--C-----------
Confidence 2 22355789999999999987 6899999999999999999999999999887665554432 1
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCcccccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE-EALADPYFKGL 319 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~-elL~hp~f~~~ 319 (560)
.+ .....+++.+.+||++||+.||.+|||++ |+++||||+++
T Consensus 219 --------------~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 219 --------------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp --------------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred --------------CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 11 11235789999999999999999999995 89999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-54 Score=432.74 Aligned_cols=287 Identities=37% Similarity=0.590 Sum_probs=235.7
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|+++++||+|+||+||+|++..+|+.||||+++..........++.+|+.+|+.++||||+++++++... ..+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence 589999999999999999999999999999999976555556678899999999999999999999999554 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCCCC
Q 008607 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (560)
Q Consensus 103 ~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (560)
++|++++.+ +|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999996 6777777788899999999999999999999999999999999999999999999999999987543322
Q ss_pred CcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCC-CCCCChhhHHHHHHHhcCCCCHHHHHHhhh
Q 008607 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (560)
Q Consensus 182 ~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 260 (560)
......+++.|+|||++.+. ..++.++|||||||++|||++|+.| |.+.+..+++..+....+.+....+.....
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 22445788999999998763 4578999999999999999999976 677888888888988888876543322211
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.. .+...-............+.+++.+.+||++||+.||.+||||+|+|+||||+++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cc--cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 00 00000000111233445567899999999999999999999999999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=433.75 Aligned_cols=251 Identities=25% Similarity=0.441 Sum_probs=209.0
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccCh----hHHHHHHHHHHHHHhcC--CCCccccceeecCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLR--HPDIVEIKHILLPP 94 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~----~~~~~i~rEi~iL~~l~--HpnIv~l~~i~~~~ 94 (560)
..++|++.++||+|+||+||+|++..+|+.||||++.+..... ....++.+|+.+|+.++ |||||++++++...
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 3578999999999999999999999999999999987432111 12234678999999997 89999999998543
Q ss_pred CcCCCccEEEEEecCCc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC-CcEEEeccc
Q 008607 95 SRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFG 171 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~g--dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~-~~lKL~DFG 171 (560)
..+|+||||+.+ ++.+++..+..++++.++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 82 -----~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 82 -----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp -----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred -----CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccc
Confidence 468999999974 888999888899999999999999999999999999999999999999855 799999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
+|+..... ..+..+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +..
T Consensus 157 ~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~------ 218 (273)
T d1xwsa_ 157 SGALLKDT-----VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------ 218 (273)
T ss_dssp TCEECCSS-----CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH------
T ss_pred cceecccc-----cccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hhh------
Confidence 99864332 23567899999999998652 3346789999999999999999999975321 110
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
.. . .....+++++.+||++||++||.+|||++|+|+||||+++
T Consensus 219 --------------------~~--~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 219 --------------------GQ--V---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp --------------------CC--C---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --------------------cc--c---CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 00 0 1124678999999999999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-53 Score=439.73 Aligned_cols=287 Identities=30% Similarity=0.564 Sum_probs=225.4
Q ss_pred ccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 008607 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR 96 (560)
Q Consensus 18 ~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~ 96 (560)
+|++.++|+++++||+|+||+||+|+++.+|+.||||+++. ....++.+|+.+|+.++ ||||+++++++...
T Consensus 30 ~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~-- 102 (328)
T d3bqca1 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDP-- 102 (328)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT--
T ss_pred CCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEec--
Confidence 46788899999999999999999999999999999999864 23567889999999996 99999999998543
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCC-cEEEecccccc
Q 008607 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLAR 174 (560)
Q Consensus 97 ~~~~~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~-~lKL~DFGla~ 174 (560)
....+|+|||||++ +|..+ .+.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 103 -~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 103 -VSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp -TTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred -CCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 22468999999995 77654 34699999999999999999999999999999999999998755 69999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCC-CChhhHHHHHHHhcCCCCHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~-~~~~~~~~~i~~~~g~p~~~ 253 (560)
....... ....++|+.|+|||++.+. ..|+.++|||||||++|+|++|+.||.. .+..++...+...+|.|...
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 179 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred eccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 7544332 2557899999999998763 4689999999999999999999999865 45666777788877765443
Q ss_pred HHHHhhhHHH-HHHHHhhccCCCCCC-----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccccc
Q 008607 254 AIARVRNEKA-RRYLSSMRKKKPIPF-----SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 254 ~~~~~~~~~~-~~~l~~~~~~~~~~~-----~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~~ 320 (560)
.......... ..+...........+ ......++++++|||++||++||.+|||++|||+||||+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 3221111000 001011111111111 112234789999999999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-53 Score=428.93 Aligned_cols=265 Identities=26% Similarity=0.397 Sum_probs=213.1
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... +.....++.+|+.+|+.++||||+++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 5789999999999999999999999999999999975433 3445567899999999999999999999986533 2234
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 101 ~i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
.+|||||||+| +|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 58999999995 89999999889999999999999999999999999999999999999999999999999998765444
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHhh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 259 (560)
..........+||+.|+|||++.+ ..|+.++|||||||++|+|+||++||.+.+..+.+..+..
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~-------------- 228 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-------------- 228 (277)
T ss_dssp --------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------------
T ss_pred cccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh--------------
Confidence 433334466789999999999976 5799999999999999999999999998886655443322
Q ss_pred hHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHhcCcccc
Q 008607 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-TAEEALADPYFK 317 (560)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-ta~elL~hp~f~ 317 (560)
..+.+.....+++++.+.+||++||++||.+|| |++++ .|+|++
T Consensus 229 -------------~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 229 -------------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp -------------CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred -------------cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 222233344567899999999999999999999 55555 466653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=445.16 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=208.2
Q ss_pred CceEEEE-EEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHH-hcCCCCccccceeecCCCcCCCc
Q 008607 23 SRYKIEE-VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR-LLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 23 ~~Y~i~~-~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~-~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
++|++++ +||+|+||+||+|++..+|+.||||++++ ...+.+|+.++. .++|||||+++++|.+.. ....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~ 82 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRK 82 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCC
Confidence 4698875 69999999999999999999999999863 235678999865 558999999999985421 2235
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC---CCcEEEecccccc
Q 008607 101 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLAR 174 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~---~~~lKL~DFGla~ 174 (560)
.+|||||||+ |+|.++|...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 6899999998 59999998753 6999999999999999999999999999999999999986 4679999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
....... ....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+.......+.....
T Consensus 163 ~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~------ 230 (335)
T d2ozaa1 163 ETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR------ 230 (335)
T ss_dssp ECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC------
T ss_pred eccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh------
Confidence 7544332 255789999999999987 5799999999999999999999999988775544333322110
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~~ 319 (560)
..........+..+++.+.+||++||+.||.+|||++|+|+||||.+.
T Consensus 231 -----------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 231 -----------------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp -----------------SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred -----------------cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 000000011223578999999999999999999999999999999753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=420.07 Aligned_cols=257 Identities=22% Similarity=0.349 Sum_probs=207.4
Q ss_pred CceEEE-EEEeecCCeEEEEEEEC--CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 23 SRYKIE-EVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 23 ~~Y~i~-~~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
+.+.+. ++||+|+||+||+|.+. .+++.||||+++....+.....++.+|+++|+.++|||||++++++...
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~----- 80 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE----- 80 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-----
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-----
Confidence 345554 46999999999999764 4567899999976545555567899999999999999999999988432
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
..|||||||+ |+|.+++.....+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 81 -~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 81 -SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp -SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred -CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 4799999998 59999999988999999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
............||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+....+..
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~------------ 225 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------------ 225 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------------
T ss_pred cccccccccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc------------
Confidence 4333333345679999999999976 578999999999999999998 8999998776554443322
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCcccc
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA---LADPYFK 317 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~el---L~hp~f~ 317 (560)
.... .....+++.+.+||.+||+.||.+|||++++ |+|+|+.
T Consensus 226 ---------------~~~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 226 ---------------GERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp ---------------TCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---------------CCCC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 1111 1124678999999999999999999999998 4566654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=418.28 Aligned_cols=257 Identities=24% Similarity=0.310 Sum_probs=207.7
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
.++|++.+.||+|+||+||+|+. +..||||+++...........+.+|+.+|+.++|||||++++++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 47899999999999999999964 3469999998655556677889999999999999999999998632 24
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 799999999 6999999765 46999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCcccccccccccc-cCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
... ......+||+.|+|||++.+. ...|+.++|||||||+||||+||+.||.+.+...++..+...
T Consensus 158 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~------------ 224 (276)
T d1uwha_ 158 SGS-HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------------ 224 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH------------
T ss_pred CCc-ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc------------
Confidence 221 223557899999999998542 245889999999999999999999999987765554333221
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
............++++.+.+||.+||+.||.+|||++|++++
T Consensus 225 -------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 225 -------------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -------------TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111112233446788999999999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-52 Score=419.50 Aligned_cols=261 Identities=20% Similarity=0.404 Sum_probs=212.4
Q ss_pred ccccccCC-CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeec
Q 008607 14 DFFTEYGE-GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (560)
Q Consensus 14 ~~~~~~~~-~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~ 92 (560)
..|.+|.+ .++|++.+.||+|+||+||+|+++.+|+.||||+++.. ....+++.+|+.+|+.++|||||++++++.
T Consensus 7 p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp TTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 34455554 47899999999999999999999999999999998743 234567899999999999999999999985
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEec
Q 008607 93 PPSRREFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~D 169 (560)
.. ..+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 84 ~~-----~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~D 158 (287)
T d1opja_ 84 RE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD 158 (287)
T ss_dssp SS-----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred eC-----CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcc
Confidence 43 45899999998 6999998764 4689999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCC-CCCCChhhHHHHHHHhcC
Q 008607 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~~~~i~~~~g 248 (560)
||+|+........ ......||+.|+|||++.+ ..|+.++|||||||++|||++|..| |.+.+.....+.+..
T Consensus 159 FG~a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~--- 231 (287)
T d1opja_ 159 FGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--- 231 (287)
T ss_dssp CCCTTTCCSSSSE--EETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT---
T ss_pred ccceeecCCCCce--eeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc---
Confidence 9999875433221 2244568999999999976 6899999999999999999997655 555444333222211
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~hp~f~~ 318 (560)
.... .....+++.+.+||.+||+.||++|||++|+++ +|+.
T Consensus 232 ------------------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~ 272 (287)
T d1opja_ 232 ------------------------DYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFET 272 (287)
T ss_dssp ------------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred ------------------------CCCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHH
Confidence 1111 122467899999999999999999999999975 4543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-51 Score=416.75 Aligned_cols=259 Identities=24% Similarity=0.370 Sum_probs=200.5
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEECCCCc---EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecC
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~ 93 (560)
+.-...++|++.++||+|+||+||+|+++.+++ .||||++... ........+.+|+.+|+.++|||||++++++..
T Consensus 20 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp SCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred chhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 333446789999999999999999999987765 5888988643 234455679999999999999999999999854
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccc
Q 008607 94 PSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFG 171 (560)
. ..+|||||||+ |+|.+++... +.+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 99 ~-----~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 99 S-----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp S-----SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred C-----CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcc
Confidence 3 35899999998 5899988774 469999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCc--ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcC
Q 008607 172 LARVAFNDTPTA--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLG 248 (560)
Q Consensus 172 la~~~~~~~~~~--~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g 248 (560)
+|+......... .......||+.|+|||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..+....
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~- 250 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY- 250 (299)
T ss_dssp ----------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 998764432221 11223568999999999976 579999999999999999998 899999887665554443211
Q ss_pred CCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 249 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.. ....++++.+.+||.+||+.||.+|||+.|++++
T Consensus 251 --------------------------~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 251 --------------------------RL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp --------------------------CC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------------CC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11 1124678999999999999999999999999863
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=409.54 Aligned_cols=250 Identities=25% Similarity=0.428 Sum_probs=198.3
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.+++|++++.||+|+||.||+|++. +++.||||+++.. ......+.+|+++|+.++|||||++++++... .
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~ 73 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----A 73 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----S
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccC-----C
Confidence 4678999999999999999999986 5678999999753 23346789999999999999999999999544 3
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|+|||||+ |+|.+++... ..++++.+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 5899999998 6999988765 4689999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
..... .....||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..+....
T Consensus 154 ~~~~~--~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~---------- 219 (263)
T d1sm2a_ 154 DQYTS--STGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------- 219 (263)
T ss_dssp -------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC----------
T ss_pred CCcee--ecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC----------
Confidence 32221 234679999999999987 679999999999999999999 567777766655544443211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.. .....+++.+.+||.+||+.||++|||++|+|+|
T Consensus 220 -----------------~~---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 -----------------RL---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CC---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 00 0113567899999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=414.79 Aligned_cols=258 Identities=22% Similarity=0.357 Sum_probs=213.2
Q ss_pred CCCceEEEEE-EeecCCeEEEEEEECC--CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 21 EGSRYKIEEV-IGKGSYGVVCSAYDTR--TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 21 ~~~~Y~i~~~-IG~G~~G~Vy~a~d~~--tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
..++|.+.+. ||+|+||+||+|.++. ++..||||+++.. .......++.+|+++|+.++|||||++++++..
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---- 80 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 80 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----
Confidence 3467999985 9999999999998764 4557999999753 344566789999999999999999999998843
Q ss_pred CCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 98 EFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..+|||||||+ |+|.+++.. +..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 --~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 81 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp --SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred --CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 24799999999 599998765 45799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~ 254 (560)
..............+||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.+..|.+.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-------- 228 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-------- 228 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--------
T ss_pred ccccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence 6544433333345678999999999976 578999999999999999998 89999987765544433221
Q ss_pred HHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCcccc
Q 008607 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA---LADPYFK 317 (560)
Q Consensus 255 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~el---L~hp~f~ 317 (560)
... ...+.+++.+.+||.+||+.||++|||+.+| |+|+|+.
T Consensus 229 -------------------~~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 229 -------------------KRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -------------------CCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------CCC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111 1235678999999999999999999999887 6688875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=412.03 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=206.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||+|+||.||+|+++ ++..||||+++... .....+.+|+.+|+.++|||||++++++.. ..+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~ 82 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPI 82 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCe
Confidence 68999999999999999999975 67889999997532 334678999999999999999999998743 246
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 99999998 5898877543 25999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhC-CCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
.. .......||+.|+|||++.+ ..|+.++|||||||++|||+|| .+||.+.+..+.+..+...
T Consensus 163 ~~--~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~------------ 226 (272)
T d1qpca_ 163 EY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG------------ 226 (272)
T ss_dssp CE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred cc--ccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc------------
Confidence 21 12245679999999999976 5789999999999999999995 5666666654444333221
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--Ccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYFK 317 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~--hp~f~ 317 (560)
... .....+++.+.+||++||+.||++|||++|+++ |+||.
T Consensus 227 ---------------~~~---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 ---------------YRM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------CCC---CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 111 112467889999999999999999999999998 78875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-51 Score=419.17 Aligned_cols=253 Identities=25% Similarity=0.413 Sum_probs=206.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCc-----EEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE-----KVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~-----~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~ 96 (560)
++|++.++||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|+.+ +|||||++++++...
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-- 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence 689999999999999999999876554 69999986432 233456788999999988 899999999999543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 152 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~-----------------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDL 152 (560)
..+|||||||+ |+|.++|+... .+++..++.|+.||+.||+|||++||+||||
T Consensus 114 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 114 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred ---CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 45899999998 59999997642 4899999999999999999999999999999
Q ss_pred CCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCC
Q 008607 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLF 231 (560)
Q Consensus 153 KP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF 231 (560)
||+|||++.++.+||+|||+|+........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++ |++||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred chhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCC
Confidence 999999999999999999999875443322 22345678999999999976 689999999999999999997 89999
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008607 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (560)
Q Consensus 232 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL 311 (560)
.+.+....+..+... .... .....+++.+.+||.+||+.||++|||++||+
T Consensus 268 ~~~~~~~~~~~~~~~--------------------------~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 268 PGIPVDANFYKLIQN--------------------------GFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp TTCCCSHHHHHHHHT--------------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHhc--------------------------CCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 987765544433221 1111 11246789999999999999999999999999
Q ss_pred cC
Q 008607 312 AD 313 (560)
Q Consensus 312 ~h 313 (560)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=403.66 Aligned_cols=250 Identities=21% Similarity=0.326 Sum_probs=210.1
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (560)
.++.|++.++||+|+||+||+|++ +++..||||+++... .....+.+|+++++.++||||+++++++... .
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~ 72 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----R 72 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----S
T ss_pred ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----C
Confidence 357899999999999999999998 478899999997532 2345789999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccC
Q 008607 101 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (560)
Q Consensus 101 ~i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~ 178 (560)
.+|+||||++ |+|.+++.. ...+++..++.|+.||++||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 6999999998 688888765 44699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 008607 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~ 257 (560)
.... ......||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+....+.+..
T Consensus 153 ~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~---------- 218 (258)
T d1k2pa_ 153 DEYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---------- 218 (258)
T ss_dssp SSCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----------
T ss_pred CCce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC----------
Confidence 3222 2245679999999999987 689999999999999999998 899999888666554443211
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
..+ ....+++.+.+||++||+.||++|||++|||+|
T Consensus 219 -----------------~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 -----------------RLY---RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -----------------CCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCC---CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 011 123567899999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=421.09 Aligned_cols=264 Identities=23% Similarity=0.389 Sum_probs=215.5
Q ss_pred CceEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEecCcc--cChhHHHHHHHHHHHHHhcCC-CCccccceeecCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSR 96 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~rEi~iL~~l~H-pnIv~l~~i~~~~~~ 96 (560)
++|++++.||+|+||+||+|++. .+|+.||||++++.. ........+.+|+++|++++| |||+++++++...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 67999999999999999999984 478999999997532 222334567899999999976 8999999998443
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEeccccccc
Q 008607 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~ 175 (560)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 102 ---~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 ---TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp ---TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ---CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 46999999998 59999999998999999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... .......|++.|+|||.+.+....++.++|||||||+||+|++|+.||.+.+..+....+...
T Consensus 179 ~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--------- 247 (322)
T d1vzoa_ 179 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--------- 247 (322)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---------
T ss_pred hccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---------
Confidence 533222 123457899999999998654346788999999999999999999999887655544433221
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccccc
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----ta~elL~hp~f~~~~ 320 (560)
.. ... ......+++.+.+||++||+.||.+|| |++|+|+||||+++.
T Consensus 248 ----------~~---~~~-----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 248 ----------IL---KSE-----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp ----------HH---HCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ----------cc---cCC-----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 00 011 112346899999999999999999999 599999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=404.24 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=200.0
Q ss_pred cCCC-CceEEEEEEeecCCeEEEEEEECCCC---cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 008607 19 YGEG-SRYKIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (560)
Q Consensus 19 ~~~~-~~Y~i~~~IG~G~~G~Vy~a~d~~tg---~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~ 94 (560)
|.+. ++|++.+.||+|+||+||+|++..++ ..||||+++.. ........+.+|+.+|+.++|||||++++++..
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 79 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 79 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3444 68999999999999999999987554 46899988643 334455678999999999999999999998842
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccc
Q 008607 95 SRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGl 172 (560)
..+|+|||||+ |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 -----~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 -----NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp -----SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred -----CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchh
Confidence 35799999998 588887765 44699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCC
Q 008607 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPS 251 (560)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~ 251 (560)
|+........ ..+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 155 a~~~~~~~~~--~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~----- 225 (273)
T d1mp8a_ 155 SRYMEDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG----- 225 (273)
T ss_dssp ------------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----
T ss_pred heeccCCcce--eccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----
Confidence 9865432221 2245678999999999976 689999999999999999998 89999988876655544321
Q ss_pred HHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 252 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.. ....+++++.+.+||.+||+.||.+|||++||++|
T Consensus 226 ----------------------~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 226 ----------------------ER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ----------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CC---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11 12235788999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=400.48 Aligned_cols=254 Identities=23% Similarity=0.333 Sum_probs=196.6
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCC----cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTG----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg----~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.+++|++.++||+|+||.||+|.+..++ ..||||+++.. ........+.+|+++|+.++|||||++++++...
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-- 81 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-- 81 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC--
Confidence 4578999999999999999999887655 46999999743 2334556789999999999999999999998543
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 97 REFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 97 ~~~~~i~lV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
..+++|||||.+ +|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+
T Consensus 82 ---~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 ---KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp ---SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ---CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhh
Confidence 458999999985 777777654 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCC-CCCCCCChhhHHHHHHHhcCCCCHH
Q 008607 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPE 253 (560)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~~~~i~~~~g~p~~~ 253 (560)
................||+.|+|||++.+ ..|+.++|||||||++|||++|. +||.+.+..+.+..+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~------- 229 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG------- 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------
T ss_pred cccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-------
Confidence 76544332222344678999999999976 68999999999999999999965 555555544333332211
Q ss_pred HHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 254 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ....+++..+.+||.+||+.||++|||+.|+++
T Consensus 230 --------------------~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 230 --------------------FRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp --------------------CCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------CCC---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 111 112357889999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=406.00 Aligned_cols=251 Identities=22% Similarity=0.365 Sum_probs=201.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCc----EEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
..|+++++||+|+||+||+|.+..+|+ +||+|+++.. ........+.+|+.+|+.++|||||++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 569999999999999999999988886 5888888643 2333457789999999999999999999998653
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccc
Q 008607 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (560)
Q Consensus 99 ~~~i~lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~ 176 (560)
..++|+|++. ++|.+.+... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 --~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp --SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred --CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 3678888887 6888887764 47999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 008607 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (560)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~ 255 (560)
...... .......||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+...
T Consensus 162 ~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~--------- 229 (317)
T d1xkka_ 162 GAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------- 229 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---------
T ss_pred cccccc-ccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------
Confidence 443322 12244578999999999976 579999999999999999998 78999887765544433321
Q ss_pred HHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
... ...+.+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 230 ------------------~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 230 ------------------ERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------CCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCC---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 000 1124678999999999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=399.51 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=202.9
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||+|+||.||+|++..+ +.||||+++... .....+.+|+.+|+.++|||||++++++.. ..+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~ 86 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 86 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCe
Confidence 6899999999999999999998765 579999997532 334678999999999999999999998743 247
Q ss_pred EEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
|+|||||+ |+|..++.. ...+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999 578877754 346999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhC-CCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
... ......||+.|+|||++.. ..++.++|||||||+||||++| +++|.+.+..+.+..+...
T Consensus 167 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~------------ 230 (285)
T d1fmka3 167 EYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------------ 230 (285)
T ss_dssp -----------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred Cce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc------------
Confidence 221 2244679999999999976 6889999999999999999995 5566666655544443321
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--Ccccccc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYFKGL 319 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~--hp~f~~~ 319 (560)
... ...+.+++.+.+||.+||+.||++|||++++++ ++||...
T Consensus 231 ---------------~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 231 ---------------YRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ---------------CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---------------CCC---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 111 123567899999999999999999999999988 8888764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=398.13 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=197.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECC-----CCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~ 96 (560)
++|++.+.||+|+||.||+|++.. +++.||||+++.. ........+.+|..++..+ +|+||+.+++++....
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~- 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC-
Confidence 689999999999999999999754 4568999998743 2334456777888888766 6899999999875432
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeee
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 159 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl 159 (560)
..+++|||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+||||
T Consensus 91 ---~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp ---SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ---CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 35899999998 6999999753 248999999999999999999999999999999999999
Q ss_pred CCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhC-CCCCCCCChhh
Q 008607 160 NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVH 238 (560)
Q Consensus 160 ~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~ 238 (560)
+.++.+||+|||+|+........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp CGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999865433222 22355789999999999977 6899999999999999999986 57898766544
Q ss_pred HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 239 QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 239 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.+..+.. ..... .....+++.+.+||.+||+.||.+|||++|+++|
T Consensus 245 ~~~~~~~--------------------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLK--------------------------EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHH--------------------------HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHh--------------------------cCCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4332211 00011 1224578999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=395.38 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=202.1
Q ss_pred cccCCCCceEEEEEEeecCCeEEEEEEEC-CCCc--EEEEEEecCccc-ChhHHHHHHHHHHHHHhcCCCCccccceeec
Q 008607 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDT-RTGE--KVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (560)
Q Consensus 17 ~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~-~tg~--~vAiK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~ 92 (560)
|.+-..++|++.+.||+|+||.||+|+.. .+++ .||||++..... .......+.+|+.+|+.++||||+++++++.
T Consensus 2 t~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ceEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 44556678999999999999999999764 3333 689999875433 3344567899999999999999999999985
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecc
Q 008607 93 PPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DF 170 (560)
.+ .+++|||||+ |+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~------~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 82 TP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp SS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred ec------chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 42 4699999998 588877655 446999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCC
Q 008607 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 249 (560)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~ 249 (560)
|+++................|+..|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+.+..|...
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~--- 230 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--- 230 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS---
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC---
Confidence 999986554443333445678899999999987 578999999999999999998 89999998877665544321
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
... ....+.+++.+.+||++||..||++|||++||++
T Consensus 231 -----------------------~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 231 -----------------------GER---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -----------------------CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCC---CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 1123567899999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=388.98 Aligned_cols=242 Identities=23% Similarity=0.401 Sum_probs=196.8
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~i 102 (560)
++|++.+.||+|+||.||+|++ +|+.||||++++ ....+.+.+|+++|+.++||||+++++++.... ..+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~ 76 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGL 76 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC----CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CC
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECc----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcE
Confidence 5799999999999999999987 478999999964 234567899999999999999999999885432 347
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 103 ~lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
||||||++ |+|.+++.... .++++.+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999998 59999986543 4999999999999999999999999999999999999999999999999999864332
Q ss_pred CCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHh
Q 008607 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (560)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~~g~p~~~~~~~~ 258 (560)
. ....+|..|+|||++.+ ..++.++|||||||++|||+| |++||.+.+..+.+..+..
T Consensus 157 ~------~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~------------- 215 (262)
T d1byga_ 157 Q------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------- 215 (262)
T ss_dssp -----------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-------------
T ss_pred C------ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------------
Confidence 2 34578999999999976 579999999999999999998 7899988776655444321
Q ss_pred hhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
.... .....+++.+.+||++||+.||.+|||+.++++
T Consensus 216 --------------~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 216 --------------GYKM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp --------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCC---CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1111 123467899999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-48 Score=392.74 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=206.8
Q ss_pred CceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~ 97 (560)
++|++.+.||+|+||+||+|+++ .+++.||||+++.. .......++.+|+.+|+.++||||+.+++++...
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--- 88 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG--- 88 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC---
Confidence 57999999999999999999875 45678999999753 2334456799999999999999999999998543
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Q 008607 98 EFKDIYVVFELME-SDLHQVIKAND------------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 152 (560)
Q Consensus 98 ~~~~i~lV~E~~~-gdL~~~i~~~~------------------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDL 152 (560)
..+++|||||+ |+|.+++.... .+++..+..|+.||+.||+|||+.+|+||||
T Consensus 89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 45899999998 69999986532 3889999999999999999999999999999
Q ss_pred CCCCeeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCC-CCC
Q 008607 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLF 231 (560)
Q Consensus 153 KP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~-~pF 231 (560)
||+|||++.++.+||+|||+|+........ ...+..+||+.|+|||++.+ ..|+.++|||||||++|||++|. +||
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cccceEECCCCcEEEccchhheeccCCccc-cccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999999865433221 12345678999999999987 68999999999999999999995 789
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008607 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (560)
Q Consensus 232 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL 311 (560)
.+.+..+.+..+.+. .. ......+++.+.+||.+||+.||++|||+.||+
T Consensus 244 ~~~~~~e~~~~v~~~---------------------------~~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDG---------------------------NI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293 (301)
T ss_dssp TTSCHHHHHHHHHTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHcC---------------------------CC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 887766655443321 11 112346789999999999999999999999996
Q ss_pred c
Q 008607 312 A 312 (560)
Q Consensus 312 ~ 312 (560)
+
T Consensus 294 ~ 294 (301)
T d1lufa_ 294 R 294 (301)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-48 Score=391.70 Aligned_cols=266 Identities=20% Similarity=0.248 Sum_probs=205.5
Q ss_pred cCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008607 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (560)
Q Consensus 19 ~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (560)
..+|++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++|+|++..+..+.. +
T Consensus 3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~ 74 (299)
T d1ckia_ 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----E 74 (299)
T ss_dssp CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEE----E
T ss_pred CeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEe----c
Confidence 3568899999999999999999999999999999999865322 2346789999999998877666555432 2
Q ss_pred CccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC---CCcEEEecccccc
Q 008607 99 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLAR 174 (560)
Q Consensus 99 ~~~i~lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~---~~~lKL~DFGla~ 174 (560)
....++|||||+++|...+.. ...+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+
T Consensus 75 ~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 75 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred CCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 346899999999988887765 457999999999999999999999999999999999998764 4579999999998
Q ss_pred cccCCCCCc----ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCCC
Q 008607 175 VAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (560)
Q Consensus 175 ~~~~~~~~~----~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~p 250 (560)
......... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~-- 230 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-- 230 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH--
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc--
Confidence 764432211 12245689999999999987 5799999999999999999999999987665443332221100
Q ss_pred CHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH---HhcCcccc
Q 008607 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE---ALADPYFK 317 (560)
Q Consensus 251 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~e---lL~hp~f~ 317 (560)
.....+.....+++++.+.+||++||+.||.+||++++ +|+|+|.+
T Consensus 231 ---------------------~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 231 ---------------------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ---------------------HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------------------ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 00001111223567899999999999999999999875 56777654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=388.30 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=203.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCC-------cEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-------EKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg-------~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~ 93 (560)
.++|++.+.||+|+||.||+|++..++ ..||||+++... .......+.+|..++..+ +|||||++++++..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 478999999999999999999876554 479999997533 334556788899999888 79999999999954
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 008607 94 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (560)
Q Consensus 94 ~~~~~~~~i~lV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~N 156 (560)
. ..+|+|||||+ |+|.++|.... .+++..++.|+.||+.||+|||+.+|+||||||+|
T Consensus 91 ~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 91 D-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp S-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred C-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 3 46899999998 69999997542 48999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 008607 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (560)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 235 (560)
||++.++.+||+|||+++......... .....++|+.|+|||.+.+ ..|+.++|||||||++|||++ |.+||.+.+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTC-CCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeecCCCCeEeccchhhcccccccccc-ccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999999999998765543322 2355689999999999976 689999999999999999998 789998877
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 236 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
....+..+.. .... .....+++.+.+||.+||+.||.+|||+.|+|+
T Consensus 243 ~~~~~~~i~~---------------------------~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKE---------------------------GHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHT---------------------------TCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHc---------------------------CCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 6544333221 1111 112467899999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=395.33 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=202.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcE--EEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~--vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (560)
++|++.++||+|+||+||+|+++.+|.. ||||++.... .....+.+.+|+++|+.+ +|||||++++++...
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~----- 83 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----- 83 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----
Confidence 6899999999999999999999888874 6778775432 223456789999999998 699999999999643
Q ss_pred ccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCC
Q 008607 100 KDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~ 162 (560)
..+|||||||+ |+|.+++..+ ..+++..+..++.||+.||.|||+.+|+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 46899999999 6999999754 469999999999999999999999999999999999999999
Q ss_pred CcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCC-CCCCCCChhhHHH
Q 008607 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLD 241 (560)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~~~ 241 (560)
+.+||+|||+|+........ ....||..|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+.+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~----~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp GCEEECCTTCEESSCEECCC--------CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CceEEccccccccccccccc----cceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999764332221 34578999999999976 67999999999999999999965 6788877655443
Q ss_pred HHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 242 ~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
.+.+ .... .....+++.+.+||.+||+.||++|||++|||+|
T Consensus 238 ~i~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 238 KLPQ---------------------------GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HGGG---------------------------TCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHh---------------------------cCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3321 1111 1224678999999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=388.60 Aligned_cols=252 Identities=21% Similarity=0.356 Sum_probs=208.9
Q ss_pred CCceEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~ 96 (560)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+++|+.++||||+++++++...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-- 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC--
Confidence 389999999999999999999875 34678999999753 3444556789999999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcE
Q 008607 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (560)
Q Consensus 97 ~~~~~i~lV~E~~~-gdL~~~i~~~----------~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~l 165 (560)
..+++|||||. |+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 96 ---~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 ---QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ---CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 35899999998 6999988642 247899999999999999999999999999999999999999999
Q ss_pred EEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhC-CCCCCCCChhhHHHHHH
Q 008607 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMT 244 (560)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~~~~i~ 244 (560)
||+|||+|+........ ......+||+.|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+.+..+.
T Consensus 173 Kl~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp EECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EEeecccceeccCCcce-eeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999865433221 22344578999999999977 6789999999999999999998 58898877666555443
Q ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 245 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
+. .. ....+.+++.+.+||.+||+.||.+|||++|+++
T Consensus 250 ~~---------------------------~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 250 EG---------------------------GL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hC---------------------------CC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 21 11 1122467889999999999999999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=385.32 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=209.4
Q ss_pred CCceEEEEEEeecCCeEEEEEEE-----CCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~i~~~~~ 95 (560)
.++|++.++||+|+||.||+|.+ ..+++.||||+++.. ........+.+|+.+++.+ +|||||++++++...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~- 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence 47999999999999999999986 356789999999753 3445666789999999999 699999999999543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 008607 96 RREFKDIYVVFELME-SDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (560)
Q Consensus 96 ~~~~~~i~lV~E~~~-gdL~~~i~~~~------------------~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~N 156 (560)
..+|||||||+ |+|.+++.... .+++..+..|+.||+.||+|||++||+||||||+|
T Consensus 100 ----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 35899999998 59999987643 58999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhh-CCCCCCCCC
Q 008607 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (560)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 235 (560)
||++.++.+||+|||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999987644332 223355789999999999976 578999999999999999998 677787777
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 236 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
....+..+.+. .++ . .....+++.+.+||.+||+.||.+|||++|||+
T Consensus 253 ~~~~~~~~i~~----------------------~~~----~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKE----------------------GFR----M---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHH----------------------TCC----C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhc----------------------CCC----C---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 65554433221 010 0 111356899999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-46 Score=387.72 Aligned_cols=282 Identities=25% Similarity=0.359 Sum_probs=211.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-----------CCCccccceee
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-----------HPDIVEIKHIL 91 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-----------HpnIv~l~~i~ 91 (560)
+||+++++||+|+||+||+|+++.+|+.||||++++ .......+.+|+++|+.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~---~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec---cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 579999999999999999999999999999999974 2234466788999998875 47788888887
Q ss_pred cCCCcCCCccEEEEEecCC--ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeeeCCCC---
Q 008607 92 LPPSRREFKDIYVVFELME--SDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADC--- 163 (560)
Q Consensus 92 ~~~~~~~~~~i~lV~E~~~--gdL~~~i~--~~~~lse~~~~~i~~Qll~aL~yLHs-~gIiHrDLKP~NILl~~~~--- 163 (560)
.... ....++|++++. ++...... ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 90 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKG---PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEE---TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred eecc---ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 4322 234556666554 34333333 34579999999999999999999998 8999999999999998765
Q ss_pred ---cEEEecccccccccCCCCCcccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCC-----
Q 008607 164 ---KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN----- 235 (560)
Q Consensus 164 ---~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~----- 235 (560)
.+||+|||.+....... ...+||+.|+|||++.. ..|+.++||||+||++++|++|+.||.+.+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeeccccccccccc------ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 39999999997543222 45689999999999876 679999999999999999999999997543
Q ss_pred -hhhHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCC-------------CCCCCCCCHHHHHHHHHhcccCC
Q 008607 236 -VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-------------SQKFPNANPLALRLLERMLAFEP 301 (560)
Q Consensus 236 -~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~-------------~~~~~~~s~~~~dLI~~mL~~DP 301 (560)
..+.+..+...+|.++.+.+...... ..++........... .......++.+.|||.+||++||
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred chhHHHHHHHHHhCCCCHHHhhccccc--ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 34566777788898877665433221 111111000000000 01112346789999999999999
Q ss_pred CCCCCHHHHhcCccccccc
Q 008607 302 KDRPTAEEALADPYFKGLA 320 (560)
Q Consensus 302 ~~Rpta~elL~hp~f~~~~ 320 (560)
.+|||++|||+||||++..
T Consensus 317 ~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTCBCHHHHHTCGGGTTCT
T ss_pred hHCcCHHHHhcCcccCCCC
Confidence 9999999999999999654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-46 Score=379.28 Aligned_cols=258 Identities=18% Similarity=0.238 Sum_probs=205.8
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCC-CCccccceeecCCCcCCC
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSRREF 99 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~H-pnIv~l~~i~~~~~~~~~ 99 (560)
++++|++++.||+|+||+||+|++..+|+.||||++.... +...+.+|+++++.|+| +|++.+++++.. .
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~ 73 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----G 73 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----T
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----C
Confidence 4689999999999999999999999999999999886432 22346789999999975 899999888743 3
Q ss_pred ccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCC-----CCcEEEeccccc
Q 008607 100 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLA 173 (560)
Q Consensus 100 ~~i~lV~E~~~gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~-----~~~lKL~DFGla 173 (560)
...|+||||++++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 74 ~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 74 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 4689999999999999997754 6999999999999999999999999999999999999975 578999999999
Q ss_pred ccccCCCCCc----ccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHHhcCC
Q 008607 174 RVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (560)
Q Consensus 174 ~~~~~~~~~~----~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~~g~ 249 (560)
+......... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~-- 229 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG-- 229 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH--
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH--
Confidence 8764332211 12345689999999999987 679999999999999999999999998765443332221110
Q ss_pred CCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 250 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
..+ ...+.....+++++++.+|++.|+..+|++||+.+.+.+
T Consensus 230 ----------~~~-----------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 230 ----------EKK-----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp ----------HHH-----------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------hcc-----------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 000 000111223567889999999999999999999887654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=379.19 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=199.5
Q ss_pred eEEEEEEeecCCeEEEEEEECCCC---cEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg---~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (560)
+.+.++||+|+||+||+|++..++ ..||||++++ ........++.+|+++|++++||||+++++++.... ..
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~ 103 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GS 103 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cc
Confidence 344789999999999999987643 3689999974 335566788999999999999999999999875432 36
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEecccccccccCC
Q 008607 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (560)
Q Consensus 102 i~lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (560)
+++|||||+ ++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 899999999 58888887544 5788899999999999999999999999999999999999999999999999875433
Q ss_pred CCC-cccccccccCcccccccccccccCCCCCccchhhHHHHHHHHhhCCCCCCCCChh-hHHHHHHHhcCCCCHHHHHH
Q 008607 180 TPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGTPSPEAIAR 257 (560)
Q Consensus 180 ~~~-~~~~~~~~gT~~Y~APEll~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~~~~i~~~~g~p~~~~~~~ 257 (560)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...... +....+.
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~------------- 248 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------------- 248 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-------------
T ss_pred ccccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------------
Confidence 222 222345679999999999876 57899999999999999999988777543322 1111111
Q ss_pred hhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008607 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (560)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~h 313 (560)
. .... ...+.+++.+.+||.+||+.||++|||+.|+++|
T Consensus 249 ----------~----g~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 249 ----------Q----GRRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ----------T----TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------c----CCCC---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1 1111 1124578899999999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=379.96 Aligned_cols=273 Identities=23% Similarity=0.265 Sum_probs=194.3
Q ss_pred CCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHH--HHHHHHhcCCCCccccceeecCCCcCCC
Q 008607 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILR--EIKLLRLLRHPDIVEIKHILLPPSRREF 99 (560)
Q Consensus 22 ~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~r--Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (560)
..+|.+.++||+|+||.||+|++ +|+.||||+++.. ......+ |+..+..++||||+++++++.... ...
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Ccc
Confidence 46799999999999999999975 6899999998642 2333444 444556789999999999986543 233
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCeeeccCCCCCeeeCCCCcEEEecc
Q 008607 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------ANVFHRDLKPKNILANADCKLKICDF 170 (560)
Q Consensus 100 ~~i~lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs--------~gIiHrDLKP~NILl~~~~~lKL~DF 170 (560)
..+|+|||||+ |+|.+++++. .++++.+..++.|++.||.|||+ +||+||||||+||||+.++.+||+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 46899999998 5999999875 69999999999999999999996 59999999999999999999999999
Q ss_pred cccccccCCCCCc-ccccccccCcccccccccccccC----CCCCccchhhHHHHHHHHhhCCCCCCCCChhhHHHHHHH
Q 008607 171 GLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245 (560)
Q Consensus 171 Gla~~~~~~~~~~-~~~~~~~gT~~Y~APEll~~~~~----~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~ 245 (560)
|+++......... ......+||+.|+|||++.+... .++.++|||||||+||||+||..||......... ....
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~~ 231 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDL 231 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhhc
Confidence 9998765433221 12345789999999999865211 2567899999999999999999887543211100 0000
Q ss_pred hcCCCCHHHHHHhhhHHHHHHHHhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008607 246 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (560)
Q Consensus 246 ~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rpta~elL~ 312 (560)
....+..+.+. ..+..-......+-..........+.+|+.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~--------~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 232 VPSDPSVEEMR--------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCSSCCHHHHH--------HHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccccchHHHHH--------HHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 01112211111 111100000111100001122345889999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.8e-25 Score=209.31 Aligned_cols=135 Identities=18% Similarity=0.182 Sum_probs=106.7
Q ss_pred eEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccC----------------hhHHHHHHHHHHHHHhcCCCCccccc
Q 008607 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH----------------VSDATRILREIKLLRLLRHPDIVEIK 88 (560)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~----------------~~~~~~i~rEi~iL~~l~HpnIv~l~ 88 (560)
|.+.++||+|+||+||+|++. +|+.||||+++..... ......+.+|+..|..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999985 6899999987521100 01123455789999999999998877
Q ss_pred eeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeeeCCCCcEEEe
Q 008607 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (560)
Q Consensus 89 ~i~~~~~~~~~~~i~lV~E~~~gdL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~gIiHrDLKP~NILl~~~~~lKL~ 168 (560)
+.. ..++||||+++... ..+++..+..++.||+.+|+|||++||+||||||+|||++++ .++|+
T Consensus 81 ~~~---------~~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEE---------TTEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred Eec---------CCEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence 653 12799999997421 135666778899999999999999999999999999999965 58999
Q ss_pred cccccccc
Q 008607 169 DFGLARVA 176 (560)
Q Consensus 169 DFGla~~~ 176 (560)
|||+|...
T Consensus 145 DFG~a~~~ 152 (191)
T d1zara2 145 DFPQSVEV 152 (191)
T ss_dssp CCTTCEET
T ss_pred ECCCcccC
Confidence 99999754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.34 E-value=7.7e-07 Score=84.98 Aligned_cols=138 Identities=12% Similarity=0.112 Sum_probs=86.6
Q ss_pred CceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCcc
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKD 101 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~i~~~~~~~~~~~ 101 (560)
..|++++..+-++.+.||+.. ..+..++||+...... .....+.+|..+|+.|. +--+.+++.... ..+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-----~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEe-----cCCc
Confidence 357777776656667899874 5677788988754221 12335678999988875 322444444432 2245
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 008607 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------------------------------- 145 (560)
Q Consensus 102 i~lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~Qll~aL~yLHs~----------------------------------- 145 (560)
.|+||++++| .+.+..... .....++.++...|+.||+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 7999999997 454332111 11122333344444444421
Q ss_pred ------------------------CeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 146 ------------------------NVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 146 ------------------------gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 27999999999999987767899999774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.81 E-value=2.9e-05 Score=78.96 Aligned_cols=83 Identities=20% Similarity=0.146 Sum_probs=47.7
Q ss_pred CCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecC----ccc-ChhHHHHHHHHHHHHHhcC-C-C-Cccccceeec
Q 008607 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND----IFE-HVSDATRILREIKLLRLLR-H-P-DIVEIKHILL 92 (560)
Q Consensus 21 ~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~----~~~-~~~~~~~i~rEi~iL~~l~-H-p-nIv~l~~i~~ 92 (560)
.....+ .+.||.|....||++.+..+++.|+||.-.. ... ......+..+|...|+.+. + | .+.+++...
T Consensus 25 ~~~~l~-~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d- 102 (392)
T d2pula1 25 SKSTLT-CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD- 102 (392)
T ss_dssp ---CCE-EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-
T ss_pred CCCCee-EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-
Confidence 334444 4568999999999998888889999996431 111 1123445667999988774 2 2 233343322
Q ss_pred CCCcCCCccEEEEEecCCc
Q 008607 93 PPSRREFKDIYVVFELMES 111 (560)
Q Consensus 93 ~~~~~~~~~i~lV~E~~~g 111 (560)
. ...++|||++++
T Consensus 103 -~-----~~~~lvmE~L~~ 115 (392)
T d2pula1 103 -T-----EMAVTVMEDLSH 115 (392)
T ss_dssp -T-----TTTEEEECCCTT
T ss_pred -C-----CCCEEEEeccCC
Confidence 1 123789999985
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.61 E-value=5.9e-05 Score=70.97 Aligned_cols=71 Identities=8% Similarity=0.005 Sum_probs=45.0
Q ss_pred EEeecCC-eEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCccEEEEE
Q 008607 30 VIGKGSY-GVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSRREFKDIYVVF 106 (560)
Q Consensus 30 ~IG~G~~-G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~i~~~~~~~~~~~i~lV~ 106 (560)
.+..|.. +.||+... ..+..+++|..... ....+.+|..+|+.|.... +.+++.+... .+..++||
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEE
Confidence 4455554 57898863 45777888876432 2234667888888775433 3445554422 23579999
Q ss_pred ecCCc
Q 008607 107 ELMES 111 (560)
Q Consensus 107 E~~~g 111 (560)
++++|
T Consensus 86 ~~i~G 90 (255)
T d1nd4a_ 86 GEVPG 90 (255)
T ss_dssp ECCSS
T ss_pred Eeeec
Confidence 99986
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.01 E-value=0.00084 Score=65.79 Aligned_cols=74 Identities=14% Similarity=0.071 Sum_probs=44.2
Q ss_pred cCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCC--CcCCCccEEEEEecCCc
Q 008607 34 GSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP--SRREFKDIYVVFELMES 111 (560)
Q Consensus 34 G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~--~~~~~~~i~lV~E~~~g 111 (560)
+.--.||++.. ..|..|++|+.+. .......+..|+..|..|....|.-..-+.... ........+.|+++++|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp---~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRP---ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECT---TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCC---CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 44568999964 5788899998753 222456678899999888643332111111111 11123457889999885
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.82 E-value=0.001 Score=64.47 Aligned_cols=152 Identities=15% Similarity=0.122 Sum_probs=78.7
Q ss_pred cccccCCCCceEEEEEEeecCCeEEEEEEECCCCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 008607 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (560)
Q Consensus 15 ~~~~~~~~~~Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~i~~~~ 94 (560)
++..|+.++ ..-.+.|..|---+.|++... +.++++|++... .+...+..|+++|..|...++.-..-+ ...
T Consensus 11 ~l~~Y~lg~-~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~----~~~~~l~~~~~~l~~L~~~g~pvp~pi-~~~ 82 (316)
T d2ppqa1 11 FLTQYDVGS-LTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPL-PRK 82 (316)
T ss_dssp HHTTBCCCC-EEEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBC-CBT
T ss_pred HHHhCCCCC-ceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCC----CCHHHHHHHHHHHHhhhhccccccccc-eec
Confidence 566788764 555567778888889998643 346899987532 233456678888888753332110000 000
Q ss_pred CcC----CCccEEEEEecCCc------cHH--H----H---HHh-CC--------CCCHH------------------HH
Q 008607 95 SRR----EFKDIYVVFELMES------DLH--Q----V---IKA-ND--------DLTPE------------------HY 128 (560)
Q Consensus 95 ~~~----~~~~i~lV~E~~~g------dL~--~----~---i~~-~~--------~lse~------------------~~ 128 (560)
+.. .......++.++.| +.. . . +.. .. ..... ..
T Consensus 83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (316)
T d2ppqa1 83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 162 (316)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence 000 01224455555543 111 0 0 000 00 00010 11
Q ss_pred HHHHHHHHHHHHHHHh----CCeeeccCCCCCeeeCCCCcEEEecccccc
Q 008607 129 QFFLYQLLRGLKYIHT----ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (560)
Q Consensus 129 ~~i~~Qll~aL~yLHs----~gIiHrDLKP~NILl~~~~~lKL~DFGla~ 174 (560)
...+..+...+.-.+. .||||+|+.++|||++.+...-|+||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1222233333333332 379999999999999998878899999774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.42 E-value=0.0065 Score=60.79 Aligned_cols=75 Identities=15% Similarity=0.169 Sum_probs=49.1
Q ss_pred CceEEEEEEeecCCeEEEEEEECC-------CCcEEEEEEecCcccChhHHHHHHHHHHHHHhcCCCCc-cccceeecCC
Q 008607 23 SRYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPP 94 (560)
Q Consensus 23 ~~Y~i~~~IG~G~~G~Vy~a~d~~-------tg~~vAiK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI-v~l~~i~~~~ 94 (560)
+..+| +.|+.|-.-.+|++.... ..+.|.+++... ........+|..+++.+.-.++ .++++++.
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~----~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~-- 115 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN----PETESHLVAESVIFTLLSERHLGPKLYGIFS-- 115 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS----CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC----cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--
Confidence 34555 568878899999997653 345677776642 1223345689999998864444 35566551
Q ss_pred CcCCCccEEEEEecCCc
Q 008607 95 SRREFKDIYVVFELMES 111 (560)
Q Consensus 95 ~~~~~~~i~lV~E~~~g 111 (560)
. .+|+||++|
T Consensus 116 ~-------g~I~efi~g 125 (395)
T d1nw1a_ 116 G-------GRLEEYIPS 125 (395)
T ss_dssp T-------EEEECCCCE
T ss_pred C-------ceEEEEecc
Confidence 1 688999986
|